data_2k73_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k73 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.019 0.438 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -45.53 -42.0 10.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.549 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -62.79 -41.06 99.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.7 -41.15 42.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.01 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -67.49 -29.56 69.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.891 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -74.9 -50.72 15.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 p -76.76 -36.44 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.771 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -70.7 2.57 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.09 148.98 18.95 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -70.78 -49.24 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.291 . . . . 0.0 110.702 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.21 -44.86 6.24 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.3 81.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.559 -0.32 . . . . 0.0 110.253 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -58.53 -46.55 86.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.234 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.19 -28.27 67.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.0 -31.45 67.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.634 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . 55.7 mtt -70.65 -33.93 71.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.66 32.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.674 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.74 -31.47 64.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -67.23 -52.57 39.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.512 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.12 69.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.471 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -77.75 -41.79 36.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.68 -33.87 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.23 -35.46 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.277 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -71.42 -43.3 67.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.652 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.07 -57.91 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 p -51.06 -30.24 15.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.297 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.36 -43.44 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -14.56 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -91.96 -36.62 13.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.426 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 36' ' ' MET . 2.6 m-85 -58.67 -40.32 83.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -75.78 -35.78 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.221 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -28.89 66.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.484 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.5 m -105.24 -38.21 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.652 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 36' ' ' MET . 1.8 tmt? -80.5 -0.04 35.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.511 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 48.52 47.57 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tt -83.63 150.76 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -117.88 137.85 24.78 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.3 Cg_endo -75.44 167.72 26.03 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.454 2.102 . . . . 0.0 112.155 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.45 175.51 7.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.099 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 33.2 t -58.38 -53.72 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.0 tp -65.16 -48.28 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 p -48.75 -47.84 41.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.591 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.52 -44.27 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.364 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.33 -46.6 89.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.92 -38.04 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.327 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -60.7 -29.4 69.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.821 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.01 -37.01 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.478 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.54 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.483 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' VAL . 6.1 tp -76.37 -54.02 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.28 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -44.03 -38.87 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.44 -41.63 90.42 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.6 t -62.62 -47.81 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-O 121.212 0.529 . . . . 0.0 109.757 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.3 -49.23 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.218 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.54 -29.38 69.4 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -69.47 -33.13 72.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.667 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.86 -24.3 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.92 -39.28 63.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.405 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.18 -35.29 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.695 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -65.49 -38.5 94.87 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.94 11.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.919 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.3 mt -83.7 -29.01 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.533 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.03 78.1 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.404 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.23 22.81 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.58 2.187 . . . . 0.0 112.083 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 64' ' ' ALA . 27.3 ttpt -111.09 -6.27 14.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.55 163.19 20.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.672 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -40.92 -13.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.505 2.137 . . . . 0.0 112.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 mt -42.42 -34.99 0.91 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 94.2 mtt180 -39.0 -67.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.338 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -48.96 -34.27 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.69 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.9 t -68.34 -46.02 81.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -43.87 21.86 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.992 -0.442 . . . . 0.0 111.137 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.473 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.07 -16.73 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.797 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.537 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 1.1 t -57.78 -32.5 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.637 0.732 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.7 -34.09 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.895 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.9 t-105 -64.3 -45.18 89.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.933 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 81' ' ' ALA . 1.3 tp -68.62 -46.33 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.221 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -45.69 -41.92 11.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.122 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -80.77 -23.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.387 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.24 -59.59 5.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -74.84 -53.62 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -66.23 -46.89 75.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.3 86.83 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.5 t -66.39 -47.39 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 86' ' ' GLN . 1.4 tm0? -56.85 -44.74 82.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.81 -51.41 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 39.8 p -48.13 -23.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.256 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.422 ' O ' ' OG1' ' A' ' 92' ' ' THR . 2.7 t80 -73.66 -45.16 54.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.53 -38.09 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.136 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -67.95 -42.11 81.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 41.2 p -66.62 -51.56 54.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.729 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' TYR . 16.5 ttt -56.34 -51.49 68.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.95 -41.6 99.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.423 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -55.97 -44.29 78.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.228 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.54 -6.56 40.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.339 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' MET . 9.5 t80 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.305 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 14.2 mp0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.88 -2.76 58.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.157 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.665 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.9 mt -126.34 80.19 69.36 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 48.6 Cg_exo -52.89 5.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.69 2.26 . . . . 0.0 112.164 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.665 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -61.67 -33.31 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.201 0.524 . . . . 0.0 110.075 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -96.94 -43.04 7.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -45.24 80.75 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.221 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.1 t90 -74.63 -12.9 60.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.792 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.9 t -142.63 72.67 20.19 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.59 -17.08 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.712 2.274 . . . . 0.0 111.8 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -54.96 -53.78 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.798 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.6 t -105.94 58.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.6 m-85 -162.85 -42.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 130.4 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.4 156.32 16.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' PRO . 67.3 m -160.99 99.93 1.23 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.66 179.89 17.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.34 150.29 23.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 110.235 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.594 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 68.4 m -101.43 129.07 47.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.821 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.56 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.21 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.66 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.859 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -100.58 132.84 45.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.536 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -130.28 -8.24 4.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.812 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.432 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 10.1 t-105 -173.91 132.41 0.42 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.86 160.32 39.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.93 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -117.87 139.04 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.078 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mt 49.66 17.05 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.56 20.64 40.09 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.7 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.03 139.19 54.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -70.24 146.4 50.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.149 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.411 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.37 -58.88 5.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.366 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.1 Cg_exo -37.21 -37.84 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -70.52 -45.19 66.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.111 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.6 m95 -66.95 -57.39 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.232 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 mt -43.49 -37.03 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.978 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.57 -36.35 83.5 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -55.59 -39.68 75.9 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.3 mt -71.02 -44.27 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 110.463 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -47.69 -42.54 25.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.23 -46.29 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.801 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.24 48.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.063 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.0 m-85 -57.2 -36.88 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 6.1 tt -63.53 -29.79 71.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.89 -39.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.02 -38.82 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.827 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.579 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -72.24 -48.41 42.98 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.71 -37.08 74.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.73 -41.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -23.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.05 -45.74 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.45 -21.49 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -57.59 -28.29 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -76.92 -43.29 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.544 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mt -50.58 -41.02 53.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.357 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -65.62 -27.57 68.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 110.064 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.44 -47.91 14.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.522 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.81 71.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.668 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.4 m -76.53 -39.69 52.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.62 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.517 HE22 ' C ' ' A' ' 65' ' ' PRO . 19.1 tp60 -66.85 5.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.481 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.75 141.97 15.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -68.11 -48.22 66.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.01 -45.36 6.02 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.62 76.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.108 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -54.62 -42.48 71.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.6 -26.95 65.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.995 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -70.16 -35.01 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.662 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.451 ' O ' ' OG1' ' A' ' 21' ' ' THR . 2.0 mtt -71.6 -32.93 68.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.35 45.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -52.31 -43.79 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.4 p -58.23 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.691 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.42 -39.04 31.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -42.03 69.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.839 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -45.98 -42.27 12.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.709 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 10.7 mp -71.12 -32.08 68.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -70.68 -49.93 41.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -57.72 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 68.7 p -49.95 -30.34 10.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.622 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.93 -47.09 13.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.45 -14.22 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.533 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.42 -36.3 10.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.36 . . . . 0.0 110.515 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -42.1 79.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.437 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 40' ' ' PRO . 39.6 mt-30 -69.57 -46.08 67.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.17 -18.81 50.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -101.61 -43.92 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 mmt -89.96 8.45 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.767 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLN . 3.8 tp 44.87 45.74 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.646 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -80.05 154.43 28.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -127.53 83.84 64.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.361 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 75.5 Cg_exo -47.02 178.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 8.4 t -116.29 -175.83 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.384 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.416 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.1 p -64.52 -36.18 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.314 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.55 -47.53 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.543 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -53.61 -49.56 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.691 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 45' ' ' ILE . 55.7 mt -65.8 -37.81 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -59.76 -48.36 81.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.16 -37.05 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -32.37 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.95 79.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.33 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -77.19 -52.1 9.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.07 -40.12 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.4 -44.71 89.83 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 t -61.21 -47.67 92.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.49 . . . . 0.0 109.758 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -44.62 -46.05 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.785 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.47 80.89 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.2 -40.71 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.358 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.04 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.367 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.03 -28.47 49.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.428 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.14 -39.35 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.493 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.99 -32.76 77.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.36 5.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' GLY . 76.7 mt -76.56 -36.8 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.94 72.06 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.499 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.517 ' C ' HE22 ' A' ' 10' ' ' GLN . 16.4 Cg_exo -64.36 16.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.879 2.386 . . . . 0.0 112.131 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.0 tmtm? -109.37 -5.67 15.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.004 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.38 164.31 16.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.567 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -41.19 -12.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.6 mm? -44.84 -34.79 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.406 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.2 ptt180 -40.43 -68.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.736 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 27.4 t80 -54.0 -28.48 38.27 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 4.9 t -70.86 -52.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.697 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.08 63.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.269 0.557 . . . . 0.0 109.987 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 ttt -59.3 -10.42 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.047 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 4.4 p -62.78 -36.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.428 0.632 . . . . 0.0 110.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mm -86.65 -32.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.754 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 8.3 t-105 -62.96 -52.64 62.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.935 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -46.33 88.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.609 ' CD2' ' NH1' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -47.05 -45.78 21.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.56 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.5 p -76.59 -25.94 54.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.669 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.0 -60.6 3.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.024 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -73.33 -54.24 8.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 79' ' ' TYR . 23.0 ttm105 -67.26 -47.49 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.68 -48.47 65.74 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' A' ' 88' ' ' THR . 88.3 t -69.1 -50.89 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.438 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -48.34 -28.05 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -77.83 -39.25 44.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 80.6 p -54.13 -29.56 45.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.31 -48.75 69.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.342 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -54.95 -39.84 69.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.469 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -71.84 -56.79 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -53.16 -52.78 57.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' TYR . 61.7 mmm -49.41 -46.59 47.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.8 -45.37 78.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.359 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -57.84 -38.82 76.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.2 -12.12 28.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.0 t80 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.639 0.257 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -96.52 -4.57 41.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.932 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 mt -123.65 78.77 55.84 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.201 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.4 Cg_exo -51.87 -0.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -59.21 -33.21 70.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.106 0.479 . . . . 0.0 110.367 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -96.8 -42.08 8.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.636 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -70.12 -45.09 67.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.568 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.3 t90 -74.1 -16.13 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.04 71.32 48.44 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.21 -19.58 10.43 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.854 2.37 . . . . 0.0 111.77 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -52.46 -44.98 65.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.683 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 t -118.98 56.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.947 0.403 . . . . 0.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.523 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.3 t80 -160.35 -40.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.256 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.23 127.53 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.483 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.14 22.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 127' ' ' SER . 17.2 p -169.13 103.49 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.472 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.35 -175.43 21.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.3 140.87 29.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.799 0.333 . . . . 0.0 110.225 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.1 m -89.65 135.47 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.98 1.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 133' ' ' ARG . 2.4 tm-20 -67.11 145.27 55.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.493 ' N ' ' OE2' ' A' ' 132' ' ' GLU . 6.6 ptp180 -100.07 130.23 46.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -118.83 -25.17 6.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 140.74 52.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.98 119.46 11.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.218 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.18 133.83 51.44 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.17 17.51 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.349 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.93 58.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.26 145.11 50.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.2 mp0 -75.94 157.38 33.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.1 mtt -56.47 -50.93 84.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.911 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 142' ' ' MET . 88.1 Cg_exo -43.86 -38.03 9.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.357 2.038 . . . . 0.0 112.158 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -70.76 -52.67 19.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.06 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.6 m95 -58.62 -57.17 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.967 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.46 -37.77 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -35.91 76.68 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.8 -44.9 95.6 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.14 -39.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.243 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 0.1 OUTLIER -52.68 -47.84 66.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.903 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.12 -48.05 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.33 -46.59 66.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.703 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.453 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 6.1 m-85 -55.12 -40.54 70.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.294 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 150' ' ' PHE . 1.4 mt -65.85 -30.58 71.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.12 -29.5 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.622 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.478 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 75.3 t -69.8 -36.55 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.486 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -79.99 -35.99 36.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.202 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.4 -38.93 83.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.101 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.79 -27.81 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.736 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 41.3 t -78.31 -26.23 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.25 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 162' ' ' ILE . 2.5 p -83.25 -41.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.438 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 70.2 mt -74.22 -19.31 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.842 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.989 0.423 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -56.84 -28.1 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.299 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.34 -42.95 58.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.2 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.1 mm? -51.51 -41.54 61.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.406 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 1.1 m-20 -66.37 -31.72 72.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -77.54 -49.51 14.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.9 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -76.65 -34.2 58.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -74.16 5.91 3.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.583 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.11 145.64 17.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -70.54 -21.15 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.614 0.245 . . . . 0.0 110.673 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 -45.14 67.09 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.93 75.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.83 0.348 . . . . 0.0 110.178 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -56.48 -41.63 76.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.328 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.16 -31.36 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.001 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -28.84 66.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.558 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.82 -32.97 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.978 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.55 5.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -49.35 -48.43 46.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.435 ' OG1' ' OH ' ' A' ' 153' ' ' TYR . 3.1 p -51.76 -62.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.776 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.25 -31.69 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.04 -41.72 63.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.505 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.86 -35.13 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.77 -34.38 71.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.29 -42.6 71.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.755 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.98 -57.82 3.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.485 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 23.2 p -48.17 -31.86 6.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.72 -32.18 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.71 -17.31 62.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -94.41 -37.54 11.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.672 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -54.35 -45.97 72.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -74.56 -31.56 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.42 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.449 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -61.0 -32.16 71.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.576 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.23 -41.55 7.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.2 tpt -78.03 -0.61 28.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt 48.96 49.87 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.01 147.95 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.82 136.53 20.0 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.202 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.91 143.81 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.353 2.035 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -100.23 161.57 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 41.4 t -51.21 -51.58 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.409 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mt -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.068 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 p -48.63 -43.03 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.27 -47.16 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.975 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.61 -46.54 80.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -40.25 96.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.554 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -63.66 -35.85 81.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.93 76.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.96 85.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.62 -49.9 11.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -46.42 -41.36 13.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.04 88.65 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.1 t -62.94 -44.16 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.276 0.56 . . . . 0.0 109.681 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.3 -48.3 9.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.323 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.69 89.58 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.01 -37.69 88.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 110.304 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.29 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.316 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.42 -25.4 57.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.541 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -84.21 -40.77 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.2 -30.85 76.1 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.92 9.81 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 ' H ' ' C ' ' A' ' 61' ' ' GLY . 67.1 mt -79.79 -41.92 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.95 71.04 0.34 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.318 . . . . 0.0 110.385 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.43 13.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.959 2.44 . . . . 0.0 112.228 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 64' ' ' ALA . 19.5 pttp -113.09 -5.38 13.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.493 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.14 161.27 29.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.691 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.73 -12.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.325 2.017 . . . . 0.0 112.045 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -42.95 -35.55 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' LEU . 89.5 mtt180 -37.82 -65.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -51.46 -25.04 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.833 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 6.4 t -78.39 -52.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 75' ' ' VAL . . . -73.78 -45.31 52.45 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.135 0.493 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.49 -8.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.085 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 3.9 p -61.75 -34.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.596 0.712 . . . . 0.0 110.145 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.31 -31.82 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.594 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -65.65 -51.06 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.934 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.56 -43.87 83.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -46.24 -45.56 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.956 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -58.38 8.81 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.215 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.51 -53.85 9.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.354 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -67.87 -45.91 73.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.29 -47.91 78.89 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.7 t -68.78 -46.31 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.506 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.407 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 1.6 tm0? -54.43 -24.96 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 tp -87.25 -41.85 13.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.634 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 22.5 p -51.61 -25.74 7.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.381 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -71.31 -35.33 71.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.11 -33.85 75.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.26 -44.94 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -59.72 -52.6 64.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.518 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.646 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.7 ttt -54.34 -48.49 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.46 -37.96 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.805 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.52 -39.2 85.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 96' ' ' LEU . 3.8 mm? -90.02 -5.56 56.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.7 t80 . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.161 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.46 0.059 0 CA-C-O 120.74 0.305 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -126.64 15.24 7.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.378 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.2 mt -120.52 80.25 30.33 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.707 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 11.3 Cg_exo -68.07 7.95 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.637 2.225 . . . . 0.0 111.386 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -76.51 -30.87 57.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 110.357 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.37 -41.11 8.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -67.58 -44.87 77.12 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.418 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.7 t90 -77.32 -13.11 60.0 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.519 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.54 74.28 71.3 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.87 -25.68 4.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.846 2.364 . . . . 0.0 111.872 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -52.43 -52.16 55.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.7 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.72 55.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -158.93 -40.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.416 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -54.99 128.81 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.37 148.9 21.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.1 p -155.91 128.66 7.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 106.11 -163.22 13.78 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -102.02 156.52 17.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.394 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.594 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 21.0 m -108.11 130.94 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 99.85 -7.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 158.03 32.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' CZ ' ' OD2' ' A' ' 136' ' ' ASP . 53.2 ttt180 -97.67 141.93 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.236 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -134.42 -31.66 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.69 146.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.707 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.476 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.0 p30 -143.24 161.1 39.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 111.993 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -114.44 136.39 53.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.773 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.22 16.77 0.28 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.99 19.7 33.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.194 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 35.2 mt -125.64 140.44 52.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.052 0.426 . . . . 0.0 110.254 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.21 148.03 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -48.7 -51.96 49.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.546 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 142' ' ' MET . 87.8 Cg_exo -44.23 -34.51 7.08 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.35 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -48.82 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.579 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.1 m95 -57.94 -57.98 10.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.879 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.0 mt -43.89 -38.74 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.83 -37.3 71.03 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.31 -41.2 96.77 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 mt -76.61 -25.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.767 0.318 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.53 -46.16 80.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.36 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 pt -64.26 -41.54 92.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.288 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.34 -49.45 77.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.358 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.439 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 4.1 m-85 -59.77 -45.13 93.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 154' ' ' LEU . 0.4 OUTLIER -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.836 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.51 -32.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.565 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.66 -48.4 76.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.502 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -57.28 -53.63 55.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.44 -49.2 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 -23.11 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.1 t -81.56 -50.83 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.918 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 34.4 mm -68.66 -12.38 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.274 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.388 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 9.6 mp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.955 0.407 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -56.53 -37.36 70.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.561 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.99 -45.46 88.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.16 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -50.22 -41.27 49.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.071 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.7 m120 -68.75 -26.75 65.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.898 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.4 -50.48 15.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.448 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.63 69.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.0 m -76.47 -37.69 56.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -73.68 8.83 1.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.83 141.11 15.17 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 13' ' ' GLY . 3.8 ptp85 -68.49 -49.7 57.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.656 0.265 . . . . 0.0 110.713 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 12' ' ' ARG . . . -43.05 -45.77 6.16 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.12 87.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -60.49 -44.52 95.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.152 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.12 -30.14 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.8 -28.06 65.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.633 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.459 ' O ' ' OG1' ' A' ' 21' ' ' THR . 20.1 mmt -74.5 -33.64 62.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.52 -54.67 15.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.564 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.22 -49.25 53.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.703 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 18' ' ' MET . 20.3 p -48.7 -57.08 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.13 -39.5 28.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.55 -41.47 69.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -47.14 -36.41 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.544 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.85 -36.32 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.23 -53.54 42.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.818 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -62.41 -57.97 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.833 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 28.9 p -46.96 -29.24 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.732 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -45.41 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.8 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -15.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -93.32 -34.7 13.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.483 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.98 -42.38 80.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -69.02 -47.68 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.01 -9.05 13.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.498 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.17 -41.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.601 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.6 mmt -96.39 10.12 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 tp 48.47 45.33 20.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.6 mt -79.54 146.65 32.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.352 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -107.61 131.22 21.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.444 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 165.22 28.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.137 1.892 . . . . 0.0 111.761 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -127.96 -175.22 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.512 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 4.1 mm? -69.88 -49.93 47.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.612 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.2 p -49.68 -51.14 40.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.488 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.55 -40.49 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -59.48 -43.15 93.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.787 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -59.02 -44.41 91.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.432 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -58.97 -29.63 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.25 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.51 72.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.316 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.3 63.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -54.82 9.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.035 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -48.65 -32.11 7.79 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.814 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.31 -46.29 72.31 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.945 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.24 45.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.366 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.03 -46.47 75.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.284 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.71 86.41 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.01 95.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.78 -0.71 . . . . 0.0 110.557 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -29.54 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.503 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.5 tp -74.25 -32.03 62.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.57 -33.81 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -78.08 -30.13 51.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.57 5.25 1.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 0.0 110.317 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.4 mt -89.12 -23.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.607 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 177.02 70.09 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.794 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.45 26.6 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.702 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' ALA . 53.9 tttp -109.2 -7.19 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.395 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.88 173.73 2.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.13 -8.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.22 1.947 . . . . 0.0 111.852 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -42.27 -38.74 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.4 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 10.4 mtp180 -40.04 -70.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.606 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -51.6 -18.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.092 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.0 t -83.16 -46.6 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.61 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' VAL . . . -72.12 -40.04 68.41 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.81 -8.84 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.353 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' ALA . 55.6 t -56.84 -43.97 81.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.396 0.617 . . . . 0.0 110.145 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.49 -33.36 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.405 ' CZ2' ' CD2' ' A' ' 153' ' ' TYR . 5.4 t-105 -60.19 -55.9 28.21 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.801 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.54 -48.2 82.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -45.17 -43.95 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.6 p -79.84 -24.54 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.577 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.05 -61.24 2.75 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.69 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.42 -55.94 5.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -65.97 -51.5 57.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.68 -47.31 58.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.501 ' O ' ' OG1' ' A' ' 88' ' ' THR . 91.1 t -68.86 -47.5 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -53.17 -30.23 36.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -42.61 63.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.4 p -54.61 -28.59 47.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.969 0.414 . . . . 0.0 110.237 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -63.34 -46.1 88.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -61.86 -40.17 94.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.718 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -70.81 -45.88 63.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.773 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.5 p -64.61 -47.69 77.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.727 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 97' ' ' TYR . 28.6 ttt -56.24 -51.35 68.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.57 -50.98 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.329 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -51.91 -37.78 53.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.388 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.71 -15.69 28.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 93' ' ' MET . 84.9 t80 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.746 0.308 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.44 5.75 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.622 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 116' ' ' LEU . 77.9 mt -117.37 83.48 16.48 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -54.14 7.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.583 2.188 . . . . 0.0 112.428 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 114' ' ' LEU . 8.2 mp -74.88 -28.43 60.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.693 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -95.8 -40.8 9.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -65.65 -33.69 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -88.63 -20.73 24.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.184 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.51 69.03 12.39 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.82 -18.06 52.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.712 2.274 . . . . 0.0 111.538 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.59 -3.81 42.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.179 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.521 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 48.3 t -131.76 36.13 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.102 0.477 . . . . 0.0 110.741 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 15.9 m-85 -161.33 -43.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.72 129.8 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.066 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.09 152.83 18.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.5 t -160.68 99.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.05 -174.11 22.31 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 13.2 m-20 -88.0 157.34 18.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 2.6 m -107.86 127.63 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 95.05 -4.25 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.131 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -67.58 128.84 37.95 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.791 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.711 ' NE ' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -74.08 142.63 45.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.472 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -131.96 -26.81 1.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.792 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -173.0 147.82 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 20.0 p-10 -142.98 167.57 21.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 112.112 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -134.75 138.15 44.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.844 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.68 17.32 3.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.02 59.22 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.87 131.52 54.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.3 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -68.99 150.58 47.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.6 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.67 -54.4 23.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.082 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.97 -36.47 11.27 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.246 1.964 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.95 -46.04 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.0 m95 -65.31 -56.98 9.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.873 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -42.99 -37.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.15 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.36 -34.06 77.42 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.97 -40.68 91.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.79 -40.53 76.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.277 . . . . 0.0 110.279 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.37 -40.63 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.99 -46.62 93.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.75 -51.16 66.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.405 ' CD2' ' CZ2' ' A' ' 77' ' ' TRP . 4.6 m-85 -66.76 -43.69 83.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.6 tt -49.11 -30.76 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.313 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.69 -37.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.938 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 87.0 t -51.64 -37.45 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.587 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.91 -44.36 20.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.935 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.0 t -52.07 -44.48 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.215 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.407 ' O ' ' OG ' ' A' ' 163' ' ' SER . 7.7 tp -81.3 -36.43 29.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.792 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 45.9 t -69.94 -31.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.259 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.7 -49.29 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.107 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -19.34 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.033 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 20.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.922 0.392 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -51.62 -43.41 62.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.44 -39.87 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.4 tt -53.43 -44.8 69.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.75 -31.81 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -75.22 -48.57 22.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.654 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.7 p -76.16 -32.03 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 4.4 tt0 -74.24 9.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.965 0.412 . . . . 0.0 110.319 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.82 151.8 17.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -69.05 -20.24 64.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.713 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.74 -44.09 64.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.39 61.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.533 0.206 . . . . 0.0 110.991 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -54.85 -51.08 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.76 -27.61 66.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -26.09 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.09 -34.85 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.67 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.725 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' LEU . 27.0 t80 -52.9 -53.41 49.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.715 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.4 p -43.74 -53.4 5.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.442 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -26.58 66.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -79.92 -42.24 24.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.42 -36.24 61.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.756 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.38 -38.95 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.14 -45.75 79.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -57.79 5.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.572 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 28.1 p -46.76 -31.67 3.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.477 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.67 -44.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 tp -51.06 -17.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.654 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 31.4 t90 -91.44 -35.83 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.538 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 1.7 m-85 -56.47 -36.99 69.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.349 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.95 -39.71 23.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.53 -22.4 61.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 36' ' ' MET . 7.5 p -109.03 -44.01 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.45 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 5.4 ttt -83.98 6.47 21.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.6 mt 40.57 42.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.729 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.71 154.11 39.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.339 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -123.61 115.54 28.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.5 Cg_endo -78.29 179.95 6.02 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.274 1.983 . . . . 0.0 112.283 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 2.2 t -119.61 -175.73 3.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -65.12 -39.68 86.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.297 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -65.21 -50.12 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.257 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.2 m -49.74 -48.21 50.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.703 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 45' ' ' ILE . 95.7 mt -61.95 -42.97 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.36 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -56.74 -45.89 81.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.053 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.17 -42.37 98.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.3 ttp85 -62.44 -34.83 77.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.45 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.137 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.59 -47.29 82.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -76.99 -47.95 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -46.9 -44.31 19.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.087 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.08 93.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 57' ' ' ALA . 27.6 t -61.42 -47.33 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.154 0.502 . . . . 0.0 110.0 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -46.46 -45.38 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.63 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.56 74.11 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.04 -30.67 71.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.908 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.25 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.223 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.0 -43.1 99.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 60' ' ' ILE . 20.9 mm -79.22 -35.97 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.45 -33.41 81.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 9.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -83.35 -35.06 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.723 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.22 76.45 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.712 0.291 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.78 20.7 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.579 2.186 . . . . 0.0 112.062 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.8 mtmt -109.61 -7.28 15.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.09 162.86 18.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.6 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -38.69 -16.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.512 2.141 . . . . 0.0 112.256 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 67' ' ' THR . 38.9 mt -44.05 -31.18 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 61.0 mtt180 -38.13 -65.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.39 -33.15 52.62 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.416 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 11.9 t -66.36 -57.75 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.496 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.35 82.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.307 0.575 . . . . 0.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -14.94 45.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.262 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 1.9 p -60.25 -32.64 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.499 0.666 . . . . 0.0 110.198 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -89.34 -32.97 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.927 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.4 t-105 -67.16 -49.58 64.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.874 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.4 tt -63.9 -51.84 62.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.924 0.393 . . . . 0.0 110.158 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.405 ' HH ' ' CD ' ' A' ' 83' ' ' ARG . 87.8 t80 -40.96 -43.21 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.36 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 p -78.89 -21.5 47.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.53 -61.22 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.816 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.61 -53.56 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.38 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.405 ' CD ' ' HH ' ' A' ' 79' ' ' TYR . 7.9 ttt-85 -68.1 -39.24 82.89 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 88' ' ' THR . . . -66.44 -44.79 89.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.43 -38.47 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.563 0.22 . . . . 0.0 111.453 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -66.46 -43.91 84.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.278 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.17 -45.91 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 84' ' ' GLY . 6.9 p -46.94 -50.28 19.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.502 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -53.05 -30.68 37.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.506 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.45 -39.96 89.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.494 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 2.8 m170 -64.75 -43.62 92.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.189 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -65.19 -38.87 91.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' TYR . 37.6 ttp -52.06 -45.02 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.4 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.302 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -55.9 -41.24 74.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.433 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 tp -89.09 -18.24 27.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.8 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.94 0.4 . . . . 0.0 110.62 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.656 0.265 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -84.8 -3.21 58.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.7 ' C ' ' H ' ' A' ' 116' ' ' LEU . 20.7 mt -118.76 88.11 34.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.917 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.6 Cg_exo -53.76 11.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.153 . . . . 0.0 112.261 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.7 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -71.4 -30.12 65.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 109.868 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.444 ' CG ' ' CE1' ' A' ' 124' ' ' PHE . 74.5 m-20 -97.29 -40.79 8.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -72.36 -45.77 58.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.821 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.8 t90 -72.91 -12.84 61.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.77 74.01 39.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.563 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.55 -20.69 10.63 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.756 2.304 . . . . 0.0 112.038 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.22 -53.11 55.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.23 55.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.017 0.437 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.444 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 37.2 t80 -158.78 -42.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.22 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -58.02 128.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.43 160.61 14.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' PRO . 43.2 p -173.8 103.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.562 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.66 177.29 18.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -81.61 140.11 34.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.183 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 57.2 m -87.93 132.83 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.947 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 92.97 2.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.223 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -67.54 144.76 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -93.74 125.3 38.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 110.797 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.56 -23.26 6.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.764 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.45 138.95 47.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.841 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -141.7 119.68 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -123.04 132.99 54.35 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.29 17.31 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.65 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.88 17.54 56.16 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.633 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.2 mp -123.49 144.08 49.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.0 mp0 -77.72 157.82 29.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.646 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.419 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.6 OUTLIER -51.12 -53.58 47.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.8 Cg_exo -40.54 -38.86 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.375 2.05 . . . . 0.0 112.304 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.414 HE21 ' CD ' ' A' ' 141' ' ' GLU . 58.2 mt-30 -69.8 -54.19 14.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.508 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.607 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.1 m95 -62.81 -57.79 9.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.463 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 tt -42.92 -36.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.509 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.77 -33.02 74.91 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.86 -44.99 96.57 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -76.04 -25.88 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -62.63 -44.85 95.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.486 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 pt -69.4 -36.65 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.358 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.91 71.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.97 -49.43 66.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.793 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.486 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 19.3 mt -62.65 -31.94 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.68 -32.47 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -70.63 -46.01 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -55.09 -48.56 73.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.77 -24.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.424 ' O ' ' OG ' ' A' ' 163' ' ' SER . 9.8 tp -78.01 -41.54 35.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.251 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.4 -20.38 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.7 t -81.19 -50.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.81 -21.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.446 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 44.3 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.284 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 2.1 pp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.824 0.345 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -53.2 -32.47 48.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.586 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 7' ' ' GLN . 91.9 t80 -76.86 -42.61 39.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -46.59 -45.1 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.545 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 4.3 p-10 -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' PHE . 8.5 tt0 -78.41 -48.28 15.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.16 96.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 11' ' ' GLY . 14.7 m -76.69 -36.11 57.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 13.9 tt0 -64.45 2.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.287 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.66 150.69 19.54 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.2 mtt85 -70.48 -45.53 65.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.465 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.11 -45.26 15.01 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.37 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -60.93 -48.44 81.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.64 -31.22 66.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.081 0.467 . . . . 0.0 109.781 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.49 -25.71 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.791 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.3 mmt -74.34 -34.17 63.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.22 -54.29 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.861 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.04 -47.92 61.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.752 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 p -52.54 -50.22 63.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.29 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.734 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.29 -39.17 82.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.04 -36.78 60.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.78 -35.6 62.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' OE1' ' NH2' ' A' ' 48' ' ' ARG . 3.8 tp10 -68.73 -46.89 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.927 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.71 -58.16 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 p -48.91 -32.35 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.62 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.6 mt -53.37 -13.56 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -95.1 -31.89 13.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.69 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.13 -34.36 77.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.73 -43.17 23.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -18.63 53.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.81 -48.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.647 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 tpt -83.33 6.49 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 41.69 41.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.44 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.83 151.85 37.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 90.61 17.88 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.241 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.62 146.39 34.58 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.554 2.169 . . . . 0.0 112.337 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.9 t -99.83 173.25 6.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.09 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 10.0 p -61.04 -41.4 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 1.8 mp -68.11 -47.79 67.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.272 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 m -50.2 -48.95 53.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.703 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.47 -44.24 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.49 -45.7 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.07 -39.8 93.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.679 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' NH2' ' OE1' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -61.11 -34.43 74.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.289 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 -39.04 88.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.568 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.5 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.1 -51.45 15.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -45.33 -43.19 10.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.053 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.9 96.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' ALA . 66.2 t -57.72 -46.47 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.26 0.553 . . . . 0.0 110.172 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.1 tp -48.48 -43.25 34.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.698 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.99 71.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.72 -35.15 60.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.566 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.93 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.75 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.42 -40.86 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.789 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -78.63 -31.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.23 -31.82 33.34 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.32 0.88 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.709 0.29 . . . . 0.0 110.885 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.8 mm -88.45 -24.08 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.98 65.6 0.3 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.808 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.55 18.7 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.736 2.291 . . . . 0.0 111.625 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -106.54 -10.24 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.643 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -109.77 176.48 1.53 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.819 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.06 1.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.234 1.956 . . . . 0.0 111.796 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.643 ' H ' ' C ' ' A' ' 67' ' ' THR . 12.2 tp -58.35 -31.27 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -39.86 -64.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.757 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -53.19 -33.56 53.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.455 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.57 -46.56 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.85 -40.43 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.214 0.531 . . . . 0.0 109.925 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.8 mmt -59.89 -25.99 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.367 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 t -52.28 -29.08 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.488 0.661 . . . . 0.0 109.712 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 76' ' ' ILE . 96.7 mt -91.11 -31.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.091 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.469 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.8 t-105 -63.91 -46.26 85.6 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' ALA . 3.9 tt -67.77 -52.46 37.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -41.75 -41.55 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.297 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 p -81.39 -24.49 36.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.65 -59.04 6.08 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.989 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -74.89 -51.4 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.204 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.38 -46.09 77.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.78 -47.36 90.8 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 ' O ' ' OG1' ' A' ' 88' ' ' THR . 83.4 t -68.6 -56.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.217 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -49.87 -21.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.818 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.77 -35.91 14.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.033 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 11.9 p -59.05 -55.18 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.03 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.531 ' CZ ' ' SD ' ' A' ' 93' ' ' MET . 87.6 t80 -52.23 -38.61 58.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -57.14 -40.14 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -35.04 79.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 66.4 p -72.92 -36.54 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' TYR . 58.8 mmm -54.02 -49.06 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.52 -49.93 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -50.23 -36.46 31.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.06 -9.77 20.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.641 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 93' ' ' MET . 25.5 t80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.798 0.332 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -2.24 56.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.653 ' C ' ' H ' ' A' ' 116' ' ' LEU . 41.5 mt -120.11 87.12 38.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.6 Cg_exo -51.78 4.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.64 2.227 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.653 ' H ' ' C ' ' A' ' 114' ' ' LEU . 13.8 mt -64.07 -30.23 71.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.1 -43.05 7.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.6 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -71.53 -44.96 63.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.437 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.3 t90 -74.64 -15.98 60.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.71 71.15 64.94 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.2 -22.87 10.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 111.919 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.1 -53.98 48.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.25 63.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.547 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -169.28 -42.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.81 131.05 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.67 156.45 16.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.59 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 85.2 p -166.76 100.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.4 -167.3 25.03 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -100.27 166.88 10.76 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.3 m -112.23 130.1 56.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 96.74 6.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.028 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.28 139.33 46.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -100.14 126.38 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.661 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.2 -14.4 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.6 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -173.38 132.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -143.25 161.29 38.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.258 0.551 . . . . 0.0 112.077 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -123.22 138.98 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.158 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 54.26 17.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.164 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.19 57.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mt -124.41 136.64 54.21 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.02 148.32 50.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.424 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mtp -49.12 -52.01 51.54 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 142' ' ' MET . 71.1 Cg_exo -45.6 -38.12 16.24 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.41 2.073 . . . . 0.0 112.321 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -68.92 -46.18 68.94 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 148' ' ' GLY . 62.1 m95 -62.75 -56.15 20.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.211 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mt -43.12 -37.94 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.943 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -63.91 -35.22 79.94 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.92 -36.82 75.07 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.02 -33.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.75 -44.35 90.52 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.034 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 151' ' ' ILE . 20.9 mm -59.56 -49.24 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.022 0.439 . . . . 0.0 109.843 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.37 57.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.066 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -61.16 -49.83 75.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.332 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 tt -47.53 -32.23 5.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.442 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.27 -38.11 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.14 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.503 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 79.3 t -54.39 -39.88 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.34 -45.55 25.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.313 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.7 t -52.27 -42.53 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mt -84.12 -41.41 17.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.433 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 44.5 t -61.87 -25.37 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.756 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -83.08 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 109.969 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.0 -8.59 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.312 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.821 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.874 0.369 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -50.48 -36.1 32.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' GLN . 44.6 m-85 -75.47 -40.23 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.323 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.9 tp -45.06 -40.48 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -70.16 -21.75 63.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.404 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' PHE . 40.7 tt0 -79.93 -47.0 15.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.92 -31.72 73.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.95 0.405 . . . . 0.0 110.314 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' GLY . 28.9 m -76.03 -41.47 50.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.21 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 10' ' ' GLN . 1.6 pp0? -70.4 8.93 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.558 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.76 142.43 16.08 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -65.76 -20.64 66.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.659 0.266 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.82 -47.57 54.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.36 -51.61 68.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 0.0 110.469 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -55.78 -46.36 77.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.517 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.63 -31.73 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -28.11 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -74.89 -33.91 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.796 0.331 . . . . 0.0 110.138 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.49 43.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 71.4 t80 -54.33 -53.44 53.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.73 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.1 p -43.12 -49.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.678 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.49 69.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.3 tt -76.98 -38.72 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.639 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.25 42.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.9 mp -75.85 -31.45 59.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.571 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -49.89 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.96 -57.55 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.599 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -45.19 -34.82 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' C ' ' N ' ' A' ' 31' ' ' TRP . . . -82.96 -46.44 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.97 -16.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.531 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.402 ' N ' ' C ' ' A' ' 29' ' ' ALA . 44.1 t90 -94.19 -25.98 16.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 135' ' ' TRP . 0.2 OUTLIER -70.26 -43.15 71.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.519 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' LEU . 34.8 tt0 -73.74 -48.04 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.613 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -49.99 -28.63 7.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.714 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.12 -45.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.696 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 2.07 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.506 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLN . 16.2 mt 43.15 43.64 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.4 149.66 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.395 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -115.37 88.31 18.59 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.79 174.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 112.008 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.59 -172.58 2.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.39 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 10.7 m -64.44 -42.94 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 7.6 mt -64.94 -49.09 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.304 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -59.1 -50.54 73.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.17 -47.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.11 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -57.76 -44.18 85.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 109.971 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -61.7 -38.52 88.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.464 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -60.96 -33.49 73.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 -34.64 76.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.225 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.6 77.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.326 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.8 tt -72.9 -55.36 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.906 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -42.51 -38.41 1.93 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.35 -41.32 94.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 57' ' ' ALA . 56.1 t -61.7 -47.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.38 -46.12 18.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.505 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.6 -27.64 70.08 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.71 -31.12 70.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 110.293 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.65 -30.99 59.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.329 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.21 -37.92 72.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.334 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 60' ' ' ILE . 91.9 mt -76.84 -36.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.34 -26.39 63.79 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.79 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.14 -28.71 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.61 77.07 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.503 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.86 22.2 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.6 2.2 . . . . 0.0 112.129 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -113.29 -7.56 13.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -109.87 161.67 23.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.677 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.62 -15.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.482 2.121 . . . . 0.0 112.091 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.7 mp -44.64 -29.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttp180 -40.67 -67.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.577 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -56.03 -28.7 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 t -69.11 -45.72 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.34 -34.58 36.51 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.302 0.573 . . . . 0.0 110.244 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 74' ' ' MET . 7.0 tmm? -61.72 -13.55 24.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.276 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -57.97 -36.82 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 mm -88.05 -31.97 5.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.177 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.501 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -64.11 -52.81 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -65.2 -47.29 77.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.681 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -44.27 -43.69 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 p -79.97 -22.77 42.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.654 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.08 -60.99 2.95 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.07 -53.2 9.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.209 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -66.4 -46.27 77.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.64 -46.85 91.68 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.46 ' O ' ' OG1' ' A' ' 88' ' ' THR . 87.6 t -67.73 -44.93 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -58.07 -27.21 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 tp -81.29 -44.06 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.415 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 17.2 p -52.8 -25.47 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 0.0 110.168 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -48.49 53.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.6 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -51.93 -38.33 56.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -65.57 -46.77 78.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -65.37 -47.06 77.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' TYR . 27.2 mmm -44.74 -47.67 10.78 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.5 -50.17 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.628 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.7 -29.62 7.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.39 -15.5 17.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.384 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 8.8 mp0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.502 0.192 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.2 p-90 -87.52 -1.28 57.83 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.315 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.588 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.0 79.78 50.97 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.388 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.5 Cg_exo -49.5 -1.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.619 2.213 . . . . 0.0 112.298 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.84 -33.1 68.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.479 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 46.3 m-20 -96.3 -43.64 7.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.3 -45.17 77.34 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.413 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 34.1 t-105 -73.93 -16.81 61.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.912 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.8 68.69 10.83 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.78 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.72 -11.72 26.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.871 2.381 . . . . 0.0 111.649 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -71.67 -6.4 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.205 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 35.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.8 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.479 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 72.7 t80 -153.29 -39.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.351 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.56 128.25 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.93 155.76 16.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -166.29 108.14 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.706 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 133.52 177.83 15.19 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.1 138.04 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 26.9 m -89.95 132.4 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 89.04 -4.14 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.97 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.19 129.11 38.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.174 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -85.0 117.44 23.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -122.32 -3.82 8.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.52 ' NE1' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 t90 -172.78 129.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -145.52 158.54 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.293 0.568 . . . . 0.0 112.019 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -122.98 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.632 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 55.38 17.28 2.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.53 53.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mt -123.91 134.28 53.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 7.0 pm0 -71.06 149.6 46.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 145' ' ' TRP . 8.2 mtt -45.83 -62.16 1.99 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.1 Cg_exo -34.57 -37.66 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -41.15 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.625 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.5 m95 -67.06 -58.26 5.26 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.758 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.0 mt -43.98 -38.22 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -34.49 75.76 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -62.68 -48.93 77.63 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.53 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.08 -35.09 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -38.86 72.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.846 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.17 -40.04 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.019 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.42 73.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.149 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.0 -41.39 97.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.339 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.0 tt -52.24 -33.25 40.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.57 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -82.71 -38.72 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.659 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -52.92 -40.53 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.71 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.501 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -78.07 -46.89 19.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -52.71 -50.17 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.26 -33.99 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.023 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 163' ' ' SER . 48.0 t -75.74 -26.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.87 -45.28 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.74 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 39.8 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.704 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -31.86 68.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.3 -45.07 67.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.111 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -50.08 -37.59 34.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.996 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -66.89 -28.79 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.183 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -80.22 -49.43 11.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.702 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.23 -32.59 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.9 p -76.86 -38.69 53.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.504 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.551 ' NE2' ' HZ3' ' A' ' 66' ' ' LYS . 36.5 mt-30 -68.01 5.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.26 141.04 15.23 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -69.13 -51.14 41.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 110.661 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.92 -45.58 5.95 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.32 90.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -62.3 -40.05 95.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.123 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.79 -31.11 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.6 -28.51 64.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.68 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.66 -34.49 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.103 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.13 27.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' LEU . 13.8 t80 -53.7 -53.8 46.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.751 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 p -44.59 -55.18 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.613 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' OE2' ' A' ' 26' ' ' GLU . . . -58.54 -22.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.62 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -85.17 -41.57 15.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -51.24 -40.03 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.53 -35.77 68.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.772 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -70.6 -44.25 67.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.17 -58.08 4.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.622 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 25.4 p -47.22 -34.14 6.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.254 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -79.09 -42.88 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.6 -16.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.794 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -91.68 -34.0 14.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.629 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 4.9 m-85 -62.48 -31.21 71.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.459 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 6.9 mp0 -81.02 -44.86 17.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -63.62 -17.67 63.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 36' ' ' MET . 9.8 p -109.3 -41.59 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.439 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 8.1 tpt -85.9 4.9 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.754 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.4 mp 48.06 34.61 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.63 154.71 28.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.742 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -125.24 128.23 24.81 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.563 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.83 -179.84 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.383 2.055 . . . . 0.0 112.073 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -128.31 -170.97 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.297 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 9.9 p -66.26 -44.72 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 83.8 mt -67.22 -50.43 60.79 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -50.35 -50.89 49.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.52 -41.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.96 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -57.28 -47.81 80.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.854 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.94 -43.28 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.089 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -56.46 -33.64 66.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.901 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.117 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.8 -48.68 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.084 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.4 mm? -75.0 -47.47 28.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 51' ' ' LEU . 38.9 t80 -44.01 -39.67 4.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.42 -39.82 87.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' LEU . 71.5 t -60.33 -17.47 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.368 0.604 . . . . 0.0 109.423 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 tp -83.43 -39.49 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.79 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.3 -38.94 81.98 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.81 72.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.61 -23.22 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.26 -37.09 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.852 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.69 -38.22 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.018 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -63.64 -40.57 98.75 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.52 11.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.064 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 61' ' ' GLY . 90.8 mt -88.32 -25.67 5.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.25 68.76 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.697 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.65 21.01 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.609 2.206 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.551 ' HZ3' ' NE2' ' A' ' 10' ' ' GLN . 26.5 tttp -112.62 -3.67 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.87 166.02 12.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -42.57 -11.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.238 1.959 . . . . 0.0 112.076 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -41.51 -38.55 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.345 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.7 mtm105 -38.66 -69.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.26 -17.1 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.042 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.6 t -83.14 -48.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.249 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 -34.49 60.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.274 0.559 . . . . 0.0 110.043 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.2 ttt -59.51 -9.56 2.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.112 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.65 -43.39 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.425 0.631 . . . . 0.0 110.423 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -88.26 -29.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.645 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.533 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 3.1 t-105 -65.63 -53.34 42.85 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.781 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.98 -45.36 85.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -44.19 -45.49 8.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.966 0.412 . . . . 0.0 110.357 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 p -80.3 -21.06 42.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.049 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.53 -62.28 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.921 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -73.59 -49.34 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.297 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -72.24 -43.69 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.72 -48.33 85.6 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' O ' ' OG1' ' A' ' 88' ' ' THR . 75.1 t -72.83 -50.94 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.637 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.406 ' C ' ' OE1' ' A' ' 86' ' ' GLN . 1.1 tm0? -50.11 -23.39 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.022 0.439 . . . . 0.0 109.991 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.67 -41.33 14.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.589 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 23.6 p -51.87 -23.68 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -71.19 -31.02 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.492 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.44 -37.61 51.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -70.29 -58.61 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -54.69 -43.28 72.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.706 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.7 ttt -57.78 -44.77 86.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.58 -48.4 81.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.663 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -52.26 -43.04 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 10.1 mp -91.08 -9.77 44.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.17 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.6 t80 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -0.85 54.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.605 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 11.8 mt -121.81 81.81 41.83 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.289 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.2 Cg_exo -51.25 2.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.757 2.305 . . . . 0.0 112.635 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.8 mt -62.57 -32.74 73.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.947 0.403 . . . . 0.0 110.142 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.7 p30 -96.43 -40.59 9.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.47 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 78.1 tttt -72.1 -45.4 60.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.663 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -72.78 -15.57 61.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.128 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.54 73.39 29.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.66 -17.89 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.848 2.366 . . . . 0.0 111.886 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -52.59 -49.24 65.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.847 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.49 54.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.78 -41.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.296 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.07 129.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.48 155.05 17.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -167.34 112.08 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.594 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 129.42 -179.98 16.37 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 m-20 -81.97 137.08 35.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.225 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.3 m -90.68 132.49 35.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 89.82 -6.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -67.88 152.35 45.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -85.08 138.0 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.634 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -128.79 -29.43 2.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.357 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -174.92 138.96 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -133.65 163.44 29.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.48 0.657 . . . . 0.0 112.394 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -123.32 135.55 54.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.766 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 51.43 17.13 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.28 52.11 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.189 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.68 139.84 51.6 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 24.4 mp0 -73.2 154.11 40.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.598 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.46 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 5.9 mtt -49.24 -63.17 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.256 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.6 Cg_exo -31.72 -41.72 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.95 2.433 . . . . 0.0 112.594 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.75 -49.48 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.408 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -63.91 -57.44 9.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt -43.7 -39.57 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.89 -35.76 79.29 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.84 -41.38 91.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.6 mp -80.41 -26.77 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -60.99 -48.78 80.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.533 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 tt -67.73 -39.52 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.81 40.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.096 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -65.4 -44.27 88.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.007 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 66.6 mt -63.33 -30.87 71.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.74 -27.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 25.6 t -75.29 -29.8 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.533 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -73.67 -50.87 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.989 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.6 m -54.27 -52.07 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.934 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 mt -63.29 -36.65 84.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.623 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 9.4 t -65.76 -33.91 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.7 -52.73 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 109.818 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.44 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 1.7 mp -60.69 -9.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.214 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.763 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.867 0.365 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -56.0 -39.89 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.564 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLN . 17.9 m-85 -69.72 -42.8 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.61 -40.41 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.176 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.72 -21.69 63.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.102 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.1 tp-100 -80.53 -47.01 14.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.541 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 -32.68 73.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.625 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.2 p -76.45 -33.66 58.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.12 10.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 110.489 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.31 142.57 15.52 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -65.05 -20.51 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.244 . . . . 0.0 110.416 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.45 -46.23 71.73 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.12 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 0.0 110.366 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -56.19 -49.43 74.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.712 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.77 -31.77 73.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.525 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.09 -27.76 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.545 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 31.9 mtt -76.76 -33.85 58.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.348 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.09 -55.2 11.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.696 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . 83.0 t80 -53.88 -54.64 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.661 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -42.72 -58.87 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.662 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -24.51 59.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' PHE . 6.2 tp -80.26 -41.32 25.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.4 -34.32 61.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.57 -35.04 72.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.54 -49.94 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.613 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 30' ' ' LEU . 35.8 mt -64.91 -57.37 8.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.612 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 35.7 m -44.24 -40.42 5.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.389 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.47 -27.14 46.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.36 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.4 tp -63.98 -18.76 64.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.653 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -83.32 -37.3 23.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' O ' ' CB ' ' A' ' 36' ' ' MET . 13.7 m-85 -62.75 -36.65 83.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -79.46 -47.02 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.919 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 57.9 t-80 -62.6 -15.88 53.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.35 -46.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.439 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tpt -87.71 9.92 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.065 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.7 mp 43.26 48.58 5.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.33 146.5 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.377 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -115.47 84.18 11.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.246 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.78 172.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.531 2.154 . . . . 0.0 112.235 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.69 171.59 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.569 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 61.8 t -47.59 -42.99 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.313 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.9 mp -75.05 -40.66 60.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.572 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -55.74 -49.77 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.007 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 pt -66.16 -37.02 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.451 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.26 -45.82 92.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.936 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.95 -39.87 79.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.88 -31.22 70.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.28 76.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.305 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.76 -48.58 81.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.26 -51.58 11.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -45.12 -37.74 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.79 84.38 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.81 -47.1 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.934 0.397 . . . . 0.0 110.025 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.72 -48.51 10.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.474 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.57 97.95 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.38 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.695 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.41 64.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tp -76.64 -37.75 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 60' ' ' ILE . 29.1 mm -81.76 -31.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -71.71 -30.46 66.18 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.66 5.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.56 0.219 . . . . 0.0 111.149 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -85.52 -25.59 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.624 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.22 74.91 0.27 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 73.6 Cg_endo -79.38 16.81 1.33 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.728 2.286 . . . . 0.0 112.242 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -113.76 -3.86 13.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.39 162.18 22.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.691 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.69 -16.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.038 . . . . 0.0 111.792 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 tp -42.95 -33.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.362 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.69 -67.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -55.86 -21.82 22.03 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.69 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' LEU . 10.5 t -76.99 -43.34 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.584 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.26 62.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.19 -10.42 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.267 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.09 -43.42 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.349 0.595 . . . . 0.0 110.144 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -86.96 -32.59 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.458 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -61.49 -55.57 29.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.051 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.14 -47.19 80.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -44.38 -45.3 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.311 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -79.24 -22.88 44.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.78 -59.43 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.991 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.02 -53.49 9.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -66.66 -46.02 77.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.08 -47.84 84.3 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' A' ' 88' ' ' THR . 78.8 t -68.47 -50.32 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -48.63 -26.12 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.97 -38.76 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 68.8 p -55.49 -29.56 59.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.765 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.15 -41.82 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.721 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.12 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -43.04 40.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.651 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.4 p -72.14 -43.6 64.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 22.4 ttp -54.49 -51.11 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.705 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -49.32 75.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.425 ' NE2' ' CD ' ' A' ' 141' ' ' GLU . 26.8 tt0 -55.71 -44.72 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.37 -22.55 35.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.754 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 12.3 t80 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.34 11.68 35.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.75 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.654 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.7 tp -123.13 61.16 17.64 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.13 11.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.6 2.2 . . . . 0.0 112.038 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -77.72 -29.96 51.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 109.655 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 4.3 p-10 -96.05 -42.34 8.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.266 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -60.38 -38.09 82.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -83.4 -12.59 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.583 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.3 76.52 18.61 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.889 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.51 -19.39 10.19 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 111.909 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -68.63 -3.88 13.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.336 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 124' ' ' PHE . 2.4 t -145.22 37.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 123' ' ' VAL . 16.9 m-85 -153.56 -40.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.534 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.0 131.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.564 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.3 146.9 23.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 t -159.64 100.11 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.7 -171.43 23.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -96.96 151.8 19.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.27 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 28.1 m -103.79 129.81 51.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.58 -7.63 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -67.83 156.91 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.53 ' H ' ' CD ' ' A' ' 132' ' ' GLU . 29.8 mtp85 -97.11 126.51 42.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.807 0.337 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.2 -29.84 4.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -174.1 141.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.45 161.11 39.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.193 0.52 . . . . 0.0 111.83 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.0 139.8 49.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.144 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.5 16.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.42 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.3 23.02 32.99 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.887 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 mt -127.67 139.61 52.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.425 ' CD ' ' NE2' ' A' ' 95' ' ' GLN . 9.9 mt-10 -68.45 145.01 54.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.426 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.9 mtt -47.29 -53.75 26.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.45 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 142' ' ' MET . 82.5 Cg_exo -41.55 -36.64 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.356 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -69.76 -52.96 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 109.9 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 77.9 m95 -56.88 -56.82 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.908 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -42.9 -36.13 1.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.03 82.56 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.488 0.661 . . . . 0.0 109.325 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.35 -45.97 94.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -74.38 -30.45 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.43 -45.14 92.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.64 -43.74 98.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.282 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.26 -47.52 62.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.42 -41.38 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.479 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 4.5 tt -55.31 -34.52 64.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.138 0.494 . . . . 0.0 110.318 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.69 -45.04 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 160' ' ' VAL . 84.4 t -48.99 -32.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.868 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.47 ' O ' ' CG2' ' A' ' 161' ' ' VAL . . . -74.5 -42.92 58.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.53 -33.81 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.72 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.438 ' O ' ' OG ' ' A' ' 163' ' ' SER . 4.1 mm? -85.07 -36.32 21.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.743 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 156' ' ' VAL . 7.1 p -76.63 -23.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.375 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 157' ' ' ALA . 70.1 t -81.95 -51.64 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.9 mm -71.86 -11.84 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.394 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.0 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 8.6 mp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.932 0.396 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -50.94 -42.51 59.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.385 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.5 -39.93 95.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.37 -38.58 59.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.25 -31.28 72.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.491 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 31.5 mm-40 -74.85 -48.23 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.13 -29.66 69.45 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.483 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' GLY . 95.8 p -75.92 -42.41 48.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -71.52 10.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.156 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.62 145.6 16.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.493 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -63.13 -19.91 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.745 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.94 -47.68 64.65 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.36 67.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -52.72 -49.73 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.86 -29.31 68.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.569 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -69.18 -31.38 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.9 mtt -74.37 -34.02 63.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.62 -53.45 41.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.486 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.85 -54.13 49.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.756 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 p -41.17 -56.41 2.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.36 65.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.483 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.97 -40.28 78.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.86 -43.12 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.585 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.59 -31.94 69.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.6 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.03 -43.27 71.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 8.3 tp -72.81 -57.87 3.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.613 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.0 p -44.81 -37.72 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.151 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.12 -31.83 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.115 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.5 tp -59.13 -18.68 37.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -87.97 -27.54 22.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.351 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' MET . 4.6 m-85 -69.67 -50.93 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.7 -12.29 61.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -79.22 -34.97 42.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.293 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.48 -16.56 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.6 tpp -99.51 -9.39 23.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.39 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 45.68 49.11 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.27 143.98 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.441 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -105.49 130.8 22.47 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.169 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.0 167.58 25.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.302 2.002 . . . . 0.0 112.341 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.83 166.4 21.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.36 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 86.4 t -53.52 -48.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.7 mp -70.1 -47.34 62.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.462 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -52.73 -51.11 61.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.07 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.336 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -43.37 71.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -62.29 -39.25 92.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -59.68 -38.6 81.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.72 -34.15 76.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.02 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.81 98.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.544 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.49 -53.07 7.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -45.96 -43.33 13.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.0 -44.15 89.41 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.35 -46.98 94.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 109.895 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -44.78 -48.3 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.638 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.98 -48.03 88.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -30.46 12.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.257 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.73 66.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.78 -42.59 85.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.52 -35.64 75.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.21 -22.99 78.64 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 1.27 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.3 mt -83.89 -36.88 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.683 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.1 73.11 0.23 Allowed Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.036 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.07 22.7 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.709 2.273 . . . . 0.0 111.72 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -108.32 -12.57 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.159 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -107.41 161.28 23.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.715 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.34 -15.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.564 2.176 . . . . 0.0 112.203 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 mt -46.25 -27.41 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 69' ' ' LEU . 45.7 mtm180 -38.81 -62.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 28.9 t80 -52.87 -37.66 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.192 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 69' ' ' LEU . 17.8 t -60.93 -43.56 96.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.57 -35.8 57.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.195 0.522 . . . . 0.0 110.067 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.1 mtp -59.37 -17.86 33.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.492 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 71.5 t -52.37 -41.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.408 0.623 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 mm -88.1 -31.52 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.767 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.519 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 3.8 t-105 -66.65 -54.75 19.98 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.9 tp -64.19 -49.07 73.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.769 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -42.84 -42.24 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -78.57 -21.66 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.59 -62.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.692 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -72.9 -53.47 11.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.426 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -69.45 -45.41 69.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.75 86.99 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 88' ' ' THR . 67.8 t -68.1 -49.81 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.348 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -50.76 -24.78 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.9 tp -79.83 -38.34 33.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.26 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 82.3 p -56.06 -29.95 61.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 110.207 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.13 -42.06 85.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.648 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.8 -39.43 81.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.366 . . . . 0.0 110.611 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.51 -44.1 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.2 p -69.26 -50.6 45.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 mmt -46.31 -47.58 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -47.19 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.47 -34.7 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.3 mt -100.87 -12.09 19.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.615 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.725 0.298 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -125.47 27.27 6.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.584 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 tp -118.42 61.16 4.39 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.69 6.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.698 2.265 . . . . 0.0 112.685 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.584 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.6 mp -78.5 -25.47 45.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.392 0.615 . . . . 0.0 109.863 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -96.22 -42.79 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.914 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.47 -44.68 95.8 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.048 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 36.4 m0 -78.23 -15.61 58.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.16 77.09 10.99 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.65 -14.89 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.52 -3.61 31.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.07 32.61 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.225 0.536 . . . . 0.0 110.768 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -155.45 -44.58 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.38 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.18 129.39 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.05 153.49 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.565 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t -167.28 99.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.85 -165.02 26.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.9 148.39 22.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.246 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 36.4 m -101.72 132.0 47.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.962 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 88.2 -2.95 0.5 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.896 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.13 129.42 39.85 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.139 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.88 130.06 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -16.94 5.42 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.507 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -172.84 138.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -145.74 160.93 41.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.179 0.514 . . . . 0.0 112.0 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -121.98 138.48 54.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.063 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.3 17.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.15 22.1 53.1 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.49 133.58 54.59 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.27 146.0 53.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.411 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.8 mtt -45.78 -54.11 17.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 142' ' ' MET . 89.1 Cg_exo -41.86 -35.47 2.98 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.4 2.066 . . . . 0.0 112.16 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -71.57 -52.11 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.952 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.4 m95 -59.92 -57.24 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.106 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -44.18 -36.97 2.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -33.02 73.51 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.13 -50.78 58.17 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.315 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.5 mt -69.83 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.024 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -63.54 -42.9 98.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.145 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.7 tp -69.95 -31.64 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.262 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.17 70.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.74 -51.21 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.675 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.41 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 33.7 mt -56.22 -31.59 63.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.635 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.78 -35.84 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.073 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.87 -36.88 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.519 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -68.56 -43.3 76.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.59 -24.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.928 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.447 ' O ' ' OG ' ' A' ' 163' ' ' SER . 44.5 tp -80.76 -43.76 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.37 -34.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.29 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.8 t -68.36 -48.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 110.395 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -22.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 21.3 m . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.973 0.416 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -51.12 -34.53 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.3 t80 -69.36 -44.39 71.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.123 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.2 tp -47.8 -38.7 16.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.484 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -67.43 -26.16 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.485 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' PHE . 23.6 mt-30 -80.48 -47.02 14.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.791 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.36 -38.74 90.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.1 m -76.67 -32.39 57.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.495 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 8.2 tt0 -71.38 5.62 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.008 0.432 . . . . 0.0 110.576 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.2 148.34 18.71 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -70.01 -20.79 63.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.91 -45.74 55.93 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.95 -50.49 73.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.74 0.305 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -56.4 -44.79 80.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.487 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.63 -30.43 71.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.306 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -70.21 -26.94 64.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.686 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.469 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -76.87 -34.27 57.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -56.55 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -52.81 -51.12 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.692 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -45.3 -60.91 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -33.37 61.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.463 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.58 -41.44 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.91 -33.18 61.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.216 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.21 -32.69 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.252 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.41 -45.37 55.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.46 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.06 -52.06 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.332 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 17.4 m -56.06 -30.77 62.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -33.36 38.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.884 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -17.22 64.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -91.03 -34.63 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' MET . 27.3 t80 -60.5 -39.07 86.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.07 -40.3 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.594 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.52 -22.66 65.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 36' ' ' MET . 9.7 p -109.3 -42.83 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 6.7 tpt -84.82 5.91 26.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.684 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt 42.99 44.67 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -63.11 147.05 51.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 81.8 mttt -113.13 90.83 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.225 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.11 172.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.45 2.1 . . . . 0.0 112.415 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.96 168.98 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.943 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 91.6 t -53.94 -51.33 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.9 mp -66.15 -50.0 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.8 m -50.57 -49.86 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.752 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.37 -42.45 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -47.5 75.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.78 -40.19 79.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.418 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -58.12 -33.96 69.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.38 84.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.443 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.38 73.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.4 tp -73.06 -53.28 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -42.86 -41.25 3.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.89 -40.38 95.42 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.4 t -61.11 -47.66 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.223 0.535 . . . . 0.0 109.559 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -45.5 -47.12 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.491 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.64 -28.26 69.55 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.39 -34.96 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.61 -34.14 75.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.237 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.39 -32.39 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.218 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -77.59 -42.65 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.342 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -23.79 75.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.6 4.73 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.625 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -84.9 -34.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.738 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.55 73.63 0.11 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.54 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.51 12.37 2.9 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.891 2.394 . . . . 0.0 111.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 10' ' ' GLN . 8.8 mttm -96.93 -10.01 27.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.61 161.29 28.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.692 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -38.14 -19.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.519 2.146 . . . . 0.0 112.197 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' THR . 8.3 mp -43.7 -30.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.24 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttm180 -38.14 -51.7 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -55.21 -35.78 65.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.503 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.7 t -61.96 -58.45 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.152 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.73 79.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.366 0.603 . . . . 0.0 109.774 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -8.88 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 53.4 t -60.58 -43.86 95.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.529 0.68 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 76' ' ' ILE . 79.8 mt -87.98 -29.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.894 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.1 t-105 -65.0 -52.33 56.72 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.772 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.8 tp -64.85 -48.56 73.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.586 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -43.69 -42.79 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.888 0.375 . . . . 0.0 110.356 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -23.09 36.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.87 -61.7 2.42 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.912 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE2' ' OE1' ' A' ' 86' ' ' GLN . 70.4 t80 -75.43 -46.96 29.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.397 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -72.11 -41.01 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.78 -48.19 87.48 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' A' ' 88' ' ' THR . 16.5 m -71.46 -45.83 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.496 ' OE1' ' CE2' ' A' ' 82' ' ' PHE . 56.4 tt0 -52.24 -27.5 15.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.401 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.74 -44.19 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.37 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 48.4 p -49.5 -25.29 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.82 -45.18 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.75 -45.7 85.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.739 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.22 -40.91 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.0 p -71.57 -41.95 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.585 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -47.12 -47.71 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.326 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.65 -47.22 82.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -51.47 -40.23 59.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.71 -12.49 27.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.551 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 93' ' ' MET . 30.9 t80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.745 0.307 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.64 -5.62 19.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.613 ' C ' ' H ' ' A' ' 116' ' ' LEU . 18.6 mt -120.05 83.3 30.69 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.8 Cg_exo -54.4 4.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 112.052 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -66.01 -30.23 70.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.084 0.468 . . . . 0.0 110.321 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.19 -42.19 7.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -73.63 -45.23 54.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -73.27 -15.58 61.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.375 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.29 72.25 32.37 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.9 -16.87 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.91 2.407 . . . . 0.0 112.042 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 -19.14 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.878 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.33 39.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.464 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.29 -42.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.069 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.06 128.09 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.41 156.24 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.6 t -168.29 99.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.19 -172.3 23.53 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.61 150.9 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 54.5 m -102.26 132.29 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.027 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.44 -3.52 0.29 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -69.32 150.06 47.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.253 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -86.38 113.16 22.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -106.61 -16.31 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.536 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 135' ' ' TRP . 13.7 t90 -173.92 119.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.4 t70 -109.08 151.64 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.205 0.526 . . . . 0.0 112.034 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 8.2 t80 -153.7 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.901 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 50.9 mt 79.06 17.87 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.45 7.04 88.77 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 mt -120.63 150.65 40.59 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 44.1 mm-40 -77.36 161.07 28.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.331 0.586 . . . . 0.0 111.3 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 4.3 ttt -44.09 -58.66 4.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.425 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 142' ' ' MET . 6.8 Cg_endo -49.33 -20.45 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.298 1.999 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 141' ' ' GLU . 6.6 mm-40 -75.45 -58.11 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.811 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -64.35 -53.4 49.21 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.983 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 tt -43.42 -45.83 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.2 tp -52.85 -37.62 60.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.22 -40.19 83.6 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.544 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -77.3 -35.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.682 0.277 . . . . 0.0 110.302 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.29 69.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.09 -39.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.161 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.6 -48.99 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.37 -45.68 93.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 7.8 tt -54.7 -31.11 57.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.411 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.69 -26.88 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.25 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.486 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 58.0 t -74.3 -32.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.388 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.521 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -51.41 8.73 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.534 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.68 -40.41 69.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.355 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -77.21 -35.13 55.91 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.378 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 54.8 t -76.87 -22.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.057 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 t -77.15 -46.66 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.342 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.99 -19.62 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 23.5 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 ttm105 -55.7 -41.06 73.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.31 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.35 -44.77 95.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.406 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.43 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -49.36 -41.07 37.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 19.2 t30 -67.0 -29.72 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -77.16 -49.64 14.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.69 71.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.5 m -76.52 -42.32 43.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 6' ' ' ASN . 1.1 mp0 -67.61 5.69 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.37 141.07 15.24 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -69.07 -50.32 49.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.593 0.235 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -46.31 6.18 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.7 89.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.114 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -59.81 -38.99 83.49 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.78 -30.15 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.949 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.95 -27.83 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.4 mtt -75.88 -33.92 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.77 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 4.3 m-85 -57.58 -50.15 74.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.558 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.0 m -42.87 -60.27 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.16 -25.94 48.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -78.94 -40.62 31.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.41 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -70.58 -35.21 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.593 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.41 -49.6 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.531 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.02 -57.88 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.626 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -46.33 -37.88 8.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.36 -17.32 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -95.56 -36.46 11.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.927 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CZ ' ' CZ2' ' A' ' 135' ' ' TRP . 2.5 m-85 -54.46 -46.14 73.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.733 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -40.74 76.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -60.03 -20.05 55.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.33 -35.32 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 31.7 mtt -87.72 3.49 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt 50.66 49.81 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.692 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.38 155.76 18.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 140.91 40.0 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.266 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.52 177.47 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.52 2.147 . . . . 0.0 112.091 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -131.75 -166.41 1.72 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.632 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 35.8 t -65.55 -51.3 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.833 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 10.6 mp -65.95 -50.1 65.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -48.59 -45.2 37.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.21 -38.16 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.094 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.9 -48.06 82.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.958 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -61.28 -38.1 85.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -58.96 -40.1 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.24 83.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.4 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.78 -52.45 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.198 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.46 -39.63 7.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.77 -43.84 90.78 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 34.8 t -62.7 -47.36 93.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.166 0.507 . . . . 0.0 109.748 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.53 -45.87 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.603 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -30.05 76.64 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.73 -40.06 91.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.71 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.01 -25.22 60.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 3.3 mm? -79.47 -37.75 36.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -79.94 -35.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -22.99 72.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.94 6.65 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 110.74 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -80.24 -31.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.426 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.7 77.14 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.633 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.87 26.88 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.661 2.241 . . . . 0.0 111.947 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -106.84 -9.77 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.059 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.29 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.464 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.4 -5.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.089 1.859 . . . . 0.0 111.773 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 tt -44.44 -37.66 3.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.431 HH21 ' NE2' ' A' ' 10' ' ' GLN . 59.7 mtt180 -40.78 -70.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.666 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.03 -31.54 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.133 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.61 -46.95 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.84 -33.87 52.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.235 0.54 . . . . 0.0 110.109 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.16 -17.35 40.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.539 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 69.2 t -53.41 -40.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.425 0.631 . . . . 0.0 110.38 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.87 -33.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.524 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.491 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.7 t-105 -61.79 -55.88 25.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.48 -48.49 77.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -45.86 -45.71 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.259 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -76.84 -25.3 53.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.387 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.68 -59.07 5.98 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.01 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.37 -54.33 8.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.174 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -66.14 -45.36 81.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.23 89.93 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' O ' ' OG1' ' A' ' 88' ' ' THR . 89.3 t -68.74 -52.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.393 . . . . 0.0 110.578 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -51.16 -25.14 4.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.06 -40.91 17.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.548 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 42.1 p -54.11 -24.99 19.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -73.47 -48.16 35.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -51.19 -32.76 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.426 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 12.5 t-80 -73.38 -45.23 56.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.671 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -45.86 70.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' TYR . 32.9 ttp -51.36 -49.77 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -49.82 54.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.455 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 5.4 tt0 -52.36 -48.81 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.25 -19.5 26.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.023 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.74 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.65 0.262 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 9.6 p-90 -124.56 -5.13 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.5 tp -119.69 80.49 23.98 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.48 -5.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.688 2.259 . . . . 0.0 112.556 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.1 mt -57.89 -28.97 64.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.473 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 12.6 t0 -96.53 -39.39 9.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.598 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.574 ' HZ2' ' HE1' ' A' ' 119' ' ' TRP . 6.0 ttpp -68.61 -45.28 72.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.574 ' HE1' ' HZ2' ' A' ' 118' ' ' LYS . 41.5 m0 -77.74 -18.55 56.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.86 76.43 17.18 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 -17.68 9.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.742 2.294 . . . . 0.0 111.654 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -52.41 -50.84 61.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.865 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.81 55.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.473 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -157.59 -44.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -56.11 130.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.61 146.55 24.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.801 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -159.04 99.81 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.14 -171.56 22.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.97 160.38 14.3 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.66 0.267 . . . . 0.0 110.363 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 85.4 m -108.11 134.95 50.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 98.38 -9.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.736 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.72 129.23 39.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.9 ptt85 -65.84 129.18 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -124.17 -29.45 3.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.435 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.551 ' CZ2' ' CZ ' ' A' ' 32' ' ' PHE . 5.4 t90 -173.74 137.82 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.779 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -142.21 160.44 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 112.135 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -118.98 138.41 52.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.046 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.68 17.35 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.155 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.78 22.87 40.99 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.81 135.88 54.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.455 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 8.9 mt-10 -68.74 146.36 53.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.598 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtp -48.75 -52.41 45.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.63 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 142' ' ' MET . 81.1 Cg_exo -44.46 -37.07 10.43 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.049 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.428 ' NE2' ' C ' ' A' ' 144' ' ' GLN . 0.6 OUTLIER -70.92 -49.33 46.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.98 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.571 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.1 m95 -59.54 -56.77 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.244 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -44.07 -39.35 4.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.9 -37.24 73.64 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.33 -43.34 97.4 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.731 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.6 mt -69.61 -26.7 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.8 0.333 . . . . 0.0 110.408 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -42.89 94.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.976 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.64 -47.98 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.045 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.3 -50.57 73.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.78 -44.38 96.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.739 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.53 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -61.33 -30.02 70.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.157 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.1 mt -73.55 -39.45 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.491 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.1 t -59.08 -38.2 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -74.1 -43.49 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.403 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.97 -37.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.398 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.67 -25.02 38.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.792 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 163' ' ' SER . 38.0 t -78.33 -25.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.526 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.9 p -82.97 -45.08 19.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.347 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.3 mm -65.39 -28.57 44.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.379 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 13.3 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.518 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.559 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.5 mm? . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -51.1 -33.99 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.09 -40.69 64.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.421 ' O ' ' OG ' ' A' ' 9' ' ' SER . 6.4 tp -49.3 -45.17 44.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.494 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -67.06 -24.21 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.025 0.441 . . . . 0.0 110.066 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -78.69 -47.39 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -32.23 73.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.5 m -76.1 -37.79 57.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.236 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -72.11 11.95 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.245 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.14 141.46 15.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.84 -50.57 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.22 5.72 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -61.05 -46.29 91.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.307 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -61.83 -34.04 75.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.19 -30.92 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.017 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.84 -28.52 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.646 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.47 -34.76 60.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.79 -54.8 16.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.723 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 23' ' ' LEU . 17.4 t80 -54.51 -51.64 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.615 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 18' ' ' MET . 6.3 p -43.22 -56.01 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.7 56.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.9 tt -77.56 -39.58 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.539 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.02 -44.5 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.621 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.8 mp -71.54 -32.08 67.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.458 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.57 -48.51 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.1 -58.09 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 25.3 p -46.03 -33.68 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.78 -32.02 27.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.393 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -62.43 -16.02 52.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.636 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -91.41 -38.74 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 36' ' ' MET . 5.1 m-85 -56.08 -45.62 79.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.442 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -73.24 -36.77 66.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.554 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -56.65 -35.62 68.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.547 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.05 -50.82 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.8 tpp -69.91 0.64 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 42.25 45.5 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 110.115 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.83 149.29 47.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.896 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HZ2' ' HG ' ' A' ' 127' ' ' SER . 16.8 mtpp -117.87 83.46 18.65 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.77 154.38 1.98 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 112.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 4.7 t -106.52 -171.68 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.53 -50.5 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.652 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 10.4 mp -58.39 -40.79 83.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.097 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -53.85 -42.51 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.41 -46.53 92.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.65 -48.62 72.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -64.56 -36.02 82.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.74 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -68.92 -39.26 79.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.499 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.18 88.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.15 -48.28 73.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -48.98 22.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.12 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.73 -43.21 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 109.811 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.93 97.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -59.46 -47.26 91.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.782 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.56 -46.5 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.371 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.01 -27.69 70.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.96 -33.45 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.72 71.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.68 -35.3 80.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.0 -37.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.41 -16.62 71.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.82 2.04 32.0 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.015 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -84.05 -38.85 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.99 78.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.614 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.62 20.5 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.718 2.279 . . . . 0.0 112.164 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -107.56 -7.07 16.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.34 165.01 13.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.49 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -39.64 -14.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.45 2.1 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 67' ' ' THR . 75.0 mt -44.64 -32.0 1.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 69' ' ' LEU . 41.2 mtm180 -40.03 -63.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -57.27 -22.36 40.95 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.122 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.5 t -76.17 -44.27 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.993 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.84 59.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.518 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -57.5 -14.05 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.799 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.68 -44.99 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.44 0.638 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -88.19 -28.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.838 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.455 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -64.66 -53.65 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.209 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.73 -45.3 71.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -45.47 -46.16 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.592 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -77.82 -23.38 49.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.93 -60.01 4.52 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.279 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.47 -52.02 13.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -67.26 -41.69 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.12 92.31 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.7 t -75.18 -56.87 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -47.19 -27.57 1.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.838 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.43 -35.32 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.988 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 29.4 p -56.7 -51.38 69.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.139 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -33.87 3.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.196 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.79 -40.15 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.922 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 88' ' ' THR . 1.6 t60 -66.99 -40.7 87.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.426 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.4 p -73.32 -51.82 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.875 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.8 ttt -43.75 -43.03 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.49 -40.08 77.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -66.95 -46.38 74.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.915 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.03 -28.97 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.41 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.954 0.407 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.671 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -114.73 7.27 15.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.0 tp -120.68 83.63 35.79 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.948 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -52.69 6.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.777 2.318 . . . . 0.0 112.699 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.637 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -66.39 -31.09 71.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 109.942 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 1.1 m-20 -96.73 -41.17 8.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.365 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -70.37 -44.14 68.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.752 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.452 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.7 t90 -76.63 -14.81 59.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.59 69.36 13.63 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.743 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 -11.2 17.43 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.765 2.31 . . . . 0.0 112.068 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.433 ' H ' ' CD ' ' A' ' 122' ' ' GLN . 25.1 mp0 -59.66 -54.21 49.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.11 50.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 111.103 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -156.32 -38.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.176 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.16 124.24 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.75 157.6 16.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.756 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.671 ' HG ' ' HZ2' ' A' ' 39' ' ' LYS . 44.1 t -162.96 144.6 10.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.239 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.4 23.25 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 4.4 p30 -103.65 168.91 8.84 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.3 m -115.02 135.34 54.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.797 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 87.95 -0.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -67.98 152.06 46.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.566 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -89.34 137.33 32.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.43 -30.37 2.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.02 139.78 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.05 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -140.0 167.83 21.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.521 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.8 t80 -143.59 120.14 11.06 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.6 tp 78.39 16.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 12.84 76.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 mt -119.99 135.24 54.99 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.842 0.354 . . . . 0.0 110.195 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -72.89 154.25 40.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.409 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -48.24 -61.73 2.87 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.614 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 95.3 Cg_exo -34.09 -39.18 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.71 2.273 . . . . 0.0 112.506 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -72.43 -49.2 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.598 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.9 m95 -60.46 -57.67 11.77 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.022 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.4 tp -43.35 -40.54 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.219 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.08 -34.09 71.58 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.88 -44.62 95.92 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.5 mt -76.14 -36.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.347 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.75 -47.2 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.97 -41.71 90.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.585 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -49.29 -46.3 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.409 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -64.87 -44.66 88.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 tp -49.34 -46.81 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.036 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.46 -45.3 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.264 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 75.1 t -49.8 -36.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 111.022 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.56 -31.73 57.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.38 -46.36 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 0.0 110.989 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 163' ' ' SER . 10.1 mp -77.4 -28.18 52.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 46.3 t -78.17 -35.2 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.918 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 162' ' ' ILE . 6.4 p -73.62 -46.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.201 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.476 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 5.6 pt -71.99 -24.89 23.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.058 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 4.4 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.368 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.855 0.36 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -55.73 -36.19 66.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.38 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 7' ' ' GLN . 1.4 t80 -68.64 -46.27 69.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.181 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.15 -40.77 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.0 OUTLIER -69.11 -22.85 63.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.351 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' PHE . 14.1 tm0? -81.07 -46.95 14.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.713 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.74 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' GLY . 52.2 p -76.2 -30.93 58.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -75.92 12.14 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.333 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.44 144.46 16.27 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -19.07 63.49 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.386 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.07 -46.41 65.93 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -51.27 68.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -56.53 -40.12 74.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.779 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.2 -32.6 63.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mt -68.89 -30.75 69.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.531 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.25 -34.29 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.88 -56.67 7.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.446 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.77 -53.35 49.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 p -42.96 -56.64 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.437 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.04 -33.71 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.452 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.04 -40.38 68.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.69 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 10.4 mp -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.485 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -72.39 -43.88 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.681 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.42 -57.78 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.512 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.2 p -47.37 -36.99 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.68 -35.35 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -18.0 56.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.358 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -94.75 -34.02 12.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -55.48 -48.87 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.534 HE21 ' CB ' ' A' ' 38' ' ' LEU . 5.3 mt-30 -75.18 -20.82 59.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.446 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -68.88 -28.99 67.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.56 -31.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 mtt -84.48 0.52 49.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.729 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.7 mt 48.86 48.65 20.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.898 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.534 ' CB ' HE21 ' A' ' 33' ' ' GLN . 13.3 mt -97.51 156.5 16.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.308 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -119.72 148.54 46.41 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.252 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.47 175.02 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.44 2.094 . . . . 0.0 112.179 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -128.91 175.36 8.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.5 t -61.5 -54.73 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.757 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.495 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 7.9 mt -67.2 -46.67 73.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -48.7 -46.12 40.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.516 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.412 HG21 HD12 ' A' ' 45' ' ' ILE . 83.7 mt -64.44 -43.7 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.94 -45.55 74.86 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.51 -30.9 71.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.037 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -63.33 -37.94 89.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.969 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.99 -33.16 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.11 77.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.2 tt -77.28 -56.06 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.033 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -43.36 -38.25 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.48 -41.0 91.11 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 51' ' ' LEU . 14.8 t -65.92 -43.26 92.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 109.73 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -47.6 -47.54 28.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.721 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.95 -34.38 89.77 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.72 92.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.091 -0.554 . . . . 0.0 110.457 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.25 75.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.377 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.11 -36.23 77.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.631 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.95 -33.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.52 -12.51 83.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.74 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 111.043 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -91.52 -24.11 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.89 73.27 0.11 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.6 22.6 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.911 2.407 . . . . 0.0 112.371 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -115.65 -4.64 12.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -110.46 161.29 25.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.848 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -37.07 -19.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.683 2.256 . . . . 0.0 112.196 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.0 mm? -44.67 -29.03 0.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -40.59 -67.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.679 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -53.6 -34.7 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.289 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 11.7 t -63.67 -57.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.362 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.29 80.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.0 ttt -64.88 -13.68 57.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 2.9 p -60.44 -35.11 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.292 0.567 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -88.67 -32.46 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.032 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.578 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.0 t-105 -59.59 -51.92 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.84 -43.06 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.624 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -47.44 -47.31 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 p -78.52 -23.64 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -58.09 10.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.205 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.9 -53.86 9.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.974 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -66.1 -45.53 80.85 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.48 -47.28 91.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.432 ' O ' ' OG1' ' A' ' 88' ' ' THR . 57.9 t -65.0 -39.36 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.52 -31.36 69.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -78.03 -45.7 22.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.346 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 63.1 p -49.13 -31.46 8.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -42.47 79.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.291 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -60.67 -31.65 70.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -75.94 -46.68 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.56 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -66.44 -49.39 66.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.2 mmt -50.35 -49.71 53.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.487 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 33.8 tt0 -51.18 -39.36 56.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.68 -11.97 22.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.739 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.1 t80 . . . . . 0 CA--C 1.532 0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.565 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.674 0.273 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -125.56 -5.77 7.02 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.608 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.661 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.6 mt -115.57 87.64 17.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.44 6.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.696 2.264 . . . . 0.0 112.73 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.661 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tp -73.74 -26.36 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -96.38 -36.97 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.844 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.04 -41.44 67.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -75.59 -20.78 58.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.913 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 p -165.13 84.93 1.08 Allowed Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.685 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -80.74 -2.52 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.784 2.323 . . . . 0.0 111.816 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -60.12 -54.32 47.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 123' ' ' VAL . 8.6 p -97.49 59.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.628 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -165.67 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 m -57.52 128.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.8 153.94 17.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.837 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 t -170.15 99.96 0.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.473 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.12 -167.6 26.35 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' O ' ' OE2' ' A' ' 132' ' ' GLU . 4.0 m-20 -99.84 146.22 26.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.698 0.285 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 62.7 m -98.77 136.72 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.991 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 91.44 -3.62 0.21 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.872 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' OE2' ' O ' ' A' ' 129' ' ' ASP . 12.3 pt-20 -67.74 153.23 44.16 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.309 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -88.4 138.81 31.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.26 -31.04 2.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.648 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -171.94 136.22 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.265 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.3 t70 -119.61 158.35 26.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 111.943 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.548 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 83.2 t80 -144.82 111.16 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.95 17.38 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 136' ' ' ASP . . . 84.76 9.22 81.48 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 6.4 mt -115.49 133.95 55.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.128 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.487 ' OE1' ' NE2' ' A' ' 95' ' ' GLN . 5.2 mt-10 -70.46 154.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.443 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -54.17 -51.0 81.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.995 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 142' ' ' MET . 69.5 Cg_exo -47.11 -40.13 26.47 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.383 2.055 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -71.2 -38.73 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 148' ' ' GLY . 32.6 m95 -67.11 -56.56 9.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.271 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 tp -43.06 -42.95 4.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 147' ' ' LEU . 2.6 tm? -59.7 -37.07 77.83 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.31 -40.92 92.66 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.924 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.59 -25.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.682 0.277 . . . . 0.0 110.357 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -42.75 92.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.084 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 151' ' ' ILE . 8.6 mm -63.0 -43.68 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.024 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.78 64.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.456 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.6 m-85 -56.2 -37.28 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.7 tp -66.34 -30.22 70.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.412 . . . . 0.0 110.6 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.9 -39.99 59.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.06 -34.52 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.026 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.05 -31.03 58.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.16 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.2 t -64.24 -42.89 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.413 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.99 -24.05 38.29 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.205 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.1 -39.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.344 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.02 -50.15 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.577 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.65 -8.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.289 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.592 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 8.8 mp . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.826 0.346 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -50.95 -46.39 61.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.54 -45.53 92.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.67 -46.42 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -68.01 -21.85 65.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.077 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.97 -46.17 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.642 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.27 75.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.545 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.7 p -76.2 -38.01 57.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.504 HE22 ' C ' ' A' ' 65' ' ' PRO . 18.7 tp60 -70.75 10.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.151 0.5 . . . . 0.0 110.235 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.71 141.61 15.42 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.679 ' N ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -69.8 -49.98 47.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.522 0.201 . . . . 0.0 110.822 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.72 -46.02 5.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -63.13 -46.71 86.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.166 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -56.62 -40.69 75.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.1 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.04 -26.44 66.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.92 -43.43 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.32 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -64.73 -30.79 71.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.0 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.576 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.94 -36.57 70.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.948 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.5 p -66.94 -44.64 80.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.608 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.91 98.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.766 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.44 -36.72 60.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.704 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.74 -37.07 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.073 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.22 -39.47 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 0.0 110.668 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 26' ' ' GLU . 2.2 tm-20 -63.42 -38.83 92.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.584 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.92 -57.81 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -45.22 -27.24 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.633 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.9 -37.24 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' CD1' ' OE1' ' A' ' 26' ' ' GLU . 19.2 mt -63.07 -13.85 41.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.563 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.454 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 20.4 t-105 -96.49 -28.54 14.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.499 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.9 m-85 -71.59 -50.05 34.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.22 -58.05 10.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.94 0.4 . . . . 0.0 110.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -56.17 -14.04 2.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.949 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 31' ' ' TRP . 79.4 t -108.99 -21.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.0 tpt -104.33 0.76 29.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt 49.14 31.04 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.442 ' CD1' HE22 ' A' ' 134' ' ' GLN . 0.6 OUTLIER -80.23 154.41 27.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.02 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -116.75 127.34 26.8 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.5 -179.9 5.77 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.322 2.015 . . . . 0.0 112.063 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.88 178.45 5.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 9.2 p -64.99 -41.25 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 5.2 tp -64.28 -49.05 73.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -50.08 -48.84 53.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.662 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.528 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.97 -46.94 81.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.43 -35.36 78.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.314 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -64.19 -34.38 77.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.53 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 tt -77.53 -55.44 5.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.26 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -44.55 -40.98 6.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.56 96.39 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.7 t -60.17 -46.99 93.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.157 0.503 . . . . 0.0 109.834 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.99 -44.36 20.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.393 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -25.85 71.23 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.87 -42.19 61.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -27.06 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.132 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.482 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.8 tp -74.66 -39.94 61.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.52 -35.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.084 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.22 -18.95 70.51 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.88 0.54 43.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.612 0.244 . . . . 0.0 110.938 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 6.3 mm -88.11 -22.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.568 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -177.81 65.58 0.19 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.504 ' C ' HE22 ' A' ' 10' ' ' GLN . 59.1 Cg_endo -75.77 19.17 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.609 2.206 . . . . 0.0 112.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 64' ' ' ALA . 26.4 pttt -109.64 -7.79 15.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -110.93 161.67 23.95 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.563 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -34.97 -19.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.749 2.299 . . . . 0.0 112.404 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.661 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 mm? -42.24 -29.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.386 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -40.27 -66.07 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.657 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.2 -36.13 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.148 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.28 -51.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.609 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.74 -33.07 71.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.184 0.516 . . . . 0.0 109.741 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttm -61.49 -9.45 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.535 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 40.5 t -61.07 -41.74 90.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.05 -27.79 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.196 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.479 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.0 t-105 -69.05 -54.48 14.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.6 tp -62.17 -50.13 73.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.309 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.5 m-85 -42.58 -41.57 3.08 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.012 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.2 p -80.08 -22.48 42.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.72 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.752 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 2.0 t80 -74.2 -49.54 23.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.204 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -69.85 -43.32 72.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.01 94.49 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.51 -37.39 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.436 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 82' ' ' PHE . 55.3 tt0 -68.32 -31.26 70.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 110.93 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.52 -42.17 17.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.944 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 p -49.68 -51.79 35.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.495 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.422 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -51.17 -50.13 59.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.143 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -43.66 -41.84 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -65.64 -53.16 45.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 51.8 p -51.8 -40.7 60.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.616 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.3 ttm -61.41 -40.92 96.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.476 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tp -67.4 -35.12 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -67.06 -40.45 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.469 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.79 -13.97 25.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.169 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' OE2' ' CH2' ' A' ' 113' ' ' TRP . 10.4 pt-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.591 0.234 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.481 ' CH2' ' OE2' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -101.22 -6.53 24.09 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.268 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.698 ' C ' ' H ' ' A' ' 116' ' ' LEU . 34.6 mt -119.35 91.94 44.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.932 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.1 Cg_exo -52.52 9.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.543 2.162 . . . . 0.0 112.344 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.698 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -68.98 -30.1 68.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.994 0.426 . . . . 0.0 110.168 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 2.0 m-20 -98.17 -39.33 8.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.488 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -73.4 -45.34 55.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.889 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.446 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 13.6 t-105 -76.19 -13.69 60.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.217 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.64 71.19 13.98 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.15 -12.62 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.71 2.273 . . . . 0.0 111.621 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.46 -28.89 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.782 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.489 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.0 t -129.97 49.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.691 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 3.4 m-85 -156.83 -39.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.053 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.1 p -64.7 126.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.71 159.14 16.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.576 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.6 t -177.32 99.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.417 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.99 -162.49 27.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -97.68 142.82 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 3.4 m -94.37 132.16 39.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.5 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 92.57 4.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -70.95 142.84 51.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.203 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' C ' ' OE1' ' A' ' 134' ' ' GLN . 32.0 ptt85 -99.11 133.84 42.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.442 HE22 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mm100 -103.22 -28.35 11.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 13.3 t-105 -174.17 145.83 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 6.3 p30 -133.85 163.48 29.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 112.462 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -126.59 138.59 53.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.578 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 50.82 17.53 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.442 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 22.56 37.89 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -123.26 136.23 54.62 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.05 154.74 41.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.056 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.561 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.7 ttt -51.3 -56.77 17.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 142' ' ' MET . 1.6 Cg_endo -43.76 -36.75 7.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -69.88 -56.73 6.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.267 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 56.5 m95 -56.95 -57.33 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -43.38 -37.1 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -35.85 76.05 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.29 -42.76 98.9 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -80.41 -25.75 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.076 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -64.55 -48.53 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.625 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 152' ' ' ALA . 13.3 tt -67.19 -41.81 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.467 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.439 ' N ' ' CG2' ' A' ' 151' ' ' ILE . . . -50.68 -47.89 58.66 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.476 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.97 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.711 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 154' ' ' LEU . 2.3 mp -70.07 -34.12 72.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.71 -27.17 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.44 -38.88 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.54 -52.9 22.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.259 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -56.18 -32.11 33.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.79 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.9 tp -81.37 -30.51 33.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.419 ' O ' ' OG ' ' A' ' 163' ' ' SER . 25.6 t -75.49 -25.64 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.97 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.76 -46.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -71.12 -16.73 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.965 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 85.6 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 2' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.885 0.374 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -57.55 -33.36 68.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.82 -44.83 76.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 mt -51.11 -38.55 52.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.9 t-20 -64.61 -28.79 69.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.34 -48.5 11.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.696 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.04 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 11' ' ' GLY . 12.0 m -76.7 -37.12 56.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.611 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 24.1 mm-40 -67.11 5.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.491 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.19 145.98 17.86 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -69.22 -48.66 61.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.639 0.257 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.68 6.11 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.78 83.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 18' ' ' MET . 60.3 m95 -59.36 -43.48 92.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.171 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -30.06 71.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 mp -70.18 -26.67 64.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.455 ' SD ' ' CE3' ' A' ' 15' ' ' TRP . 52.2 mtt -76.29 -34.3 59.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.741 0.305 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.34 23.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.823 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.0 -45.65 78.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 p -52.17 -62.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.71 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.661 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.75 -38.98 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.7 -38.05 63.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.06 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.824 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.02 -43.97 50.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.16 -56.24 10.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -48.72 -42.9 36.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.45 -28.87 59.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.22 -17.56 64.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.037 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -86.61 -38.84 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.534 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.36 -35.06 79.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -80.86 2.78 25.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.779 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -117.01 -49.64 2.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.657 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -72.88 -27.35 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.748 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' LEU . 8.7 tpp -109.35 13.88 23.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.673 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' MET . 9.7 mt 37.73 37.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.0 147.71 52.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.677 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -109.38 124.78 32.97 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 178.35 7.75 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.245 1.963 . . . . 0.0 112.263 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.74 172.18 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.637 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.2 t -56.46 -51.73 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mm? -56.23 -38.42 71.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.558 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.2 t -58.37 -43.31 88.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.143 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 45' ' ' ILE . 46.4 mm -61.36 -50.95 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.81 73.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.021 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.93 -37.97 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -36.98 84.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.14 80.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.93 -47.28 87.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.344 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 mt -77.18 -53.58 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.31 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -43.18 -41.89 3.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.08 94.99 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 51' ' ' LEU . 39.1 t -61.19 -19.4 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.266 0.555 . . . . 0.0 110.164 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.72 -41.23 23.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.053 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.17 -28.59 73.28 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.08 -47.74 23.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.99 68.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.389 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -44.73 77.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.37 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.56 -39.36 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.42 -16.67 75.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.55 0.88 48.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.77 0.319 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.42 -38.36 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.7 73.51 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.86 21.46 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.92 2.413 . . . . 0.0 112.046 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -97.4 -10.14 26.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.148 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.07 179.27 0.8 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.549 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 50.3 Cg_exo -52.22 -0.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.232 1.954 . . . . 0.0 112.164 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.582 ' H ' ' C ' ' A' ' 67' ' ' THR . 14.5 mt -56.19 -33.01 64.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 77.0 mtm180 -38.77 -61.6 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.774 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -52.1 -35.41 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.226 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 14.5 t -63.29 -52.86 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.961 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.93 61.54 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.275 0.56 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 mmt -57.94 -13.3 4.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 43.6 t -59.31 -36.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.595 0.712 . . . . 0.0 110.279 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -89.83 -27.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.285 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.506 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.6 t-105 -69.58 -52.85 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.983 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.07 -47.6 70.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.1 m-85 -46.79 -44.39 19.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.369 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -74.57 -24.68 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.62 -59.77 4.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.41 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.84 -51.25 16.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -44.64 73.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.9 -48.1 84.52 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.5 t -70.45 -53.54 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.848 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -47.98 -23.53 0.82 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.832 0.349 . . . . 0.0 110.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.57 -35.93 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 37.8 p -58.64 -23.36 58.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.628 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.11 -44.37 60.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.581 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -59.56 -34.25 72.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.472 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 91' ' ' HIS . 2.3 m-70 -72.3 -44.8 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -43.52 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.654 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 97' ' ' TYR . 50.1 mtp -55.63 -42.23 74.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.599 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.34 -47.29 64.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.37 -42.4 91.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.37 -18.83 29.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.371 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.099 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 111.297 0.11 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -125.1 -5.28 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.81 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.612 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.1 mt -111.56 72.74 1.01 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 9.9 Cg_endo -54.31 4.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.524 2.149 . . . . 0.0 112.058 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' ' C ' ' A' ' 114' ' ' LEU . 18.6 mt -74.66 -24.67 58.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -98.83 -38.85 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.499 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -82.35 -45.82 14.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.786 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -69.83 -16.92 63.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.632 -179.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 p -154.34 72.03 6.21 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 110.837 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.9 -4.51 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.068 2.512 . . . . 0.0 111.799 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.67 -52.26 41.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.7 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.57 49.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.464 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.28 -44.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.96 132.68 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.088 0.471 . . . . 0.0 110.689 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.54 161.04 13.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.474 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 t -165.75 99.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.543 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.68 -177.96 20.07 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 17.3 t0 -85.84 148.4 25.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 110.151 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.568 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 52.5 m -101.21 129.57 47.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.762 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 94.69 -8.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.727 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.74 148.77 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -86.09 123.6 31.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.456 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -128.37 -23.21 3.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -172.95 125.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.58 158.81 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 111.719 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -113.45 139.56 48.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.928 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 mt 47.91 17.02 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.488 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 92.35 21.98 30.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.041 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.06 138.53 54.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 16.3 mp0 -70.97 147.07 49.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.433 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.5 mmt -46.49 -61.81 2.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.161 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 80.9 Cg_exo -33.73 -39.61 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.878 2.385 . . . . 0.0 112.648 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -70.72 -55.66 8.16 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.917 0.389 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.584 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -55.6 -57.1 13.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.963 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -43.79 -37.67 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -37.31 72.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.49 -45.73 95.07 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.17 -30.7 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 110.194 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -58.85 -48.55 80.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.12 -46.25 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.26 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.42 -46.76 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.487 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -58.45 -44.05 89.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.63 -30.25 69.74 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.292 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.64 -27.43 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 94.9 t -75.03 -36.11 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 111.111 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.506 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -74.63 -53.13 9.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.6 m -56.39 -42.65 75.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.07 -31.67 64.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.259 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 33.8 t -78.2 -28.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.229 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.86 -51.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.394 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 52.1 mt -62.32 -33.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.05 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.774 0.321 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -53.87 -34.09 58.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.348 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -72.51 -44.38 62.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.287 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp -47.19 -37.66 10.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -67.54 -27.52 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' PHE . 9.6 tp-100 -80.77 -47.57 13.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.692 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -39.5 86.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.67 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 11' ' ' GLY . 53.2 p -76.67 -37.28 56.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 18.3 tt0 -65.21 2.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.472 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.69 148.82 19.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -69.71 -20.47 63.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.76 -45.12 59.84 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -51.1 68.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.185 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -56.1 -45.78 79.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 tp -64.64 -30.44 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.37 -32.41 70.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.1 mmt -71.14 -33.34 69.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.58 -51.96 30.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -50.02 -45.9 52.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.683 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 p -59.01 -60.88 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.04 8.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tp -80.07 -40.48 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.8 -41.99 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 10.6 mp -69.08 -26.87 65.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.81 -37.78 76.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.95 -57.53 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -44.15 -39.9 4.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.51 -35.07 63.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.767 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -18.49 62.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.761 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.41 -24.89 20.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.854 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -73.56 -38.02 65.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.59 0.84 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -119.15 -52.59 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.24 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.31 -40.48 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 37' ' ' LEU . 29.8 mtt -108.17 15.16 24.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.64 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 36' ' ' MET . 29.1 mt 37.03 41.85 0.21 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.064 0.459 . . . . 0.0 110.15 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 153.35 40.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.016 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' CB ' ' NZ ' ' A' ' 39' ' ' LYS . 6.5 mtmp? -124.7 108.12 28.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.69 169.03 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.229 1.953 . . . . 0.0 112.111 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -110.36 -175.4 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.461 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.37 -44.52 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.64 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.55 -48.29 81.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.779 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.0 m -60.8 -46.98 88.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.15 -49.8 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -54.52 -48.3 72.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -53.67 -47.57 70.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.084 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -50.7 -36.01 33.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.91 98.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.492 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.08 79.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' VAL . 9.5 mp -72.62 -50.69 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -43.39 -41.95 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.08 -37.82 92.02 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 51.8 t -62.64 -19.23 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.403 0.62 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 tt -79.76 -46.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.817 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.85 -31.77 81.53 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.44 74.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.891 0.377 . . . . 0.0 110.018 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.45 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.004 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.22 -31.22 62.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.475 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.6 mt -80.46 -42.89 21.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.09 77.0 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 7.49 3.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.654 0.264 . . . . 0.0 110.855 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.48 -55.06 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.269 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.77 84.29 0.29 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.03 24.04 0.7 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.678 2.252 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -99.25 -11.62 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -106.52 179.26 0.93 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 76.5 Cg_exo -47.46 -5.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.019 1.813 . . . . 0.0 112.02 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -49.98 -33.04 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.236 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -38.32 -66.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.031 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -57.49 -36.84 72.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.639 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.4 -52.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.804 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.31 -34.55 78.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.335 0.588 . . . . 0.0 109.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 ttt -63.61 -8.33 9.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.765 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.11 -40.85 90.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.452 0.644 . . . . 0.0 111.069 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.472 ' C ' ' CD1' ' A' ' 76' ' ' ILE . 1.4 pp -89.23 -28.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.676 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.416 ' CD1' ' HB1' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -69.15 -47.48 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.689 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.97 -45.78 80.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -49.2 -44.36 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.105 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -80.22 -23.26 41.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.431 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -59.43 -60.08 4.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.336 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -77.78 -45.37 24.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.282 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -69.96 -40.89 75.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.805 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.6 -46.47 89.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 12.7 m -79.26 -35.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -26.27 67.05 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.958 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.4 -28.46 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.704 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 20.0 p -60.94 -51.9 67.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.572 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -50.87 -29.71 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.527 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.67 -37.93 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.145 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -68.37 -37.07 80.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.272 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.1 p -72.46 -39.24 67.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.471 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.0 ttt -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.17 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.74 -38.52 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.596 HE22 HE22 ' A' ' 144' ' ' GLN . 81.2 mt-30 -72.16 -38.02 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.769 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.57 -22.66 20.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 93' ' ' MET . 86.2 m-85 . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 2.0 p-90 -113.23 10.62 18.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.679 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 tp -119.75 86.24 35.11 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 40.7 Cg_exo -54.48 15.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.847 2.365 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.679 ' H ' ' C ' ' A' ' 114' ' ' LEU . 40.6 tp -75.63 -30.44 59.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.005 0.431 . . . . 0.0 110.004 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -97.38 -39.64 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.191 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -72.46 -45.2 60.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.99 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.5 t90 -75.69 -12.44 60.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.388 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.6 67.91 78.77 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.41 -22.07 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.906 2.404 . . . . 0.0 111.689 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -55.53 -53.97 49.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.19 54.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.544 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.4 t80 -159.07 -35.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.64 130.48 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.83 163.04 13.15 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.3 t -174.67 101.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 141.46 177.95 17.18 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.47 135.74 36.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 15.0 m -91.16 129.42 37.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.56 -1.63 0.24 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.653 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -67.98 145.09 54.84 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -87.3 116.06 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -117.51 -22.3 8.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -175.75 128.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.474 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -140.54 158.74 43.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.269 0.557 . . . . 0.0 112.238 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 17.5 t80 -117.09 139.18 51.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.936 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 49.95 17.09 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.379 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.63 21.85 35.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.794 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -125.87 137.11 53.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.73 149.6 47.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.44 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -49.14 -51.5 56.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.0 Cg_exo -44.06 -37.98 10.08 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.542 2.161 . . . . 0.0 112.454 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.596 HE22 HE22 ' A' ' 95' ' ' GLN . 0.3 OUTLIER -70.71 -46.93 62.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.156 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.6 m95 -63.84 -57.25 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.3 mt -43.68 -38.56 3.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -54.39 -39.07 64.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -80.96 -27.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 110.118 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -59.67 -51.62 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.8 tt -64.2 -42.47 95.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.69 67.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.179 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -57.82 -38.64 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.58 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.75 -32.32 73.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.852 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -33.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.5 -43.37 90.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 77' ' ' TRP . . . -73.51 -48.79 30.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.23 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.0 t -51.25 -43.37 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.751 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.43 ' O ' ' OG ' ' A' ' 163' ' ' SER . 8.8 mp -75.1 -43.59 52.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.761 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.07 -29.46 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.202 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -80.51 -47.76 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 74.2 mt -70.64 -2.72 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.397 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 49.5 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.45 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -52.76 -38.24 60.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLN . 7.2 t80 -71.69 -46.3 59.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -45.48 -44.06 12.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.322 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 47.2 t30 -70.96 -20.87 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PHE . 44.2 tp60 -79.92 -47.86 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.21 74.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLY . 78.4 p -76.46 -34.17 58.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 6' ' ' ASN . 15.7 mt-30 -73.9 10.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.513 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.03 140.91 15.33 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -19.7 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.68 59.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.21 68.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -53.47 -41.54 66.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.303 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.64 -29.57 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.294 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' O ' ' OG1' ' A' ' 21' ' ' THR . 49.8 tp -68.53 -34.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mtm -73.95 -34.58 64.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.091 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.33 65.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.604 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -60.83 -33.1 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.608 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 17' ' ' LEU . 15.7 m -56.75 -54.85 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.88 -27.48 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.361 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.14 -41.84 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.12 -45.11 61.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.687 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.28 -33.28 74.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.07 -44.61 68.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.29 -58.09 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -47.21 -36.67 9.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.43 -31.12 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -18.55 63.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.416 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 11.0 t-105 -86.69 -41.03 14.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 110.36 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -56.15 -38.42 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.037 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 33' ' ' GLN . 12.9 tm0? -79.05 -23.74 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.217 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 36' ' ' MET . 11.7 p -108.41 -44.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.452 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 9.3 tpt -77.15 -2.38 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt 46.16 45.75 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.08 146.33 54.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -110.57 108.58 58.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.961 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.1 145.11 17.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.25 1.967 . . . . 0.0 111.513 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -107.49 -161.87 0.8 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.595 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.6 t -63.32 -42.6 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.2 tp -62.57 -49.31 75.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.198 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -54.66 -49.48 70.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.676 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.83 -45.35 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -59.71 -46.58 88.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.24 -47.69 84.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.257 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -56.74 -33.15 66.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.356 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.56 74.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -73.31 -50.67 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -43.8 -41.73 5.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.32 94.11 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.43 -47.73 90.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.97 -46.52 16.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.502 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -48.79 76.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.66 62.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.127 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.92 73.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 tp -72.28 -25.53 61.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.101 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.29 -39.53 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.67 -25.87 75.06 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.49 7.8 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.4 mt -79.46 -48.52 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -179.45 80.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.61 31.56 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.68 -9.7 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.946 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.99 170.52 5.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.784 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.84 -12.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 mt -43.73 -32.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.51 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -41.05 -70.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -27.37 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.677 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.32 -46.15 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.565 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.67 -35.05 60.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.599 . . . . 0.0 109.619 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 ttt -59.59 -15.72 20.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 70.9 t -55.22 -40.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.262 0.554 . . . . 0.0 110.345 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 76' ' ' ILE . 43.2 mm -85.48 -34.86 8.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.228 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.549 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.0 t-105 -61.89 -56.15 22.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.8 tp -62.84 -50.28 71.56 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -42.88 -44.87 4.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.187 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.52 -21.37 45.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.495 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -61.38 -59.91 4.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.184 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.53 -46.69 58.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -77.32 -40.29 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.32 -48.92 83.64 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.397 -0.906 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 25.3 m -67.77 -44.74 85.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.819 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.91 -28.41 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.112 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.35 61.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.236 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 70.0 p -54.79 -30.69 57.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.332 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.23 -48.34 76.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.13 -30.77 66.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 3.8 m170 -77.46 -49.04 15.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -64.56 -48.42 75.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 97' ' ' TYR . 26.7 ttt -52.71 -51.39 60.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.484 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.74 -49.36 73.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -52.35 -44.65 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 96' ' ' LEU . 3.9 mm? -88.39 -13.31 40.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 93' ' ' MET . 7.8 t80 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.277 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.1 p-90 -110.13 0.64 18.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -114.34 94.25 34.82 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.033 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.03 0.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.698 2.265 . . . . 0.0 112.935 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.8 tp -70.27 -26.13 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.71 -34.78 11.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -67.01 -35.16 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 -95.99 -23.96 16.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.364 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.8 t -149.64 87.79 5.08 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.52 -15.73 8.45 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.606 2.204 . . . . 0.0 112.521 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -85.69 -4.01 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.722 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.3 p -112.54 18.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.109 0.48 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -147.24 -43.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.433 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.67 129.96 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.88 154.57 17.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.7 p -158.53 99.78 1.61 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.509 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.55 -176.97 20.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -96.65 150.13 21.01 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 73.9 m -102.22 132.2 48.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 99.89 -10.35 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.999 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -69.53 129.16 38.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.657 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -67.96 109.45 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -115.7 -23.54 8.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.781 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 16.9 t90 -172.02 132.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 1.1 p30 -146.16 159.37 43.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -120.68 139.89 52.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.899 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.49 17.35 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.91 21.25 53.62 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 mp -123.21 135.26 54.21 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 141' ' ' GLU . 9.7 mp0 -71.65 148.81 46.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.465 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtt -45.25 -63.7 1.12 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.25 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 88.2 Cg_exo -32.35 -38.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.092 2.528 . . . . 0.0 112.801 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.455 ' CD ' ' N ' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -72.47 -51.68 19.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.004 0.43 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 72.6 m95 -56.36 -57.46 12.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.903 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -43.76 -39.14 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tt -56.27 -35.77 67.84 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -63.01 -48.42 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.489 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.45 -26.23 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.08 -41.49 97.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.75 -29.73 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.366 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.66 -52.02 62.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.272 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -57.06 -41.74 79.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.534 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 154' ' ' LEU . 4.1 mp -61.32 -30.91 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.736 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.48 -26.8 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.223 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.35 -35.1 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -71.98 -53.76 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.263 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.71 -45.92 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.913 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 163' ' ' SER . 2.3 tp -67.11 -30.21 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.731 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.467 ' O ' ' OG ' ' A' ' 163' ' ' SER . 18.4 t -74.98 -29.92 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.9 t -83.66 -51.53 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 110.318 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 40.0 mm -68.67 -12.72 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.067 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.905 0.383 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -54.96 -36.49 65.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.313 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 7' ' ' GLN . 2.6 t80 -69.77 -43.02 73.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.174 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.45 -38.31 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 2.3 m-20 -68.32 -26.8 65.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.275 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.1 mm-40 -78.08 -48.86 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.382 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.74 80.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 11' ' ' GLY . 40.1 m -76.65 -37.3 56.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.538 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 11.3 mm100 -70.24 7.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.372 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.64 145.77 16.25 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -72.33 -51.54 20.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.632 0.254 . . . . 0.0 110.744 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.97 -47.3 6.29 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.29 86.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -58.7 -37.28 75.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.19 -29.58 69.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.721 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.98 -27.73 64.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.395 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.444 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.1 mtp -76.09 -34.07 59.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.3 -54.85 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' LEU . 66.7 t80 -52.1 -52.69 49.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.4 p -44.11 -51.62 7.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -21.69 65.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -85.51 -42.37 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.468 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.63 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.54 -35.29 68.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' CD ' ' NH1' ' A' ' 48' ' ' ARG . 4.9 tp10 -64.99 -35.61 81.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.55 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.42 -56.54 4.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.659 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -45.26 -41.5 8.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.78 -32.35 65.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.567 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.03 -19.77 65.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.583 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -93.5 -19.79 20.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.21 -50.36 19.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 34' ' ' HIS . 2.0 pp0? -73.61 -9.15 58.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.12 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.608 ' N ' ' NE2' ' A' ' 33' ' ' GLN . 14.3 t-160 -77.89 -31.01 51.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.102 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.78 -9.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.8 mmt -107.05 -3.19 20.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.631 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.2 mt 47.21 50.19 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 110.282 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 39' ' ' LYS . 2.1 tt -65.07 142.19 58.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.629 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 14.9 mttm -107.31 99.66 29.03 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.455 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 127' ' ' SER . 72.1 Cg_exo -46.5 168.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.575 2.183 . . . . 0.0 112.784 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.9 161.49 32.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.187 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.506 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.7 t -48.81 -46.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 3.6 mm? -73.0 -33.88 66.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 t -58.07 -45.8 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.2 pt -69.56 -35.99 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.337 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.3 -47.36 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.91 -36.71 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' NH1' ' CD ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -63.42 -32.58 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.63 77.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.233 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.44 77.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.4 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.88 -55.51 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -44.52 -38.34 4.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.42 94.67 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -62.22 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 109.831 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -45.83 -44.63 14.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.591 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.27 -27.98 73.04 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.98 -43.21 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.616 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.74 65.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.463 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -80.84 -36.08 31.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.428 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -80.89 -34.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -75.49 -32.83 54.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.56 6.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -88.43 -22.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.518 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.63 67.82 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.82 24.61 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.672 2.248 . . . . 0.0 111.845 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 64' ' ' ALA . 37.5 mttp -111.3 -6.16 14.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.13 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.33 163.86 17.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.647 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.17 -13.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.442 2.095 . . . . 0.0 112.217 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mt -43.07 -34.46 1.04 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 59.0 mtm-85 -38.57 -66.57 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.732 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -54.15 -27.22 32.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.786 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 69' ' ' LEU . 6.2 t -72.86 -51.12 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.496 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.244 0.545 . . . . 0.0 109.913 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.23 -15.75 48.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.882 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -56.58 -36.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.453 0.644 . . . . 0.0 110.408 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.2 mt -87.38 -34.51 7.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.775 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.524 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.0 t-105 -60.61 -54.59 43.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.926 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.88 -44.93 91.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.83 -23.04 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.96 -60.83 3.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.623 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -72.47 -56.24 5.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.177 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -68.26 -47.73 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.1 -46.81 84.29 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 92.6 t -67.57 -36.09 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.58 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.45 -34.89 69.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.255 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.28 -44.64 17.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.548 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 49.2 p -45.3 -32.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.58 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -73.45 -40.83 63.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -56.34 -37.66 70.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.5 m170 -68.62 -42.7 77.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -66.47 -51.4 57.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.7 ttt -49.48 -49.54 45.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 97' ' ' TYR . 3.8 tp -61.48 -47.92 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -54.33 -37.89 65.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -90.58 -15.79 29.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.465 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 37.2 t80 . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.283 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.561 0.219 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -125.41 -6.06 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.782 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -119.52 78.47 20.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.39 11.37 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.263 1.975 . . . . 0.0 112.22 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.9 mt -77.36 -29.76 53.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.111 0.481 . . . . 0.0 109.771 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.475 ' OD1' ' CD2' ' A' ' 124' ' ' PHE . 3.4 m-20 -96.2 -42.19 8.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.729 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' CB ' ' NZ ' ' A' ' 118' ' ' LYS . 5.4 ttpm? -64.88 -44.75 88.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.066 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 27.1 t-105 -76.12 -12.95 60.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.88 73.64 13.55 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.781 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.78 -12.9 13.35 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.819 2.346 . . . . 0.0 111.948 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -55.87 -54.11 48.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.289 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.74 26.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.249 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CD2' ' OD1' ' A' ' 117' ' ' ASP . 39.8 m-85 -134.69 -6.4 2.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.193 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.88 132.65 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.412 ' O ' ' OG ' ' A' ' 127' ' ' SER . . . -101.48 154.85 18.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' PRO . 69.6 m -167.64 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.355 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.71 -174.3 21.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.73 154.14 21.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.293 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 97.9 m -101.48 131.77 47.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 88.14 1.19 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.49 160.26 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.043 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -100.14 140.01 34.99 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -132.71 -27.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -174.77 142.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.72 167.9 20.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.527 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 69.4 t80 -145.58 118.46 8.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.509 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 3.5 tp 78.89 17.34 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.86 11.33 79.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mp -116.82 132.9 56.58 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -71.07 153.02 42.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.276 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.1 mmm -50.71 -59.5 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.2 Cg_exo -36.55 -41.31 0.59 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.458 2.105 . . . . 0.0 112.237 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -71.79 -44.7 63.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.333 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.2 m95 -61.26 -56.82 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.065 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 tp -43.41 -44.55 5.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.007 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mp -53.61 -36.45 62.0 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.85 -42.29 94.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.24 -29.76 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 110.628 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.16 -48.31 80.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.103 0.478 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.9 pt -68.01 -41.55 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.11 -45.91 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.513 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 5.6 m-85 -64.28 -39.66 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' A' ' 154' ' ' LEU . 0.3 OUTLIER -60.0 -45.31 93.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.258 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -73.97 -26.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.93 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.8 t -68.62 -33.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.106 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.524 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -71.98 -46.88 55.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.851 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.16 -24.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.093 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.96 -41.48 51.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.057 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.464 ' C ' ' HG ' ' A' ' 163' ' ' SER . 21.9 m -78.78 -21.87 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.832 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.56 -48.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.26 -28.57 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.746 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.464 ' HG ' ' C ' ' A' ' 160' ' ' VAL . 100.0 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.992 0.425 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -58.12 -31.97 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.119 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.62 -42.94 67.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.068 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 mp -50.54 -38.74 46.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -67.95 -30.55 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -79.69 -49.89 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.47 78.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.742 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' GLY . 17.5 m -76.72 -30.48 56.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.822 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 28.6 tt0 -73.39 6.07 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 110.515 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.49 146.47 17.25 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -66.42 -20.69 66.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.339 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.13 -44.39 76.89 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.512 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.89 -51.25 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -60.53 -43.84 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.73 -35.54 81.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.52 -28.83 66.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -72.56 -32.82 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.29 26.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.523 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.42 -46.76 63.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.829 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 18' ' ' MET . 27.4 p -52.72 -53.13 52.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.37 81.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.76 -42.15 74.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.942 0.401 . . . . 0.0 110.702 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.47 -42.45 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -71.17 -34.45 70.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.735 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.59 -43.84 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.32 -58.17 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.519 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 35.0 p -44.43 -32.62 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.62 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.45 -41.53 16.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.568 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tp -49.13 -21.98 0.86 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.772 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -85.46 -32.53 22.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -58.81 -44.32 90.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.139 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -75.98 -28.96 58.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.712 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -65.41 -31.42 72.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.497 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.78 -47.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 5.4 tpt -73.22 1.78 8.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.705 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.2 mt 43.53 45.62 5.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.518 ' CD2' ' NE2' ' A' ' 134' ' ' GLN . 4.8 tt -69.67 145.96 51.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 46.4 mttp -115.23 90.82 25.54 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.51 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 127' ' ' SER . 51.4 Cg_exo -51.23 165.88 0.5 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.669 2.246 . . . . 0.0 112.518 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 8.3 t -112.95 -175.45 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.316 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.415 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 p -69.09 -36.9 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.76 -49.64 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.605 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 t -49.15 -51.51 31.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -64.27 -38.95 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -55.6 -44.62 77.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -56.97 -47.43 80.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.263 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -52.62 -30.41 31.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.926 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.91 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.565 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 8.8 mp -73.28 -50.96 19.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.82 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -44.29 -38.54 3.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.85 90.28 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' ALA . 24.8 t -61.61 -47.35 93.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 109.725 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.37 -45.78 9.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.682 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.67 -29.48 75.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.57 -40.03 84.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.619 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.56 58.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.67 -47.04 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.377 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.78 -29.75 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -74.54 -33.96 54.98 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 2.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 110.585 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -84.54 -23.64 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.71 74.15 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.91 21.93 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.857 2.371 . . . . 0.0 112.023 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -115.55 -4.68 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.091 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.59 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -110.51 159.91 30.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.693 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -36.09 -22.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 mp -44.18 -26.18 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -43.68 -65.46 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.608 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.3 -37.71 67.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.979 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.55 -48.69 84.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.776 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 -31.76 65.2 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.436 0.636 . . . . 0.0 109.749 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.3 ttp -63.18 -11.81 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.355 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.84 -39.24 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.399 0.618 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.7 mt -83.65 -36.59 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 15.9 t90 -59.65 -52.61 64.79 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.688 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.435 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 2.4 tt -58.98 -53.66 55.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 110.529 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -42.27 -45.13 4.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.748 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -81.49 -24.53 36.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.25 -61.41 2.62 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.801 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 5.8 m-85 -75.13 -53.72 8.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -65.08 -45.03 86.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.89 -45.89 95.05 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 90.2 t -69.55 -35.67 67.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.603 0.239 . . . . 0.0 111.227 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 82' ' ' PHE . 1.1 mp0 -71.29 -39.52 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.708 0.289 . . . . 0.0 110.934 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 tp -73.05 -43.94 61.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.6 p -52.68 -52.25 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' O ' ' OG1' ' A' ' 92' ' ' THR . 18.2 t80 -47.37 -38.63 13.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -59.52 -40.93 88.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.863 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 91' ' ' HIS . 1.8 m-70 -60.95 -35.85 77.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.367 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 72.3 p -76.49 -42.54 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.0 ttt -50.34 -49.88 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.13 -47.81 81.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -52.91 -37.81 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.5 mp -94.35 -15.87 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 93' ' ' MET . 13.3 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 3.7 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.555 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.82 -3.47 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.648 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.6 tp -125.81 79.37 68.43 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 121.017 0.437 . . . . 0.0 110.043 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.1 Cg_exo -54.59 9.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.731 2.288 . . . . 0.0 112.52 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.648 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -65.48 -32.91 74.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.048 0.451 . . . . 0.0 109.925 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -97.71 -40.1 8.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.014 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.9 -45.34 67.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.9 t90 -76.12 -12.16 60.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.189 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.89 70.74 36.06 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.19 -18.67 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.705 2.27 . . . . 0.0 111.871 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -55.46 -54.12 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.897 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.495 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 10.6 m -105.48 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.828 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.2 m-85 -164.96 -38.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -58.23 129.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.83 152.68 18.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' PRO . 54.0 p -156.53 104.99 2.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.09 -169.75 21.57 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 3.6 m-20 -96.19 170.26 9.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 110.238 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.2 m -119.04 128.44 54.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.72 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.49 -10.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -69.56 149.03 48.63 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.712 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -100.01 134.09 43.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.518 ' NE2' ' CD2' ' A' ' 38' ' ' LEU . 1.6 pt20 -132.58 -13.59 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -173.9 133.73 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -145.37 158.0 43.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.178 0.513 . . . . 0.0 112.002 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.427 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.5 t80 -114.29 140.28 48.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.159 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp 49.11 16.72 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.088 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.97 23.02 31.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.072 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 77.6 mt -127.42 138.99 53.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.985 0.392 . . . . 0.0 110.174 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -68.05 146.18 53.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.62 -54.32 19.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.455 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.3 Cg_exo -41.48 -34.17 1.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.334 2.023 . . . . 0.0 111.941 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -72.03 -48.46 44.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 94.6 m95 -60.44 -57.79 11.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.827 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.8 mp -43.97 -37.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.085 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.45 -35.1 73.4 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.6 -40.88 98.5 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.48 -25.8 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.451 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -44.91 87.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.35 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.47 -38.12 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.026 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.73 62.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.904 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.92 -39.9 91.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.644 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.98 -30.96 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.353 0.597 . . . . 0.0 109.868 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -82.67 -30.84 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.815 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 53.0 t -67.88 -42.74 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -79.34 -48.34 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.581 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -51.98 -34.42 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.217 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.1 -36.13 21.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 40.0 t -67.02 -30.46 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.292 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 162' ' ' ILE . 7.5 p -79.26 -49.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.407 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 0.9 OUTLIER -64.21 -10.53 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.113 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.585 179.816 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -51.17 70.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 110.037 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -45.53 -42.0 10.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.549 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -62.79 -41.06 99.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.7 -41.15 42.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.01 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -67.49 -29.56 69.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.891 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -74.9 -50.72 15.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 p -76.76 -36.44 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.771 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -70.7 2.57 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.09 148.98 18.95 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -70.78 -49.24 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.291 . . . . 0.0 110.702 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.21 -44.86 6.24 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.3 81.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.559 -0.32 . . . . 0.0 110.253 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -58.53 -46.55 86.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.234 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.19 -28.27 67.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.0 -31.45 67.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.634 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . 55.7 mtt -70.65 -33.93 71.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.66 32.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.674 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.74 -31.47 64.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -67.23 -52.57 39.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.512 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.12 69.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.471 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -77.75 -41.79 36.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.68 -33.87 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.23 -35.46 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.277 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -71.42 -43.3 67.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.652 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.07 -57.91 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 p -51.06 -30.24 15.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.297 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.36 -43.44 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -14.56 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -91.96 -36.62 13.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.426 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 36' ' ' MET . 2.6 m-85 -58.67 -40.32 83.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -75.78 -35.78 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.221 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -28.89 66.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.484 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.5 m -105.24 -38.21 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.652 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 36' ' ' MET . 1.8 tmt? -80.5 -0.04 35.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.511 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 48.52 47.57 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tt -83.63 150.76 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -117.88 137.85 24.78 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.3 Cg_endo -75.44 167.72 26.03 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.454 2.102 . . . . 0.0 112.155 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.45 175.51 7.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.099 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 33.2 t -58.38 -53.72 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.0 tp -65.16 -48.28 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 p -48.75 -47.84 41.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.591 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.52 -44.27 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.364 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.33 -46.6 89.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.92 -38.04 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.327 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -60.7 -29.4 69.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.821 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.01 -37.01 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.478 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.54 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.483 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' VAL . 6.1 tp -76.37 -54.02 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.28 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -44.03 -38.87 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.44 -41.63 90.42 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.6 t -62.62 -47.81 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-O 121.212 0.529 . . . . 0.0 109.757 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.3 -49.23 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.218 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.54 -29.38 69.4 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -69.47 -33.13 72.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.667 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.86 -24.3 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.92 -39.28 63.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.405 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.18 -35.29 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.695 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -65.49 -38.5 94.87 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.94 11.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.919 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.3 mt -83.7 -29.01 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.533 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.03 78.1 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.404 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.23 22.81 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.58 2.187 . . . . 0.0 112.083 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 64' ' ' ALA . 27.3 ttpt -111.09 -6.27 14.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.55 163.19 20.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.672 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -40.92 -13.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.505 2.137 . . . . 0.0 112.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 mt -42.42 -34.99 0.91 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' NH1' ' CB ' ' A' ' 164' ' ' GLN . 94.2 mtt180 -39.0 -67.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.338 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -48.96 -34.27 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.69 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.9 t -68.34 -46.02 81.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -43.87 21.86 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.992 -0.442 . . . . 0.0 111.137 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.473 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.07 -16.73 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.797 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 1.1 t -57.78 -32.5 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.637 0.732 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.7 -34.09 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.895 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.9 t-105 -64.3 -45.18 89.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.933 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 81' ' ' ALA . 1.3 tp -68.62 -46.33 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.221 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -45.69 -41.92 11.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.122 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -80.77 -23.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.387 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.24 -59.59 5.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -74.84 -53.62 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -66.23 -46.89 75.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.3 86.83 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.5 t -66.39 -47.39 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 86' ' ' GLN . 1.4 tm0? -56.85 -44.74 82.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.81 -51.41 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 39.8 p -48.13 -23.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.256 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.422 ' O ' ' OG1' ' A' ' 92' ' ' THR . 2.7 t80 -73.66 -45.16 54.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.53 -38.09 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.136 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -67.95 -42.11 81.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 41.2 p -66.62 -51.56 54.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.729 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' TYR . 16.5 ttt -56.34 -51.49 68.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.95 -41.6 99.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.423 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -55.97 -44.29 78.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.228 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.54 -6.56 40.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.339 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' MET . 9.5 t80 -139.11 67.05 39.93 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.305 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.47 116.11 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 80.6 p -170.17 58.72 0.31 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.415 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -71.75 176.82 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.675 2.25 . . . . 0.0 112.161 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.67 -140.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.585 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.19 -79.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.694 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 t -140.59 44.62 1.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.626 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 106' ' ' PHE . 58.9 p -49.64 -25.79 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -66.1 74.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.532 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 104' ' ' SER . 60.8 t80 -122.66 77.31 1.42 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 29.8 mtt 44.98 -164.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.535 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -95.99 121.59 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.536 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.6 108.56 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.39 147.39 59.89 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.397 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 113' ' ' TRP . 37.5 Cg_endo -67.42 135.12 35.46 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.465 2.11 . . . . 0.0 112.06 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 14.2 mp0 -68.02 7.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.543 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.88 -2.76 58.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.157 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.665 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.9 mt -126.34 80.19 69.36 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 48.6 Cg_exo -52.89 5.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.69 2.26 . . . . 0.0 112.164 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.665 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -61.67 -33.31 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.201 0.524 . . . . 0.0 110.075 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -96.94 -43.04 7.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -45.24 80.75 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.221 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.1 t90 -74.63 -12.9 60.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.792 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.9 t -142.63 72.67 20.19 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.59 -17.08 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.712 2.274 . . . . 0.0 111.8 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -54.96 -53.78 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.798 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.6 t -105.94 58.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.6 m-85 -162.85 -42.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 130.4 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.4 156.32 16.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' PRO . 67.3 m -160.99 99.93 1.23 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.66 179.89 17.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.34 150.29 23.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 110.235 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.594 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 68.4 m -101.43 129.07 47.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.821 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.56 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.21 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.66 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.859 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -100.58 132.84 45.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.536 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -130.28 -8.24 4.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.812 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.432 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 10.1 t-105 -173.91 132.41 0.42 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.86 160.32 39.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.93 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -117.87 139.04 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.078 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mt 49.66 17.05 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.56 20.64 40.09 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.7 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.03 139.19 54.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -70.24 146.4 50.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.149 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.411 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.37 -58.88 5.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.366 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.1 Cg_exo -37.21 -37.84 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -70.52 -45.19 66.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.111 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.6 m95 -66.95 -57.39 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.232 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 mt -43.49 -37.03 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.978 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.57 -36.35 83.5 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -55.59 -39.68 75.9 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.3 mt -71.02 -44.27 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 110.463 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -47.69 -42.54 25.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.23 -46.29 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.801 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.24 48.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.063 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.0 m-85 -57.2 -36.88 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 6.1 tt -63.53 -29.79 71.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.89 -39.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.02 -38.82 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.827 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.579 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -72.24 -48.41 42.98 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.71 -37.08 74.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.73 -41.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -23.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.05 -45.74 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.45 -21.49 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.0 m -61.93 -13.36 24.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.428 ' CB ' ' NH1' ' A' ' 70' ' ' ARG . 10.0 pt20 -52.37 148.44 12.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.294 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -38.22 -30.11 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.461 2.108 . . . . 0.0 112.019 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 164' ' ' GLN . 10.0 t80 42.56 -135.04 0.39 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.669 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.0 tttp 60.24 -131.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 65.49 124.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.379 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 170' ' ' LYS . 45.8 mtpt -97.52 -25.4 15.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.837 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' LYS . 10.8 mtpp -48.37 -99.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 48.82 72.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 173' ' ' LEU . 3.7 p30 -74.72 122.78 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 172' ' ' ASP . 13.7 mt 57.57 142.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.796 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -172.6 103.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 94.95 136.1 8.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -80.82 160.45 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.638 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -101.26 -96.49 2.26 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 54.87 81.71 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.603 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -160.21 15.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.473 ' O ' ' ND1' ' A' ' 180' ' ' HIS . 44.7 t-80 -78.7 -15.55 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.471 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.98 -158.92 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.419 ' O ' ' OXT' ' A' ' 183' ' ' HIS . 18.2 t60 -152.51 152.74 32.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.419 ' OXT' ' O ' ' A' ' 182' ' ' HIS . 63.9 t60 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.17 -40.09 82.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.422 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -57.59 -28.29 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -76.92 -43.29 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.544 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mt -50.58 -41.02 53.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.357 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -65.62 -27.57 68.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 110.064 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.44 -47.91 14.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.522 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.81 71.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.668 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.4 m -76.53 -39.69 52.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.62 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.517 HE22 ' C ' ' A' ' 65' ' ' PRO . 19.1 tp60 -66.85 5.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.481 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.75 141.97 15.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -68.11 -48.22 66.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.01 -45.36 6.02 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.62 76.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.108 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -54.62 -42.48 71.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.6 -26.95 65.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.995 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -70.16 -35.01 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.662 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.451 ' O ' ' OG1' ' A' ' 21' ' ' THR . 2.0 mtt -71.6 -32.93 68.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.35 45.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -52.31 -43.79 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.4 p -58.23 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.691 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.42 -39.04 31.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -42.03 69.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.839 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -45.98 -42.27 12.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.709 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 10.7 mp -71.12 -32.08 68.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -70.68 -49.93 41.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.615 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -57.72 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 68.7 p -49.95 -30.34 10.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.622 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.93 -47.09 13.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.45 -14.22 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.533 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.42 -36.3 10.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.36 . . . . 0.0 110.515 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -42.1 79.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.437 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 40' ' ' PRO . 39.6 mt-30 -69.57 -46.08 67.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.17 -18.81 50.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -101.61 -43.92 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 mmt -89.96 8.45 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.767 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLN . 3.8 tp 44.87 45.74 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.646 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -80.05 154.43 28.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -127.53 83.84 64.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.361 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 75.5 Cg_exo -47.02 178.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 8.4 t -116.29 -175.83 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.384 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.416 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.1 p -64.52 -36.18 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.314 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.55 -47.53 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.543 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -53.61 -49.56 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.691 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 45' ' ' ILE . 55.7 mt -65.8 -37.81 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -59.76 -48.36 81.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.16 -37.05 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -32.37 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.95 79.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.33 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -77.19 -52.1 9.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.07 -40.12 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.4 -44.71 89.83 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 t -61.21 -47.67 92.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.49 . . . . 0.0 109.758 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -44.62 -46.05 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.785 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.47 80.89 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.2 -40.71 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.358 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.04 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.367 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.03 -28.47 49.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.428 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.14 -39.35 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.493 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.99 -32.76 77.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.36 5.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' GLY . 76.7 mt -76.56 -36.8 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.94 72.06 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.499 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.517 ' C ' HE22 ' A' ' 10' ' ' GLN . 16.4 Cg_exo -64.36 16.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.879 2.386 . . . . 0.0 112.131 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.0 tmtm? -109.37 -5.67 15.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.004 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.38 164.31 16.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.567 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -41.19 -12.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.6 mm? -44.84 -34.79 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.406 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.2 ptt180 -40.43 -68.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.736 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 27.4 t80 -54.0 -28.48 38.27 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 4.9 t -70.86 -52.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.697 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.08 63.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.269 0.557 . . . . 0.0 109.987 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 ttt -59.3 -10.42 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.047 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 4.4 p -62.78 -36.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.428 0.632 . . . . 0.0 110.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mm -86.65 -32.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.754 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 8.3 t-105 -62.96 -52.64 62.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.935 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -46.33 88.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.609 ' CD2' ' NH1' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -47.05 -45.78 21.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.56 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.5 p -76.59 -25.94 54.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.669 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.0 -60.6 3.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.024 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -73.33 -54.24 8.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 79' ' ' TYR . 23.0 ttm105 -67.26 -47.49 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.68 -48.47 65.74 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' A' ' 88' ' ' THR . 88.3 t -69.1 -50.89 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.438 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -48.34 -28.05 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -77.83 -39.25 44.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 80.6 p -54.13 -29.56 45.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.31 -48.75 69.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.342 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -54.95 -39.84 69.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.469 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -71.84 -56.79 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -53.16 -52.78 57.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' TYR . 61.7 mmm -49.41 -46.59 47.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.8 -45.37 78.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.359 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -57.84 -38.82 76.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.2 -12.12 28.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.0 t80 -137.96 65.78 45.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.93 124.39 11.28 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.733 2.289 . . . . 0.0 112.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.5 ' N ' ' CD ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -87.32 -48.85 0.47 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.639 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 99' ' ' SER . 97.4 Cg_endo -84.18 -170.44 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.656 2.237 . . . . 0.0 112.056 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -173.18 111.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . 63.15 7.42 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.721 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 20.4 m -166.24 121.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.55 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 p -136.96 168.37 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.503 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 29.5 m-20 -85.35 -160.3 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.582 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 51.4 m-85 -157.31 -160.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.503 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.593 ' C ' ' H ' ' A' ' 109' ' ' ARG . 17.9 mmt -142.62 -92.37 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.277 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t 66.97 -34.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.145 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.593 ' H ' ' C ' ' A' ' 107' ' ' MET . 31.7 ttt85 -77.75 101.24 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.666 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.75 159.45 36.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.156 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.59 155.42 58.7 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.606 2.204 . . . . 0.0 111.815 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -103.61 -14.56 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -96.52 -4.57 41.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.932 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 mt -123.65 78.77 55.84 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.201 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.4 Cg_exo -51.87 -0.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -59.21 -33.21 70.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.106 0.479 . . . . 0.0 110.367 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -96.8 -42.08 8.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.636 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -70.12 -45.09 67.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.568 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.3 t90 -74.1 -16.13 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.04 71.32 48.44 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.21 -19.58 10.43 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.854 2.37 . . . . 0.0 111.77 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -52.46 -44.98 65.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.683 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 t -118.98 56.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.947 0.403 . . . . 0.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.523 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.3 t80 -160.35 -40.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.256 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.23 127.53 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.483 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.14 22.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 127' ' ' SER . 17.2 p -169.13 103.49 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.472 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.35 -175.43 21.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.3 140.87 29.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.799 0.333 . . . . 0.0 110.225 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.1 m -89.65 135.47 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.98 1.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 133' ' ' ARG . 2.4 tm-20 -67.11 145.27 55.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.493 ' N ' ' OE2' ' A' ' 132' ' ' GLU . 6.6 ptp180 -100.07 130.23 46.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -118.83 -25.17 6.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 140.74 52.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.98 119.46 11.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.218 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.18 133.83 51.44 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.17 17.51 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.349 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.93 58.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.26 145.11 50.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.2 mp0 -75.94 157.38 33.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.1 mtt -56.47 -50.93 84.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.911 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 142' ' ' MET . 88.1 Cg_exo -43.86 -38.03 9.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.357 2.038 . . . . 0.0 112.158 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -70.76 -52.67 19.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.06 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.6 m95 -58.62 -57.17 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.967 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.46 -37.77 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -35.91 76.68 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.8 -44.9 95.6 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.14 -39.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.243 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 0.1 OUTLIER -52.68 -47.84 66.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.903 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.12 -48.05 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.33 -46.59 66.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.703 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.453 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 6.1 m-85 -55.12 -40.54 70.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.294 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 150' ' ' PHE . 1.4 mt -65.85 -30.58 71.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.12 -29.5 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.622 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.478 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 75.3 t -69.8 -36.55 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.486 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -79.99 -35.99 36.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.202 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.4 -38.93 83.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.101 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.79 -27.81 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.736 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 41.3 t -78.31 -26.23 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.25 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 162' ' ' ILE . 2.5 p -83.25 -41.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.438 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 70.2 mt -74.22 -19.31 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.443 ' C ' HE21 ' A' ' 164' ' ' GLN . 74.9 p -85.14 0.22 52.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.684 ' N ' HE21 ' A' ' 164' ' ' GLN . 0.0 OUTLIER -87.04 -55.37 0.36 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.792 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' ' 166' ' ' PHE . 77.4 Cg_exo -42.84 -43.23 9.1 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 165' ' ' PRO . 22.0 t80 36.92 43.78 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.938 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -116.46 156.44 26.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.528 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -176.24 140.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.507 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -134.95 156.31 49.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -163.55 18.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.519 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -153.46 124.64 7.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -45.81 -66.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.2 mt -56.67 162.32 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 59.26 172.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.665 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 177.47 -104.97 0.19 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -56.92 -50.04 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.512 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.92 -160.66 13.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -156.24 -26.22 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.327 . . . . 0.0 110.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 181' ' ' HIS . 16.7 m80 46.67 32.3 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 12.2 t-80 -73.71 8.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 32.7 m-70 -141.9 -178.04 5.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.374 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 182' ' ' HIS . 58.2 t-80 -84.78 11.47 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.554 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.2 t60 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.607 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 tp -49.87 -39.08 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.989 0.423 . . . . 0.0 110.018 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -56.84 -28.1 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.299 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.34 -42.95 58.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.2 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.1 mm? -51.51 -41.54 61.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.406 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 1.1 m-20 -66.37 -31.72 72.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -77.54 -49.51 14.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.9 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -76.65 -34.2 58.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -74.16 5.91 3.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.583 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.11 145.64 17.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -70.54 -21.15 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.614 0.245 . . . . 0.0 110.673 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 -45.14 67.09 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.93 75.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.83 0.348 . . . . 0.0 110.178 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -56.48 -41.63 76.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.328 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.16 -31.36 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.001 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 -28.84 66.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.558 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.82 -32.97 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.978 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.55 5.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -49.35 -48.43 46.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.435 ' OG1' ' OH ' ' A' ' 153' ' ' TYR . 3.1 p -51.76 -62.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.776 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.25 -31.69 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.04 -41.72 63.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.505 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.86 -35.13 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.77 -34.38 71.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.29 -42.6 71.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.755 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.98 -57.82 3.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.485 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 23.2 p -48.17 -31.86 6.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.72 -32.18 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.71 -17.31 62.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -94.41 -37.54 11.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.672 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -54.35 -45.97 72.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -74.56 -31.56 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.42 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.449 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -61.0 -32.16 71.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.576 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.23 -41.55 7.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.2 tpt -78.03 -0.61 28.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt 48.96 49.87 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.01 147.95 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.82 136.53 20.0 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.202 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.91 143.81 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.353 2.035 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -100.23 161.57 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 41.4 t -51.21 -51.58 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.409 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mt -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.068 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 p -48.63 -43.03 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.27 -47.16 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.975 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.61 -46.54 80.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -40.25 96.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.554 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -63.66 -35.85 81.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.93 76.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.96 85.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.62 -49.9 11.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -46.42 -41.36 13.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.04 88.65 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.1 t -62.94 -44.16 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.276 0.56 . . . . 0.0 109.681 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.3 -48.3 9.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.323 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.69 89.58 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.01 -37.69 88.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 110.304 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.29 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.316 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.42 -25.4 57.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.541 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -84.21 -40.77 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.2 -30.85 76.1 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.92 9.81 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 ' H ' ' C ' ' A' ' 61' ' ' GLY . 67.1 mt -79.79 -41.92 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.95 71.04 0.34 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.318 . . . . 0.0 110.385 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.43 13.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.959 2.44 . . . . 0.0 112.228 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 64' ' ' ALA . 19.5 pttp -113.09 -5.38 13.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.493 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.14 161.27 29.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.691 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.73 -12.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.325 2.017 . . . . 0.0 112.045 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -42.95 -35.55 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' LEU . 89.5 mtt180 -37.82 -65.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -51.46 -25.04 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.833 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 6.4 t -78.39 -52.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 75' ' ' VAL . . . -73.78 -45.31 52.45 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.135 0.493 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.49 -8.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.085 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 3.9 p -61.75 -34.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.596 0.712 . . . . 0.0 110.145 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.31 -31.82 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.594 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -65.65 -51.06 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.934 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.56 -43.87 83.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -46.24 -45.56 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.956 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -58.38 8.81 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.215 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.51 -53.85 9.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.354 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -67.87 -45.91 73.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.29 -47.91 78.89 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.7 t -68.78 -46.31 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.506 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.407 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 1.6 tm0? -54.43 -24.96 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 tp -87.25 -41.85 13.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.634 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 22.5 p -51.61 -25.74 7.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.381 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -71.31 -35.33 71.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.11 -33.85 75.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.26 -44.94 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -59.72 -52.6 64.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.518 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.646 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.7 ttt -54.34 -48.49 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.46 -37.96 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.805 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.52 -39.2 85.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 96' ' ' LEU . 3.8 mm? -90.02 -5.56 56.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.7 t80 -130.48 77.46 75.9 Favored Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.161 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 97' ' ' TYR . 49.3 Cg_exo -53.04 -143.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.998 2.466 . . . . 0.0 112.56 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 98' ' ' PRO . 1.2 t 78.4 54.17 0.16 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.62 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 99' ' ' SER . 43.6 Cg_endo -70.1 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.698 2.266 . . . . 0.0 112.107 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 103' ' ' THR . 46.4 m-85 -39.91 -52.6 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.724 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . -45.11 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 101' ' ' PHE . 19.2 p 54.71 58.32 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -70.46 166.18 20.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' SD ' ' A' ' 107' ' ' MET . 1.5 m-20 -76.77 120.71 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.501 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -44.84 107.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 107' ' ' MET . 1.1 mpt? -74.91 151.18 38.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.672 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t 57.38 92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -122.07 117.93 27.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.79 129.89 90.72 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.395 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 160.34 25.96 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.573 2.182 . . . . 0.0 111.789 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.26 -40.98 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.676 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -126.64 15.24 7.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.378 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.2 mt -120.52 80.25 30.33 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.707 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 11.3 Cg_exo -68.07 7.95 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.637 2.225 . . . . 0.0 111.386 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -76.51 -30.87 57.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 110.357 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.37 -41.11 8.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -67.58 -44.87 77.12 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.418 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.7 t90 -77.32 -13.11 60.0 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.519 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.54 74.28 71.3 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.87 -25.68 4.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.846 2.364 . . . . 0.0 111.872 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -52.43 -52.16 55.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.7 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.72 55.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -158.93 -40.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.416 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -54.99 128.81 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.37 148.9 21.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.1 p -155.91 128.66 7.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 106.11 -163.22 13.78 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -102.02 156.52 17.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.394 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.594 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 21.0 m -108.11 130.94 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 99.85 -7.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 158.03 32.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' CZ ' ' OD2' ' A' ' 136' ' ' ASP . 53.2 ttt180 -97.67 141.93 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.236 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -134.42 -31.66 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.69 146.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.707 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.476 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.0 p30 -143.24 161.1 39.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 111.993 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -114.44 136.39 53.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.773 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.22 16.77 0.28 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.99 19.7 33.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.194 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 35.2 mt -125.64 140.44 52.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.052 0.426 . . . . 0.0 110.254 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.21 148.03 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -48.7 -51.96 49.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.546 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 142' ' ' MET . 87.8 Cg_exo -44.23 -34.51 7.08 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.35 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -48.82 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.579 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.1 m95 -57.94 -57.98 10.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.879 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.0 mt -43.89 -38.74 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.83 -37.3 71.03 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.31 -41.2 96.77 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 mt -76.61 -25.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.767 0.318 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.53 -46.16 80.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.36 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 pt -64.26 -41.54 92.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.288 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.34 -49.45 77.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.358 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.439 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 4.1 m-85 -59.77 -45.13 93.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 154' ' ' LEU . 0.4 OUTLIER -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.836 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.51 -32.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.565 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.66 -48.4 76.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.502 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -57.28 -53.63 55.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.44 -49.2 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 -23.11 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.1 t -81.56 -50.83 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.918 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 164' ' ' GLN . 34.4 mm -68.66 -12.38 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.274 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.8 p -53.87 -10.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.388 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 162' ' ' ILE . 15.4 tp60 -152.22 84.05 4.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.383 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -84.57 34.64 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.878 2.385 . . . . 0.0 112.157 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.97 89.85 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.405 ' CG ' ' H ' ' A' ' 168' ' ' ALA . 17.8 pttt -52.05 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.45 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' H ' ' CG ' ' A' ' 167' ' ' LYS . . . 64.01 -161.6 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.598 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 168' ' ' ALA . 63.7 mttm 53.39 104.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.599 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -62.97 -96.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -159.91 -149.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.589 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 13.8 t70 -131.41 -148.82 0.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.37 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.517 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 1.0 OUTLIER -160.75 107.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.35 113.77 2.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -155.33 36.53 0.64 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 47.58 -155.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.487 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -157.68 -15.28 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -84.33 96.54 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -78.59 67.95 4.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.662 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 43.19 -165.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -70.81 -93.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.679 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 0.9 OUTLIER -160.13 -137.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.679 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 8.2 t60 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 9.6 mp -58.59 -45.33 89.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.331 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -56.53 -37.36 70.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.561 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.99 -45.46 88.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.16 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -50.22 -41.27 49.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.071 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.7 m120 -68.75 -26.75 65.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.898 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.4 -50.48 15.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.448 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.63 69.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.0 m -76.47 -37.69 56.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -73.68 8.83 1.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.83 141.11 15.17 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 13' ' ' GLY . 3.8 ptp85 -68.49 -49.7 57.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.656 0.265 . . . . 0.0 110.713 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 12' ' ' ARG . . . -43.05 -45.77 6.16 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.12 87.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -60.49 -44.52 95.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.152 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.12 -30.14 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.8 -28.06 65.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.633 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.459 ' O ' ' OG1' ' A' ' 21' ' ' THR . 20.1 mmt -74.5 -33.64 62.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.52 -54.67 15.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.564 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.22 -49.25 53.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.703 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 18' ' ' MET . 20.3 p -48.7 -57.08 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.13 -39.5 28.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.55 -41.47 69.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -47.14 -36.41 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.544 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.85 -36.32 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.23 -53.54 42.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.818 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -62.41 -57.97 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.833 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 28.9 p -46.96 -29.24 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.732 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -45.41 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.8 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -15.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -93.32 -34.7 13.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.483 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.98 -42.38 80.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -69.02 -47.68 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.01 -9.05 13.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.498 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.17 -41.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.601 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.6 mmt -96.39 10.12 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 tp 48.47 45.33 20.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.6 mt -79.54 146.65 32.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.352 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -107.61 131.22 21.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.444 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 165.22 28.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.137 1.892 . . . . 0.0 111.761 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -127.96 -175.22 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.512 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 4.1 mm? -69.88 -49.93 47.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.612 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.2 p -49.68 -51.14 40.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.488 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.55 -40.49 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -59.48 -43.15 93.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.787 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -59.02 -44.41 91.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.432 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -58.97 -29.63 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.25 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.51 72.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.316 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.3 63.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -54.82 9.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.035 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -48.65 -32.11 7.79 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.814 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.31 -46.29 72.31 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.945 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.24 45.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.366 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.03 -46.47 75.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.284 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.71 86.41 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.01 95.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.78 -0.71 . . . . 0.0 110.557 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -29.54 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.503 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.5 tp -74.25 -32.03 62.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.57 -33.81 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -78.08 -30.13 51.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.57 5.25 1.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 0.0 110.317 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.4 mt -89.12 -23.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.607 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 177.02 70.09 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.794 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.45 26.6 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.702 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' ALA . 53.9 tttp -109.2 -7.19 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.395 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.88 173.73 2.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.13 -8.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.22 1.947 . . . . 0.0 111.852 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -42.27 -38.74 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.4 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 10.4 mtp180 -40.04 -70.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.606 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -51.6 -18.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.092 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.0 t -83.16 -46.6 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.61 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' VAL . . . -72.12 -40.04 68.41 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.81 -8.84 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.353 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' ALA . 55.6 t -56.84 -43.97 81.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.396 0.617 . . . . 0.0 110.145 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.49 -33.36 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.405 ' CZ2' ' CD2' ' A' ' 153' ' ' TYR . 5.4 t-105 -60.19 -55.9 28.21 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.801 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.54 -48.2 82.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -45.17 -43.95 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.6 p -79.84 -24.54 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.577 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.05 -61.24 2.75 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.69 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.42 -55.94 5.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -65.97 -51.5 57.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.68 -47.31 58.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.501 ' O ' ' OG1' ' A' ' 88' ' ' THR . 91.1 t -68.86 -47.5 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -53.17 -30.23 36.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -42.61 63.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.4 p -54.61 -28.59 47.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.969 0.414 . . . . 0.0 110.237 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -63.34 -46.1 88.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -61.86 -40.17 94.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.718 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -70.81 -45.88 63.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.773 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.5 p -64.61 -47.69 77.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.727 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 97' ' ' TYR . 28.6 ttt -56.24 -51.35 68.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.57 -50.98 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.329 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -51.91 -37.78 53.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.388 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.71 -15.69 28.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 93' ' ' MET . 84.9 t80 -140.04 74.85 30.43 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -47.21 117.09 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.828 2.352 . . . . 0.0 112.297 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 101' ' ' PHE . 42.0 t -137.95 66.14 46.54 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.463 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -44.23 87.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.862 2.375 . . . . 0.0 112.252 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 99' ' ' SER . 37.0 p90 -82.3 -11.95 58.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.59 75.12 0.84 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.236 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.1 p -42.57 138.1 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 p 47.24 -151.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t0 63.74 28.32 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.685 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -48.7 -40.53 28.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.7 ptm -55.75 143.64 30.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.94 130.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.56 100.04 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.318 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -62.53 150.15 86.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.34 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.67 153.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.34 2.027 . . . . 0.0 112.062 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.61 -2.57 47.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.535 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.44 5.75 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.622 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 116' ' ' LEU . 77.9 mt -117.37 83.48 16.48 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -54.14 7.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.583 2.188 . . . . 0.0 112.428 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 114' ' ' LEU . 8.2 mp -74.88 -28.43 60.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.693 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -95.8 -40.8 9.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -65.65 -33.69 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -88.63 -20.73 24.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.184 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.51 69.03 12.39 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.82 -18.06 52.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.712 2.274 . . . . 0.0 111.538 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.59 -3.81 42.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.179 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.521 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 48.3 t -131.76 36.13 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.102 0.477 . . . . 0.0 110.741 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 15.9 m-85 -161.33 -43.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.72 129.8 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.066 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.09 152.83 18.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.5 t -160.68 99.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.05 -174.11 22.31 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 13.2 m-20 -88.0 157.34 18.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 2.6 m -107.86 127.63 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 95.05 -4.25 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.131 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -67.58 128.84 37.95 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.791 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.711 ' NE ' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -74.08 142.63 45.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.472 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -131.96 -26.81 1.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.792 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -173.0 147.82 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 20.0 p-10 -142.98 167.57 21.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 112.112 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -134.75 138.15 44.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.844 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.68 17.32 3.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.02 59.22 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.87 131.52 54.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.3 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -68.99 150.58 47.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.6 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.67 -54.4 23.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.082 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.97 -36.47 11.27 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.246 1.964 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.95 -46.04 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.0 m95 -65.31 -56.98 9.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.873 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -42.99 -37.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.15 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.36 -34.06 77.42 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.97 -40.68 91.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.79 -40.53 76.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.277 . . . . 0.0 110.279 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.37 -40.63 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.99 -46.62 93.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.75 -51.16 66.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.405 ' CD2' ' CZ2' ' A' ' 77' ' ' TRP . 4.6 m-85 -66.76 -43.69 83.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.6 tt -49.11 -30.76 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.313 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.69 -37.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.938 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 87.0 t -51.64 -37.45 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.587 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.91 -44.36 20.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.935 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.0 t -52.07 -44.48 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.215 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' O ' ' OG ' ' A' ' 163' ' ' SER . 7.7 tp -81.3 -36.43 29.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.792 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 45.9 t -69.94 -31.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.259 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.7 -49.29 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.107 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.56 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.3 mp -62.78 -19.34 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 20.1 m -52.72 -6.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.56 ' H ' ' C ' ' A' ' 162' ' ' ILE . 1.9 mm100 -124.86 76.29 65.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.08 21.41 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.591 2.194 . . . . 0.0 112.132 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 55.6 165.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.531 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -173.23 -56.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.406 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.78 112.67 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.416 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.434 ' HZ3' ' HB2' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -141.16 17.29 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.476 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -92.93 21.57 5.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.549 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -80.58 -67.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.525 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 172' ' ' ASP . 1.2 p30 -151.87 88.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.471 ' H ' ' CD2' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -71.16 131.51 43.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.364 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -165.43 -41.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 45.79 -163.65 0.1 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -125.52 132.21 52.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.42 76.61 0.22 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -171.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.737 0.303 . . . . 0.0 110.537 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.4 -179.18 7.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.603 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.627 ' CG ' ' H ' ' A' ' 181' ' ' HIS . 76.5 t60 -160.81 175.45 12.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 180' ' ' HIS . 4.3 t-80 67.38 -72.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.448 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 10.7 t-80 39.19 -130.37 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.7 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.6 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 43.8 t60 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.65 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.13 -45.35 83.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -51.62 -43.41 62.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.44 -39.87 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.4 tt -53.43 -44.8 69.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.75 -31.81 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -75.22 -48.57 22.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.654 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.7 p -76.16 -32.03 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 4.4 tt0 -74.24 9.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.965 0.412 . . . . 0.0 110.319 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.82 151.8 17.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -69.05 -20.24 64.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.713 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.74 -44.09 64.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.39 61.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.533 0.206 . . . . 0.0 110.991 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -54.85 -51.08 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.76 -27.61 66.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -26.09 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.09 -34.85 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.67 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.725 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' LEU . 27.0 t80 -52.9 -53.41 49.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.715 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.4 p -43.74 -53.4 5.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.442 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -26.58 66.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -79.92 -42.24 24.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.42 -36.24 61.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.756 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.38 -38.95 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.14 -45.75 79.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -57.79 5.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.572 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 28.1 p -46.76 -31.67 3.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.477 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.67 -44.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 tp -51.06 -17.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.654 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 31.4 t90 -91.44 -35.83 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.538 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 1.7 m-85 -56.47 -36.99 69.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.349 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.95 -39.71 23.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.53 -22.4 61.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 36' ' ' MET . 7.5 p -109.03 -44.01 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.45 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 5.4 ttt -83.98 6.47 21.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.6 mt 40.57 42.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.729 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.71 154.11 39.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.339 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -123.61 115.54 28.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.5 Cg_endo -78.29 179.95 6.02 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.274 1.983 . . . . 0.0 112.283 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 2.2 t -119.61 -175.73 3.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -65.12 -39.68 86.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.297 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -65.21 -50.12 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.257 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.2 m -49.74 -48.21 50.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.703 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 45' ' ' ILE . 95.7 mt -61.95 -42.97 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.36 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -56.74 -45.89 81.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.053 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.17 -42.37 98.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.3 ttp85 -62.44 -34.83 77.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.45 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.137 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.59 -47.29 82.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -76.99 -47.95 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -46.9 -44.31 19.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.087 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.08 93.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 57' ' ' ALA . 27.6 t -61.42 -47.33 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.154 0.502 . . . . 0.0 110.0 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -46.46 -45.38 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.63 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.56 74.11 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.04 -30.67 71.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.908 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.25 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.223 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.0 -43.1 99.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 60' ' ' ILE . 20.9 mm -79.22 -35.97 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.45 -33.41 81.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 9.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -83.35 -35.06 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.723 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.22 76.45 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.712 0.291 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.78 20.7 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.579 2.186 . . . . 0.0 112.062 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.8 mtmt -109.61 -7.28 15.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.09 162.86 18.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.6 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -38.69 -16.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.512 2.141 . . . . 0.0 112.256 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 67' ' ' THR . 38.9 mt -44.05 -31.18 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 61.0 mtt180 -38.13 -65.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.39 -33.15 52.62 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.416 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 11.9 t -66.36 -57.75 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.496 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.35 82.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.307 0.575 . . . . 0.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -14.94 45.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.262 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 1.9 p -60.25 -32.64 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.499 0.666 . . . . 0.0 110.198 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -89.34 -32.97 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.927 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.4 t-105 -67.16 -49.58 64.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.874 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.4 tt -63.9 -51.84 62.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.924 0.393 . . . . 0.0 110.158 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.405 ' HH ' ' CD ' ' A' ' 83' ' ' ARG . 87.8 t80 -40.96 -43.21 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.36 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 p -78.89 -21.5 47.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.53 -61.22 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.816 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.61 -53.56 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.38 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.405 ' CD ' ' HH ' ' A' ' 79' ' ' TYR . 7.9 ttt-85 -68.1 -39.24 82.89 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 88' ' ' THR . . . -66.44 -44.79 89.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.43 -38.47 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.563 0.22 . . . . 0.0 111.453 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -66.46 -43.91 84.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.278 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.17 -45.91 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 84' ' ' GLY . 6.9 p -46.94 -50.28 19.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.502 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -53.05 -30.68 37.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.506 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.45 -39.96 89.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.494 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 2.8 m170 -64.75 -43.62 92.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.189 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -65.19 -38.87 91.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' TYR . 37.6 ttp -52.06 -45.02 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.4 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.302 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -55.9 -41.24 74.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.433 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 tp -89.09 -18.24 27.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.8 t80 -142.35 75.9 19.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.94 0.4 . . . . 0.0 110.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 97' ' ' TYR . 52.0 Cg_exo -51.41 -167.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.722 2.281 . . . . 0.0 112.173 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -139.25 168.1 16.61 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.356 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 99' ' ' SER . 77.4 Cg_exo -44.85 175.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.628 2.218 . . . . 0.0 112.291 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -126.69 121.41 32.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.433 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -161.19 49.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.8 p 45.73 33.16 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.553 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 m -75.9 78.59 2.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -76.55 118.37 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.419 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' A' ' 107' ' ' MET . 29.2 t80 -62.34 -56.38 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 106' ' ' PHE . 12.8 ttp 59.65 123.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.561 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.4 p -48.06 120.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -150.9 99.73 2.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.469 ' O ' ' OE1' ' A' ' 112' ' ' GLU . 1.6 m-85 -132.4 156.64 79.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.023 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -37.68 150.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.801 2.334 . . . . 0.0 112.433 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.469 ' OE1' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -107.08 7.98 30.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.468 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -84.8 -3.21 58.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.7 ' C ' ' H ' ' A' ' 116' ' ' LEU . 20.7 mt -118.76 88.11 34.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.917 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.6 Cg_exo -53.76 11.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.153 . . . . 0.0 112.261 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.7 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -71.4 -30.12 65.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 109.868 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.444 ' CG ' ' CE1' ' A' ' 124' ' ' PHE . 74.5 m-20 -97.29 -40.79 8.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -72.36 -45.77 58.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.821 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.8 t90 -72.91 -12.84 61.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.77 74.01 39.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.563 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.55 -20.69 10.63 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.756 2.304 . . . . 0.0 112.038 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.22 -53.11 55.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.23 55.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.017 0.437 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.444 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 37.2 t80 -158.78 -42.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.22 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -58.02 128.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.584 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.43 160.61 14.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' PRO . 43.2 p -173.8 103.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.562 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.66 177.29 18.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -81.61 140.11 34.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.183 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 57.2 m -87.93 132.83 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.947 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 92.97 2.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.223 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -67.54 144.76 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -93.74 125.3 38.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 110.797 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.56 -23.26 6.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.764 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.45 138.95 47.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.841 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -141.7 119.68 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -123.04 132.99 54.35 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.29 17.31 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.65 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.88 17.54 56.16 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.633 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.2 mp -123.49 144.08 49.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.0 mp0 -77.72 157.82 29.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.646 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.419 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.6 OUTLIER -51.12 -53.58 47.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.8 Cg_exo -40.54 -38.86 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.375 2.05 . . . . 0.0 112.304 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.414 HE21 ' CD ' ' A' ' 141' ' ' GLU . 58.2 mt-30 -69.8 -54.19 14.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.508 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.607 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.1 m95 -62.81 -57.79 9.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.463 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 tt -42.92 -36.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.509 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.77 -33.02 74.91 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.86 -44.99 96.57 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -76.04 -25.88 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -62.63 -44.85 95.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.486 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 pt -69.4 -36.65 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.358 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.91 71.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.97 -49.43 66.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.793 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.486 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 19.3 mt -62.65 -31.94 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.68 -32.47 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -70.63 -46.01 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -55.09 -48.56 73.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.77 -24.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.424 ' O ' ' OG ' ' A' ' 163' ' ' SER . 9.8 tp -78.01 -41.54 35.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.251 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.4 -20.38 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.7 t -81.19 -50.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.81 -21.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.446 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 164' ' ' GLN . 44.3 m -52.86 -44.42 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.284 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.573 ' C ' ' H ' ' A' ' 166' ' ' PHE . 37.9 mt-30 55.52 151.5 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.62 17.89 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.313 2.008 . . . . 0.0 111.862 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.573 ' H ' ' C ' ' A' ' 164' ' ' GLN . 74.8 t80 -94.89 138.53 32.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.538 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.472 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -109.6 -177.14 3.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -178.06 -91.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.363 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.21 158.41 31.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.407 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -134.77 -111.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.506 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -130.03 139.93 50.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 173' ' ' LEU . 42.4 t0 -158.99 -100.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.583 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 172' ' ' ASP . 14.1 mt 54.51 108.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -150.75 135.52 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.17 157.41 23.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -160.74 -34.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.07 131.07 4.96 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 178' ' ' HIS . 26.8 p-80 -152.61 83.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.512 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -151.64 161.96 41.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -93.24 158.75 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 53.74 91.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -140.2 121.38 14.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 20.2 m170 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.537 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 2.1 pp -64.25 -37.85 88.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.335 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -53.2 -32.47 48.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.586 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 7' ' ' GLN . 91.9 t80 -76.86 -42.61 39.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -46.59 -45.1 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.545 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 4.3 p-10 -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' PHE . 8.5 tt0 -78.41 -48.28 15.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.16 96.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 11' ' ' GLY . 14.7 m -76.69 -36.11 57.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 13.9 tt0 -64.45 2.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.287 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.66 150.69 19.54 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.2 mtt85 -70.48 -45.53 65.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.465 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.11 -45.26 15.01 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.37 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -60.93 -48.44 81.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.64 -31.22 66.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.081 0.467 . . . . 0.0 109.781 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.49 -25.71 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.791 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.3 mmt -74.34 -34.17 63.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.22 -54.29 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.861 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.04 -47.92 61.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.752 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 p -52.54 -50.22 63.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.29 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.734 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.29 -39.17 82.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.04 -36.78 60.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.78 -35.6 62.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' OE1' ' NH2' ' A' ' 48' ' ' ARG . 3.8 tp10 -68.73 -46.89 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.927 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.71 -58.16 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 p -48.91 -32.35 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.62 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.6 mt -53.37 -13.56 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -95.1 -31.89 13.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.69 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.13 -34.36 77.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.73 -43.17 23.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -18.63 53.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.81 -48.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.647 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 tpt -83.33 6.49 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 41.69 41.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.44 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.83 151.85 37.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.117 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 90.61 17.88 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.241 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.62 146.39 34.58 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.554 2.169 . . . . 0.0 112.337 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.9 t -99.83 173.25 6.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.09 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 10.0 p -61.04 -41.4 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 1.8 mp -68.11 -47.79 67.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.272 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 m -50.2 -48.95 53.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.703 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.47 -44.24 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.49 -45.7 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.07 -39.8 93.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.679 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' NH2' ' OE1' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -61.11 -34.43 74.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.289 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 -39.04 88.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.568 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.5 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.1 -51.45 15.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -45.33 -43.19 10.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.053 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.9 96.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' ALA . 66.2 t -57.72 -46.47 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.26 0.553 . . . . 0.0 110.172 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.1 tp -48.48 -43.25 34.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.698 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.99 71.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.72 -35.15 60.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.566 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.93 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.75 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.42 -40.86 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.789 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -78.63 -31.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.23 -31.82 33.34 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.32 0.88 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.709 0.29 . . . . 0.0 110.885 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.8 mm -88.45 -24.08 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.98 65.6 0.3 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.808 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.55 18.7 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.736 2.291 . . . . 0.0 111.625 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -106.54 -10.24 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.643 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -109.77 176.48 1.53 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.819 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.06 1.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.234 1.956 . . . . 0.0 111.796 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.643 ' H ' ' C ' ' A' ' 67' ' ' THR . 12.2 tp -58.35 -31.27 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -39.86 -64.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.757 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -53.19 -33.56 53.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.455 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.57 -46.56 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.85 -40.43 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.214 0.531 . . . . 0.0 109.925 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.8 mmt -59.89 -25.99 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.367 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 t -52.28 -29.08 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.488 0.661 . . . . 0.0 109.712 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 76' ' ' ILE . 96.7 mt -91.11 -31.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.091 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.469 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.8 t-105 -63.91 -46.26 85.6 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' ALA . 3.9 tt -67.77 -52.46 37.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -41.75 -41.55 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.297 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 p -81.39 -24.49 36.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.65 -59.04 6.08 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.989 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -74.89 -51.4 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.204 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.38 -46.09 77.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.78 -47.36 90.8 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' O ' ' OG1' ' A' ' 88' ' ' THR . 83.4 t -68.6 -56.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.217 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -49.87 -21.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.818 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.77 -35.91 14.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.033 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 11.9 p -59.05 -55.18 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.03 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.531 ' CZ ' ' SD ' ' A' ' 93' ' ' MET . 87.6 t80 -52.23 -38.61 58.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -57.14 -40.14 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -35.04 79.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 66.4 p -72.92 -36.54 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' TYR . 58.8 mmm -54.02 -49.06 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.52 -49.93 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -50.23 -36.46 31.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.06 -9.77 20.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.641 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 93' ' ' MET . 25.5 t80 -125.59 75.75 69.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.42 89.03 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -141.2 153.6 66.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -38.45 99.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.5 44.09 2.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -37.6 102.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.4 p -56.31 149.78 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.7 p -85.14 -87.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.78 61.29 0.76 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.588 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.47 69.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.488 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.67 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -166.98 95.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.158 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.7 -15.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.67 ' H ' ' C ' ' A' ' 107' ' ' MET . 14.0 ttp180 -95.41 106.55 18.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.395 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 157.43 76.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.348 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -36.76 125.76 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.851 2.367 . . . . 0.0 112.264 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -86.9 -11.02 51.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -2.24 56.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.653 ' C ' ' H ' ' A' ' 116' ' ' LEU . 41.5 mt -120.11 87.12 38.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.6 Cg_exo -51.78 4.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.64 2.227 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.653 ' H ' ' C ' ' A' ' 114' ' ' LEU . 13.8 mt -64.07 -30.23 71.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.1 -43.05 7.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.6 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -71.53 -44.96 63.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.437 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.3 t90 -74.64 -15.98 60.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.71 71.15 64.94 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.2 -22.87 10.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 111.919 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.1 -53.98 48.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.25 63.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.547 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -169.28 -42.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.81 131.05 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.67 156.45 16.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.59 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 85.2 p -166.76 100.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.4 -167.3 25.03 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -100.27 166.88 10.76 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.3 m -112.23 130.1 56.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 96.74 6.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.028 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.28 139.33 46.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -100.14 126.38 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.661 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.2 -14.4 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.6 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -173.38 132.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -143.25 161.29 38.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.258 0.551 . . . . 0.0 112.077 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -123.22 138.98 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.158 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 54.26 17.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.164 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.19 57.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mt -124.41 136.64 54.21 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.02 148.32 50.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.424 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mtp -49.12 -52.01 51.54 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 142' ' ' MET . 71.1 Cg_exo -45.6 -38.12 16.24 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.41 2.073 . . . . 0.0 112.321 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -68.92 -46.18 68.94 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 148' ' ' GLY . 62.1 m95 -62.75 -56.15 20.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.211 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mt -43.12 -37.94 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.943 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -63.91 -35.22 79.94 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.92 -36.82 75.07 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.02 -33.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.75 -44.35 90.52 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.034 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 151' ' ' ILE . 20.9 mm -59.56 -49.24 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.022 0.439 . . . . 0.0 109.843 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.37 57.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.066 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -61.16 -49.83 75.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.332 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 tt -47.53 -32.23 5.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.442 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.27 -38.11 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.14 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.503 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 79.3 t -54.39 -39.88 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.34 -45.55 25.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.313 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.7 t -52.27 -42.53 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mt -84.12 -41.41 17.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.433 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 44.5 t -61.87 -25.37 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.756 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -83.08 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 109.969 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 164' ' ' GLN . 80.6 mt -65.0 -8.59 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.312 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 60.2 p -53.9 -10.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.821 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.568 ' C ' ' H ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -135.48 75.17 58.45 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.647 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.96 20.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.857 2.371 . . . . 0.0 112.097 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 164' ' ' GLN . 42.5 t80 -64.43 163.01 14.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.45 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.5 tttt 59.03 49.51 9.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.447 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -178.64 134.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.615 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.0 159.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -73.15 -136.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.38 -174.81 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.534 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -157.6 146.02 19.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -175.2 115.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.536 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -177.44 -35.72 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -142.73 136.26 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.844 0.354 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' A' ' 179' ' ' HIS . . . 161.75 -85.91 0.11 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 179' ' ' HIS . 0.8 OUTLIER 63.4 -6.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.71 0.29 . . . . 0.0 110.767 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 177' ' ' GLY . 29.1 m80 -158.76 80.14 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.524 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.644 ' HD1' ' N ' ' A' ' 180' ' ' HIS . 0.0 OUTLIER -162.73 83.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.582 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 86.0 t60 -69.98 -107.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.564 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.582 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 91.7 m-70 56.54 86.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.559 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.598 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.4 -38.54 87.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.192 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -50.48 -36.1 32.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' GLN . 44.6 m-85 -75.47 -40.23 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.323 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.9 tp -45.06 -40.48 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -70.16 -21.75 63.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.404 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' PHE . 40.7 tt0 -79.93 -47.0 15.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.92 -31.72 73.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.95 0.405 . . . . 0.0 110.314 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' GLY . 28.9 m -76.03 -41.47 50.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.21 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 10' ' ' GLN . 1.6 pp0? -70.4 8.93 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.558 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.76 142.43 16.08 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -65.76 -20.64 66.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.659 0.266 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.82 -47.57 54.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.36 -51.61 68.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 0.0 110.469 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -55.78 -46.36 77.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.517 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.63 -31.73 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -28.11 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -74.89 -33.91 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.796 0.331 . . . . 0.0 110.138 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.49 43.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 71.4 t80 -54.33 -53.44 53.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.73 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.1 p -43.12 -49.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.678 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.49 69.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.3 tt -76.98 -38.72 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.639 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.25 42.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.9 mp -75.85 -31.45 59.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.571 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -49.89 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.96 -57.55 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.599 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -45.19 -34.82 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' C ' ' N ' ' A' ' 31' ' ' TRP . . . -82.96 -46.44 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.97 -16.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.531 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.402 ' N ' ' C ' ' A' ' 29' ' ' ALA . 44.1 t90 -94.19 -25.98 16.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 135' ' ' TRP . 0.2 OUTLIER -70.26 -43.15 71.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.519 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' LEU . 34.8 tt0 -73.74 -48.04 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.613 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -49.99 -28.63 7.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.714 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.12 -45.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.696 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 2.07 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.506 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLN . 16.2 mt 43.15 43.64 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.4 149.66 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.395 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -115.37 88.31 18.59 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.79 174.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 112.008 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.59 -172.58 2.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.39 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 10.7 m -64.44 -42.94 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 7.6 mt -64.94 -49.09 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.304 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -59.1 -50.54 73.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.17 -47.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.11 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' OH ' ' CE1' ' A' ' 110' ' ' PHE . 3.7 m-85 -57.76 -44.18 85.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 109.971 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -61.7 -38.52 88.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.464 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -60.96 -33.49 73.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 -34.64 76.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.225 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.6 77.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.326 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.8 tt -72.9 -55.36 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.906 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -42.51 -38.41 1.93 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.35 -41.32 94.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 57' ' ' ALA . 56.1 t -61.7 -47.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.38 -46.12 18.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.505 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.6 -27.64 70.08 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.71 -31.12 70.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 110.293 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.65 -30.99 59.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.329 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.21 -37.92 72.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.334 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 60' ' ' ILE . 91.9 mt -76.84 -36.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.34 -26.39 63.79 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.79 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.14 -28.71 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.61 77.07 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.503 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.86 22.2 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.6 2.2 . . . . 0.0 112.129 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -113.29 -7.56 13.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -109.87 161.67 23.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.677 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.62 -15.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.482 2.121 . . . . 0.0 112.091 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.7 mp -44.64 -29.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttp180 -40.67 -67.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.577 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -56.03 -28.7 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 t -69.11 -45.72 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.34 -34.58 36.51 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.302 0.573 . . . . 0.0 110.244 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 74' ' ' MET . 7.0 tmm? -61.72 -13.55 24.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.276 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -57.97 -36.82 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 mm -88.05 -31.97 5.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.177 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.501 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -64.11 -52.81 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -65.2 -47.29 77.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.681 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -44.27 -43.69 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 p -79.97 -22.77 42.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.654 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.08 -60.99 2.95 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.07 -53.2 9.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.209 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -66.4 -46.27 77.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.64 -46.85 91.68 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.46 ' O ' ' OG1' ' A' ' 88' ' ' THR . 87.6 t -67.73 -44.93 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -58.07 -27.21 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 tp -81.29 -44.06 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.415 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 17.2 p -52.8 -25.47 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 0.0 110.168 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -48.49 53.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.6 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -51.93 -38.33 56.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -65.57 -46.77 78.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -65.37 -47.06 77.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' TYR . 27.2 mmm -44.74 -47.67 10.78 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.5 -50.17 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.628 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.7 -29.62 7.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.39 -15.5 17.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.384 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 m-85 -128.81 75.48 79.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.212 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -48.35 175.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.697 2.265 . . . . 0.0 112.181 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -170.7 67.73 0.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.437 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.58 154.5 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.761 2.307 . . . . 0.0 112.124 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.59 166.27 33.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.58 -25.7 54.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.633 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 106' ' ' PHE . 10.6 t -130.55 143.75 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 106' ' ' PHE . 78.1 p -92.63 -75.64 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -48.0 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 104' ' ' SER . 6.2 m-85 -91.62 77.71 5.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.374 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ttt -62.73 140.34 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.284 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.59 161.8 34.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.694 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -130.62 99.75 5.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.507 ' CE1' ' OH ' ' A' ' 46' ' ' TYR . 1.7 m-85 -79.43 158.81 73.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.146 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 110' ' ' PHE . 82.8 Cg_exo -35.6 158.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.685 2.257 . . . . 0.0 112.157 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 8.8 mp0 -105.81 15.31 26.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.2 p-90 -87.52 -1.28 57.83 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.315 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.588 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.0 79.78 50.97 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.388 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.5 Cg_exo -49.5 -1.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.619 2.213 . . . . 0.0 112.298 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.84 -33.1 68.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.479 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 46.3 m-20 -96.3 -43.64 7.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.3 -45.17 77.34 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.413 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 34.1 t-105 -73.93 -16.81 61.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.912 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.8 68.69 10.83 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.78 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.72 -11.72 26.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.871 2.381 . . . . 0.0 111.649 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -71.67 -6.4 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.205 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 35.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.8 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.479 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 72.7 t80 -153.29 -39.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.351 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.56 128.25 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.93 155.76 16.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -166.29 108.14 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.706 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 133.52 177.83 15.19 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.1 138.04 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 26.9 m -89.95 132.4 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 89.04 -4.14 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.97 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.19 129.11 38.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.174 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -85.0 117.44 23.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -122.32 -3.82 8.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.52 ' NE1' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 t90 -172.78 129.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -145.52 158.54 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.293 0.568 . . . . 0.0 112.019 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -122.98 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.632 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 55.38 17.28 2.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.53 53.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mt -123.91 134.28 53.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 7.0 pm0 -71.06 149.6 46.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 145' ' ' TRP . 8.2 mtt -45.83 -62.16 1.99 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.1 Cg_exo -34.57 -37.66 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -41.15 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.625 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.5 m95 -67.06 -58.26 5.26 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.758 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.0 mt -43.98 -38.22 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -34.49 75.76 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -62.68 -48.93 77.63 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.53 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.08 -35.09 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -38.86 72.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.846 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.17 -40.04 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.019 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.42 73.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.149 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.0 -41.39 97.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.339 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.0 tt -52.24 -33.25 40.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.57 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -82.71 -38.72 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.659 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -52.92 -40.53 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.71 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.501 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -78.07 -46.89 19.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -52.71 -50.17 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.26 -33.99 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.023 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 163' ' ' SER . 48.0 t -75.74 -26.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.87 -45.28 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -71.87 -25.74 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 39.8 p -54.83 -7.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.704 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 162' ' ' ILE . 5.4 pt20 -43.56 148.98 0.64 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.437 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.436 2.091 . . . . 0.0 112.044 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -66.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.477 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -139.91 126.72 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -165.91 -149.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.459 ' CB ' ' NZ ' ' A' ' 169' ' ' LYS . 6.1 mtpm? 55.74 164.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -172.48 167.92 5.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.519 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -45.21 118.65 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -163.87 71.15 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.71 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.0 mt -145.96 -16.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.372 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 174' ' ' PHE . 38.7 p90 -73.12 129.77 38.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.706 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 177' ' ' GLY . . . -126.93 54.2 0.77 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 64.52 -68.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.833 0.349 . . . . 0.0 110.423 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 175' ' ' GLY . . . 71.37 -115.49 5.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -52.04 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.585 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.654 ' HD1' ' N ' ' A' ' 180' ' ' HIS . 1.2 p80 -167.25 -149.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.654 ' N ' ' HD1' ' A' ' 179' ' ' HIS . 77.1 m80 -79.32 119.18 22.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.92 115.54 22.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.328 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -49.5 106.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.573 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 tpt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.2 -36.32 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.362 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -31.86 68.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.3 -45.07 67.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.111 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -50.08 -37.59 34.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.996 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -66.89 -28.79 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.183 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -80.22 -49.43 11.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.702 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.23 -32.59 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.9 p -76.86 -38.69 53.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.504 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.551 ' NE2' ' HZ3' ' A' ' 66' ' ' LYS . 36.5 mt-30 -68.01 5.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.26 141.04 15.23 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -69.13 -51.14 41.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 110.661 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.92 -45.58 5.95 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.32 90.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -62.3 -40.05 95.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.123 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.79 -31.11 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.6 -28.51 64.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.68 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.66 -34.49 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.103 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.13 27.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' LEU . 13.8 t80 -53.7 -53.8 46.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.751 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 p -44.59 -55.18 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.613 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' OE2' ' A' ' 26' ' ' GLU . . . -58.54 -22.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.62 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -85.17 -41.57 15.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -51.24 -40.03 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.53 -35.77 68.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.772 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -70.6 -44.25 67.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.17 -58.08 4.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.622 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 25.4 p -47.22 -34.14 6.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.254 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -79.09 -42.88 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.6 -16.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.794 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -91.68 -34.0 14.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.629 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 4.9 m-85 -62.48 -31.21 71.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.459 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 6.9 mp0 -81.02 -44.86 17.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -63.62 -17.67 63.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 36' ' ' MET . 9.8 p -109.3 -41.59 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.439 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 8.1 tpt -85.9 4.9 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.754 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.4 mp 48.06 34.61 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.63 154.71 28.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.742 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -125.24 128.23 24.81 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.563 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.83 -179.84 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.383 2.055 . . . . 0.0 112.073 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -128.31 -170.97 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.297 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 9.9 p -66.26 -44.72 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 83.8 mt -67.22 -50.43 60.79 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -50.35 -50.89 49.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.52 -41.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.96 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -57.28 -47.81 80.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.854 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.94 -43.28 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.089 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -56.46 -33.64 66.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.901 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.117 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.8 -48.68 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.084 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.4 mm? -75.0 -47.47 28.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 51' ' ' LEU . 38.9 t80 -44.01 -39.67 4.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.42 -39.82 87.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' LEU . 71.5 t -60.33 -17.47 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.368 0.604 . . . . 0.0 109.423 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 tp -83.43 -39.49 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.79 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.3 -38.94 81.98 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.81 72.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.61 -23.22 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.26 -37.09 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.852 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.69 -38.22 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.018 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -63.64 -40.57 98.75 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.52 11.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.064 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 61' ' ' GLY . 90.8 mt -88.32 -25.67 5.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.25 68.76 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.697 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.65 21.01 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.609 2.206 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.551 ' HZ3' ' NE2' ' A' ' 10' ' ' GLN . 26.5 tttp -112.62 -3.67 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.87 166.02 12.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -42.57 -11.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.238 1.959 . . . . 0.0 112.076 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -41.51 -38.55 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.345 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.7 mtm105 -38.66 -69.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.26 -17.1 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.042 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.6 t -83.14 -48.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.249 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 -34.49 60.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.274 0.559 . . . . 0.0 110.043 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.2 ttt -59.51 -9.56 2.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.112 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.65 -43.39 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.425 0.631 . . . . 0.0 110.423 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -88.26 -29.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.645 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.533 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 3.1 t-105 -65.63 -53.34 42.85 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.781 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.98 -45.36 85.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -44.19 -45.49 8.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.966 0.412 . . . . 0.0 110.357 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 p -80.3 -21.06 42.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.049 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.53 -62.28 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.921 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -73.59 -49.34 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.297 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -72.24 -43.69 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.72 -48.33 85.6 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' O ' ' OG1' ' A' ' 88' ' ' THR . 75.1 t -72.83 -50.94 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.637 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' C ' ' OE1' ' A' ' 86' ' ' GLN . 1.1 tm0? -50.11 -23.39 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.022 0.439 . . . . 0.0 109.991 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.67 -41.33 14.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.589 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 23.6 p -51.87 -23.68 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -71.19 -31.02 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.492 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.44 -37.61 51.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -70.29 -58.61 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -54.69 -43.28 72.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.706 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.7 ttt -57.78 -44.77 86.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.58 -48.4 81.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.663 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -52.26 -43.04 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 10.1 mp -91.08 -9.77 44.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.17 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.6 t80 -131.33 71.51 81.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.85 -167.92 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.379 2.053 . . . . 0.0 111.912 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.08 164.66 17.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -39.26 117.7 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 43.21 -165.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.45 42.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.553 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 p -79.36 -156.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.535 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m -123.96 -58.4 1.56 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.406 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 49.59 -136.13 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' MET . 88.4 m-85 -69.22 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 106' ' ' PHE . 5.6 mmt 56.73 114.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.463 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 108' ' ' VAL . 8.1 p 37.5 43.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.156 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.09 99.91 2.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.132 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -122.22 160.85 45.96 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.237 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -38.41 137.15 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.822 2.348 . . . . 0.0 112.236 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.98 -4.62 58.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.522 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -0.85 54.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.605 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 11.8 mt -121.81 81.81 41.83 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.289 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.2 Cg_exo -51.25 2.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.757 2.305 . . . . 0.0 112.635 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.8 mt -62.57 -32.74 73.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.947 0.403 . . . . 0.0 110.142 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 110' ' ' PHE . 2.7 p30 -96.43 -40.59 9.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.47 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 78.1 tttt -72.1 -45.4 60.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.663 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -72.78 -15.57 61.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.128 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.54 73.39 29.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.66 -17.89 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.848 2.366 . . . . 0.0 111.886 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -52.59 -49.24 65.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.847 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.49 54.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.78 -41.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.296 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.07 129.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.48 155.05 17.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -167.34 112.08 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.594 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 129.42 -179.98 16.37 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 m-20 -81.97 137.08 35.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.225 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.3 m -90.68 132.49 35.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 89.82 -6.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -67.88 152.35 45.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -85.08 138.0 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.634 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -128.79 -29.43 2.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.357 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -174.92 138.96 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -133.65 163.44 29.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.48 0.657 . . . . 0.0 112.394 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -123.32 135.55 54.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.766 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 51.43 17.13 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.28 52.11 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.189 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.68 139.84 51.6 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 24.4 mp0 -73.2 154.11 40.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.598 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.46 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 5.9 mtt -49.24 -63.17 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.256 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.6 Cg_exo -31.72 -41.72 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.95 2.433 . . . . 0.0 112.594 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.75 -49.48 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.408 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -63.91 -57.44 9.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt -43.7 -39.57 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.89 -35.76 79.29 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.84 -41.38 91.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.6 mp -80.41 -26.77 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -60.99 -48.78 80.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.533 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 tt -67.73 -39.52 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.81 40.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.096 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -65.4 -44.27 88.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.007 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 66.6 mt -63.33 -30.87 71.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.74 -27.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 25.6 t -75.29 -29.8 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.533 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -73.67 -50.87 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.989 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.6 m -54.27 -52.07 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.934 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 mt -63.29 -36.65 84.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.623 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 9.4 t -65.76 -33.91 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.7 -52.73 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 109.818 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.547 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.7 mp -60.69 -9.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.214 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 92.1 p -52.25 -8.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 162' ' ' ILE . 16.4 mt-30 -86.33 153.88 56.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -36.72 -26.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.789 2.326 . . . . 0.0 112.421 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 164' ' ' GLN . 79.0 t80 -54.46 119.02 4.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.621 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -94.79 -173.72 3.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.8 171.53 12.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.763 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 170' ' ' LYS . 14.3 pttt -88.85 -52.08 5.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.445 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 169' ' ' LYS . 39.9 mttp -150.36 -177.39 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -71.57 148.62 46.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.555 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.67 -166.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' H ' ' CD2' ' A' ' 173' ' ' LEU . 0.2 OUTLIER -80.21 -167.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 173' ' ' LEU . 9.8 m-85 -45.08 171.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -165.58 -142.98 3.58 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.664 HH11 ' HD1' ' A' ' 178' ' ' HIS . 55.0 ttp85 -157.15 91.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.52 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -107.46 79.28 0.25 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.664 ' HD1' HH11 ' A' ' 176' ' ' ARG . 16.7 m80 -78.59 167.17 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.355 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -81.76 139.13 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.688 ' ND1' ' H ' ' A' ' 181' ' ' HIS . 8.5 p80 -86.31 -113.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.517 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.688 ' H ' ' ND1' ' A' ' 180' ' ' HIS . 39.6 t-80 -162.5 161.08 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.617 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.555 ' HD1' ' N ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -48.37 110.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.555 ' N ' ' HD1' ' A' ' 182' ' ' HIS . 12.4 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.481 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mpp? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt -58.5 -38.45 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.449 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -56.0 -39.89 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.564 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLN . 17.9 m-85 -69.72 -42.8 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.61 -40.41 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.176 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.72 -21.69 63.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.102 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.1 tp-100 -80.53 -47.01 14.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.541 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 -32.68 73.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.625 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.2 p -76.45 -33.66 58.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.12 10.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 110.489 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.31 142.57 15.52 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -65.05 -20.51 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.244 . . . . 0.0 110.416 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.45 -46.23 71.73 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.12 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 0.0 110.366 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -56.19 -49.43 74.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.712 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.77 -31.77 73.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.525 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.09 -27.76 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.545 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 31.9 mtt -76.76 -33.85 58.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.348 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.09 -55.2 11.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.696 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . 83.0 t80 -53.88 -54.64 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.661 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -42.72 -58.87 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.662 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -24.51 59.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' PHE . 6.2 tp -80.26 -41.32 25.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.4 -34.32 61.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.57 -35.04 72.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.54 -49.94 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.613 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 30' ' ' LEU . 35.8 mt -64.91 -57.37 8.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.612 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 35.7 m -44.24 -40.42 5.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.389 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.47 -27.14 46.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.36 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.4 tp -63.98 -18.76 64.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.653 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -83.32 -37.3 23.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' O ' ' CB ' ' A' ' 36' ' ' MET . 13.7 m-85 -62.75 -36.65 83.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -79.46 -47.02 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.919 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 57.9 t-80 -62.6 -15.88 53.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.35 -46.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.439 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tpt -87.71 9.92 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.065 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.7 mp 43.26 48.58 5.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.33 146.5 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.377 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -115.47 84.18 11.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.246 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.78 172.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.531 2.154 . . . . 0.0 112.235 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.69 171.59 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.569 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 61.8 t -47.59 -42.99 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.313 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.9 mp -75.05 -40.66 60.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.572 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -55.74 -49.77 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.007 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 pt -66.16 -37.02 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.451 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.26 -45.82 92.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.936 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.95 -39.87 79.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.88 -31.22 70.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.28 76.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.305 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.76 -48.58 81.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.26 -51.58 11.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -45.12 -37.74 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.79 84.38 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.81 -47.1 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.934 0.397 . . . . 0.0 110.025 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.72 -48.51 10.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.474 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.57 97.95 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.38 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.695 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.41 64.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tp -76.64 -37.75 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 60' ' ' ILE . 29.1 mm -81.76 -31.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -71.71 -30.46 66.18 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.66 5.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.56 0.219 . . . . 0.0 111.149 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -85.52 -25.59 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.624 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.22 74.91 0.27 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 73.6 Cg_endo -79.38 16.81 1.33 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.728 2.286 . . . . 0.0 112.242 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -113.76 -3.86 13.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.39 162.18 22.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.691 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.69 -16.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.038 . . . . 0.0 111.792 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 tp -42.95 -33.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.362 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.69 -67.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -55.86 -21.82 22.03 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.69 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' LEU . 10.5 t -76.99 -43.34 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.584 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.26 62.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.19 -10.42 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.267 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.09 -43.42 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.349 0.595 . . . . 0.0 110.144 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -86.96 -32.59 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.458 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -61.49 -55.57 29.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.051 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.14 -47.19 80.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -44.38 -45.3 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.311 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -79.24 -22.88 44.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.78 -59.43 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.991 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.02 -53.49 9.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -66.66 -46.02 77.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.08 -47.84 84.3 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' A' ' 88' ' ' THR . 78.8 t -68.47 -50.32 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -48.63 -26.12 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.97 -38.76 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 68.8 p -55.49 -29.56 59.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.765 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.15 -41.82 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.721 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.12 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -43.04 40.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.651 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.4 p -72.14 -43.6 64.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 22.4 ttp -54.49 -51.11 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.705 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -49.32 75.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.425 ' NE2' ' CD ' ' A' ' 141' ' ' GLU . 26.8 tt0 -55.71 -44.72 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.37 -22.55 35.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.754 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 12.3 t80 -144.27 81.8 11.16 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.3 134.12 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.633 2.222 . . . . 0.0 111.972 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 161.07 60.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 101' ' ' PHE . 55.4 Cg_endo -71.12 94.87 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.637 2.224 . . . . 0.0 112.03 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 100' ' ' PRO . 74.8 t80 55.72 111.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.91 4.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -48.02 97.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.7 t -155.45 54.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 2.0 p30 -151.91 97.25 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -81.4 -171.82 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.0 tpt -161.71 -37.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.2 m -40.91 -40.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -81.26 100.04 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.344 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.61 155.48 37.35 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.85 159.12 9.74 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.582 2.188 . . . . 0.0 111.892 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.23 -12.16 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.34 11.68 35.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.75 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.654 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.7 tp -123.13 61.16 17.64 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.13 11.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.6 2.2 . . . . 0.0 112.038 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -77.72 -29.96 51.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 109.655 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 4.3 p-10 -96.05 -42.34 8.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.266 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -60.38 -38.09 82.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -83.4 -12.59 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.583 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.3 76.52 18.61 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.889 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.51 -19.39 10.19 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 111.909 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -68.63 -3.88 13.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.336 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 124' ' ' PHE . 2.4 t -145.22 37.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 123' ' ' VAL . 16.9 m-85 -153.56 -40.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.534 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.0 131.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.564 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.3 146.9 23.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 t -159.64 100.11 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.7 -171.43 23.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -96.96 151.8 19.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.27 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 28.1 m -103.79 129.81 51.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.58 -7.63 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -67.83 156.91 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.53 ' H ' ' CD ' ' A' ' 132' ' ' GLU . 29.8 mtp85 -97.11 126.51 42.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.807 0.337 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.2 -29.84 4.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -174.1 141.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.45 161.11 39.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.193 0.52 . . . . 0.0 111.83 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.0 139.8 49.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.144 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.5 16.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.42 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.3 23.02 32.99 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.887 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 mt -127.67 139.61 52.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.425 ' CD ' ' NE2' ' A' ' 95' ' ' GLN . 9.9 mt-10 -68.45 145.01 54.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.426 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.9 mtt -47.29 -53.75 26.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.45 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 142' ' ' MET . 82.5 Cg_exo -41.55 -36.64 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.356 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -69.76 -52.96 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 109.9 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 77.9 m95 -56.88 -56.82 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.908 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -42.9 -36.13 1.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.03 82.56 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.488 0.661 . . . . 0.0 109.325 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.35 -45.97 94.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -74.38 -30.45 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.43 -45.14 92.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.64 -43.74 98.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.282 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.26 -47.52 62.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.42 -41.38 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.479 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 4.5 tt -55.31 -34.52 64.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.138 0.494 . . . . 0.0 110.318 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.69 -45.04 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 160' ' ' VAL . 84.4 t -48.99 -32.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.868 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.47 ' O ' ' CG2' ' A' ' 161' ' ' VAL . . . -74.5 -42.92 58.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.53 -33.81 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.72 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.438 ' O ' ' OG ' ' A' ' 163' ' ' SER . 4.1 mm? -85.07 -36.32 21.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.743 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 156' ' ' VAL . 7.1 p -76.63 -23.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.375 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 157' ' ' ALA . 70.1 t -81.95 -51.64 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.9 mm -71.86 -11.84 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.394 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.0 m -52.86 -22.1 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 166' ' ' PHE . 28.6 mt-30 -94.09 148.58 35.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.2 32.1 0.31 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.57 2.18 . . . . 0.0 112.169 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 164' ' ' GLN . 69.6 m-85 -135.93 142.5 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.537 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -108.31 137.48 46.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.17 166.46 12.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.546 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -74.96 155.19 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -120.06 170.07 9.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.622 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -84.27 177.31 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -92.35 -90.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.445 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tp 61.38 122.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.803 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -96.54 -41.79 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.371 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.28 -25.99 8.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -54.99 -23.52 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.69 177.88 49.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -99.89 95.59 6.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.589 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -80.27 122.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.462 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -62.25 -156.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.6 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 181' ' ' HIS . 0.2 OUTLIER 177.11 7.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.533 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' HIS . 5.3 t-160 55.37 109.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.553 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 8.6 mp -64.05 -44.82 91.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.272 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -50.94 -42.51 59.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.385 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.5 -39.93 95.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.37 -38.58 59.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.25 -31.28 72.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.491 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 31.5 mm-40 -74.85 -48.23 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.13 -29.66 69.45 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.483 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' GLY . 95.8 p -75.92 -42.41 48.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -71.52 10.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.156 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.62 145.6 16.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.493 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -63.13 -19.91 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.745 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.94 -47.68 64.65 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.36 67.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -52.72 -49.73 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.86 -29.31 68.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.569 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -69.18 -31.38 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.9 mtt -74.37 -34.02 63.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.62 -53.45 41.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.486 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.85 -54.13 49.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.756 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 p -41.17 -56.41 2.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.36 65.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.483 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.97 -40.28 78.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.86 -43.12 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.585 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.59 -31.94 69.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.6 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.03 -43.27 71.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 8.3 tp -72.81 -57.87 3.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.613 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.0 p -44.81 -37.72 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.151 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.12 -31.83 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.115 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.5 tp -59.13 -18.68 37.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -87.97 -27.54 22.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.351 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' MET . 4.6 m-85 -69.67 -50.93 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.7 -12.29 61.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -79.22 -34.97 42.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.293 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.48 -16.56 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.6 tpp -99.51 -9.39 23.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.39 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 45.68 49.11 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.27 143.98 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.441 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -105.49 130.8 22.47 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.169 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.0 167.58 25.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.302 2.002 . . . . 0.0 112.341 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.83 166.4 21.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.36 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 86.4 t -53.52 -48.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.7 mp -70.1 -47.34 62.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.462 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -52.73 -51.11 61.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.07 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.336 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -43.37 71.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -62.29 -39.25 92.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -59.68 -38.6 81.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.72 -34.15 76.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.02 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.81 98.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.544 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.49 -53.07 7.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -45.96 -43.33 13.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.0 -44.15 89.41 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.35 -46.98 94.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 109.895 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -44.78 -48.3 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.638 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.98 -48.03 88.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -30.46 12.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.257 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.73 66.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.78 -42.59 85.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.52 -35.64 75.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.21 -22.99 78.64 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 1.27 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.3 mt -83.89 -36.88 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.683 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.1 73.11 0.23 Allowed Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.036 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.07 22.7 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.709 2.273 . . . . 0.0 111.72 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -108.32 -12.57 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.159 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -107.41 161.28 23.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.715 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.34 -15.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.564 2.176 . . . . 0.0 112.203 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 mt -46.25 -27.41 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 69' ' ' LEU . 45.7 mtm180 -38.81 -62.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 28.9 t80 -52.87 -37.66 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.192 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 69' ' ' LEU . 17.8 t -60.93 -43.56 96.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.57 -35.8 57.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.195 0.522 . . . . 0.0 110.067 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.1 mtp -59.37 -17.86 33.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.492 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 71.5 t -52.37 -41.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.408 0.623 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 mm -88.1 -31.52 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.767 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.519 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 3.8 t-105 -66.65 -54.75 19.98 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.9 tp -64.19 -49.07 73.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.769 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -42.84 -42.24 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -78.57 -21.66 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.59 -62.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.692 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -72.9 -53.47 11.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.426 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -69.45 -45.41 69.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.75 86.99 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 88' ' ' THR . 67.8 t -68.1 -49.81 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.348 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -50.76 -24.78 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.9 tp -79.83 -38.34 33.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.26 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 82.3 p -56.06 -29.95 61.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 110.207 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.13 -42.06 85.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.648 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.8 -39.43 81.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.366 . . . . 0.0 110.611 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.51 -44.1 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.2 p -69.26 -50.6 45.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 mmt -46.31 -47.58 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -47.19 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.47 -34.7 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.3 mt -100.87 -12.09 19.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 -136.56 74.17 53.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.615 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.85 133.17 50.1 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.83 2.353 . . . . 0.0 112.068 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.9 p -97.49 116.55 65.87 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.301 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.18 -55.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.143 1.895 . . . . 0.0 112.242 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -79.32 134.3 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.654 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 51.23 92.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.626 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.4 p -72.1 57.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.497 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 t 45.06 61.65 2.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.524 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 31.7 t0 61.25 -138.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.528 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 80.3 m-85 -159.74 -99.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.9 ttp -66.72 134.74 52.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.427 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.23 149.18 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.611 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -127.59 121.69 31.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.375 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -97.5 130.0 30.37 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.494 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -41.5 159.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.386 2.057 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -77.34 3.68 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.571 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -125.47 27.27 6.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.584 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 tp -118.42 61.16 4.39 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.69 6.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.698 2.265 . . . . 0.0 112.685 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.584 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.6 mp -78.5 -25.47 45.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.392 0.615 . . . . 0.0 109.863 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 110' ' ' PHE . 4.1 t70 -96.22 -42.79 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.914 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.47 -44.68 95.8 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.048 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 36.4 m0 -78.23 -15.61 58.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.16 77.09 10.99 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.65 -14.89 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.52 -3.61 31.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.07 32.61 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.225 0.536 . . . . 0.0 110.768 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -155.45 -44.58 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.38 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.18 129.39 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.05 153.49 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.565 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t -167.28 99.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.85 -165.02 26.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.9 148.39 22.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.246 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 36.4 m -101.72 132.0 47.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.962 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 88.2 -2.95 0.5 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.896 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.13 129.42 39.85 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.139 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.88 130.06 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -16.94 5.42 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.507 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -172.84 138.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -145.74 160.93 41.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.179 0.514 . . . . 0.0 112.0 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -121.98 138.48 54.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.063 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.3 17.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.15 22.1 53.1 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.49 133.58 54.59 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.27 146.0 53.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.411 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.8 mtt -45.78 -54.11 17.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 142' ' ' MET . 89.1 Cg_exo -41.86 -35.47 2.98 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.4 2.066 . . . . 0.0 112.16 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -71.57 -52.11 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.952 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.4 m95 -59.92 -57.24 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.106 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -44.18 -36.97 2.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -33.02 73.51 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.13 -50.78 58.17 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.315 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.5 mt -69.83 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.024 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -63.54 -42.9 98.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.145 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.7 tp -69.95 -31.64 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.262 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.17 70.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.74 -51.21 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.675 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.41 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 33.7 mt -56.22 -31.59 63.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.635 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.78 -35.84 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.073 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.87 -36.88 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.519 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -68.56 -43.3 76.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.59 -24.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.928 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.447 ' O ' ' OG ' ' A' ' 163' ' ' SER . 44.5 tp -80.76 -43.76 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.37 -34.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.29 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.8 t -68.36 -48.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 110.395 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -22.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 21.3 m -52.68 -44.11 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.624 ' C ' ' H ' ' A' ' 166' ' ' PHE . 47.2 tt0 58.52 84.65 0.2 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.168 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.35 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.556 2.17 . . . . 0.0 111.912 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.624 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.1 OUTLIER 60.01 -166.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.487 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.32 39.93 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.43 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.39 143.88 10.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.708 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -84.17 165.74 18.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -173.43 46.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.417 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -87.82 128.59 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -158.59 49.71 0.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.519 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 7.4 tp -153.57 130.26 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.777 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.52 ' C ' ' H ' ' A' ' 176' ' ' ARG . 2.4 m-85 -159.23 -24.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.348 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.34 -25.92 1.07 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 174' ' ' PHE . 53.6 ttp85 -45.39 133.88 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 178' ' ' HIS . . . 159.56 23.36 0.03 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.441 ' C ' ' HD1' ' A' ' 179' ' ' HIS . 14.6 m-70 -49.37 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 110.6 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' A' ' 180' ' ' HIS . 0.4 OUTLIER -102.6 178.81 4.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.537 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 179' ' ' HIS . 0.0 OUTLIER -142.72 103.51 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.41 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 181' ' ' HIS . 0.1 OUTLIER -42.62 158.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.625 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 12.7 t-80 63.05 -171.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 25.4 m80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.05 -45.2 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.3 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -51.12 -34.53 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.3 t80 -69.36 -44.39 71.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.123 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.2 tp -47.8 -38.7 16.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.484 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -67.43 -26.16 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.485 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 4' ' ' PHE . 23.6 mt-30 -80.48 -47.02 14.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.791 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.36 -38.74 90.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.1 m -76.67 -32.39 57.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.495 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 8.2 tt0 -71.38 5.62 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.008 0.432 . . . . 0.0 110.576 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.2 148.34 18.71 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -70.01 -20.79 63.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.91 -45.74 55.93 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.95 -50.49 73.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.74 0.305 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -56.4 -44.79 80.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.487 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.63 -30.43 71.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.306 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -70.21 -26.94 64.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.686 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.469 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -76.87 -34.27 57.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -56.55 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -52.81 -51.12 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.692 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -45.3 -60.91 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -33.37 61.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.463 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.58 -41.44 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.91 -33.18 61.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.216 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.21 -32.69 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.252 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.41 -45.37 55.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.46 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.06 -52.06 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.332 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 17.4 m -56.06 -30.77 62.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -33.36 38.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.884 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -17.22 64.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -91.03 -34.63 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' MET . 27.3 t80 -60.5 -39.07 86.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.07 -40.3 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.594 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.52 -22.66 65.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 36' ' ' MET . 9.7 p -109.3 -42.83 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 6.7 tpt -84.82 5.91 26.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.684 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt 42.99 44.67 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -63.11 147.05 51.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 81.8 mttt -113.13 90.83 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.225 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.11 172.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.45 2.1 . . . . 0.0 112.415 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.96 168.98 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.943 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 91.6 t -53.94 -51.33 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.9 mp -66.15 -50.0 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.8 m -50.57 -49.86 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.752 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.37 -42.45 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -47.5 75.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.78 -40.19 79.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.418 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -58.12 -33.96 69.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.38 84.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.443 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.38 73.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.4 tp -73.06 -53.28 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -42.86 -41.25 3.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.89 -40.38 95.42 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.4 t -61.11 -47.66 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.223 0.535 . . . . 0.0 109.559 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -45.5 -47.12 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.491 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.64 -28.26 69.55 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.39 -34.96 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.61 -34.14 75.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.237 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.39 -32.39 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.218 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -77.59 -42.65 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.342 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -23.79 75.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.6 4.73 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.625 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -84.9 -34.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.738 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.55 73.63 0.11 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.54 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.51 12.37 2.9 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.891 2.394 . . . . 0.0 111.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 10' ' ' GLN . 8.8 mttm -96.93 -10.01 27.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.61 161.29 28.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.692 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -38.14 -19.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.519 2.146 . . . . 0.0 112.197 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' THR . 8.3 mp -43.7 -30.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.24 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttm180 -38.14 -51.7 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -55.21 -35.78 65.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.503 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.7 t -61.96 -58.45 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.152 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.73 79.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.366 0.603 . . . . 0.0 109.774 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -8.88 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 53.4 t -60.58 -43.86 95.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.529 0.68 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 76' ' ' ILE . 79.8 mt -87.98 -29.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.894 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.1 t-105 -65.0 -52.33 56.72 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.772 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.8 tp -64.85 -48.56 73.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.586 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -43.69 -42.79 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.888 0.375 . . . . 0.0 110.356 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -23.09 36.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.87 -61.7 2.42 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.912 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE2' ' OE1' ' A' ' 86' ' ' GLN . 70.4 t80 -75.43 -46.96 29.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.397 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -72.11 -41.01 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.78 -48.19 87.48 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' A' ' 88' ' ' THR . 16.5 m -71.46 -45.83 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.496 ' OE1' ' CE2' ' A' ' 82' ' ' PHE . 56.4 tt0 -52.24 -27.5 15.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.401 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.74 -44.19 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.37 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 48.4 p -49.5 -25.29 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.82 -45.18 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.75 -45.7 85.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.739 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.22 -40.91 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.0 p -71.57 -41.95 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.585 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -47.12 -47.71 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.326 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.65 -47.22 82.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -51.47 -40.23 59.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.71 -12.49 27.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.551 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 98' ' ' PRO . 30.9 t80 -129.89 77.71 76.27 Favored Pre-proline 0 N--CA 1.462 0.169 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 97' ' ' TYR . 44.1 Cg_exo -53.84 -141.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.954 2.436 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 m 62.87 143.9 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.231 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 -177.31 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.408 2.072 . . . . 0.0 112.23 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -174.17 -31.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.57 133.18 35.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' SER . 3.3 m -85.27 45.27 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' THR . 45.9 p 46.11 97.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.576 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -161.51 -59.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 85.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.053 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.574 ' C ' ' H ' ' A' ' 109' ' ' ARG . 11.2 mtt -153.69 108.33 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.595 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.9 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 107' ' ' MET . 82.4 mtt180 -88.4 108.4 19.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.45 146.31 56.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.284 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -37.35 138.17 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.583 2.189 . . . . 0.0 112.193 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -94.4 6.01 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.706 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.64 -5.62 19.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.613 ' C ' ' H ' ' A' ' 116' ' ' LEU . 18.6 mt -120.05 83.3 30.69 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.8 Cg_exo -54.4 4.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 112.052 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -66.01 -30.23 70.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.084 0.468 . . . . 0.0 110.321 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.19 -42.19 7.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -73.63 -45.23 54.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -73.27 -15.58 61.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.375 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.29 72.25 32.37 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.9 -16.87 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.91 2.407 . . . . 0.0 112.042 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 -19.14 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.878 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.33 39.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.464 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.29 -42.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.069 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.06 128.09 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.41 156.24 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.6 t -168.29 99.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.19 -172.3 23.53 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.61 150.9 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 54.5 m -102.26 132.29 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.027 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.44 -3.52 0.29 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -69.32 150.06 47.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.253 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -86.38 113.16 22.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -106.61 -16.31 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.536 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 135' ' ' TRP . 13.7 t90 -173.92 119.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.4 t70 -109.08 151.64 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.205 0.526 . . . . 0.0 112.034 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 8.2 t80 -153.7 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.901 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 50.9 mt 79.06 17.87 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.45 7.04 88.77 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 mt -120.63 150.65 40.59 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 44.1 mm-40 -77.36 161.07 28.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.331 0.586 . . . . 0.0 111.3 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 4.3 ttt -44.09 -58.66 4.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.425 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 142' ' ' MET . 6.8 Cg_endo -49.33 -20.45 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.298 1.999 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 141' ' ' GLU . 6.6 mm-40 -75.45 -58.11 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.811 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -64.35 -53.4 49.21 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.983 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 tt -43.42 -45.83 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.2 tp -52.85 -37.62 60.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.22 -40.19 83.6 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.544 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -77.3 -35.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.682 0.277 . . . . 0.0 110.302 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.29 69.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.09 -39.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.161 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.6 -48.99 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.37 -45.68 93.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 7.8 tt -54.7 -31.11 57.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.411 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.69 -26.88 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.25 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.486 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 58.0 t -74.3 -32.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.388 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.521 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -51.41 8.73 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.534 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.68 -40.41 69.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.355 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -77.21 -35.13 55.91 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.378 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 54.8 t -76.87 -22.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.057 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 t -77.15 -46.66 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.342 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.99 -19.62 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 23.5 m -62.82 -26.29 68.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -171.03 79.85 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.697 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 166' ' ' PHE . 73.8 Cg_endo -81.24 7.04 5.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.591 2.194 . . . . 0.0 111.661 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 62.4 m-85 -160.71 157.35 26.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -134.23 158.81 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.305 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.52 112.98 4.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.641 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 171' ' ' ARG . 3.9 tptm -52.2 155.4 1.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.319 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -136.34 8.59 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.738 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.471 ' O ' ' NZ ' ' A' ' 169' ' ' LYS . 10.4 ptp85 -157.99 140.49 14.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -114.7 -16.95 11.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 16.6 mt 52.87 -97.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.445 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -72.75 130.41 40.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -85.65 -60.69 1.77 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -141.28 -92.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.66 -55.91 0.72 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.553 ' HD1' ' N ' ' A' ' 178' ' ' HIS . 0.9 OUTLIER -81.53 -178.42 6.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.751 0.31 . . . . 0.0 110.545 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 180' ' ' HIS . 10.1 p80 -176.28 176.74 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 179' ' ' HIS . 36.0 m170 -50.55 -175.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.574 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -135.23 142.66 46.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.541 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 56.5 p-80 -100.71 -144.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.451 ' N ' ' CD2' ' A' ' 182' ' ' HIS . 16.1 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.522 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.68 -37.09 80.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.207 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 ttm105 -55.7 -41.06 73.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.31 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.35 -44.77 95.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.406 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.43 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -49.36 -41.07 37.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 19.2 t30 -67.0 -29.72 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -77.16 -49.64 14.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.69 71.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.5 m -76.52 -42.32 43.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 6' ' ' ASN . 1.1 mp0 -67.61 5.69 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.37 141.07 15.24 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -69.07 -50.32 49.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.593 0.235 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -46.31 6.18 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.7 89.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.114 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -59.81 -38.99 83.49 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.78 -30.15 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.949 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.95 -27.83 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.4 mtt -75.88 -33.92 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.77 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 4.3 m-85 -57.58 -50.15 74.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.558 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.0 m -42.87 -60.27 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.16 -25.94 48.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -78.94 -40.62 31.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.41 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -70.58 -35.21 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.593 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.41 -49.6 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.531 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.02 -57.88 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.626 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -46.33 -37.88 8.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.36 -17.32 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -95.56 -36.46 11.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.927 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CZ ' ' CZ2' ' A' ' 135' ' ' TRP . 2.5 m-85 -54.46 -46.14 73.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.733 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -40.74 76.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -60.03 -20.05 55.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.33 -35.32 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 31.7 mtt -87.72 3.49 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt 50.66 49.81 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.692 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.38 155.76 18.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 140.91 40.0 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.266 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.52 177.47 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.52 2.147 . . . . 0.0 112.091 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -131.75 -166.41 1.72 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.632 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 35.8 t -65.55 -51.3 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.833 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 10.6 mp -65.95 -50.1 65.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -48.59 -45.2 37.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.21 -38.16 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.094 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.9 -48.06 82.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.958 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -61.28 -38.1 85.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -58.96 -40.1 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.24 83.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.4 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.78 -52.45 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.198 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.46 -39.63 7.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.77 -43.84 90.78 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 34.8 t -62.7 -47.36 93.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.166 0.507 . . . . 0.0 109.748 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.53 -45.87 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.603 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -30.05 76.64 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.73 -40.06 91.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.71 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.01 -25.22 60.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 3.3 mm? -79.47 -37.75 36.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -79.94 -35.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -22.99 72.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.94 6.65 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 110.74 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -80.24 -31.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.426 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.7 77.14 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.633 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.87 26.88 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.661 2.241 . . . . 0.0 111.947 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -106.84 -9.77 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.059 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.29 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.464 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.4 -5.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.089 1.859 . . . . 0.0 111.773 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 tt -44.44 -37.66 3.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.431 HH21 ' NE2' ' A' ' 10' ' ' GLN . 59.7 mtt180 -40.78 -70.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.666 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.03 -31.54 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.133 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.61 -46.95 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.84 -33.87 52.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.235 0.54 . . . . 0.0 110.109 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.16 -17.35 40.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.539 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 69.2 t -53.41 -40.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.425 0.631 . . . . 0.0 110.38 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.87 -33.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.524 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.491 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.7 t-105 -61.79 -55.88 25.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.48 -48.49 77.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -45.86 -45.71 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.259 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -76.84 -25.3 53.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.387 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.68 -59.07 5.98 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.01 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.37 -54.33 8.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.174 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -66.14 -45.36 81.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.23 89.93 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' O ' ' OG1' ' A' ' 88' ' ' THR . 89.3 t -68.74 -52.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.393 . . . . 0.0 110.578 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -51.16 -25.14 4.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.06 -40.91 17.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.548 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 42.1 p -54.11 -24.99 19.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -73.47 -48.16 35.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -51.19 -32.76 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.426 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 12.5 t-80 -73.38 -45.23 56.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.671 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -45.86 70.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' TYR . 32.9 ttp -51.36 -49.77 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -49.82 54.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.455 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 5.4 tt0 -52.36 -48.81 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.25 -19.5 26.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.023 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -139.53 83.46 17.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.74 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.42 82.53 2.37 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.594 2.196 . . . . 0.0 111.91 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 100' ' ' PRO . 0.3 OUTLIER -67.71 -43.04 38.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 99' ' ' SER . 72.7 Cg_endo -83.45 11.87 3.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.622 2.215 . . . . 0.0 112.287 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' PRO . 3.7 m-85 54.58 109.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.17 -167.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.55 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.89 -26.85 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' PHE . 20.0 t 47.24 -104.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 107' ' ' MET . 9.9 t70 62.44 -71.48 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER 66.43 -71.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.538 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.16 141.88 44.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.28 103.31 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.443 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -62.91 146.54 95.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.11 144.58 57.99 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.49 2.127 . . . . 0.0 111.945 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -101.45 5.31 41.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 9.6 p-90 -124.56 -5.13 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.5 tp -119.69 80.49 23.98 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.48 -5.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.688 2.259 . . . . 0.0 112.556 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.1 mt -57.89 -28.97 64.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.473 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 12.6 t0 -96.53 -39.39 9.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.598 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.574 ' HZ2' ' HE1' ' A' ' 119' ' ' TRP . 6.0 ttpp -68.61 -45.28 72.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.574 ' HE1' ' HZ2' ' A' ' 118' ' ' LYS . 41.5 m0 -77.74 -18.55 56.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.86 76.43 17.18 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 -17.68 9.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.742 2.294 . . . . 0.0 111.654 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -52.41 -50.84 61.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.865 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.81 55.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.473 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -157.59 -44.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -56.11 130.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.61 146.55 24.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.801 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -159.04 99.81 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.14 -171.56 22.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.97 160.38 14.3 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.66 0.267 . . . . 0.0 110.363 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 85.4 m -108.11 134.95 50.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 98.38 -9.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.736 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.72 129.23 39.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.9 ptt85 -65.84 129.18 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -124.17 -29.45 3.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.435 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.551 ' CZ2' ' CZ ' ' A' ' 32' ' ' PHE . 5.4 t90 -173.74 137.82 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.779 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -142.21 160.44 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 112.135 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -118.98 138.41 52.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.046 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.68 17.35 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.155 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.78 22.87 40.99 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.81 135.88 54.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.455 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 8.9 mt-10 -68.74 146.36 53.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.598 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtp -48.75 -52.41 45.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.63 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 142' ' ' MET . 81.1 Cg_exo -44.46 -37.07 10.43 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.049 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.428 ' NE2' ' C ' ' A' ' 144' ' ' GLN . 0.6 OUTLIER -70.92 -49.33 46.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.98 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.571 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.1 m95 -59.54 -56.77 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.244 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -44.07 -39.35 4.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.9 -37.24 73.64 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.33 -43.34 97.4 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.731 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.6 mt -69.61 -26.7 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.8 0.333 . . . . 0.0 110.408 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -42.89 94.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.976 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.64 -47.98 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.045 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.3 -50.57 73.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.78 -44.38 96.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.739 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.53 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -61.33 -30.02 70.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.157 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.1 mt -73.55 -39.45 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.491 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.1 t -59.08 -38.2 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -74.1 -43.49 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.403 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.97 -37.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.398 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.67 -25.02 38.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.792 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 163' ' ' SER . 38.0 t -78.33 -25.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.526 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.9 p -82.97 -45.08 19.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.347 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 164' ' ' GLN . 35.3 mm -65.39 -28.57 44.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 13.3 p -57.16 0.06 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.518 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.595 ' H ' ' C ' ' A' ' 162' ' ' ILE . 8.2 mm100 -124.49 67.76 49.0 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.7 18.6 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.501 2.134 . . . . 0.0 112.087 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 164' ' ' GLN . 66.1 t80 -87.56 -105.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.455 ' N ' ' CD2' ' A' ' 166' ' ' PHE . 67.3 mmtt 43.08 -122.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.684 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -175.42 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.436 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -161.05 133.21 5.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -111.77 -48.04 3.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 62.6 138.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.534 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.84 170.63 8.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.441 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.12 -174.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.356 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -41.72 117.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -129.51 -63.16 0.11 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.5 mmt-85 45.27 -161.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -161.06 -151.96 6.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' A' ' 179' ' ' HIS . 29.1 t-80 -102.11 177.05 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.338 . . . . 0.0 110.549 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.656 ' H ' ' HD1' ' A' ' 179' ' ' HIS . 0.6 OUTLIER -84.73 95.91 9.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.503 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 13.3 m80 62.14 -72.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 179' ' ' HIS . 0.1 OUTLIER -154.08 -159.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.493 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -82.95 151.38 25.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 10.5 t60 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.613 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.559 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.5 mm? -68.75 -45.5 71.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -51.1 -33.99 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.09 -40.69 64.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.421 ' O ' ' OG ' ' A' ' 9' ' ' SER . 6.4 tp -49.3 -45.17 44.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.494 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -67.06 -24.21 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.025 0.441 . . . . 0.0 110.066 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -78.69 -47.39 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -32.23 73.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.5 m -76.1 -37.79 57.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.236 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -72.11 11.95 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.245 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.14 141.46 15.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.84 -50.57 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.22 5.72 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -61.05 -46.29 91.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.307 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -61.83 -34.04 75.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.19 -30.92 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.017 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.84 -28.52 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.646 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.47 -34.76 60.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.79 -54.8 16.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.723 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 23' ' ' LEU . 17.4 t80 -54.51 -51.64 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.615 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 18' ' ' MET . 6.3 p -43.22 -56.01 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.7 56.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.9 tt -77.56 -39.58 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.539 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.02 -44.5 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.621 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.8 mp -71.54 -32.08 67.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.458 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.57 -48.51 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.1 -58.09 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 25.3 p -46.03 -33.68 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.78 -32.02 27.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.393 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -62.43 -16.02 52.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.636 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -91.41 -38.74 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 36' ' ' MET . 5.1 m-85 -56.08 -45.62 79.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.442 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -73.24 -36.77 66.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.554 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -56.65 -35.62 68.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.547 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.05 -50.82 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.8 tpp -69.91 0.64 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 42.25 45.5 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 110.115 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.83 149.29 47.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.896 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HZ2' ' HG ' ' A' ' 127' ' ' SER . 16.8 mtpp -117.87 83.46 18.65 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.77 154.38 1.98 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 112.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 4.7 t -106.52 -171.68 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.53 -50.5 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.652 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 10.4 mp -58.39 -40.79 83.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.097 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -53.85 -42.51 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.41 -46.53 92.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.65 -48.62 72.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -64.56 -36.02 82.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.74 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -68.92 -39.26 79.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.499 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.18 88.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.15 -48.28 73.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -48.98 22.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.12 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.73 -43.21 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 109.811 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.93 97.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -59.46 -47.26 91.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.782 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.56 -46.5 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.371 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.01 -27.69 70.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.96 -33.45 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.72 71.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.68 -35.3 80.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.0 -37.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.41 -16.62 71.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.82 2.04 32.0 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.015 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -84.05 -38.85 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.99 78.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.614 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.62 20.5 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.718 2.279 . . . . 0.0 112.164 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -107.56 -7.07 16.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.34 165.01 13.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.49 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -39.64 -14.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.45 2.1 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 67' ' ' THR . 75.0 mt -44.64 -32.0 1.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 69' ' ' LEU . 41.2 mtm180 -40.03 -63.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -57.27 -22.36 40.95 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.122 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.5 t -76.17 -44.27 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.993 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.84 59.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.518 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -57.5 -14.05 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.799 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.68 -44.99 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.44 0.638 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -88.19 -28.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.838 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.455 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -64.66 -53.65 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.209 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.73 -45.3 71.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -45.47 -46.16 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.592 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -77.82 -23.38 49.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.93 -60.01 4.52 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.279 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.47 -52.02 13.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -67.26 -41.69 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.12 92.31 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.7 t -75.18 -56.87 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -47.19 -27.57 1.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.838 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.43 -35.32 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.988 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 29.4 p -56.7 -51.38 69.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.139 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -33.87 3.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.196 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.79 -40.15 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.922 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 88' ' ' THR . 1.6 t60 -66.99 -40.7 87.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.426 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.4 p -73.32 -51.82 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.875 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.8 ttt -43.75 -43.03 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.49 -40.08 77.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -66.95 -46.38 74.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.915 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.03 -28.97 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.6 OUTLIER -126.39 91.59 47.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.41 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.34 154.77 21.73 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.486 2.124 . . . . 0.0 112.162 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.4 ' O ' ' OG1' ' A' ' 103' ' ' THR . 13.2 t -150.3 76.94 8.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.515 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.12 21.78 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.589 2.193 . . . . 0.0 112.05 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.82 109.94 22.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.91 34.34 23.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.442 ' O ' ' CB ' ' A' ' 104' ' ' SER . 0.8 OUTLIER -84.58 -145.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.391 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 105' ' ' ASP . 1.4 t 163.48 179.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.249 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 51.6 m-20 -157.67 156.62 32.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.558 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 81.2 m-85 -158.51 164.6 35.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.649 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.0 mmt -75.97 169.59 17.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.36 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.463 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 11.8 p -76.29 108.89 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 110.397 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -103.43 99.93 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.374 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -98.51 148.54 34.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.46 138.7 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.535 2.157 . . . . 0.0 112.354 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -84.01 9.58 12.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.279 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.671 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -114.73 7.27 15.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.0 tp -120.68 83.63 35.79 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.948 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -52.69 6.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.777 2.318 . . . . 0.0 112.699 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.637 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -66.39 -31.09 71.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 109.942 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 1.1 m-20 -96.73 -41.17 8.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.365 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -70.37 -44.14 68.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.752 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.452 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.7 t90 -76.63 -14.81 59.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.59 69.36 13.63 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.743 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 -11.2 17.43 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.765 2.31 . . . . 0.0 112.068 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.433 ' H ' ' CD ' ' A' ' 122' ' ' GLN . 25.1 mp0 -59.66 -54.21 49.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.11 50.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 111.103 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -156.32 -38.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.176 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.16 124.24 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.75 157.6 16.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.756 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.671 ' HG ' ' HZ2' ' A' ' 39' ' ' LYS . 44.1 t -162.96 144.6 10.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.239 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.4 23.25 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 4.4 p30 -103.65 168.91 8.84 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.3 m -115.02 135.34 54.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.797 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 87.95 -0.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -67.98 152.06 46.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.566 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -89.34 137.33 32.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.43 -30.37 2.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.02 139.78 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.05 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -140.0 167.83 21.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.521 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.8 t80 -143.59 120.14 11.06 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.6 tp 78.39 16.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 12.84 76.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 mt -119.99 135.24 54.99 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.842 0.354 . . . . 0.0 110.195 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -72.89 154.25 40.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.409 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -48.24 -61.73 2.87 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.614 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 95.3 Cg_exo -34.09 -39.18 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.71 2.273 . . . . 0.0 112.506 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -72.43 -49.2 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.598 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.9 m95 -60.46 -57.67 11.77 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.022 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.4 tp -43.35 -40.54 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.219 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.08 -34.09 71.58 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.88 -44.62 95.92 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.5 mt -76.14 -36.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.347 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.75 -47.2 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.97 -41.71 90.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.585 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -49.29 -46.3 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.409 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -64.87 -44.66 88.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 tp -49.34 -46.81 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.036 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.46 -45.3 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.264 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 75.1 t -49.8 -36.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 111.022 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.56 -31.73 57.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.38 -46.36 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 0.0 110.989 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 163' ' ' SER . 10.1 mp -77.4 -28.18 52.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 46.3 t -78.17 -35.2 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.918 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 162' ' ' ILE . 6.4 p -73.62 -46.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.201 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.476 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 5.6 pt -71.99 -24.89 23.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.058 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 4.4 m -52.66 -11.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.368 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 166' ' ' PHE . 20.4 pt20 -61.69 147.75 88.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 166' ' ' PHE . 43.7 Cg_endo -68.16 36.86 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 111.916 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 164' ' ' GLN . 80.6 t80 58.84 130.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -143.96 -172.11 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.336 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -39.13 149.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -47.26 171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.667 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -157.77 121.95 4.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -167.68 -141.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.549 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 39.8 t0 -154.94 -179.17 7.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.535 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 0.1 OUTLIER -149.13 106.66 3.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.474 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -79.75 134.16 36.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 157.29 170.8 22.59 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -168.62 -62.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.706 0.289 . . . . 0.0 110.679 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.476 ' C ' ' ND1' ' A' ' 178' ' ' HIS . . . 76.65 156.48 7.05 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.476 ' ND1' ' C ' ' A' ' 177' ' ' GLY . 5.5 m80 -153.35 132.89 12.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.341 . . . . 0.0 110.6 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.601 ' H ' ' ND1' ' A' ' 179' ' ' HIS . 6.9 p-80 -79.97 127.87 32.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.257 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 156.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.422 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -89.15 -157.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -166.87 -145.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.6 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.453 ' N ' ' CG ' ' A' ' 182' ' ' HIS . 73.0 t60 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.541 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.26 -49.89 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -55.73 -36.19 66.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.38 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 7' ' ' GLN . 1.4 t80 -68.64 -46.27 69.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.181 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.15 -40.77 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.0 OUTLIER -69.11 -22.85 63.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.351 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' PHE . 14.1 tm0? -81.07 -46.95 14.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.713 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.74 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' GLY . 52.2 p -76.2 -30.93 58.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -75.92 12.14 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.333 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.44 144.46 16.27 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -19.07 63.49 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.386 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.07 -46.41 65.93 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -51.27 68.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -56.53 -40.12 74.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.779 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.2 -32.6 63.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mt -68.89 -30.75 69.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.531 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.25 -34.29 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.88 -56.67 7.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.446 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.77 -53.35 49.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 p -42.96 -56.64 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.437 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.04 -33.71 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.452 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.04 -40.38 68.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.69 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 10.4 mp -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.485 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -72.39 -43.88 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.681 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.42 -57.78 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.512 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.2 p -47.37 -36.99 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.68 -35.35 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -18.0 56.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.358 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -94.75 -34.02 12.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -55.48 -48.87 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.534 HE21 ' CB ' ' A' ' 38' ' ' LEU . 5.3 mt-30 -75.18 -20.82 59.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.446 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -68.88 -28.99 67.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.56 -31.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 mtt -84.48 0.52 49.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.729 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.7 mt 48.86 48.65 20.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.898 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.534 ' CB ' HE21 ' A' ' 33' ' ' GLN . 13.3 mt -97.51 156.5 16.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.308 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -119.72 148.54 46.41 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.252 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.47 175.02 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.44 2.094 . . . . 0.0 112.179 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -128.91 175.36 8.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.5 t -61.5 -54.73 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.757 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.495 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 7.9 mt -67.2 -46.67 73.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -48.7 -46.12 40.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.516 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.412 HG21 HD12 ' A' ' 45' ' ' ILE . 83.7 mt -64.44 -43.7 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.94 -45.55 74.86 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.51 -30.9 71.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.037 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -63.33 -37.94 89.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.969 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.99 -33.16 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.11 77.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.2 tt -77.28 -56.06 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.033 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -43.36 -38.25 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.48 -41.0 91.11 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 51' ' ' LEU . 14.8 t -65.92 -43.26 92.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 109.73 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -47.6 -47.54 28.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.721 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.95 -34.38 89.77 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.72 92.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.091 -0.554 . . . . 0.0 110.457 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.25 75.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.377 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.11 -36.23 77.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.631 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.95 -33.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.52 -12.51 83.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.74 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 111.043 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -91.52 -24.11 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.89 73.27 0.11 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.6 22.6 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.911 2.407 . . . . 0.0 112.371 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -115.65 -4.64 12.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -110.46 161.29 25.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.848 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -37.07 -19.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.683 2.256 . . . . 0.0 112.196 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.0 mm? -44.67 -29.03 0.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -40.59 -67.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.679 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -53.6 -34.7 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.289 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 11.7 t -63.67 -57.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.362 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.29 80.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.0 ttt -64.88 -13.68 57.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 2.9 p -60.44 -35.11 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.292 0.567 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -88.67 -32.46 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.032 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.578 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.0 t-105 -59.59 -51.92 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.84 -43.06 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.624 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -47.44 -47.31 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 p -78.52 -23.64 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -58.09 10.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.205 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.9 -53.86 9.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.974 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -66.1 -45.53 80.85 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.48 -47.28 91.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.432 ' O ' ' OG1' ' A' ' 88' ' ' THR . 57.9 t -65.0 -39.36 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.52 -31.36 69.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -78.03 -45.7 22.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.346 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 63.1 p -49.13 -31.46 8.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -42.47 79.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.291 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -60.67 -31.65 70.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -75.94 -46.68 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.56 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -66.44 -49.39 66.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.2 mmt -50.35 -49.71 53.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.487 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 33.8 tt0 -51.18 -39.36 56.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.68 -11.97 22.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.739 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.1 t80 -127.81 103.18 21.69 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.565 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.73 -167.58 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.195 1.93 . . . . 0.0 112.136 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.4 m 56.67 67.84 2.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.47 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.77 179.76 5.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.666 2.244 . . . . 0.0 112.101 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -151.85 -9.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.22 -175.58 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.587 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.68 113.53 12.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.618 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.6 t -172.94 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.524 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.62 43.1 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 1.3 m-85 65.5 124.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.553 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 106' ' ' PHE . 29.7 tpp 53.08 106.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.573 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -87.36 -173.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.665 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -106.11 116.26 31.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.453 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -68.42 145.83 97.5 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.445 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.99 151.65 67.83 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.42 2.08 . . . . 0.0 111.867 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -110.0 17.3 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.69 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -125.56 -5.77 7.02 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.608 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.661 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.6 mt -115.57 87.64 17.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.44 6.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.696 2.264 . . . . 0.0 112.73 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.661 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tp -73.74 -26.36 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -96.38 -36.97 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.844 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.04 -41.44 67.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -75.59 -20.78 58.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.913 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 p -165.13 84.93 1.08 Allowed Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.685 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -80.74 -2.52 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.784 2.323 . . . . 0.0 111.816 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -60.12 -54.32 47.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 123' ' ' VAL . 8.6 p -97.49 59.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.628 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -165.67 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 m -57.52 128.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.8 153.94 17.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.837 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 t -170.15 99.96 0.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.473 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.12 -167.6 26.35 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' O ' ' OE2' ' A' ' 132' ' ' GLU . 4.0 m-20 -99.84 146.22 26.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.698 0.285 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 62.7 m -98.77 136.72 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.991 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 91.44 -3.62 0.21 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.872 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' OE2' ' O ' ' A' ' 129' ' ' ASP . 12.3 pt-20 -67.74 153.23 44.16 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.309 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -88.4 138.81 31.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.26 -31.04 2.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.648 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -171.94 136.22 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.265 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.3 t70 -119.61 158.35 26.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 111.943 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.548 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 83.2 t80 -144.82 111.16 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.95 17.38 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 136' ' ' ASP . . . 84.76 9.22 81.48 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 6.4 mt -115.49 133.95 55.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.128 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.487 ' OE1' ' NE2' ' A' ' 95' ' ' GLN . 5.2 mt-10 -70.46 154.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.443 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -54.17 -51.0 81.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.995 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 142' ' ' MET . 69.5 Cg_exo -47.11 -40.13 26.47 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.383 2.055 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -71.2 -38.73 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 148' ' ' GLY . 32.6 m95 -67.11 -56.56 9.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.271 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 tp -43.06 -42.95 4.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 147' ' ' LEU . 2.6 tm? -59.7 -37.07 77.83 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.31 -40.92 92.66 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.924 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.59 -25.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.682 0.277 . . . . 0.0 110.357 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -42.75 92.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.084 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 151' ' ' ILE . 8.6 mm -63.0 -43.68 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.024 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.78 64.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.456 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.6 m-85 -56.2 -37.28 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.7 tp -66.34 -30.22 70.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.412 . . . . 0.0 110.6 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.9 -39.99 59.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.06 -34.52 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.026 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.05 -31.03 58.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.16 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.2 t -64.24 -42.89 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.413 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.99 -24.05 38.29 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.205 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.1 -39.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.344 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.02 -50.15 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.577 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.65 -8.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.289 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 p -52.58 -45.16 66.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.554 ' C ' ' H ' ' A' ' 166' ' ' PHE . 1.7 pt20 179.28 81.74 0.17 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.567 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -47.48 -6.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.655 2.236 . . . . 0.0 112.191 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 164' ' ' GLN . 28.4 p90 -131.53 -162.39 1.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.377 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -171.55 115.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -133.24 -109.85 0.23 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.618 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -142.72 131.7 23.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.58 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -84.44 -72.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.421 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 41.15 39.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.03 105.56 2.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.5 -63.3 1.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.45 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -73.96 87.0 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.465 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -163.29 54.5 0.29 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -81.57 -159.06 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.453 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.494 ' O ' ' ND1' ' A' ' 178' ' ' HIS . . . 160.11 175.95 31.66 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 177' ' ' GLY . 28.3 m80 -152.32 -13.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' A' ' 178' ' ' HIS . 2.0 p-80 -53.71 -167.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.517 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -39.37 127.02 1.82 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 183' ' ' HIS . 82.9 m-70 -86.23 122.99 31.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.618 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 57.56 -78.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 181' ' ' HIS . 39.4 t-80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.519 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 8.8 mp -75.29 -49.71 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -50.95 -46.39 61.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.54 -45.53 92.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.67 -46.42 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -68.01 -21.85 65.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.077 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.97 -46.17 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.642 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.27 75.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.545 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.7 p -76.2 -38.01 57.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.504 HE22 ' C ' ' A' ' 65' ' ' PRO . 18.7 tp60 -70.75 10.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.151 0.5 . . . . 0.0 110.235 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.71 141.61 15.42 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.679 ' N ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -69.8 -49.98 47.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.522 0.201 . . . . 0.0 110.822 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.72 -46.02 5.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -63.13 -46.71 86.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.166 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -56.62 -40.69 75.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.1 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.04 -26.44 66.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.92 -43.43 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.32 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -64.73 -30.79 71.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.0 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.576 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.94 -36.57 70.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.948 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.5 p -66.94 -44.64 80.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.608 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.91 98.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.766 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.44 -36.72 60.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.704 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.74 -37.07 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.073 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.22 -39.47 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 0.0 110.668 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 26' ' ' GLU . 2.2 tm-20 -63.42 -38.83 92.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.584 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.92 -57.81 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -45.22 -27.24 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.633 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.9 -37.24 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' CD1' ' OE1' ' A' ' 26' ' ' GLU . 19.2 mt -63.07 -13.85 41.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.563 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.454 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 20.4 t-105 -96.49 -28.54 14.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.499 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.9 m-85 -71.59 -50.05 34.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.22 -58.05 10.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.94 0.4 . . . . 0.0 110.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -56.17 -14.04 2.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.949 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 31' ' ' TRP . 79.4 t -108.99 -21.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.0 tpt -104.33 0.76 29.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt 49.14 31.04 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.442 ' CD1' HE22 ' A' ' 134' ' ' GLN . 0.6 OUTLIER -80.23 154.41 27.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.02 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -116.75 127.34 26.8 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.5 -179.9 5.77 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.322 2.015 . . . . 0.0 112.063 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.88 178.45 5.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 9.2 p -64.99 -41.25 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 5.2 tp -64.28 -49.05 73.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -50.08 -48.84 53.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.662 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.528 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.97 -46.94 81.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.43 -35.36 78.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.314 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -64.19 -34.38 77.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.53 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 tt -77.53 -55.44 5.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.26 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -44.55 -40.98 6.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.56 96.39 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.7 t -60.17 -46.99 93.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.157 0.503 . . . . 0.0 109.834 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.99 -44.36 20.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.393 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -25.85 71.23 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.87 -42.19 61.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.19 -27.06 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.132 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.482 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.8 tp -74.66 -39.94 61.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.52 -35.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.084 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.22 -18.95 70.51 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.88 0.54 43.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.612 0.244 . . . . 0.0 110.938 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 6.3 mm -88.11 -22.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.568 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -177.81 65.58 0.19 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.504 ' C ' HE22 ' A' ' 10' ' ' GLN . 59.1 Cg_endo -75.77 19.17 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.609 2.206 . . . . 0.0 112.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 64' ' ' ALA . 26.4 pttt -109.64 -7.79 15.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -110.93 161.67 23.95 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.563 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -34.97 -19.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.749 2.299 . . . . 0.0 112.404 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.661 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 mm? -42.24 -29.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.386 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.657 HH12 ' NE2' ' A' ' 164' ' ' GLN . 64.0 mtm180 -40.27 -66.07 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.657 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.2 -36.13 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.148 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.28 -51.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.609 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.74 -33.07 71.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.184 0.516 . . . . 0.0 109.741 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttm -61.49 -9.45 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.535 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 40.5 t -61.07 -41.74 90.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.05 -27.79 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.196 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.479 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.0 t-105 -69.05 -54.48 14.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.6 tp -62.17 -50.13 73.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.309 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.5 m-85 -42.58 -41.57 3.08 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.012 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.2 p -80.08 -22.48 42.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.72 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.752 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 2.0 t80 -74.2 -49.54 23.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.204 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -69.85 -43.32 72.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.01 94.49 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.51 -37.39 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.436 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 82' ' ' PHE . 55.3 tt0 -68.32 -31.26 70.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 110.93 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.52 -42.17 17.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.944 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 p -49.68 -51.79 35.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.495 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.422 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -51.17 -50.13 59.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.143 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -43.66 -41.84 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -65.64 -53.16 45.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 51.8 p -51.8 -40.7 60.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.616 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.3 ttm -61.41 -40.92 96.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.476 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tp -67.4 -35.12 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -67.06 -40.45 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.469 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.79 -13.97 25.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -149.72 81.0 7.27 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.169 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.04 -37.74 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.655 2.237 . . . . 0.0 112.884 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.78 93.36 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.359 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.06 133.36 8.85 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.393 2.062 . . . . 0.0 112.191 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -105.67 -68.11 0.89 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.624 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -172.25 27.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.571 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 t -169.87 156.77 6.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.1 t -77.0 -112.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 17.9 p-10 -108.51 -61.12 1.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.58 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.496 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 22.6 t80 57.94 97.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.512 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.553 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -134.71 -109.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.534 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 3.3 t 60.78 -1.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.565 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 107' ' ' MET . 76.3 mtt180 -95.4 108.67 20.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.583 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -117.91 162.31 29.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.167 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.89 120.97 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.553 2.169 . . . . 0.0 111.708 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' OE2' ' CH2' ' A' ' 113' ' ' TRP . 10.4 pt-20 -84.34 2.05 42.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.919 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.481 ' CH2' ' OE2' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -101.22 -6.53 24.09 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.268 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.698 ' C ' ' H ' ' A' ' 116' ' ' LEU . 34.6 mt -119.35 91.94 44.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.932 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.1 Cg_exo -52.52 9.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.543 2.162 . . . . 0.0 112.344 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.698 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -68.98 -30.1 68.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.994 0.426 . . . . 0.0 110.168 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 2.0 m-20 -98.17 -39.33 8.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.488 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -73.4 -45.34 55.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.889 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.446 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 13.6 t-105 -76.19 -13.69 60.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.217 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.64 71.19 13.98 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.15 -12.62 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.71 2.273 . . . . 0.0 111.621 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.46 -28.89 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.782 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.489 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.0 t -129.97 49.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.691 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 3.4 m-85 -156.83 -39.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.053 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.1 p -64.7 126.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.71 159.14 16.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.576 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.6 t -177.32 99.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.417 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.99 -162.49 27.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -97.68 142.82 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 3.4 m -94.37 132.16 39.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.5 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 92.57 4.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -70.95 142.84 51.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.203 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' C ' ' OE1' ' A' ' 134' ' ' GLN . 32.0 ptt85 -99.11 133.84 42.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.442 HE22 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mm100 -103.22 -28.35 11.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 13.3 t-105 -174.17 145.83 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 6.3 p30 -133.85 163.48 29.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 112.462 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -126.59 138.59 53.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.578 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 50.82 17.53 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.442 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 22.56 37.89 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -123.26 136.23 54.62 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.05 154.74 41.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.056 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.561 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.7 ttt -51.3 -56.77 17.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 142' ' ' MET . 1.6 Cg_endo -43.76 -36.75 7.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -69.88 -56.73 6.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.267 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 56.5 m95 -56.95 -57.33 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -43.38 -37.1 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -35.85 76.05 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.29 -42.76 98.9 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -80.41 -25.75 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.076 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -64.55 -48.53 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.625 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 152' ' ' ALA . 13.3 tt -67.19 -41.81 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.467 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.439 ' N ' ' CG2' ' A' ' 151' ' ' ILE . . . -50.68 -47.89 58.66 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.476 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.97 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.711 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 154' ' ' LEU . 2.3 mp -70.07 -34.12 72.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.71 -27.17 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.44 -38.88 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.54 -52.9 22.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.259 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -56.18 -32.11 33.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.79 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.9 tp -81.37 -30.51 33.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' O ' ' OG ' ' A' ' 163' ' ' SER . 25.6 t -75.49 -25.64 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.97 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.76 -46.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.3 mp -71.12 -16.73 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.965 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 85.6 p -52.9 -11.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.657 ' NE2' HH12 ' A' ' 70' ' ' ARG . 3.4 tp-100 -43.21 128.14 3.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.267 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.17 16.81 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.209 1.939 . . . . 0.0 111.948 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 164' ' ' GLN . 2.4 m-85 43.28 -146.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.0 pttp -97.69 -4.65 36.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.827 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 56.88 -77.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -41.12 143.78 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.655 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 60.23 91.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -64.39 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -159.75 -68.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.371 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 175' ' ' GLY . 5.9 tp -166.62 -25.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.39 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.0 t80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.641 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 173' ' ' LEU . . . 92.54 115.37 2.24 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.533 ' CG ' ' H ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -53.48 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.483 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.533 ' H ' ' CG ' ' A' ' 176' ' ' ARG . . . 89.35 171.94 45.55 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.415 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 0.5 OUTLIER -84.25 34.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.602 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 50.35 -166.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.412 ' H ' ' CD2' ' A' ' 180' ' ' HIS . 0.2 OUTLIER -131.47 -174.54 3.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -150.1 -23.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -155.7 -16.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.557 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.517 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -64.05 -43.69 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -57.55 -33.36 68.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.82 -44.83 76.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 mt -51.11 -38.55 52.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.9 t-20 -64.61 -28.79 69.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.34 -48.5 11.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.696 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.04 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 11' ' ' GLY . 12.0 m -76.7 -37.12 56.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.611 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 24.1 mm-40 -67.11 5.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.491 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.19 145.98 17.86 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -69.22 -48.66 61.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.639 0.257 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.68 6.11 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.78 83.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 18' ' ' MET . 60.3 m95 -59.36 -43.48 92.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.171 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -30.06 71.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 mp -70.18 -26.67 64.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.455 ' SD ' ' CE3' ' A' ' 15' ' ' TRP . 52.2 mtt -76.29 -34.3 59.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.741 0.305 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.34 23.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.823 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.0 -45.65 78.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 p -52.17 -62.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.71 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.661 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.75 -38.98 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.7 -38.05 63.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.06 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.824 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.02 -43.97 50.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.16 -56.24 10.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -48.72 -42.9 36.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.45 -28.87 59.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.22 -17.56 64.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.037 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -86.61 -38.84 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.534 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.36 -35.06 79.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -80.86 2.78 25.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.779 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -117.01 -49.64 2.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.657 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -72.88 -27.35 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.748 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' LEU . 8.7 tpp -109.35 13.88 23.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.673 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' MET . 9.7 mt 37.73 37.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.0 147.71 52.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.677 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -109.38 124.78 32.97 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 178.35 7.75 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.245 1.963 . . . . 0.0 112.263 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.74 172.18 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.637 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.2 t -56.46 -51.73 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mm? -56.23 -38.42 71.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.558 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.2 t -58.37 -43.31 88.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.143 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 45' ' ' ILE . 46.4 mm -61.36 -50.95 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.81 73.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.021 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.93 -37.97 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -36.98 84.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.14 80.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.93 -47.28 87.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.344 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 mt -77.18 -53.58 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.31 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -43.18 -41.89 3.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.08 94.99 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 51' ' ' LEU . 39.1 t -61.19 -19.4 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.266 0.555 . . . . 0.0 110.164 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.72 -41.23 23.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.053 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.17 -28.59 73.28 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.08 -47.74 23.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.99 68.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.389 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -44.73 77.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.37 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.56 -39.36 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.42 -16.67 75.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.55 0.88 48.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.77 0.319 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.42 -38.36 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.7 73.51 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.86 21.46 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.92 2.413 . . . . 0.0 112.046 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -97.4 -10.14 26.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.148 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.07 179.27 0.8 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.549 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 50.3 Cg_exo -52.22 -0.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.232 1.954 . . . . 0.0 112.164 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.582 ' H ' ' C ' ' A' ' 67' ' ' THR . 14.5 mt -56.19 -33.01 64.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 77.0 mtm180 -38.77 -61.6 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.774 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -52.1 -35.41 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.226 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 14.5 t -63.29 -52.86 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.961 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.93 61.54 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.275 0.56 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 mmt -57.94 -13.3 4.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 43.6 t -59.31 -36.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.595 0.712 . . . . 0.0 110.279 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -89.83 -27.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.285 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.506 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.6 t-105 -69.58 -52.85 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.983 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.07 -47.6 70.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.1 m-85 -46.79 -44.39 19.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.369 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -74.57 -24.68 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.62 -59.77 4.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.41 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.84 -51.25 16.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -44.64 73.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.9 -48.1 84.52 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.5 t -70.45 -53.54 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.848 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -47.98 -23.53 0.82 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.832 0.349 . . . . 0.0 110.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.57 -35.93 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 37.8 p -58.64 -23.36 58.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.628 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.11 -44.37 60.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.581 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -59.56 -34.25 72.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.472 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 91' ' ' HIS . 2.3 m-70 -72.3 -44.8 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -43.52 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.654 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 97' ' ' TYR . 50.1 mtp -55.63 -42.23 74.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.599 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.34 -47.29 64.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.37 -42.4 91.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.37 -18.83 29.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.371 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.4 OUTLIER -141.6 72.62 24.93 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.099 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 97' ' ' TYR . 43.8 Cg_exo -53.86 -153.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.963 2.442 . . . . 0.0 112.315 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 98' ' ' PRO . 0.0 OUTLIER -170.8 166.8 4.54 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.174 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -40.52 123.54 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.666 2.244 . . . . 0.0 112.127 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.2 118.48 5.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.04 -43.17 10.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.3 m 54.96 72.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 p -163.37 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.585 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 34.4 t70 -69.7 -119.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.498 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.494 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 73.38 -72.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.455 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 59.2 mtm -99.23 127.9 45.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.545 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.3 m -87.15 -178.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.753 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -100.64 113.77 26.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.18 132.69 95.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.728 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -77.68 160.65 31.25 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.535 2.157 . . . . 0.0 112.114 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -110.41 -7.18 14.81 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.297 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -125.1 -5.28 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.81 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.612 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.1 mt -111.56 72.74 1.01 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 9.9 Cg_endo -54.31 4.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.524 2.149 . . . . 0.0 112.058 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' ' C ' ' A' ' 114' ' ' LEU . 18.6 mt -74.66 -24.67 58.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -98.83 -38.85 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.499 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -82.35 -45.82 14.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.786 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -69.83 -16.92 63.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.632 -179.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 p -154.34 72.03 6.21 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 110.837 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.9 -4.51 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.068 2.512 . . . . 0.0 111.799 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.67 -52.26 41.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.7 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.57 49.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.464 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.28 -44.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.96 132.68 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.088 0.471 . . . . 0.0 110.689 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.54 161.04 13.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.474 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 t -165.75 99.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.543 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.68 -177.96 20.07 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 17.3 t0 -85.84 148.4 25.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 110.151 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.568 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 52.5 m -101.21 129.57 47.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.762 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 94.69 -8.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.727 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.74 148.77 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -86.09 123.6 31.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.456 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -128.37 -23.21 3.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -172.95 125.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.58 158.81 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 111.719 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -113.45 139.56 48.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.928 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 mt 47.91 17.02 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.488 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 92.35 21.98 30.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.041 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.06 138.53 54.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 16.3 mp0 -70.97 147.07 49.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.433 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.5 mmt -46.49 -61.81 2.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.161 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 80.9 Cg_exo -33.73 -39.61 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.878 2.385 . . . . 0.0 112.648 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -70.72 -55.66 8.16 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.917 0.389 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.584 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -55.6 -57.1 13.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.963 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -43.79 -37.67 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -37.31 72.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.49 -45.73 95.07 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.17 -30.7 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 110.194 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -58.85 -48.55 80.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.12 -46.25 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.26 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.42 -46.76 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.487 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -58.45 -44.05 89.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.63 -30.25 69.74 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.292 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.64 -27.43 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 94.9 t -75.03 -36.11 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 111.111 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -74.63 -53.13 9.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.6 m -56.39 -42.65 75.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.07 -31.67 64.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.259 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 33.8 t -78.2 -28.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.229 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.4 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 46.1 t -74.86 -51.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.394 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 164' ' ' GLN . 52.1 mt -62.32 -33.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.05 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.1 p -59.05 0.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' A' ' 162' ' ' ILE . 3.3 pt20 -65.66 146.99 98.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 166' ' ' PHE . 73.7 Cg_exo -42.87 -14.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.518 2.145 . . . . 0.0 112.265 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 164' ' ' GLN . 10.4 t80 77.84 -49.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -140.5 -74.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.503 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -167.84 -95.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.54 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 62.3 mttm 52.83 105.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.635 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -69.61 154.06 42.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -143.26 -144.94 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.61 -162.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.53 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.407 ' C ' ' CD1' ' A' ' 173' ' ' LEU . 0.3 OUTLIER -140.59 -73.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.511 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -78.84 -60.64 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.586 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.85 125.41 0.66 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -168.44 -38.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.797 0.332 . . . . 0.0 110.591 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.88 -158.68 20.78 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -127.28 159.64 33.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.827 0.346 . . . . 0.0 110.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -153.21 -18.63 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.43 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -83.7 116.1 22.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -117.72 -103.57 0.41 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.532 ' O ' ' ND1' ' A' ' 182' ' ' HIS . 4.0 t-80 56.74 52.4 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.441 ' OXT' ' O ' ' A' ' 182' ' ' HIS . 52.5 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.22 -41.78 60.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.457 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -53.87 -34.09 58.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.348 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -72.51 -44.38 62.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.287 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp -47.19 -37.66 10.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -67.54 -27.52 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' PHE . 9.6 tp-100 -80.77 -47.57 13.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.692 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -39.5 86.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.67 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 11' ' ' GLY . 53.2 p -76.67 -37.28 56.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 18.3 tt0 -65.21 2.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.472 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.69 148.82 19.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -69.71 -20.47 63.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.76 -45.12 59.84 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -51.1 68.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.185 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -56.1 -45.78 79.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 tp -64.64 -30.44 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.37 -32.41 70.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.1 mmt -71.14 -33.34 69.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.58 -51.96 30.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -50.02 -45.9 52.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.683 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 p -59.01 -60.88 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.04 8.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tp -80.07 -40.48 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.8 -41.99 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 10.6 mp -69.08 -26.87 65.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.81 -37.78 76.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.95 -57.53 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -44.15 -39.9 4.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.51 -35.07 63.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.767 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.72 -18.49 62.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.761 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.41 -24.89 20.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.854 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -73.56 -38.02 65.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.59 0.84 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -119.15 -52.59 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.24 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.31 -40.48 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 37' ' ' LEU . 29.8 mtt -108.17 15.16 24.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.64 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 36' ' ' MET . 29.1 mt 37.03 41.85 0.21 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.064 0.459 . . . . 0.0 110.15 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 153.35 40.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.016 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' CB ' ' NZ ' ' A' ' 39' ' ' LYS . 6.5 mtmp? -124.7 108.12 28.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.69 169.03 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.229 1.953 . . . . 0.0 112.111 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -110.36 -175.4 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.461 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.37 -44.52 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.64 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.55 -48.29 81.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.779 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.0 m -60.8 -46.98 88.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.15 -49.8 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -54.52 -48.3 72.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -53.67 -47.57 70.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.084 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -50.7 -36.01 33.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.91 98.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.492 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.08 79.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' VAL . 9.5 mp -72.62 -50.69 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -43.39 -41.95 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.08 -37.82 92.02 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 51.8 t -62.64 -19.23 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.403 0.62 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 tt -79.76 -46.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.817 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.85 -31.77 81.53 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.44 74.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.891 0.377 . . . . 0.0 110.018 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.45 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.004 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.22 -31.22 62.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.475 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.6 mt -80.46 -42.89 21.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.09 77.0 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 7.49 3.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.654 0.264 . . . . 0.0 110.855 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.48 -55.06 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.269 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.77 84.29 0.29 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.03 24.04 0.7 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.678 2.252 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -99.25 -11.62 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -106.52 179.26 0.93 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 76.5 Cg_exo -47.46 -5.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.019 1.813 . . . . 0.0 112.02 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -49.98 -33.04 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.236 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' NH1' ' CD ' ' A' ' 164' ' ' GLN . 24.8 mtt180 -38.32 -66.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.031 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -57.49 -36.84 72.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.639 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.4 -52.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.804 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.31 -34.55 78.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.335 0.588 . . . . 0.0 109.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 ttt -63.61 -8.33 9.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.765 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.11 -40.85 90.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.452 0.644 . . . . 0.0 111.069 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' C ' ' CD1' ' A' ' 76' ' ' ILE . 1.4 pp -89.23 -28.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.676 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.416 ' CD1' ' HB1' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -69.15 -47.48 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.689 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.97 -45.78 80.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -49.2 -44.36 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.105 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -80.22 -23.26 41.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.431 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -59.43 -60.08 4.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.336 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -77.78 -45.37 24.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.282 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -69.96 -40.89 75.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.805 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.6 -46.47 89.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 12.7 m -79.26 -35.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -26.27 67.05 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.958 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.4 -28.46 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.704 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 20.0 p -60.94 -51.9 67.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.572 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -50.87 -29.71 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.527 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.67 -37.93 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.145 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -68.37 -37.07 80.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.272 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.1 p -72.46 -39.24 67.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.471 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.0 ttt -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.17 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.74 -38.52 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.596 HE22 HE22 ' A' ' 144' ' ' GLN . 81.2 mt-30 -72.16 -38.02 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.769 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.57 -22.66 20.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 93' ' ' MET . 86.2 m-85 -148.85 83.11 6.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.906 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.26 -19.93 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.61 2.206 . . . . 0.0 112.194 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.44 166.04 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 101' ' ' PHE . 76.2 Cg_exo -43.12 110.14 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.725 2.283 . . . . 0.0 112.21 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' PRO . 13.4 t80 60.09 123.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.666 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -137.77 -9.76 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m 60.07 153.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -154.71 41.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.492 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -166.38 108.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.695 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -152.41 157.13 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.315 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 29.9 ttm -85.84 130.37 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 m -43.55 108.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -102.84 100.36 10.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.551 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.484 ' CD2' ' OD2' ' A' ' 117' ' ' ASP . 1.4 m-85 -128.31 159.55 66.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.136 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -38.61 151.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.678 2.252 . . . . 0.0 112.165 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.47 1.37 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.573 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 2.0 p-90 -113.23 10.62 18.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.679 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 tp -119.75 86.24 35.11 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 40.7 Cg_exo -54.48 15.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.847 2.365 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.679 ' H ' ' C ' ' A' ' 114' ' ' LEU . 40.6 tp -75.63 -30.44 59.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.005 0.431 . . . . 0.0 110.004 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -97.38 -39.64 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.191 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -72.46 -45.2 60.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.99 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.5 t90 -75.69 -12.44 60.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.388 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.6 67.91 78.77 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.41 -22.07 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.906 2.404 . . . . 0.0 111.689 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -55.53 -53.97 49.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.19 54.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.544 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.4 t80 -159.07 -35.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.64 130.48 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.83 163.04 13.15 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.3 t -174.67 101.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 141.46 177.95 17.18 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.47 135.74 36.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 15.0 m -91.16 129.42 37.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.56 -1.63 0.24 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.653 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -67.98 145.09 54.84 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -87.3 116.06 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -117.51 -22.3 8.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -175.75 128.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.474 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -140.54 158.74 43.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.269 0.557 . . . . 0.0 112.238 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 17.5 t80 -117.09 139.18 51.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.936 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 49.95 17.09 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.379 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.63 21.85 35.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.794 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -125.87 137.11 53.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.73 149.6 47.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.44 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -49.14 -51.5 56.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.0 Cg_exo -44.06 -37.98 10.08 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.542 2.161 . . . . 0.0 112.454 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.596 HE22 HE22 ' A' ' 95' ' ' GLN . 0.3 OUTLIER -70.71 -46.93 62.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.156 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.6 m95 -63.84 -57.25 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.3 mt -43.68 -38.56 3.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -54.39 -39.07 64.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -80.96 -27.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 110.118 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -59.67 -51.62 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.134 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.8 tt -64.2 -42.47 95.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.69 67.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.179 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -57.82 -38.64 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.58 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.75 -32.32 73.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.852 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -33.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.5 -43.37 90.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 77' ' ' TRP . . . -73.51 -48.79 30.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.23 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.0 t -51.25 -43.37 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.751 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.43 ' O ' ' OG ' ' A' ' 163' ' ' SER . 8.8 mp -75.1 -43.59 52.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.761 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.07 -29.46 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.202 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -80.51 -47.76 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 74.2 mt -70.64 -2.72 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.397 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 49.5 m -61.69 -30.28 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.846 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 166' ' ' PHE . 1.0 OUTLIER -71.47 146.17 91.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.29 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.4 20.03 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.546 2.164 . . . . 0.0 112.164 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.533 ' C ' ' H ' ' A' ' 168' ' ' ALA . 8.5 m-85 47.77 79.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.35 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 54.9 mttp -73.69 34.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.399 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 166' ' ' PHE . . . 53.3 169.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.513 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -157.44 -2.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.355 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -154.52 121.36 5.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 -41.94 147.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 174' ' ' PHE . 18.6 t70 -154.56 175.58 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.44 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 7.4 mp -73.75 34.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.521 ' H ' ' C ' ' A' ' 172' ' ' ASP . 67.0 t80 -91.54 59.51 3.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.43 -178.37 44.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -150.9 35.94 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.768 0.318 . . . . 0.0 110.665 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -65.4 -18.24 65.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -90.2 123.31 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -166.31 159.91 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.519 ' H ' ' HD1' ' A' ' 180' ' ' HIS . 6.6 p-80 -48.23 138.87 9.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -163.25 -3.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.607 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 20.0 t60 50.32 70.19 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.55 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.601 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.45 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -57.89 -34.11 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.356 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -52.76 -38.24 60.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLN . 7.2 t80 -71.69 -46.3 59.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -45.48 -44.06 12.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.322 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 47.2 t30 -70.96 -20.87 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PHE . 44.2 tp60 -79.92 -47.86 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.21 74.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLY . 78.4 p -76.46 -34.17 58.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 6' ' ' ASN . 15.7 mt-30 -73.9 10.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.513 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.03 140.91 15.33 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -19.7 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.68 59.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.21 68.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -53.47 -41.54 66.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.303 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.64 -29.57 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.294 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' O ' ' OG1' ' A' ' 21' ' ' THR . 49.8 tp -68.53 -34.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mtm -73.95 -34.58 64.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.091 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.33 65.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.604 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -60.83 -33.1 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.608 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 17' ' ' LEU . 15.7 m -56.75 -54.85 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.88 -27.48 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.361 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.14 -41.84 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.12 -45.11 61.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.687 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.28 -33.28 74.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.07 -44.61 68.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.29 -58.09 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -47.21 -36.67 9.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.43 -31.12 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -18.55 63.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.416 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 11.0 t-105 -86.69 -41.03 14.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 110.36 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -56.15 -38.42 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.037 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 33' ' ' GLN . 12.9 tm0? -79.05 -23.74 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.217 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 36' ' ' MET . 11.7 p -108.41 -44.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.452 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 9.3 tpt -77.15 -2.38 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt 46.16 45.75 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.08 146.33 54.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -110.57 108.58 58.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.961 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.1 145.11 17.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.25 1.967 . . . . 0.0 111.513 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -107.49 -161.87 0.8 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.595 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.6 t -63.32 -42.6 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.2 tp -62.57 -49.31 75.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.198 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -54.66 -49.48 70.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.676 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.83 -45.35 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -59.71 -46.58 88.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.24 -47.69 84.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.257 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -56.74 -33.15 66.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.356 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.56 74.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -73.31 -50.67 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -43.8 -41.73 5.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.32 94.11 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.43 -47.73 90.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.97 -46.52 16.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.502 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -48.79 76.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.66 62.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.127 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.92 73.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 tp -72.28 -25.53 61.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.101 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.29 -39.53 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.67 -25.87 75.06 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.49 7.8 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.4 mt -79.46 -48.52 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -179.45 80.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.61 31.56 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.68 -9.7 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.946 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.99 170.52 5.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.784 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.84 -12.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 mt -43.73 -32.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.51 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -41.05 -70.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -27.37 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.677 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.32 -46.15 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.565 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.67 -35.05 60.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.599 . . . . 0.0 109.619 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 ttt -59.59 -15.72 20.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 70.9 t -55.22 -40.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.262 0.554 . . . . 0.0 110.345 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 76' ' ' ILE . 43.2 mm -85.48 -34.86 8.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.228 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.549 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.0 t-105 -61.89 -56.15 22.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.8 tp -62.84 -50.28 71.56 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -42.88 -44.87 4.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.187 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.52 -21.37 45.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.495 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -61.38 -59.91 4.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.184 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.53 -46.69 58.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -77.32 -40.29 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.32 -48.92 83.64 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.397 -0.906 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 25.3 m -67.77 -44.74 85.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.819 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.91 -28.41 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.112 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.35 61.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.236 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 70.0 p -54.79 -30.69 57.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.332 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.23 -48.34 76.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.13 -30.77 66.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 3.8 m170 -77.46 -49.04 15.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -64.56 -48.42 75.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 97' ' ' TYR . 26.7 ttt -52.71 -51.39 60.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.484 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.74 -49.36 73.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -52.35 -44.65 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 96' ' ' LEU . 3.9 mm? -88.39 -13.31 40.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 93' ' ' MET . 7.8 t80 -133.88 71.77 73.64 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.75 122.61 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.831 2.354 . . . . 0.0 112.378 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -167.57 63.32 0.65 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.522 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.02 113.07 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.765 2.31 . . . . 0.0 112.287 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -87.77 120.36 29.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.339 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.79 121.24 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.652 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.517 ' CG2' ' H ' ' A' ' 104' ' ' SER . 8.5 t -159.2 -55.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.517 ' H ' ' CG2' ' A' ' 103' ' ' THR . 45.2 t -176.79 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 15.0 t70 54.53 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.638 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 13.6 t80 54.44 87.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 ttt 58.17 95.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.305 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 m -92.45 -172.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.759 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -111.47 116.2 30.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.399 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -70.22 147.67 95.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.483 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.56 143.81 58.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.479 2.12 . . . . 0.0 112.196 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.88 3.91 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.1 p-90 -110.13 0.64 18.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -114.34 94.25 34.82 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.033 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.03 0.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.698 2.265 . . . . 0.0 112.935 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.8 tp -70.27 -26.13 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.71 -34.78 11.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -67.01 -35.16 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 -95.99 -23.96 16.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.364 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.8 t -149.64 87.79 5.08 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.52 -15.73 8.45 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.606 2.204 . . . . 0.0 112.521 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -85.69 -4.01 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.722 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.3 p -112.54 18.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.109 0.48 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -147.24 -43.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.433 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.67 129.96 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.88 154.57 17.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.7 p -158.53 99.78 1.61 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.509 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.55 -176.97 20.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -96.65 150.13 21.01 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 73.9 m -102.22 132.2 48.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 99.89 -10.35 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.999 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -69.53 129.16 38.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.657 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -67.96 109.45 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -115.7 -23.54 8.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.781 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 16.9 t90 -172.02 132.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 1.1 p30 -146.16 159.37 43.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -120.68 139.89 52.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.899 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.49 17.35 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.91 21.25 53.62 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 mp -123.21 135.26 54.21 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 141' ' ' GLU . 9.7 mp0 -71.65 148.81 46.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.465 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtt -45.25 -63.7 1.12 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.25 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 88.2 Cg_exo -32.35 -38.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.092 2.528 . . . . 0.0 112.801 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.455 ' CD ' ' N ' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -72.47 -51.68 19.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.004 0.43 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 72.6 m95 -56.36 -57.46 12.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.903 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -43.76 -39.14 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tt -56.27 -35.77 67.84 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -63.01 -48.42 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.489 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.45 -26.23 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.08 -41.49 97.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.5 tt -73.75 -29.73 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.366 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.66 -52.02 62.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.272 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -57.06 -41.74 79.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.534 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 154' ' ' LEU . 4.1 mp -61.32 -30.91 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.736 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.48 -26.8 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.223 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.35 -35.1 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -71.98 -53.76 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.263 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.71 -45.92 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.913 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 163' ' ' SER . 2.3 tp -67.11 -30.21 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.731 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.467 ' O ' ' OG ' ' A' ' 163' ' ' SER . 18.4 t -74.98 -29.92 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.9 t -83.66 -51.53 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 110.318 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 40.0 mm -68.67 -12.72 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -52.66 -39.61 62.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.067 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 166' ' ' PHE . 12.5 mt-30 54.17 157.3 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.519 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.28 25.02 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.479 2.119 . . . . 0.0 111.916 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 164' ' ' GLN . 34.7 m-85 54.84 -110.18 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.674 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp 66.94 -2.92 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.513 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 166' ' ' PHE . . . -159.15 149.1 19.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.519 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.618 ' NZ ' ' NH1' ' A' ' 171' ' ' ARG . 51.2 tttm -164.44 129.86 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.531 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -159.97 -54.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.618 ' NH1' ' NZ ' ' A' ' 169' ' ' LYS . 16.7 mtm-85 53.81 -131.56 2.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.56 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -156.53 179.67 9.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.503 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.73 165.67 24.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -85.7 99.91 11.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 170.26 -135.36 3.5 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -147.64 -63.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.542 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.3 -158.4 31.35 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.658 ' HD1' ' N ' ' A' ' 179' ' ' HIS . 2.2 t-80 -162.05 -136.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.658 ' N ' ' HD1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 48.55 -176.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.316 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -60.09 -21.97 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.457 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 49.47 41.33 20.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -81.27 -36.56 29.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 11.5 m-70 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.501 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt -76.42 -44.69 34.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.322 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -54.96 -36.49 65.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.313 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 7' ' ' GLN . 2.6 t80 -69.77 -43.02 73.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.174 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.45 -38.31 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 2.3 m-20 -68.32 -26.8 65.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.275 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.1 mm-40 -78.08 -48.86 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.382 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.74 80.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 11' ' ' GLY . 40.1 m -76.65 -37.3 56.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.538 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 11.3 mm100 -70.24 7.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.372 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.64 145.77 16.25 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -72.33 -51.54 20.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.632 0.254 . . . . 0.0 110.744 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.97 -47.3 6.29 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.29 86.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -58.7 -37.28 75.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.19 -29.58 69.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.721 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.98 -27.73 64.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.395 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.444 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.1 mtp -76.09 -34.07 59.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.3 -54.85 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' LEU . 66.7 t80 -52.1 -52.69 49.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.4 p -44.11 -51.62 7.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -21.69 65.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -85.51 -42.37 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.468 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.63 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.54 -35.29 68.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' CD ' ' NH1' ' A' ' 48' ' ' ARG . 4.9 tp10 -64.99 -35.61 81.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.55 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.42 -56.54 4.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.659 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -45.26 -41.5 8.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.78 -32.35 65.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.567 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.03 -19.77 65.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.583 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -93.5 -19.79 20.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.21 -50.36 19.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 34' ' ' HIS . 2.0 pp0? -73.61 -9.15 58.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.12 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.608 ' N ' ' NE2' ' A' ' 33' ' ' GLN . 14.3 t-160 -77.89 -31.01 51.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.102 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.78 -9.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.8 mmt -107.05 -3.19 20.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.631 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.2 mt 47.21 50.19 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 110.282 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 39' ' ' LYS . 2.1 tt -65.07 142.19 58.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.629 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 14.9 mttm -107.31 99.66 29.03 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.455 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 127' ' ' SER . 72.1 Cg_exo -46.5 168.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.575 2.183 . . . . 0.0 112.784 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.9 161.49 32.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.187 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.7 t -48.81 -46.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 3.6 mm? -73.0 -33.88 66.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 t -58.07 -45.8 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.2 pt -69.56 -35.99 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.337 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.3 -47.36 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.91 -36.71 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' NH1' ' CD ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -63.42 -32.58 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.63 77.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.233 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.44 77.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.4 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.88 -55.51 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -44.52 -38.34 4.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.42 94.67 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -62.22 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 109.831 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -45.83 -44.63 14.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.591 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.27 -27.98 73.04 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.98 -43.21 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.616 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.74 65.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.463 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -80.84 -36.08 31.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.428 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -80.89 -34.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -75.49 -32.83 54.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.56 6.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -88.43 -22.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.518 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.63 67.82 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.82 24.61 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.672 2.248 . . . . 0.0 111.845 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 64' ' ' ALA . 37.5 mttp -111.3 -6.16 14.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.13 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.33 163.86 17.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.647 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.17 -13.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.442 2.095 . . . . 0.0 112.217 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mt -43.07 -34.46 1.04 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 59.0 mtm-85 -38.57 -66.57 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.732 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -54.15 -27.22 32.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.786 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 69' ' ' LEU . 6.2 t -72.86 -51.12 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.496 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.244 0.545 . . . . 0.0 109.913 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.23 -15.75 48.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.882 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -56.58 -36.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.453 0.644 . . . . 0.0 110.408 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.2 mt -87.38 -34.51 7.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.775 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.524 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.0 t-105 -60.61 -54.59 43.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.926 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.88 -44.93 91.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.83 -23.04 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.96 -60.83 3.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.623 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -72.47 -56.24 5.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.177 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -68.26 -47.73 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.1 -46.81 84.29 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 92.6 t -67.57 -36.09 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.58 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.45 -34.89 69.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.255 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.28 -44.64 17.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.548 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 49.2 p -45.3 -32.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.58 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -73.45 -40.83 63.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -56.34 -37.66 70.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.5 m170 -68.62 -42.7 77.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -66.47 -51.4 57.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.7 ttt -49.48 -49.54 45.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 97' ' ' TYR . 3.8 tp -61.48 -47.92 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -54.33 -37.89 65.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -90.58 -15.79 29.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.465 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 37.2 t80 -109.06 114.74 57.84 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.283 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -77.29 97.2 1.13 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.217 1.944 . . . . 0.0 112.065 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -173.18 60.04 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 27.8 Cg_endo -63.88 106.83 0.68 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.577 2.184 . . . . 0.0 111.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 100' ' ' PRO . 48.4 p90 43.97 -175.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.835 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 175.54 10.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.423 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.2 m -150.47 -62.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.1 p -148.0 166.01 29.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.496 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.45 ' OD2' ' CB ' ' A' ' 101' ' ' PHE . 67.2 m-20 -157.65 151.05 23.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.69 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.11 177.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.407 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.3 ttm -171.19 84.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.536 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 108' ' ' VAL . 7.2 p 35.1 43.62 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.211 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -93.6 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.12 145.23 37.64 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.99 160.49 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.696 2.264 . . . . 0.0 111.865 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -101.27 5.49 42.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -125.41 -6.06 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.782 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -119.52 78.47 20.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.39 11.37 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.263 1.975 . . . . 0.0 112.22 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.9 mt -77.36 -29.76 53.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.111 0.481 . . . . 0.0 109.771 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.475 ' OD1' ' CD2' ' A' ' 124' ' ' PHE . 3.4 m-20 -96.2 -42.19 8.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.729 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' CB ' ' NZ ' ' A' ' 118' ' ' LYS . 5.4 ttpm? -64.88 -44.75 88.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.066 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 27.1 t-105 -76.12 -12.95 60.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.88 73.64 13.55 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.781 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.78 -12.9 13.35 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.819 2.346 . . . . 0.0 111.948 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -55.87 -54.11 48.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.289 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.74 26.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.249 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CD2' ' OD1' ' A' ' 117' ' ' ASP . 39.8 m-85 -134.69 -6.4 2.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.193 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.88 132.65 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.412 ' O ' ' OG ' ' A' ' 127' ' ' SER . . . -101.48 154.85 18.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' PRO . 69.6 m -167.64 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.355 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.71 -174.3 21.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.73 154.14 21.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.293 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 97.9 m -101.48 131.77 47.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 88.14 1.19 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.49 160.26 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.043 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -100.14 140.01 34.99 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -132.71 -27.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -174.77 142.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.72 167.9 20.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.527 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 69.4 t80 -145.58 118.46 8.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.509 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 3.5 tp 78.89 17.34 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.86 11.33 79.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mp -116.82 132.9 56.58 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -71.07 153.02 42.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.276 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.1 mmm -50.71 -59.5 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.2 Cg_exo -36.55 -41.31 0.59 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.458 2.105 . . . . 0.0 112.237 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -71.79 -44.7 63.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.333 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.2 m95 -61.26 -56.82 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.065 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 tp -43.41 -44.55 5.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.007 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 mp -53.61 -36.45 62.0 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.85 -42.29 94.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.24 -29.76 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 110.628 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.16 -48.31 80.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.103 0.478 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.9 pt -68.01 -41.55 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.11 -45.91 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.513 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 5.6 m-85 -64.28 -39.66 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' A' ' 154' ' ' LEU . 0.3 OUTLIER -60.0 -45.31 93.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.258 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -73.97 -26.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.93 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.8 t -68.62 -33.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.106 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.524 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -71.98 -46.88 55.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.851 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.16 -24.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.093 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.96 -41.48 51.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.057 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.464 ' C ' ' HG ' ' A' ' 163' ' ' SER . 21.9 m -78.78 -21.87 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.832 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.56 -48.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.26 -28.57 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.746 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.464 ' HG ' ' C ' ' A' ' 160' ' ' VAL . 100.0 p -56.18 -19.71 14.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.442 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.401 ' C ' ' H ' ' A' ' 166' ' ' PHE . 37.8 tt0 -124.33 78.43 61.1 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 166' ' ' PHE . 65.2 Cg_endo -77.42 24.63 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.143 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 22.0 p90 41.33 -167.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.79 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -139.62 -14.58 1.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.05 85.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.671 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -146.33 29.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.352 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.05 -97.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -159.88 -31.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.545 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 56.7 170.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.09 0.16 54.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.58 -66.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.21 -152.55 52.08 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -76.76 54.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.563 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -88.57 -121.17 1.78 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.455 ' N ' ' ND1' ' A' ' 178' ' ' HIS . 2.0 m-70 -62.29 158.82 16.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 110.546 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.425 ' CD2' ' N ' ' A' ' 179' ' ' HIS . 0.4 OUTLIER -149.69 36.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.581 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -171.92 -9.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.595 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 181' ' ' HIS . 21.3 t60 -117.49 19.52 13.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.544 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.476 ' CD2' ' H ' ' A' ' 182' ' ' HIS . 8.8 p80 -88.03 80.67 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.552 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.86 -36.35 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 109.92 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -58.12 -31.97 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.119 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.62 -42.94 67.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.068 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 mp -50.54 -38.74 46.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -67.95 -30.55 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -79.69 -49.89 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.47 78.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.742 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' GLY . 17.5 m -76.72 -30.48 56.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.822 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 28.6 tt0 -73.39 6.07 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 110.515 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.49 146.47 17.25 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -66.42 -20.69 66.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.339 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.13 -44.39 76.89 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.512 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.89 -51.25 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -60.53 -43.84 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.73 -35.54 81.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.52 -28.83 66.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -72.56 -32.82 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.29 26.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.523 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.42 -46.76 63.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.829 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 18' ' ' MET . 27.4 p -52.72 -53.13 52.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.37 81.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.76 -42.15 74.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.942 0.401 . . . . 0.0 110.702 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.47 -42.45 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -71.17 -34.45 70.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.735 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.59 -43.84 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.32 -58.17 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.519 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 35.0 p -44.43 -32.62 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.62 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.45 -41.53 16.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.568 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tp -49.13 -21.98 0.86 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.772 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -85.46 -32.53 22.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -58.81 -44.32 90.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.139 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -75.98 -28.96 58.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.712 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -65.41 -31.42 72.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.497 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.78 -47.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 5.4 tpt -73.22 1.78 8.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.705 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.2 mt 43.53 45.62 5.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.518 ' CD2' ' NE2' ' A' ' 134' ' ' GLN . 4.8 tt -69.67 145.96 51.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 46.4 mttp -115.23 90.82 25.54 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.51 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 127' ' ' SER . 51.4 Cg_exo -51.23 165.88 0.5 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.669 2.246 . . . . 0.0 112.518 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 8.3 t -112.95 -175.45 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.316 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.415 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 p -69.09 -36.9 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.76 -49.64 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.605 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 t -49.15 -51.51 31.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -64.27 -38.95 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -55.6 -44.62 77.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -56.97 -47.43 80.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.263 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -52.62 -30.41 31.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.926 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.91 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.565 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 8.8 mp -73.28 -50.96 19.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.82 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -44.29 -38.54 3.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.85 90.28 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' ALA . 24.8 t -61.61 -47.35 93.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 109.725 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.37 -45.78 9.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.682 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.67 -29.48 75.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.57 -40.03 84.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.619 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.56 58.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.67 -47.04 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.377 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.78 -29.75 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -74.54 -33.96 54.98 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 2.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 110.585 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -84.54 -23.64 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.71 74.15 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.91 21.93 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.857 2.371 . . . . 0.0 112.023 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -115.55 -4.68 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.091 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.59 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -110.51 159.91 30.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.693 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -36.09 -22.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 mp -44.18 -26.18 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -43.68 -65.46 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.608 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.3 -37.71 67.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.979 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.55 -48.69 84.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.776 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 -31.76 65.2 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.436 0.636 . . . . 0.0 109.749 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.3 ttp -63.18 -11.81 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.355 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.84 -39.24 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.399 0.618 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.7 mt -83.65 -36.59 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 15.9 t90 -59.65 -52.61 64.79 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.688 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.435 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 2.4 tt -58.98 -53.66 55.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 110.529 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -42.27 -45.13 4.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.748 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -81.49 -24.53 36.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.25 -61.41 2.62 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.801 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 5.8 m-85 -75.13 -53.72 8.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -65.08 -45.03 86.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.89 -45.89 95.05 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 90.2 t -69.55 -35.67 67.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.603 0.239 . . . . 0.0 111.227 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 82' ' ' PHE . 1.1 mp0 -71.29 -39.52 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.708 0.289 . . . . 0.0 110.934 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 tp -73.05 -43.94 61.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.6 p -52.68 -52.25 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' O ' ' OG1' ' A' ' 92' ' ' THR . 18.2 t80 -47.37 -38.63 13.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -59.52 -40.93 88.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.863 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 91' ' ' HIS . 1.8 m-70 -60.95 -35.85 77.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.367 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 72.3 p -76.49 -42.54 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.0 ttt -50.34 -49.88 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.13 -47.81 81.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -52.91 -37.81 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.5 mp -94.35 -15.87 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 93' ' ' MET . 13.3 m-85 -156.26 75.44 4.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.625 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.12 160.15 8.69 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.795 2.33 . . . . 0.0 112.058 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 t -168.31 60.59 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.761 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.7 81.93 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.853 2.369 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -163.08 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.546 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.82 67.21 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.592 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -167.26 131.17 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.486 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.4 m -81.97 45.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.66 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -111.42 125.12 53.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.713 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -161.02 -38.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.541 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.5 ptm -156.64 156.77 34.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -58.62 113.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -145.76 100.03 3.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -125.3 148.55 61.28 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.169 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 113' ' ' TRP . 85.7 Cg_exo -38.99 132.16 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.451 2.101 . . . . 0.0 112.149 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 3.7 mp0 -69.75 11.02 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.555 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.82 -3.47 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.648 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.6 tp -125.81 79.37 68.43 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 121.017 0.437 . . . . 0.0 110.043 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.1 Cg_exo -54.59 9.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.731 2.288 . . . . 0.0 112.52 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.648 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -65.48 -32.91 74.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.048 0.451 . . . . 0.0 109.925 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -97.71 -40.1 8.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.014 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.9 -45.34 67.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.9 t90 -76.12 -12.16 60.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.189 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.89 70.74 36.06 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.19 -18.67 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.705 2.27 . . . . 0.0 111.871 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -55.46 -54.12 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.897 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.495 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 10.6 m -105.48 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.828 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.2 m-85 -164.96 -38.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -58.23 129.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.83 152.68 18.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' PRO . 54.0 p -156.53 104.99 2.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.09 -169.75 21.57 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 3.6 m-20 -96.19 170.26 9.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 110.238 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.2 m -119.04 128.44 54.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.72 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.49 -10.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -69.56 149.03 48.63 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.712 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -100.01 134.09 43.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.518 ' NE2' ' CD2' ' A' ' 38' ' ' LEU . 1.6 pt20 -132.58 -13.59 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -173.9 133.73 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -145.37 158.0 43.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.178 0.513 . . . . 0.0 112.002 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.427 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.5 t80 -114.29 140.28 48.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.159 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp 49.11 16.72 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.088 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.97 23.02 31.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.072 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 77.6 mt -127.42 138.99 53.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.985 0.392 . . . . 0.0 110.174 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -68.05 146.18 53.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.62 -54.32 19.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.455 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.3 Cg_exo -41.48 -34.17 1.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.334 2.023 . . . . 0.0 111.941 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -72.03 -48.46 44.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 94.6 m95 -60.44 -57.79 11.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.827 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.8 mp -43.97 -37.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.085 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.45 -35.1 73.4 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.6 -40.88 98.5 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.48 -25.8 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.451 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -44.91 87.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.35 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.47 -38.12 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.026 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.73 62.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.904 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.92 -39.9 91.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.644 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.98 -30.96 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.353 0.597 . . . . 0.0 109.868 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -82.67 -30.84 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.815 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 53.0 t -67.88 -42.74 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -79.34 -48.34 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.581 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -51.98 -34.42 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.217 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.1 -36.13 21.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 40.0 t -67.02 -30.46 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.292 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 162' ' ' ILE . 7.5 p -79.26 -49.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.407 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 0.9 OUTLIER -64.21 -10.53 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.113 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 m -54.31 -38.54 66.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.585 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -164.78 73.4 1.52 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.74 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.17 1.04 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.933 2.422 . . . . 0.0 112.127 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.542 ' CG ' ' N ' ' A' ' 167' ' ' LYS . 91.3 t80 -149.89 165.42 32.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.612 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.542 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 21.2 ttmt -85.0 58.5 5.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.535 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.48 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.341 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -141.51 43.88 1.74 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.598 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -72.73 125.94 28.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -126.4 -137.14 0.26 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.428 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.516 ' OD1' ' CZ ' ' A' ' 174' ' ' PHE . 1.7 p30 -55.22 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.15 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 0.2 OUTLIER 59.17 101.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 1.3 m-85 -89.62 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 176' ' ' ARG . . . -54.05 100.5 0.07 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 175' ' ' GLY . 9.0 ttt180 58.26 127.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.931 0.396 . . . . 0.0 110.569 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -88.36 -134.02 4.61 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -162.01 106.28 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.484 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.47 ' C ' ' HD1' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -157.96 -65.02 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 46.27 -109.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -98.58 -114.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.92 -23.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.561 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 183' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.552 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.019 0.438 . . . . 0.0 110.037 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -45.53 -42.0 10.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.549 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -62.79 -41.06 99.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -49.7 -41.15 42.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.01 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -67.49 -29.56 69.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.891 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -74.9 -50.72 15.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 p -76.76 -36.44 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.771 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -70.7 2.57 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.09 148.98 18.95 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -70.78 -49.24 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.291 . . . . 0.0 110.702 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.21 -44.86 6.24 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.3 81.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.559 -0.32 . . . . 0.0 110.253 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -58.53 -46.55 86.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.234 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.19 -28.27 67.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.0 -31.45 67.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.634 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . 55.7 mtt -70.65 -33.93 71.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.66 32.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.674 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.74 -31.47 64.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -67.23 -52.57 39.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.512 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -65.57 -29.12 69.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.471 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -77.75 -41.79 36.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.68 -33.87 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -73.23 -35.46 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.277 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -71.42 -43.3 67.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.652 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.07 -57.91 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 p -51.06 -30.24 15.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.297 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.36 -43.44 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -14.56 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -91.96 -36.62 13.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.426 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 36' ' ' MET . 2.6 m-85 -58.67 -40.32 83.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -75.78 -35.78 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.221 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -28.89 66.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.484 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 36' ' ' MET . 22.5 m -105.24 -38.21 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.652 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 36' ' ' MET . 1.8 tmt? -80.5 -0.04 35.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.511 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 48.52 47.57 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tt -83.63 150.76 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -117.88 137.85 24.78 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.3 Cg_endo -75.44 167.72 26.03 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.454 2.102 . . . . 0.0 112.155 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.45 175.51 7.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.099 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 33.2 t -58.38 -53.72 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.0 tp -65.16 -48.28 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 p -48.75 -47.84 41.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.591 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.52 -44.27 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.364 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.33 -46.6 89.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.92 -38.04 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.327 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -60.7 -29.4 69.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.821 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.01 -37.01 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.478 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.54 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.483 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' VAL . 6.1 tp -76.37 -54.02 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.28 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -44.03 -38.87 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.44 -41.63 90.42 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.6 t -62.62 -47.81 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-O 121.212 0.529 . . . . 0.0 109.757 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -49.23 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.218 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.54 -29.38 69.4 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -69.47 -33.13 72.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.667 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.86 -24.3 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 59' ' ' LEU . 3.2 mm? -73.92 -39.28 63.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.405 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.18 -35.29 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.695 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -65.49 -38.5 94.87 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.94 11.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.919 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.3 mt -83.7 -29.01 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.533 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.03 78.1 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.404 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.23 22.81 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.58 2.187 . . . . 0.0 112.083 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -111.09 -6.27 14.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.78 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.55 163.19 20.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.672 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -40.92 -13.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.505 2.137 . . . . 0.0 112.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 mt -42.42 -34.99 0.91 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 94.2 mtt180 -39.0 -67.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.338 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.9 m-85 -48.96 -34.27 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.9 t -68.34 -46.02 81.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -43.87 21.86 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.992 -0.442 . . . . 0.0 111.137 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.473 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.07 -16.73 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.797 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -57.78 -32.5 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.637 0.732 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.7 -34.09 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.895 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.9 t-105 -64.3 -45.18 89.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.933 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 81' ' ' ALA . 1.3 tp -68.62 -46.33 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.221 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -45.69 -41.92 11.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.122 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -80.77 -23.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.387 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.24 -59.59 5.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -74.84 -53.62 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -66.23 -46.89 75.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.78 -47.3 86.83 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.5 t -66.39 -47.39 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.85 -44.74 82.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 87' ' ' LEU . 1.2 tt -64.81 -51.41 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.8 p -48.13 -23.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.256 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.66 -45.16 54.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.53 -38.09 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.136 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -67.95 -42.11 81.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -66.62 -51.56 54.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.729 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' TYR . 16.5 ttt -56.34 -51.49 68.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.95 -41.6 99.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.423 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -55.97 -44.29 78.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.228 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 96' ' ' LEU . 5.9 tt -95.54 -6.56 40.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' MET . 9.5 t80 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.305 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.88 -2.76 58.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.157 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.628 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.9 mt -126.34 80.19 69.36 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 48.6 Cg_exo -52.89 5.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.69 2.26 . . . . 0.0 112.164 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.628 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -61.67 -33.31 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.201 0.524 . . . . 0.0 110.075 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -96.94 -43.04 7.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -45.24 80.75 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.221 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.1 t90 -74.63 -12.9 60.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.792 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.9 t -142.63 72.67 20.19 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.59 -17.08 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.712 2.274 . . . . 0.0 111.8 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -54.96 -53.78 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.798 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.6 t -105.94 58.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.6 m-85 -162.85 -42.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 130.4 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.4 156.32 16.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' PRO . 67.3 m -160.99 99.93 1.23 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.66 179.89 17.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.34 150.29 23.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 110.235 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 68.4 m -101.43 129.07 47.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.821 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.56 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.21 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.66 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.859 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.486 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -100.58 132.84 45.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.536 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -130.28 -8.24 4.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.812 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.432 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 10.1 t-105 -173.91 132.41 0.42 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.86 160.32 39.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.93 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -117.87 139.04 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.078 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mt 49.66 17.05 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.56 20.64 40.09 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.7 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.03 139.19 54.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -70.24 146.4 50.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.149 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.37 -58.88 5.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.366 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.1 Cg_exo -37.21 -37.84 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -70.52 -45.19 66.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.111 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.6 m95 -66.95 -57.39 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.232 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 mt -43.49 -37.03 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.978 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 88' ' ' THR . 28.6 tp -63.57 -36.35 83.5 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -55.59 -39.68 75.9 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.3 mt -71.02 -44.27 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 110.463 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -47.69 -42.54 25.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.23 -46.29 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.801 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -56.66 -54.24 48.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.0 m-85 -57.2 -36.88 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 154' ' ' LEU . 6.1 tt -63.53 -29.79 71.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.89 -39.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 m -62.02 -38.82 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.827 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.579 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -72.24 -48.41 42.98 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.71 -37.08 74.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.73 -41.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 156' ' ' VAL . 75.5 t -72.0 -23.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 157' ' ' ALA . 15.0 t -76.05 -45.74 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.45 -21.49 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -57.59 -28.29 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -76.92 -43.29 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.544 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mt -50.58 -41.02 53.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.357 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -65.62 -27.57 68.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 110.064 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -79.44 -47.91 14.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.522 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.81 71.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.668 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.4 m -76.53 -39.69 52.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.62 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.542 HE22 ' C ' ' A' ' 65' ' ' PRO . 19.1 tp60 -66.85 5.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.481 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.75 141.97 15.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -68.11 -48.22 66.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.01 -45.36 6.02 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.62 76.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.108 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -54.62 -42.48 71.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.6 -26.95 65.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.995 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -70.16 -35.01 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.662 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.451 ' O ' ' OG1' ' A' ' 21' ' ' THR . 2.0 mtt -71.6 -32.93 68.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.35 45.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -52.31 -43.79 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.4 p -58.23 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.691 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.42 -39.04 31.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -42.03 69.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.839 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . . . -45.98 -42.27 12.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.709 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -71.12 -32.08 68.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 30' ' ' LEU . 3.4 tm-20 -70.68 -49.93 41.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.07 -57.72 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 24' ' ' ALA . 68.7 p -49.95 -30.34 10.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.622 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.93 -47.09 13.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -54.45 -14.22 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.42 -36.3 10.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.36 . . . . 0.0 110.515 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -42.1 79.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.437 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 40' ' ' PRO . 39.6 mt-30 -69.57 -46.08 67.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.17 -18.81 50.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -101.61 -43.92 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 mmt -89.96 8.45 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.767 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLN . 3.8 tp 44.87 45.74 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.646 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -80.05 154.43 28.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -127.53 83.84 64.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.361 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 75.5 Cg_exo -47.02 178.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 8.4 t -116.29 -175.83 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.384 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.1 p -64.52 -36.18 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.314 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.55 -47.53 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.543 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -53.61 -49.56 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.691 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.7 mt -65.8 -37.81 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.368 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -59.76 -48.36 81.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.16 -37.05 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -32.37 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.95 79.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.33 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -77.19 -52.1 9.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.07 -40.12 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.4 -44.71 89.83 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 t -61.21 -47.67 92.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.49 . . . . 0.0 109.758 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -44.62 -46.05 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.785 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.47 80.89 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.2 -40.71 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.358 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.04 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.367 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.03 -28.47 49.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.428 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.14 -39.35 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.493 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.99 -32.76 77.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.36 5.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 61' ' ' GLY . 76.7 mt -76.56 -36.8 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.94 72.06 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.499 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' C ' HE22 ' A' ' 10' ' ' GLN . 16.4 Cg_exo -64.36 16.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.879 2.386 . . . . 0.0 112.131 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.0 tmtm? -109.37 -5.67 15.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.004 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.38 164.31 16.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.567 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -41.19 -12.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.6 mm? -44.84 -34.79 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.406 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.2 ptt180 -40.43 -68.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.736 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.453 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 27.4 t80 -54.0 -28.48 38.27 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 t -70.86 -52.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.697 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.08 63.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.269 0.557 . . . . 0.0 109.987 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 23.4 ttt -59.3 -10.42 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.047 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 72' ' ' VAL . 4.4 p -62.78 -36.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.428 0.632 . . . . 0.0 110.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 76' ' ' ILE . 35.7 mm -86.65 -32.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.754 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 8.3 t-105 -62.96 -52.64 62.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.935 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -46.33 88.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.609 ' CD2' ' NH1' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -47.05 -45.78 21.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.56 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.5 p -76.59 -25.94 54.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.669 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.0 -60.6 3.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.024 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -73.33 -54.24 8.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 79' ' ' TYR . 23.0 ttm105 -67.26 -47.49 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' THR . . . -54.68 -48.47 65.74 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.1 -50.89 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.438 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -48.34 -28.05 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -77.83 -39.25 44.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 147' ' ' LEU . 80.6 p -54.13 -29.56 45.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.31 -48.75 69.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.342 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -54.95 -39.84 69.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.469 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -71.84 -56.79 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -53.16 -52.78 57.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' TYR . 61.7 mmm -49.41 -46.59 47.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.8 -45.37 78.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.359 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -57.84 -38.82 76.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.2 -12.12 28.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.0 t80 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.639 0.257 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -96.52 -4.57 41.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.932 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 mt -123.65 78.77 55.84 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.201 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.4 Cg_exo -51.87 -0.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -59.21 -33.21 70.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.106 0.479 . . . . 0.0 110.367 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -96.8 -42.08 8.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.636 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -70.12 -45.09 67.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.568 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.3 t90 -74.1 -16.13 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.04 71.32 48.44 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.21 -19.58 10.43 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.854 2.37 . . . . 0.0 111.77 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.46 -44.98 65.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.683 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 t -118.98 56.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.947 0.403 . . . . 0.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.523 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.3 t80 -160.35 -40.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.256 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.23 127.53 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.483 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.14 22.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 127' ' ' SER . 17.2 p -169.13 103.49 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.472 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.35 -175.43 21.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.3 140.87 29.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.799 0.333 . . . . 0.0 110.225 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.1 m -89.65 135.47 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.98 1.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 133' ' ' ARG . 2.4 tm-20 -67.11 145.27 55.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.493 ' N ' ' OE2' ' A' ' 132' ' ' GLU . 6.6 ptp180 -100.07 130.23 46.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -118.83 -25.17 6.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 140.74 52.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.98 119.46 11.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.218 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.18 133.83 51.44 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.17 17.51 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.349 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.93 58.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.26 145.11 50.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.673 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.2 mp0 -75.94 157.38 33.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.1 mtt -56.47 -50.93 84.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.911 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 142' ' ' MET . 88.1 Cg_exo -43.86 -38.03 9.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.357 2.038 . . . . 0.0 112.158 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -70.76 -52.67 19.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.06 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.6 m95 -58.62 -57.17 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.967 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.46 -37.77 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -60.3 -35.91 76.68 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.8 -44.9 95.6 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.14 -39.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.243 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -52.68 -47.84 66.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.903 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.12 -48.05 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.33 -46.59 66.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.703 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.453 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 6.1 m-85 -55.12 -40.54 70.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.294 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 158' ' ' VAL . 1.4 mt -65.85 -30.58 71.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.12 -29.5 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.622 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.3 t -69.8 -36.55 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.486 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -79.99 -35.99 36.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.202 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 154' ' ' LEU . 47.3 t -65.4 -38.93 83.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.101 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.79 -27.81 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.736 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 156' ' ' VAL . 41.3 t -78.31 -26.23 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.25 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 74' ' ' MET . 2.5 p -83.25 -41.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.438 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 70.2 mt -74.22 -19.31 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.842 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.989 0.423 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 3' ' ' ARG . 36.7 mtp180 -56.84 -28.1 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.299 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.34 -42.95 58.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.2 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.46 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -51.51 -41.54 61.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.406 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 1.1 m-20 -66.37 -31.72 72.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -77.54 -49.51 14.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.9 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -76.65 -34.2 58.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -74.16 5.91 3.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.583 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.11 145.64 17.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -70.54 -21.15 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.614 0.245 . . . . 0.0 110.673 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 -45.14 67.09 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.93 75.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.83 0.348 . . . . 0.0 110.178 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -56.48 -41.63 76.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.328 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -69.16 -31.36 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.001 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.14 -28.84 66.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.558 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.82 -32.97 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.978 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.55 5.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -49.35 -48.43 46.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -51.76 -62.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.776 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -55.25 -31.69 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.2 tt -73.04 -41.72 63.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.505 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.13 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.77 -34.38 71.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.29 -42.6 71.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.755 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.98 -57.82 3.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.485 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 p -48.17 -31.86 6.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.72 -32.18 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.71 -17.31 62.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -94.41 -37.54 11.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.672 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -54.35 -45.97 72.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -74.56 -31.56 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.42 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.449 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -61.0 -32.16 71.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.576 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 36' ' ' MET . 19.9 m -103.23 -41.55 7.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 5.2 tpt -78.03 -0.61 28.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt 48.96 49.87 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.01 147.95 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.82 136.53 20.0 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.202 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.91 143.81 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.353 2.035 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -100.23 161.57 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 41.4 t -51.21 -51.58 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.409 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mt -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.068 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 p -48.63 -43.03 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 124' ' ' PHE . 25.2 mt -63.27 -47.16 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.61 -46.54 80.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -40.25 96.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.554 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -63.66 -35.85 81.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.93 76.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.55 -46.96 85.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.62 -49.9 11.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -46.42 -41.36 13.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.04 88.65 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 54.1 t -62.94 -44.16 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.276 0.56 . . . . 0.0 109.681 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -48.3 9.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.323 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.69 89.58 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -63.01 -37.69 88.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 110.304 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.29 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.316 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.42 -25.4 57.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.541 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -84.21 -40.77 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.2 -30.85 76.1 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.92 9.81 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.503 ' H ' ' C ' ' A' ' 61' ' ' GLY . 67.1 mt -79.79 -41.92 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.95 71.04 0.34 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.318 . . . . 0.0 110.385 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.43 13.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.959 2.44 . . . . 0.0 112.228 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 64' ' ' ALA . 19.5 pttp -113.09 -5.38 13.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.493 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.14 161.27 29.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.691 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.73 -12.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.325 2.017 . . . . 0.0 112.045 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -42.95 -35.55 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' LEU . 89.5 mtt180 -37.82 -65.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -51.46 -25.04 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.833 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.4 t -78.39 -52.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.78 -45.31 52.45 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.135 0.493 . . . . 0.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.49 -8.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.085 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.9 p -61.75 -34.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.596 0.712 . . . . 0.0 110.145 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.31 -31.82 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.594 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -65.65 -51.06 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.934 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.56 -43.87 83.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -46.24 -45.56 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.956 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -58.38 8.81 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.215 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.51 -53.85 9.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.354 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -67.87 -45.91 73.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.29 -47.91 78.89 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.7 t -68.78 -46.31 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.506 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.407 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 1.6 tm0? -54.43 -24.96 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 tp -87.25 -41.85 13.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.634 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 22.5 p -51.61 -25.74 7.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.381 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -71.31 -35.33 71.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.11 -33.85 75.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.26 -44.94 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -59.72 -52.6 64.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.518 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.646 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.7 ttt -54.34 -48.49 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.46 -37.96 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.805 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.52 -39.2 85.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.8 mm? -90.02 -5.56 56.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.7 t80 . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.161 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.46 0.059 0 CA-C-O 120.74 0.305 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -126.64 15.24 7.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.378 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.2 mt -120.52 80.25 30.33 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.707 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 11.3 Cg_exo -68.07 7.95 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.637 2.225 . . . . 0.0 111.386 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -76.51 -30.87 57.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 110.357 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.37 -41.11 8.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -67.58 -44.87 77.12 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.418 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.7 t90 -77.32 -13.11 60.0 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.519 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.54 74.28 71.3 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.87 -25.68 4.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.846 2.364 . . . . 0.0 111.872 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -52.43 -52.16 55.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.7 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.72 55.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.709 ' O ' HD13 ' A' ' 45' ' ' ILE . 38.1 t80 -158.93 -40.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 125' ' ' VAL . 12.1 p -54.99 128.81 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.67 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.37 148.9 21.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.1 p -155.91 128.66 7.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 106.11 -163.22 13.78 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -102.02 156.52 17.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.394 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 21.0 m -108.11 130.94 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.85 -7.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 158.03 32.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' CZ ' ' OD2' ' A' ' 136' ' ' ASP . 53.2 ttt180 -97.67 141.93 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.236 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -134.42 -31.66 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.69 146.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.707 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.476 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.0 p30 -143.24 161.1 39.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 111.993 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -114.44 136.39 53.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.773 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.22 16.77 0.28 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.99 19.7 33.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.194 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.416 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 35.2 mt -125.64 140.44 52.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.052 0.426 . . . . 0.0 110.254 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.21 148.03 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -48.7 -51.96 49.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.546 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 142' ' ' MET . 87.8 Cg_exo -44.23 -34.51 7.08 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.35 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -48.82 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.579 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.1 m95 -57.94 -57.98 10.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.879 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.0 mt -43.89 -38.74 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.2 tt -56.83 -37.3 71.03 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.31 -41.2 96.77 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 mt -76.61 -25.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.767 0.318 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.53 -46.16 80.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.36 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 pt -64.26 -41.54 92.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.288 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.34 -49.45 77.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.358 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.439 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 4.1 m-85 -59.77 -45.13 93.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.724 ' C ' HD12 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.836 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.51 -32.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.565 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 34.1 t -67.66 -48.4 76.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.502 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -57.28 -53.63 55.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 154' ' ' LEU . 96.1 t -51.44 -49.2 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.8 t -73.4 -23.11 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.1 t -81.56 -50.83 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.918 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 34.4 mm -68.66 -12.38 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.274 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.388 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 2' ' ' LEU . 9.6 mp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.955 0.407 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -56.53 -37.36 70.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.561 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.99 -45.46 88.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.16 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -50.22 -41.27 49.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.071 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -68.75 -26.75 65.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.898 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -75.4 -50.48 15.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.448 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.63 69.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -76.47 -37.69 56.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.661 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -73.68 8.83 1.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.83 141.11 15.17 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 13' ' ' GLY . 3.8 ptp85 -68.49 -49.7 57.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.656 0.265 . . . . 0.0 110.713 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 12' ' ' ARG . . . -43.05 -45.77 6.16 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.12 87.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -60.49 -44.52 95.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.152 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.12 -30.14 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 21' ' ' THR . 20.9 tp -69.8 -28.06 65.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.633 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.459 ' O ' ' OG1' ' A' ' 21' ' ' THR . 20.1 mmt -74.5 -33.64 62.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.52 -54.67 15.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.564 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.22 -49.25 53.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.703 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 18' ' ' MET . 20.3 p -48.7 -57.08 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.13 -39.5 28.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.55 -41.47 69.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' THR . . . -47.14 -36.41 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.544 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.85 -36.32 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.23 -53.54 42.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.818 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -62.41 -57.97 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.833 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.9 p -46.96 -29.24 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.732 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -45.41 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.8 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -52.27 -15.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.8 t90 -93.32 -34.7 13.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.483 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.98 -42.38 80.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -69.02 -47.68 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.01 -9.05 13.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.498 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' TRP . 55.7 t -107.17 -41.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.6 mmt -96.39 10.12 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 tp 48.47 45.33 20.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.6 mt -79.54 146.65 32.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.352 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -107.61 131.22 21.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.444 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 165.22 28.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.137 1.892 . . . . 0.0 111.761 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -127.96 -175.22 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.512 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.1 mm? -69.88 -49.93 47.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.612 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.2 p -49.68 -51.14 40.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.488 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.55 -40.49 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -59.48 -43.15 93.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.787 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -59.02 -44.41 91.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.432 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -58.97 -29.63 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.25 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.51 72.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.316 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 54' ' ' VAL . . . -62.7 -52.3 63.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -54.82 9.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.035 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -48.65 -32.11 7.79 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.814 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.31 -46.29 72.31 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.945 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -70.73 -31.24 45.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.366 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.03 -46.47 75.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.284 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.71 86.41 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.01 95.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.78 -0.71 . . . . 0.0 110.557 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -29.54 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.503 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.5 tp -74.25 -32.03 62.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.57 -33.81 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -78.08 -30.13 51.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.57 5.25 1.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 0.0 110.317 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.4 mt -89.12 -23.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.607 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.02 70.09 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.794 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.45 26.6 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.702 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -109.2 -7.19 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.395 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.88 173.73 2.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.13 -8.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.22 1.947 . . . . 0.0 111.852 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -42.27 -38.74 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.4 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 10.4 mtp180 -40.04 -70.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.606 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -51.6 -18.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.092 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 69' ' ' LEU . 4.0 t -83.16 -46.6 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.61 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -40.04 68.41 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.81 -8.84 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.353 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.84 -43.97 81.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.396 0.617 . . . . 0.0 110.145 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.49 -33.36 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.4 t-105 -60.19 -55.9 28.21 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.801 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.54 -48.2 82.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -45.17 -43.95 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.6 p -79.84 -24.54 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.577 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.05 -61.24 2.75 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.69 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.42 -55.94 5.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -65.97 -51.5 57.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.68 -47.31 58.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 81' ' ' ALA . 91.1 t -68.86 -47.5 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -53.17 -30.23 36.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -42.61 63.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.4 p -54.61 -28.59 47.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.969 0.414 . . . . 0.0 110.237 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -63.34 -46.1 88.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -61.86 -40.17 94.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.718 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -70.81 -45.88 63.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.773 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.5 p -64.61 -47.69 77.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.727 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 97' ' ' TYR . 28.6 ttt -56.24 -51.35 68.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.57 -50.98 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.329 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -51.91 -37.78 53.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.388 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -91.71 -15.69 28.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.315 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 93' ' ' MET . 84.9 t80 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.746 0.308 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.44 5.75 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.622 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.599 ' C ' ' H ' ' A' ' 116' ' ' LEU . 77.9 mt -117.37 83.48 16.48 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -54.14 7.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.583 2.188 . . . . 0.0 112.428 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 116' ' ' LEU . 8.2 mp -74.88 -28.43 60.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.693 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -95.8 -40.8 9.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -65.65 -33.69 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -88.63 -20.73 24.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.184 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.51 69.03 12.39 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.82 -18.06 52.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.712 2.274 . . . . 0.0 111.538 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -77.59 -3.81 42.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.179 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.704 ' O ' HG12 ' A' ' 123' ' ' VAL . 48.3 t -131.76 36.13 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.102 0.477 . . . . 0.0 110.741 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 15.9 m-85 -161.33 -43.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.72 129.8 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.066 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.09 152.83 18.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.5 t -160.68 99.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.05 -174.11 22.31 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 13.2 m-20 -88.0 157.34 18.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 2.6 m -107.86 127.63 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.05 -4.25 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.131 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -67.58 128.84 37.95 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.791 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.789 ' NE ' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -74.08 142.63 45.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.472 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -131.96 -26.81 1.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.792 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -173.0 147.82 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 20.0 p-10 -142.98 167.57 21.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 112.112 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -134.75 138.15 44.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.844 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.68 17.32 3.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.457 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 83.41 21.02 59.22 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 139' ' ' GLY . 7.0 mp -120.87 131.52 54.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.3 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -68.99 150.58 47.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.6 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.67 -54.4 23.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.082 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.97 -36.47 11.27 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.246 1.964 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -70.95 -46.04 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.0 m95 -65.31 -56.98 9.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.873 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -42.99 -37.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.15 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.36 -34.06 77.42 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.97 -40.68 91.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.79 -40.53 76.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.277 . . . . 0.0 110.279 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.37 -40.63 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.99 -46.62 93.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.75 -51.16 66.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.405 ' CD2' ' CZ2' ' A' ' 77' ' ' TRP . 4.6 m-85 -66.76 -43.69 83.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.6 tt -49.11 -30.76 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.313 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.69 -37.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.938 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 160' ' ' VAL . 87.0 t -51.64 -37.45 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.587 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -79.91 -44.36 20.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.935 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 154' ' ' LEU . 67.0 t -52.07 -44.48 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.215 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tp -81.3 -36.43 29.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.792 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.9 t -69.94 -31.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.259 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.7 -49.29 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.107 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -19.34 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.033 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.922 0.392 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -51.62 -43.41 62.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.44 -39.87 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 159' ' ' LEU . 1.4 tt -53.43 -44.8 69.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.75 -31.81 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -75.22 -48.57 22.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -64.75 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.654 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.7 p -76.16 -32.03 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 4.4 tt0 -74.24 9.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.965 0.412 . . . . 0.0 110.319 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.82 151.8 17.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 16' ' ' LEU . 57.9 mtm180 -69.05 -20.24 64.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.74 -44.09 64.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.24 -51.39 61.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.533 0.206 . . . . 0.0 110.991 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -54.85 -51.08 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 12' ' ' ARG . 7.0 mp -59.76 -27.61 66.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -70.46 -26.09 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.09 -34.85 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.67 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.725 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 27.0 t80 -52.9 -53.41 49.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.715 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.4 p -43.74 -53.4 5.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.442 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -26.58 66.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -79.92 -42.24 24.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.42 -36.24 61.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.756 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.38 -38.95 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.14 -45.75 79.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -57.79 5.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.572 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.1 p -46.76 -31.67 3.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.477 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.67 -44.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 tp -51.06 -17.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.654 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' VAL . 31.4 t90 -91.44 -35.83 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 1.7 m-85 -56.47 -36.99 69.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.349 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.95 -39.71 23.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.53 -22.4 61.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -109.03 -44.01 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 35' ' ' VAL . 5.4 ttt -83.98 6.47 21.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.6 mt 40.57 42.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.729 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.71 154.11 39.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.339 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -123.61 115.54 28.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.5 Cg_endo -78.29 179.95 6.02 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.274 1.983 . . . . 0.0 112.283 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 2.2 t -119.61 -175.73 3.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -65.12 -39.68 86.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.297 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.584 HD11 ' CG ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -65.21 -50.12 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.257 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.2 m -49.74 -48.21 50.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.703 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.95 -42.97 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.36 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -56.74 -45.89 81.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.053 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.17 -42.37 98.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.3 ttp85 -62.44 -34.83 77.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.45 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.137 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.59 -47.29 82.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -76.99 -47.95 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -46.9 -44.31 19.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.087 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.08 93.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 27.6 t -61.42 -47.33 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.154 0.502 . . . . 0.0 110.0 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 55' ' ' LEU . 1.3 tt -46.46 -45.38 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.63 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.56 74.11 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -65.04 -30.67 71.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.908 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.25 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.223 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.0 -43.1 99.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 mm -79.22 -35.97 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.45 -33.41 81.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 9.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 91.9 mt -83.35 -35.06 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.723 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.22 76.45 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.712 0.291 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.78 20.7 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.579 2.186 . . . . 0.0 112.062 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -109.61 -7.28 15.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.158 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.09 162.86 18.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.6 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -38.69 -16.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.512 2.141 . . . . 0.0 112.256 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 67' ' ' THR . 38.9 mt -44.05 -31.18 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 61.0 mtt180 -38.13 -65.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.39 -33.15 52.62 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.416 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.9 t -66.36 -57.75 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.496 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.35 82.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.307 0.575 . . . . 0.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -14.94 45.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.262 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 72' ' ' VAL . 1.9 p -60.25 -32.64 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.499 0.666 . . . . 0.0 110.198 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -89.34 -32.97 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.927 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.4 t-105 -67.16 -49.58 64.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.874 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 78' ' ' LEU . 4.4 tt -63.9 -51.84 62.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.924 0.393 . . . . 0.0 110.158 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -40.96 -43.21 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.36 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 p -78.89 -21.5 47.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.53 -61.22 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.816 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.61 -53.56 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.38 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -68.1 -39.24 82.89 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . . . -66.44 -44.79 89.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.43 -38.47 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.563 0.22 . . . . 0.0 111.453 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -66.46 -43.91 84.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.278 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.17 -45.91 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.9 p -46.94 -50.28 19.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.502 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -53.05 -30.68 37.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.506 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.45 -39.96 89.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.584 ' CG ' HD11 ' A' ' 43' ' ' LEU . 2.8 m170 -64.75 -43.62 92.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.189 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -65.19 -38.87 91.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' TYR . 37.6 ttp -52.06 -45.02 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.4 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.302 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -55.9 -41.24 74.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.433 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 tp -89.09 -18.24 27.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.8 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.94 0.4 . . . . 0.0 110.62 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.656 0.265 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.544 ' HE1' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.8 -3.21 58.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.662 ' C ' ' H ' ' A' ' 116' ' ' LEU . 20.7 mt -118.76 88.11 34.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.917 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.6 Cg_exo -53.76 11.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.153 . . . . 0.0 112.261 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.662 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -71.4 -30.12 65.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 109.868 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.444 ' CG ' ' CE1' ' A' ' 124' ' ' PHE . 74.5 m-20 -97.29 -40.79 8.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -72.36 -45.77 58.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.821 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.8 t90 -72.91 -12.84 61.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.77 74.01 39.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.563 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.55 -20.69 10.63 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.756 2.304 . . . . 0.0 112.038 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -53.22 -53.11 55.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.23 55.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.017 0.437 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.444 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 37.2 t80 -158.78 -42.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.22 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 125' ' ' VAL . 12.4 p -58.02 128.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.584 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.43 160.61 14.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' PRO . 43.2 p -173.8 103.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.562 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.66 177.29 18.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -81.61 140.11 34.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.183 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 57.2 m -87.93 132.83 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.947 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.97 2.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.223 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -67.54 144.76 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -93.74 125.3 38.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 110.797 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.56 -23.26 6.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.764 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.45 138.95 47.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.841 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -141.7 119.68 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -123.04 132.99 54.35 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.29 17.31 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.65 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.88 17.54 56.16 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.633 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.2 mp -123.49 144.08 49.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.632 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.0 mp0 -77.72 157.82 29.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.646 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.6 OUTLIER -51.12 -53.58 47.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.8 Cg_exo -40.54 -38.86 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.375 2.05 . . . . 0.0 112.304 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -69.8 -54.19 14.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.607 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.1 m95 -62.81 -57.79 9.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.463 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 tt -42.92 -36.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.509 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.77 -33.02 74.91 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.86 -44.99 96.57 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.724 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -76.04 -25.88 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 154' ' ' LEU . 32.5 t80 -62.63 -44.85 95.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.486 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 155' ' ' ILE . 20.4 pt -69.4 -36.65 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.358 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.91 71.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.97 -49.43 66.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.793 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.541 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 19.3 mt -62.65 -31.94 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.3 mp -72.68 -32.47 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -70.63 -46.01 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -55.09 -48.56 73.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.77 -24.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 5' ' ' LEU . 9.8 tp -78.01 -41.54 35.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.251 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.4 -20.38 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 157' ' ' ALA . 39.7 t -81.19 -50.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.81 -21.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.446 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.284 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 2.1 pp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.824 0.345 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -53.2 -32.47 48.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.586 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 91.9 t80 -76.86 -42.61 39.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -46.59 -45.1 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.545 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 4.3 p-10 -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 62.7 tt0 -78.41 -48.28 15.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.16 96.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 11' ' ' GLY . 14.7 m -76.69 -36.11 57.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 13.9 tt0 -64.45 2.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.287 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.66 150.69 19.54 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.2 mtt85 -70.48 -45.53 65.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.465 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.11 -45.26 15.01 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.37 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -60.93 -48.44 81.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -57.64 -31.22 66.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.081 0.467 . . . . 0.0 109.781 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.49 -25.71 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.791 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.3 mmt -74.34 -34.17 63.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.22 -54.29 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.861 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.04 -47.92 61.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.752 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 p -52.54 -50.22 63.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.29 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.734 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.29 -39.17 82.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.04 -36.78 60.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.78 -35.6 62.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' OE1' ' NH2' ' A' ' 48' ' ' ARG . 3.8 tp10 -68.73 -46.89 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.927 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.3 tt -65.71 -58.16 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 p -48.91 -32.35 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.62 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.6 mt -53.37 -13.56 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -95.1 -31.89 13.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.69 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.13 -34.36 77.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.73 -43.17 23.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -18.63 53.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.81 -48.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.647 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 tpt -83.33 6.49 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 41.69 41.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.44 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 39' ' ' LYS . 5.8 tt -62.83 151.85 37.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.117 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -113.47 90.61 17.88 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.241 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.62 146.39 34.58 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.554 2.169 . . . . 0.0 112.337 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.9 t -99.83 173.25 6.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.09 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 10.0 p -61.04 -41.4 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.8 mp -68.11 -47.79 67.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.272 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 m -50.2 -48.95 53.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.703 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.47 -44.24 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.49 -45.7 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.07 -39.8 93.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.679 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' NH2' ' OE1' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -61.11 -34.43 74.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.289 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 -39.04 88.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.568 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.5 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.1 -51.45 15.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -45.33 -43.19 10.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.053 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.9 96.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' ALA . 66.2 t -57.72 -46.47 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.26 0.553 . . . . 0.0 110.172 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.1 tp -48.48 -43.25 34.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.698 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.99 71.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.72 -35.15 60.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.566 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.93 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.75 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' O ' HD11 ' A' ' 63' ' ' ILE . 12.0 mt -75.42 -40.86 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.789 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -78.63 -31.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.23 -31.82 33.34 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.32 0.88 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.709 0.29 . . . . 0.0 110.885 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 59' ' ' LEU . 7.8 mm -88.45 -24.08 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.98 65.6 0.3 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.808 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.55 18.7 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.736 2.291 . . . . 0.0 111.625 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -106.54 -10.24 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.627 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -109.77 176.48 1.53 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.819 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.06 1.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.234 1.956 . . . . 0.0 111.796 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 67' ' ' THR . 12.2 tp -58.35 -31.27 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -39.86 -64.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.757 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 75' ' ' VAL . 23.7 t80 -53.19 -33.56 53.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.57 -46.56 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.85 -40.43 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.214 0.531 . . . . 0.0 109.925 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.8 mmt -59.89 -25.99 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.367 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -52.28 -29.08 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.488 0.661 . . . . 0.0 109.712 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.11 -31.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.091 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.469 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.8 t-105 -63.91 -46.26 85.6 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 78' ' ' LEU . 3.9 tt -67.77 -52.46 37.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -41.75 -41.55 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.297 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 p -81.39 -24.49 36.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.65 -59.04 6.08 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.989 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -74.89 -51.4 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.204 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.38 -46.09 77.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.78 -47.36 90.8 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.4 t -68.6 -56.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.217 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -49.87 -21.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.818 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.77 -35.91 14.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.033 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.9 p -59.05 -55.18 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.03 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.531 ' CZ ' ' SD ' ' A' ' 93' ' ' MET . 87.6 t80 -52.23 -38.61 58.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -57.14 -40.14 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -35.04 79.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.4 p -72.92 -36.54 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' TYR . 58.8 mmm -54.02 -49.06 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -60.52 -49.93 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.422 ' C ' HD12 ' A' ' 96' ' ' LEU . 51.5 mt-30 -50.23 -36.46 31.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 96' ' ' LEU . 11.1 mp -102.06 -9.77 20.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.641 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 93' ' ' MET . 25.5 t80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.798 0.332 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -2.24 56.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 116' ' ' LEU . 41.5 mt -120.11 87.12 38.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.6 Cg_exo -51.78 4.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.64 2.227 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 114' ' ' LEU . 13.8 mt -64.07 -30.23 71.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.1 -43.05 7.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.6 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -71.53 -44.96 63.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.437 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.3 t90 -74.64 -15.98 60.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.71 71.15 64.94 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.2 -22.87 10.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 111.919 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -55.1 -53.98 48.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.25 63.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.547 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -169.28 -42.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.81 131.05 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.67 156.45 16.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.59 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 85.2 p -166.76 100.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.4 -167.3 25.03 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -100.27 166.88 10.76 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -112.23 130.1 56.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 96.74 6.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.028 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.28 139.33 46.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -100.14 126.38 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.661 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -127.2 -14.4 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.6 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -173.38 132.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -143.25 161.29 38.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.258 0.551 . . . . 0.0 112.077 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 23.6 t80 -123.22 138.98 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.158 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 1.1 mm? 54.26 17.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.164 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.19 57.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 9.5 mt -124.41 136.64 54.21 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.02 148.32 50.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.424 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mtp -49.12 -52.01 51.54 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 142' ' ' MET . 71.1 Cg_exo -45.6 -38.12 16.24 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.41 2.073 . . . . 0.0 112.321 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -68.92 -46.18 68.94 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 148' ' ' GLY . 62.1 m95 -62.75 -56.15 20.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.211 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mt -43.12 -37.94 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.943 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -63.91 -35.22 79.94 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.92 -36.82 75.07 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.02 -33.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.75 -44.35 90.52 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.034 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.56 -49.24 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.022 0.439 . . . . 0.0 109.843 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.37 57.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.066 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -61.16 -49.83 75.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.332 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 154' ' ' LEU . 8.1 tt -47.53 -32.23 5.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.442 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.27 -38.11 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.14 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.3 t -54.39 -39.88 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.34 -45.55 25.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.313 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 34.7 t -52.27 -42.53 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.202 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mt -84.12 -41.41 17.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.433 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 156' ' ' VAL . 44.5 t -61.87 -25.37 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.756 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' ALA . 64.7 t -83.08 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 109.969 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 162' ' ' ILE . 80.6 mt -65.0 -8.59 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.312 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.821 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 2' ' ' LEU . 6.7 mp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.874 0.369 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -50.48 -36.1 32.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' GLN . 44.6 m-85 -75.47 -40.23 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.323 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.9 tp -45.06 -40.48 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -70.16 -21.75 63.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.404 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' PHE . 40.7 tt0 -79.93 -47.0 15.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.92 -31.72 73.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.95 0.405 . . . . 0.0 110.314 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 28.9 m -76.03 -41.47 50.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.21 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 10' ' ' GLN . 1.6 pp0? -70.4 8.93 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.558 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.76 142.43 16.08 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -65.76 -20.64 66.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.659 0.266 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.82 -47.57 54.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.36 -51.61 68.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 0.0 110.469 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -55.78 -46.36 77.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.517 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.63 -31.73 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -69.39 -28.11 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -74.89 -33.91 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.796 0.331 . . . . 0.0 110.138 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.49 43.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 71.4 t80 -54.33 -53.44 53.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.73 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.1 p -43.12 -49.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.678 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.49 69.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.3 tt -76.98 -38.72 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.639 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.25 42.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -75.85 -31.45 59.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.571 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -49.89 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.4 tt -63.96 -57.55 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.599 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -45.19 -34.82 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' C ' ' N ' ' A' ' 31' ' ' TRP . . . -82.96 -46.44 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.97 -16.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.531 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.402 ' N ' ' C ' ' A' ' 29' ' ' ALA . 44.1 t90 -94.19 -25.98 16.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 135' ' ' TRP . 0.2 OUTLIER -70.26 -43.15 71.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.519 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' LEU . 34.8 tt0 -73.74 -48.04 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.613 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -49.99 -28.63 7.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.714 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.12 -45.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.696 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 2.07 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.506 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLN . 16.2 mt 43.15 43.64 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.4 149.66 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.395 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -115.37 88.31 18.59 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.79 174.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 112.008 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.59 -172.58 2.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.39 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 43' ' ' LEU . 10.7 m -64.44 -42.94 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' N ' HG23 ' A' ' 42' ' ' VAL . 7.6 mt -64.94 -49.09 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.304 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -59.1 -50.54 73.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.17 -47.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.11 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -57.76 -44.18 85.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 109.971 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -61.7 -38.52 88.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.464 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -60.96 -33.49 73.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 -34.64 76.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.225 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.6 77.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.326 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 51' ' ' LEU . 2.8 tt -72.9 -55.36 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.906 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -42.51 -38.41 1.93 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.35 -41.32 94.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -61.7 -47.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.38 -46.12 18.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.505 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.6 -27.64 70.08 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.71 -31.12 70.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 110.293 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.65 -30.99 59.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.329 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.21 -37.92 72.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.334 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.84 -36.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.34 -26.39 63.79 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.79 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -83.14 -28.71 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.667 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.61 77.07 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.86 22.2 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.6 2.2 . . . . 0.0 112.129 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -113.29 -7.56 13.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -109.87 161.67 23.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.677 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.62 -15.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.482 2.121 . . . . 0.0 112.091 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.7 mp -44.64 -29.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttp180 -40.67 -67.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.577 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.745 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.9 t80 -56.03 -28.7 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 t -69.11 -45.72 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.34 -34.58 36.51 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.302 0.573 . . . . 0.0 110.244 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 74' ' ' MET . 7.0 tmm? -61.72 -13.55 24.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.276 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 71' ' ' TYR . 75.0 t -57.97 -36.82 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 110.257 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 mm -88.05 -31.97 5.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.177 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.501 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -64.11 -52.81 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -65.2 -47.29 77.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.681 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -44.27 -43.69 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 p -79.97 -22.77 42.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.654 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.08 -60.99 2.95 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.07 -53.2 9.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.209 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -66.4 -46.27 77.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.64 -46.85 91.68 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' ALA . 87.6 t -67.73 -44.93 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -58.07 -27.21 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 tp -81.29 -44.06 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.415 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 17.2 p -52.8 -25.47 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 0.0 110.168 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -48.49 53.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.6 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -51.93 -38.33 56.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -65.57 -46.77 78.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -65.37 -47.06 77.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' TYR . 27.2 mmm -44.74 -47.67 10.78 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.5 -50.17 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.628 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.7 -29.62 7.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.39 -15.5 17.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.384 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 8.8 mp0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.502 0.192 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.2 p-90 -87.52 -1.28 57.83 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.315 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.0 79.78 50.97 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.388 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.5 Cg_exo -49.5 -1.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.619 2.213 . . . . 0.0 112.298 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -57.84 -33.1 68.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.479 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 46.3 m-20 -96.3 -43.64 7.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.3 -45.17 77.34 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.413 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 34.1 t-105 -73.93 -16.81 61.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.912 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 123' ' ' VAL . 2.4 t -147.8 68.69 10.83 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.78 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.72 -11.72 26.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.871 2.381 . . . . 0.0 111.649 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.67 -6.4 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.205 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 120' ' ' VAL . 17.4 m -138.57 35.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.479 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 72.7 t80 -153.29 -39.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.351 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.56 128.25 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.93 155.76 16.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -166.29 108.14 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.706 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 133.52 177.83 15.19 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.1 138.04 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 26.9 m -89.95 132.4 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.04 -4.14 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.97 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.19 129.11 38.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.174 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -85.0 117.44 23.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -122.32 -3.82 8.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.52 ' NE1' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 t90 -172.78 129.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -145.52 158.54 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.293 0.568 . . . . 0.0 112.019 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -122.98 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.632 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 55.38 17.28 2.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.53 53.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mt -123.91 134.28 53.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.698 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 7.0 pm0 -71.06 149.6 46.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 145' ' ' TRP . 8.2 mtt -45.83 -62.16 1.99 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.1 Cg_exo -34.57 -37.66 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -74.31 -41.15 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.625 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.5 m95 -67.06 -58.26 5.26 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.758 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.0 mt -43.98 -38.22 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -34.49 75.76 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -62.68 -48.93 77.63 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.53 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.08 -35.09 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -38.86 72.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.846 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.17 -40.04 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.019 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.42 73.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.149 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.0 -41.39 97.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.339 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.0 tt -52.24 -33.25 40.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -82.71 -38.72 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.659 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 160' ' ' VAL . 64.8 t -52.92 -40.53 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.71 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.501 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -78.07 -46.89 19.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 154' ' ' LEU . 70.5 t -52.71 -50.17 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.982 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.26 -33.99 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.023 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 156' ' ' VAL . 48.0 t -75.74 -26.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.9 t -68.87 -45.28 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.74 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.704 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.62 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.4 tt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -31.86 68.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.3 -45.07 67.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.111 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.4 mm? -50.08 -37.59 34.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.996 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.491 ' OD1' ' NE2' ' A' ' 10' ' ' GLN . 9.5 t-20 -66.89 -28.79 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.183 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -80.22 -49.43 11.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.702 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.23 -32.59 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.9 p -76.86 -38.69 53.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.504 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.491 ' NE2' ' OD1' ' A' ' 6' ' ' ASN . 41.3 mt-30 -68.01 5.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.26 141.04 15.23 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -69.13 -51.14 41.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 110.661 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.92 -45.58 5.95 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.32 90.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -62.3 -40.05 95.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.123 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.79 -31.11 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 21' ' ' THR . 5.3 mt -70.6 -28.51 64.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.68 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.66 -34.49 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.103 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.13 27.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' LEU . 13.8 t80 -53.7 -53.8 46.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.751 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 17' ' ' LEU . 36.4 p -44.59 -55.18 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.613 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' OE2' ' A' ' 26' ' ' GLU . . . -58.54 -22.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.62 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.17 -41.57 15.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -40.03 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -72.53 -35.77 68.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.772 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -70.6 -44.25 67.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.17 -58.08 4.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.622 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p -47.22 -34.14 6.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.254 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -79.09 -42.88 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.6 -16.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.794 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.443 ' O ' HG12 ' A' ' 35' ' ' VAL . 66.9 t-105 -91.68 -34.0 14.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.629 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 4.9 m-85 -62.48 -31.21 71.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.459 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 6.9 mp0 -81.02 -44.86 17.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -63.62 -17.67 63.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 36' ' ' MET . 9.8 p -109.3 -41.59 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.51 ' N ' HG13 ' A' ' 35' ' ' VAL . 8.1 tpt -85.9 4.9 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.754 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.4 mp 48.06 34.61 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 134' ' ' GLN . 20.8 mt -79.63 154.71 28.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -125.24 128.23 24.81 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.563 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.83 -179.84 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.383 2.055 . . . . 0.0 112.073 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -128.31 -170.97 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.297 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.9 p -66.26 -44.72 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' N ' HG13 ' A' ' 42' ' ' VAL . 83.8 mt -67.22 -50.43 60.79 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -50.35 -50.89 49.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.52 -41.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.96 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -57.28 -47.81 80.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.854 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.94 -43.28 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.089 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -56.46 -33.64 66.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.901 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.117 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.8 -48.68 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.084 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.4 mm? -75.0 -47.47 28.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 51' ' ' LEU . 38.9 t80 -44.01 -39.67 4.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.42 -39.82 87.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' LEU . 71.5 t -60.33 -17.47 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.368 0.604 . . . . 0.0 109.423 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 tp -83.43 -39.49 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.79 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.3 -38.94 81.98 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.81 72.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.61 -23.22 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.26 -37.09 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.852 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.69 -38.22 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.018 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -63.64 -40.57 98.75 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.52 11.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.064 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' H ' ' C ' ' A' ' 61' ' ' GLY . 90.8 mt -88.32 -25.67 5.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.25 68.76 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.697 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.65 21.01 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.609 2.206 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 26.5 tttp -112.62 -3.67 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.87 166.02 12.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -42.57 -11.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.238 1.959 . . . . 0.0 112.076 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -41.51 -38.55 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.345 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.7 mtm105 -38.66 -69.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.26 -17.1 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.042 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.6 t -83.14 -48.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.249 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 -34.49 60.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.274 0.559 . . . . 0.0 110.043 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.2 ttt -59.51 -9.56 2.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.112 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.65 -43.39 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.425 0.631 . . . . 0.0 110.423 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -88.26 -29.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.645 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.654 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.1 t-105 -65.63 -53.34 42.85 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.781 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.98 -45.36 85.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -44.19 -45.49 8.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.966 0.412 . . . . 0.0 110.357 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 p -80.3 -21.06 42.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.049 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.53 -62.28 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.921 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -73.59 -49.34 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.297 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -72.24 -43.69 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.72 -48.33 85.6 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' O ' ' OG1' ' A' ' 88' ' ' THR . 75.1 t -72.83 -50.94 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.637 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.406 ' C ' ' OE1' ' A' ' 86' ' ' GLN . 1.1 tm0? -50.11 -23.39 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.022 0.439 . . . . 0.0 109.991 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.67 -41.33 14.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.589 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 84' ' ' GLY . 23.6 p -51.87 -23.68 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -71.19 -31.02 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.492 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.44 -37.61 51.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -70.29 -58.61 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -54.69 -43.28 72.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.706 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.7 ttt -57.78 -44.77 86.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.58 -48.4 81.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.663 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -52.26 -43.04 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.1 mp -91.08 -9.77 44.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.17 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.6 t80 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -0.85 54.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.605 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' A' ' 116' ' ' LEU . 11.8 mt -121.81 81.81 41.83 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.289 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.2 Cg_exo -51.25 2.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.757 2.305 . . . . 0.0 112.635 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.8 mt -62.57 -32.74 73.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.947 0.403 . . . . 0.0 110.142 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.7 p30 -96.43 -40.59 9.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.47 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 78.1 tttt -72.1 -45.4 60.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.663 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -72.78 -15.57 61.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.128 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.54 73.39 29.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.66 -17.89 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.848 2.366 . . . . 0.0 111.886 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -52.59 -49.24 65.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.847 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.49 54.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.78 -41.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.296 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.07 129.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.48 155.05 17.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -167.34 112.08 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.594 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 129.42 -179.98 16.37 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 m-20 -81.97 137.08 35.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.225 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -90.68 132.49 35.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.82 -6.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -67.88 152.35 45.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -85.08 138.0 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.634 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.465 ' HB3' HD22 ' A' ' 38' ' ' LEU . 15.2 mt-30 -128.79 -29.43 2.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -174.92 138.96 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -133.65 163.44 29.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.48 0.657 . . . . 0.0 112.394 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.688 ' CE2' HD23 ' A' ' 138' ' ' LEU . 35.7 t80 -123.32 135.55 54.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.766 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.688 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.8 mm? 51.43 17.13 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.649 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 94.09 14.28 52.11 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.189 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 139' ' ' GLY . 4.0 mm? -119.68 139.84 51.6 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 24.4 mp0 -73.2 154.11 40.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.598 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.46 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 5.9 mtt -49.24 -63.17 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.256 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.541 ' O ' HD13 ' A' ' 147' ' ' LEU . 86.6 Cg_exo -31.72 -41.72 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.95 2.433 . . . . 0.0 112.594 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.75 -49.48 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.408 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -63.91 -57.44 9.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt -43.7 -39.57 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 143' ' ' PRO . 3.5 mp -61.89 -35.76 79.29 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.84 -41.38 91.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.6 mp -80.41 -26.77 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 154' ' ' LEU . 43.2 t80 -60.99 -48.78 80.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.533 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 tt -67.73 -39.52 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -48.76 -45.81 40.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.096 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -65.4 -44.27 88.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.007 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 150' ' ' PHE . 66.6 mt -63.33 -30.87 71.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.74 -27.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 160' ' ' VAL . 25.6 t -75.29 -29.8 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.654 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -73.67 -50.87 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.989 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 159' ' ' LEU . 19.6 m -54.27 -52.07 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.934 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 158' ' ' VAL . 5.3 mt -63.29 -36.65 84.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.623 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 156' ' ' VAL . 9.4 t -65.76 -33.91 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.7 -52.73 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 109.818 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.44 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 1.7 mp -60.69 -9.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.214 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.763 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.867 0.365 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -56.0 -39.89 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.564 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLN . 17.9 m-85 -69.72 -42.8 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.61 -40.41 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.176 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.72 -21.69 63.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.102 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' PHE . 11.5 tp60 -80.53 -47.01 14.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.541 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 -32.68 73.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.625 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.2 p -76.45 -33.66 58.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.12 10.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 110.489 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.31 142.57 15.52 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -65.05 -20.51 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.244 . . . . 0.0 110.416 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.45 -46.23 71.73 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.12 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 0.0 110.366 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -56.19 -49.43 74.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.712 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.77 -31.77 73.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.525 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.09 -27.76 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.545 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 31.9 mtt -76.76 -33.85 58.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.348 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.09 -55.2 11.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.696 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . 83.0 t80 -53.88 -54.64 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.661 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -42.72 -58.87 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.662 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -58.33 -24.51 59.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' PHE . 6.2 tp -80.26 -41.32 25.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.4 -34.32 61.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.521 HD21 HD11 ' A' ' 146' ' ' LEU . 6.1 tt -70.57 -35.04 72.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.54 -49.94 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.613 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 30' ' ' LEU . 35.8 mt -64.91 -57.37 8.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.612 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 m -44.24 -40.42 5.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.47 -27.14 46.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.36 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.4 tp -63.98 -18.76 64.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.653 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -83.32 -37.3 23.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' O ' ' CB ' ' A' ' 36' ' ' MET . 13.7 m-85 -62.75 -36.65 83.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -79.46 -47.02 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.919 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 57.9 t-80 -62.6 -15.88 53.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.35 -46.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.439 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tpt -87.71 9.92 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.065 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.7 mp 43.26 48.58 5.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.33 146.5 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.377 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -115.47 84.18 11.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.246 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.78 172.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.531 2.154 . . . . 0.0 112.235 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.69 171.59 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.569 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 61.8 t -47.59 -42.99 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.313 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 43' ' ' LEU . 8.9 mp -75.05 -40.66 60.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.572 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.4 t -55.74 -49.77 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.007 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 124' ' ' PHE . 13.0 pt -66.16 -37.02 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.451 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.26 -45.82 92.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.936 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.95 -39.87 79.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.88 -31.22 70.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.28 76.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.305 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.76 -48.58 81.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.26 -51.58 11.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -45.12 -37.74 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.79 84.38 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 78.1 t -65.81 -47.1 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.934 0.397 . . . . 0.0 110.025 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.72 -48.51 10.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.474 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.57 97.95 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -50.85 -44.38 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.695 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.41 64.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tp -76.64 -37.75 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -81.76 -31.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.686 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.71 -30.46 66.18 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.66 5.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.56 0.219 . . . . 0.0 111.149 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -85.52 -25.59 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.624 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.22 74.91 0.27 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 73.6 Cg_endo -79.38 16.81 1.33 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.728 2.286 . . . . 0.0 112.242 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -113.76 -3.86 13.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.39 162.18 22.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.691 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.69 -16.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.038 . . . . 0.0 111.792 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 tp -42.95 -33.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.362 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.69 -67.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -55.86 -21.82 22.03 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.69 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' LEU . 10.5 t -76.99 -43.34 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.584 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.26 62.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.19 -10.42 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.267 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.09 -43.42 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.349 0.595 . . . . 0.0 110.144 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -86.96 -32.59 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.818 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -61.49 -55.57 29.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.051 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.14 -47.19 80.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -44.38 -45.3 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.311 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -79.24 -22.88 44.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.78 -59.43 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.991 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.02 -53.49 9.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -66.66 -46.02 77.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.08 -47.84 84.3 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 88' ' ' THR . 78.8 t -68.47 -50.32 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -48.63 -26.12 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.97 -38.76 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 68.8 p -55.49 -29.56 59.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.765 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.15 -41.82 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.721 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.12 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -43.04 40.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.651 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.4 p -72.14 -43.6 64.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 22.4 ttp -54.49 -51.11 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.705 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -49.32 75.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.425 ' NE2' ' CD ' ' A' ' 141' ' ' GLU . 26.8 tt0 -55.71 -44.72 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.37 -22.55 35.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.754 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 12.3 t80 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.34 11.68 35.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.75 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.7 tp -123.13 61.16 17.64 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.13 11.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.6 2.2 . . . . 0.0 112.038 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -77.72 -29.96 51.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 109.655 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 4.3 p-10 -96.05 -42.34 8.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.266 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 118' ' ' LYS . 20.4 mtpt -60.38 -38.09 82.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -83.4 -12.59 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.583 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.3 76.52 18.61 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.889 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 125' ' ' VAL . 73.0 Cg_endo -79.51 -19.39 10.19 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 111.909 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -68.63 -3.88 13.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.336 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 124' ' ' PHE . 2.4 t -145.22 37.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 123' ' ' VAL . 16.9 m-85 -153.56 -40.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.534 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 121' ' ' PRO . 16.4 m -62.0 131.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.564 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.3 146.9 23.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 t -159.64 100.11 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.7 -171.43 23.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -96.96 151.8 19.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.27 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.1 m -103.79 129.81 51.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.58 -7.63 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -67.83 156.91 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.514 ' H ' ' CD ' ' A' ' 132' ' ' GLU . 29.8 mtp85 -97.11 126.51 42.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.807 0.337 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -120.2 -29.84 4.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -174.1 141.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.45 161.11 39.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.193 0.52 . . . . 0.0 111.83 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.0 139.8 49.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.144 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.5 16.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.42 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.3 23.02 32.99 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.887 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.414 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 10.2 mt -127.67 139.61 52.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.425 ' CD ' ' NE2' ' A' ' 95' ' ' GLN . 9.9 mt-10 -68.45 145.01 54.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.441 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.9 mtt -47.29 -53.75 26.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.45 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 142' ' ' MET . 82.5 Cg_exo -41.55 -36.64 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.356 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -52.96 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 109.9 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 77.9 m95 -56.88 -56.82 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.908 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 25' ' ' LEU . 4.0 mm? -42.9 -36.13 1.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -61.67 -37.03 82.56 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.488 0.661 . . . . 0.0 109.325 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.35 -45.97 94.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.736 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -74.38 -30.45 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.43 -45.14 92.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.64 -43.74 98.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.282 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.26 -47.52 62.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.42 -41.38 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 154' ' ' LEU . 4.5 tt -55.31 -34.52 64.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.138 0.494 . . . . 0.0 110.318 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.69 -45.04 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 160' ' ' VAL . 84.4 t -48.99 -32.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.868 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.5 -42.92 58.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.53 -33.81 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.72 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.1 mm? -85.07 -36.32 21.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.743 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 156' ' ' VAL . 7.1 p -76.63 -23.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.375 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 157' ' ' ALA . 70.1 t -81.95 -51.64 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 162' ' ' ILE . 38.9 mm -71.86 -11.84 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.394 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 179.745 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.6 mp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.932 0.396 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -50.94 -42.51 59.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.385 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.5 -39.93 95.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -52.37 -38.58 59.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.122 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -66.25 -31.28 72.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.491 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 31.5 mm-40 -74.85 -48.23 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -67.13 -29.66 69.45 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.483 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 95.8 p -75.92 -42.41 48.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -71.52 10.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.156 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.62 145.6 16.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -63.13 -19.91 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.745 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.94 -47.68 64.65 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.88 -51.36 67.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -52.72 -49.73 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.86 -29.31 68.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.569 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 21' ' ' THR . 61.6 tp -69.18 -31.38 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.9 mtt -74.37 -34.02 63.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.62 -53.45 41.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.486 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.85 -54.13 49.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.756 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.9 p -41.17 -56.41 2.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.36 65.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.483 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.97 -40.28 78.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.86 -43.12 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.585 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -70.59 -31.94 69.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.6 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.03 -43.27 71.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 8.3 tp -72.81 -57.87 3.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.613 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' ALA . 36.0 p -44.81 -37.72 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.151 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.12 -31.83 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.115 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.5 tp -59.13 -18.68 37.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -87.97 -27.54 22.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.351 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' MET . 4.6 m-85 -69.67 -50.93 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.7 -12.29 61.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -79.22 -34.97 42.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.293 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.48 -16.56 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.6 tpp -99.51 -9.39 23.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.39 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 45.68 49.11 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.27 143.98 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.441 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -105.49 130.8 22.47 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.169 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.0 167.58 25.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.302 2.002 . . . . 0.0 112.341 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.83 166.4 21.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.36 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 86.4 t -53.52 -48.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 43' ' ' LEU . 8.7 mp -70.1 -47.34 62.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.462 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 23.3 t -52.73 -51.11 61.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.067 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.07 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.336 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -43.37 71.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -62.29 -39.25 92.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -59.68 -38.6 81.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.72 -34.15 76.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.02 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -61.65 -43.81 98.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.544 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.49 -53.07 7.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -45.96 -43.33 13.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.0 -44.15 89.41 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' ALA . 40.7 t -63.35 -46.98 94.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -44.78 -48.3 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.638 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.98 -48.03 88.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -30.46 12.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.257 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.73 66.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.78 -42.59 85.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.52 -35.64 75.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.21 -22.99 78.64 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 1.27 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.3 mt -83.89 -36.88 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.683 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.1 73.11 0.23 Allowed Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.036 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.07 22.7 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.709 2.273 . . . . 0.0 111.72 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -108.32 -12.57 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.159 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -107.41 161.28 23.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.715 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.34 -15.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.564 2.176 . . . . 0.0 112.203 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 mt -46.25 -27.41 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 69' ' ' LEU . 45.7 mtm180 -38.81 -62.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 75' ' ' VAL . 28.9 t80 -52.87 -37.66 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.192 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 69' ' ' LEU . 17.8 t -60.93 -43.56 96.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.57 -35.8 57.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.195 0.522 . . . . 0.0 110.067 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.1 mtp -59.37 -17.86 33.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.492 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 71.5 t -52.37 -41.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.408 0.623 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 mm -88.1 -31.52 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.767 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.8 t-105 -66.65 -54.75 19.98 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.9 tp -64.19 -49.07 73.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.769 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -42.84 -42.24 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -78.57 -21.66 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.59 -62.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.692 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -72.9 -53.47 11.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.426 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -69.45 -45.41 69.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.75 86.99 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.1 -49.81 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.348 . . . . 0.0 110.499 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -50.76 -24.78 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.428 HD12 ' OE2' ' A' ' 90' ' ' GLU . 56.9 tp -79.83 -38.34 33.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.26 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.3 p -56.06 -29.95 61.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.13 -42.06 85.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.648 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE2' HD12 ' A' ' 87' ' ' LEU . 37.3 mt-10 -58.8 -39.43 81.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.366 . . . . 0.0 110.611 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.51 -44.1 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.2 p -69.26 -50.6 45.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 mmt -46.31 -47.58 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -47.19 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.47 -34.7 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.3 mt -100.87 -12.09 19.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.615 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.725 0.298 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -125.47 27.27 6.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 tp -118.42 61.16 4.39 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.69 6.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.698 2.265 . . . . 0.0 112.685 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -78.5 -25.47 45.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.392 0.615 . . . . 0.0 109.863 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -96.22 -42.79 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.914 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.47 -44.68 95.8 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.048 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 36.4 m0 -78.23 -15.61 58.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.16 77.09 10.99 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.65 -14.89 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -74.52 -3.61 31.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 124' ' ' PHE . 9.8 p -136.07 32.61 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.225 0.536 . . . . 0.0 110.768 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.478 ' CD2' HG13 ' A' ' 123' ' ' VAL . 19.5 m-85 -155.45 -44.58 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.38 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.18 129.39 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.05 153.49 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.565 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t -167.28 99.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.85 -165.02 26.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.9 148.39 22.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.246 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.4 m -101.72 132.0 47.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.962 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.2 -2.95 0.5 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.896 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.13 129.42 39.85 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.139 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.88 130.06 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -16.94 5.42 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.507 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -172.84 138.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -145.74 160.93 41.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.179 0.514 . . . . 0.0 112.0 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -121.98 138.48 54.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.063 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.3 17.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.15 22.1 53.1 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.2 mp -122.49 133.58 54.59 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.27 146.0 53.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.8 mtt -45.78 -54.11 17.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 142' ' ' MET . 89.1 Cg_exo -41.86 -35.47 2.98 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.4 2.066 . . . . 0.0 112.16 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -71.57 -52.11 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.952 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.4 m95 -59.92 -57.24 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.106 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -44.18 -36.97 2.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -61.94 -33.02 73.51 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.13 -50.78 58.17 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.315 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.5 mt -69.83 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.024 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.514 ' CE2' HD11 ' A' ' 154' ' ' LEU . 33.9 t80 -63.54 -42.9 98.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.145 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 155' ' ' ILE . 1.7 tp -69.95 -31.64 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.262 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.17 70.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.74 -51.21 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.675 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.514 HD11 ' CE2' ' A' ' 150' ' ' PHE . 33.7 mt -56.22 -31.59 63.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.635 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.1 mp -76.78 -35.84 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.073 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 160' ' ' VAL . 46.9 t -61.87 -36.88 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -68.56 -43.3 76.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.59 -24.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.928 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.445 ' O ' ' OG ' ' A' ' 163' ' ' SER . 44.5 tp -80.76 -43.76 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 156' ' ' VAL . 27.7 m -73.37 -34.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.29 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 157' ' ' ALA . 74.8 t -68.36 -48.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -22.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 21.3 m . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.973 0.416 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -51.12 -34.53 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -69.36 -44.39 71.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.2 tp -47.8 -38.7 16.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -67.43 -26.16 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.48 -47.02 14.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.791 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.36 -38.74 90.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -76.67 -32.39 57.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.495 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 8.2 tt0 -71.38 5.62 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.008 0.432 . . . . 0.0 110.576 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.2 148.34 18.71 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -70.01 -20.79 63.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 17' ' ' LEU . . . -69.91 -45.74 55.93 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.95 -50.49 73.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.74 0.305 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -56.4 -44.79 80.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.487 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.63 -30.43 71.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.306 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 13' ' ' GLY . 3.6 mp -70.21 -26.94 64.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.686 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.469 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -76.87 -34.27 57.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -56.55 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -52.81 -51.12 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.692 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.0 p -45.3 -60.91 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.564 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -33.37 61.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.463 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.58 -41.44 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.91 -33.18 61.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.216 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.21 -32.69 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.252 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.41 -45.37 55.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.46 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.2 tt -65.06 -52.06 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.332 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 17.4 m -56.06 -30.77 62.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -33.36 38.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.884 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -17.22 64.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . 65.5 t90 -91.03 -34.63 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' MET . 27.3 t80 -60.5 -39.07 86.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.07 -40.3 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.594 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.52 -22.66 65.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 36' ' ' MET . 9.7 p -109.3 -42.83 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.493 ' N ' HG13 ' A' ' 35' ' ' VAL . 6.7 tpt -84.82 5.91 26.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.684 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt 42.99 44.67 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.976 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -63.11 147.05 51.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.976 ' N ' HD23 ' A' ' 38' ' ' LEU . 81.8 mttt -113.13 90.83 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.225 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.11 172.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.45 2.1 . . . . 0.0 112.415 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.96 168.98 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.943 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 91.6 t -53.94 -51.33 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 43' ' ' LEU . 9.9 mp -66.15 -50.0 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 41' ' ' CYS . 14.8 m -50.57 -49.86 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.752 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.37 -42.45 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -47.5 75.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 88' ' ' THR . 3.1 tp10 -57.78 -40.19 79.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -58.12 -33.96 69.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.38 84.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.443 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.38 73.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.4 tp -73.06 -53.28 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -42.86 -41.25 3.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.89 -40.38 95.42 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 55.4 t -61.11 -47.66 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.223 0.535 . . . . 0.0 109.559 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -45.5 -47.12 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.491 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.64 -28.26 69.55 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.39 -34.96 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.61 -34.14 75.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.237 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.39 -32.39 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.218 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -77.59 -42.65 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.342 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -23.79 75.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.6 4.73 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.625 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.9 mt -84.9 -34.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.738 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.55 73.63 0.11 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.54 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.51 12.37 2.9 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.891 2.394 . . . . 0.0 111.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -96.93 -10.01 27.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.61 161.29 28.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.692 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -38.14 -19.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.519 2.146 . . . . 0.0 112.197 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' THR . 8.3 mp -43.7 -30.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.24 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttm180 -38.14 -51.7 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -55.21 -35.78 65.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.503 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.7 t -61.96 -58.45 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.152 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.73 79.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.366 0.603 . . . . 0.0 109.774 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -8.88 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 72' ' ' VAL . 53.4 t -60.58 -43.86 95.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.529 0.68 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.8 mt -87.98 -29.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.894 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.1 t-105 -65.0 -52.33 56.72 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.772 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.8 tp -64.85 -48.56 73.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.586 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -43.69 -42.79 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.888 0.375 . . . . 0.0 110.356 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -23.09 36.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.87 -61.7 2.42 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.912 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE2' ' OE1' ' A' ' 86' ' ' GLN . 70.4 t80 -75.43 -46.96 29.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.397 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -72.11 -41.01 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.78 -48.19 87.48 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 81' ' ' ALA . 16.5 m -71.46 -45.83 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.545 ' N ' HG23 ' A' ' 85' ' ' VAL . 56.4 tt0 -52.24 -27.5 15.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.401 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 87' ' ' LEU . 1.2 tt -82.74 -44.19 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.37 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 84' ' ' GLY . 48.4 p -49.5 -25.29 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.82 -45.18 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.75 -45.7 85.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.739 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.22 -40.91 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.0 p -71.57 -41.95 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.585 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -47.12 -47.71 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.326 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.65 -47.22 82.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -51.47 -40.23 59.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.71 -12.49 27.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.551 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 93' ' ' MET . 30.9 t80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.745 0.307 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.64 -5.62 19.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 18.6 mt -120.05 83.3 30.69 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.8 Cg_exo -54.4 4.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 112.052 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -66.01 -30.23 70.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.084 0.468 . . . . 0.0 110.321 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.19 -42.19 7.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -73.63 -45.23 54.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -73.27 -15.58 61.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.375 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.29 72.25 32.37 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.9 -16.87 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.91 2.407 . . . . 0.0 112.042 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 -19.14 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.878 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.33 39.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.464 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.29 -42.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.069 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.06 128.09 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.41 156.24 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.6 t -168.29 99.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.19 -172.3 23.53 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.61 150.9 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.5 m -102.26 132.29 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.027 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.44 -3.52 0.29 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -69.32 150.06 47.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.253 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -86.38 113.16 22.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -106.61 -16.31 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.536 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 135' ' ' TRP . 13.7 t90 -173.92 119.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.4 t70 -109.08 151.64 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.205 0.526 . . . . 0.0 112.034 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 8.2 t80 -153.7 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.901 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 50.9 mt 79.06 17.87 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.45 7.04 88.77 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 mt -120.63 150.65 40.59 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 44.1 mm-40 -77.36 161.07 28.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.331 0.586 . . . . 0.0 111.3 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.505 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 4.3 ttt -44.09 -58.66 4.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.425 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 142' ' ' MET . 6.8 Cg_endo -49.33 -20.45 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.298 1.999 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 141' ' ' GLU . 10.9 mm100 -75.45 -58.11 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.811 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -64.35 -53.4 49.21 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.983 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 tt -43.42 -45.83 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 88' ' ' THR . 29.2 tp -52.85 -37.62 60.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.22 -40.19 83.6 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.544 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -77.3 -35.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.682 0.277 . . . . 0.0 110.302 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.29 69.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.09 -39.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.161 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.6 -48.99 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.37 -45.68 93.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.682 HD23 ' C ' ' A' ' 154' ' ' LEU . 7.8 tt -54.7 -31.11 57.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.411 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.69 -26.88 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.25 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 58.0 t -74.3 -32.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.388 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.521 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -51.41 8.73 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.534 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 154' ' ' LEU . 27.7 m -56.68 -40.41 69.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.355 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -77.21 -35.13 55.91 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.378 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.8 t -76.87 -22.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.057 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 157' ' ' ALA . 30.8 t -77.15 -46.66 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.342 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.99 -19.62 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 ttm105 -55.7 -41.06 73.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.31 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.35 -44.77 95.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.406 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -49.36 -41.07 37.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 19.2 t30 -67.0 -29.72 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.16 -49.64 14.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.69 71.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.5 m -76.52 -42.32 43.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.451 ' NE2' HH21 ' A' ' 70' ' ' ARG . 1.1 mp0 -67.61 5.69 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.37 141.07 15.24 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -69.07 -50.32 49.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.593 0.235 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -46.31 6.18 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.7 89.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.114 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -59.81 -38.99 83.49 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.78 -30.15 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.949 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.95 -27.83 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.4 mtt -75.88 -33.92 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.77 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 4.3 m-85 -57.58 -50.15 74.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.558 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.0 m -42.87 -60.27 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.16 -25.94 48.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -78.94 -40.62 31.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.41 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -70.58 -35.21 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.593 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.41 -49.6 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.531 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.02 -57.88 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.626 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -46.33 -37.88 8.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -55.36 -17.32 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.716 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -95.56 -36.46 11.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.927 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CZ ' ' CZ2' ' A' ' 135' ' ' TRP . 2.5 m-85 -54.46 -46.14 73.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.733 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -40.74 76.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -60.03 -20.05 55.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.33 -35.32 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 31.7 mtt -87.72 3.49 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt 50.66 49.81 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.692 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.38 155.76 18.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 140.91 40.0 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.266 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.52 177.47 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.52 2.147 . . . . 0.0 112.091 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -131.75 -166.41 1.72 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.632 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 35.8 t -65.55 -51.3 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.833 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 10.6 mp -65.95 -50.1 65.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -48.59 -45.2 37.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.21 -38.16 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.094 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.9 -48.06 82.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.958 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -61.28 -38.1 85.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -58.96 -40.1 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.24 83.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.4 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.78 -52.45 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.198 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.46 -39.63 7.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.77 -43.84 90.78 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 57' ' ' ALA . 34.8 t -62.7 -47.36 93.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.166 0.507 . . . . 0.0 109.748 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.53 -45.87 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.603 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -30.05 76.64 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.73 -40.06 91.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.71 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.01 -25.22 60.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 3.3 mm? -79.47 -37.75 36.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -79.94 -35.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -22.99 72.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.94 6.65 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 110.74 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -80.24 -31.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.426 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.7 77.14 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.633 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.87 26.88 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.661 2.241 . . . . 0.0 111.947 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -106.84 -9.77 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.059 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.29 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.464 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.4 -5.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.089 1.859 . . . . 0.0 111.773 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.55 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 tt -44.44 -37.66 3.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.451 HH21 ' NE2' ' A' ' 10' ' ' GLN . 59.7 mtt180 -40.78 -70.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.666 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' HG23 ' A' ' 75' ' ' VAL . 47.4 t80 -51.03 -31.54 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.133 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.61 -46.95 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.84 -33.87 52.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.235 0.54 . . . . 0.0 110.109 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.16 -17.35 40.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.539 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 71' ' ' TYR . 69.2 t -53.41 -40.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.425 0.631 . . . . 0.0 110.38 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.87 -33.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.524 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 10.7 t-105 -61.79 -55.88 25.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.48 -48.49 77.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -45.86 -45.71 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.259 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -76.84 -25.3 53.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.387 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 154' ' ' LEU . . . -60.68 -59.07 5.98 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.01 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.37 -54.33 8.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.174 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -66.14 -45.36 81.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.67 -47.23 89.93 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 81' ' ' ALA . 89.3 t -68.74 -52.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.393 . . . . 0.0 110.578 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -51.16 -25.14 4.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.06 -40.91 17.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.548 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 84' ' ' GLY . 42.1 p -54.11 -24.99 19.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -73.47 -48.16 35.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -51.19 -32.76 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.426 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 12.5 t-80 -73.38 -45.23 56.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.671 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -45.86 70.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' TYR . 32.9 ttp -51.36 -49.77 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -49.82 54.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.455 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 5.4 tt0 -52.36 -48.81 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.25 -19.5 26.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.023 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.74 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.65 0.262 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 9.6 p-90 -124.56 -5.13 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.5 tp -119.69 80.49 23.98 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.48 -5.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.688 2.259 . . . . 0.0 112.556 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.1 mt -57.89 -28.97 64.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.473 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 12.6 t0 -96.53 -39.39 9.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.598 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HZ2' ' HD1' ' A' ' 119' ' ' TRP . 6.0 ttpp -68.61 -45.28 72.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.473 ' HD1' ' HZ2' ' A' ' 118' ' ' LYS . 41.5 m0 -77.74 -18.55 56.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.86 76.43 17.18 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 -17.68 9.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.742 2.294 . . . . 0.0 111.654 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -52.41 -50.84 61.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.865 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.81 55.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.473 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -157.59 -44.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.0 p -56.11 130.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.61 146.55 24.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.801 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -159.04 99.81 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.14 -171.56 22.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.97 160.38 14.3 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.66 0.267 . . . . 0.0 110.363 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.658 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 85.4 m -108.11 134.95 50.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.38 -9.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.736 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.72 129.23 39.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.9 ptt85 -65.84 129.18 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -124.17 -29.45 3.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.435 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.551 ' CZ2' ' CZ ' ' A' ' 32' ' ' PHE . 5.4 t90 -173.74 137.82 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.779 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -142.21 160.44 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 112.135 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 138' ' ' LEU . 89.8 t80 -118.98 138.41 52.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.046 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.603 HD23 ' CE2' ' A' ' 137' ' ' PHE . 0.7 OUTLIER 51.68 17.35 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.155 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 87.78 22.87 40.99 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 139' ' ' GLY . 5.7 mp -123.81 135.88 54.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.455 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 8.9 mt-10 -68.74 146.36 53.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.598 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtp -48.75 -52.41 45.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.63 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 142' ' ' MET . 81.1 Cg_exo -44.46 -37.07 10.43 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.049 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.92 -49.33 46.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.98 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.571 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.1 m95 -59.54 -56.77 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.244 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -44.07 -39.35 4.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.2 tt -57.9 -37.24 73.64 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.33 -43.34 97.4 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.731 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.6 mt -69.61 -26.7 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.8 0.333 . . . . 0.0 110.408 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -42.89 94.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.976 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER -60.64 -47.98 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.045 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.3 -50.57 73.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.78 -44.38 96.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.739 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -61.33 -30.02 70.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.157 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.705 ' N ' HD23 ' A' ' 154' ' ' LEU . 4.1 mt -73.55 -39.45 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 160' ' ' VAL . 78.1 t -59.08 -38.2 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.1 -43.49 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.403 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 154' ' ' LEU . 91.1 t -58.97 -37.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.398 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.67 -25.02 38.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.792 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.0 t -78.33 -25.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.526 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 162' ' ' ILE . 5.9 p -82.97 -45.08 19.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.347 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.43 ' N ' HG13 ' A' ' 161' ' ' VAL . 35.3 mm -65.39 -28.57 44.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 13.3 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.518 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.5 mm? . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -51.1 -33.99 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.09 -40.69 64.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -49.3 -45.17 44.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -67.06 -24.21 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.025 0.441 . . . . 0.0 110.066 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -78.69 -47.39 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -32.23 73.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.5 m -76.1 -37.79 57.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.236 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -72.11 11.95 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.245 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.14 141.46 15.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.84 -50.57 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.22 5.72 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -61.05 -46.29 91.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.307 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -61.83 -34.04 75.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.19 -30.92 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.017 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 21' ' ' THR . 56.3 mt -70.84 -28.52 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.646 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.47 -34.76 60.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.79 -54.8 16.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.723 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -54.51 -51.64 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.615 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.3 p -43.22 -56.01 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.7 56.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -77.56 -39.58 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.539 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.02 -44.5 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.621 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp -71.54 -32.08 67.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.458 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.57 -48.51 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.5 tt -68.1 -58.09 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 110.527 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -46.03 -33.68 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.78 -32.02 27.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.393 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -62.43 -16.02 52.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.636 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -91.41 -38.74 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 36' ' ' MET . 5.1 m-85 -56.08 -45.62 79.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.442 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -73.24 -36.77 66.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.554 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -56.65 -35.62 68.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.547 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.05 -50.82 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.8 tpp -69.91 0.64 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 42.25 45.5 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 110.115 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.83 149.29 47.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.896 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.87 83.46 18.65 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.77 154.38 1.98 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 112.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 4.7 t -106.52 -171.68 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.406 HG22 ' CB ' ' A' ' 126' ' ' ALA . 47.1 t -66.53 -50.5 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.652 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 43' ' ' LEU . 10.4 mp -58.39 -40.79 83.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.097 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -53.85 -42.51 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 124' ' ' PHE . 79.2 mt -64.41 -46.53 92.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.65 -48.62 72.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -64.56 -36.02 82.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.74 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -68.92 -39.26 79.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.499 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.18 88.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.15 -48.28 73.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -48.98 22.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.12 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.73 -43.21 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 109.811 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.93 97.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 53.6 t -59.46 -47.26 91.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.782 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 55' ' ' LEU . 4.8 tt -45.56 -46.5 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.371 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.01 -27.69 70.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.96 -33.45 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.72 71.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.68 -35.3 80.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.0 -37.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.41 -16.62 71.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.82 2.04 32.0 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.015 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -84.05 -38.85 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.99 78.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.614 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.62 20.5 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.718 2.279 . . . . 0.0 112.164 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -107.56 -7.07 16.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.34 165.01 13.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.49 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -39.64 -14.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.45 2.1 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 67' ' ' THR . 75.0 mt -44.64 -32.0 1.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 69' ' ' LEU . 41.2 mtm180 -40.03 -63.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -57.27 -22.36 40.95 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.122 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.5 t -76.17 -44.27 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.993 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.84 59.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.518 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -57.5 -14.05 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.799 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.68 -44.99 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.44 0.638 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -88.19 -28.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.838 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -64.66 -53.65 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.209 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.73 -45.3 71.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -45.47 -46.16 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.592 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -77.82 -23.38 49.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' CB ' HD13 ' A' ' 154' ' ' LEU . . . -59.93 -60.01 4.52 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.279 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.47 -52.02 13.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -67.26 -41.69 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.891 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.94 -46.12 92.31 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.7 t -75.18 -56.87 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.19 -27.57 1.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.838 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.43 -35.32 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.988 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 84' ' ' GLY . 29.4 p -56.7 -51.38 69.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.139 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -33.87 3.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.196 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.79 -40.15 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.922 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 88' ' ' THR . 1.6 t60 -66.99 -40.7 87.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.426 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.4 p -73.32 -51.82 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.875 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.8 ttt -43.75 -43.03 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.49 -40.08 77.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -66.95 -46.38 74.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.915 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.03 -28.97 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.41 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.954 0.407 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.671 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -114.73 7.27 15.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.598 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.0 tp -120.68 83.63 35.79 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.948 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -52.69 6.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.777 2.318 . . . . 0.0 112.699 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -66.39 -31.09 71.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 109.942 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 1.1 m-20 -96.73 -41.17 8.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.365 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -70.37 -44.14 68.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.752 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.452 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.7 t90 -76.63 -14.81 59.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.59 69.36 13.63 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.743 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 -11.2 17.43 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.765 2.31 . . . . 0.0 112.068 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.503 ' CD ' ' H ' ' A' ' 122' ' ' GLN . 25.1 mp0 -59.66 -54.21 49.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 123' ' ' VAL . 31.0 m -99.11 50.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 111.103 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -156.32 -38.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.176 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 125' ' ' VAL . 14.4 p -56.16 124.24 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -92.75 157.6 16.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.756 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.1 t -162.96 144.6 10.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.239 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.4 23.25 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 4.4 p30 -103.65 168.91 8.84 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -115.02 135.34 54.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.797 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.95 -0.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -67.98 152.06 46.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.566 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -89.34 137.33 32.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.43 -30.37 2.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.02 139.78 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.05 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -140.0 167.83 21.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.521 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.8 t80 -143.59 120.14 11.06 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.6 tp 78.39 16.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 12.84 76.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 mt -119.99 135.24 54.99 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.842 0.354 . . . . 0.0 110.195 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -72.89 154.25 40.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.409 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -48.24 -61.73 2.87 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.614 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.554 ' O ' HD23 ' A' ' 147' ' ' LEU . 95.3 Cg_exo -34.09 -39.18 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.71 2.273 . . . . 0.0 112.506 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -72.43 -49.2 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.598 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.9 m95 -60.46 -57.67 11.77 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.022 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.4 tp -43.35 -40.54 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.219 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.6 mm? -59.08 -34.09 71.58 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.88 -44.62 95.92 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.5 mt -76.14 -36.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.347 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.75 -47.2 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.97 -41.71 90.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.585 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -49.29 -46.3 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.409 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -64.87 -44.66 88.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.573 HD13 ' CB ' ' A' ' 81' ' ' ALA . 6.0 tp -49.34 -46.81 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.036 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.46 -45.3 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.264 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.1 t -49.8 -36.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 111.022 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.536 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -76.56 -31.73 57.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.38 -46.36 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 0.0 110.989 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 159' ' ' LEU . 10.1 mp -77.4 -28.18 52.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' VAL . 46.3 t -78.17 -35.2 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.918 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 162' ' ' ILE . 6.4 p -73.62 -46.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.201 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.516 ' N ' HG13 ' A' ' 161' ' ' VAL . 5.6 pt -71.99 -24.89 23.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.058 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.368 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.855 0.36 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -55.73 -36.19 66.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.38 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 7' ' ' GLN . 1.4 t80 -68.64 -46.27 69.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.181 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.15 -40.77 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.11 -22.85 63.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.351 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' PHE . 14.1 tm0? -81.07 -46.95 14.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.713 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.74 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLY . 52.2 p -76.2 -30.93 58.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -75.92 12.14 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.333 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.44 144.46 16.27 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -19.07 63.49 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.386 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.07 -46.41 65.93 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -51.27 68.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -56.53 -40.12 74.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.779 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.2 -32.6 63.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 21' ' ' THR . 9.1 mt -68.89 -30.75 69.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.531 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.25 -34.29 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.88 -56.67 7.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.446 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.77 -53.35 49.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.2 p -42.96 -56.64 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.04 -33.71 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.452 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.04 -40.38 68.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.69 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.4 mp -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.485 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -72.39 -43.88 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.681 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.42 -57.78 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.512 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.2 p -47.37 -36.99 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.68 -35.35 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -61.26 -18.0 56.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.358 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -94.75 -34.02 12.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -55.48 -48.87 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -75.18 -20.82 59.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.446 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -68.88 -28.99 67.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.56 -31.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 mtt -84.48 0.52 49.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.729 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.7 mt 48.86 48.65 20.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.898 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.3 mt -97.51 156.5 16.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.308 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -119.72 148.54 46.41 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.252 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.47 175.02 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.44 2.094 . . . . 0.0 112.179 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -128.91 175.36 8.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.5 t -61.5 -54.73 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.757 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.495 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 7.9 mt -67.2 -46.67 73.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -48.7 -46.12 40.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.516 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.44 -43.7 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.94 -45.55 74.86 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.51 -30.9 71.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.037 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -63.33 -37.94 89.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.969 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.99 -33.16 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.11 77.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.2 tt -77.28 -56.06 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.033 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -43.36 -38.25 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.48 -41.0 91.11 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 14.8 t -65.92 -43.26 92.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 109.73 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -47.6 -47.54 28.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.721 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.95 -34.38 89.77 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -59.18 -44.72 92.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.091 -0.554 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.25 75.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.377 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.11 -36.23 77.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.631 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.95 -33.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.52 -12.51 83.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.74 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 111.043 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -91.52 -24.11 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.89 73.27 0.11 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.6 22.6 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.911 2.407 . . . . 0.0 112.371 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -115.65 -4.64 12.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -110.46 161.29 25.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.848 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -37.07 -19.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.683 2.256 . . . . 0.0 112.196 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.0 mm? -44.67 -29.03 0.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -40.59 -67.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.679 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -53.6 -34.7 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.289 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.7 t -63.67 -57.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.362 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.29 80.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.0 ttt -64.88 -13.68 57.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.9 p -60.44 -35.11 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.292 0.567 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -88.67 -32.46 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.032 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.578 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.0 t-105 -59.59 -51.92 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.84 -43.06 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.624 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -47.44 -47.31 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 p -78.52 -23.64 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.03 -58.09 10.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.205 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.9 -53.86 9.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.974 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -66.1 -45.53 80.85 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.48 -47.28 91.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.9 t -65.0 -39.36 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.52 -31.36 69.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -78.03 -45.7 22.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.346 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 84' ' ' GLY . 63.1 p -49.13 -31.46 8.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -42.47 79.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.291 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -60.67 -31.65 70.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -75.94 -46.68 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.56 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -66.44 -49.39 66.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.2 mmt -50.35 -49.71 53.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.541 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 24.0 tt0 -51.18 -39.36 56.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.68 -11.97 22.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.739 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.1 t80 . . . . . 0 CA--C 1.532 0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.565 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.674 0.273 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -125.56 -5.77 7.02 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.608 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.6 mt -115.57 87.64 17.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.44 6.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.696 2.264 . . . . 0.0 112.73 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tp -73.74 -26.36 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -96.38 -36.97 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.844 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.04 -41.44 67.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -75.59 -20.78 58.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.913 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 116' ' ' LEU . 3.3 p -165.13 84.93 1.08 Allowed Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.607 ' O ' HG22 ' A' ' 125' ' ' VAL . 65.9 Cg_endo -80.74 -2.52 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.784 2.323 . . . . 0.0 111.816 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -60.12 -54.32 47.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.6 p -97.49 59.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.628 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -165.67 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 121' ' ' PRO . 21.6 m -57.52 128.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.8 153.94 17.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.837 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 t -170.15 99.96 0.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.473 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.12 -167.6 26.35 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' O ' ' OE2' ' A' ' 132' ' ' GLU . 4.0 m-20 -99.84 146.22 26.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.698 0.285 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 62.7 m -98.77 136.72 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.991 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 91.44 -3.62 0.21 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.872 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' OE2' ' O ' ' A' ' 129' ' ' ASP . 12.3 pt-20 -67.74 153.23 44.16 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.309 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -88.4 138.81 31.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.26 -31.04 2.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.648 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -171.94 136.22 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.265 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.3 t70 -119.61 158.35 26.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 111.943 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.548 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 83.2 t80 -144.82 111.16 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.95 17.38 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 136' ' ' ASP . . . 84.76 9.22 81.48 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 6.4 mt -115.49 133.95 55.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.128 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.541 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 5.2 mt-10 -70.46 154.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.443 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -54.17 -51.0 81.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.995 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 142' ' ' MET . 69.5 Cg_exo -47.11 -40.13 26.47 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.383 2.055 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.2 -38.73 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 148' ' ' GLY . 32.6 m95 -67.11 -56.56 9.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.271 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 tp -43.06 -42.95 4.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.705 HD13 ' C ' ' A' ' 147' ' ' LEU . 2.6 tm? -59.7 -37.07 77.83 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.31 -40.92 92.66 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.924 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 149' ' ' ILE . 2.3 mp -70.59 -25.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.682 0.277 . . . . 0.0 110.357 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -42.75 92.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.084 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.6 mm -63.0 -43.68 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.024 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -63.25 -51.78 64.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.456 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.6 m-85 -56.2 -37.28 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 158' ' ' VAL . 33.7 tp -66.34 -30.22 70.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.412 . . . . 0.0 110.6 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.9 -39.99 59.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.06 -34.52 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.026 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.05 -31.03 58.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.16 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 154' ' ' LEU . 24.2 t -64.24 -42.89 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.413 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.99 -24.05 38.29 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.205 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 156' ' ' VAL . 6.0 t -65.1 -39.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.344 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.2 p -81.02 -50.15 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.577 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 161' ' ' VAL . 36.8 mm -63.65 -8.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.289 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.592 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.8 mp . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.826 0.346 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -50.95 -46.39 61.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.54 -45.53 92.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.67 -46.42 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -68.01 -21.85 65.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.077 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.97 -46.17 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.642 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.27 75.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.545 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.7 p -76.2 -38.01 57.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.75 10.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.151 0.5 . . . . 0.0 110.235 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.71 141.61 15.42 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.696 ' N ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -69.8 -49.98 47.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.522 0.201 . . . . 0.0 110.822 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.72 -46.02 5.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -63.13 -46.71 86.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.166 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -56.62 -40.69 75.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.1 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.04 -26.44 66.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.92 -43.43 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.32 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -64.73 -30.79 71.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.0 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.576 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.94 -36.57 70.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.948 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.5 p -66.94 -44.64 80.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.608 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.91 98.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.766 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -75.44 -36.72 60.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.704 -179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.74 -37.07 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.073 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.22 -39.47 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 0.0 110.668 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 26' ' ' GLU . 2.2 tm-20 -63.42 -38.83 92.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.584 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.2 tt -74.92 -57.81 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.646 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.7 p -45.22 -27.24 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.633 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.9 -37.24 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' CD1' ' OE1' ' A' ' 26' ' ' GLU . 19.2 mt -63.07 -13.85 41.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.563 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.526 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.4 t-105 -96.49 -28.54 14.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.499 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.9 m-85 -71.59 -50.05 34.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.05 10.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.94 0.4 . . . . 0.0 110.264 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -56.17 -14.04 2.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.949 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' TRP . 79.4 t -108.99 -21.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.0 tpt -104.33 0.76 29.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt 49.14 31.04 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 HE22 ' A' ' 134' ' ' GLN . 0.6 OUTLIER -80.23 154.41 27.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.02 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -116.75 127.34 26.8 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.5 -179.9 5.77 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.322 2.015 . . . . 0.0 112.063 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.88 178.45 5.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.2 p -64.99 -41.25 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 5.2 tp -64.28 -49.05 73.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -50.08 -48.84 53.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.662 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.528 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.97 -46.94 81.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.43 -35.36 78.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.314 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -64.19 -34.38 77.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.53 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -62.74 -47.7 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.7 tt -77.53 -55.44 5.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -44.55 -40.98 6.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.56 96.39 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.7 t -60.17 -46.99 93.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.157 0.503 . . . . 0.0 109.834 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 55' ' ' LEU . 1.1 tt -46.99 -44.36 20.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.393 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -25.85 71.23 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.87 -42.19 61.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -63.19 -27.06 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 63' ' ' ILE . 11.8 tp -74.66 -39.94 61.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.52 -35.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.084 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.22 -18.95 70.51 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . -82.88 0.54 43.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.612 0.244 . . . . 0.0 110.938 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 59' ' ' LEU . 6.3 mm -88.11 -22.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.568 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.81 65.58 0.19 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.77 19.17 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.609 2.206 . . . . 0.0 112.024 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -109.64 -7.79 15.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -110.93 161.67 23.95 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.563 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -34.97 -19.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.749 2.299 . . . . 0.0 112.404 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.661 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 mm? -42.24 -29.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.386 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -40.27 -66.07 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.657 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.2 -36.13 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.148 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.28 -51.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.609 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.74 -33.07 71.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.184 0.516 . . . . 0.0 109.741 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttm -61.49 -9.45 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.535 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 40.5 t -61.07 -41.74 90.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.05 -27.79 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.196 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.534 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.0 t-105 -69.05 -54.48 14.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.6 tp -62.17 -50.13 73.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.309 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.5 m-85 -42.58 -41.57 3.08 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.012 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.2 p -80.08 -22.48 42.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.72 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.752 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 2.0 t80 -74.2 -49.54 23.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.204 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -69.85 -43.32 72.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.87 -46.01 94.49 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.51 -37.39 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.436 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 82' ' ' PHE . 55.3 tt0 -68.32 -31.26 70.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 110.93 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.52 -42.17 17.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.944 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 84' ' ' GLY . 5.5 p -49.68 -51.79 35.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.495 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -50.13 59.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.143 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -43.66 -41.84 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -65.64 -53.16 45.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.8 p -51.8 -40.7 60.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.616 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.3 ttm -61.41 -40.92 96.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.476 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tp -67.4 -35.12 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -67.06 -40.45 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.469 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.79 -13.97 25.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.169 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' OE2' ' CH2' ' A' ' 113' ' ' TRP . 10.4 pt-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.591 0.234 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.481 ' CH2' ' OE2' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -101.22 -6.53 24.09 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.268 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.657 ' C ' ' H ' ' A' ' 116' ' ' LEU . 34.6 mt -119.35 91.94 44.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.932 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.1 Cg_exo -52.52 9.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.543 2.162 . . . . 0.0 112.344 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.657 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -68.98 -30.1 68.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.994 0.426 . . . . 0.0 110.168 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 2.0 m-20 -98.17 -39.33 8.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.488 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -73.4 -45.34 55.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.889 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.446 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 13.6 t-105 -76.19 -13.69 60.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.217 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.64 71.19 13.98 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 125' ' ' VAL . 70.3 Cg_endo -78.15 -12.62 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.71 2.273 . . . . 0.0 111.621 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.46 -28.89 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.782 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.489 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.0 t -129.97 49.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.691 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 3.4 m-85 -156.83 -39.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.053 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 125' ' ' VAL . 9.1 p -64.7 126.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.71 159.14 16.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.576 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.6 t -177.32 99.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.417 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.99 -162.49 27.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -97.68 142.82 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.4 m -94.37 132.16 39.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.5 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.57 4.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -70.95 142.84 51.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.203 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' C ' ' OE1' ' A' ' 134' ' ' GLN . 32.0 ptt85 -99.11 133.84 42.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.951 HE22 HD12 ' A' ' 38' ' ' LEU . 2.5 mm100 -103.22 -28.35 11.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 13.3 t-105 -174.17 145.83 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 6.3 p30 -133.85 163.48 29.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 112.462 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -126.59 138.59 53.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.578 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 50.82 17.53 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.442 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 22.56 37.89 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -123.26 136.23 54.62 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.05 154.74 41.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.056 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.7 ttt -51.3 -56.77 17.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 142' ' ' MET . 1.6 Cg_endo -43.76 -36.75 7.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -69.88 -56.73 6.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.267 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 56.5 m95 -56.95 -57.33 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 142' ' ' MET . 2.2 mm? -43.38 -37.1 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -60.06 -35.85 76.05 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.29 -42.76 98.9 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -80.41 -25.75 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.076 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.503 ' O ' HD13 ' A' ' 154' ' ' LEU . 18.4 t80 -64.55 -48.53 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.625 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 152' ' ' ALA . 13.3 tt -67.19 -41.81 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.467 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -50.68 -47.89 58.66 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.476 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.97 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.711 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.534 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 2.3 mp -70.07 -34.12 72.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.71 -27.17 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 160' ' ' VAL . 54.9 t -71.44 -38.88 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -69.54 -52.9 22.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -56.18 -32.11 33.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.79 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.9 tp -81.37 -30.51 33.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 156' ' ' VAL . 25.6 t -75.49 -25.64 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.97 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.76 -46.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -71.12 -16.73 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.965 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 85.6 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.885 0.374 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -57.55 -33.36 68.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.82 -44.83 76.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 mt -51.11 -38.55 52.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.9 t-20 -64.61 -28.79 69.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.34 -48.5 11.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.696 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.04 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 12.0 m -76.7 -37.12 56.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.611 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 24.1 mm-40 -67.11 5.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.491 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.19 145.98 17.86 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -69.22 -48.66 61.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.639 0.257 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.68 6.11 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.78 83.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 18' ' ' MET . 60.3 m95 -59.36 -43.48 92.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.171 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -30.06 71.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' THR . 1.7 mp -70.18 -26.67 64.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.455 ' SD ' ' CE3' ' A' ' 15' ' ' TRP . 52.2 mtt -76.29 -34.3 59.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.741 0.305 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.34 23.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.823 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.0 -45.65 78.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.3 p -52.17 -62.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.73 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.71 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.661 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -79.75 -38.98 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.7 -38.05 63.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.06 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.824 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.02 -43.97 50.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.16 -56.24 10.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -48.72 -42.9 36.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.45 -28.87 59.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.22 -17.56 64.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.037 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.4 t-105 -86.61 -38.84 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.534 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.36 -35.06 79.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -80.86 2.78 25.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.779 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -117.01 -49.64 2.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.657 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 31' ' ' TRP . 12.1 m -72.88 -27.35 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.748 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' LEU . 8.7 tpp -109.35 13.88 23.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.673 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' MET . 9.7 mt 37.73 37.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.0 147.71 52.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.677 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -109.38 124.78 32.97 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 178.35 7.75 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.245 1.963 . . . . 0.0 112.263 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.74 172.18 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.637 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.2 t -56.46 -51.73 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 91' ' ' HIS . 4.1 mm? -56.23 -38.42 71.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.558 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.2 t -58.37 -43.31 88.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.143 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.4 mm -61.36 -50.95 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.81 73.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.021 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.93 -37.97 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -36.98 84.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.14 80.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.93 -47.28 87.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.344 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 mt -77.18 -53.58 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.31 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -43.18 -41.89 3.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.08 94.99 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 51' ' ' LEU . 39.1 t -61.19 -19.4 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.266 0.555 . . . . 0.0 110.164 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.72 -41.23 23.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.053 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.17 -28.59 73.28 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.08 -47.74 23.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.99 68.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.389 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -44.73 77.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.37 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.56 -39.36 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.42 -16.67 75.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.55 0.88 48.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.77 0.319 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.5 mt -78.42 -38.36 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.7 73.51 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.86 21.46 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.92 2.413 . . . . 0.0 112.046 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -97.4 -10.14 26.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.148 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.07 179.27 0.8 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.549 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 50.3 Cg_exo -52.22 -0.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.232 1.954 . . . . 0.0 112.164 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' THR . 14.5 mt -56.19 -33.01 64.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 77.0 mtm180 -38.77 -61.6 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.774 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.845 ' O ' HG23 ' A' ' 75' ' ' VAL . 42.2 m-85 -52.1 -35.41 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.226 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' LEU . 14.5 t -63.29 -52.86 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.961 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.93 61.54 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.275 0.56 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 15.7 mmt -57.94 -13.3 4.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 71' ' ' TYR . 43.6 t -59.31 -36.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.595 0.712 . . . . 0.0 110.279 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -89.83 -27.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.285 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 4.6 t-105 -69.58 -52.85 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.983 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 7.0 tt -67.07 -47.6 70.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.1 m-85 -46.79 -44.39 19.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.369 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -74.57 -24.68 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 78' ' ' LEU . . . -59.62 -59.77 4.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.41 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.84 -51.25 16.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -44.64 73.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.9 -48.1 84.52 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.5 t -70.45 -53.54 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.848 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -47.98 -23.53 0.82 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.832 0.349 . . . . 0.0 110.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.57 -35.93 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 84' ' ' GLY . 37.8 p -58.64 -23.36 58.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.628 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.11 -44.37 60.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.581 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -59.56 -34.25 72.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.472 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.489 ' CE1' HD12 ' A' ' 43' ' ' LEU . 2.3 m-70 -72.3 -44.8 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -43.52 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.654 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 97' ' ' TYR . 50.1 mtp -55.63 -42.23 74.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.599 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.34 -47.29 64.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.37 -42.4 91.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.37 -18.83 29.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.371 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.099 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 111.297 0.11 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -125.1 -5.28 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.81 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.597 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.1 mt -111.56 72.74 1.01 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 9.9 Cg_endo -54.31 4.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.524 2.149 . . . . 0.0 112.058 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.597 ' H ' ' C ' ' A' ' 114' ' ' LEU . 18.6 mt -74.66 -24.67 58.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -98.83 -38.85 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.499 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -82.35 -45.82 14.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.786 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -69.83 -16.92 63.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.632 -179.43 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 116' ' ' LEU . 6.0 p -154.34 72.03 6.21 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 110.837 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 125' ' ' VAL . 2.5 Cg_endo -77.9 -4.51 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.068 2.512 . . . . 0.0 111.799 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.67 -52.26 41.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.7 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.57 49.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.464 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.28 -44.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 121' ' ' PRO . 29.8 m -57.96 132.68 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.088 0.471 . . . . 0.0 110.689 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.54 161.04 13.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.474 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 t -165.75 99.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.543 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.68 -177.96 20.07 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 17.3 t0 -85.84 148.4 25.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 110.151 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 52.5 m -101.21 129.57 47.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.762 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 94.69 -8.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.727 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.74 148.77 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -86.09 123.6 31.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.456 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -128.37 -23.21 3.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -172.95 125.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.58 158.81 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 111.719 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -113.45 139.56 48.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.928 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 mt 47.91 17.02 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.488 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.35 21.98 30.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.041 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 139' ' ' GLY . 2.9 mp -125.06 138.53 54.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 16.3 mp0 -70.97 147.07 49.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.433 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.5 mmt -46.49 -61.81 2.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.161 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 80.9 Cg_exo -33.73 -39.61 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.878 2.385 . . . . 0.0 112.648 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -70.72 -55.66 8.16 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.917 0.389 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.584 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -55.6 -57.1 13.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.963 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -43.79 -37.67 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.8 OUTLIER -57.32 -37.31 72.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.49 -45.73 95.07 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.17 -30.7 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 110.194 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -58.85 -48.55 80.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.12 -46.25 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.26 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.42 -46.76 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.487 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -58.45 -44.05 89.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 158' ' ' VAL . 9.7 mt -60.63 -30.25 69.74 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.292 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.64 -27.43 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 160' ' ' VAL . 94.9 t -75.03 -36.11 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 111.111 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -74.63 -53.13 9.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 159' ' ' LEU . 32.6 m -56.39 -42.65 75.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.497 ' N ' HG23 ' A' ' 158' ' ' VAL . 6.9 tp -73.07 -31.67 64.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.259 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 156' ' ' VAL . 33.8 t -78.2 -28.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.229 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.86 -51.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.394 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 52.1 mt -62.32 -33.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.05 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 2' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.774 0.321 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -53.87 -34.09 58.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.348 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -72.51 -44.38 62.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.287 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp -47.19 -37.66 10.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -67.54 -27.52 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' PHE . 9.6 tp-100 -80.77 -47.57 13.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.692 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -39.5 86.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.67 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLY . 53.2 p -76.67 -37.28 56.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 18.3 tt0 -65.21 2.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.472 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.69 148.82 19.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -69.71 -20.47 63.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.76 -45.12 59.84 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -51.1 68.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.185 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -56.1 -45.78 79.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 tp -64.64 -30.44 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.37 -32.41 70.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.1 mmt -71.14 -33.34 69.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.58 -51.96 30.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -50.02 -45.9 52.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.683 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 p -59.01 -60.88 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.04 8.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tp -80.07 -40.48 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.8 -41.99 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.6 mp -69.08 -26.87 65.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.81 -37.78 76.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.95 -57.53 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -44.15 -39.9 4.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.51 -35.07 63.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.767 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.72 -18.49 62.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.761 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.41 -24.89 20.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.854 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -73.56 -38.02 65.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.59 0.84 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -119.15 -52.59 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.24 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.31 -40.48 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 37' ' ' LEU . 29.8 mtt -108.17 15.16 24.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.64 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 36' ' ' MET . 29.1 mt 37.03 41.85 0.21 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.064 0.459 . . . . 0.0 110.15 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 153.35 40.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.016 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' CB ' ' NZ ' ' A' ' 39' ' ' LYS . 6.5 mtmp? -124.7 108.12 28.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.69 169.03 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.229 1.953 . . . . 0.0 112.111 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -110.36 -175.4 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.461 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 2.6 p -64.37 -44.52 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.55 -48.29 81.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.779 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.0 m -60.8 -46.98 88.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.15 -49.8 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 28.9 t80 -54.52 -48.3 72.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -53.67 -47.57 70.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.084 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -50.7 -36.01 33.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -63.51 -40.91 98.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.492 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.08 79.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 51' ' ' LEU . 9.5 mp -72.62 -50.69 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -43.39 -41.95 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.08 -37.82 92.02 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 51.8 t -62.64 -19.23 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.403 0.62 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 tt -79.76 -46.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.817 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.85 -31.77 81.53 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.44 74.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.891 0.377 . . . . 0.0 110.018 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.45 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.004 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.22 -31.22 62.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.475 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.6 mt -80.46 -42.89 21.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.09 77.0 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 7.49 3.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.654 0.264 . . . . 0.0 110.855 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.48 -55.06 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.269 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.77 84.29 0.29 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.03 24.04 0.7 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.678 2.252 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -99.25 -11.62 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -106.52 179.26 0.93 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 76.5 Cg_exo -47.46 -5.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.019 1.813 . . . . 0.0 112.02 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -49.98 -33.04 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.236 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -38.32 -66.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.031 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -57.49 -36.84 72.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.639 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.4 -52.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.804 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.31 -34.55 78.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.335 0.588 . . . . 0.0 109.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 78' ' ' LEU . 2.4 ttt -63.61 -8.33 9.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.765 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.11 -40.85 90.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.452 0.644 . . . . 0.0 111.069 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.711 ' C ' HD12 ' A' ' 76' ' ' ILE . 1.4 pp -89.23 -28.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.676 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.527 ' N ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -69.15 -47.48 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.689 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.438 HD11 ' SD ' ' A' ' 74' ' ' MET . 7.6 mt -65.97 -45.78 80.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -49.2 -44.36 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.105 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -80.22 -23.26 41.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.741 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.43 -60.08 4.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.336 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -77.78 -45.37 24.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.282 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -69.96 -40.89 75.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.805 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 88' ' ' THR . . . -64.6 -46.47 89.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 81' ' ' ALA . 12.7 m -79.26 -35.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -26.27 67.05 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.958 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.4 -28.46 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.704 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 84' ' ' GLY . 20.0 p -60.94 -51.9 67.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.572 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -50.87 -29.71 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.527 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.67 -37.93 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.145 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -68.37 -37.07 80.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.272 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.539 ' HA ' HE21 ' A' ' 95' ' ' GLN . 67.1 p -72.46 -39.24 67.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.471 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.0 ttt -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.17 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.74 -38.52 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.539 HE21 ' HA ' ' A' ' 92' ' ' THR . 34.2 mt-30 -72.16 -38.02 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.769 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.57 -22.66 20.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 93' ' ' MET . 86.2 m-85 . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 2.0 p-90 -113.23 10.62 18.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 tp -119.75 86.24 35.11 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 40.7 Cg_exo -54.48 15.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.847 2.365 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.638 ' H ' ' C ' ' A' ' 114' ' ' LEU . 40.6 tp -75.63 -30.44 59.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.005 0.431 . . . . 0.0 110.004 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -97.38 -39.64 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.191 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -72.46 -45.2 60.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.99 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.5 t90 -75.69 -12.44 60.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.388 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.6 67.91 78.77 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 71.7 Cg_endo -80.41 -22.07 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.906 2.404 . . . . 0.0 111.689 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -55.53 -53.97 49.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.19 54.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.544 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.4 t80 -159.07 -35.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' PRO . 75.3 t -65.64 130.48 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.821 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . . . -96.83 163.04 13.15 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.3 t -174.67 101.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 141.46 177.95 17.18 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.47 135.74 36.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 15.0 m -91.16 129.42 37.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.56 -1.63 0.24 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.653 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -67.98 145.09 54.84 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -87.3 116.06 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -117.51 -22.3 8.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -175.75 128.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.474 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -140.54 158.74 43.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.269 0.557 . . . . 0.0 112.238 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 17.5 t80 -117.09 139.18 51.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.936 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.0 mm? 49.95 17.09 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.379 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.63 21.85 35.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.794 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -125.87 137.11 53.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.73 149.6 47.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.44 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -49.14 -51.5 56.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' HD13 ' A' ' 147' ' ' LEU . 89.0 Cg_exo -44.06 -37.98 10.08 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.542 2.161 . . . . 0.0 112.454 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 0.3 OUTLIER -70.71 -46.93 62.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.156 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.6 m95 -63.84 -57.25 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.3 mt -43.68 -38.56 3.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 143' ' ' PRO . 2.4 mp -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -54.39 -39.07 64.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -80.96 -27.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 110.118 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' LEU . 75.7 t80 -59.67 -51.62 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.134 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 9.8 tt -64.2 -42.47 95.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.238 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -52.85 -47.69 67.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.179 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -57.82 -38.64 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.58 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 150' ' ' PHE . 74.6 mt -66.75 -32.32 73.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.852 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -33.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 160' ' ' VAL . 42.0 t -59.5 -43.37 90.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.424 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -73.51 -48.79 30.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.23 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 69.0 t -51.25 -43.37 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.751 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.1 -43.59 52.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.761 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.8 t -62.07 -29.46 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.202 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -80.51 -47.76 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 162' ' ' ILE . 74.2 mt -70.64 -2.72 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.397 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.846 -179.825 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -52.76 -38.24 60.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLN . 7.2 t80 -71.69 -46.3 59.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -45.48 -44.06 12.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.322 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.96 -20.87 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.229 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PHE . 44.2 tp60 -79.92 -47.86 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.21 74.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 78.4 p -76.46 -34.17 58.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -73.9 10.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.513 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.03 140.91 15.33 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -19.7 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.68 59.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.21 68.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -53.47 -41.54 66.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.303 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.64 -29.57 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.294 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -34.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mtm -73.95 -34.58 64.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.091 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.33 65.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.604 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -60.83 -33.1 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.608 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.7 m -56.75 -54.85 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.88 -27.48 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.361 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.14 -41.84 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.12 -45.11 61.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.687 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.28 -33.28 74.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.07 -44.61 68.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.9 tt -65.29 -58.09 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -47.21 -36.67 9.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.43 -31.12 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -63.32 -18.55 63.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.416 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 11.0 t-105 -86.69 -41.03 14.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 110.36 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -56.15 -38.42 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.037 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 33' ' ' GLN . 12.9 tm0? -79.05 -23.74 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.217 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 36' ' ' MET . 11.7 p -108.41 -44.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.562 ' N ' HG13 ' A' ' 35' ' ' VAL . 9.3 tpt -77.15 -2.38 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt 46.16 45.75 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.08 146.33 54.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -110.57 108.58 58.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.961 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.1 145.11 17.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.25 1.967 . . . . 0.0 111.513 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -107.49 -161.87 0.8 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.595 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.6 t -63.32 -42.6 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.2 tp -62.57 -49.31 75.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.198 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -54.66 -49.48 70.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.676 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.83 -45.35 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -59.71 -46.58 88.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.24 -47.69 84.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.257 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -56.74 -33.15 66.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.356 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.56 74.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -73.31 -50.67 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -43.8 -41.73 5.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.32 94.11 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.43 -47.73 90.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.97 -46.52 16.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.502 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -48.79 76.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.66 62.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.127 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.92 73.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 tp -72.28 -25.53 61.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.101 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.29 -39.53 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.67 -25.87 75.06 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.49 7.8 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.46 -48.52 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -179.45 80.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.61 31.56 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.68 -9.7 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.946 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.99 170.52 5.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.784 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.84 -12.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 mt -43.73 -32.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.51 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -41.05 -70.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -54.68 -27.37 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.677 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.32 -46.15 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.565 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.67 -35.05 60.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.599 . . . . 0.0 109.619 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 ttt -59.59 -15.72 20.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 70.9 t -55.22 -40.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.262 0.554 . . . . 0.0 110.345 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.2 mm -85.48 -34.86 8.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.228 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.586 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 5.0 t-105 -61.89 -56.15 22.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.8 tp -62.84 -50.28 71.56 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -42.88 -44.87 4.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.187 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.52 -21.37 45.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.495 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.38 -59.91 4.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.184 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.53 -46.69 58.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -77.32 -40.29 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.32 -48.92 83.64 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.397 -0.906 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 81' ' ' ALA . 25.3 m -67.77 -44.74 85.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.819 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.518 ' N ' HG23 ' A' ' 85' ' ' VAL . 26.4 tt0 -54.91 -28.41 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.112 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.35 61.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.236 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 70.0 p -54.79 -30.69 57.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.332 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.23 -48.34 76.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.13 -30.77 66.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 3.8 m170 -77.46 -49.04 15.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -64.56 -48.42 75.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 97' ' ' TYR . 26.7 ttt -52.71 -51.39 60.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.484 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.74 -49.36 73.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -52.35 -44.65 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.9 mm? -88.39 -13.31 40.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 93' ' ' MET . 7.8 t80 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.277 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.1 p-90 -110.13 0.64 18.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -114.34 94.25 34.82 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.033 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.03 0.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.698 2.265 . . . . 0.0 112.935 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.8 tp -70.27 -26.13 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.71 -34.78 11.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -67.01 -35.16 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 -95.99 -23.96 16.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.364 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.8 t -149.64 87.79 5.08 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.52 -15.73 8.45 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.606 2.204 . . . . 0.0 112.521 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -85.69 -4.01 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.722 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.3 p -112.54 18.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.109 0.48 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -147.24 -43.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.433 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.67 129.96 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.407 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.88 154.57 17.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.7 p -158.53 99.78 1.61 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.509 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.55 -176.97 20.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -96.65 150.13 21.01 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 73.9 m -102.22 132.2 48.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.89 -10.35 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.999 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -69.53 129.16 38.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.657 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -67.96 109.45 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -115.7 -23.54 8.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.781 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 16.9 t90 -172.02 132.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 1.1 p30 -146.16 159.37 43.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -120.68 139.89 52.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.899 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.49 17.35 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.91 21.25 53.62 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -123.21 135.26 54.21 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 141' ' ' GLU . 9.7 mp0 -71.65 148.81 46.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.465 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtt -45.25 -63.7 1.12 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.25 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 88.2 Cg_exo -32.35 -38.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.092 2.528 . . . . 0.0 112.801 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.455 ' CD ' ' N ' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -72.47 -51.68 19.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.004 0.43 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 72.6 m95 -56.36 -57.46 12.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.903 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -43.76 -39.14 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.1 tt -56.27 -35.77 67.84 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -63.01 -48.42 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.489 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.45 -26.23 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.57 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.4 t80 -64.08 -41.49 97.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 148' ' ' GLY . 3.5 tt -73.75 -29.73 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.66 -52.02 62.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.272 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -57.06 -41.74 79.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.534 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -61.32 -30.91 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.736 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.48 -26.8 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.223 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' VAL . 74.6 t -73.35 -35.1 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.586 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -71.98 -53.76 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.263 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 159' ' ' LEU . 34.9 m -53.71 -45.92 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.913 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 158' ' ' VAL . 2.3 tp -67.11 -30.21 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.731 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 156' ' ' VAL . 18.4 t -74.98 -29.92 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.9 t -83.66 -51.53 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 110.318 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 162' ' ' ILE . 40.0 mm -68.67 -12.72 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.107 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.067 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.905 0.383 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -54.96 -36.49 65.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.313 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 7' ' ' GLN . 2.6 t80 -69.77 -43.02 73.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.174 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -48.45 -38.31 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 2.3 m-20 -68.32 -26.8 65.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.275 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.1 mm-40 -78.08 -48.86 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.382 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.74 80.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 40.1 m -76.65 -37.3 56.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.538 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 11.3 mm100 -70.24 7.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.372 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.64 145.77 16.25 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -72.33 -51.54 20.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.632 0.254 . . . . 0.0 110.744 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.97 -47.3 6.29 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.29 86.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -58.7 -37.28 75.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.19 -29.58 69.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.721 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' THR . 2.3 tp -69.98 -27.73 64.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.44 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.1 mtp -76.09 -34.07 59.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.3 -54.85 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 23' ' ' LEU . 66.7 t80 -52.1 -52.69 49.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 15.4 p -44.11 -51.62 7.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -21.69 65.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.51 -42.37 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.468 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.63 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.54 -35.29 68.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' CD ' ' NH1' ' A' ' 48' ' ' ARG . 4.9 tp10 -64.99 -35.61 81.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.55 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.42 -56.54 4.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.659 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -45.26 -41.5 8.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.78 -32.35 65.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.567 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -64.03 -19.77 65.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.583 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -93.5 -19.79 20.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.21 -50.36 19.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.458 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -73.61 -9.15 58.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.12 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.458 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 5.6 t60 -77.89 -31.01 51.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.102 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.78 -9.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.8 mmt -107.05 -3.19 20.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.631 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.2 mt 47.21 50.19 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 110.282 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 39' ' ' LYS . 2.1 tt -65.07 142.19 58.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.629 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.861 ' N ' HD23 ' A' ' 38' ' ' LEU . 14.9 mttm -107.31 99.66 29.03 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.455 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 127' ' ' SER . 72.1 Cg_exo -46.5 168.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.575 2.183 . . . . 0.0 112.784 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.9 161.49 32.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.187 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.506 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.7 t -48.81 -46.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.593 ' N ' HD22 ' A' ' 43' ' ' LEU . 3.6 mm? -73.0 -33.88 66.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.1 t -58.07 -45.8 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.824 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 126' ' ' ALA . 24.2 pt -69.56 -35.99 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.3 -47.36 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.91 -36.71 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' NH1' ' CD ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -63.42 -32.58 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.63 77.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.233 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.44 77.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.4 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.88 -55.51 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -44.52 -38.34 4.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.42 94.67 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -62.22 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 109.831 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -45.83 -44.63 14.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.591 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.27 -27.98 73.04 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.98 -43.21 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.616 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.74 65.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.463 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -80.84 -36.08 31.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.428 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -80.89 -34.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -75.49 -32.83 54.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.56 6.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -88.43 -22.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.518 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 67.82 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.82 24.61 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.672 2.248 . . . . 0.0 111.845 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 64' ' ' ALA . 37.5 mttp -111.3 -6.16 14.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.13 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.33 163.86 17.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.647 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.17 -13.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.442 2.095 . . . . 0.0 112.217 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mt -43.07 -34.46 1.04 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 59.0 mtm-85 -38.57 -66.57 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.732 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -54.15 -27.22 32.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.786 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.2 t -72.86 -51.12 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.496 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.244 0.545 . . . . 0.0 109.913 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 5.7 ttt -62.23 -15.75 48.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.882 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.2 p -56.58 -36.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.453 0.644 . . . . 0.0 110.408 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.2 mt -87.38 -34.51 7.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.775 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.581 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 6.0 t-105 -60.61 -54.59 43.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.926 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.88 -44.93 91.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.83 -23.04 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 154' ' ' LEU . . . -60.96 -60.83 3.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.623 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -72.47 -56.24 5.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.177 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -68.26 -47.73 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.1 -46.81 84.29 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 81' ' ' ALA . 92.6 t -67.57 -36.09 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.58 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.45 -34.89 69.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.255 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.28 -44.64 17.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.548 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 84' ' ' GLY . 49.2 p -45.3 -32.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.58 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -73.45 -40.83 63.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -56.34 -37.66 70.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.5 m170 -68.62 -42.7 77.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -66.47 -51.4 57.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.7 ttt -49.48 -49.54 45.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 97' ' ' TYR . 3.8 tp -61.48 -47.92 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -54.33 -37.89 65.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 96' ' ' LEU . 11.1 mp -90.58 -15.79 29.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.465 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 37.2 t80 . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.283 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.561 0.219 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -125.41 -6.06 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.782 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -119.52 78.47 20.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.39 11.37 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.263 1.975 . . . . 0.0 112.22 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.9 mt -77.36 -29.76 53.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.111 0.481 . . . . 0.0 109.771 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.475 ' OD1' ' CD2' ' A' ' 124' ' ' PHE . 3.4 m-20 -96.2 -42.19 8.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.729 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' CB ' ' NZ ' ' A' ' 118' ' ' LYS . 5.4 ttpm? -64.88 -44.75 88.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.066 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 27.1 t-105 -76.12 -12.95 60.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.88 73.64 13.55 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.781 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.78 -12.9 13.35 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.819 2.346 . . . . 0.0 111.948 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.87 -54.11 48.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.289 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.74 26.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.249 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CD2' ' OD1' ' A' ' 117' ' ' ASP . 39.8 m-85 -134.69 -6.4 2.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.193 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.88 132.65 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -101.48 154.85 18.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' PRO . 69.6 m -167.64 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.355 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.71 -174.3 21.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.73 154.14 21.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.293 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 97.9 m -101.48 131.77 47.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.14 1.19 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.49 160.26 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.043 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -100.14 140.01 34.99 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -132.71 -27.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -174.77 142.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.72 167.9 20.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.527 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 69.4 t80 -145.58 118.46 8.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.509 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 3.5 tp 78.89 17.34 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.86 11.33 79.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.7 mp -116.82 132.9 56.58 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -71.07 153.02 42.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.276 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.1 mmm -50.71 -59.5 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.708 ' O ' HD13 ' A' ' 147' ' ' LEU . 83.2 Cg_exo -36.55 -41.31 0.59 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.458 2.105 . . . . 0.0 112.237 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.79 -44.7 63.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.333 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.2 m95 -61.26 -56.82 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.065 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 tp -43.41 -44.55 5.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.007 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' PRO . 4.5 mp -53.61 -36.45 62.0 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.85 -42.29 94.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.24 -29.76 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 110.628 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.16 -48.31 80.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.103 0.478 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 155' ' ' ILE . 12.9 pt -68.01 -41.55 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.11 -45.91 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.524 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 5.6 m-85 -64.28 -39.66 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -60.0 -45.31 93.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.258 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -73.97 -26.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.93 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 155' ' ' ILE . 5.8 t -68.62 -33.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.106 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -71.98 -46.88 55.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.851 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.16 -24.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.093 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.96 -41.48 51.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.057 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 156' ' ' VAL . 21.9 m -78.78 -21.87 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.832 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.6 t -74.56 -48.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.115 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 162' ' ' ILE . 2.2 pp -69.26 -28.57 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.442 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.992 0.425 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -58.12 -31.97 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.119 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.62 -42.94 67.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.068 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 mp -50.54 -38.74 46.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -67.95 -30.55 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -79.69 -49.89 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.47 78.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.742 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -76.72 -30.48 56.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.822 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 28.6 tt0 -73.39 6.07 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 110.515 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.49 146.47 17.25 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -66.42 -20.69 66.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.339 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.13 -44.39 76.89 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.512 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.89 -51.25 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -60.53 -43.84 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.73 -35.54 81.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 21' ' ' THR . 10.1 tp -69.52 -28.83 66.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -72.56 -32.82 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.29 26.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.523 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.42 -46.76 63.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.829 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 18' ' ' MET . 27.4 p -52.72 -53.13 52.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.37 81.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.6 tt -69.76 -42.15 74.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.942 0.401 . . . . 0.0 110.702 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.47 -42.45 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -71.17 -34.45 70.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.735 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.59 -43.84 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.6 tt -74.32 -58.17 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.519 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 24' ' ' ALA . 35.0 p -44.43 -32.62 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.62 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.45 -41.53 16.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.568 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tp -49.13 -21.98 0.86 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.772 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -85.46 -32.53 22.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -58.81 -44.32 90.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.139 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.423 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 15.6 pt20 -75.98 -28.96 58.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.712 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -65.41 -31.42 72.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.497 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.78 -47.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 5.4 tpt -73.22 1.78 8.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.705 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.2 mt 43.53 45.62 5.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -69.67 145.96 51.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.949 ' N ' HD23 ' A' ' 38' ' ' LEU . 46.4 mttp -115.23 90.82 25.54 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.51 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 127' ' ' SER . 51.4 Cg_exo -51.23 165.88 0.5 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.669 2.246 . . . . 0.0 112.518 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 8.3 t -112.95 -175.45 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.316 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.438 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.2 p -69.09 -36.9 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' ND1' ' A' ' 91' ' ' HIS . 5.9 mp -77.76 -49.64 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.605 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 t -49.15 -51.51 31.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 46' ' ' TYR . 18.5 tt -64.27 -38.95 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.218 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 19.4 t80 -55.6 -44.62 77.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -56.97 -47.43 80.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.263 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -52.62 -30.41 31.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.926 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -70.33 -38.25 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.91 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.565 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 8.8 mp -73.28 -50.96 19.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.82 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -44.29 -38.54 3.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.85 90.28 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' ALA . 24.8 t -61.61 -47.35 93.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 109.725 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.37 -45.78 9.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.682 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.67 -29.48 75.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.57 -40.03 84.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.619 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.56 58.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -73.67 -47.04 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.377 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.78 -29.75 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -74.54 -33.96 54.98 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 2.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 110.585 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -84.54 -23.64 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.71 74.15 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.91 21.93 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.857 2.371 . . . . 0.0 112.023 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -115.55 -4.68 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.091 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.59 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -110.51 159.91 30.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.693 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -36.09 -22.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 mp -44.18 -26.18 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -43.68 -65.46 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.608 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.6 m-85 -55.3 -37.71 67.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.979 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.55 -48.69 84.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.776 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 -31.76 65.2 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.436 0.636 . . . . 0.0 109.749 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.3 ttp -63.18 -11.81 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.355 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 71' ' ' TYR . 63.4 t -62.84 -39.24 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.399 0.618 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.7 mt -83.65 -36.59 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.784 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 15.9 t90 -59.65 -52.61 64.79 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.688 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 78' ' ' LEU . 2.4 tt -58.98 -53.66 55.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 110.529 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -42.27 -45.13 4.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.748 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -81.49 -24.53 36.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.25 -61.41 2.62 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.801 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 5.8 m-85 -75.13 -53.72 8.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -65.08 -45.03 86.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.89 -45.89 95.05 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' ALA . 90.2 t -69.55 -35.67 67.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.603 0.239 . . . . 0.0 111.227 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 82' ' ' PHE . 1.1 mp0 -71.29 -39.52 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.708 0.289 . . . . 0.0 110.934 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 tp -73.05 -43.94 61.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.6 p -52.68 -52.25 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -47.37 -38.63 13.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -59.52 -40.93 88.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.863 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.576 ' ND1' HD23 ' A' ' 43' ' ' LEU . 1.8 m-70 -60.95 -35.85 77.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.367 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.3 p -76.49 -42.54 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.0 ttt -50.34 -49.88 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.13 -47.81 81.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -52.91 -37.81 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.5 mp -94.35 -15.87 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 93' ' ' MET . 13.3 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.7 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.555 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.82 -3.47 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.609 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.6 tp -125.81 79.37 68.43 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 121.017 0.437 . . . . 0.0 110.043 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.1 Cg_exo -54.59 9.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.731 2.288 . . . . 0.0 112.52 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.609 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -65.48 -32.91 74.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.048 0.451 . . . . 0.0 109.925 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -97.71 -40.1 8.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.014 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.9 -45.34 67.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.9 t90 -76.12 -12.16 60.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.189 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.89 70.74 36.06 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.42 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.8 Cg_endo -77.19 -18.67 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.705 2.27 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -55.46 -54.12 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.897 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.495 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 10.6 m -105.48 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.828 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.2 m-85 -164.96 -38.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.1 p -58.23 129.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.548 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.83 152.68 18.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' PRO . 54.0 p -156.53 104.99 2.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.09 -169.75 21.57 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 3.6 m-20 -96.19 170.26 9.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 110.238 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.2 m -119.04 128.44 54.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.72 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.49 -10.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -69.56 149.03 48.63 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.712 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -100.01 134.09 43.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.677 ' OE1' HD21 ' A' ' 38' ' ' LEU . 5.3 pt20 -132.58 -13.59 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -173.9 133.73 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -145.37 158.0 43.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.178 0.513 . . . . 0.0 112.002 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.427 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.5 t80 -114.29 140.28 48.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.159 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp 49.11 16.72 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.088 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.97 23.02 31.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.072 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 144' ' ' GLN . 77.6 mt -127.42 138.99 53.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.985 0.392 . . . . 0.0 110.174 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -68.05 146.18 53.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.435 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.62 -54.32 19.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.455 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.3 Cg_exo -41.48 -34.17 1.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.334 2.023 . . . . 0.0 111.941 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.459 ' OE1' HD22 ' A' ' 140' ' ' LEU . 12.4 tt0 -72.03 -48.46 44.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 94.6 m95 -60.44 -57.79 11.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.827 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 146' ' ' LEU . 10.8 mp -43.97 -37.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.085 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.45 -35.1 73.4 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.6 -40.88 98.5 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.48 -25.8 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.451 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -44.91 87.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.35 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 151' ' ' ILE . 5.8 tt -66.47 -38.12 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.026 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -51.4 -48.73 62.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.904 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.92 -39.9 91.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.644 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.8 ' O ' HD23 ' A' ' 154' ' ' LEU . 7.3 tt -59.98 -30.96 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.353 0.597 . . . . 0.0 109.868 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -82.67 -30.84 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.815 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -67.88 -42.74 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.784 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.34 -48.34 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.581 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -51.98 -34.42 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.217 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.1 -36.13 21.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.0 t -67.02 -30.46 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.292 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.5 p -79.26 -49.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.587 ' N ' HG13 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -64.21 -10.53 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.113 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.585 179.816 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -61.28 -51.17 70.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 110.037 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -45.53 -42.0 10.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.549 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -62.79 -41.06 99.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -49.7 -41.15 42.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.01 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -67.49 -29.56 69.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.891 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -74.9 -50.72 15.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 p -76.76 -36.44 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.771 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -70.7 2.57 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.09 148.98 18.95 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -70.78 -49.24 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.291 . . . . 0.0 110.702 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.21 -44.86 6.24 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.3 81.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.559 -0.32 . . . . 0.0 110.253 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -58.53 -46.55 86.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.234 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.19 -28.27 67.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.0 -31.45 67.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.634 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . 55.7 mtt -70.65 -33.93 71.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.66 32.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.674 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.74 -31.47 64.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -67.23 -52.57 39.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.512 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -65.57 -29.12 69.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.471 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -77.75 -41.79 36.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.68 -33.87 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -73.23 -35.46 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.277 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -71.42 -43.3 67.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.652 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.07 -57.91 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 p -51.06 -30.24 15.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.297 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.36 -43.44 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -14.56 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -91.96 -36.62 13.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.426 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 36' ' ' MET . 2.6 m-85 -58.67 -40.32 83.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -75.78 -35.78 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.221 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -28.89 66.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.484 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 36' ' ' MET . 22.5 m -105.24 -38.21 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.652 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 36' ' ' MET . 1.8 tmt? -80.5 -0.04 35.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.511 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 48.52 47.57 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tt -83.63 150.76 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -117.88 137.85 24.78 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.3 Cg_endo -75.44 167.72 26.03 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.454 2.102 . . . . 0.0 112.155 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.45 175.51 7.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.099 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 33.2 t -58.38 -53.72 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.0 tp -65.16 -48.28 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 p -48.75 -47.84 41.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.591 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.52 -44.27 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.364 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.33 -46.6 89.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.92 -38.04 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.327 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -60.7 -29.4 69.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.821 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.01 -37.01 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.478 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.54 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.483 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' VAL . 6.1 tp -76.37 -54.02 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.28 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -44.03 -38.87 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.44 -41.63 90.42 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.6 t -62.62 -47.81 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-O 121.212 0.529 . . . . 0.0 109.757 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -49.23 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.218 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.54 -29.38 69.4 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -69.47 -33.13 72.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.667 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.86 -24.3 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 59' ' ' LEU . 3.2 mm? -73.92 -39.28 63.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.405 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.18 -35.29 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.695 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -65.49 -38.5 94.87 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.94 11.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.919 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.3 mt -83.7 -29.01 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.533 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.03 78.1 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.404 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.23 22.81 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.58 2.187 . . . . 0.0 112.083 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -111.09 -6.27 14.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.78 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.55 163.19 20.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.672 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -40.92 -13.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.505 2.137 . . . . 0.0 112.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 mt -42.42 -34.99 0.91 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' NH1' ' CB ' ' A' ' 164' ' ' GLN . 94.2 mtt180 -39.0 -67.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.338 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.9 m-85 -48.96 -34.27 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.9 t -68.34 -46.02 81.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -43.87 21.86 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.992 -0.442 . . . . 0.0 111.137 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.473 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.07 -16.73 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.797 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -57.78 -32.5 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.637 0.732 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.7 -34.09 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.895 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.9 t-105 -64.3 -45.18 89.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.933 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 81' ' ' ALA . 1.3 tp -68.62 -46.33 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.221 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -45.69 -41.92 11.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.122 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -80.77 -23.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.387 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.24 -59.59 5.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -74.84 -53.62 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -66.23 -46.89 75.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.78 -47.3 86.83 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.5 t -66.39 -47.39 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.85 -44.74 82.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 87' ' ' LEU . 1.2 tt -64.81 -51.41 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.8 p -48.13 -23.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.256 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.66 -45.16 54.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.53 -38.09 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.136 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -67.95 -42.11 81.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -66.62 -51.56 54.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.729 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' TYR . 16.5 ttt -56.34 -51.49 68.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.95 -41.6 99.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.423 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -55.97 -44.29 78.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.228 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 96' ' ' LEU . 5.9 tt -95.54 -6.56 40.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' MET . 9.5 t80 -139.11 67.05 39.93 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.305 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.47 116.11 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 80.6 p -170.17 58.72 0.31 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.415 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -71.75 176.82 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.675 2.25 . . . . 0.0 112.161 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.67 -140.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.585 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.19 -79.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.694 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 t -140.59 44.62 1.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.626 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 106' ' ' PHE . 58.9 p -49.64 -25.79 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -66.1 74.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.532 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 104' ' ' SER . 60.8 t80 -122.66 77.31 1.42 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 29.8 mtt 44.98 -164.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.535 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -95.99 121.59 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.536 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.6 108.56 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.39 147.39 59.89 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.397 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 113' ' ' TRP . 37.5 Cg_endo -67.42 135.12 35.46 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.465 2.11 . . . . 0.0 112.06 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 14.2 mp0 -68.02 7.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.543 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.88 -2.76 58.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.157 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.628 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.9 mt -126.34 80.19 69.36 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 48.6 Cg_exo -52.89 5.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.69 2.26 . . . . 0.0 112.164 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.628 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -61.67 -33.31 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.201 0.524 . . . . 0.0 110.075 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -96.94 -43.04 7.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -45.24 80.75 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.221 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.1 t90 -74.63 -12.9 60.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.792 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.9 t -142.63 72.67 20.19 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.59 -17.08 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.712 2.274 . . . . 0.0 111.8 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -54.96 -53.78 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.798 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.6 t -105.94 58.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.6 m-85 -162.85 -42.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 130.4 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.4 156.32 16.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' PRO . 67.3 m -160.99 99.93 1.23 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.66 179.89 17.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.34 150.29 23.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 110.235 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 68.4 m -101.43 129.07 47.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.821 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.56 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.21 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.66 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.859 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.486 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -100.58 132.84 45.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.536 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -130.28 -8.24 4.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.812 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.432 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 10.1 t-105 -173.91 132.41 0.42 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.86 160.32 39.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.93 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -117.87 139.04 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.078 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mt 49.66 17.05 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.56 20.64 40.09 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.7 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.03 139.19 54.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -70.24 146.4 50.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.149 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.37 -58.88 5.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.366 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.1 Cg_exo -37.21 -37.84 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -70.52 -45.19 66.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.111 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.6 m95 -66.95 -57.39 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.232 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 mt -43.49 -37.03 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.978 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 88' ' ' THR . 28.6 tp -63.57 -36.35 83.5 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -55.59 -39.68 75.9 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.3 mt -71.02 -44.27 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 110.463 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -47.69 -42.54 25.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.23 -46.29 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.801 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -56.66 -54.24 48.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.0 m-85 -57.2 -36.88 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 154' ' ' LEU . 6.1 tt -63.53 -29.79 71.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.89 -39.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 m -62.02 -38.82 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.827 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.579 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -72.24 -48.41 42.98 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.71 -37.08 74.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.73 -41.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 156' ' ' VAL . 75.5 t -72.0 -23.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 157' ' ' ALA . 15.0 t -76.05 -45.74 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.45 -21.49 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.0 m -61.93 -13.36 24.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.428 ' CB ' ' NH1' ' A' ' 70' ' ' ARG . 10.0 pt20 -52.37 148.44 12.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.294 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -38.22 -30.11 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.461 2.108 . . . . 0.0 112.019 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 164' ' ' GLN . 10.0 t80 42.56 -135.04 0.39 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.669 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 26.0 tttp 60.24 -131.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 167' ' ' LYS . . . 65.49 124.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.379 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 170' ' ' LYS . 45.8 mtpt -97.52 -25.4 15.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.837 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' LYS . 10.8 mtpp -48.37 -99.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 48.82 72.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 173' ' ' LEU . 3.7 p30 -74.72 122.78 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 172' ' ' ASP . 13.7 mt 57.57 142.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.796 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -172.6 103.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 94.95 136.1 8.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -80.82 160.45 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.638 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -101.26 -96.49 2.26 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 54.87 81.71 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.603 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -160.21 15.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.473 ' O ' ' ND1' ' A' ' 180' ' ' HIS . 44.7 t-80 -78.7 -15.55 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.471 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.98 -158.92 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.419 ' O ' ' OXT' ' A' ' 183' ' ' HIS . 56.3 t-80 -152.51 152.74 32.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.419 ' OXT' ' O ' ' A' ' 182' ' ' HIS . 43.6 t-80 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.17 -40.09 82.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.422 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -57.59 -28.29 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -76.92 -43.29 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.544 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mt -50.58 -41.02 53.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.357 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -65.62 -27.57 68.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 110.064 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -79.44 -47.91 14.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.522 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.81 71.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.668 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.4 m -76.53 -39.69 52.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.62 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.542 HE22 ' C ' ' A' ' 65' ' ' PRO . 19.1 tp60 -66.85 5.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.481 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.75 141.97 15.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -68.11 -48.22 66.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.01 -45.36 6.02 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.62 76.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.108 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -54.62 -42.48 71.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.6 -26.95 65.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.995 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -70.16 -35.01 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.662 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.451 ' O ' ' OG1' ' A' ' 21' ' ' THR . 2.0 mtt -71.6 -32.93 68.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.35 45.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -52.31 -43.79 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.4 p -58.23 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.691 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.42 -39.04 31.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -42.03 69.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.839 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . . . -45.98 -42.27 12.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.709 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -71.12 -32.08 68.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 30' ' ' LEU . 3.4 tm-20 -70.68 -49.93 41.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.07 -57.72 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 24' ' ' ALA . 68.7 p -49.95 -30.34 10.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.622 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.93 -47.09 13.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -54.45 -14.22 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.42 -36.3 10.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.36 . . . . 0.0 110.515 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -42.1 79.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.437 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 40' ' ' PRO . 39.6 mt-30 -69.57 -46.08 67.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.17 -18.81 50.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -101.61 -43.92 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 mmt -89.96 8.45 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.767 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLN . 3.8 tp 44.87 45.74 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.646 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -80.05 154.43 28.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -127.53 83.84 64.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.361 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 75.5 Cg_exo -47.02 178.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 8.4 t -116.29 -175.83 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.384 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.1 p -64.52 -36.18 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.314 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.55 -47.53 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.543 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -53.61 -49.56 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.691 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.7 mt -65.8 -37.81 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.368 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -59.76 -48.36 81.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.16 -37.05 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -32.37 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.95 79.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.33 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -77.19 -52.1 9.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.07 -40.12 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.4 -44.71 89.83 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 t -61.21 -47.67 92.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.49 . . . . 0.0 109.758 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -44.62 -46.05 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.785 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.47 80.89 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.2 -40.71 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.358 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.04 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.367 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.03 -28.47 49.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.428 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.14 -39.35 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.493 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.99 -32.76 77.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.36 5.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 61' ' ' GLY . 76.7 mt -76.56 -36.8 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.94 72.06 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.499 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' C ' HE22 ' A' ' 10' ' ' GLN . 16.4 Cg_exo -64.36 16.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.879 2.386 . . . . 0.0 112.131 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.0 tmtm? -109.37 -5.67 15.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.004 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.38 164.31 16.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.567 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -41.19 -12.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.6 mm? -44.84 -34.79 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.406 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.2 ptt180 -40.43 -68.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.736 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.453 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 27.4 t80 -54.0 -28.48 38.27 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 t -70.86 -52.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.697 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.08 63.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.269 0.557 . . . . 0.0 109.987 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 23.4 ttt -59.3 -10.42 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.047 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 72' ' ' VAL . 4.4 p -62.78 -36.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.428 0.632 . . . . 0.0 110.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 76' ' ' ILE . 35.7 mm -86.65 -32.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.754 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 8.3 t-105 -62.96 -52.64 62.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.935 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -46.33 88.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.609 ' CD2' ' NH1' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -47.05 -45.78 21.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.56 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.5 p -76.59 -25.94 54.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.669 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.0 -60.6 3.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.024 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -73.33 -54.24 8.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 79' ' ' TYR . 23.0 ttm105 -67.26 -47.49 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' THR . . . -54.68 -48.47 65.74 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.1 -50.89 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.438 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -48.34 -28.05 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -77.83 -39.25 44.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 147' ' ' LEU . 80.6 p -54.13 -29.56 45.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.31 -48.75 69.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.342 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -54.95 -39.84 69.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.469 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -71.84 -56.79 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -53.16 -52.78 57.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' TYR . 61.7 mmm -49.41 -46.59 47.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.8 -45.37 78.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.359 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -57.84 -38.82 76.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.2 -12.12 28.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.0 t80 -137.96 65.78 45.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.93 124.39 11.28 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.733 2.289 . . . . 0.0 112.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.5 ' N ' ' CD ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -87.32 -48.85 0.47 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.639 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 99' ' ' SER . 97.4 Cg_endo -84.18 -170.44 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.656 2.237 . . . . 0.0 112.056 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -173.18 111.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . 63.15 7.42 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.721 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 20.4 m -166.24 121.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.55 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 p -136.96 168.37 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.503 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 29.5 m-20 -85.35 -160.3 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.582 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 51.4 m-85 -157.31 -160.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.503 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.553 ' C ' ' H ' ' A' ' 109' ' ' ARG . 17.9 mmt -142.62 -92.37 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.277 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t 66.97 -34.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.145 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 107' ' ' MET . 31.7 ttt85 -77.75 101.24 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.666 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.75 159.45 36.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.156 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.59 155.42 58.7 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.606 2.204 . . . . 0.0 111.815 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -103.61 -14.56 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -96.52 -4.57 41.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.932 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 mt -123.65 78.77 55.84 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.201 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.4 Cg_exo -51.87 -0.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -59.21 -33.21 70.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.106 0.479 . . . . 0.0 110.367 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -96.8 -42.08 8.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.636 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -70.12 -45.09 67.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.568 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.3 t90 -74.1 -16.13 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.04 71.32 48.44 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.21 -19.58 10.43 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.854 2.37 . . . . 0.0 111.77 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.46 -44.98 65.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.683 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 t -118.98 56.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.947 0.403 . . . . 0.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.523 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.3 t80 -160.35 -40.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.256 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.23 127.53 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.483 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.14 22.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 127' ' ' SER . 17.2 p -169.13 103.49 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.472 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.35 -175.43 21.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.3 140.87 29.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.799 0.333 . . . . 0.0 110.225 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.1 m -89.65 135.47 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.98 1.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 133' ' ' ARG . 2.4 tm-20 -67.11 145.27 55.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.493 ' N ' ' OE2' ' A' ' 132' ' ' GLU . 6.6 ptp180 -100.07 130.23 46.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -118.83 -25.17 6.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 140.74 52.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.98 119.46 11.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.218 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.18 133.83 51.44 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.17 17.51 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.349 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.93 58.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.26 145.11 50.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.673 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.2 mp0 -75.94 157.38 33.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.1 mtt -56.47 -50.93 84.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.911 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 142' ' ' MET . 88.1 Cg_exo -43.86 -38.03 9.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.357 2.038 . . . . 0.0 112.158 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -70.76 -52.67 19.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.06 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.6 m95 -58.62 -57.17 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.967 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.46 -37.77 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -60.3 -35.91 76.68 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.8 -44.9 95.6 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.14 -39.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.243 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -52.68 -47.84 66.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.903 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.12 -48.05 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.33 -46.59 66.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.703 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.453 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 6.1 m-85 -55.12 -40.54 70.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.294 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 158' ' ' VAL . 1.4 mt -65.85 -30.58 71.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.12 -29.5 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.622 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.3 t -69.8 -36.55 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.486 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -79.99 -35.99 36.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.202 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 154' ' ' LEU . 47.3 t -65.4 -38.93 83.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.101 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.79 -27.81 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.736 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 156' ' ' VAL . 41.3 t -78.31 -26.23 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.25 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 74' ' ' MET . 2.5 p -83.25 -41.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.438 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 70.2 mt -74.22 -19.31 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.9 p -85.14 0.22 52.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.842 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.04 -55.37 0.36 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.792 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' ' 166' ' ' PHE . 77.4 Cg_exo -42.84 -43.23 9.1 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 165' ' ' PRO . 22.0 t80 36.92 43.78 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.938 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -116.46 156.44 26.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.528 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -176.24 140.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.507 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -134.95 156.31 49.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -163.55 18.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.519 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -153.46 124.64 7.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -45.81 -66.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.2 mt -56.67 162.32 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 59.26 172.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.665 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 177.47 -104.97 0.19 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -56.92 -50.04 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.512 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.92 -160.66 13.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -156.24 -26.22 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.327 . . . . 0.0 110.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.7 m80 46.67 32.3 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 12.2 t-80 -73.71 8.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 32.7 m-70 -141.9 -178.04 5.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.374 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 182' ' ' HIS . 58.2 t-80 -84.78 11.47 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.554 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.2 t60 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.607 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 tp -49.87 -39.08 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.989 0.423 . . . . 0.0 110.018 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 3' ' ' ARG . 36.7 mtp180 -56.84 -28.1 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.299 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.34 -42.95 58.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.2 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.46 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -51.51 -41.54 61.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.406 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 1.1 m-20 -66.37 -31.72 72.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -77.54 -49.51 14.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.9 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -76.65 -34.2 58.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -74.16 5.91 3.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.583 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.11 145.64 17.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -70.54 -21.15 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.614 0.245 . . . . 0.0 110.673 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 -45.14 67.09 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.93 75.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.83 0.348 . . . . 0.0 110.178 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -56.48 -41.63 76.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.328 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -69.16 -31.36 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.001 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.14 -28.84 66.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.558 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.82 -32.97 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.978 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.55 5.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -49.35 -48.43 46.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -51.76 -62.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.776 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -55.25 -31.69 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.2 tt -73.04 -41.72 63.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.505 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.13 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.77 -34.38 71.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.29 -42.6 71.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.755 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.98 -57.82 3.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.485 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 p -48.17 -31.86 6.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.72 -32.18 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.71 -17.31 62.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -94.41 -37.54 11.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.672 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -54.35 -45.97 72.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -74.56 -31.56 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.42 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.449 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -61.0 -32.16 71.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.576 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 36' ' ' MET . 19.9 m -103.23 -41.55 7.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 5.2 tpt -78.03 -0.61 28.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt 48.96 49.87 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.01 147.95 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.82 136.53 20.0 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.202 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.91 143.81 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.353 2.035 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -100.23 161.57 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 41.4 t -51.21 -51.58 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.409 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mt -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.068 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 p -48.63 -43.03 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 124' ' ' PHE . 25.2 mt -63.27 -47.16 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.61 -46.54 80.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -40.25 96.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.554 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -63.66 -35.85 81.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.93 76.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.55 -46.96 85.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.62 -49.9 11.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -46.42 -41.36 13.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.04 88.65 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 54.1 t -62.94 -44.16 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.276 0.56 . . . . 0.0 109.681 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -48.3 9.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.323 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.69 89.58 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -63.01 -37.69 88.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 110.304 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.29 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.316 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.42 -25.4 57.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.541 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -84.21 -40.77 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.2 -30.85 76.1 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.92 9.81 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.503 ' H ' ' C ' ' A' ' 61' ' ' GLY . 67.1 mt -79.79 -41.92 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.95 71.04 0.34 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.318 . . . . 0.0 110.385 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.43 13.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.959 2.44 . . . . 0.0 112.228 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 64' ' ' ALA . 19.5 pttp -113.09 -5.38 13.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.493 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.14 161.27 29.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.691 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.73 -12.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.325 2.017 . . . . 0.0 112.045 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -42.95 -35.55 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' LEU . 89.5 mtt180 -37.82 -65.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -51.46 -25.04 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.833 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.4 t -78.39 -52.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.78 -45.31 52.45 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.135 0.493 . . . . 0.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.49 -8.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.085 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.9 p -61.75 -34.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.596 0.712 . . . . 0.0 110.145 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.31 -31.82 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.594 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -65.65 -51.06 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.934 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.56 -43.87 83.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -46.24 -45.56 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.956 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -58.38 8.81 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.215 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.51 -53.85 9.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.354 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -67.87 -45.91 73.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.29 -47.91 78.89 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.7 t -68.78 -46.31 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.506 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.407 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 1.6 tm0? -54.43 -24.96 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 tp -87.25 -41.85 13.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.634 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 22.5 p -51.61 -25.74 7.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.381 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -71.31 -35.33 71.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.11 -33.85 75.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.26 -44.94 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -59.72 -52.6 64.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.518 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.646 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.7 ttt -54.34 -48.49 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.46 -37.96 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.805 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.52 -39.2 85.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.8 mm? -90.02 -5.56 56.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.7 t80 -130.48 77.46 75.9 Favored Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.161 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 97' ' ' TYR . 49.3 Cg_exo -53.04 -143.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.998 2.466 . . . . 0.0 112.56 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 98' ' ' PRO . 1.2 t 78.4 54.17 0.16 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.62 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 99' ' ' SER . 43.6 Cg_endo -70.1 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.698 2.266 . . . . 0.0 112.107 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 103' ' ' THR . 46.4 m-85 -39.91 -52.6 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.724 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.11 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 101' ' ' PHE . 19.2 p 54.71 58.32 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -70.46 166.18 20.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' SD ' ' A' ' 107' ' ' MET . 1.5 m-20 -76.77 120.71 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.501 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -44.84 107.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 107' ' ' MET . 1.1 mpt? -74.91 151.18 38.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.672 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t 57.38 92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -122.07 117.93 27.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.79 129.89 90.72 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.395 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 160.34 25.96 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.573 2.182 . . . . 0.0 111.789 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.26 -40.98 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.676 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -126.64 15.24 7.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.378 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.2 mt -120.52 80.25 30.33 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.707 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 11.3 Cg_exo -68.07 7.95 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.637 2.225 . . . . 0.0 111.386 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -76.51 -30.87 57.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 110.357 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.37 -41.11 8.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -67.58 -44.87 77.12 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.418 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.7 t90 -77.32 -13.11 60.0 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.519 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.54 74.28 71.3 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.87 -25.68 4.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.846 2.364 . . . . 0.0 111.872 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -52.43 -52.16 55.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.7 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.72 55.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.709 ' O ' HD13 ' A' ' 45' ' ' ILE . 38.1 t80 -158.93 -40.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 125' ' ' VAL . 12.1 p -54.99 128.81 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.67 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.37 148.9 21.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.1 p -155.91 128.66 7.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 106.11 -163.22 13.78 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -102.02 156.52 17.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.394 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 21.0 m -108.11 130.94 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.85 -7.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 158.03 32.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' CZ ' ' OD2' ' A' ' 136' ' ' ASP . 53.2 ttt180 -97.67 141.93 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.236 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -134.42 -31.66 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.69 146.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.707 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.476 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.0 p30 -143.24 161.1 39.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 111.993 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -114.44 136.39 53.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.773 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.22 16.77 0.28 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.99 19.7 33.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.194 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.416 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 35.2 mt -125.64 140.44 52.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.052 0.426 . . . . 0.0 110.254 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.21 148.03 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -48.7 -51.96 49.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.546 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 142' ' ' MET . 87.8 Cg_exo -44.23 -34.51 7.08 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.35 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -48.82 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.579 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.1 m95 -57.94 -57.98 10.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.879 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.0 mt -43.89 -38.74 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.2 tt -56.83 -37.3 71.03 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.31 -41.2 96.77 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 mt -76.61 -25.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.767 0.318 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.53 -46.16 80.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.36 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 pt -64.26 -41.54 92.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.288 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.34 -49.45 77.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.358 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.439 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 4.1 m-85 -59.77 -45.13 93.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.724 ' C ' HD12 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.836 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.51 -32.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.565 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 34.1 t -67.66 -48.4 76.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.502 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -57.28 -53.63 55.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 154' ' ' LEU . 96.1 t -51.44 -49.2 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.8 t -73.4 -23.11 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.1 t -81.56 -50.83 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.918 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 164' ' ' GLN . 34.4 mm -68.66 -12.38 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.274 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.8 p -53.87 -10.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.388 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 162' ' ' ILE . 15.4 tp60 -152.22 84.05 4.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.383 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -84.57 34.64 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.878 2.385 . . . . 0.0 112.157 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.97 89.85 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -52.05 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.45 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . 64.01 -161.6 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.598 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 168' ' ' ALA . 63.7 mttm 53.39 104.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.599 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -62.97 -96.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -159.91 -149.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.589 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 13.8 t70 -131.41 -148.82 0.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.37 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.508 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 1.0 OUTLIER -160.75 107.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.35 113.77 2.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -155.33 36.53 0.64 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 47.58 -155.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.487 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 178' ' ' HIS . . . -157.68 -15.28 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.421 ' H ' ' H ' ' A' ' 177' ' ' GLY . 41.1 t60 -84.33 96.54 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.556 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -78.59 67.95 4.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.662 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 43.19 -165.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -70.81 -93.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.639 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 0.9 OUTLIER -160.13 -137.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.639 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 34.0 t-80 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 2' ' ' LEU . 9.6 mp -58.59 -45.33 89.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.331 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -56.53 -37.36 70.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.561 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.99 -45.46 88.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.16 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -50.22 -41.27 49.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.071 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -68.75 -26.75 65.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.898 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -75.4 -50.48 15.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.448 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.63 69.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -76.47 -37.69 56.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.661 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -73.68 8.83 1.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.83 141.11 15.17 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 13' ' ' GLY . 3.8 ptp85 -68.49 -49.7 57.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.656 0.265 . . . . 0.0 110.713 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 12' ' ' ARG . . . -43.05 -45.77 6.16 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.12 87.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -60.49 -44.52 95.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.152 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.12 -30.14 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 21' ' ' THR . 20.9 tp -69.8 -28.06 65.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.633 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.459 ' O ' ' OG1' ' A' ' 21' ' ' THR . 20.1 mmt -74.5 -33.64 62.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.52 -54.67 15.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.564 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.22 -49.25 53.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.703 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 18' ' ' MET . 20.3 p -48.7 -57.08 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.13 -39.5 28.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.55 -41.47 69.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' THR . . . -47.14 -36.41 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.544 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.85 -36.32 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.23 -53.54 42.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.818 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -62.41 -57.97 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.833 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.9 p -46.96 -29.24 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.732 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -45.41 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.8 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -52.27 -15.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.8 t90 -93.32 -34.7 13.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.483 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.98 -42.38 80.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -69.02 -47.68 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.01 -9.05 13.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.498 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' TRP . 55.7 t -107.17 -41.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.6 mmt -96.39 10.12 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 tp 48.47 45.33 20.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.6 mt -79.54 146.65 32.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.352 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -107.61 131.22 21.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.444 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 165.22 28.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.137 1.892 . . . . 0.0 111.761 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -127.96 -175.22 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.512 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.1 mm? -69.88 -49.93 47.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.612 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.2 p -49.68 -51.14 40.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.488 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.55 -40.49 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -59.48 -43.15 93.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.787 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -59.02 -44.41 91.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.432 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -58.97 -29.63 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.25 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.51 72.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.316 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 54' ' ' VAL . . . -62.7 -52.3 63.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -54.82 9.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.035 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -48.65 -32.11 7.79 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.814 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.31 -46.29 72.31 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.945 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -70.73 -31.24 45.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.366 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.03 -46.47 75.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.284 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.71 86.41 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.01 95.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.78 -0.71 . . . . 0.0 110.557 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -29.54 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.503 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.5 tp -74.25 -32.03 62.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.57 -33.81 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -78.08 -30.13 51.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.57 5.25 1.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 0.0 110.317 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.4 mt -89.12 -23.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.607 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.02 70.09 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.794 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.45 26.6 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.702 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -109.2 -7.19 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.395 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.88 173.73 2.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.13 -8.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.22 1.947 . . . . 0.0 111.852 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -42.27 -38.74 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.4 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 10.4 mtp180 -40.04 -70.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.606 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -51.6 -18.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.092 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 69' ' ' LEU . 4.0 t -83.16 -46.6 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.61 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -40.04 68.41 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.81 -8.84 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.353 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.84 -43.97 81.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.396 0.617 . . . . 0.0 110.145 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.49 -33.36 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.4 t-105 -60.19 -55.9 28.21 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.801 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.54 -48.2 82.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -45.17 -43.95 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.6 p -79.84 -24.54 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.577 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.05 -61.24 2.75 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.69 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.42 -55.94 5.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -65.97 -51.5 57.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.68 -47.31 58.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 81' ' ' ALA . 91.1 t -68.86 -47.5 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -53.17 -30.23 36.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -42.61 63.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.4 p -54.61 -28.59 47.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.969 0.414 . . . . 0.0 110.237 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -63.34 -46.1 88.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -61.86 -40.17 94.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.718 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -70.81 -45.88 63.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.773 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.5 p -64.61 -47.69 77.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.727 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 97' ' ' TYR . 28.6 ttt -56.24 -51.35 68.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.57 -50.98 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.329 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -51.91 -37.78 53.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.388 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -91.71 -15.69 28.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.315 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 93' ' ' MET . 84.9 t80 -140.04 74.85 30.43 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -47.21 117.09 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.828 2.352 . . . . 0.0 112.297 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 101' ' ' PHE . 42.0 t -137.95 66.14 46.54 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.463 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -44.23 87.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.862 2.375 . . . . 0.0 112.252 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 99' ' ' SER . 37.0 p90 -82.3 -11.95 58.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.59 75.12 0.84 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.236 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.1 p -42.57 138.1 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 p 47.24 -151.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t0 63.74 28.32 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.685 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -48.7 -40.53 28.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.7 ptm -55.75 143.64 30.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.94 130.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.56 100.04 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.318 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -62.53 150.15 86.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.34 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.67 153.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.34 2.027 . . . . 0.0 112.062 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.61 -2.57 47.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.535 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.44 5.75 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.622 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.599 ' C ' ' H ' ' A' ' 116' ' ' LEU . 77.9 mt -117.37 83.48 16.48 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -54.14 7.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.583 2.188 . . . . 0.0 112.428 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 116' ' ' LEU . 8.2 mp -74.88 -28.43 60.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.693 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -95.8 -40.8 9.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -65.65 -33.69 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -88.63 -20.73 24.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.184 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.51 69.03 12.39 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.82 -18.06 52.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.712 2.274 . . . . 0.0 111.538 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -77.59 -3.81 42.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.179 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.704 ' O ' HG12 ' A' ' 123' ' ' VAL . 48.3 t -131.76 36.13 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.102 0.477 . . . . 0.0 110.741 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 15.9 m-85 -161.33 -43.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.72 129.8 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.066 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.09 152.83 18.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.5 t -160.68 99.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.05 -174.11 22.31 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 13.2 m-20 -88.0 157.34 18.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 2.6 m -107.86 127.63 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.05 -4.25 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.131 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -67.58 128.84 37.95 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.791 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.789 ' NE ' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -74.08 142.63 45.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.472 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -131.96 -26.81 1.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.792 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -173.0 147.82 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 20.0 p-10 -142.98 167.57 21.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 112.112 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -134.75 138.15 44.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.844 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.68 17.32 3.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.457 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 83.41 21.02 59.22 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 139' ' ' GLY . 7.0 mp -120.87 131.52 54.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.3 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -68.99 150.58 47.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.6 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.67 -54.4 23.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.082 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.97 -36.47 11.27 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.246 1.964 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -70.95 -46.04 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.0 m95 -65.31 -56.98 9.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.873 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -42.99 -37.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.15 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.36 -34.06 77.42 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.97 -40.68 91.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.79 -40.53 76.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.277 . . . . 0.0 110.279 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.37 -40.63 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.99 -46.62 93.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.75 -51.16 66.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.405 ' CD2' ' CZ2' ' A' ' 77' ' ' TRP . 4.6 m-85 -66.76 -43.69 83.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.6 tt -49.11 -30.76 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.313 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.69 -37.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.938 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 160' ' ' VAL . 87.0 t -51.64 -37.45 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.587 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -79.91 -44.36 20.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.935 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 154' ' ' LEU . 67.0 t -52.07 -44.48 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.215 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tp -81.3 -36.43 29.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.792 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.9 t -69.94 -31.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.259 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.7 -49.29 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.107 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.3 mp -62.78 -19.34 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m -52.72 -6.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 162' ' ' ILE . 36.3 mm-40 -124.86 76.29 65.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.08 21.41 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.591 2.194 . . . . 0.0 112.132 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 55.6 165.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.531 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -173.23 -56.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.406 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.78 112.67 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.416 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.16 17.29 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.476 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -92.93 21.57 5.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.549 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -80.58 -67.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.525 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 172' ' ' ASP . 1.2 p30 -151.87 88.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -71.16 131.51 43.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.364 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -165.43 -41.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 45.79 -163.65 0.1 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -125.52 132.21 52.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.42 76.61 0.22 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -171.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.737 0.303 . . . . 0.0 110.537 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.4 -179.18 7.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.603 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.601 ' CG ' ' H ' ' A' ' 181' ' ' HIS . 54.5 t-80 -160.81 175.45 12.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 180' ' ' HIS . 4.3 t-80 67.38 -72.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.448 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 10.7 t-80 39.19 -130.37 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.7 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.57 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 43.8 t60 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.65 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.13 -45.35 83.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -51.62 -43.41 62.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.44 -39.87 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 159' ' ' LEU . 1.4 tt -53.43 -44.8 69.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.75 -31.81 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -75.22 -48.57 22.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -64.75 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.654 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.7 p -76.16 -32.03 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 4.4 tt0 -74.24 9.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.965 0.412 . . . . 0.0 110.319 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.82 151.8 17.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 16' ' ' LEU . 57.9 mtm180 -69.05 -20.24 64.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.74 -44.09 64.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.24 -51.39 61.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.533 0.206 . . . . 0.0 110.991 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -54.85 -51.08 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 12' ' ' ARG . 7.0 mp -59.76 -27.61 66.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -70.46 -26.09 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.09 -34.85 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.67 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.725 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 27.0 t80 -52.9 -53.41 49.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.715 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.4 p -43.74 -53.4 5.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.442 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -26.58 66.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -79.92 -42.24 24.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.42 -36.24 61.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.756 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.38 -38.95 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.14 -45.75 79.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -57.79 5.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.572 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.1 p -46.76 -31.67 3.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.477 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.67 -44.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 tp -51.06 -17.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.654 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' VAL . 31.4 t90 -91.44 -35.83 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 1.7 m-85 -56.47 -36.99 69.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.349 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.95 -39.71 23.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.53 -22.4 61.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -109.03 -44.01 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 35' ' ' VAL . 5.4 ttt -83.98 6.47 21.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.6 mt 40.57 42.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.729 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.71 154.11 39.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.339 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -123.61 115.54 28.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.5 Cg_endo -78.29 179.95 6.02 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.274 1.983 . . . . 0.0 112.283 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 2.2 t -119.61 -175.73 3.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -65.12 -39.68 86.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.297 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.584 HD11 ' CG ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -65.21 -50.12 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.257 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.2 m -49.74 -48.21 50.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.703 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.95 -42.97 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.36 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -56.74 -45.89 81.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.053 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.17 -42.37 98.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.3 ttp85 -62.44 -34.83 77.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.45 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.137 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.59 -47.29 82.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -76.99 -47.95 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -46.9 -44.31 19.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.087 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.08 93.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 27.6 t -61.42 -47.33 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.154 0.502 . . . . 0.0 110.0 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 55' ' ' LEU . 1.3 tt -46.46 -45.38 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.63 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.56 74.11 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -65.04 -30.67 71.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.908 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.25 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.223 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.0 -43.1 99.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 mm -79.22 -35.97 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.45 -33.41 81.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 9.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 91.9 mt -83.35 -35.06 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.723 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.22 76.45 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.712 0.291 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.78 20.7 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.579 2.186 . . . . 0.0 112.062 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -109.61 -7.28 15.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.158 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.09 162.86 18.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.6 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -38.69 -16.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.512 2.141 . . . . 0.0 112.256 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 67' ' ' THR . 38.9 mt -44.05 -31.18 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 61.0 mtt180 -38.13 -65.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.39 -33.15 52.62 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.416 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.9 t -66.36 -57.75 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.496 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.35 82.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.307 0.575 . . . . 0.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -14.94 45.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.262 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 72' ' ' VAL . 1.9 p -60.25 -32.64 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.499 0.666 . . . . 0.0 110.198 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -89.34 -32.97 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.927 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.4 t-105 -67.16 -49.58 64.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.874 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 78' ' ' LEU . 4.4 tt -63.9 -51.84 62.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.924 0.393 . . . . 0.0 110.158 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -40.96 -43.21 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.36 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 p -78.89 -21.5 47.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.53 -61.22 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.816 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.61 -53.56 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.38 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -68.1 -39.24 82.89 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . . . -66.44 -44.79 89.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.43 -38.47 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.563 0.22 . . . . 0.0 111.453 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -66.46 -43.91 84.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.278 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.17 -45.91 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.9 p -46.94 -50.28 19.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.502 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -53.05 -30.68 37.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.506 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.45 -39.96 89.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.584 ' CG ' HD11 ' A' ' 43' ' ' LEU . 2.8 m170 -64.75 -43.62 92.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.189 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -65.19 -38.87 91.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' TYR . 37.6 ttp -52.06 -45.02 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.4 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.302 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -55.9 -41.24 74.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.433 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 tp -89.09 -18.24 27.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.8 t80 -142.35 75.9 19.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.94 0.4 . . . . 0.0 110.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 97' ' ' TYR . 52.0 Cg_exo -51.41 -167.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.722 2.281 . . . . 0.0 112.173 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -139.25 168.1 16.61 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.356 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 99' ' ' SER . 77.4 Cg_exo -44.85 175.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.628 2.218 . . . . 0.0 112.291 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -126.69 121.41 32.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.433 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -161.19 49.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.8 p 45.73 33.16 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.553 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 m -75.9 78.59 2.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -76.55 118.37 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.419 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' A' ' 107' ' ' MET . 29.2 t80 -62.34 -56.38 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 106' ' ' PHE . 12.8 ttp 59.65 123.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.561 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 108' ' ' VAL . 8.4 p -48.06 120.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -150.9 99.73 2.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.469 ' O ' ' OE1' ' A' ' 112' ' ' GLU . 1.6 m-85 -132.4 156.64 79.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.023 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -37.68 150.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.801 2.334 . . . . 0.0 112.433 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.469 ' OE1' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -107.08 7.98 30.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.468 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.544 ' HE1' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.8 -3.21 58.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.662 ' C ' ' H ' ' A' ' 116' ' ' LEU . 20.7 mt -118.76 88.11 34.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.917 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.6 Cg_exo -53.76 11.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.153 . . . . 0.0 112.261 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.662 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -71.4 -30.12 65.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 109.868 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.444 ' CG ' ' CE1' ' A' ' 124' ' ' PHE . 74.5 m-20 -97.29 -40.79 8.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -72.36 -45.77 58.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.821 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.8 t90 -72.91 -12.84 61.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.77 74.01 39.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.563 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.55 -20.69 10.63 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.756 2.304 . . . . 0.0 112.038 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -53.22 -53.11 55.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.23 55.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.017 0.437 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.444 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 37.2 t80 -158.78 -42.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.22 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 125' ' ' VAL . 12.4 p -58.02 128.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.584 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.43 160.61 14.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' PRO . 43.2 p -173.8 103.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.562 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.66 177.29 18.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -81.61 140.11 34.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.183 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 57.2 m -87.93 132.83 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.947 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.97 2.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.223 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -67.54 144.76 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -93.74 125.3 38.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 110.797 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.56 -23.26 6.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.764 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.45 138.95 47.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.841 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -141.7 119.68 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -123.04 132.99 54.35 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.29 17.31 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.65 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.88 17.54 56.16 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.633 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.2 mp -123.49 144.08 49.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.632 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.0 mp0 -77.72 157.82 29.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.646 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.6 OUTLIER -51.12 -53.58 47.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.8 Cg_exo -40.54 -38.86 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.375 2.05 . . . . 0.0 112.304 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -69.8 -54.19 14.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.607 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.1 m95 -62.81 -57.79 9.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.463 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 tt -42.92 -36.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.509 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.77 -33.02 74.91 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.86 -44.99 96.57 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.724 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -76.04 -25.88 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 154' ' ' LEU . 32.5 t80 -62.63 -44.85 95.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.486 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 155' ' ' ILE . 20.4 pt -69.4 -36.65 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.358 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.91 71.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.97 -49.43 66.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.793 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.541 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 19.3 mt -62.65 -31.94 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.3 mp -72.68 -32.47 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -70.63 -46.01 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -55.09 -48.56 73.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.77 -24.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 5' ' ' LEU . 9.8 tp -78.01 -41.54 35.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.251 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.4 -20.38 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 157' ' ' ALA . 39.7 t -81.19 -50.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.81 -21.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.446 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 164' ' ' GLN . 44.3 m -52.86 -44.42 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.284 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.538 ' C ' ' H ' ' A' ' 166' ' ' PHE . 37.9 mt-30 55.52 151.5 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.62 17.89 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.313 2.008 . . . . 0.0 111.862 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.538 ' H ' ' C ' ' A' ' 164' ' ' GLN . 74.8 t80 -94.89 138.53 32.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.538 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.472 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -109.6 -177.14 3.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -178.06 -91.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.363 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.21 158.41 31.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.407 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -134.77 -111.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.506 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -130.03 139.93 50.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 173' ' ' LEU . 42.4 t0 -158.99 -100.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.583 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 172' ' ' ASP . 14.1 mt 54.51 108.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -150.75 135.52 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.17 157.41 23.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -160.74 -34.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.07 131.07 4.96 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 178' ' ' HIS . 26.8 p-80 -152.61 83.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.512 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -151.64 161.96 41.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -93.24 158.75 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 53.74 91.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -140.2 121.38 14.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 20.2 m170 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.537 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 2.1 pp -64.25 -37.85 88.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.335 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -53.2 -32.47 48.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.586 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 91.9 t80 -76.86 -42.61 39.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -46.59 -45.1 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.545 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 4.3 p-10 -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 62.7 tt0 -78.41 -48.28 15.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.16 96.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 11' ' ' GLY . 14.7 m -76.69 -36.11 57.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 13.9 tt0 -64.45 2.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.287 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.66 150.69 19.54 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.2 mtt85 -70.48 -45.53 65.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.465 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.11 -45.26 15.01 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.37 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -60.93 -48.44 81.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -57.64 -31.22 66.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.081 0.467 . . . . 0.0 109.781 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.49 -25.71 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.791 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.3 mmt -74.34 -34.17 63.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.22 -54.29 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.861 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.04 -47.92 61.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.752 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 p -52.54 -50.22 63.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.29 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.734 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.29 -39.17 82.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.04 -36.78 60.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.78 -35.6 62.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' OE1' ' NH2' ' A' ' 48' ' ' ARG . 3.8 tp10 -68.73 -46.89 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.927 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.3 tt -65.71 -58.16 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 p -48.91 -32.35 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.62 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.6 mt -53.37 -13.56 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -95.1 -31.89 13.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.69 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.13 -34.36 77.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.73 -43.17 23.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -18.63 53.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.81 -48.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.647 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 tpt -83.33 6.49 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 41.69 41.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.44 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 39' ' ' LYS . 5.8 tt -62.83 151.85 37.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.117 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -113.47 90.61 17.88 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.241 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.62 146.39 34.58 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.554 2.169 . . . . 0.0 112.337 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.9 t -99.83 173.25 6.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.09 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 10.0 p -61.04 -41.4 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.8 mp -68.11 -47.79 67.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.272 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 m -50.2 -48.95 53.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.703 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.47 -44.24 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.49 -45.7 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.07 -39.8 93.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.679 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' NH2' ' OE1' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -61.11 -34.43 74.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.289 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 -39.04 88.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.568 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.5 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.1 -51.45 15.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -45.33 -43.19 10.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.053 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.9 96.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' ALA . 66.2 t -57.72 -46.47 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.26 0.553 . . . . 0.0 110.172 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.1 tp -48.48 -43.25 34.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.698 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.99 71.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.72 -35.15 60.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.566 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.93 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.75 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.45 ' O ' HD11 ' A' ' 63' ' ' ILE . 12.0 mt -75.42 -40.86 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.789 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -78.63 -31.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.23 -31.82 33.34 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.32 0.88 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.709 0.29 . . . . 0.0 110.885 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 59' ' ' LEU . 7.8 mm -88.45 -24.08 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.98 65.6 0.3 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.808 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.55 18.7 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.736 2.291 . . . . 0.0 111.625 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -106.54 -10.24 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.627 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -109.77 176.48 1.53 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.819 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.06 1.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.234 1.956 . . . . 0.0 111.796 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 67' ' ' THR . 12.2 tp -58.35 -31.27 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -39.86 -64.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.757 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 75' ' ' VAL . 23.7 t80 -53.19 -33.56 53.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.57 -46.56 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.85 -40.43 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.214 0.531 . . . . 0.0 109.925 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.8 mmt -59.89 -25.99 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.367 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -52.28 -29.08 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.488 0.661 . . . . 0.0 109.712 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.11 -31.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.091 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.469 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.8 t-105 -63.91 -46.26 85.6 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 78' ' ' LEU . 3.9 tt -67.77 -52.46 37.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -41.75 -41.55 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.297 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 p -81.39 -24.49 36.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.65 -59.04 6.08 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.989 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -74.89 -51.4 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.204 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.38 -46.09 77.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.78 -47.36 90.8 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.4 t -68.6 -56.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.217 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -49.87 -21.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.818 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.77 -35.91 14.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.033 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.9 p -59.05 -55.18 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.03 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.531 ' CZ ' ' SD ' ' A' ' 93' ' ' MET . 87.6 t80 -52.23 -38.61 58.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -57.14 -40.14 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -35.04 79.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.4 p -72.92 -36.54 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' TYR . 58.8 mmm -54.02 -49.06 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -60.52 -49.93 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.422 ' C ' HD12 ' A' ' 96' ' ' LEU . 51.5 mt-30 -50.23 -36.46 31.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 96' ' ' LEU . 11.1 mp -102.06 -9.77 20.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.641 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 93' ' ' MET . 25.5 t80 -125.59 75.75 69.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.42 89.03 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -141.2 153.6 66.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -38.45 99.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.5 44.09 2.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -37.6 102.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.4 p -56.31 149.78 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.7 p -85.14 -87.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.78 61.29 0.76 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.588 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.47 69.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.488 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.634 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -166.98 95.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.158 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.7 -15.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.634 ' H ' ' C ' ' A' ' 107' ' ' MET . 14.0 ttp180 -95.41 106.55 18.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.395 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 157.43 76.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.348 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -36.76 125.76 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.851 2.367 . . . . 0.0 112.264 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -86.9 -11.02 51.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -2.24 56.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 116' ' ' LEU . 41.5 mt -120.11 87.12 38.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.6 Cg_exo -51.78 4.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.64 2.227 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 114' ' ' LEU . 13.8 mt -64.07 -30.23 71.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.1 -43.05 7.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.6 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -71.53 -44.96 63.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.437 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.3 t90 -74.64 -15.98 60.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.71 71.15 64.94 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.2 -22.87 10.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 111.919 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -55.1 -53.98 48.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.25 63.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.547 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -169.28 -42.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.81 131.05 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.67 156.45 16.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.59 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 85.2 p -166.76 100.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.4 -167.3 25.03 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -100.27 166.88 10.76 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -112.23 130.1 56.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 96.74 6.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.028 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.28 139.33 46.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -100.14 126.38 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.661 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -127.2 -14.4 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.6 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -173.38 132.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -143.25 161.29 38.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.258 0.551 . . . . 0.0 112.077 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 23.6 t80 -123.22 138.98 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.158 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 1.1 mm? 54.26 17.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.164 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.19 57.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 9.5 mt -124.41 136.64 54.21 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.02 148.32 50.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.424 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mtp -49.12 -52.01 51.54 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 142' ' ' MET . 71.1 Cg_exo -45.6 -38.12 16.24 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.41 2.073 . . . . 0.0 112.321 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -68.92 -46.18 68.94 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 148' ' ' GLY . 62.1 m95 -62.75 -56.15 20.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.211 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mt -43.12 -37.94 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.943 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -63.91 -35.22 79.94 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.92 -36.82 75.07 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.02 -33.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.75 -44.35 90.52 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.034 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.56 -49.24 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.022 0.439 . . . . 0.0 109.843 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.37 57.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.066 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -61.16 -49.83 75.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.332 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 154' ' ' LEU . 8.1 tt -47.53 -32.23 5.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.442 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.27 -38.11 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.14 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.3 t -54.39 -39.88 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.34 -45.55 25.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.313 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 34.7 t -52.27 -42.53 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.202 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mt -84.12 -41.41 17.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.433 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 156' ' ' VAL . 44.5 t -61.87 -25.37 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.756 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' ALA . 64.7 t -83.08 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 109.969 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 162' ' ' ILE . 80.6 mt -65.0 -8.59 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.312 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 60.2 p -53.9 -10.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.821 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.548 ' C ' ' H ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -135.48 75.17 58.45 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.647 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.96 20.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.857 2.371 . . . . 0.0 112.097 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.548 ' H ' ' C ' ' A' ' 164' ' ' GLN . 42.5 t80 -64.43 163.01 14.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.45 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.5 tttt 59.03 49.51 9.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.447 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -178.64 134.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.615 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.0 159.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -73.15 -136.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.38 -174.81 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.534 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -157.6 146.02 19.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER 51.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -175.2 115.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.536 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -177.44 -35.72 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -142.73 136.26 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.844 0.354 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 179' ' ' HIS . . . 161.75 -85.91 0.11 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.466 ' O ' ' CG ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER 63.4 -6.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.71 0.29 . . . . 0.0 110.767 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 177' ' ' GLY . 69.6 m-70 -158.76 80.14 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.524 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.605 ' N ' ' ND1' ' A' ' 180' ' ' HIS . 0.0 OUTLIER -162.73 83.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.582 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 44.3 t-80 -69.98 -107.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.564 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.582 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 91.7 m-70 56.54 86.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.559 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.598 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 2' ' ' LEU . 6.7 mp -66.4 -38.54 87.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.192 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -50.48 -36.1 32.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' GLN . 44.6 m-85 -75.47 -40.23 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.323 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.9 tp -45.06 -40.48 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -70.16 -21.75 63.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.404 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' PHE . 40.7 tt0 -79.93 -47.0 15.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.92 -31.72 73.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.95 0.405 . . . . 0.0 110.314 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 28.9 m -76.03 -41.47 50.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.21 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 10' ' ' GLN . 1.6 pp0? -70.4 8.93 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.558 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.76 142.43 16.08 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -65.76 -20.64 66.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.659 0.266 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.82 -47.57 54.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.36 -51.61 68.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 0.0 110.469 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -55.78 -46.36 77.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.517 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.63 -31.73 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -69.39 -28.11 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -74.89 -33.91 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.796 0.331 . . . . 0.0 110.138 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.49 43.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 71.4 t80 -54.33 -53.44 53.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.73 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.1 p -43.12 -49.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.678 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.49 69.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.3 tt -76.98 -38.72 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.639 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.25 42.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -75.85 -31.45 59.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.571 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -49.89 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.4 tt -63.96 -57.55 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.599 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -45.19 -34.82 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' C ' ' N ' ' A' ' 31' ' ' TRP . . . -82.96 -46.44 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.97 -16.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.531 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.402 ' N ' ' C ' ' A' ' 29' ' ' ALA . 44.1 t90 -94.19 -25.98 16.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 135' ' ' TRP . 0.2 OUTLIER -70.26 -43.15 71.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.519 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' LEU . 34.8 tt0 -73.74 -48.04 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.613 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -49.99 -28.63 7.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.714 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.12 -45.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.696 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 2.07 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.506 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLN . 16.2 mt 43.15 43.64 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.4 149.66 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.395 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -115.37 88.31 18.59 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.79 174.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 112.008 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.59 -172.58 2.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.39 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 43' ' ' LEU . 10.7 m -64.44 -42.94 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' N ' HG23 ' A' ' 42' ' ' VAL . 7.6 mt -64.94 -49.09 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.304 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -59.1 -50.54 73.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.17 -47.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.11 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' OH ' ' CE1' ' A' ' 110' ' ' PHE . 3.7 m-85 -57.76 -44.18 85.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 109.971 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -61.7 -38.52 88.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.464 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -60.96 -33.49 73.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 -34.64 76.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.225 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.6 77.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.326 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 51' ' ' LEU . 2.8 tt -72.9 -55.36 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.906 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -42.51 -38.41 1.93 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.35 -41.32 94.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -61.7 -47.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.38 -46.12 18.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.505 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.6 -27.64 70.08 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.71 -31.12 70.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 110.293 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.65 -30.99 59.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.329 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.21 -37.92 72.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.334 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.84 -36.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.34 -26.39 63.79 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.79 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -83.14 -28.71 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.667 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.61 77.07 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.86 22.2 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.6 2.2 . . . . 0.0 112.129 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -113.29 -7.56 13.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -109.87 161.67 23.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.677 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.62 -15.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.482 2.121 . . . . 0.0 112.091 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.7 mp -44.64 -29.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttp180 -40.67 -67.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.577 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.745 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.9 t80 -56.03 -28.7 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 t -69.11 -45.72 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.34 -34.58 36.51 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.302 0.573 . . . . 0.0 110.244 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 74' ' ' MET . 7.0 tmm? -61.72 -13.55 24.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.276 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 71' ' ' TYR . 75.0 t -57.97 -36.82 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 110.257 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 mm -88.05 -31.97 5.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.177 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.501 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -64.11 -52.81 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -65.2 -47.29 77.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.681 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -44.27 -43.69 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 p -79.97 -22.77 42.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.654 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.08 -60.99 2.95 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.07 -53.2 9.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.209 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -66.4 -46.27 77.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.64 -46.85 91.68 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' ALA . 87.6 t -67.73 -44.93 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -58.07 -27.21 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 tp -81.29 -44.06 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.415 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 17.2 p -52.8 -25.47 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 0.0 110.168 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -48.49 53.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.6 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -51.93 -38.33 56.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -65.57 -46.77 78.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -65.37 -47.06 77.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' TYR . 27.2 mmm -44.74 -47.67 10.78 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.5 -50.17 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.628 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.7 -29.62 7.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.39 -15.5 17.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.384 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 m-85 -128.81 75.48 79.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.212 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -48.35 175.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.697 2.265 . . . . 0.0 112.181 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -170.7 67.73 0.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.437 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.58 154.5 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.761 2.307 . . . . 0.0 112.124 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.59 166.27 33.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.58 -25.7 54.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.633 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.439 HG23 ' CZ ' ' A' ' 106' ' ' PHE . 10.6 t -130.55 143.75 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 106' ' ' PHE . 78.1 p -92.63 -75.64 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -48.0 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 104' ' ' SER . 6.2 m-85 -91.62 77.71 5.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.374 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ttt -62.73 140.34 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.284 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.59 161.8 34.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.694 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -130.62 99.75 5.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.507 ' CE1' ' OH ' ' A' ' 46' ' ' TYR . 1.7 m-85 -79.43 158.81 73.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.146 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 110' ' ' PHE . 82.8 Cg_exo -35.6 158.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.685 2.257 . . . . 0.0 112.157 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 8.8 mp0 -105.81 15.31 26.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.2 p-90 -87.52 -1.28 57.83 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.315 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.0 79.78 50.97 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.388 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.5 Cg_exo -49.5 -1.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.619 2.213 . . . . 0.0 112.298 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -57.84 -33.1 68.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.479 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 46.3 m-20 -96.3 -43.64 7.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.3 -45.17 77.34 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.413 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 34.1 t-105 -73.93 -16.81 61.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.912 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 123' ' ' VAL . 2.4 t -147.8 68.69 10.83 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.78 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.72 -11.72 26.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.871 2.381 . . . . 0.0 111.649 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.67 -6.4 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.205 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 120' ' ' VAL . 17.4 m -138.57 35.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.479 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 72.7 t80 -153.29 -39.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.351 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.56 128.25 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.93 155.76 16.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -166.29 108.14 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.706 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 133.52 177.83 15.19 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.1 138.04 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 26.9 m -89.95 132.4 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.04 -4.14 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.97 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.19 129.11 38.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.174 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -85.0 117.44 23.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -122.32 -3.82 8.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.52 ' NE1' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 t90 -172.78 129.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -145.52 158.54 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.293 0.568 . . . . 0.0 112.019 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -122.98 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.632 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 55.38 17.28 2.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.53 53.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mt -123.91 134.28 53.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.698 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 7.0 pm0 -71.06 149.6 46.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 145' ' ' TRP . 8.2 mtt -45.83 -62.16 1.99 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.1 Cg_exo -34.57 -37.66 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -74.31 -41.15 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.625 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.5 m95 -67.06 -58.26 5.26 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.758 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.0 mt -43.98 -38.22 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -34.49 75.76 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -62.68 -48.93 77.63 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.53 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.08 -35.09 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -38.86 72.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.846 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.17 -40.04 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.019 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.42 73.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.149 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.0 -41.39 97.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.339 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.0 tt -52.24 -33.25 40.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -82.71 -38.72 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.659 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 160' ' ' VAL . 64.8 t -52.92 -40.53 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.71 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.501 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -78.07 -46.89 19.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 154' ' ' LEU . 70.5 t -52.71 -50.17 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.982 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.26 -33.99 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.023 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 156' ' ' VAL . 48.0 t -75.74 -26.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.9 t -68.87 -45.28 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -71.87 -25.74 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.8 p -54.83 -7.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.704 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 162' ' ' ILE . 5.4 pt20 -43.56 148.98 0.64 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.437 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.436 2.091 . . . . 0.0 112.044 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -66.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.477 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -139.91 126.72 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -165.91 -149.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.459 ' CB ' ' NZ ' ' A' ' 169' ' ' LYS . 6.1 mtpm? 55.74 164.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -172.48 167.92 5.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.519 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -45.21 118.65 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -163.87 71.15 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.71 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.0 mt -145.96 -16.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.372 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 174' ' ' PHE . 38.7 p90 -73.12 129.77 38.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.706 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 177' ' ' GLY . . . -126.93 54.2 0.77 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 64.52 -68.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.833 0.349 . . . . 0.0 110.423 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 175' ' ' GLY . . . 71.37 -115.49 5.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -52.04 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.585 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.495 ' ND1' ' N ' ' A' ' 180' ' ' HIS . 1.2 p80 -167.25 -149.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 179' ' ' HIS . 77.1 m80 -79.32 119.18 22.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.92 115.54 22.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.328 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -49.5 106.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.573 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 tpt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.62 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.4 tt -54.2 -36.32 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -31.86 68.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.3 -45.07 67.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.111 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.4 mm? -50.08 -37.59 34.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.996 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.491 ' OD1' ' NE2' ' A' ' 10' ' ' GLN . 9.5 t-20 -66.89 -28.79 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.183 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -80.22 -49.43 11.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.702 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.23 -32.59 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.9 p -76.86 -38.69 53.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.504 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.491 ' NE2' ' OD1' ' A' ' 6' ' ' ASN . 41.3 mt-30 -68.01 5.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.26 141.04 15.23 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -69.13 -51.14 41.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 110.661 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.92 -45.58 5.95 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.32 90.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -62.3 -40.05 95.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.123 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.79 -31.11 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 21' ' ' THR . 5.3 mt -70.6 -28.51 64.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.68 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.66 -34.49 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.103 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.13 27.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' LEU . 13.8 t80 -53.7 -53.8 46.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.751 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 17' ' ' LEU . 36.4 p -44.59 -55.18 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.613 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' OE2' ' A' ' 26' ' ' GLU . . . -58.54 -22.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.62 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.17 -41.57 15.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -40.03 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -72.53 -35.77 68.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.772 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -70.6 -44.25 67.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.17 -58.08 4.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.622 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p -47.22 -34.14 6.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.254 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -79.09 -42.88 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.6 -16.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.794 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.443 ' O ' HG12 ' A' ' 35' ' ' VAL . 66.9 t-105 -91.68 -34.0 14.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.629 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 4.9 m-85 -62.48 -31.21 71.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.459 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 6.9 mp0 -81.02 -44.86 17.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -63.62 -17.67 63.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 36' ' ' MET . 9.8 p -109.3 -41.59 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.51 ' N ' HG13 ' A' ' 35' ' ' VAL . 8.1 tpt -85.9 4.9 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.754 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.4 mp 48.06 34.61 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 134' ' ' GLN . 20.8 mt -79.63 154.71 28.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -125.24 128.23 24.81 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.563 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.83 -179.84 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.383 2.055 . . . . 0.0 112.073 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -128.31 -170.97 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.297 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.9 p -66.26 -44.72 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' N ' HG13 ' A' ' 42' ' ' VAL . 83.8 mt -67.22 -50.43 60.79 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -50.35 -50.89 49.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.52 -41.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.96 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -57.28 -47.81 80.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.854 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.94 -43.28 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.089 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -56.46 -33.64 66.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.901 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.117 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.8 -48.68 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.084 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.4 mm? -75.0 -47.47 28.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 51' ' ' LEU . 38.9 t80 -44.01 -39.67 4.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.42 -39.82 87.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' LEU . 71.5 t -60.33 -17.47 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.368 0.604 . . . . 0.0 109.423 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 tp -83.43 -39.49 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.79 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.3 -38.94 81.98 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.81 72.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.61 -23.22 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.26 -37.09 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.852 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.69 -38.22 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.018 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -63.64 -40.57 98.75 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.52 11.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.064 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' H ' ' C ' ' A' ' 61' ' ' GLY . 90.8 mt -88.32 -25.67 5.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.25 68.76 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.697 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.65 21.01 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.609 2.206 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 26.5 tttp -112.62 -3.67 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.87 166.02 12.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -42.57 -11.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.238 1.959 . . . . 0.0 112.076 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -41.51 -38.55 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.345 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.7 mtm105 -38.66 -69.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.26 -17.1 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.042 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.6 t -83.14 -48.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.249 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 -34.49 60.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.274 0.559 . . . . 0.0 110.043 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.2 ttt -59.51 -9.56 2.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.112 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.65 -43.39 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.425 0.631 . . . . 0.0 110.423 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -88.26 -29.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.645 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.654 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.1 t-105 -65.63 -53.34 42.85 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.781 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.98 -45.36 85.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -44.19 -45.49 8.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.966 0.412 . . . . 0.0 110.357 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 p -80.3 -21.06 42.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.049 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.53 -62.28 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.921 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -73.59 -49.34 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.297 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -72.24 -43.69 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.72 -48.33 85.6 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' O ' ' OG1' ' A' ' 88' ' ' THR . 75.1 t -72.83 -50.94 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.637 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' C ' ' OE1' ' A' ' 86' ' ' GLN . 1.1 tm0? -50.11 -23.39 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.022 0.439 . . . . 0.0 109.991 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.67 -41.33 14.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.589 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 84' ' ' GLY . 23.6 p -51.87 -23.68 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -71.19 -31.02 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.492 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.44 -37.61 51.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -70.29 -58.61 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -54.69 -43.28 72.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.706 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.7 ttt -57.78 -44.77 86.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.58 -48.4 81.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.663 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -52.26 -43.04 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.1 mp -91.08 -9.77 44.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.17 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.6 t80 -131.33 71.51 81.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.85 -167.92 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.379 2.053 . . . . 0.0 111.912 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.08 164.66 17.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -39.26 117.7 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 43.21 -165.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.45 42.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.553 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 p -79.36 -156.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.535 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m -123.96 -58.4 1.56 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.406 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 49.59 -136.13 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' MET . 88.4 m-85 -69.22 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 106' ' ' PHE . 5.6 mmt 56.73 114.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.463 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.722 ' O ' HG22 ' A' ' 108' ' ' VAL . 8.1 p 37.5 43.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.156 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.09 99.91 2.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.132 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -122.22 160.85 45.96 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.237 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -38.41 137.15 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.822 2.348 . . . . 0.0 112.236 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.98 -4.62 58.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.522 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -0.85 54.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.605 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' A' ' 116' ' ' LEU . 11.8 mt -121.81 81.81 41.83 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.289 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.2 Cg_exo -51.25 2.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.757 2.305 . . . . 0.0 112.635 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.8 mt -62.57 -32.74 73.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.947 0.403 . . . . 0.0 110.142 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 110' ' ' PHE . 2.7 p30 -96.43 -40.59 9.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.47 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 78.1 tttt -72.1 -45.4 60.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.663 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -72.78 -15.57 61.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.128 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.54 73.39 29.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.66 -17.89 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.848 2.366 . . . . 0.0 111.886 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -52.59 -49.24 65.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.847 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.49 54.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.78 -41.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.296 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.07 129.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.48 155.05 17.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -167.34 112.08 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.594 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 129.42 -179.98 16.37 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 m-20 -81.97 137.08 35.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.225 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -90.68 132.49 35.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.82 -6.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -67.88 152.35 45.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -85.08 138.0 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.634 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.465 ' HB3' HD22 ' A' ' 38' ' ' LEU . 15.2 mt-30 -128.79 -29.43 2.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -174.92 138.96 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -133.65 163.44 29.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.48 0.657 . . . . 0.0 112.394 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.688 ' CE2' HD23 ' A' ' 138' ' ' LEU . 35.7 t80 -123.32 135.55 54.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.766 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.688 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.8 mm? 51.43 17.13 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.649 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 94.09 14.28 52.11 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.189 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 139' ' ' GLY . 4.0 mm? -119.68 139.84 51.6 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 24.4 mp0 -73.2 154.11 40.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.598 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.46 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 5.9 mtt -49.24 -63.17 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.256 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.541 ' O ' HD13 ' A' ' 147' ' ' LEU . 86.6 Cg_exo -31.72 -41.72 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.95 2.433 . . . . 0.0 112.594 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.75 -49.48 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.408 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -63.91 -57.44 9.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt -43.7 -39.57 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 143' ' ' PRO . 3.5 mp -61.89 -35.76 79.29 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.84 -41.38 91.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.6 mp -80.41 -26.77 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 154' ' ' LEU . 43.2 t80 -60.99 -48.78 80.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.533 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 tt -67.73 -39.52 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -48.76 -45.81 40.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.096 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -65.4 -44.27 88.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.007 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 150' ' ' PHE . 66.6 mt -63.33 -30.87 71.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.74 -27.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 160' ' ' VAL . 25.6 t -75.29 -29.8 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.654 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -73.67 -50.87 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.989 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 159' ' ' LEU . 19.6 m -54.27 -52.07 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.934 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 158' ' ' VAL . 5.3 mt -63.29 -36.65 84.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.623 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 156' ' ' VAL . 9.4 t -65.76 -33.91 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.7 -52.73 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 109.818 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.7 mp -60.69 -9.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.214 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 92.1 p -52.25 -8.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 162' ' ' ILE . 16.4 mt-30 -86.33 153.88 56.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -36.72 -26.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.789 2.326 . . . . 0.0 112.421 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 164' ' ' GLN . 79.0 t80 -54.46 119.02 4.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.621 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -94.79 -173.72 3.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.8 171.53 12.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.763 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 170' ' ' LYS . 14.3 pttt -88.85 -52.08 5.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.445 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 169' ' ' LYS . 39.9 mttp -150.36 -177.39 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -71.57 148.62 46.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.555 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.67 -166.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER -80.21 -167.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 173' ' ' LEU . 9.8 m-85 -45.08 171.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -165.58 -142.98 3.58 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -157.15 91.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.52 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -107.46 79.28 0.25 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -78.59 167.17 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.355 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -81.76 139.13 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.497 ' H ' ' CD2' ' A' ' 180' ' ' HIS . 8.5 p80 -86.31 -113.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.517 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 39.6 t-80 -162.5 161.08 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.617 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.477 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 0.3 OUTLIER -48.37 110.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.481 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpp? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt -58.5 -38.45 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.449 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -56.0 -39.89 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.564 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLN . 17.9 m-85 -69.72 -42.8 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.61 -40.41 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.176 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.72 -21.69 63.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.102 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' PHE . 11.5 tp60 -80.53 -47.01 14.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.541 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 -32.68 73.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.625 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.2 p -76.45 -33.66 58.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.12 10.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 110.489 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.31 142.57 15.52 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -65.05 -20.51 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.244 . . . . 0.0 110.416 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.45 -46.23 71.73 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.12 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 0.0 110.366 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -56.19 -49.43 74.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.712 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.77 -31.77 73.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.525 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.09 -27.76 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.545 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 31.9 mtt -76.76 -33.85 58.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.348 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.09 -55.2 11.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.696 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . 83.0 t80 -53.88 -54.64 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.661 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -42.72 -58.87 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.662 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -58.33 -24.51 59.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' PHE . 6.2 tp -80.26 -41.32 25.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.4 -34.32 61.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.521 HD21 HD11 ' A' ' 146' ' ' LEU . 6.1 tt -70.57 -35.04 72.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.54 -49.94 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.613 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 30' ' ' LEU . 35.8 mt -64.91 -57.37 8.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.612 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 m -44.24 -40.42 5.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.47 -27.14 46.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.36 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.4 tp -63.98 -18.76 64.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.653 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -83.32 -37.3 23.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' O ' ' CB ' ' A' ' 36' ' ' MET . 13.7 m-85 -62.75 -36.65 83.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -79.46 -47.02 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.919 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 57.9 t-80 -62.6 -15.88 53.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.35 -46.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.439 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tpt -87.71 9.92 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.065 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.7 mp 43.26 48.58 5.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.33 146.5 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.377 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -115.47 84.18 11.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.246 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.78 172.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.531 2.154 . . . . 0.0 112.235 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.69 171.59 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.569 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 61.8 t -47.59 -42.99 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.313 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 43' ' ' LEU . 8.9 mp -75.05 -40.66 60.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.572 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.4 t -55.74 -49.77 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.007 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 124' ' ' PHE . 13.0 pt -66.16 -37.02 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.451 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.26 -45.82 92.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.936 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.95 -39.87 79.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.88 -31.22 70.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.28 76.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.305 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.76 -48.58 81.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.26 -51.58 11.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -45.12 -37.74 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.79 84.38 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 78.1 t -65.81 -47.1 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.934 0.397 . . . . 0.0 110.025 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.72 -48.51 10.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.474 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.57 97.95 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -50.85 -44.38 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.695 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.41 64.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tp -76.64 -37.75 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -81.76 -31.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.686 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.71 -30.46 66.18 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.66 5.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.56 0.219 . . . . 0.0 111.149 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -85.52 -25.59 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.624 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.22 74.91 0.27 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 73.6 Cg_endo -79.38 16.81 1.33 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.728 2.286 . . . . 0.0 112.242 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -113.76 -3.86 13.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.39 162.18 22.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.691 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.69 -16.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.038 . . . . 0.0 111.792 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 tp -42.95 -33.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.362 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.69 -67.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -55.86 -21.82 22.03 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.69 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' LEU . 10.5 t -76.99 -43.34 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.584 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.26 62.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.19 -10.42 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.267 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.09 -43.42 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.349 0.595 . . . . 0.0 110.144 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -86.96 -32.59 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.818 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -61.49 -55.57 29.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.051 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.14 -47.19 80.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -44.38 -45.3 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.311 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -79.24 -22.88 44.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.78 -59.43 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.991 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.02 -53.49 9.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -66.66 -46.02 77.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.08 -47.84 84.3 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 88' ' ' THR . 78.8 t -68.47 -50.32 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -48.63 -26.12 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.97 -38.76 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 68.8 p -55.49 -29.56 59.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.765 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.15 -41.82 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.721 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.12 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -43.04 40.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.651 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.4 p -72.14 -43.6 64.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 22.4 ttp -54.49 -51.11 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.705 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -49.32 75.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.425 ' NE2' ' CD ' ' A' ' 141' ' ' GLU . 26.8 tt0 -55.71 -44.72 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.37 -22.55 35.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.754 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 12.3 t80 -144.27 81.8 11.16 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.3 134.12 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.633 2.222 . . . . 0.0 111.972 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 161.07 60.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 101' ' ' PHE . 55.4 Cg_endo -71.12 94.87 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.637 2.224 . . . . 0.0 112.03 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 100' ' ' PRO . 74.8 t80 55.72 111.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.91 4.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -48.02 97.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.7 t -155.45 54.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 2.0 p30 -151.91 97.25 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -81.4 -171.82 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.0 tpt -161.71 -37.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 109' ' ' ARG . 29.2 m -40.91 -40.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' N ' HG23 ' A' ' 108' ' ' VAL . 20.7 mtt85 -81.26 100.04 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.344 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.61 155.48 37.35 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.85 159.12 9.74 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.582 2.188 . . . . 0.0 111.892 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.23 -12.16 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.34 11.68 35.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.75 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.7 tp -123.13 61.16 17.64 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.13 11.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.6 2.2 . . . . 0.0 112.038 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -77.72 -29.96 51.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 109.655 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 4.3 p-10 -96.05 -42.34 8.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.266 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 118' ' ' LYS . 20.4 mtpt -60.38 -38.09 82.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -83.4 -12.59 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.583 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.3 76.52 18.61 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.889 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 125' ' ' VAL . 73.0 Cg_endo -79.51 -19.39 10.19 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 111.909 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -68.63 -3.88 13.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.336 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 124' ' ' PHE . 2.4 t -145.22 37.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 123' ' ' VAL . 16.9 m-85 -153.56 -40.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.534 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 121' ' ' PRO . 16.4 m -62.0 131.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.564 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.3 146.9 23.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 t -159.64 100.11 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.7 -171.43 23.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -96.96 151.8 19.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.27 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.1 m -103.79 129.81 51.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.58 -7.63 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -67.83 156.91 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.514 ' H ' ' CD ' ' A' ' 132' ' ' GLU . 29.8 mtp85 -97.11 126.51 42.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.807 0.337 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -120.2 -29.84 4.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -174.1 141.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.45 161.11 39.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.193 0.52 . . . . 0.0 111.83 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.0 139.8 49.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.144 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.5 16.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.42 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.3 23.02 32.99 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.887 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.414 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 10.2 mt -127.67 139.61 52.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.425 ' CD ' ' NE2' ' A' ' 95' ' ' GLN . 9.9 mt-10 -68.45 145.01 54.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.441 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.9 mtt -47.29 -53.75 26.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.45 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 142' ' ' MET . 82.5 Cg_exo -41.55 -36.64 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.356 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -52.96 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 109.9 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 77.9 m95 -56.88 -56.82 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.908 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 25' ' ' LEU . 4.0 mm? -42.9 -36.13 1.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -61.67 -37.03 82.56 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.488 0.661 . . . . 0.0 109.325 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.35 -45.97 94.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.736 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -74.38 -30.45 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.43 -45.14 92.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.64 -43.74 98.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.282 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.26 -47.52 62.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.42 -41.38 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 154' ' ' LEU . 4.5 tt -55.31 -34.52 64.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.138 0.494 . . . . 0.0 110.318 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.69 -45.04 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 160' ' ' VAL . 84.4 t -48.99 -32.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.868 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.5 -42.92 58.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.53 -33.81 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.72 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.1 mm? -85.07 -36.32 21.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.743 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 156' ' ' VAL . 7.1 p -76.63 -23.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.375 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 157' ' ' ALA . 70.1 t -81.95 -51.64 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 162' ' ' ILE . 38.9 mm -71.86 -11.84 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.394 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 -22.1 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 166' ' ' PHE . 28.6 mt-30 -94.09 148.58 35.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.2 32.1 0.31 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.57 2.18 . . . . 0.0 112.169 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 164' ' ' GLN . 69.6 m-85 -135.93 142.5 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.537 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -108.31 137.48 46.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.17 166.46 12.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.546 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -74.96 155.19 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -120.06 170.07 9.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.622 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -84.27 177.31 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -92.35 -90.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.445 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tp 61.38 122.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.803 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -96.54 -41.79 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.371 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.28 -25.99 8.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -54.99 -23.52 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.69 177.88 49.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -99.89 95.59 6.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.589 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -80.27 122.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.462 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -62.25 -156.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.6 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 182' ' ' HIS . 0.0 OUTLIER 177.11 7.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.533 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' HIS . 1.5 t-80 55.37 109.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.553 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.6 mp -64.05 -44.82 91.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.272 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -50.94 -42.51 59.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.385 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.5 -39.93 95.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -52.37 -38.58 59.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.122 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.25 -31.28 72.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.491 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 31.5 mm-40 -74.85 -48.23 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -67.13 -29.66 69.45 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.483 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 95.8 p -75.92 -42.41 48.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -71.52 10.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.156 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.62 145.6 16.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -63.13 -19.91 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.745 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.94 -47.68 64.65 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.88 -51.36 67.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -52.72 -49.73 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.86 -29.31 68.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.569 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 21' ' ' THR . 61.6 tp -69.18 -31.38 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.9 mtt -74.37 -34.02 63.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.62 -53.45 41.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.486 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.85 -54.13 49.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.756 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.9 p -41.17 -56.41 2.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.36 65.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.483 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.97 -40.28 78.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.86 -43.12 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.585 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -70.59 -31.94 69.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.6 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.03 -43.27 71.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 8.3 tp -72.81 -57.87 3.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.613 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' ALA . 36.0 p -44.81 -37.72 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.151 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.12 -31.83 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.115 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.5 tp -59.13 -18.68 37.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -87.97 -27.54 22.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.351 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' MET . 4.6 m-85 -69.67 -50.93 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.7 -12.29 61.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -79.22 -34.97 42.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.293 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.48 -16.56 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.6 tpp -99.51 -9.39 23.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.39 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 45.68 49.11 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.27 143.98 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.441 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -105.49 130.8 22.47 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.169 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.0 167.58 25.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.302 2.002 . . . . 0.0 112.341 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.83 166.4 21.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.36 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 86.4 t -53.52 -48.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 43' ' ' LEU . 8.7 mp -70.1 -47.34 62.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.462 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 23.3 t -52.73 -51.11 61.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.067 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.07 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.336 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -43.37 71.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -62.29 -39.25 92.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -59.68 -38.6 81.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.72 -34.15 76.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.02 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -61.65 -43.81 98.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.544 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.49 -53.07 7.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -45.96 -43.33 13.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.0 -44.15 89.41 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' ALA . 40.7 t -63.35 -46.98 94.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -44.78 -48.3 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.638 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.98 -48.03 88.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -30.46 12.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.257 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.73 66.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.78 -42.59 85.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.52 -35.64 75.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.21 -22.99 78.64 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 1.27 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.3 mt -83.89 -36.88 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.683 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.1 73.11 0.23 Allowed Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.036 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.07 22.7 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.709 2.273 . . . . 0.0 111.72 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -108.32 -12.57 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.159 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -107.41 161.28 23.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.715 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.34 -15.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.564 2.176 . . . . 0.0 112.203 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 mt -46.25 -27.41 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 69' ' ' LEU . 45.7 mtm180 -38.81 -62.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 75' ' ' VAL . 28.9 t80 -52.87 -37.66 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.192 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 69' ' ' LEU . 17.8 t -60.93 -43.56 96.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.57 -35.8 57.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.195 0.522 . . . . 0.0 110.067 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.1 mtp -59.37 -17.86 33.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.492 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 71.5 t -52.37 -41.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.408 0.623 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 mm -88.1 -31.52 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.767 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.8 t-105 -66.65 -54.75 19.98 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.9 tp -64.19 -49.07 73.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.769 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -42.84 -42.24 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -78.57 -21.66 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.59 -62.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.692 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -72.9 -53.47 11.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.426 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -69.45 -45.41 69.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.75 86.99 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.1 -49.81 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.348 . . . . 0.0 110.499 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -50.76 -24.78 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD12 ' OE2' ' A' ' 90' ' ' GLU . 56.9 tp -79.83 -38.34 33.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.26 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.3 p -56.06 -29.95 61.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.13 -42.06 85.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.648 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE2' HD12 ' A' ' 87' ' ' LEU . 37.3 mt-10 -58.8 -39.43 81.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.366 . . . . 0.0 110.611 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.51 -44.1 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.2 p -69.26 -50.6 45.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 mmt -46.31 -47.58 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -47.19 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.47 -34.7 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.3 mt -100.87 -12.09 19.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 -136.56 74.17 53.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.615 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.85 133.17 50.1 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.83 2.353 . . . . 0.0 112.068 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.9 p -97.49 116.55 65.87 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.301 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.18 -55.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.143 1.895 . . . . 0.0 112.242 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -79.32 134.3 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.654 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 51.23 92.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.626 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.4 p -72.1 57.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.497 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 t 45.06 61.65 2.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.524 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 31.7 t0 61.25 -138.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 80.3 m-85 -159.74 -99.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.9 ttp -66.72 134.74 52.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.427 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.23 149.18 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.611 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -127.59 121.69 31.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.375 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -97.5 130.0 30.37 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.494 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -41.5 159.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.386 2.057 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -77.34 3.68 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.571 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -125.47 27.27 6.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 tp -118.42 61.16 4.39 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.69 6.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.698 2.265 . . . . 0.0 112.685 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -78.5 -25.47 45.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.392 0.615 . . . . 0.0 109.863 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 110' ' ' PHE . 4.1 t70 -96.22 -42.79 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.914 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.47 -44.68 95.8 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.048 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 36.4 m0 -78.23 -15.61 58.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.16 77.09 10.99 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.65 -14.89 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -74.52 -3.61 31.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 124' ' ' PHE . 9.8 p -136.07 32.61 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.225 0.536 . . . . 0.0 110.768 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.478 ' CD2' HG13 ' A' ' 123' ' ' VAL . 19.5 m-85 -155.45 -44.58 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.38 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.18 129.39 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.05 153.49 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.565 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t -167.28 99.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.85 -165.02 26.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.9 148.39 22.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.246 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.4 m -101.72 132.0 47.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.962 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.2 -2.95 0.5 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.896 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.13 129.42 39.85 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.139 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.88 130.06 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -16.94 5.42 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.507 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -172.84 138.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -145.74 160.93 41.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.179 0.514 . . . . 0.0 112.0 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -121.98 138.48 54.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.063 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.3 17.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.15 22.1 53.1 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.2 mp -122.49 133.58 54.59 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.27 146.0 53.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.8 mtt -45.78 -54.11 17.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 142' ' ' MET . 89.1 Cg_exo -41.86 -35.47 2.98 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.4 2.066 . . . . 0.0 112.16 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -71.57 -52.11 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.952 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.4 m95 -59.92 -57.24 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.106 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -44.18 -36.97 2.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -61.94 -33.02 73.51 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.13 -50.78 58.17 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.315 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.5 mt -69.83 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.024 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.514 ' CE2' HD11 ' A' ' 154' ' ' LEU . 33.9 t80 -63.54 -42.9 98.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.145 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 155' ' ' ILE . 1.7 tp -69.95 -31.64 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.262 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.17 70.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.74 -51.21 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.675 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.514 HD11 ' CE2' ' A' ' 150' ' ' PHE . 33.7 mt -56.22 -31.59 63.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.635 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.1 mp -76.78 -35.84 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.073 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 160' ' ' VAL . 46.9 t -61.87 -36.88 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -68.56 -43.3 76.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.59 -24.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.928 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.445 ' O ' ' OG ' ' A' ' 163' ' ' SER . 44.5 tp -80.76 -43.76 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 156' ' ' VAL . 27.7 m -73.37 -34.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.29 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 157' ' ' ALA . 74.8 t -68.36 -48.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -22.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 21.3 m -52.68 -44.11 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.587 ' C ' ' H ' ' A' ' 166' ' ' PHE . 47.2 tt0 58.52 84.65 0.2 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.168 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.35 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.556 2.17 . . . . 0.0 111.912 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.587 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.1 OUTLIER 60.01 -166.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.487 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.32 39.93 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.43 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.39 143.88 10.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.708 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -84.17 165.74 18.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -173.43 46.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.417 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -87.82 128.59 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -158.59 49.71 0.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.519 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 7.4 tp -153.57 130.26 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.777 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 176' ' ' ARG . 2.4 m-85 -159.23 -24.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.348 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.34 -25.92 1.07 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.481 ' H ' ' C ' ' A' ' 174' ' ' PHE . 53.6 ttp85 -45.39 133.88 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 178' ' ' HIS . . . 159.56 23.36 0.03 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 177' ' ' GLY . 14.6 m-70 -49.37 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 110.6 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' A' ' 180' ' ' HIS . 0.4 OUTLIER -102.6 178.81 4.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.537 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 179' ' ' HIS . 0.0 OUTLIER -142.72 103.51 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.41 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -42.62 158.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 12.7 t-80 63.05 -171.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.594 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 25.4 m80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.05 -45.2 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.3 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -51.12 -34.53 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -69.36 -44.39 71.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.2 tp -47.8 -38.7 16.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -67.43 -26.16 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.48 -47.02 14.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.791 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.36 -38.74 90.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -76.67 -32.39 57.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.495 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 18.8 tt0 -71.38 5.62 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.008 0.432 . . . . 0.0 110.576 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.2 148.34 18.71 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -70.01 -20.79 63.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 17' ' ' LEU . . . -69.91 -45.74 55.93 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.95 -50.49 73.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.74 0.305 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -56.4 -44.79 80.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.487 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.63 -30.43 71.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.306 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 13' ' ' GLY . 3.6 mp -70.21 -26.94 64.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.686 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.469 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -76.87 -34.27 57.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -56.55 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -52.81 -51.12 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.692 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.0 p -45.3 -60.91 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.564 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -33.37 61.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.463 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.58 -41.44 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.91 -33.18 61.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.216 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.21 -32.69 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.252 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.41 -45.37 55.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.46 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.2 tt -65.06 -52.06 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.332 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 17.4 m -56.06 -30.77 62.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -33.36 38.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.884 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -17.22 64.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . 65.5 t90 -91.03 -34.63 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' MET . 27.3 t80 -60.5 -39.07 86.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.07 -40.3 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.594 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.52 -22.66 65.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 36' ' ' MET . 9.7 p -109.3 -42.83 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.493 ' N ' HG13 ' A' ' 35' ' ' VAL . 6.7 tpt -84.82 5.91 26.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.684 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt 42.99 44.67 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.976 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -63.11 147.05 51.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.976 ' N ' HD23 ' A' ' 38' ' ' LEU . 81.8 mttt -113.13 90.83 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.225 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.11 172.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.45 2.1 . . . . 0.0 112.415 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.96 168.98 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.943 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 91.6 t -53.94 -51.33 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 43' ' ' LEU . 9.9 mp -66.15 -50.0 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 41' ' ' CYS . 14.8 m -50.57 -49.86 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.752 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.37 -42.45 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -47.5 75.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 88' ' ' THR . 3.1 tp10 -57.78 -40.19 79.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -58.12 -33.96 69.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.38 84.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.443 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.38 73.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.4 tp -73.06 -53.28 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -42.86 -41.25 3.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.89 -40.38 95.42 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 55.4 t -61.11 -47.66 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.223 0.535 . . . . 0.0 109.559 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -45.5 -47.12 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.491 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.64 -28.26 69.55 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.39 -34.96 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.61 -34.14 75.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.237 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.39 -32.39 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.218 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -77.59 -42.65 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.342 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -23.79 75.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.6 4.73 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.625 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.9 mt -84.9 -34.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.738 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.55 73.63 0.11 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.54 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.51 12.37 2.9 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.891 2.394 . . . . 0.0 111.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -96.93 -10.01 27.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.61 161.29 28.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.692 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -38.14 -19.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.519 2.146 . . . . 0.0 112.197 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' THR . 8.3 mp -43.7 -30.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.24 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttm180 -38.14 -51.7 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -55.21 -35.78 65.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.503 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.7 t -61.96 -58.45 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.152 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.73 79.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.366 0.603 . . . . 0.0 109.774 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -8.88 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 72' ' ' VAL . 53.4 t -60.58 -43.86 95.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.529 0.68 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.8 mt -87.98 -29.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.894 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.1 t-105 -65.0 -52.33 56.72 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.772 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.8 tp -64.85 -48.56 73.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.586 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -43.69 -42.79 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.888 0.375 . . . . 0.0 110.356 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -23.09 36.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.87 -61.7 2.42 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.912 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE2' ' OE1' ' A' ' 86' ' ' GLN . 70.4 t80 -75.43 -46.96 29.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.397 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -72.11 -41.01 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.78 -48.19 87.48 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 81' ' ' ALA . 16.5 m -71.46 -45.83 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.545 ' N ' HG23 ' A' ' 85' ' ' VAL . 56.4 tt0 -52.24 -27.5 15.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.401 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 87' ' ' LEU . 1.2 tt -82.74 -44.19 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.37 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 84' ' ' GLY . 48.4 p -49.5 -25.29 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.82 -45.18 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.75 -45.7 85.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.739 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.22 -40.91 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.0 p -71.57 -41.95 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.585 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -47.12 -47.71 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.326 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.65 -47.22 82.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -51.47 -40.23 59.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.71 -12.49 27.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.551 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 98' ' ' PRO . 30.9 t80 -129.89 77.71 76.27 Favored Pre-proline 0 N--CA 1.462 0.169 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 97' ' ' TYR . 44.1 Cg_exo -53.84 -141.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.954 2.436 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 m 62.87 143.9 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.231 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 -177.31 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.408 2.072 . . . . 0.0 112.23 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -174.17 -31.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.57 133.18 35.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' SER . 3.3 m -85.27 45.27 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' THR . 45.9 p 46.11 97.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.576 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -161.51 -59.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 85.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.053 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.553 ' C ' ' H ' ' A' ' 109' ' ' ARG . 11.2 mtt -153.69 108.33 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.595 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.9 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 107' ' ' MET . 82.4 mtt180 -88.4 108.4 19.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.45 146.31 56.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.284 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -37.35 138.17 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.583 2.189 . . . . 0.0 112.193 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -94.4 6.01 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.706 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.64 -5.62 19.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 18.6 mt -120.05 83.3 30.69 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.8 Cg_exo -54.4 4.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 112.052 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -66.01 -30.23 70.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.084 0.468 . . . . 0.0 110.321 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.19 -42.19 7.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -73.63 -45.23 54.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -73.27 -15.58 61.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.375 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.29 72.25 32.37 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.9 -16.87 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.91 2.407 . . . . 0.0 112.042 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 -19.14 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.878 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.33 39.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.464 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.29 -42.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.069 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.06 128.09 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.41 156.24 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.6 t -168.29 99.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.19 -172.3 23.53 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.61 150.9 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.5 m -102.26 132.29 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.027 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.44 -3.52 0.29 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -69.32 150.06 47.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.253 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -86.38 113.16 22.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -106.61 -16.31 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.536 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 135' ' ' TRP . 13.7 t90 -173.92 119.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.4 t70 -109.08 151.64 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.205 0.526 . . . . 0.0 112.034 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 8.2 t80 -153.7 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.901 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 50.9 mt 79.06 17.87 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.45 7.04 88.77 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 mt -120.63 150.65 40.59 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 44.1 mm-40 -77.36 161.07 28.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.331 0.586 . . . . 0.0 111.3 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.505 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 4.3 ttt -44.09 -58.66 4.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.425 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 142' ' ' MET . 6.8 Cg_endo -49.33 -20.45 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.298 1.999 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 141' ' ' GLU . 10.9 mm100 -75.45 -58.11 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.811 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -64.35 -53.4 49.21 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.983 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 tt -43.42 -45.83 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 88' ' ' THR . 29.2 tp -52.85 -37.62 60.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.22 -40.19 83.6 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.544 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -77.3 -35.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.682 0.277 . . . . 0.0 110.302 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.29 69.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.09 -39.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.161 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.6 -48.99 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.37 -45.68 93.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.682 HD23 ' C ' ' A' ' 154' ' ' LEU . 7.8 tt -54.7 -31.11 57.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.411 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.69 -26.88 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.25 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 58.0 t -74.3 -32.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.388 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.521 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -51.41 8.73 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.534 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 154' ' ' LEU . 27.7 m -56.68 -40.41 69.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.355 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -77.21 -35.13 55.91 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.378 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.8 t -76.87 -22.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.057 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 157' ' ' ALA . 30.8 t -77.15 -46.66 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.342 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.99 -19.62 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 -26.29 68.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -171.03 79.85 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.697 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 166' ' ' PHE . 73.8 Cg_endo -81.24 7.04 5.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.591 2.194 . . . . 0.0 111.661 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 62.4 m-85 -160.71 157.35 26.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -134.23 158.81 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.305 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.52 112.98 4.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.641 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 171' ' ' ARG . 3.9 tptm -52.2 155.4 1.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.319 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -136.34 8.59 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.738 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.471 ' O ' ' NZ ' ' A' ' 169' ' ' LYS . 10.4 ptp85 -157.99 140.49 14.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -114.7 -16.95 11.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 16.6 mt 52.87 -97.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.445 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -72.75 130.41 40.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -85.65 -60.69 1.77 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -141.28 -92.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.66 -55.91 0.72 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 178' ' ' HIS . 0.9 OUTLIER -81.53 -178.42 6.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.751 0.31 . . . . 0.0 110.545 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 180' ' ' HIS . 10.1 p80 -176.28 176.74 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 179' ' ' HIS . 36.0 m170 -50.55 -175.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.574 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -135.23 142.66 46.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.541 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 56.5 p-80 -100.71 -144.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.451 ' N ' ' CD2' ' A' ' 182' ' ' HIS . 16.1 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.522 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.68 -37.09 80.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.207 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 ttm105 -55.7 -41.06 73.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.31 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.35 -44.77 95.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.406 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -49.36 -41.07 37.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 19.2 t30 -67.0 -29.72 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.16 -49.64 14.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.69 71.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.5 m -76.52 -42.32 43.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.451 ' NE2' HH21 ' A' ' 70' ' ' ARG . 1.1 mp0 -67.61 5.69 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.37 141.07 15.24 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -69.07 -50.32 49.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.593 0.235 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -46.31 6.18 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.7 89.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.114 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -59.81 -38.99 83.49 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.78 -30.15 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.949 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.95 -27.83 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.4 mtt -75.88 -33.92 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.77 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 4.3 m-85 -57.58 -50.15 74.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.558 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.0 m -42.87 -60.27 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.16 -25.94 48.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -78.94 -40.62 31.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.41 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -70.58 -35.21 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.593 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.41 -49.6 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.531 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.02 -57.88 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.626 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -46.33 -37.88 8.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -55.36 -17.32 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.716 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -95.56 -36.46 11.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.927 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CZ ' ' CZ2' ' A' ' 135' ' ' TRP . 2.5 m-85 -54.46 -46.14 73.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.733 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -40.74 76.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -60.03 -20.05 55.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.33 -35.32 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 31.7 mtt -87.72 3.49 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt 50.66 49.81 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.692 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.38 155.76 18.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 140.91 40.0 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.266 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.52 177.47 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.52 2.147 . . . . 0.0 112.091 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -131.75 -166.41 1.72 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.632 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 35.8 t -65.55 -51.3 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.833 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 10.6 mp -65.95 -50.1 65.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -48.59 -45.2 37.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.21 -38.16 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.094 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.9 -48.06 82.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.958 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -61.28 -38.1 85.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -58.96 -40.1 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.24 83.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.4 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.78 -52.45 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.198 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.46 -39.63 7.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.77 -43.84 90.78 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 57' ' ' ALA . 34.8 t -62.7 -47.36 93.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.166 0.507 . . . . 0.0 109.748 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.53 -45.87 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.603 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -30.05 76.64 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.73 -40.06 91.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.71 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.01 -25.22 60.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 3.3 mm? -79.47 -37.75 36.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -79.94 -35.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -22.99 72.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.94 6.65 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 110.74 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -80.24 -31.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.426 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.7 77.14 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.633 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.87 26.88 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.661 2.241 . . . . 0.0 111.947 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -106.84 -9.77 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.059 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.29 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.464 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.4 -5.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.089 1.859 . . . . 0.0 111.773 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.55 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 tt -44.44 -37.66 3.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.451 HH21 ' NE2' ' A' ' 10' ' ' GLN . 59.7 mtt180 -40.78 -70.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.666 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' HG23 ' A' ' 75' ' ' VAL . 47.4 t80 -51.03 -31.54 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.133 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.61 -46.95 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.84 -33.87 52.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.235 0.54 . . . . 0.0 110.109 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.16 -17.35 40.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.539 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 71' ' ' TYR . 69.2 t -53.41 -40.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.425 0.631 . . . . 0.0 110.38 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.87 -33.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.524 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 10.7 t-105 -61.79 -55.88 25.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.48 -48.49 77.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -45.86 -45.71 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.259 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -76.84 -25.3 53.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.387 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 154' ' ' LEU . . . -60.68 -59.07 5.98 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.01 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.37 -54.33 8.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.174 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -66.14 -45.36 81.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.67 -47.23 89.93 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 81' ' ' ALA . 89.3 t -68.74 -52.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.393 . . . . 0.0 110.578 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -51.16 -25.14 4.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.06 -40.91 17.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.548 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 84' ' ' GLY . 42.1 p -54.11 -24.99 19.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -73.47 -48.16 35.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -51.19 -32.76 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.426 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 12.5 t-80 -73.38 -45.23 56.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.671 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -45.86 70.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' TYR . 32.9 ttp -51.36 -49.77 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -49.82 54.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.455 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 5.4 tt0 -52.36 -48.81 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.25 -19.5 26.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.023 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -139.53 83.46 17.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.74 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.42 82.53 2.37 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.594 2.196 . . . . 0.0 111.91 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 100' ' ' PRO . 0.3 OUTLIER -67.71 -43.04 38.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 99' ' ' SER . 72.7 Cg_endo -83.45 11.87 3.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.622 2.215 . . . . 0.0 112.287 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' PRO . 3.7 m-85 54.58 109.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.17 -167.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.55 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.89 -26.85 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' PHE . 20.0 t 47.24 -104.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 107' ' ' MET . 9.9 t70 62.44 -71.48 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER 66.43 -71.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.538 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.16 141.88 44.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.28 103.31 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.443 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -62.91 146.54 95.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.11 144.58 57.99 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.49 2.127 . . . . 0.0 111.945 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -101.45 5.31 41.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 9.6 p-90 -124.56 -5.13 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.5 tp -119.69 80.49 23.98 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.48 -5.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.688 2.259 . . . . 0.0 112.556 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.1 mt -57.89 -28.97 64.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.473 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 12.6 t0 -96.53 -39.39 9.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.598 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HZ2' ' HD1' ' A' ' 119' ' ' TRP . 6.0 ttpp -68.61 -45.28 72.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.473 ' HD1' ' HZ2' ' A' ' 118' ' ' LYS . 41.5 m0 -77.74 -18.55 56.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.86 76.43 17.18 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 -17.68 9.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.742 2.294 . . . . 0.0 111.654 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -52.41 -50.84 61.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.865 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.81 55.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.473 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -157.59 -44.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.0 p -56.11 130.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.61 146.55 24.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.801 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -159.04 99.81 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.14 -171.56 22.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.97 160.38 14.3 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.66 0.267 . . . . 0.0 110.363 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.658 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 85.4 m -108.11 134.95 50.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.38 -9.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.736 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.72 129.23 39.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.9 ptt85 -65.84 129.18 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -124.17 -29.45 3.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.435 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.551 ' CZ2' ' CZ ' ' A' ' 32' ' ' PHE . 5.4 t90 -173.74 137.82 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.779 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -142.21 160.44 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 112.135 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 138' ' ' LEU . 89.8 t80 -118.98 138.41 52.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.046 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.603 HD23 ' CE2' ' A' ' 137' ' ' PHE . 0.7 OUTLIER 51.68 17.35 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.155 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 87.78 22.87 40.99 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 139' ' ' GLY . 5.7 mp -123.81 135.88 54.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.455 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 8.9 mt-10 -68.74 146.36 53.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.598 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtp -48.75 -52.41 45.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.63 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 142' ' ' MET . 81.1 Cg_exo -44.46 -37.07 10.43 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.049 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.92 -49.33 46.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.98 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.571 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.1 m95 -59.54 -56.77 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.244 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -44.07 -39.35 4.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.2 tt -57.9 -37.24 73.64 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.33 -43.34 97.4 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.731 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.6 mt -69.61 -26.7 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.8 0.333 . . . . 0.0 110.408 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -42.89 94.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.976 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER -60.64 -47.98 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.045 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.3 -50.57 73.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.78 -44.38 96.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.739 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -61.33 -30.02 70.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.157 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.705 ' N ' HD23 ' A' ' 154' ' ' LEU . 4.1 mt -73.55 -39.45 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 160' ' ' VAL . 78.1 t -59.08 -38.2 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.1 -43.49 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.403 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 154' ' ' LEU . 91.1 t -58.97 -37.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.398 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.67 -25.02 38.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.792 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.0 t -78.33 -25.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.526 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 162' ' ' ILE . 5.9 p -82.97 -45.08 19.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.347 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 164' ' ' GLN . 35.3 mm -65.39 -28.57 44.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 13.3 p -57.16 0.06 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.518 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.577 ' H ' ' C ' ' A' ' 162' ' ' ILE . 8.2 mm100 -124.49 67.76 49.0 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.7 18.6 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.501 2.134 . . . . 0.0 112.087 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.455 ' CD2' ' N ' ' A' ' 167' ' ' LYS . 66.1 t80 -87.56 -105.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.455 ' N ' ' CD2' ' A' ' 166' ' ' PHE . 67.3 mmtt 43.08 -122.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.684 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -175.42 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.436 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -161.05 133.21 5.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -111.77 -48.04 3.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 62.6 138.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.534 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.84 170.63 8.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.441 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.12 -174.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.356 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -41.72 117.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -129.51 -63.16 0.11 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.5 mmt-85 45.27 -161.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -161.06 -151.96 6.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.499 ' CG ' ' H ' ' A' ' 179' ' ' HIS . 29.1 t-80 -102.11 177.05 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.338 . . . . 0.0 110.549 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.549 ' ND1' ' N ' ' A' ' 179' ' ' HIS . 0.6 OUTLIER -84.73 95.91 9.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.503 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 13.3 m80 62.14 -72.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 179' ' ' HIS . 0.1 OUTLIER -154.08 -159.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.493 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -82.95 151.38 25.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 10.5 t60 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.613 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.5 mm? -68.75 -45.5 71.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -51.1 -33.99 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.09 -40.69 64.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -49.3 -45.17 44.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -67.06 -24.21 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.025 0.441 . . . . 0.0 110.066 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -78.69 -47.39 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -32.23 73.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.5 m -76.1 -37.79 57.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.236 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -72.11 11.95 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.245 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.14 141.46 15.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.84 -50.57 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.22 5.72 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -61.05 -46.29 91.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.307 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -61.83 -34.04 75.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.19 -30.92 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.017 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 21' ' ' THR . 56.3 mt -70.84 -28.52 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.646 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.47 -34.76 60.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.79 -54.8 16.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.723 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -54.51 -51.64 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.615 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.3 p -43.22 -56.01 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.7 56.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -77.56 -39.58 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.539 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.02 -44.5 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.621 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp -71.54 -32.08 67.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.458 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.57 -48.51 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.5 tt -68.1 -58.09 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 110.527 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -46.03 -33.68 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.78 -32.02 27.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.393 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -62.43 -16.02 52.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.636 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -91.41 -38.74 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 36' ' ' MET . 5.1 m-85 -56.08 -45.62 79.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.442 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -73.24 -36.77 66.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.554 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -56.65 -35.62 68.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.547 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.05 -50.82 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.8 tpp -69.91 0.64 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 42.25 45.5 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 110.115 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.83 149.29 47.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.896 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.87 83.46 18.65 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.77 154.38 1.98 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 112.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 4.7 t -106.52 -171.68 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.406 HG22 ' CB ' ' A' ' 126' ' ' ALA . 47.1 t -66.53 -50.5 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.652 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 43' ' ' LEU . 10.4 mp -58.39 -40.79 83.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.097 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -53.85 -42.51 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 124' ' ' PHE . 79.2 mt -64.41 -46.53 92.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.65 -48.62 72.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -64.56 -36.02 82.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.74 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -68.92 -39.26 79.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.499 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.18 88.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.15 -48.28 73.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -48.98 22.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.12 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.73 -43.21 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 109.811 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.93 97.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 53.6 t -59.46 -47.26 91.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.782 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 55' ' ' LEU . 4.8 tt -45.56 -46.5 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.371 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.01 -27.69 70.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.96 -33.45 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.72 71.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.68 -35.3 80.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.0 -37.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.41 -16.62 71.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.82 2.04 32.0 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.015 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -84.05 -38.85 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.99 78.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.614 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.62 20.5 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.718 2.279 . . . . 0.0 112.164 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -107.56 -7.07 16.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.34 165.01 13.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.49 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -39.64 -14.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.45 2.1 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 67' ' ' THR . 75.0 mt -44.64 -32.0 1.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 69' ' ' LEU . 41.2 mtm180 -40.03 -63.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -57.27 -22.36 40.95 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.122 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.5 t -76.17 -44.27 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.993 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.84 59.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.518 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -57.5 -14.05 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.799 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.68 -44.99 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.44 0.638 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -88.19 -28.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.838 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -64.66 -53.65 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.209 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.73 -45.3 71.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -45.47 -46.16 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.592 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -77.82 -23.38 49.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' CB ' HD13 ' A' ' 154' ' ' LEU . . . -59.93 -60.01 4.52 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.279 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.47 -52.02 13.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -67.26 -41.69 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.891 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.94 -46.12 92.31 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.7 t -75.18 -56.87 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.19 -27.57 1.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.838 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.43 -35.32 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.988 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 84' ' ' GLY . 29.4 p -56.7 -51.38 69.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.139 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -33.87 3.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.196 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.79 -40.15 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.922 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 88' ' ' THR . 1.6 t60 -66.99 -40.7 87.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.426 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.4 p -73.32 -51.82 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.875 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.8 ttt -43.75 -43.03 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.49 -40.08 77.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -66.95 -46.38 74.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.915 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.03 -28.97 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.6 OUTLIER -126.39 91.59 47.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.41 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.34 154.77 21.73 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.486 2.124 . . . . 0.0 112.162 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 t -150.3 76.94 8.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.12 21.78 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.589 2.193 . . . . 0.0 112.05 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.82 109.94 22.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.91 34.34 23.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 104' ' ' SER . 0.8 OUTLIER -84.58 -145.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.391 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.526 ' H ' HG22 ' A' ' 103' ' ' THR . 1.4 t 163.48 179.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.249 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 51.6 m-20 -157.67 156.62 32.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.558 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 81.2 m-85 -158.51 164.6 35.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.649 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.0 mmt -75.97 169.59 17.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.36 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 108' ' ' VAL . 11.8 p -76.29 108.89 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 110.397 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -103.43 99.93 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.374 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -98.51 148.54 34.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.46 138.7 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.535 2.157 . . . . 0.0 112.354 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -84.01 9.58 12.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.279 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.671 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -114.73 7.27 15.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.598 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.0 tp -120.68 83.63 35.79 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.948 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -52.69 6.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.777 2.318 . . . . 0.0 112.699 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -66.39 -31.09 71.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 109.942 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 1.1 m-20 -96.73 -41.17 8.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.365 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -70.37 -44.14 68.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.752 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.452 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.7 t90 -76.63 -14.81 59.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.59 69.36 13.63 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.743 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 -11.2 17.43 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.765 2.31 . . . . 0.0 112.068 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.503 ' CD ' ' H ' ' A' ' 122' ' ' GLN . 25.1 mp0 -59.66 -54.21 49.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 123' ' ' VAL . 31.0 m -99.11 50.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 111.103 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -156.32 -38.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.176 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 125' ' ' VAL . 14.4 p -56.16 124.24 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -92.75 157.6 16.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.756 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.1 t -162.96 144.6 10.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.239 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.4 23.25 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 4.4 p30 -103.65 168.91 8.84 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -115.02 135.34 54.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.797 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.95 -0.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -67.98 152.06 46.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.566 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -89.34 137.33 32.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.43 -30.37 2.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.02 139.78 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.05 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -140.0 167.83 21.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.521 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.8 t80 -143.59 120.14 11.06 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.6 tp 78.39 16.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 12.84 76.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 mt -119.99 135.24 54.99 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.842 0.354 . . . . 0.0 110.195 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -72.89 154.25 40.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.409 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -48.24 -61.73 2.87 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.614 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.554 ' O ' HD23 ' A' ' 147' ' ' LEU . 95.3 Cg_exo -34.09 -39.18 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.71 2.273 . . . . 0.0 112.506 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -72.43 -49.2 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.598 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.9 m95 -60.46 -57.67 11.77 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.022 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.4 tp -43.35 -40.54 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.219 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.6 mm? -59.08 -34.09 71.58 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.88 -44.62 95.92 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.5 mt -76.14 -36.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.347 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.75 -47.2 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.97 -41.71 90.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.585 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -49.29 -46.3 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.409 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -64.87 -44.66 88.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.573 HD13 ' CB ' ' A' ' 81' ' ' ALA . 6.0 tp -49.34 -46.81 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.036 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.46 -45.3 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.264 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.1 t -49.8 -36.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 111.022 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.536 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -76.56 -31.73 57.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.38 -46.36 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 0.0 110.989 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 159' ' ' LEU . 10.1 mp -77.4 -28.18 52.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' VAL . 46.3 t -78.17 -35.2 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.918 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 162' ' ' ILE . 6.4 p -73.62 -46.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.201 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.516 ' N ' HG13 ' A' ' 161' ' ' VAL . 5.6 pt -71.99 -24.89 23.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.058 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m -52.66 -11.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.368 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 166' ' ' PHE . 20.4 pt20 -61.69 147.75 88.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 166' ' ' PHE . 43.7 Cg_endo -68.16 36.86 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 111.916 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 164' ' ' GLN . 80.6 t80 58.84 130.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -143.96 -172.11 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.336 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -39.13 149.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -47.26 171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.667 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -157.77 121.95 4.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -167.68 -141.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.549 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 39.8 t0 -154.94 -179.17 7.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 0.1 OUTLIER -149.13 106.66 3.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.474 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -79.75 134.16 36.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 157.29 170.8 22.59 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -168.62 -62.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.706 0.289 . . . . 0.0 110.679 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.476 ' C ' ' ND1' ' A' ' 178' ' ' HIS . . . 76.65 156.48 7.05 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.476 ' ND1' ' C ' ' A' ' 177' ' ' GLY . 5.5 m80 -153.35 132.89 12.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.341 . . . . 0.0 110.6 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -79.97 127.87 32.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.257 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 156.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.422 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -89.15 -157.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 183' ' ' HIS . 0.6 OUTLIER -166.87 -145.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.6 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.453 ' N ' ' CG ' ' A' ' 182' ' ' HIS . 73.0 t60 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.541 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.26 -49.89 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -55.73 -36.19 66.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.38 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 7' ' ' GLN . 1.4 t80 -68.64 -46.27 69.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.181 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 1' ' ' MET . 4.8 mp -46.15 -40.77 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.11 -22.85 63.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.351 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' PHE . 14.1 tm0? -81.07 -46.95 14.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.713 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.74 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLY . 52.2 p -76.2 -30.93 58.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -75.92 12.14 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.333 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.44 144.46 16.27 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -19.07 63.49 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.386 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.07 -46.41 65.93 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -51.27 68.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -56.53 -40.12 74.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.779 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.2 -32.6 63.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 21' ' ' THR . 9.1 mt -68.89 -30.75 69.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.531 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.25 -34.29 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.88 -56.67 7.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.446 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.77 -53.35 49.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.2 p -42.96 -56.64 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.04 -33.71 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.452 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.04 -40.38 68.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.69 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.4 mp -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.485 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -72.39 -43.88 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.681 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.42 -57.78 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.512 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.2 p -47.37 -36.99 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.68 -35.35 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -61.26 -18.0 56.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.358 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -94.75 -34.02 12.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -55.48 -48.87 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -75.18 -20.82 59.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.446 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -68.88 -28.99 67.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.56 -31.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 mtt -84.48 0.52 49.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.729 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.7 mt 48.86 48.65 20.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.898 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.3 mt -97.51 156.5 16.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.308 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -119.72 148.54 46.41 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.252 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.47 175.02 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.44 2.094 . . . . 0.0 112.179 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -128.91 175.36 8.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.5 t -61.5 -54.73 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.757 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.495 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 7.9 mt -67.2 -46.67 73.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -48.7 -46.12 40.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.516 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.44 -43.7 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.94 -45.55 74.86 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.51 -30.9 71.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.037 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -63.33 -37.94 89.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.969 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.99 -33.16 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.11 77.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.2 tt -77.28 -56.06 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.033 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -43.36 -38.25 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.48 -41.0 91.11 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 14.8 t -65.92 -43.26 92.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 109.73 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -47.6 -47.54 28.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.721 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.95 -34.38 89.77 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -59.18 -44.72 92.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.091 -0.554 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.25 75.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.377 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.11 -36.23 77.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.631 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.95 -33.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.52 -12.51 83.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.74 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 111.043 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -91.52 -24.11 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.89 73.27 0.11 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.6 22.6 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.911 2.407 . . . . 0.0 112.371 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -115.65 -4.64 12.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -110.46 161.29 25.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.848 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -37.07 -19.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.683 2.256 . . . . 0.0 112.196 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.0 mm? -44.67 -29.03 0.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -40.59 -67.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.679 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -53.6 -34.7 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.289 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.7 t -63.67 -57.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.362 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.29 80.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.0 ttt -64.88 -13.68 57.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.9 p -60.44 -35.11 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.292 0.567 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -88.67 -32.46 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.032 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.578 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.0 t-105 -59.59 -51.92 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.84 -43.06 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.624 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -47.44 -47.31 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 p -78.52 -23.64 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.03 -58.09 10.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.205 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.9 -53.86 9.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.974 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -66.1 -45.53 80.85 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.48 -47.28 91.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.9 t -65.0 -39.36 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.52 -31.36 69.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -78.03 -45.7 22.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.346 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 84' ' ' GLY . 63.1 p -49.13 -31.46 8.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -42.47 79.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.291 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -60.67 -31.65 70.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -75.94 -46.68 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.56 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -66.44 -49.39 66.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.2 mmt -50.35 -49.71 53.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.541 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 24.0 tt0 -51.18 -39.36 56.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.68 -11.97 22.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.739 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.1 t80 -127.81 103.18 21.69 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.565 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.73 -167.58 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.195 1.93 . . . . 0.0 112.136 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.4 m 56.67 67.84 2.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.47 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.77 179.76 5.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.666 2.244 . . . . 0.0 112.101 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -151.85 -9.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.22 -175.58 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.587 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -74.68 113.53 12.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.618 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.6 t -172.94 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.524 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.62 43.1 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 1.3 m-85 65.5 124.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.553 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 106' ' ' PHE . 29.7 tpp 53.08 106.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.573 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -87.36 -173.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.665 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -106.11 116.26 31.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.453 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -68.42 145.83 97.5 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.445 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.99 151.65 67.83 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.42 2.08 . . . . 0.0 111.867 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -110.0 17.3 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.69 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -125.56 -5.77 7.02 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.608 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.6 mt -115.57 87.64 17.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.44 6.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.696 2.264 . . . . 0.0 112.73 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tp -73.74 -26.36 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -96.38 -36.97 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.844 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.04 -41.44 67.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -75.59 -20.78 58.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.913 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 116' ' ' LEU . 3.3 p -165.13 84.93 1.08 Allowed Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.607 ' O ' HG22 ' A' ' 125' ' ' VAL . 65.9 Cg_endo -80.74 -2.52 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.784 2.323 . . . . 0.0 111.816 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -60.12 -54.32 47.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.6 p -97.49 59.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.628 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -165.67 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 121' ' ' PRO . 21.6 m -57.52 128.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.8 153.94 17.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.837 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 t -170.15 99.96 0.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.473 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.12 -167.6 26.35 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' O ' ' OE2' ' A' ' 132' ' ' GLU . 4.0 m-20 -99.84 146.22 26.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.698 0.285 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 62.7 m -98.77 136.72 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.991 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 91.44 -3.62 0.21 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.872 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' OE2' ' O ' ' A' ' 129' ' ' ASP . 12.3 pt-20 -67.74 153.23 44.16 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.309 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -88.4 138.81 31.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.26 -31.04 2.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.648 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -171.94 136.22 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.265 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.3 t70 -119.61 158.35 26.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 111.943 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.548 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 83.2 t80 -144.82 111.16 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.95 17.38 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 136' ' ' ASP . . . 84.76 9.22 81.48 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 6.4 mt -115.49 133.95 55.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.128 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.541 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 5.2 mt-10 -70.46 154.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.443 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -54.17 -51.0 81.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.995 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 142' ' ' MET . 69.5 Cg_exo -47.11 -40.13 26.47 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.383 2.055 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.2 -38.73 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 148' ' ' GLY . 32.6 m95 -67.11 -56.56 9.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.271 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 tp -43.06 -42.95 4.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.705 HD13 ' C ' ' A' ' 147' ' ' LEU . 2.6 tm? -59.7 -37.07 77.83 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.31 -40.92 92.66 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.924 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 149' ' ' ILE . 2.3 mp -70.59 -25.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.682 0.277 . . . . 0.0 110.357 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -42.75 92.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.084 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.6 mm -63.0 -43.68 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.024 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -63.25 -51.78 64.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.456 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.6 m-85 -56.2 -37.28 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 158' ' ' VAL . 33.7 tp -66.34 -30.22 70.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.412 . . . . 0.0 110.6 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.9 -39.99 59.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.06 -34.52 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.026 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.05 -31.03 58.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.16 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 154' ' ' LEU . 24.2 t -64.24 -42.89 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.413 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.99 -24.05 38.29 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.205 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 156' ' ' VAL . 6.0 t -65.1 -39.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.344 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.2 p -81.02 -50.15 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.577 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 161' ' ' VAL . 36.8 mm -63.65 -8.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.289 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 p -52.58 -45.16 66.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 166' ' ' PHE . 1.7 pt20 179.28 81.74 0.17 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.567 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -47.48 -6.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.655 2.236 . . . . 0.0 112.191 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 164' ' ' GLN . 28.4 p90 -131.53 -162.39 1.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.377 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -171.55 115.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -133.24 -109.85 0.23 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.618 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -142.72 131.7 23.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.58 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -84.44 -72.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.421 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 41.15 39.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.03 105.56 2.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.5 -63.3 1.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.45 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -73.96 87.0 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.465 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -163.29 54.5 0.29 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -81.57 -159.06 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.453 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.494 ' O ' ' ND1' ' A' ' 178' ' ' HIS . . . 160.11 175.95 31.66 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 177' ' ' GLY . 28.3 m80 -152.32 -13.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' A' ' 178' ' ' HIS . 2.0 p-80 -53.71 -167.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.517 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -39.37 127.02 1.82 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 183' ' ' HIS . 82.9 m-70 -86.23 122.99 31.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.618 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 57.56 -78.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 181' ' ' HIS . 39.4 t-80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.519 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.8 mp -75.29 -49.71 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -50.95 -46.39 61.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.54 -45.53 92.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.67 -46.42 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -68.01 -21.85 65.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.077 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.97 -46.17 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.642 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.27 75.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.545 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.7 p -76.2 -38.01 57.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.75 10.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.151 0.5 . . . . 0.0 110.235 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.71 141.61 15.42 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.696 ' N ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -69.8 -49.98 47.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.522 0.201 . . . . 0.0 110.822 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.72 -46.02 5.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -63.13 -46.71 86.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.166 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -56.62 -40.69 75.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.1 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.04 -26.44 66.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.92 -43.43 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.32 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -64.73 -30.79 71.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.0 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.576 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.94 -36.57 70.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.948 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.5 p -66.94 -44.64 80.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.608 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.91 98.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.766 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -75.44 -36.72 60.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.704 -179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.74 -37.07 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.073 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.22 -39.47 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 0.0 110.668 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 26' ' ' GLU . 2.2 tm-20 -63.42 -38.83 92.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.584 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.2 tt -74.92 -57.81 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.646 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.7 p -45.22 -27.24 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.633 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.9 -37.24 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' CD1' ' OE1' ' A' ' 26' ' ' GLU . 19.2 mt -63.07 -13.85 41.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.563 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.526 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.4 t-105 -96.49 -28.54 14.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.499 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.9 m-85 -71.59 -50.05 34.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.05 10.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.94 0.4 . . . . 0.0 110.264 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -56.17 -14.04 2.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.949 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' TRP . 79.4 t -108.99 -21.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.0 tpt -104.33 0.76 29.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt 49.14 31.04 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 HE22 ' A' ' 134' ' ' GLN . 0.6 OUTLIER -80.23 154.41 27.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.02 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -116.75 127.34 26.8 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.5 -179.9 5.77 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.322 2.015 . . . . 0.0 112.063 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.88 178.45 5.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.2 p -64.99 -41.25 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 5.2 tp -64.28 -49.05 73.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -50.08 -48.84 53.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.662 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.528 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.97 -46.94 81.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.43 -35.36 78.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.314 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -64.19 -34.38 77.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.53 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -62.74 -47.7 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.7 tt -77.53 -55.44 5.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -44.55 -40.98 6.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.56 96.39 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.7 t -60.17 -46.99 93.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.157 0.503 . . . . 0.0 109.834 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 55' ' ' LEU . 1.1 tt -46.99 -44.36 20.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.393 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -25.85 71.23 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.87 -42.19 61.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -63.19 -27.06 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 63' ' ' ILE . 11.8 tp -74.66 -39.94 61.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.52 -35.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.084 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.22 -18.95 70.51 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . -82.88 0.54 43.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.612 0.244 . . . . 0.0 110.938 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 59' ' ' LEU . 6.3 mm -88.11 -22.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.568 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.81 65.58 0.19 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.77 19.17 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.609 2.206 . . . . 0.0 112.024 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -109.64 -7.79 15.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -110.93 161.67 23.95 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.563 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -34.97 -19.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.749 2.299 . . . . 0.0 112.404 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.661 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 mm? -42.24 -29.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.386 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.484 ' NH1' ' OE1' ' A' ' 164' ' ' GLN . 64.0 mtm180 -40.27 -66.07 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.657 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.2 -36.13 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.148 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.28 -51.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.609 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.74 -33.07 71.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.184 0.516 . . . . 0.0 109.741 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttm -61.49 -9.45 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.535 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 40.5 t -61.07 -41.74 90.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.05 -27.79 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.196 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.534 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.0 t-105 -69.05 -54.48 14.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.6 tp -62.17 -50.13 73.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.309 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.5 m-85 -42.58 -41.57 3.08 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.012 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.2 p -80.08 -22.48 42.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.72 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.752 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 2.0 t80 -74.2 -49.54 23.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.204 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -69.85 -43.32 72.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.87 -46.01 94.49 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.51 -37.39 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.436 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 82' ' ' PHE . 55.3 tt0 -68.32 -31.26 70.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 110.93 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.52 -42.17 17.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.944 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 84' ' ' GLY . 5.5 p -49.68 -51.79 35.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.495 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -50.13 59.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.143 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -43.66 -41.84 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -65.64 -53.16 45.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.8 p -51.8 -40.7 60.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.616 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.3 ttm -61.41 -40.92 96.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.476 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tp -67.4 -35.12 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -67.06 -40.45 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.469 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.79 -13.97 25.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -149.72 81.0 7.27 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.169 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.04 -37.74 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.655 2.237 . . . . 0.0 112.884 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.78 93.36 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.359 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.06 133.36 8.85 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.393 2.062 . . . . 0.0 112.191 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -105.67 -68.11 0.89 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.624 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -172.25 27.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.571 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 t -169.87 156.77 6.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.1 t -77.0 -112.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.9 p-10 -108.51 -61.12 1.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.58 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 22.6 t80 57.94 97.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.512 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.532 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -134.71 -109.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.534 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 3.3 t 60.78 -1.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.565 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 107' ' ' MET . 76.3 mtt180 -95.4 108.67 20.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.583 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -117.91 162.31 29.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.167 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.89 120.97 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.553 2.169 . . . . 0.0 111.708 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' OE2' ' CH2' ' A' ' 113' ' ' TRP . 10.4 pt-20 -84.34 2.05 42.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.919 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.481 ' CH2' ' OE2' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -101.22 -6.53 24.09 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.268 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.657 ' C ' ' H ' ' A' ' 116' ' ' LEU . 34.6 mt -119.35 91.94 44.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.932 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.1 Cg_exo -52.52 9.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.543 2.162 . . . . 0.0 112.344 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.657 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -68.98 -30.1 68.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.994 0.426 . . . . 0.0 110.168 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 2.0 m-20 -98.17 -39.33 8.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.488 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -73.4 -45.34 55.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.889 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.446 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 13.6 t-105 -76.19 -13.69 60.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.217 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.64 71.19 13.98 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 125' ' ' VAL . 70.3 Cg_endo -78.15 -12.62 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.71 2.273 . . . . 0.0 111.621 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.46 -28.89 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.782 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.489 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.0 t -129.97 49.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.691 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 3.4 m-85 -156.83 -39.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.053 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 125' ' ' VAL . 9.1 p -64.7 126.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.71 159.14 16.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.576 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.6 t -177.32 99.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.417 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.99 -162.49 27.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -97.68 142.82 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.4 m -94.37 132.16 39.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.5 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.57 4.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -70.95 142.84 51.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.203 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' C ' ' OE1' ' A' ' 134' ' ' GLN . 32.0 ptt85 -99.11 133.84 42.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.951 HE22 HD12 ' A' ' 38' ' ' LEU . 2.5 mm100 -103.22 -28.35 11.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 13.3 t-105 -174.17 145.83 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 6.3 p30 -133.85 163.48 29.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 112.462 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -126.59 138.59 53.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.578 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 50.82 17.53 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.442 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 22.56 37.89 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -123.26 136.23 54.62 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.05 154.74 41.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.056 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.7 ttt -51.3 -56.77 17.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 142' ' ' MET . 1.6 Cg_endo -43.76 -36.75 7.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -69.88 -56.73 6.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.267 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 56.5 m95 -56.95 -57.33 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 142' ' ' MET . 2.2 mm? -43.38 -37.1 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -60.06 -35.85 76.05 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.29 -42.76 98.9 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -80.41 -25.75 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.076 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.503 ' O ' HD13 ' A' ' 154' ' ' LEU . 18.4 t80 -64.55 -48.53 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.625 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 152' ' ' ALA . 13.3 tt -67.19 -41.81 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.467 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -50.68 -47.89 58.66 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.476 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.97 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.711 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.534 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 2.3 mp -70.07 -34.12 72.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.71 -27.17 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 160' ' ' VAL . 54.9 t -71.44 -38.88 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -69.54 -52.9 22.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -56.18 -32.11 33.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.79 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.9 tp -81.37 -30.51 33.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 156' ' ' VAL . 25.6 t -75.49 -25.64 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.97 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.76 -46.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -71.12 -16.73 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.965 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 85.6 p -52.9 -11.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.484 ' OE1' ' NH1' ' A' ' 70' ' ' ARG . 30.7 tp60 -43.21 128.14 3.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.267 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.17 16.81 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.209 1.939 . . . . 0.0 111.948 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 164' ' ' GLN . 2.4 m-85 43.28 -146.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.0 pttp -97.69 -4.65 36.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.827 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 56.88 -77.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -41.12 143.78 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.655 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 60.23 91.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -64.39 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -159.75 -68.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.371 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 175' ' ' GLY . 5.9 tp -166.62 -25.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.39 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.0 t80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.641 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 173' ' ' LEU . . . 92.54 115.37 2.24 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.498 ' CG ' ' H ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -53.48 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.483 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 176' ' ' ARG . . . 89.35 171.94 45.55 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.25 34.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.602 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 50.35 -166.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 -174.54 3.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -150.1 -23.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -155.7 -16.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.557 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.517 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.638 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -64.05 -43.69 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -57.55 -33.36 68.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.82 -44.83 76.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 mt -51.11 -38.55 52.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.9 t-20 -64.61 -28.79 69.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.34 -48.5 11.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.696 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.04 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 12.0 m -76.7 -37.12 56.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.611 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 24.1 mm-40 -67.11 5.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.491 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.19 145.98 17.86 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -69.22 -48.66 61.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.639 0.257 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.68 6.11 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.78 83.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 18' ' ' MET . 60.3 m95 -59.36 -43.48 92.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.171 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -30.06 71.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' THR . 1.7 mp -70.18 -26.67 64.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.455 ' SD ' ' CE3' ' A' ' 15' ' ' TRP . 52.2 mtt -76.29 -34.3 59.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.741 0.305 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.34 23.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.823 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.0 -45.65 78.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.3 p -52.17 -62.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.73 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.71 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.661 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -79.75 -38.98 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.7 -38.05 63.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.06 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.824 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.02 -43.97 50.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.16 -56.24 10.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -48.72 -42.9 36.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.45 -28.87 59.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.22 -17.56 64.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.037 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.4 t-105 -86.61 -38.84 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.534 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.36 -35.06 79.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -80.86 2.78 25.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.779 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -117.01 -49.64 2.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.657 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 31' ' ' TRP . 12.1 m -72.88 -27.35 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.748 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' LEU . 8.7 tpp -109.35 13.88 23.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.673 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' MET . 9.7 mt 37.73 37.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.0 147.71 52.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.677 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -109.38 124.78 32.97 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 178.35 7.75 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.245 1.963 . . . . 0.0 112.263 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.74 172.18 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.637 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.2 t -56.46 -51.73 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 91' ' ' HIS . 4.1 mm? -56.23 -38.42 71.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.558 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.2 t -58.37 -43.31 88.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.143 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.4 mm -61.36 -50.95 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.81 73.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.021 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.93 -37.97 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -36.98 84.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.14 80.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.93 -47.28 87.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.344 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 mt -77.18 -53.58 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.31 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -43.18 -41.89 3.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.08 94.99 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 51' ' ' LEU . 39.1 t -61.19 -19.4 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.266 0.555 . . . . 0.0 110.164 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.72 -41.23 23.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.053 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.17 -28.59 73.28 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.08 -47.74 23.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.99 68.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.389 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -44.73 77.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.37 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.56 -39.36 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.42 -16.67 75.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.55 0.88 48.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.77 0.319 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.5 mt -78.42 -38.36 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.7 73.51 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.86 21.46 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.92 2.413 . . . . 0.0 112.046 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -97.4 -10.14 26.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.148 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.07 179.27 0.8 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.549 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 50.3 Cg_exo -52.22 -0.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.232 1.954 . . . . 0.0 112.164 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' THR . 14.5 mt -56.19 -33.01 64.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 77.0 mtm180 -38.77 -61.6 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.774 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.845 ' O ' HG23 ' A' ' 75' ' ' VAL . 42.2 m-85 -52.1 -35.41 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.226 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' LEU . 14.5 t -63.29 -52.86 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.961 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.93 61.54 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.275 0.56 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 15.7 mmt -57.94 -13.3 4.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 71' ' ' TYR . 43.6 t -59.31 -36.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.595 0.712 . . . . 0.0 110.279 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -89.83 -27.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.285 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 4.6 t-105 -69.58 -52.85 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.983 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 7.0 tt -67.07 -47.6 70.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.1 m-85 -46.79 -44.39 19.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.369 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -74.57 -24.68 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 78' ' ' LEU . . . -59.62 -59.77 4.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.41 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.84 -51.25 16.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -44.64 73.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.9 -48.1 84.52 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.5 t -70.45 -53.54 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.848 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -47.98 -23.53 0.82 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.832 0.349 . . . . 0.0 110.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.57 -35.93 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 84' ' ' GLY . 37.8 p -58.64 -23.36 58.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.628 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.11 -44.37 60.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.581 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -59.56 -34.25 72.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.472 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.489 ' CE1' HD12 ' A' ' 43' ' ' LEU . 2.3 m-70 -72.3 -44.8 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -43.52 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.654 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 97' ' ' TYR . 50.1 mtp -55.63 -42.23 74.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.599 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.34 -47.29 64.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.37 -42.4 91.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.37 -18.83 29.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.371 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.4 OUTLIER -141.6 72.62 24.93 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.099 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 97' ' ' TYR . 43.8 Cg_exo -53.86 -153.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.963 2.442 . . . . 0.0 112.315 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.8 166.8 4.54 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.174 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -40.52 123.54 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.666 2.244 . . . . 0.0 112.127 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.2 118.48 5.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.04 -43.17 10.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.3 m 54.96 72.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 p -163.37 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.585 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 34.4 t70 -69.7 -119.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.498 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 73.38 -72.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.455 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 59.2 mtm -99.23 127.9 45.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.545 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.3 m -87.15 -178.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.753 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -100.64 113.77 26.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.18 132.69 95.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.728 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -77.68 160.65 31.25 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.535 2.157 . . . . 0.0 112.114 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -110.41 -7.18 14.81 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.297 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -125.1 -5.28 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.81 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.597 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.1 mt -111.56 72.74 1.01 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 9.9 Cg_endo -54.31 4.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.524 2.149 . . . . 0.0 112.058 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.597 ' H ' ' C ' ' A' ' 114' ' ' LEU . 18.6 mt -74.66 -24.67 58.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -98.83 -38.85 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.499 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -82.35 -45.82 14.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.786 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -69.83 -16.92 63.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.632 -179.43 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 116' ' ' LEU . 6.0 p -154.34 72.03 6.21 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 110.837 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 125' ' ' VAL . 2.5 Cg_endo -77.9 -4.51 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.068 2.512 . . . . 0.0 111.799 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.67 -52.26 41.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.7 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.57 49.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.464 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.28 -44.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 121' ' ' PRO . 29.8 m -57.96 132.68 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.088 0.471 . . . . 0.0 110.689 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.54 161.04 13.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.474 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 t -165.75 99.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.543 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.68 -177.96 20.07 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 17.3 t0 -85.84 148.4 25.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 110.151 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 52.5 m -101.21 129.57 47.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.762 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 94.69 -8.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.727 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.74 148.77 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -86.09 123.6 31.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.456 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -128.37 -23.21 3.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -172.95 125.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.58 158.81 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 111.719 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -113.45 139.56 48.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.928 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 mt 47.91 17.02 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.488 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.35 21.98 30.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.041 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 139' ' ' GLY . 2.9 mp -125.06 138.53 54.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 16.3 mp0 -70.97 147.07 49.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.433 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.5 mmt -46.49 -61.81 2.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.161 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 80.9 Cg_exo -33.73 -39.61 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.878 2.385 . . . . 0.0 112.648 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -70.72 -55.66 8.16 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.917 0.389 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.584 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -55.6 -57.1 13.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.963 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -43.79 -37.67 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.8 OUTLIER -57.32 -37.31 72.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.49 -45.73 95.07 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.17 -30.7 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 110.194 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -58.85 -48.55 80.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.12 -46.25 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.26 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.42 -46.76 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.487 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -58.45 -44.05 89.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 158' ' ' VAL . 9.7 mt -60.63 -30.25 69.74 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.292 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.64 -27.43 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 160' ' ' VAL . 94.9 t -75.03 -36.11 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 111.111 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -74.63 -53.13 9.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 159' ' ' LEU . 32.6 m -56.39 -42.65 75.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.497 ' N ' HG23 ' A' ' 158' ' ' VAL . 6.9 tp -73.07 -31.67 64.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.259 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 156' ' ' VAL . 33.8 t -78.2 -28.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.229 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.4 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 46.1 t -74.86 -51.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.394 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 164' ' ' GLN . 52.1 mt -62.32 -33.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.05 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.1 p -59.05 0.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 166' ' ' PHE . 3.3 pt20 -65.66 146.99 98.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 166' ' ' PHE . 73.7 Cg_exo -42.87 -14.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.518 2.145 . . . . 0.0 112.265 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 164' ' ' GLN . 10.4 t80 77.84 -49.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -140.5 -74.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.503 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -167.84 -95.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.54 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 62.3 mttm 52.83 105.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.635 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -69.61 154.06 42.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -143.26 -144.94 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.61 -162.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.53 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 173' ' ' LEU . 0.3 OUTLIER -140.59 -73.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.511 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -78.84 -60.64 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.586 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.85 125.41 0.66 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -168.44 -38.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.797 0.332 . . . . 0.0 110.591 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.88 -158.68 20.78 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -127.28 159.64 33.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.827 0.346 . . . . 0.0 110.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -153.21 -18.63 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.43 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -83.7 116.1 22.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -117.72 -103.57 0.41 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.532 ' O ' ' ND1' ' A' ' 182' ' ' HIS . 4.0 t-80 56.74 52.4 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.441 ' OXT' ' O ' ' A' ' 182' ' ' HIS . 52.5 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 2' ' ' LEU . 5.6 mp -74.22 -41.78 60.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.457 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -53.87 -34.09 58.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.348 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -72.51 -44.38 62.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.287 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp -47.19 -37.66 10.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -67.54 -27.52 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' PHE . 9.6 tp-100 -80.77 -47.57 13.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.692 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -39.5 86.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.67 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLY . 53.2 p -76.67 -37.28 56.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 18.3 tt0 -65.21 2.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.472 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.69 148.82 19.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -69.71 -20.47 63.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.76 -45.12 59.84 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -51.1 68.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.185 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -56.1 -45.78 79.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 tp -64.64 -30.44 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.37 -32.41 70.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.1 mmt -71.14 -33.34 69.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.58 -51.96 30.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -50.02 -45.9 52.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.683 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 p -59.01 -60.88 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.04 8.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tp -80.07 -40.48 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.8 -41.99 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.6 mp -69.08 -26.87 65.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.81 -37.78 76.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.95 -57.53 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -44.15 -39.9 4.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.51 -35.07 63.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.767 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.72 -18.49 62.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.761 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.41 -24.89 20.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.854 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -73.56 -38.02 65.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.59 0.84 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -119.15 -52.59 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.24 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.31 -40.48 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 37' ' ' LEU . 29.8 mtt -108.17 15.16 24.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.64 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 36' ' ' MET . 29.1 mt 37.03 41.85 0.21 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.064 0.459 . . . . 0.0 110.15 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 153.35 40.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.016 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' CB ' ' NZ ' ' A' ' 39' ' ' LYS . 6.5 mtmp? -124.7 108.12 28.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.69 169.03 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.229 1.953 . . . . 0.0 112.111 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -110.36 -175.4 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.461 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 2.6 p -64.37 -44.52 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.55 -48.29 81.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.779 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.0 m -60.8 -46.98 88.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.15 -49.8 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 28.9 t80 -54.52 -48.3 72.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -53.67 -47.57 70.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.084 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -50.7 -36.01 33.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -63.51 -40.91 98.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.492 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.08 79.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 51' ' ' LEU . 9.5 mp -72.62 -50.69 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -43.39 -41.95 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.08 -37.82 92.02 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 51.8 t -62.64 -19.23 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.403 0.62 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 tt -79.76 -46.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.817 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.85 -31.77 81.53 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.44 74.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.891 0.377 . . . . 0.0 110.018 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.45 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.004 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.22 -31.22 62.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.475 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.6 mt -80.46 -42.89 21.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.09 77.0 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 7.49 3.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.654 0.264 . . . . 0.0 110.855 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.48 -55.06 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.269 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.77 84.29 0.29 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.03 24.04 0.7 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.678 2.252 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -99.25 -11.62 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -106.52 179.26 0.93 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 76.5 Cg_exo -47.46 -5.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.019 1.813 . . . . 0.0 112.02 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -49.98 -33.04 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.236 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' NH1' ' CD ' ' A' ' 164' ' ' GLN . 24.8 mtt180 -38.32 -66.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.031 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -57.49 -36.84 72.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.639 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.4 -52.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.804 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.31 -34.55 78.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.335 0.588 . . . . 0.0 109.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 78' ' ' LEU . 2.4 ttt -63.61 -8.33 9.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.765 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.11 -40.85 90.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.452 0.644 . . . . 0.0 111.069 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.711 ' C ' HD12 ' A' ' 76' ' ' ILE . 1.4 pp -89.23 -28.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.676 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.527 ' N ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -69.15 -47.48 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.689 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD11 ' SD ' ' A' ' 74' ' ' MET . 7.6 mt -65.97 -45.78 80.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -49.2 -44.36 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.105 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -80.22 -23.26 41.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.741 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.43 -60.08 4.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.336 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -77.78 -45.37 24.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.282 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -69.96 -40.89 75.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.805 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 88' ' ' THR . . . -64.6 -46.47 89.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 81' ' ' ALA . 12.7 m -79.26 -35.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -26.27 67.05 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.958 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.4 -28.46 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.704 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 84' ' ' GLY . 20.0 p -60.94 -51.9 67.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.572 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -50.87 -29.71 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.527 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.67 -37.93 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.145 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -68.37 -37.07 80.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.272 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.539 ' HA ' HE21 ' A' ' 95' ' ' GLN . 67.1 p -72.46 -39.24 67.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.471 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.0 ttt -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.17 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.74 -38.52 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.539 HE21 ' HA ' ' A' ' 92' ' ' THR . 34.2 mt-30 -72.16 -38.02 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.769 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.57 -22.66 20.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 93' ' ' MET . 86.2 m-85 -148.85 83.11 6.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.906 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.26 -19.93 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.61 2.206 . . . . 0.0 112.194 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.44 166.04 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 101' ' ' PHE . 76.2 Cg_exo -43.12 110.14 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.725 2.283 . . . . 0.0 112.21 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' PRO . 13.4 t80 60.09 123.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.666 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -137.77 -9.76 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m 60.07 153.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -154.71 41.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.492 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -166.38 108.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.695 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -152.41 157.13 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.315 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 29.9 ttm -85.84 130.37 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 m -43.55 108.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -102.84 100.36 10.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.551 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.484 ' CD2' ' OD2' ' A' ' 117' ' ' ASP . 1.4 m-85 -128.31 159.55 66.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.136 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -38.61 151.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.678 2.252 . . . . 0.0 112.165 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.47 1.37 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.573 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 2.0 p-90 -113.23 10.62 18.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 tp -119.75 86.24 35.11 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 40.7 Cg_exo -54.48 15.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.847 2.365 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.638 ' H ' ' C ' ' A' ' 114' ' ' LEU . 40.6 tp -75.63 -30.44 59.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.005 0.431 . . . . 0.0 110.004 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -97.38 -39.64 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.191 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -72.46 -45.2 60.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.99 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.5 t90 -75.69 -12.44 60.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.388 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.6 67.91 78.77 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 71.7 Cg_endo -80.41 -22.07 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.906 2.404 . . . . 0.0 111.689 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -55.53 -53.97 49.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.19 54.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.544 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.4 t80 -159.07 -35.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' PRO . 75.3 t -65.64 130.48 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.821 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . . . -96.83 163.04 13.15 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.3 t -174.67 101.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 141.46 177.95 17.18 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.47 135.74 36.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 15.0 m -91.16 129.42 37.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.56 -1.63 0.24 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.653 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -67.98 145.09 54.84 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -87.3 116.06 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -117.51 -22.3 8.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -175.75 128.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.474 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -140.54 158.74 43.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.269 0.557 . . . . 0.0 112.238 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 17.5 t80 -117.09 139.18 51.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.936 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.0 mm? 49.95 17.09 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.379 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.63 21.85 35.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.794 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -125.87 137.11 53.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.73 149.6 47.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.44 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -49.14 -51.5 56.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' HD13 ' A' ' 147' ' ' LEU . 89.0 Cg_exo -44.06 -37.98 10.08 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.542 2.161 . . . . 0.0 112.454 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 0.3 OUTLIER -70.71 -46.93 62.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.156 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.6 m95 -63.84 -57.25 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.3 mt -43.68 -38.56 3.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 143' ' ' PRO . 2.4 mp -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -54.39 -39.07 64.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -80.96 -27.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 110.118 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' LEU . 75.7 t80 -59.67 -51.62 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.134 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 9.8 tt -64.2 -42.47 95.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.238 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -52.85 -47.69 67.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.179 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -57.82 -38.64 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.58 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 150' ' ' PHE . 74.6 mt -66.75 -32.32 73.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.852 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -33.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 160' ' ' VAL . 42.0 t -59.5 -43.37 90.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.424 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -73.51 -48.79 30.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.23 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 69.0 t -51.25 -43.37 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.751 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.1 -43.59 52.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.761 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.8 t -62.07 -29.46 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.202 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -80.51 -47.76 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 162' ' ' ILE . 74.2 mt -70.64 -2.72 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.397 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.5 m -61.69 -30.28 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 166' ' ' PHE . 1.0 OUTLIER -71.47 146.17 91.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.29 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.4 20.03 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.546 2.164 . . . . 0.0 112.164 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 168' ' ' ALA . 8.5 m-85 47.77 79.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.35 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 54.9 mttp -73.69 34.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.399 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 166' ' ' PHE . . . 53.3 169.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.513 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -157.44 -2.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.355 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -154.52 121.36 5.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 -41.94 147.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 174' ' ' PHE . 18.6 t70 -154.56 175.58 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.44 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.4 mp -73.75 34.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 172' ' ' ASP . 67.0 t80 -91.54 59.51 3.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.43 -178.37 44.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -150.9 35.94 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.768 0.318 . . . . 0.0 110.665 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -65.4 -18.24 65.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -90.2 123.31 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -166.31 159.91 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 180' ' ' HIS . 6.6 p-80 -48.23 138.87 9.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 182' ' ' HIS . 27.4 t60 -163.25 -3.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 181' ' ' HIS . 20.0 t60 50.32 70.19 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.55 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.687 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -57.89 -34.11 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.356 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -52.76 -38.24 60.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLN . 7.2 t80 -71.69 -46.3 59.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -45.48 -44.06 12.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.322 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.96 -20.87 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.229 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PHE . 44.2 tp60 -79.92 -47.86 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.21 74.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 78.4 p -76.46 -34.17 58.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -73.9 10.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.513 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.03 140.91 15.33 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -19.7 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.68 59.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.21 68.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -53.47 -41.54 66.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.303 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.64 -29.57 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.294 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -34.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mtm -73.95 -34.58 64.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.091 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.33 65.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.604 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -60.83 -33.1 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.608 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.7 m -56.75 -54.85 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.88 -27.48 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.361 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.14 -41.84 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.12 -45.11 61.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.687 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.28 -33.28 74.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.07 -44.61 68.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.9 tt -65.29 -58.09 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -47.21 -36.67 9.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.43 -31.12 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -63.32 -18.55 63.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.416 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 11.0 t-105 -86.69 -41.03 14.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 110.36 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -56.15 -38.42 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.037 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 33' ' ' GLN . 12.9 tm0? -79.05 -23.74 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.217 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 36' ' ' MET . 11.7 p -108.41 -44.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.562 ' N ' HG13 ' A' ' 35' ' ' VAL . 9.3 tpt -77.15 -2.38 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt 46.16 45.75 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.08 146.33 54.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -110.57 108.58 58.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.961 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.1 145.11 17.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.25 1.967 . . . . 0.0 111.513 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -107.49 -161.87 0.8 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.595 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.6 t -63.32 -42.6 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.2 tp -62.57 -49.31 75.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.198 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -54.66 -49.48 70.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.676 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.83 -45.35 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -59.71 -46.58 88.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.24 -47.69 84.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.257 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -56.74 -33.15 66.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.356 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.56 74.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -73.31 -50.67 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -43.8 -41.73 5.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.32 94.11 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.43 -47.73 90.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.97 -46.52 16.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.502 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -48.79 76.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.66 62.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.127 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.92 73.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 tp -72.28 -25.53 61.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.101 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.29 -39.53 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.67 -25.87 75.06 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.49 7.8 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.46 -48.52 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -179.45 80.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.61 31.56 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.68 -9.7 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.946 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.99 170.52 5.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.784 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.84 -12.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 mt -43.73 -32.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.51 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -41.05 -70.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -54.68 -27.37 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.677 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.32 -46.15 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.565 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.67 -35.05 60.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.599 . . . . 0.0 109.619 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 ttt -59.59 -15.72 20.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 70.9 t -55.22 -40.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.262 0.554 . . . . 0.0 110.345 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.2 mm -85.48 -34.86 8.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.228 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.586 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 5.0 t-105 -61.89 -56.15 22.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.8 tp -62.84 -50.28 71.56 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -42.88 -44.87 4.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.187 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.52 -21.37 45.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.495 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.38 -59.91 4.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.184 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.53 -46.69 58.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -77.32 -40.29 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.32 -48.92 83.64 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.397 -0.906 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 81' ' ' ALA . 25.3 m -67.77 -44.74 85.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.819 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.518 ' N ' HG23 ' A' ' 85' ' ' VAL . 26.4 tt0 -54.91 -28.41 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.112 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.35 61.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.236 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 70.0 p -54.79 -30.69 57.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.332 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.23 -48.34 76.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.13 -30.77 66.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 3.8 m170 -77.46 -49.04 15.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -64.56 -48.42 75.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 97' ' ' TYR . 26.7 ttt -52.71 -51.39 60.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.484 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.74 -49.36 73.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -52.35 -44.65 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.9 mm? -88.39 -13.31 40.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 93' ' ' MET . 7.8 t80 -133.88 71.77 73.64 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.75 122.61 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.831 2.354 . . . . 0.0 112.378 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -167.57 63.32 0.65 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.522 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.02 113.07 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.765 2.31 . . . . 0.0 112.287 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -87.77 120.36 29.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.339 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.79 121.24 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.652 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.693 HG23 ' N ' ' A' ' 104' ' ' SER . 8.5 t -159.2 -55.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.693 ' N ' HG23 ' A' ' 103' ' ' THR . 45.2 t -176.79 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 15.0 t70 54.53 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.638 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.4 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 13.6 t80 54.44 87.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 ttt 58.17 95.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.305 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 m -92.45 -172.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.759 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -111.47 116.2 30.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.399 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -70.22 147.67 95.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.483 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.56 143.81 58.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.479 2.12 . . . . 0.0 112.196 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.88 3.91 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.1 p-90 -110.13 0.64 18.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -114.34 94.25 34.82 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.033 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.03 0.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.698 2.265 . . . . 0.0 112.935 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.8 tp -70.27 -26.13 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.71 -34.78 11.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -67.01 -35.16 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 -95.99 -23.96 16.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.364 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.8 t -149.64 87.79 5.08 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.52 -15.73 8.45 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.606 2.204 . . . . 0.0 112.521 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -85.69 -4.01 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.722 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.3 p -112.54 18.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.109 0.48 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -147.24 -43.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.433 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.67 129.96 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.407 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.88 154.57 17.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.7 p -158.53 99.78 1.61 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.509 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.55 -176.97 20.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -96.65 150.13 21.01 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 73.9 m -102.22 132.2 48.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.89 -10.35 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.999 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -69.53 129.16 38.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.657 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -67.96 109.45 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -115.7 -23.54 8.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.781 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 16.9 t90 -172.02 132.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 1.1 p30 -146.16 159.37 43.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -120.68 139.89 52.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.899 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.49 17.35 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.91 21.25 53.62 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -123.21 135.26 54.21 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 141' ' ' GLU . 9.7 mp0 -71.65 148.81 46.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.465 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtt -45.25 -63.7 1.12 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.25 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 88.2 Cg_exo -32.35 -38.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.092 2.528 . . . . 0.0 112.801 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.455 ' CD ' ' N ' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -72.47 -51.68 19.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.004 0.43 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 72.6 m95 -56.36 -57.46 12.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.903 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -43.76 -39.14 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.1 tt -56.27 -35.77 67.84 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -63.01 -48.42 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.489 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.45 -26.23 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.57 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.4 t80 -64.08 -41.49 97.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 148' ' ' GLY . 3.5 tt -73.75 -29.73 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.66 -52.02 62.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.272 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -57.06 -41.74 79.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.534 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -61.32 -30.91 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.736 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.48 -26.8 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.223 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' VAL . 74.6 t -73.35 -35.1 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.586 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -71.98 -53.76 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.263 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 159' ' ' LEU . 34.9 m -53.71 -45.92 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.913 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 158' ' ' VAL . 2.3 tp -67.11 -30.21 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.731 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 156' ' ' VAL . 18.4 t -74.98 -29.92 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.9 t -83.66 -51.53 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 110.318 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 162' ' ' ILE . 40.0 mm -68.67 -12.72 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.107 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -52.66 -39.61 62.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.067 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 166' ' ' PHE . 12.5 mt-30 54.17 157.3 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.519 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.28 25.02 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.479 2.119 . . . . 0.0 111.916 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 164' ' ' GLN . 34.7 m-85 54.84 -110.18 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.674 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp 66.94 -2.92 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.513 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 166' ' ' PHE . . . -159.15 149.1 19.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.519 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.618 ' NZ ' ' NH1' ' A' ' 171' ' ' ARG . 51.2 tttm -164.44 129.86 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.531 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -159.97 -54.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.618 ' NH1' ' NZ ' ' A' ' 169' ' ' LYS . 16.7 mtm-85 53.81 -131.56 2.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.56 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -156.53 179.67 9.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.503 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.73 165.67 24.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -85.7 99.91 11.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 170.26 -135.36 3.5 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -147.64 -63.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.542 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.3 -158.4 31.35 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 179' ' ' HIS . 2.2 t-80 -162.05 -136.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.623 ' N ' ' ND1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 48.55 -176.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.316 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -60.09 -21.97 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.457 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 49.47 41.33 20.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -81.27 -36.56 29.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 10.4 m80 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.501 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt -76.42 -44.69 34.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.322 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -54.96 -36.49 65.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.313 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 7' ' ' GLN . 2.6 t80 -69.77 -43.02 73.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.174 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -48.45 -38.31 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 2.3 m-20 -68.32 -26.8 65.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.275 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.1 mm-40 -78.08 -48.86 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.382 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.74 80.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 40.1 m -76.65 -37.3 56.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.538 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 11.3 mm100 -70.24 7.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.372 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.64 145.77 16.25 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -72.33 -51.54 20.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.632 0.254 . . . . 0.0 110.744 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.97 -47.3 6.29 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.29 86.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -58.7 -37.28 75.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.19 -29.58 69.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.721 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' THR . 2.3 tp -69.98 -27.73 64.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.44 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.1 mtp -76.09 -34.07 59.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.3 -54.85 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 23' ' ' LEU . 66.7 t80 -52.1 -52.69 49.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 15.4 p -44.11 -51.62 7.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -21.69 65.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.51 -42.37 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.468 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.63 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.54 -35.29 68.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' CD ' ' NH1' ' A' ' 48' ' ' ARG . 4.9 tp10 -64.99 -35.61 81.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.55 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.42 -56.54 4.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.659 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -45.26 -41.5 8.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.78 -32.35 65.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.567 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -64.03 -19.77 65.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.583 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -93.5 -19.79 20.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.21 -50.36 19.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.458 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -73.61 -9.15 58.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.12 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 5.6 t60 -77.89 -31.01 51.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.102 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.78 -9.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.8 mmt -107.05 -3.19 20.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.631 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.2 mt 47.21 50.19 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 110.282 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 39' ' ' LYS . 2.1 tt -65.07 142.19 58.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.629 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.861 ' N ' HD23 ' A' ' 38' ' ' LEU . 14.9 mttm -107.31 99.66 29.03 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.455 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 127' ' ' SER . 72.1 Cg_exo -46.5 168.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.575 2.183 . . . . 0.0 112.784 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.9 161.49 32.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.187 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.7 t -48.81 -46.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.593 ' N ' HD22 ' A' ' 43' ' ' LEU . 3.6 mm? -73.0 -33.88 66.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.1 t -58.07 -45.8 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.824 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 126' ' ' ALA . 24.2 pt -69.56 -35.99 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.3 -47.36 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.91 -36.71 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' NH1' ' CD ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -63.42 -32.58 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.63 77.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.233 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.44 77.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.4 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.88 -55.51 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -44.52 -38.34 4.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.42 94.67 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -62.22 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 109.831 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -45.83 -44.63 14.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.591 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.27 -27.98 73.04 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.98 -43.21 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.616 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.74 65.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.463 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -80.84 -36.08 31.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.428 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -80.89 -34.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -75.49 -32.83 54.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.56 6.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -88.43 -22.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.518 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 67.82 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.82 24.61 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.672 2.248 . . . . 0.0 111.845 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 64' ' ' ALA . 37.5 mttp -111.3 -6.16 14.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.13 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.33 163.86 17.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.647 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.17 -13.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.442 2.095 . . . . 0.0 112.217 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mt -43.07 -34.46 1.04 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 59.0 mtm-85 -38.57 -66.57 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.732 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -54.15 -27.22 32.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.786 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.2 t -72.86 -51.12 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.496 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.244 0.545 . . . . 0.0 109.913 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 5.7 ttt -62.23 -15.75 48.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.882 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.2 p -56.58 -36.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.453 0.644 . . . . 0.0 110.408 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.2 mt -87.38 -34.51 7.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.775 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.581 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 6.0 t-105 -60.61 -54.59 43.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.926 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.88 -44.93 91.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.83 -23.04 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 154' ' ' LEU . . . -60.96 -60.83 3.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.623 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -72.47 -56.24 5.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.177 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -68.26 -47.73 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.1 -46.81 84.29 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 81' ' ' ALA . 92.6 t -67.57 -36.09 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.58 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.45 -34.89 69.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.255 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.28 -44.64 17.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.548 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 84' ' ' GLY . 49.2 p -45.3 -32.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.58 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -73.45 -40.83 63.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -56.34 -37.66 70.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.5 m170 -68.62 -42.7 77.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -66.47 -51.4 57.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.7 ttt -49.48 -49.54 45.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 97' ' ' TYR . 3.8 tp -61.48 -47.92 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -54.33 -37.89 65.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 96' ' ' LEU . 11.1 mp -90.58 -15.79 29.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.465 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 37.2 t80 -109.06 114.74 57.84 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.283 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -77.29 97.2 1.13 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.217 1.944 . . . . 0.0 112.065 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -173.18 60.04 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 27.8 Cg_endo -63.88 106.83 0.68 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.577 2.184 . . . . 0.0 111.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 100' ' ' PRO . 48.4 p90 43.97 -175.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.835 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 101' ' ' PHE . . . 175.54 10.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.423 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.2 m -150.47 -62.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.1 p -148.0 166.01 29.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.496 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.45 ' OD2' ' CB ' ' A' ' 101' ' ' PHE . 67.2 m-20 -157.65 151.05 23.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.69 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.11 177.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.407 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.3 ttm -171.19 84.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.536 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.756 ' O ' HG22 ' A' ' 108' ' ' VAL . 7.2 p 35.1 43.62 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.211 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -93.6 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.12 145.23 37.64 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.99 160.49 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.696 2.264 . . . . 0.0 111.865 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -101.27 5.49 42.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -125.41 -6.06 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.782 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -119.52 78.47 20.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.39 11.37 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.263 1.975 . . . . 0.0 112.22 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.9 mt -77.36 -29.76 53.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.111 0.481 . . . . 0.0 109.771 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.475 ' OD1' ' CD2' ' A' ' 124' ' ' PHE . 3.4 m-20 -96.2 -42.19 8.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.729 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' CB ' ' NZ ' ' A' ' 118' ' ' LYS . 5.4 ttpm? -64.88 -44.75 88.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.066 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 27.1 t-105 -76.12 -12.95 60.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.88 73.64 13.55 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.781 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.78 -12.9 13.35 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.819 2.346 . . . . 0.0 111.948 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.87 -54.11 48.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.289 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.74 26.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.249 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CD2' ' OD1' ' A' ' 117' ' ' ASP . 39.8 m-85 -134.69 -6.4 2.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.193 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.88 132.65 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -101.48 154.85 18.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' PRO . 69.6 m -167.64 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.355 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.71 -174.3 21.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.73 154.14 21.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.293 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 97.9 m -101.48 131.77 47.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.14 1.19 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.49 160.26 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.043 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -100.14 140.01 34.99 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -132.71 -27.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -174.77 142.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.72 167.9 20.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.527 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 69.4 t80 -145.58 118.46 8.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.509 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 3.5 tp 78.89 17.34 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.86 11.33 79.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.7 mp -116.82 132.9 56.58 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -71.07 153.02 42.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.276 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.1 mmm -50.71 -59.5 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.708 ' O ' HD13 ' A' ' 147' ' ' LEU . 83.2 Cg_exo -36.55 -41.31 0.59 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.458 2.105 . . . . 0.0 112.237 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.79 -44.7 63.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.333 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.2 m95 -61.26 -56.82 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.065 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 tp -43.41 -44.55 5.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.007 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' PRO . 4.5 mp -53.61 -36.45 62.0 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.85 -42.29 94.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.24 -29.76 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 110.628 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.16 -48.31 80.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.103 0.478 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 155' ' ' ILE . 12.9 pt -68.01 -41.55 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.11 -45.91 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.524 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 5.6 m-85 -64.28 -39.66 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -60.0 -45.31 93.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.258 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -73.97 -26.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.93 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 155' ' ' ILE . 5.8 t -68.62 -33.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.106 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -71.98 -46.88 55.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.851 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.16 -24.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.093 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.96 -41.48 51.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.057 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 156' ' ' VAL . 21.9 m -78.78 -21.87 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.832 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.6 t -74.56 -48.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.115 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 162' ' ' ILE . 2.2 pp -69.26 -28.57 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 100.0 p -56.18 -19.71 14.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -124.33 78.43 61.1 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 166' ' ' PHE . 65.2 Cg_endo -77.42 24.63 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.143 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 22.0 p90 41.33 -167.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.79 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -139.62 -14.58 1.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.05 85.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.671 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -146.33 29.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.352 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.05 -97.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -159.88 -31.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.545 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 56.7 170.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.09 0.16 54.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.58 -66.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.21 -152.55 52.08 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -76.76 54.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.563 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -88.57 -121.17 1.78 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.455 ' N ' ' ND1' ' A' ' 178' ' ' HIS . 2.0 m-70 -62.29 158.82 16.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 110.546 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.69 36.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.581 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -171.92 -9.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.595 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -117.49 19.52 13.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.544 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 182' ' ' HIS . 40.3 p-80 -88.03 80.67 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.552 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.86 -36.35 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 109.92 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -58.12 -31.97 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.119 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.62 -42.94 67.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.068 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 mp -50.54 -38.74 46.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -67.95 -30.55 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -79.69 -49.89 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.47 78.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.742 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -76.72 -30.48 56.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.822 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 28.6 tt0 -73.39 6.07 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 110.515 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.49 146.47 17.25 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -66.42 -20.69 66.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.339 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.13 -44.39 76.89 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.512 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.89 -51.25 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -60.53 -43.84 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.73 -35.54 81.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 21' ' ' THR . 10.1 tp -69.52 -28.83 66.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -72.56 -32.82 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.29 26.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.523 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.42 -46.76 63.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.829 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 18' ' ' MET . 27.4 p -52.72 -53.13 52.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.37 81.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.6 tt -69.76 -42.15 74.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.942 0.401 . . . . 0.0 110.702 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.47 -42.45 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -71.17 -34.45 70.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.735 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.59 -43.84 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.6 tt -74.32 -58.17 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.519 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 24' ' ' ALA . 35.0 p -44.43 -32.62 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.62 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.45 -41.53 16.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.568 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tp -49.13 -21.98 0.86 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.772 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -85.46 -32.53 22.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -58.81 -44.32 90.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.139 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.423 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 15.6 pt20 -75.98 -28.96 58.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.712 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -65.41 -31.42 72.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.497 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.78 -47.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 5.4 tpt -73.22 1.78 8.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.705 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.2 mt 43.53 45.62 5.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -69.67 145.96 51.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.949 ' N ' HD23 ' A' ' 38' ' ' LEU . 46.4 mttp -115.23 90.82 25.54 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.51 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 127' ' ' SER . 51.4 Cg_exo -51.23 165.88 0.5 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.669 2.246 . . . . 0.0 112.518 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 8.3 t -112.95 -175.45 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.316 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.438 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.2 p -69.09 -36.9 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' ND1' ' A' ' 91' ' ' HIS . 5.9 mp -77.76 -49.64 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.605 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 t -49.15 -51.51 31.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 46' ' ' TYR . 18.5 tt -64.27 -38.95 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.218 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 19.4 t80 -55.6 -44.62 77.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -56.97 -47.43 80.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.263 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -52.62 -30.41 31.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.926 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -70.33 -38.25 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.91 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.565 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 8.8 mp -73.28 -50.96 19.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.82 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -44.29 -38.54 3.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.85 90.28 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' ALA . 24.8 t -61.61 -47.35 93.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 109.725 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.37 -45.78 9.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.682 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.67 -29.48 75.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.57 -40.03 84.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.619 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.56 58.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -73.67 -47.04 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.377 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.78 -29.75 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -74.54 -33.96 54.98 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 2.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 110.585 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -84.54 -23.64 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.71 74.15 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.91 21.93 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.857 2.371 . . . . 0.0 112.023 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -115.55 -4.68 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.091 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.59 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -110.51 159.91 30.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.693 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -36.09 -22.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 mp -44.18 -26.18 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -43.68 -65.46 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.608 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.6 m-85 -55.3 -37.71 67.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.979 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.55 -48.69 84.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.776 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 -31.76 65.2 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.436 0.636 . . . . 0.0 109.749 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.3 ttp -63.18 -11.81 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.355 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 71' ' ' TYR . 63.4 t -62.84 -39.24 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.399 0.618 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.7 mt -83.65 -36.59 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.784 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 15.9 t90 -59.65 -52.61 64.79 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.688 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 78' ' ' LEU . 2.4 tt -58.98 -53.66 55.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 110.529 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -42.27 -45.13 4.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.748 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -81.49 -24.53 36.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.25 -61.41 2.62 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.801 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 5.8 m-85 -75.13 -53.72 8.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -65.08 -45.03 86.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.89 -45.89 95.05 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' ALA . 90.2 t -69.55 -35.67 67.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.603 0.239 . . . . 0.0 111.227 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 82' ' ' PHE . 1.1 mp0 -71.29 -39.52 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.708 0.289 . . . . 0.0 110.934 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 tp -73.05 -43.94 61.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.6 p -52.68 -52.25 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -47.37 -38.63 13.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -59.52 -40.93 88.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.863 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.576 ' ND1' HD23 ' A' ' 43' ' ' LEU . 1.8 m-70 -60.95 -35.85 77.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.367 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.3 p -76.49 -42.54 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.0 ttt -50.34 -49.88 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.13 -47.81 81.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -52.91 -37.81 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.5 mp -94.35 -15.87 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 93' ' ' MET . 13.3 m-85 -156.26 75.44 4.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.625 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.12 160.15 8.69 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.795 2.33 . . . . 0.0 112.058 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 t -168.31 60.59 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.761 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.7 81.93 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.853 2.369 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -163.08 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.546 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.82 67.21 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.592 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -167.26 131.17 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.486 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.4 m -81.97 45.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.66 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -111.42 125.12 53.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.713 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -161.02 -38.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.541 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.5 ptm -156.64 156.77 34.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -58.62 113.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -145.76 100.03 3.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -125.3 148.55 61.28 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.169 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 113' ' ' TRP . 85.7 Cg_exo -38.99 132.16 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.451 2.101 . . . . 0.0 112.149 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 3.7 mp0 -69.75 11.02 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.555 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.82 -3.47 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.609 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.6 tp -125.81 79.37 68.43 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 121.017 0.437 . . . . 0.0 110.043 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.1 Cg_exo -54.59 9.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.731 2.288 . . . . 0.0 112.52 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.609 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -65.48 -32.91 74.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.048 0.451 . . . . 0.0 109.925 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -97.71 -40.1 8.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.014 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.9 -45.34 67.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.9 t90 -76.12 -12.16 60.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.189 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.89 70.74 36.06 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.42 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.8 Cg_endo -77.19 -18.67 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.705 2.27 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -55.46 -54.12 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.897 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.495 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 10.6 m -105.48 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.828 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.2 m-85 -164.96 -38.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.1 p -58.23 129.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.548 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.83 152.68 18.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' PRO . 54.0 p -156.53 104.99 2.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.09 -169.75 21.57 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 3.6 m-20 -96.19 170.26 9.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 110.238 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.2 m -119.04 128.44 54.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.72 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.49 -10.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -69.56 149.03 48.63 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.712 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -100.01 134.09 43.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.677 ' OE1' HD21 ' A' ' 38' ' ' LEU . 5.3 pt20 -132.58 -13.59 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -173.9 133.73 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -145.37 158.0 43.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.178 0.513 . . . . 0.0 112.002 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.427 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.5 t80 -114.29 140.28 48.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.159 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp 49.11 16.72 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.088 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.97 23.02 31.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.072 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 144' ' ' GLN . 77.6 mt -127.42 138.99 53.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.985 0.392 . . . . 0.0 110.174 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -68.05 146.18 53.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.435 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.62 -54.32 19.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.455 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.3 Cg_exo -41.48 -34.17 1.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.334 2.023 . . . . 0.0 111.941 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.459 ' OE1' HD22 ' A' ' 140' ' ' LEU . 12.4 tt0 -72.03 -48.46 44.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 94.6 m95 -60.44 -57.79 11.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.827 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 146' ' ' LEU . 10.8 mp -43.97 -37.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.085 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.45 -35.1 73.4 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.6 -40.88 98.5 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.48 -25.8 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.451 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -44.91 87.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.35 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 151' ' ' ILE . 5.8 tt -66.47 -38.12 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.026 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -51.4 -48.73 62.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.904 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.92 -39.9 91.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.644 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.8 ' O ' HD23 ' A' ' 154' ' ' LEU . 7.3 tt -59.98 -30.96 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.353 0.597 . . . . 0.0 109.868 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -82.67 -30.84 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.815 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -67.88 -42.74 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.784 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.34 -48.34 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.581 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -51.98 -34.42 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.217 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.1 -36.13 21.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.0 t -67.02 -30.46 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.292 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.5 p -79.26 -49.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.587 ' N ' HG13 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -64.21 -10.53 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.113 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 m -54.31 -38.54 66.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.585 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -164.78 73.4 1.52 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.74 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.17 1.04 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.933 2.422 . . . . 0.0 112.127 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.542 ' CG ' ' N ' ' A' ' 167' ' ' LYS . 91.3 t80 -149.89 165.42 32.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.612 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.542 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 21.2 ttmt -85.0 58.5 5.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.535 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.48 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.341 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -141.51 43.88 1.74 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.598 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -72.73 125.94 28.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -126.4 -137.14 0.26 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.428 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.516 ' OD1' ' CZ ' ' A' ' 174' ' ' PHE . 1.7 p30 -55.22 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.15 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 0.2 OUTLIER 59.17 101.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 1.3 m-85 -89.62 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 176' ' ' ARG . . . -54.05 100.5 0.07 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 175' ' ' GLY . 9.0 ttt180 58.26 127.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.931 0.396 . . . . 0.0 110.569 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -88.36 -134.02 4.61 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -162.01 106.28 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.484 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.96 -65.02 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 46.27 -109.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -98.58 -114.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.92 -23.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.561 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.552 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.019 0.438 . . . . 0.0 110.037 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -45.53 -42.0 10.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.549 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -62.79 -41.06 99.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -49.7 -41.15 42.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.01 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -67.49 -29.56 69.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.891 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -74.9 -50.72 15.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 p -76.76 -36.44 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.771 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -70.7 2.57 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.09 148.98 18.95 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -70.78 -49.24 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.291 . . . . 0.0 110.702 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.21 -44.86 6.24 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.3 81.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.559 -0.32 . . . . 0.0 110.253 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -58.53 -46.55 86.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.234 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.19 -28.27 67.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.0 -31.45 67.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.634 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . 55.7 mtt -70.65 -33.93 71.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.66 32.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.674 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.74 -31.47 64.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -67.23 -52.57 39.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.512 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -65.57 -29.12 69.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.471 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -77.75 -41.79 36.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.68 -33.87 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -73.23 -35.46 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.277 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -71.42 -43.3 67.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.652 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.07 -57.91 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 p -51.06 -30.24 15.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.297 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.36 -43.44 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -14.56 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -91.96 -36.62 13.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.426 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 36' ' ' MET . 2.6 m-85 -58.67 -40.32 83.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -75.78 -35.78 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.221 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -28.89 66.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.484 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 36' ' ' MET . 22.5 m -105.24 -38.21 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.652 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 36' ' ' MET . 1.8 tmt? -80.5 -0.04 35.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.511 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 48.52 47.57 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tt -83.63 150.76 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -117.88 137.85 24.78 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.3 Cg_endo -75.44 167.72 26.03 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.454 2.102 . . . . 0.0 112.155 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.45 175.51 7.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.099 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 33.2 t -58.38 -53.72 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.0 tp -65.16 -48.28 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 p -48.75 -47.84 41.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.591 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.52 -44.27 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.364 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.33 -46.6 89.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.92 -38.04 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.327 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -60.7 -29.4 69.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.821 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.01 -37.01 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.478 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.54 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.483 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' VAL . 6.1 tp -76.37 -54.02 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.28 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -44.03 -38.87 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.44 -41.63 90.42 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.6 t -62.62 -47.81 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-O 121.212 0.529 . . . . 0.0 109.757 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -49.23 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.218 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.54 -29.38 69.4 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -69.47 -33.13 72.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.667 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.86 -24.3 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 59' ' ' LEU . 3.2 mm? -73.92 -39.28 63.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.405 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.18 -35.29 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.695 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -65.49 -38.5 94.87 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.94 11.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.919 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.3 mt -83.7 -29.01 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.533 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.03 78.1 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.404 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.23 22.81 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.58 2.187 . . . . 0.0 112.083 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -111.09 -6.27 14.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.78 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.55 163.19 20.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.672 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -40.92 -13.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.505 2.137 . . . . 0.0 112.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 mt -42.42 -34.99 0.91 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 94.2 mtt180 -39.0 -67.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.338 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.9 m-85 -48.96 -34.27 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.9 t -68.34 -46.02 81.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -43.87 21.86 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.992 -0.442 . . . . 0.0 111.137 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.473 ' SD ' ' C ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.07 -16.73 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.797 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -57.78 -32.5 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.637 0.732 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.7 -34.09 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.895 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.9 t-105 -64.3 -45.18 89.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.933 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 81' ' ' ALA . 1.3 tp -68.62 -46.33 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.221 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -45.69 -41.92 11.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.122 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -80.77 -23.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.387 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.24 -59.59 5.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -74.84 -53.62 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -66.23 -46.89 75.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.78 -47.3 86.83 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.5 t -66.39 -47.39 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.451 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 1.4 tm0? -56.85 -44.74 82.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.531 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.2 tt -64.81 -51.41 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.8 p -48.13 -23.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.256 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.66 -45.16 54.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.53 -38.09 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.136 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -67.95 -42.11 81.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -66.62 -51.56 54.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.729 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' TYR . 16.5 ttt -56.34 -51.49 68.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.95 -41.6 99.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.423 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -55.97 -44.29 78.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.228 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 96' ' ' LEU . 5.9 tt -95.54 -6.56 40.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' MET . 9.5 t80 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.305 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.536 ' CG ' ' O ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.88 -2.76 58.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.157 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.628 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.9 mt -126.34 80.19 69.36 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 48.6 Cg_exo -52.89 5.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.69 2.26 . . . . 0.0 112.164 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.628 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -61.67 -33.31 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.201 0.524 . . . . 0.0 110.075 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -96.94 -43.04 7.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -45.24 80.75 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.221 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.1 t90 -74.63 -12.9 60.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.792 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.9 t -142.63 72.67 20.19 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.59 -17.08 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.712 2.274 . . . . 0.0 111.8 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -54.96 -53.78 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.798 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.6 t -105.94 58.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.6 m-85 -162.85 -42.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 130.4 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.4 156.32 16.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' PRO . 67.3 m -160.99 99.93 1.23 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.66 179.89 17.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.34 150.29 23.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 110.235 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 68.4 m -101.43 129.07 47.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.821 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.56 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.21 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.66 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.859 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.486 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -100.58 132.84 45.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.536 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -130.28 -8.24 4.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.812 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.432 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 10.1 t-105 -173.91 132.41 0.42 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.86 160.32 39.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.93 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -117.87 139.04 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.078 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mt 49.66 17.05 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.56 20.64 40.09 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.7 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.03 139.19 54.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -70.24 146.4 50.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.149 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.37 -58.88 5.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.366 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.1 Cg_exo -37.21 -37.84 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -70.52 -45.19 66.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.111 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.6 m95 -66.95 -57.39 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.232 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 mt -43.49 -37.03 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.978 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 88' ' ' THR . 28.6 tp -63.57 -36.35 83.5 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -55.59 -39.68 75.9 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.3 mt -71.02 -44.27 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 110.463 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -47.69 -42.54 25.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.23 -46.29 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.801 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -56.66 -54.24 48.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.0 m-85 -57.2 -36.88 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.697 ' C ' HD23 ' A' ' 154' ' ' LEU . 6.1 tt -63.53 -29.79 71.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.89 -39.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 m -62.02 -38.82 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.827 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.579 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -72.24 -48.41 42.98 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.71 -37.08 74.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.73 -41.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 156' ' ' VAL . 75.5 t -72.0 -23.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 157' ' ' ALA . 15.0 t -76.05 -45.74 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.45 -21.49 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -57.59 -28.29 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -76.92 -43.29 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.544 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mt -50.58 -41.02 53.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.357 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -65.62 -27.57 68.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 110.064 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.44 -47.91 14.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.522 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.81 71.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.668 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.4 m -76.53 -39.69 52.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.62 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.542 HE22 ' C ' ' A' ' 65' ' ' PRO . 19.1 tp60 -66.85 5.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.481 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.75 141.97 15.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -68.11 -48.22 66.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.01 -45.36 6.02 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.62 76.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.108 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -54.62 -42.48 71.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.6 -26.95 65.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.995 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -70.16 -35.01 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.662 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.451 ' O ' ' OG1' ' A' ' 21' ' ' THR . 2.0 mtt -71.6 -32.93 68.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.35 45.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -52.31 -43.79 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.4 p -58.23 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.691 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.42 -39.04 31.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -42.03 69.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.839 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . . . -45.98 -42.27 12.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.709 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -71.12 -32.08 68.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 30' ' ' LEU . 3.4 tm-20 -70.68 -49.93 41.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.07 -57.72 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 24' ' ' ALA . 68.7 p -49.95 -30.34 10.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.622 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.93 -47.09 13.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -54.45 -14.22 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.42 -36.3 10.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.36 . . . . 0.0 110.515 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -42.1 79.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.437 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 40' ' ' PRO . 39.6 mt-30 -69.57 -46.08 67.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.17 -18.81 50.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -101.61 -43.92 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 mmt -89.96 8.45 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.767 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLN . 3.8 tp 44.87 45.74 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.646 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -80.05 154.43 28.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -127.53 83.84 64.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.361 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 75.5 Cg_exo -47.02 178.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 8.4 t -116.29 -175.83 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.384 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.1 p -64.52 -36.18 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.314 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.55 -47.53 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.543 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -53.61 -49.56 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.691 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.7 mt -65.8 -37.81 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.368 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -59.76 -48.36 81.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.16 -37.05 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -32.37 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.95 79.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.33 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -77.19 -52.1 9.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.07 -40.12 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.4 -44.71 89.83 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 t -61.21 -47.67 92.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.49 . . . . 0.0 109.758 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -44.62 -46.05 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.785 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.47 80.89 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.2 -40.71 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.358 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.04 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.367 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.03 -28.47 49.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.428 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.14 -39.35 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.493 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.99 -32.76 77.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.36 5.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 61' ' ' GLY . 76.7 mt -76.56 -36.8 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.94 72.06 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.499 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' C ' HE22 ' A' ' 10' ' ' GLN . 16.4 Cg_exo -64.36 16.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.879 2.386 . . . . 0.0 112.131 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.0 tmtm? -109.37 -5.67 15.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.004 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.38 164.31 16.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.567 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -41.19 -12.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.6 mm? -44.84 -34.79 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.406 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.2 ptt180 -40.43 -68.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.736 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.453 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 27.4 t80 -54.0 -28.48 38.27 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 t -70.86 -52.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.697 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.08 63.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.269 0.557 . . . . 0.0 109.987 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 23.4 ttt -59.3 -10.42 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.047 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 72' ' ' VAL . 4.4 p -62.78 -36.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.428 0.632 . . . . 0.0 110.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 76' ' ' ILE . 35.7 mm -86.65 -32.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.754 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 8.3 t-105 -62.96 -52.64 62.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.935 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -46.33 88.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.609 ' CD2' ' NH1' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -47.05 -45.78 21.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.56 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.5 p -76.59 -25.94 54.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.669 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.0 -60.6 3.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.024 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -73.33 -54.24 8.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 79' ' ' TYR . 23.0 ttm105 -67.26 -47.49 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' THR . . . -54.68 -48.47 65.74 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.1 -50.89 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.438 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -48.34 -28.05 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -77.83 -39.25 44.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 147' ' ' LEU . 80.6 p -54.13 -29.56 45.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.31 -48.75 69.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.342 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -54.95 -39.84 69.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.469 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -71.84 -56.79 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -53.16 -52.78 57.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' TYR . 61.7 mmm -49.41 -46.59 47.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.8 -45.37 78.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.359 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -57.84 -38.82 76.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.2 -12.12 28.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.0 t80 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.639 0.257 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -96.52 -4.57 41.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.932 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 mt -123.65 78.77 55.84 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.201 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.4 Cg_exo -51.87 -0.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.596 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -59.21 -33.21 70.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.106 0.479 . . . . 0.0 110.367 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -96.8 -42.08 8.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.636 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -70.12 -45.09 67.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.568 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.3 t90 -74.1 -16.13 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.04 71.32 48.44 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.21 -19.58 10.43 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.854 2.37 . . . . 0.0 111.77 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -52.46 -44.98 65.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.683 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 t -118.98 56.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.947 0.403 . . . . 0.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.523 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.3 t80 -160.35 -40.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.256 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.23 127.53 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.483 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.14 22.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 127' ' ' SER . 17.2 p -169.13 103.49 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.472 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.35 -175.43 21.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.3 140.87 29.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.799 0.333 . . . . 0.0 110.225 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.1 m -89.65 135.47 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.98 1.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 133' ' ' ARG . 2.4 tm-20 -67.11 145.27 55.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.493 ' N ' ' OE2' ' A' ' 132' ' ' GLU . 6.6 ptp180 -100.07 130.23 46.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -118.83 -25.17 6.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 140.74 52.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.98 119.46 11.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.218 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.18 133.83 51.44 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.17 17.51 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.349 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.93 58.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.26 145.11 50.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.2 mp0 -75.94 157.38 33.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.1 mtt -56.47 -50.93 84.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.911 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 142' ' ' MET . 88.1 Cg_exo -43.86 -38.03 9.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.357 2.038 . . . . 0.0 112.158 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -70.76 -52.67 19.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.06 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.6 m95 -58.62 -57.17 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.967 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.46 -37.77 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -60.3 -35.91 76.68 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.8 -44.9 95.6 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.14 -39.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.243 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -52.68 -47.84 66.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.903 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.12 -48.05 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.33 -46.59 66.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.703 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.453 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 6.1 m-85 -55.12 -40.54 70.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.294 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 158' ' ' VAL . 1.4 mt -65.85 -30.58 71.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.12 -29.5 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.622 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.3 t -69.8 -36.55 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.486 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -79.99 -35.99 36.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.202 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 154' ' ' LEU . 47.3 t -65.4 -38.93 83.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.101 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.79 -27.81 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.736 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 156' ' ' VAL . 41.3 t -78.31 -26.23 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.25 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 74' ' ' MET . 2.5 p -83.25 -41.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.438 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 70.2 mt -74.22 -19.31 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.842 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.989 0.423 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 3' ' ' ARG . 36.7 mtp180 -56.84 -28.1 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.299 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.34 -42.95 58.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.2 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 5' ' ' LEU . 4.1 mm? -51.51 -41.54 61.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.406 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 1.1 m-20 -66.37 -31.72 72.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -77.54 -49.51 14.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.9 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -76.65 -34.2 58.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -74.16 5.91 3.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.583 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.11 145.64 17.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -70.54 -21.15 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.614 0.245 . . . . 0.0 110.673 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 -45.14 67.09 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.93 75.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.83 0.348 . . . . 0.0 110.178 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -56.48 -41.63 76.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.328 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -69.16 -31.36 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.001 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.14 -28.84 66.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.558 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.82 -32.97 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.978 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.55 5.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -49.35 -48.43 46.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -51.76 -62.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.776 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -55.25 -31.69 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.2 tt -73.04 -41.72 63.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.505 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.13 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.77 -34.38 71.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.29 -42.6 71.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.755 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.98 -57.82 3.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.485 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 p -48.17 -31.86 6.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.72 -32.18 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.71 -17.31 62.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -94.41 -37.54 11.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.672 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -54.35 -45.97 72.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -74.56 -31.56 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.42 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.449 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -61.0 -32.16 71.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.576 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 36' ' ' MET . 19.9 m -103.23 -41.55 7.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 5.2 tpt -78.03 -0.61 28.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt 48.96 49.87 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.01 147.95 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.82 136.53 20.0 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.202 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.91 143.81 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.353 2.035 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -100.23 161.57 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 41.4 t -51.21 -51.58 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.409 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mt -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.068 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 p -48.63 -43.03 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 124' ' ' PHE . 25.2 mt -63.27 -47.16 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.61 -46.54 80.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -40.25 96.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.554 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -63.66 -35.85 81.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.93 76.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.55 -46.96 85.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.62 -49.9 11.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -46.42 -41.36 13.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.04 88.65 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 54.1 t -62.94 -44.16 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.276 0.56 . . . . 0.0 109.681 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -48.3 9.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.323 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.69 89.58 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -63.01 -37.69 88.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 110.304 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.29 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.316 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.42 -25.4 57.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.541 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -84.21 -40.77 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.2 -30.85 76.1 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.92 9.81 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.503 ' H ' ' C ' ' A' ' 61' ' ' GLY . 67.1 mt -79.79 -41.92 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.95 71.04 0.34 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.318 . . . . 0.0 110.385 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.43 13.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.959 2.44 . . . . 0.0 112.228 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 64' ' ' ALA . 19.5 pttp -113.09 -5.38 13.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.493 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.14 161.27 29.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.691 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.73 -12.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.325 2.017 . . . . 0.0 112.045 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -42.95 -35.55 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' LEU . 89.5 mtt180 -37.82 -65.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -51.46 -25.04 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.833 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.4 t -78.39 -52.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.78 -45.31 52.45 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.135 0.493 . . . . 0.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.49 -8.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.085 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.9 p -61.75 -34.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.596 0.712 . . . . 0.0 110.145 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.31 -31.82 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.594 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -65.65 -51.06 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.934 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.56 -43.87 83.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -46.24 -45.56 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.956 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -58.38 8.81 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.215 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.51 -53.85 9.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.354 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -67.87 -45.91 73.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.29 -47.91 78.89 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.7 t -68.78 -46.31 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.506 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.407 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 1.6 tm0? -54.43 -24.96 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 tp -87.25 -41.85 13.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.634 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 22.5 p -51.61 -25.74 7.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.381 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -71.31 -35.33 71.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.11 -33.85 75.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.26 -44.94 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -59.72 -52.6 64.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.518 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.646 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.7 ttt -54.34 -48.49 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.46 -37.96 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.805 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.52 -39.2 85.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.8 mm? -90.02 -5.56 56.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.7 t80 . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.161 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.46 0.059 0 CA-C-O 120.74 0.305 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -126.64 15.24 7.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.378 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.2 mt -120.52 80.25 30.33 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.707 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 11.3 Cg_exo -68.07 7.95 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.637 2.225 . . . . 0.0 111.386 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -76.51 -30.87 57.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 110.357 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.37 -41.11 8.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -67.58 -44.87 77.12 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.418 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.7 t90 -77.32 -13.11 60.0 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.519 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.54 74.28 71.3 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.87 -25.68 4.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.846 2.364 . . . . 0.0 111.872 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -52.43 -52.16 55.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.7 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.72 55.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.709 ' O ' HD13 ' A' ' 45' ' ' ILE . 38.1 t80 -158.93 -40.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 125' ' ' VAL . 12.1 p -54.99 128.81 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.67 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.37 148.9 21.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.1 p -155.91 128.66 7.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 106.11 -163.22 13.78 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -102.02 156.52 17.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.394 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 21.0 m -108.11 130.94 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.85 -7.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 158.03 32.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' CZ ' ' OD2' ' A' ' 136' ' ' ASP . 53.2 ttt180 -97.67 141.93 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.236 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -134.42 -31.66 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.69 146.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.707 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.476 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.0 p30 -143.24 161.1 39.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 111.993 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -114.44 136.39 53.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.773 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.22 16.77 0.28 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.99 19.7 33.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.194 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.416 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 35.2 mt -125.64 140.44 52.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.052 0.426 . . . . 0.0 110.254 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.21 148.03 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -48.7 -51.96 49.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.546 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 142' ' ' MET . 87.8 Cg_exo -44.23 -34.51 7.08 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.35 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -48.82 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.579 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.1 m95 -57.94 -57.98 10.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.879 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.0 mt -43.89 -38.74 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.589 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.2 tt -56.83 -37.3 71.03 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.31 -41.2 96.77 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 mt -76.61 -25.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.767 0.318 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.53 -46.16 80.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.36 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 pt -64.26 -41.54 92.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.288 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.34 -49.45 77.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.358 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.439 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 4.1 m-85 -59.77 -45.13 93.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.724 HD12 ' C ' ' A' ' 154' ' ' LEU . 0.4 OUTLIER -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.836 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.51 -32.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.565 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 34.1 t -67.66 -48.4 76.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.502 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -57.28 -53.63 55.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 154' ' ' LEU . 96.1 t -51.44 -49.2 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.8 t -73.4 -23.11 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.1 t -81.56 -50.83 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.918 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 34.4 mm -68.66 -12.38 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.274 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.388 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 2' ' ' LEU . 9.6 mp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.955 0.407 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -56.53 -37.36 70.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.561 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.99 -45.46 88.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.16 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -50.22 -41.27 49.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.071 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 6' ' ' ASN . 1.7 m120 -68.75 -26.75 65.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.898 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.4 -50.48 15.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.448 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.63 69.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -76.47 -37.69 56.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.661 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -73.68 8.83 1.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.83 141.11 15.17 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 13' ' ' GLY . 3.8 ptp85 -68.49 -49.7 57.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.656 0.265 . . . . 0.0 110.713 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 12' ' ' ARG . . . -43.05 -45.77 6.16 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.12 87.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -60.49 -44.52 95.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.152 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.12 -30.14 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 21' ' ' THR . 20.9 tp -69.8 -28.06 65.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.633 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.459 ' O ' ' OG1' ' A' ' 21' ' ' THR . 20.1 mmt -74.5 -33.64 62.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.52 -54.67 15.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.564 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.22 -49.25 53.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.703 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 18' ' ' MET . 20.3 p -48.7 -57.08 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.13 -39.5 28.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.55 -41.47 69.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' THR . . . -47.14 -36.41 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.544 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.85 -36.32 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.23 -53.54 42.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.818 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -62.41 -57.97 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.833 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.9 p -46.96 -29.24 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.732 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -45.41 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.8 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -52.27 -15.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.8 t90 -93.32 -34.7 13.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.483 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.98 -42.38 80.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -69.02 -47.68 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.01 -9.05 13.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.498 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' TRP . 55.7 t -107.17 -41.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.6 mmt -96.39 10.12 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 tp 48.47 45.33 20.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.6 mt -79.54 146.65 32.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.352 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -107.61 131.22 21.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.444 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 165.22 28.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.137 1.892 . . . . 0.0 111.761 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -127.96 -175.22 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.512 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.1 mm? -69.88 -49.93 47.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.612 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.2 p -49.68 -51.14 40.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.488 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.55 -40.49 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -59.48 -43.15 93.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.787 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -59.02 -44.41 91.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.432 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -58.97 -29.63 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.25 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.51 72.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.316 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 54' ' ' VAL . . . -62.7 -52.3 63.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -54.82 9.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.035 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -48.65 -32.11 7.79 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.814 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.31 -46.29 72.31 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.945 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -70.73 -31.24 45.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.366 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.03 -46.47 75.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.284 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.71 86.41 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.01 95.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.78 -0.71 . . . . 0.0 110.557 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -29.54 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.503 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.5 tp -74.25 -32.03 62.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.57 -33.81 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -78.08 -30.13 51.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.57 5.25 1.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 0.0 110.317 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.4 mt -89.12 -23.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.607 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.02 70.09 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.794 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.45 26.6 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.702 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -109.2 -7.19 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.395 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.88 173.73 2.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.13 -8.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.22 1.947 . . . . 0.0 111.852 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -42.27 -38.74 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.4 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 10.4 mtp180 -40.04 -70.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.606 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -51.6 -18.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.092 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 69' ' ' LEU . 4.0 t -83.16 -46.6 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.61 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -40.04 68.41 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.81 -8.84 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.353 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.84 -43.97 81.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.396 0.617 . . . . 0.0 110.145 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.49 -33.36 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.4 t-105 -60.19 -55.9 28.21 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.801 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.54 -48.2 82.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -45.17 -43.95 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.6 p -79.84 -24.54 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.577 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.05 -61.24 2.75 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.69 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.42 -55.94 5.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -65.97 -51.5 57.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.68 -47.31 58.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 81' ' ' ALA . 91.1 t -68.86 -47.5 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -53.17 -30.23 36.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -42.61 63.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.4 p -54.61 -28.59 47.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.969 0.414 . . . . 0.0 110.237 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -63.34 -46.1 88.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -61.86 -40.17 94.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.718 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -70.81 -45.88 63.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.773 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.5 p -64.61 -47.69 77.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.727 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 97' ' ' TYR . 28.6 ttt -56.24 -51.35 68.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.57 -50.98 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.329 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -51.91 -37.78 53.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.388 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.515 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -91.71 -15.69 28.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.315 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 93' ' ' MET . 84.9 t80 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.746 0.308 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.44 5.75 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.622 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.599 ' C ' ' H ' ' A' ' 116' ' ' LEU . 77.9 mt -117.37 83.48 16.48 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -54.14 7.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.583 2.188 . . . . 0.0 112.428 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 116' ' ' LEU . 8.2 mp -74.88 -28.43 60.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.693 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -95.8 -40.8 9.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -65.65 -33.69 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -88.63 -20.73 24.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.184 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.51 69.03 12.39 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.82 -18.06 52.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.712 2.274 . . . . 0.0 111.538 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.59 -3.81 42.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.179 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 123' ' ' VAL . 48.3 t -131.76 36.13 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.102 0.477 . . . . 0.0 110.741 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 15.9 m-85 -161.33 -43.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.72 129.8 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.066 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.09 152.83 18.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.5 t -160.68 99.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.05 -174.11 22.31 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 13.2 m-20 -88.0 157.34 18.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 2.6 m -107.86 127.63 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.05 -4.25 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.131 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -67.58 128.84 37.95 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.791 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.789 ' H ' ' NE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -74.08 142.63 45.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.472 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -131.96 -26.81 1.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.792 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -173.0 147.82 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 20.0 p-10 -142.98 167.57 21.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 112.112 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -134.75 138.15 44.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.844 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.68 17.32 3.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.457 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 83.41 21.02 59.22 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 139' ' ' GLY . 7.0 mp -120.87 131.52 54.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.3 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -68.99 150.58 47.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.6 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.67 -54.4 23.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.082 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.97 -36.47 11.27 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.246 1.964 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.95 -46.04 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.0 m95 -65.31 -56.98 9.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.873 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -42.99 -37.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.15 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.36 -34.06 77.42 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.97 -40.68 91.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.79 -40.53 76.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.277 . . . . 0.0 110.279 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.37 -40.63 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.99 -46.62 93.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.75 -51.16 66.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.405 ' CD2' ' CZ2' ' A' ' 77' ' ' TRP . 4.6 m-85 -66.76 -43.69 83.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.6 tt -49.11 -30.76 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.313 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.69 -37.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.938 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 160' ' ' VAL . 87.0 t -51.64 -37.45 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.587 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -79.91 -44.36 20.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.935 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 154' ' ' LEU . 67.0 t -52.07 -44.48 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.215 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tp -81.3 -36.43 29.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.792 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.9 t -69.94 -31.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.259 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.7 -49.29 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.107 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -19.34 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.033 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.922 0.392 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -51.62 -43.41 62.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.44 -39.87 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 159' ' ' LEU . 1.4 tt -53.43 -44.8 69.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.75 -31.81 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -75.22 -48.57 22.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -64.75 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.654 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.7 p -76.16 -32.03 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 4.4 tt0 -74.24 9.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.965 0.412 . . . . 0.0 110.319 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.82 151.8 17.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 16' ' ' LEU . 57.9 mtm180 -69.05 -20.24 64.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.74 -44.09 64.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.24 -51.39 61.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.533 0.206 . . . . 0.0 110.991 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -54.85 -51.08 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 12' ' ' ARG . 7.0 mp -59.76 -27.61 66.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -70.46 -26.09 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.09 -34.85 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.67 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.725 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 27.0 t80 -52.9 -53.41 49.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.715 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.4 p -43.74 -53.4 5.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.442 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -26.58 66.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -79.92 -42.24 24.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.42 -36.24 61.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.756 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.38 -38.95 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.14 -45.75 79.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -57.79 5.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.572 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.1 p -46.76 -31.67 3.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.477 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.67 -44.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 tp -51.06 -17.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.654 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' VAL . 31.4 t90 -91.44 -35.83 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 1.7 m-85 -56.47 -36.99 69.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.349 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.95 -39.71 23.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.53 -22.4 61.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -109.03 -44.01 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 35' ' ' VAL . 5.4 ttt -83.98 6.47 21.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.6 mt 40.57 42.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.729 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.71 154.11 39.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.339 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -123.61 115.54 28.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.5 Cg_endo -78.29 179.95 6.02 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.274 1.983 . . . . 0.0 112.283 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 2.2 t -119.61 -175.73 3.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -65.12 -39.68 86.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.297 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.584 HD11 ' CG ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -65.21 -50.12 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.257 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.2 m -49.74 -48.21 50.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.703 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.95 -42.97 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.36 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -56.74 -45.89 81.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.053 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.17 -42.37 98.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.3 ttp85 -62.44 -34.83 77.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.45 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.137 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.59 -47.29 82.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -76.99 -47.95 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -46.9 -44.31 19.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.087 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.08 93.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 27.6 t -61.42 -47.33 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.154 0.502 . . . . 0.0 110.0 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.507 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.3 tt -46.46 -45.38 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.63 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.56 74.11 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -65.04 -30.67 71.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.908 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.25 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.223 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.0 -43.1 99.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 mm -79.22 -35.97 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.45 -33.41 81.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 9.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 91.9 mt -83.35 -35.06 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.723 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.22 76.45 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.712 0.291 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.78 20.7 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.579 2.186 . . . . 0.0 112.062 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -109.61 -7.28 15.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.158 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.09 162.86 18.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.6 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -38.69 -16.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.512 2.141 . . . . 0.0 112.256 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 67' ' ' THR . 38.9 mt -44.05 -31.18 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 61.0 mtt180 -38.13 -65.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.39 -33.15 52.62 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.416 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.9 t -66.36 -57.75 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.496 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.35 82.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.307 0.575 . . . . 0.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -14.94 45.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.262 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 72' ' ' VAL . 1.9 p -60.25 -32.64 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.499 0.666 . . . . 0.0 110.198 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -89.34 -32.97 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.927 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.4 t-105 -67.16 -49.58 64.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.874 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 78' ' ' LEU . 4.4 tt -63.9 -51.84 62.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.924 0.393 . . . . 0.0 110.158 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -40.96 -43.21 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.36 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 p -78.89 -21.5 47.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.53 -61.22 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.816 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.61 -53.56 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.38 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -68.1 -39.24 82.89 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . . . -66.44 -44.79 89.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.43 -38.47 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.563 0.22 . . . . 0.0 111.453 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -66.46 -43.91 84.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.278 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.17 -45.91 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.9 p -46.94 -50.28 19.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.502 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -53.05 -30.68 37.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.506 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.45 -39.96 89.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.584 ' CG ' HD11 ' A' ' 43' ' ' LEU . 2.8 m170 -64.75 -43.62 92.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.189 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -65.19 -38.87 91.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' TYR . 37.6 ttp -52.06 -45.02 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.4 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.302 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -55.9 -41.24 74.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.433 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 tp -89.09 -18.24 27.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.8 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.94 0.4 . . . . 0.0 110.62 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.656 0.265 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.544 ' HE1' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.8 -3.21 58.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.662 ' C ' ' H ' ' A' ' 116' ' ' LEU . 20.7 mt -118.76 88.11 34.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.917 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.6 Cg_exo -53.76 11.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.153 . . . . 0.0 112.261 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.662 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -71.4 -30.12 65.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 109.868 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.444 ' CG ' ' CE1' ' A' ' 124' ' ' PHE . 74.5 m-20 -97.29 -40.79 8.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -72.36 -45.77 58.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.821 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.8 t90 -72.91 -12.84 61.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.77 74.01 39.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.563 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.55 -20.69 10.63 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.756 2.304 . . . . 0.0 112.038 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.22 -53.11 55.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.23 55.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.017 0.437 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.444 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 37.2 t80 -158.78 -42.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.22 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 125' ' ' VAL . 12.4 p -58.02 128.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.584 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.43 160.61 14.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' PRO . 43.2 p -173.8 103.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.562 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.66 177.29 18.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -81.61 140.11 34.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.183 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 57.2 m -87.93 132.83 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.947 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.97 2.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.223 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -67.54 144.76 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -93.74 125.3 38.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 110.797 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.56 -23.26 6.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.764 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.45 138.95 47.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.841 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -141.7 119.68 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -123.04 132.99 54.35 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.29 17.31 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.65 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.88 17.54 56.16 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.633 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.2 mp -123.49 144.08 49.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.0 mp0 -77.72 157.82 29.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.646 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.6 OUTLIER -51.12 -53.58 47.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.8 Cg_exo -40.54 -38.86 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.375 2.05 . . . . 0.0 112.304 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.447 HE21 ' CD ' ' A' ' 141' ' ' GLU . 58.2 mt-30 -69.8 -54.19 14.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.508 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.607 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.1 m95 -62.81 -57.79 9.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.463 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 tt -42.92 -36.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.509 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.77 -33.02 74.91 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.86 -44.99 96.57 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.724 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -76.04 -25.88 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 154' ' ' LEU . 32.5 t80 -62.63 -44.85 95.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.486 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 155' ' ' ILE . 20.4 pt -69.4 -36.65 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.358 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.91 71.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.97 -49.43 66.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.793 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.541 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 19.3 mt -62.65 -31.94 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.3 mp -72.68 -32.47 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -70.63 -46.01 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -55.09 -48.56 73.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.77 -24.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 5' ' ' LEU . 9.8 tp -78.01 -41.54 35.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.251 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.4 -20.38 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 157' ' ' ALA . 39.7 t -81.19 -50.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.81 -21.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.446 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.284 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 2.1 pp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.824 0.345 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -53.2 -32.47 48.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.586 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 91.9 t80 -76.86 -42.61 39.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -46.59 -45.1 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.545 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 4.3 p-10 -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 8.5 tt0 -78.41 -48.28 15.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.16 96.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 11' ' ' GLY . 14.7 m -76.69 -36.11 57.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 13.9 tt0 -64.45 2.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.287 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.66 150.69 19.54 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.2 mtt85 -70.48 -45.53 65.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.465 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.11 -45.26 15.01 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.37 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -60.93 -48.44 81.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -57.64 -31.22 66.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.081 0.467 . . . . 0.0 109.781 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.49 -25.71 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.791 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.3 mmt -74.34 -34.17 63.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.22 -54.29 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.861 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.04 -47.92 61.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.752 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 p -52.54 -50.22 63.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.29 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.734 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.29 -39.17 82.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.04 -36.78 60.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.78 -35.6 62.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' OE1' ' NH2' ' A' ' 48' ' ' ARG . 3.8 tp10 -68.73 -46.89 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.927 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 27' ' ' LEU . 2.3 tt -65.71 -58.16 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 p -48.91 -32.35 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.62 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.6 mt -53.37 -13.56 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -95.1 -31.89 13.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.69 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.13 -34.36 77.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.73 -43.17 23.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -18.63 53.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.81 -48.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.647 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 tpt -83.33 6.49 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 41.69 41.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.44 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 39' ' ' LYS . 5.8 tt -62.83 151.85 37.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.117 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -113.47 90.61 17.88 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.241 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.62 146.39 34.58 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.554 2.169 . . . . 0.0 112.337 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.9 t -99.83 173.25 6.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.09 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 10.0 p -61.04 -41.4 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.8 mp -68.11 -47.79 67.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.272 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 m -50.2 -48.95 53.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.703 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.47 -44.24 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.49 -45.7 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.07 -39.8 93.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.679 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' NH2' ' OE1' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -61.11 -34.43 74.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.289 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 -39.04 88.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.568 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.5 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.1 -51.45 15.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -45.33 -43.19 10.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.053 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.9 96.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' ALA . 66.2 t -57.72 -46.47 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.26 0.553 . . . . 0.0 110.172 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.1 tp -48.48 -43.25 34.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.698 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.99 71.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.72 -35.15 60.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.566 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.93 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.75 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' O ' HD11 ' A' ' 63' ' ' ILE . 12.0 mt -75.42 -40.86 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.789 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -78.63 -31.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.23 -31.82 33.34 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.32 0.88 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.709 0.29 . . . . 0.0 110.885 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 59' ' ' LEU . 7.8 mm -88.45 -24.08 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.98 65.6 0.3 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.808 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.55 18.7 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.736 2.291 . . . . 0.0 111.625 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -106.54 -10.24 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.627 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -109.77 176.48 1.53 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.819 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.06 1.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.234 1.956 . . . . 0.0 111.796 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 67' ' ' THR . 12.2 tp -58.35 -31.27 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -39.86 -64.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.757 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 75' ' ' VAL . 23.7 t80 -53.19 -33.56 53.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.57 -46.56 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.85 -40.43 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.214 0.531 . . . . 0.0 109.925 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.8 mmt -59.89 -25.99 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.367 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -52.28 -29.08 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.488 0.661 . . . . 0.0 109.712 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.11 -31.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.091 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.469 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.8 t-105 -63.91 -46.26 85.6 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 78' ' ' LEU . 3.9 tt -67.77 -52.46 37.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -41.75 -41.55 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.297 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 p -81.39 -24.49 36.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.65 -59.04 6.08 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.989 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -74.89 -51.4 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.204 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.38 -46.09 77.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.78 -47.36 90.8 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.4 t -68.6 -56.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.217 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -49.87 -21.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.818 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.77 -35.91 14.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.033 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.9 p -59.05 -55.18 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.03 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.531 ' CZ ' ' SD ' ' A' ' 93' ' ' MET . 87.6 t80 -52.23 -38.61 58.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -57.14 -40.14 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -35.04 79.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.4 p -72.92 -36.54 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' TYR . 58.8 mmm -54.02 -49.06 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -60.52 -49.93 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.422 ' C ' HD12 ' A' ' 96' ' ' LEU . 29.6 mt-30 -50.23 -36.46 31.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 96' ' ' LEU . 11.1 mp -102.06 -9.77 20.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.641 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 93' ' ' MET . 25.5 t80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.798 0.332 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -2.24 56.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 116' ' ' LEU . 41.5 mt -120.11 87.12 38.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.6 Cg_exo -51.78 4.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.64 2.227 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 114' ' ' LEU . 13.8 mt -64.07 -30.23 71.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.1 -43.05 7.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.6 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -71.53 -44.96 63.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.437 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.3 t90 -74.64 -15.98 60.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.71 71.15 64.94 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.2 -22.87 10.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 111.919 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.1 -53.98 48.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.25 63.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.547 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -169.28 -42.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.81 131.05 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.67 156.45 16.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.59 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 85.2 p -166.76 100.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.4 -167.3 25.03 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -100.27 166.88 10.76 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -112.23 130.1 56.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 96.74 6.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.028 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.28 139.33 46.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -100.14 126.38 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.661 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.2 -14.4 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.6 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -173.38 132.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -143.25 161.29 38.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.258 0.551 . . . . 0.0 112.077 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 23.6 t80 -123.22 138.98 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.158 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 1.1 mm? 54.26 17.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.164 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.19 57.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 9.5 mt -124.41 136.64 54.21 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.02 148.32 50.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.424 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mtp -49.12 -52.01 51.54 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 142' ' ' MET . 71.1 Cg_exo -45.6 -38.12 16.24 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.41 2.073 . . . . 0.0 112.321 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -68.92 -46.18 68.94 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 148' ' ' GLY . 62.1 m95 -62.75 -56.15 20.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.211 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mt -43.12 -37.94 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.943 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -63.91 -35.22 79.94 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.92 -36.82 75.07 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.02 -33.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.75 -44.35 90.52 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.034 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.56 -49.24 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.022 0.439 . . . . 0.0 109.843 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.37 57.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.066 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -61.16 -49.83 75.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.332 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 154' ' ' LEU . 8.1 tt -47.53 -32.23 5.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.442 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.27 -38.11 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.14 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.3 t -54.39 -39.88 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.34 -45.55 25.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.313 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 34.7 t -52.27 -42.53 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.202 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mt -84.12 -41.41 17.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.433 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 156' ' ' VAL . 44.5 t -61.87 -25.37 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.756 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' ALA . 64.7 t -83.08 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 109.969 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 162' ' ' ILE . 80.6 mt -65.0 -8.59 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.312 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.821 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 2' ' ' LEU . 6.7 mp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.874 0.369 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -50.48 -36.1 32.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' GLN . 44.6 m-85 -75.47 -40.23 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.323 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.9 tp -45.06 -40.48 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -70.16 -21.75 63.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.404 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' PHE . 40.7 tt0 -79.93 -47.0 15.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.92 -31.72 73.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.95 0.405 . . . . 0.0 110.314 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 28.9 m -76.03 -41.47 50.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.21 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.428 ' CD ' ' O ' ' A' ' 10' ' ' GLN . 1.6 pp0? -70.4 8.93 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.558 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.76 142.43 16.08 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -65.76 -20.64 66.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.659 0.266 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.82 -47.57 54.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.36 -51.61 68.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 0.0 110.469 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -55.78 -46.36 77.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.517 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.63 -31.73 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -69.39 -28.11 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -74.89 -33.91 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.796 0.331 . . . . 0.0 110.138 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.49 43.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 71.4 t80 -54.33 -53.44 53.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.73 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.1 p -43.12 -49.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.678 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.49 69.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.3 tt -76.98 -38.72 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.639 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.25 42.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -75.85 -31.45 59.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.571 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -49.89 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.4 tt -63.96 -57.55 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.599 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -45.19 -34.82 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' C ' ' N ' ' A' ' 31' ' ' TRP . . . -82.96 -46.44 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.97 -16.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.531 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.402 ' N ' ' C ' ' A' ' 29' ' ' ALA . 44.1 t90 -94.19 -25.98 16.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 135' ' ' TRP . 0.2 OUTLIER -70.26 -43.15 71.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.519 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' LEU . 34.8 tt0 -73.74 -48.04 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.613 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -49.99 -28.63 7.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.714 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.12 -45.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.696 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 2.07 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.506 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLN . 16.2 mt 43.15 43.64 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.4 149.66 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.395 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -115.37 88.31 18.59 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.79 174.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 112.008 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.59 -172.58 2.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.39 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 43' ' ' LEU . 10.7 m -64.44 -42.94 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' N ' HG23 ' A' ' 42' ' ' VAL . 7.6 mt -64.94 -49.09 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.304 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -59.1 -50.54 73.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.17 -47.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.11 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -57.76 -44.18 85.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 109.971 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -61.7 -38.52 88.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.464 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -60.96 -33.49 73.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 -34.64 76.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.225 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.6 77.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.326 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.8 tt -72.9 -55.36 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.906 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -42.51 -38.41 1.93 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.35 -41.32 94.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -61.7 -47.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.38 -46.12 18.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.505 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.6 -27.64 70.08 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.71 -31.12 70.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 110.293 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.65 -30.99 59.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.329 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.21 -37.92 72.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.334 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.84 -36.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.34 -26.39 63.79 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.79 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -83.14 -28.71 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.667 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.61 77.07 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.86 22.2 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.6 2.2 . . . . 0.0 112.129 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -113.29 -7.56 13.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -109.87 161.67 23.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.677 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.62 -15.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.482 2.121 . . . . 0.0 112.091 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.7 mp -44.64 -29.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttp180 -40.67 -67.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.577 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.745 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.9 t80 -56.03 -28.7 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 t -69.11 -45.72 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.34 -34.58 36.51 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.302 0.573 . . . . 0.0 110.244 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 74' ' ' MET . 7.0 tmm? -61.72 -13.55 24.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.276 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 71' ' ' TYR . 75.0 t -57.97 -36.82 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 110.257 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 mm -88.05 -31.97 5.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.177 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.501 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -64.11 -52.81 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -65.2 -47.29 77.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.681 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -44.27 -43.69 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 p -79.97 -22.77 42.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.654 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.08 -60.99 2.95 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.07 -53.2 9.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.209 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -66.4 -46.27 77.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.64 -46.85 91.68 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' ALA . 87.6 t -67.73 -44.93 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -58.07 -27.21 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 tp -81.29 -44.06 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.415 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 17.2 p -52.8 -25.47 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 0.0 110.168 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -48.49 53.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.6 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -51.93 -38.33 56.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -65.57 -46.77 78.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -65.37 -47.06 77.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' TYR . 27.2 mmm -44.74 -47.67 10.78 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.5 -50.17 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.628 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.7 -29.62 7.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.39 -15.5 17.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.384 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 8.8 mp0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.502 0.192 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.558 ' O ' ' CE3' ' A' ' 113' ' ' TRP . 2.2 p-90 -87.52 -1.28 57.83 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.315 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.0 79.78 50.97 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.388 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.5 Cg_exo -49.5 -1.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.619 2.213 . . . . 0.0 112.298 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -57.84 -33.1 68.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.479 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 46.3 m-20 -96.3 -43.64 7.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.3 -45.17 77.34 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.413 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 34.1 t-105 -73.93 -16.81 61.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.912 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 123' ' ' VAL . 2.4 t -147.8 68.69 10.83 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.78 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.72 -11.72 26.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.871 2.381 . . . . 0.0 111.649 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -71.67 -6.4 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.205 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 120' ' ' VAL . 17.4 m -138.57 35.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.479 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 72.7 t80 -153.29 -39.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.351 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.56 128.25 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.93 155.76 16.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -166.29 108.14 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.706 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 133.52 177.83 15.19 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.1 138.04 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 26.9 m -89.95 132.4 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.04 -4.14 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.97 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.19 129.11 38.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.174 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -85.0 117.44 23.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -122.32 -3.82 8.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.52 ' NE1' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 t90 -172.78 129.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -145.52 158.54 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.293 0.568 . . . . 0.0 112.019 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -122.98 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.632 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 55.38 17.28 2.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.53 53.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mt -123.91 134.28 53.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.698 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 7.0 pm0 -71.06 149.6 46.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 145' ' ' TRP . 8.2 mtt -45.83 -62.16 1.99 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.1 Cg_exo -34.57 -37.66 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -41.15 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.625 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.5 m95 -67.06 -58.26 5.26 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.758 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.0 mt -43.98 -38.22 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -34.49 75.76 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -62.68 -48.93 77.63 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.53 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.08 -35.09 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -38.86 72.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.846 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.17 -40.04 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.019 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.42 73.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.149 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.0 -41.39 97.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.339 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.0 tt -52.24 -33.25 40.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -82.71 -38.72 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.659 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 160' ' ' VAL . 64.8 t -52.92 -40.53 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.71 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.501 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -78.07 -46.89 19.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 154' ' ' LEU . 70.5 t -52.71 -50.17 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.982 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.26 -33.99 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.023 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 156' ' ' VAL . 48.0 t -75.74 -26.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.9 t -68.87 -45.28 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.74 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.704 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.62 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.4 tt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -31.86 68.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.3 -45.07 67.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.111 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 5' ' ' LEU . 4.4 mm? -50.08 -37.59 34.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.996 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -66.89 -28.79 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.183 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -80.22 -49.43 11.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.702 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.23 -32.59 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.9 p -76.86 -38.69 53.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.504 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.503 HE22 ' HZ2' ' A' ' 66' ' ' LYS . 36.5 mt-30 -68.01 5.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.26 141.04 15.23 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -69.13 -51.14 41.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 110.661 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.92 -45.58 5.95 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.32 90.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -62.3 -40.05 95.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.123 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.79 -31.11 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 21' ' ' THR . 5.3 mt -70.6 -28.51 64.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.68 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.66 -34.49 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.103 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.13 27.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' LEU . 13.8 t80 -53.7 -53.8 46.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.751 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 17' ' ' LEU . 36.4 p -44.59 -55.18 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.613 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' OE2' ' A' ' 26' ' ' GLU . . . -58.54 -22.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.62 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.17 -41.57 15.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -40.03 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -72.53 -35.77 68.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.772 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -70.6 -44.25 67.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.17 -58.08 4.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.622 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p -47.22 -34.14 6.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.254 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -79.09 -42.88 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.6 -16.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.794 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.443 ' O ' HG12 ' A' ' 35' ' ' VAL . 66.9 t-105 -91.68 -34.0 14.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.629 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 4.9 m-85 -62.48 -31.21 71.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.459 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 6.9 mp0 -81.02 -44.86 17.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -63.62 -17.67 63.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 36' ' ' MET . 9.8 p -109.3 -41.59 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.51 ' N ' HG13 ' A' ' 35' ' ' VAL . 8.1 tpt -85.9 4.9 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.754 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.4 mp 48.06 34.61 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 134' ' ' GLN . 20.8 mt -79.63 154.71 28.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -125.24 128.23 24.81 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.563 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.83 -179.84 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.383 2.055 . . . . 0.0 112.073 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -128.31 -170.97 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.297 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.9 p -66.26 -44.72 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' N ' HG13 ' A' ' 42' ' ' VAL . 83.8 mt -67.22 -50.43 60.79 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -50.35 -50.89 49.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.52 -41.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.96 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -57.28 -47.81 80.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.854 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.94 -43.28 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.089 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -56.46 -33.64 66.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.901 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.117 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.8 -48.68 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.084 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.4 mm? -75.0 -47.47 28.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 51' ' ' LEU . 38.9 t80 -44.01 -39.67 4.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.42 -39.82 87.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' LEU . 71.5 t -60.33 -17.47 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.368 0.604 . . . . 0.0 109.423 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 tp -83.43 -39.49 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.79 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.3 -38.94 81.98 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.81 72.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.61 -23.22 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.26 -37.09 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.852 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.69 -38.22 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.018 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -63.64 -40.57 98.75 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.52 11.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.064 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' H ' ' C ' ' A' ' 61' ' ' GLY . 90.8 mt -88.32 -25.67 5.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.25 68.76 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.697 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.65 21.01 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.609 2.206 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HZ2' HE22 ' A' ' 10' ' ' GLN . 26.5 tttp -112.62 -3.67 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.87 166.02 12.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -42.57 -11.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.238 1.959 . . . . 0.0 112.076 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -41.51 -38.55 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.345 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.7 mtm105 -38.66 -69.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.26 -17.1 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.042 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.6 t -83.14 -48.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.249 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 -34.49 60.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.274 0.559 . . . . 0.0 110.043 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.2 ttt -59.51 -9.56 2.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.112 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.65 -43.39 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.425 0.631 . . . . 0.0 110.423 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -88.26 -29.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.645 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.654 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.1 t-105 -65.63 -53.34 42.85 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.781 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.98 -45.36 85.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -44.19 -45.49 8.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.966 0.412 . . . . 0.0 110.357 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 p -80.3 -21.06 42.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.049 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.53 -62.28 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.921 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -73.59 -49.34 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.297 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -72.24 -43.69 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.72 -48.33 85.6 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' O ' ' OG1' ' A' ' 88' ' ' THR . 75.1 t -72.83 -50.94 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.637 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.406 ' C ' ' OE1' ' A' ' 86' ' ' GLN . 1.1 tm0? -50.11 -23.39 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.022 0.439 . . . . 0.0 109.991 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.67 -41.33 14.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.589 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 84' ' ' GLY . 23.6 p -51.87 -23.68 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -71.19 -31.02 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.492 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.44 -37.61 51.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -70.29 -58.61 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -54.69 -43.28 72.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.706 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.7 ttt -57.78 -44.77 86.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.58 -48.4 81.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.663 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -52.26 -43.04 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 96' ' ' LEU . 10.1 mp -91.08 -9.77 44.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.17 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.6 t80 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -0.85 54.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.605 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' A' ' 116' ' ' LEU . 11.8 mt -121.81 81.81 41.83 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.289 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.2 Cg_exo -51.25 2.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.757 2.305 . . . . 0.0 112.635 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.8 mt -62.57 -32.74 73.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.947 0.403 . . . . 0.0 110.142 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.7 p30 -96.43 -40.59 9.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.47 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 78.1 tttt -72.1 -45.4 60.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.663 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -72.78 -15.57 61.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.128 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.54 73.39 29.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.66 -17.89 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.848 2.366 . . . . 0.0 111.886 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -52.59 -49.24 65.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.847 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.49 54.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.78 -41.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.296 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.07 129.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.48 155.05 17.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -167.34 112.08 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.594 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 129.42 -179.98 16.37 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 m-20 -81.97 137.08 35.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.225 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -90.68 132.49 35.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.82 -6.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -67.88 152.35 45.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -85.08 138.0 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.634 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.465 ' HB3' HD22 ' A' ' 38' ' ' LEU . 15.2 mt-30 -128.79 -29.43 2.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -174.92 138.96 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -133.65 163.44 29.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.48 0.657 . . . . 0.0 112.394 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.688 ' CE2' HD23 ' A' ' 138' ' ' LEU . 35.7 t80 -123.32 135.55 54.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.766 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.688 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.8 mm? 51.43 17.13 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.649 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 94.09 14.28 52.11 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.189 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 139' ' ' GLY . 4.0 mm? -119.68 139.84 51.6 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 24.4 mp0 -73.2 154.11 40.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.598 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.46 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 5.9 mtt -49.24 -63.17 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.256 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.541 ' O ' HD13 ' A' ' 147' ' ' LEU . 86.6 Cg_exo -31.72 -41.72 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.95 2.433 . . . . 0.0 112.594 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.75 -49.48 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.408 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -63.91 -57.44 9.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt -43.7 -39.57 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 143' ' ' PRO . 3.5 mp -61.89 -35.76 79.29 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.84 -41.38 91.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.6 mp -80.41 -26.77 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 154' ' ' LEU . 43.2 t80 -60.99 -48.78 80.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.533 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 tt -67.73 -39.52 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -48.76 -45.81 40.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.096 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -65.4 -44.27 88.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.007 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 150' ' ' PHE . 66.6 mt -63.33 -30.87 71.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.74 -27.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 160' ' ' VAL . 25.6 t -75.29 -29.8 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.654 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -73.67 -50.87 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.989 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 159' ' ' LEU . 19.6 m -54.27 -52.07 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.934 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 158' ' ' VAL . 5.3 mt -63.29 -36.65 84.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.623 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 156' ' ' VAL . 9.4 t -65.76 -33.91 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.7 -52.73 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 109.818 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.44 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 1.7 mp -60.69 -9.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.214 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.763 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.867 0.365 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -56.0 -39.89 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.564 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLN . 17.9 m-85 -69.72 -42.8 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.61 -40.41 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.176 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.72 -21.69 63.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.102 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.1 tp-100 -80.53 -47.01 14.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.541 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 -32.68 73.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.625 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.2 p -76.45 -33.66 58.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.12 10.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 110.489 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.31 142.57 15.52 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -65.05 -20.51 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.244 . . . . 0.0 110.416 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.45 -46.23 71.73 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.12 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 0.0 110.366 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -56.19 -49.43 74.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.712 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.77 -31.77 73.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.525 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.09 -27.76 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.545 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 31.9 mtt -76.76 -33.85 58.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.348 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.09 -55.2 11.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.696 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . 83.0 t80 -53.88 -54.64 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.661 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -42.72 -58.87 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.662 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -58.33 -24.51 59.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' PHE . 6.2 tp -80.26 -41.32 25.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.4 -34.32 61.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.521 HD21 HD11 ' A' ' 146' ' ' LEU . 6.1 tt -70.57 -35.04 72.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.54 -49.94 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.613 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 30' ' ' LEU . 35.8 mt -64.91 -57.37 8.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.612 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 m -44.24 -40.42 5.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.47 -27.14 46.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.36 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.4 tp -63.98 -18.76 64.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.653 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -83.32 -37.3 23.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' O ' ' CB ' ' A' ' 36' ' ' MET . 13.7 m-85 -62.75 -36.65 83.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -79.46 -47.02 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.919 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 57.9 t-80 -62.6 -15.88 53.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.35 -46.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.439 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tpt -87.71 9.92 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.065 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.7 mp 43.26 48.58 5.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.33 146.5 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.377 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -115.47 84.18 11.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.246 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.78 172.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.531 2.154 . . . . 0.0 112.235 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.69 171.59 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.569 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 61.8 t -47.59 -42.99 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.313 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.9 mp -75.05 -40.66 60.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.572 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.4 t -55.74 -49.77 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.007 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 124' ' ' PHE . 13.0 pt -66.16 -37.02 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.451 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.26 -45.82 92.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.936 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.95 -39.87 79.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.88 -31.22 70.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.28 76.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.305 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.76 -48.58 81.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.26 -51.58 11.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -45.12 -37.74 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.79 84.38 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 78.1 t -65.81 -47.1 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.934 0.397 . . . . 0.0 110.025 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.72 -48.51 10.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.474 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.57 97.95 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -50.85 -44.38 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.695 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.41 64.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tp -76.64 -37.75 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -81.76 -31.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.686 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.71 -30.46 66.18 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.66 5.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.56 0.219 . . . . 0.0 111.149 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -85.52 -25.59 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.624 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.22 74.91 0.27 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 73.6 Cg_endo -79.38 16.81 1.33 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.728 2.286 . . . . 0.0 112.242 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -113.76 -3.86 13.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.39 162.18 22.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.691 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.69 -16.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.038 . . . . 0.0 111.792 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 tp -42.95 -33.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.362 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.69 -67.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -55.86 -21.82 22.03 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.69 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' LEU . 10.5 t -76.99 -43.34 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.584 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.26 62.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.19 -10.42 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.267 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.09 -43.42 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.349 0.595 . . . . 0.0 110.144 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -86.96 -32.59 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.818 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -61.49 -55.57 29.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.051 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.14 -47.19 80.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -44.38 -45.3 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.311 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -79.24 -22.88 44.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.78 -59.43 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.991 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.02 -53.49 9.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -66.66 -46.02 77.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.08 -47.84 84.3 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 88' ' ' THR . 78.8 t -68.47 -50.32 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -48.63 -26.12 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.97 -38.76 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 68.8 p -55.49 -29.56 59.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.765 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.15 -41.82 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.721 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.12 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -43.04 40.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.651 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.4 p -72.14 -43.6 64.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 22.4 ttp -54.49 -51.11 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.705 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -49.32 75.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.425 ' NE2' ' CD ' ' A' ' 141' ' ' GLU . 26.8 tt0 -55.71 -44.72 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.37 -22.55 35.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.754 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 12.3 t80 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.34 11.68 35.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.75 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.7 tp -123.13 61.16 17.64 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.13 11.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.6 2.2 . . . . 0.0 112.038 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -77.72 -29.96 51.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 109.655 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 4.3 p-10 -96.05 -42.34 8.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.266 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 118' ' ' LYS . 20.4 mtpt -60.38 -38.09 82.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -83.4 -12.59 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.583 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.3 76.52 18.61 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.889 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 125' ' ' VAL . 73.0 Cg_endo -79.51 -19.39 10.19 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 111.909 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -68.63 -3.88 13.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.336 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 124' ' ' PHE . 2.4 t -145.22 37.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 123' ' ' VAL . 16.9 m-85 -153.56 -40.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.534 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 121' ' ' PRO . 16.4 m -62.0 131.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.564 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.3 146.9 23.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 t -159.64 100.11 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.7 -171.43 23.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -96.96 151.8 19.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.27 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.1 m -103.79 129.81 51.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.58 -7.63 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -67.83 156.91 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.514 ' H ' ' CD ' ' A' ' 132' ' ' GLU . 29.8 mtp85 -97.11 126.51 42.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.807 0.337 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.2 -29.84 4.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -174.1 141.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.45 161.11 39.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.193 0.52 . . . . 0.0 111.83 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.0 139.8 49.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.144 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.5 16.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.42 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.3 23.02 32.99 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.887 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.414 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 10.2 mt -127.67 139.61 52.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.425 ' CD ' ' NE2' ' A' ' 95' ' ' GLN . 9.9 mt-10 -68.45 145.01 54.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.441 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.9 mtt -47.29 -53.75 26.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.45 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 142' ' ' MET . 82.5 Cg_exo -41.55 -36.64 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.356 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.464 ' O ' ' NE2' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -69.76 -52.96 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 109.9 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 77.9 m95 -56.88 -56.82 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.908 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 25' ' ' LEU . 4.0 mm? -42.9 -36.13 1.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -61.67 -37.03 82.56 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.488 0.661 . . . . 0.0 109.325 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.35 -45.97 94.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.736 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -74.38 -30.45 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.43 -45.14 92.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.64 -43.74 98.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.282 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.26 -47.52 62.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.42 -41.38 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.728 ' C ' HD23 ' A' ' 154' ' ' LEU . 4.5 tt -55.31 -34.52 64.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.138 0.494 . . . . 0.0 110.318 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.69 -45.04 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 160' ' ' VAL . 84.4 t -48.99 -32.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.868 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.5 -42.92 58.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.53 -33.81 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.72 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.1 mm? -85.07 -36.32 21.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.743 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 156' ' ' VAL . 7.1 p -76.63 -23.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.375 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 157' ' ' ALA . 70.1 t -81.95 -51.64 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 162' ' ' ILE . 38.9 mm -71.86 -11.84 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.394 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 179.745 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.6 mp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.932 0.396 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -50.94 -42.51 59.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.385 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.5 -39.93 95.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.504 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -52.37 -38.58 59.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.122 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.25 -31.28 72.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.491 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 31.5 mm-40 -74.85 -48.23 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -67.13 -29.66 69.45 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.483 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 95.8 p -75.92 -42.41 48.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -71.52 10.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.156 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.62 145.6 16.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.3 OUTLIER -63.13 -19.91 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.745 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.94 -47.68 64.65 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.88 -51.36 67.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -52.72 -49.73 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.86 -29.31 68.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.569 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 21' ' ' THR . 61.6 tp -69.18 -31.38 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.9 mtt -74.37 -34.02 63.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.62 -53.45 41.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.486 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.85 -54.13 49.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.756 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.9 p -41.17 -56.41 2.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.36 65.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.483 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.97 -40.28 78.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.86 -43.12 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.585 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -70.59 -31.94 69.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.6 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.03 -43.27 71.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 8.3 tp -72.81 -57.87 3.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.613 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' ALA . 36.0 p -44.81 -37.72 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.151 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.12 -31.83 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.115 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.5 tp -59.13 -18.68 37.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -87.97 -27.54 22.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.351 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' MET . 4.6 m-85 -69.67 -50.93 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.7 -12.29 61.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -79.22 -34.97 42.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.293 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.48 -16.56 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.6 tpp -99.51 -9.39 23.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.39 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 45.68 49.11 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.27 143.98 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.441 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -105.49 130.8 22.47 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.169 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.0 167.58 25.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.302 2.002 . . . . 0.0 112.341 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.83 166.4 21.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.36 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 86.4 t -53.52 -48.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.7 mp -70.1 -47.34 62.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.462 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 23.3 t -52.73 -51.11 61.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.067 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.07 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.336 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -43.37 71.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -62.29 -39.25 92.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -59.68 -38.6 81.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.72 -34.15 76.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.02 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -61.65 -43.81 98.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.544 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.49 -53.07 7.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -45.96 -43.33 13.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.0 -44.15 89.41 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' ALA . 40.7 t -63.35 -46.98 94.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -44.78 -48.3 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.638 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.98 -48.03 88.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -30.46 12.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.257 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.73 66.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.78 -42.59 85.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.52 -35.64 75.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.21 -22.99 78.64 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 1.27 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.3 mt -83.89 -36.88 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.683 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.1 73.11 0.23 Allowed Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.036 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.07 22.7 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.709 2.273 . . . . 0.0 111.72 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -108.32 -12.57 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.159 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -107.41 161.28 23.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.715 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.34 -15.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.564 2.176 . . . . 0.0 112.203 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 mt -46.25 -27.41 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 69' ' ' LEU . 45.7 mtm180 -38.81 -62.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 75' ' ' VAL . 28.9 t80 -52.87 -37.66 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.192 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 69' ' ' LEU . 17.8 t -60.93 -43.56 96.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.57 -35.8 57.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.195 0.522 . . . . 0.0 110.067 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.1 mtp -59.37 -17.86 33.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.492 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 71.5 t -52.37 -41.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.408 0.623 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 mm -88.1 -31.52 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.767 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.8 t-105 -66.65 -54.75 19.98 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.9 tp -64.19 -49.07 73.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.769 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -42.84 -42.24 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -78.57 -21.66 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.59 -62.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.692 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -72.9 -53.47 11.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.426 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -69.45 -45.41 69.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.75 86.99 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.1 -49.81 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.348 . . . . 0.0 110.499 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -50.76 -24.78 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.428 HD12 ' OE2' ' A' ' 90' ' ' GLU . 56.9 tp -79.83 -38.34 33.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.26 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.3 p -56.06 -29.95 61.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.13 -42.06 85.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.648 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE2' HD12 ' A' ' 87' ' ' LEU . 37.3 mt-10 -58.8 -39.43 81.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.366 . . . . 0.0 110.611 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.51 -44.1 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.2 p -69.26 -50.6 45.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 mmt -46.31 -47.58 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -47.19 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.47 -34.7 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.3 mt -100.87 -12.09 19.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.615 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.725 0.298 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -125.47 27.27 6.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 tp -118.42 61.16 4.39 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.69 6.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.698 2.265 . . . . 0.0 112.685 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -78.5 -25.47 45.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.392 0.615 . . . . 0.0 109.863 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -96.22 -42.79 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.914 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.47 -44.68 95.8 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.048 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 36.4 m0 -78.23 -15.61 58.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.16 77.09 10.99 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.65 -14.89 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.52 -3.61 31.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 124' ' ' PHE . 9.8 p -136.07 32.61 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.225 0.536 . . . . 0.0 110.768 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.478 ' CD2' HG13 ' A' ' 123' ' ' VAL . 19.5 m-85 -155.45 -44.58 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.38 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.18 129.39 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.05 153.49 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.565 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t -167.28 99.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.85 -165.02 26.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.9 148.39 22.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.246 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.4 m -101.72 132.0 47.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.962 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.2 -2.95 0.5 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.896 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.13 129.42 39.85 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.139 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.88 130.06 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -16.94 5.42 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.507 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -172.84 138.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -145.74 160.93 41.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.179 0.514 . . . . 0.0 112.0 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -121.98 138.48 54.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.063 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.3 17.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.15 22.1 53.1 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.2 mp -122.49 133.58 54.59 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.27 146.0 53.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.8 mtt -45.78 -54.11 17.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 142' ' ' MET . 89.1 Cg_exo -41.86 -35.47 2.98 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.4 2.066 . . . . 0.0 112.16 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -71.57 -52.11 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.952 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.4 m95 -59.92 -57.24 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.106 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -44.18 -36.97 2.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -61.94 -33.02 73.51 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.13 -50.78 58.17 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.315 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.5 mt -69.83 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.024 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.514 ' CE2' HD11 ' A' ' 154' ' ' LEU . 33.9 t80 -63.54 -42.9 98.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.145 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 155' ' ' ILE . 1.7 tp -69.95 -31.64 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.262 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.17 70.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.74 -51.21 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.675 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.514 HD11 ' CE2' ' A' ' 150' ' ' PHE . 33.7 mt -56.22 -31.59 63.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.635 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.1 mp -76.78 -35.84 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.073 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 160' ' ' VAL . 46.9 t -61.87 -36.88 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -68.56 -43.3 76.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.59 -24.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.928 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.445 ' O ' ' OG ' ' A' ' 163' ' ' SER . 44.5 tp -80.76 -43.76 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 156' ' ' VAL . 27.7 m -73.37 -34.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.29 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 157' ' ' ALA . 74.8 t -68.36 -48.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -22.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 21.3 m . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.973 0.416 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -51.12 -34.53 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -69.36 -44.39 71.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.2 tp -47.8 -38.7 16.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -67.43 -26.16 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.485 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -80.48 -47.02 14.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.791 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.36 -38.74 90.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -76.67 -32.39 57.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 8.2 tt0 -71.38 5.62 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.008 0.432 . . . . 0.0 110.576 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.2 148.34 18.71 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -70.01 -20.79 63.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 17' ' ' LEU . . . -69.91 -45.74 55.93 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.95 -50.49 73.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.74 0.305 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -56.4 -44.79 80.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.487 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.63 -30.43 71.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.306 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 13' ' ' GLY . 3.6 mp -70.21 -26.94 64.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.686 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.469 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -76.87 -34.27 57.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -56.55 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -52.81 -51.12 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.692 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.0 p -45.3 -60.91 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.564 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -33.37 61.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.463 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.58 -41.44 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.91 -33.18 61.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.216 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.21 -32.69 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.252 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.41 -45.37 55.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.46 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.2 tt -65.06 -52.06 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.332 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 17.4 m -56.06 -30.77 62.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -33.36 38.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.884 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -17.22 64.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . 65.5 t90 -91.03 -34.63 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' MET . 27.3 t80 -60.5 -39.07 86.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.07 -40.3 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.594 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.52 -22.66 65.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 36' ' ' MET . 9.7 p -109.3 -42.83 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.493 ' N ' HG13 ' A' ' 35' ' ' VAL . 6.7 tpt -84.82 5.91 26.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.684 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt 42.99 44.67 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.976 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -63.11 147.05 51.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.976 ' N ' HD23 ' A' ' 38' ' ' LEU . 81.8 mttt -113.13 90.83 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.225 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.11 172.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.45 2.1 . . . . 0.0 112.415 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.96 168.98 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.943 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 91.6 t -53.94 -51.33 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 43' ' ' LEU . 9.9 mp -66.15 -50.0 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 41' ' ' CYS . 14.8 m -50.57 -49.86 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.752 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.37 -42.45 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -47.5 75.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 88' ' ' THR . 3.1 tp10 -57.78 -40.19 79.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -58.12 -33.96 69.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.38 84.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.443 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.38 73.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.4 tp -73.06 -53.28 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -42.86 -41.25 3.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.89 -40.38 95.42 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 55.4 t -61.11 -47.66 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.223 0.535 . . . . 0.0 109.559 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -45.5 -47.12 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.491 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.64 -28.26 69.55 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.39 -34.96 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.61 -34.14 75.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.237 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.39 -32.39 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.218 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -77.59 -42.65 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.342 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -23.79 75.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.6 4.73 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.625 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.9 mt -84.9 -34.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.738 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.55 73.63 0.11 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.54 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.51 12.37 2.9 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.891 2.394 . . . . 0.0 111.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -96.93 -10.01 27.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.61 161.29 28.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.692 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -38.14 -19.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.519 2.146 . . . . 0.0 112.197 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' THR . 8.3 mp -43.7 -30.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.24 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttm180 -38.14 -51.7 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -55.21 -35.78 65.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.503 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.7 t -61.96 -58.45 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.152 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.73 79.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.366 0.603 . . . . 0.0 109.774 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -8.88 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 72' ' ' VAL . 53.4 t -60.58 -43.86 95.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.529 0.68 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.8 mt -87.98 -29.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.894 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.1 t-105 -65.0 -52.33 56.72 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.772 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.8 tp -64.85 -48.56 73.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.586 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -43.69 -42.79 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.888 0.375 . . . . 0.0 110.356 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -23.09 36.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.87 -61.7 2.42 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.912 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE2' ' OE1' ' A' ' 86' ' ' GLN . 70.4 t80 -75.43 -46.96 29.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.397 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -72.11 -41.01 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.78 -48.19 87.48 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 81' ' ' ALA . 16.5 m -71.46 -45.83 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.545 ' N ' HG23 ' A' ' 85' ' ' VAL . 56.4 tt0 -52.24 -27.5 15.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.401 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.2 tt -82.74 -44.19 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.37 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 84' ' ' GLY . 48.4 p -49.5 -25.29 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.82 -45.18 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.75 -45.7 85.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.739 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.22 -40.91 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.0 p -71.57 -41.95 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.585 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -47.12 -47.71 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.326 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.65 -47.22 82.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -51.47 -40.23 59.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.71 -12.49 27.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.551 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 93' ' ' MET . 30.9 t80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.745 0.307 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.64 -5.62 19.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 18.6 mt -120.05 83.3 30.69 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.8 Cg_exo -54.4 4.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 112.052 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -66.01 -30.23 70.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.084 0.468 . . . . 0.0 110.321 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.19 -42.19 7.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -73.63 -45.23 54.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -73.27 -15.58 61.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.375 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.29 72.25 32.37 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.9 -16.87 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.91 2.407 . . . . 0.0 112.042 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 -19.14 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.878 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.33 39.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.464 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.29 -42.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.069 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.06 128.09 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.41 156.24 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.6 t -168.29 99.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.19 -172.3 23.53 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.61 150.9 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.5 m -102.26 132.29 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.027 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.44 -3.52 0.29 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -69.32 150.06 47.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.253 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -86.38 113.16 22.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -106.61 -16.31 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.536 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 135' ' ' TRP . 13.7 t90 -173.92 119.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.4 t70 -109.08 151.64 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.205 0.526 . . . . 0.0 112.034 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 8.2 t80 -153.7 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.901 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 50.9 mt 79.06 17.87 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.45 7.04 88.77 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 mt -120.63 150.65 40.59 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 44.1 mm-40 -77.36 161.07 28.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.331 0.586 . . . . 0.0 111.3 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.505 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 4.3 ttt -44.09 -58.66 4.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.425 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 142' ' ' MET . 6.8 Cg_endo -49.33 -20.45 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.298 1.999 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 141' ' ' GLU . 6.6 mm-40 -75.45 -58.11 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.811 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -64.35 -53.4 49.21 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.983 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 tt -43.42 -45.83 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 88' ' ' THR . 29.2 tp -52.85 -37.62 60.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.22 -40.19 83.6 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.544 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -77.3 -35.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.682 0.277 . . . . 0.0 110.302 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.29 69.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.09 -39.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.161 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.6 -48.99 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.37 -45.68 93.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.682 ' C ' HD23 ' A' ' 154' ' ' LEU . 7.8 tt -54.7 -31.11 57.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.411 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.69 -26.88 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.25 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 58.0 t -74.3 -32.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.388 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.521 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -51.41 8.73 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.534 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 154' ' ' LEU . 27.7 m -56.68 -40.41 69.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.355 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -77.21 -35.13 55.91 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.378 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.8 t -76.87 -22.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.057 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 157' ' ' ALA . 30.8 t -77.15 -46.66 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.342 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.99 -19.62 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 ttm105 -55.7 -41.06 73.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.31 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.35 -44.77 95.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.406 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -49.36 -41.07 37.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 19.2 t30 -67.0 -29.72 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -77.16 -49.64 14.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.69 71.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.5 m -76.52 -42.32 43.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.451 ' NE2' HH21 ' A' ' 70' ' ' ARG . 1.1 mp0 -67.61 5.69 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.37 141.07 15.24 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -69.07 -50.32 49.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.593 0.235 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -46.31 6.18 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.7 89.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.114 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -59.81 -38.99 83.49 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.78 -30.15 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.949 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.95 -27.83 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.4 mtt -75.88 -33.92 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.77 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 4.3 m-85 -57.58 -50.15 74.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.558 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.0 m -42.87 -60.27 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.16 -25.94 48.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -78.94 -40.62 31.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.41 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -70.58 -35.21 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.593 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.41 -49.6 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.531 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.02 -57.88 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.626 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -46.33 -37.88 8.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -55.36 -17.32 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.716 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -95.56 -36.46 11.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.927 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CZ ' ' CZ2' ' A' ' 135' ' ' TRP . 2.5 m-85 -54.46 -46.14 73.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.733 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -40.74 76.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -60.03 -20.05 55.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.33 -35.32 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 31.7 mtt -87.72 3.49 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt 50.66 49.81 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.692 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.38 155.76 18.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 140.91 40.0 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.266 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.52 177.47 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.52 2.147 . . . . 0.0 112.091 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -131.75 -166.41 1.72 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.632 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 35.8 t -65.55 -51.3 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.833 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 10.6 mp -65.95 -50.1 65.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -48.59 -45.2 37.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.21 -38.16 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.094 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.9 -48.06 82.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.958 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -61.28 -38.1 85.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -58.96 -40.1 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.24 83.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.4 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.78 -52.45 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.198 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.46 -39.63 7.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.77 -43.84 90.78 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 57' ' ' ALA . 34.8 t -62.7 -47.36 93.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.166 0.507 . . . . 0.0 109.748 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.53 -45.87 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.603 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -30.05 76.64 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.73 -40.06 91.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.71 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.01 -25.22 60.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 3.3 mm? -79.47 -37.75 36.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -79.94 -35.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -22.99 72.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.94 6.65 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 110.74 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -80.24 -31.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.426 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.7 77.14 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.633 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.87 26.88 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.661 2.241 . . . . 0.0 111.947 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -106.84 -9.77 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.059 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.29 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.464 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.4 -5.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.089 1.859 . . . . 0.0 111.773 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.55 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 tt -44.44 -37.66 3.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.451 HH21 ' NE2' ' A' ' 10' ' ' GLN . 59.7 mtt180 -40.78 -70.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.666 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' HG23 ' A' ' 75' ' ' VAL . 47.4 t80 -51.03 -31.54 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.133 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.61 -46.95 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.84 -33.87 52.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.235 0.54 . . . . 0.0 110.109 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.16 -17.35 40.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.539 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 71' ' ' TYR . 69.2 t -53.41 -40.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.425 0.631 . . . . 0.0 110.38 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.87 -33.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.524 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 10.7 t-105 -61.79 -55.88 25.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.48 -48.49 77.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -45.86 -45.71 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.259 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -76.84 -25.3 53.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.387 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 154' ' ' LEU . . . -60.68 -59.07 5.98 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.01 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.37 -54.33 8.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.174 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -66.14 -45.36 81.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.67 -47.23 89.93 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 81' ' ' ALA . 89.3 t -68.74 -52.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.393 . . . . 0.0 110.578 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -51.16 -25.14 4.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.06 -40.91 17.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.548 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 84' ' ' GLY . 42.1 p -54.11 -24.99 19.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -73.47 -48.16 35.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -51.19 -32.76 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.426 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 12.5 t-80 -73.38 -45.23 56.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.671 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -45.86 70.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' TYR . 32.9 ttp -51.36 -49.77 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -49.82 54.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.455 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 5.4 tt0 -52.36 -48.81 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.25 -19.5 26.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.023 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.74 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.65 0.262 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 9.6 p-90 -124.56 -5.13 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.5 tp -119.69 80.49 23.98 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.48 -5.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.688 2.259 . . . . 0.0 112.556 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.1 mt -57.89 -28.97 64.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.473 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 12.6 t0 -96.53 -39.39 9.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.598 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HZ2' ' HD1' ' A' ' 119' ' ' TRP . 6.0 ttpp -68.61 -45.28 72.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.473 ' HD1' ' HZ2' ' A' ' 118' ' ' LYS . 41.5 m0 -77.74 -18.55 56.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.86 76.43 17.18 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 -17.68 9.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.742 2.294 . . . . 0.0 111.654 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -52.41 -50.84 61.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.865 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.81 55.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.473 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -157.59 -44.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.0 p -56.11 130.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.61 146.55 24.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.801 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -159.04 99.81 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.14 -171.56 22.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.97 160.38 14.3 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.66 0.267 . . . . 0.0 110.363 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.658 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 85.4 m -108.11 134.95 50.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.38 -9.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.736 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.72 129.23 39.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.9 ptt85 -65.84 129.18 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -124.17 -29.45 3.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.435 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.551 ' CZ2' ' CZ ' ' A' ' 32' ' ' PHE . 5.4 t90 -173.74 137.82 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.779 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -142.21 160.44 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 112.135 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 138' ' ' LEU . 89.8 t80 -118.98 138.41 52.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.046 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.603 HD23 ' CE2' ' A' ' 137' ' ' PHE . 0.7 OUTLIER 51.68 17.35 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.155 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 87.78 22.87 40.99 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 139' ' ' GLY . 5.7 mp -123.81 135.88 54.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.455 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 8.9 mt-10 -68.74 146.36 53.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.598 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtp -48.75 -52.41 45.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.63 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 142' ' ' MET . 81.1 Cg_exo -44.46 -37.07 10.43 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.049 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.428 ' NE2' ' C ' ' A' ' 144' ' ' GLN . 0.6 OUTLIER -70.92 -49.33 46.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.98 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.571 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.1 m95 -59.54 -56.77 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.244 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -44.07 -39.35 4.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.2 tt -57.9 -37.24 73.64 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.33 -43.34 97.4 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.731 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.6 mt -69.61 -26.7 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.8 0.333 . . . . 0.0 110.408 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -42.89 94.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.976 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER -60.64 -47.98 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.045 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.3 -50.57 73.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.78 -44.38 96.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.739 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.756 ' C ' HD23 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -61.33 -30.02 70.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.157 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.705 ' N ' HD23 ' A' ' 154' ' ' LEU . 4.1 mt -73.55 -39.45 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 160' ' ' VAL . 78.1 t -59.08 -38.2 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.1 -43.49 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.403 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 154' ' ' LEU . 91.1 t -58.97 -37.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.398 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.67 -25.02 38.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.792 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.0 t -78.33 -25.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.526 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 162' ' ' ILE . 5.9 p -82.97 -45.08 19.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.347 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.43 ' N ' HG13 ' A' ' 161' ' ' VAL . 35.3 mm -65.39 -28.57 44.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 13.3 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.518 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.5 mm? . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -51.1 -33.99 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.09 -40.69 64.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -49.3 -45.17 44.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -67.06 -24.21 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.025 0.441 . . . . 0.0 110.066 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -78.69 -47.39 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -32.23 73.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.5 m -76.1 -37.79 57.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.236 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -72.11 11.95 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.245 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.14 141.46 15.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.84 -50.57 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.22 5.72 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -61.05 -46.29 91.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.307 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -61.83 -34.04 75.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.19 -30.92 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.017 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 21' ' ' THR . 56.3 mt -70.84 -28.52 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.646 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.47 -34.76 60.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.79 -54.8 16.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.723 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -54.51 -51.64 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.615 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.3 p -43.22 -56.01 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.7 56.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -77.56 -39.58 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.539 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.02 -44.5 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.621 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp -71.54 -32.08 67.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.458 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.57 -48.51 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.5 tt -68.1 -58.09 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 110.527 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -46.03 -33.68 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.78 -32.02 27.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.393 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -62.43 -16.02 52.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.636 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -91.41 -38.74 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 36' ' ' MET . 5.1 m-85 -56.08 -45.62 79.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.442 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -73.24 -36.77 66.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.554 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -56.65 -35.62 68.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.547 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.05 -50.82 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.8 tpp -69.91 0.64 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 42.25 45.5 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 110.115 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.83 149.29 47.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.896 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.87 83.46 18.65 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.77 154.38 1.98 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 112.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 4.7 t -106.52 -171.68 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.406 HG22 ' CB ' ' A' ' 126' ' ' ALA . 47.1 t -66.53 -50.5 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.652 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 43' ' ' LEU . 10.4 mp -58.39 -40.79 83.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.097 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -53.85 -42.51 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 124' ' ' PHE . 79.2 mt -64.41 -46.53 92.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.65 -48.62 72.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -64.56 -36.02 82.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.74 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -68.92 -39.26 79.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.499 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.18 88.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.15 -48.28 73.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -48.98 22.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.12 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.73 -43.21 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 109.811 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.93 97.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 53.6 t -59.46 -47.26 91.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.782 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.553 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.8 tt -45.56 -46.5 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.371 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.01 -27.69 70.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.96 -33.45 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.72 71.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.68 -35.3 80.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.0 -37.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.41 -16.62 71.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.82 2.04 32.0 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.015 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -84.05 -38.85 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.99 78.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.614 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.62 20.5 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.718 2.279 . . . . 0.0 112.164 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -107.56 -7.07 16.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.34 165.01 13.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.49 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -39.64 -14.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.45 2.1 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 67' ' ' THR . 75.0 mt -44.64 -32.0 1.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 69' ' ' LEU . 41.2 mtm180 -40.03 -63.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -57.27 -22.36 40.95 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.122 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.5 t -76.17 -44.27 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.993 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.84 59.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -57.5 -14.05 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.799 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.68 -44.99 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.44 0.638 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -88.19 -28.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.838 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -64.66 -53.65 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.209 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.73 -45.3 71.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -45.47 -46.16 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.592 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -77.82 -23.38 49.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' CB ' HD13 ' A' ' 154' ' ' LEU . . . -59.93 -60.01 4.52 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.279 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.47 -52.02 13.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -67.26 -41.69 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.891 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.94 -46.12 92.31 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.7 t -75.18 -56.87 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -47.19 -27.57 1.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.838 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.43 -35.32 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.988 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 84' ' ' GLY . 29.4 p -56.7 -51.38 69.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.139 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -33.87 3.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.196 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.79 -40.15 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.922 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 88' ' ' THR . 1.6 t60 -66.99 -40.7 87.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.426 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.4 p -73.32 -51.82 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.875 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.8 ttt -43.75 -43.03 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.49 -40.08 77.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -66.95 -46.38 74.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.915 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.03 -28.97 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.41 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.954 0.407 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.671 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -114.73 7.27 15.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.598 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.0 tp -120.68 83.63 35.79 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.948 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -52.69 6.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.777 2.318 . . . . 0.0 112.699 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -66.39 -31.09 71.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 109.942 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 1.1 m-20 -96.73 -41.17 8.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.365 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -70.37 -44.14 68.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.752 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.452 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.7 t90 -76.63 -14.81 59.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.59 69.36 13.63 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.743 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 -11.2 17.43 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.765 2.31 . . . . 0.0 112.068 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.503 ' CD ' ' H ' ' A' ' 122' ' ' GLN . 25.1 mp0 -59.66 -54.21 49.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 123' ' ' VAL . 31.0 m -99.11 50.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 111.103 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -156.32 -38.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.176 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 125' ' ' VAL . 14.4 p -56.16 124.24 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -92.75 157.6 16.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.756 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.1 t -162.96 144.6 10.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.239 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.4 23.25 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 4.4 p30 -103.65 168.91 8.84 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -115.02 135.34 54.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.797 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.95 -0.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -67.98 152.06 46.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.566 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -89.34 137.33 32.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.43 -30.37 2.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.02 139.78 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.05 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -140.0 167.83 21.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.521 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.8 t80 -143.59 120.14 11.06 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.6 tp 78.39 16.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 12.84 76.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 mt -119.99 135.24 54.99 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.842 0.354 . . . . 0.0 110.195 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -72.89 154.25 40.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.409 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -48.24 -61.73 2.87 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.614 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.554 ' O ' HD23 ' A' ' 147' ' ' LEU . 95.3 Cg_exo -34.09 -39.18 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.71 2.273 . . . . 0.0 112.506 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -72.43 -49.2 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.598 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.9 m95 -60.46 -57.67 11.77 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.022 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.4 tp -43.35 -40.54 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.219 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.6 mm? -59.08 -34.09 71.58 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.88 -44.62 95.92 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.5 mt -76.14 -36.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.347 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.75 -47.2 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.97 -41.71 90.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.585 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -49.29 -46.3 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.409 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -64.87 -44.66 88.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.573 HD13 ' CB ' ' A' ' 81' ' ' ALA . 6.0 tp -49.34 -46.81 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.036 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.46 -45.3 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.264 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.1 t -49.8 -36.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 111.022 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.536 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -76.56 -31.73 57.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.38 -46.36 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 0.0 110.989 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 159' ' ' LEU . 10.1 mp -77.4 -28.18 52.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' VAL . 46.3 t -78.17 -35.2 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.918 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 162' ' ' ILE . 6.4 p -73.62 -46.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.201 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.516 ' N ' HG13 ' A' ' 161' ' ' VAL . 5.6 pt -71.99 -24.89 23.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.058 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.368 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.855 0.36 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -55.73 -36.19 66.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.38 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 7' ' ' GLN . 1.4 t80 -68.64 -46.27 69.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.181 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.15 -40.77 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -69.11 -22.85 63.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.351 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' PHE . 14.1 tm0? -81.07 -46.95 14.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.713 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.74 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLY . 52.2 p -76.2 -30.93 58.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -75.92 12.14 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.333 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.44 144.46 16.27 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -19.07 63.49 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.386 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.07 -46.41 65.93 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -51.27 68.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -56.53 -40.12 74.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.779 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.2 -32.6 63.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 21' ' ' THR . 9.1 mt -68.89 -30.75 69.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.531 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.25 -34.29 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.88 -56.67 7.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.446 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.77 -53.35 49.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.2 p -42.96 -56.64 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.04 -33.71 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.452 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.04 -40.38 68.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.69 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.4 mp -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.485 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -72.39 -43.88 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.681 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.42 -57.78 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.512 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.2 p -47.37 -36.99 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.68 -35.35 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -61.26 -18.0 56.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.358 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -94.75 -34.02 12.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -55.48 -48.87 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.564 HE21 ' CB ' ' A' ' 38' ' ' LEU . 5.3 mt-30 -75.18 -20.82 59.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.446 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -68.88 -28.99 67.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.56 -31.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 mtt -84.48 0.52 49.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.729 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.7 mt 48.86 48.65 20.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.898 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.564 ' CB ' HE21 ' A' ' 33' ' ' GLN . 13.3 mt -97.51 156.5 16.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.308 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -119.72 148.54 46.41 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.252 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.47 175.02 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.44 2.094 . . . . 0.0 112.179 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -128.91 175.36 8.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.5 t -61.5 -54.73 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.757 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.495 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 7.9 mt -67.2 -46.67 73.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -48.7 -46.12 40.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.516 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.44 -43.7 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.94 -45.55 74.86 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.51 -30.9 71.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.037 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -63.33 -37.94 89.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.969 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.99 -33.16 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.11 77.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.2 tt -77.28 -56.06 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.033 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -43.36 -38.25 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.48 -41.0 91.11 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 14.8 t -65.92 -43.26 92.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 109.73 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -47.6 -47.54 28.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.721 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.95 -34.38 89.77 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -59.18 -44.72 92.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.091 -0.554 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.25 75.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.377 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.11 -36.23 77.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.631 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.95 -33.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.52 -12.51 83.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.74 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 111.043 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -91.52 -24.11 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.89 73.27 0.11 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.6 22.6 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.911 2.407 . . . . 0.0 112.371 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -115.65 -4.64 12.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -110.46 161.29 25.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.848 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -37.07 -19.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.683 2.256 . . . . 0.0 112.196 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.0 mm? -44.67 -29.03 0.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -40.59 -67.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.679 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -53.6 -34.7 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.289 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.7 t -63.67 -57.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.362 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.29 80.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.0 ttt -64.88 -13.68 57.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.9 p -60.44 -35.11 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.292 0.567 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -88.67 -32.46 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.032 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.578 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.0 t-105 -59.59 -51.92 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.84 -43.06 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.624 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -47.44 -47.31 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 p -78.52 -23.64 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.03 -58.09 10.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.205 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.9 -53.86 9.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.974 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -66.1 -45.53 80.85 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.48 -47.28 91.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.9 t -65.0 -39.36 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.52 -31.36 69.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -78.03 -45.7 22.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.346 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 84' ' ' GLY . 63.1 p -49.13 -31.46 8.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -42.47 79.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.291 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -60.67 -31.65 70.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -75.94 -46.68 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.56 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -66.44 -49.39 66.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.2 mmt -50.35 -49.71 53.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.487 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 33.8 tt0 -51.18 -39.36 56.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.68 -11.97 22.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.739 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.1 t80 . . . . . 0 CA--C 1.532 0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.565 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.674 0.273 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -125.56 -5.77 7.02 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.608 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.6 mt -115.57 87.64 17.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.44 6.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.696 2.264 . . . . 0.0 112.73 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tp -73.74 -26.36 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -96.38 -36.97 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.844 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.04 -41.44 67.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -75.59 -20.78 58.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.913 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 116' ' ' LEU . 3.3 p -165.13 84.93 1.08 Allowed Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.607 ' O ' HG22 ' A' ' 125' ' ' VAL . 65.9 Cg_endo -80.74 -2.52 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.784 2.323 . . . . 0.0 111.816 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -60.12 -54.32 47.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.6 p -97.49 59.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.628 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -165.67 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 121' ' ' PRO . 21.6 m -57.52 128.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.8 153.94 17.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.837 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 t -170.15 99.96 0.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.473 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.12 -167.6 26.35 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' O ' ' OE2' ' A' ' 132' ' ' GLU . 4.0 m-20 -99.84 146.22 26.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.698 0.285 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 62.7 m -98.77 136.72 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.991 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 91.44 -3.62 0.21 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.872 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' OE2' ' O ' ' A' ' 129' ' ' ASP . 12.3 pt-20 -67.74 153.23 44.16 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.309 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -88.4 138.81 31.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.26 -31.04 2.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.648 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -171.94 136.22 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.265 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.3 t70 -119.61 158.35 26.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 111.943 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.548 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 83.2 t80 -144.82 111.16 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.95 17.38 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 136' ' ' ASP . . . 84.76 9.22 81.48 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 6.4 mt -115.49 133.95 55.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.128 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.487 ' OE1' ' NE2' ' A' ' 95' ' ' GLN . 5.2 mt-10 -70.46 154.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.443 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -54.17 -51.0 81.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.995 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 142' ' ' MET . 69.5 Cg_exo -47.11 -40.13 26.47 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.383 2.055 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -71.2 -38.73 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 148' ' ' GLY . 32.6 m95 -67.11 -56.56 9.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.271 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 tp -43.06 -42.95 4.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.705 HD13 ' C ' ' A' ' 147' ' ' LEU . 2.6 tm? -59.7 -37.07 77.83 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.31 -40.92 92.66 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.924 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 149' ' ' ILE . 2.3 mp -70.59 -25.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.682 0.277 . . . . 0.0 110.357 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -42.75 92.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.084 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.6 mm -63.0 -43.68 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.024 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -63.25 -51.78 64.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.456 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.6 m-85 -56.2 -37.28 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 158' ' ' VAL . 33.7 tp -66.34 -30.22 70.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.412 . . . . 0.0 110.6 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.9 -39.99 59.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.06 -34.52 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.026 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.05 -31.03 58.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.16 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 154' ' ' LEU . 24.2 t -64.24 -42.89 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.413 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.99 -24.05 38.29 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.205 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 156' ' ' VAL . 6.0 t -65.1 -39.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.344 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.2 p -81.02 -50.15 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.577 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 161' ' ' VAL . 36.8 mm -63.65 -8.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.289 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.592 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.8 mp . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.826 0.346 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -50.95 -46.39 61.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.54 -45.53 92.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.475 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.67 -46.42 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -68.01 -21.85 65.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.077 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.97 -46.17 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.642 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.27 75.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.545 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.7 p -76.2 -38.01 57.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.534 HE22 ' C ' ' A' ' 65' ' ' PRO . 18.7 tp60 -70.75 10.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.151 0.5 . . . . 0.0 110.235 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.71 141.61 15.42 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.696 ' HE ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -69.8 -49.98 47.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.522 0.201 . . . . 0.0 110.822 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.72 -46.02 5.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -63.13 -46.71 86.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.166 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -56.62 -40.69 75.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.1 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.04 -26.44 66.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.92 -43.43 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.32 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -64.73 -30.79 71.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.0 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.576 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.94 -36.57 70.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.948 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.5 p -66.94 -44.64 80.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.608 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.91 98.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.766 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -75.44 -36.72 60.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.704 -179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.74 -37.07 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.073 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.22 -39.47 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 0.0 110.668 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 26' ' ' GLU . 2.2 tm-20 -63.42 -38.83 92.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.584 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 27' ' ' LEU . 2.2 tt -74.92 -57.81 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.646 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.7 p -45.22 -27.24 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.633 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.9 -37.24 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' CD1' ' OE1' ' A' ' 26' ' ' GLU . 19.2 mt -63.07 -13.85 41.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.563 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.526 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.4 t-105 -96.49 -28.54 14.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.499 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.9 m-85 -71.59 -50.05 34.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.22 -58.05 10.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.94 0.4 . . . . 0.0 110.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -56.17 -14.04 2.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.949 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' TRP . 79.4 t -108.99 -21.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.0 tpt -104.33 0.76 29.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt 49.14 31.04 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 HE22 ' A' ' 134' ' ' GLN . 0.6 OUTLIER -80.23 154.41 27.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.02 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -116.75 127.34 26.8 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.5 -179.9 5.77 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.322 2.015 . . . . 0.0 112.063 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.88 178.45 5.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.2 p -64.99 -41.25 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 5.2 tp -64.28 -49.05 73.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -50.08 -48.84 53.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.662 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.528 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.97 -46.94 81.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.43 -35.36 78.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.314 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -64.19 -34.38 77.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.53 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -62.74 -47.7 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.7 tt -77.53 -55.44 5.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -44.55 -40.98 6.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.56 96.39 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.7 t -60.17 -46.99 93.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.157 0.503 . . . . 0.0 109.834 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.1 tt -46.99 -44.36 20.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.393 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -25.85 71.23 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.87 -42.19 61.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -63.19 -27.06 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 63' ' ' ILE . 11.8 tp -74.66 -39.94 61.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.52 -35.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.084 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.22 -18.95 70.51 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . -82.88 0.54 43.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.612 0.244 . . . . 0.0 110.938 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 59' ' ' LEU . 6.3 mm -88.11 -22.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.568 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.81 65.58 0.19 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.534 ' C ' HE22 ' A' ' 10' ' ' GLN . 59.1 Cg_endo -75.77 19.17 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.609 2.206 . . . . 0.0 112.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -109.64 -7.79 15.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -110.93 161.67 23.95 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.563 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -34.97 -19.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.749 2.299 . . . . 0.0 112.404 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.661 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 mm? -42.24 -29.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.386 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -40.27 -66.07 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.657 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.2 -36.13 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.148 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.28 -51.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.609 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.74 -33.07 71.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.184 0.516 . . . . 0.0 109.741 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttm -61.49 -9.45 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.535 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 40.5 t -61.07 -41.74 90.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.05 -27.79 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.196 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.534 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.0 t-105 -69.05 -54.48 14.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.6 tp -62.17 -50.13 73.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.309 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.5 m-85 -42.58 -41.57 3.08 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.012 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.2 p -80.08 -22.48 42.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.72 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.752 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 2.0 t80 -74.2 -49.54 23.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.204 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -69.85 -43.32 72.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.87 -46.01 94.49 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.51 -37.39 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.436 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 82' ' ' PHE . 55.3 tt0 -68.32 -31.26 70.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 110.93 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.52 -42.17 17.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.944 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 84' ' ' GLY . 5.5 p -49.68 -51.79 35.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.495 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -50.13 59.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.143 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -43.66 -41.84 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -65.64 -53.16 45.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.8 p -51.8 -40.7 60.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.616 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.3 ttm -61.41 -40.92 96.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.476 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tp -67.4 -35.12 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -67.06 -40.45 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.469 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.79 -13.97 25.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.169 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' OE2' ' CH2' ' A' ' 113' ' ' TRP . 10.4 pt-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.591 0.234 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.481 ' CH2' ' OE2' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -101.22 -6.53 24.09 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.268 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.657 ' C ' ' H ' ' A' ' 116' ' ' LEU . 34.6 mt -119.35 91.94 44.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.932 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.1 Cg_exo -52.52 9.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.543 2.162 . . . . 0.0 112.344 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.657 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -68.98 -30.1 68.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.994 0.426 . . . . 0.0 110.168 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 2.0 m-20 -98.17 -39.33 8.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.488 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -73.4 -45.34 55.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.889 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.446 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 13.6 t-105 -76.19 -13.69 60.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.217 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.64 71.19 13.98 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 125' ' ' VAL . 70.3 Cg_endo -78.15 -12.62 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.71 2.273 . . . . 0.0 111.621 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.46 -28.89 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.782 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.489 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.0 t -129.97 49.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.691 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 3.4 m-85 -156.83 -39.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.053 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 125' ' ' VAL . 9.1 p -64.7 126.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.71 159.14 16.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.576 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.6 t -177.32 99.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.417 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.99 -162.49 27.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -97.68 142.82 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.4 m -94.37 132.16 39.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.5 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.57 4.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -70.95 142.84 51.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.203 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' C ' ' OE1' ' A' ' 134' ' ' GLN . 32.0 ptt85 -99.11 133.84 42.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.951 HE22 HD12 ' A' ' 38' ' ' LEU . 2.5 mm100 -103.22 -28.35 11.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 13.3 t-105 -174.17 145.83 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 6.3 p30 -133.85 163.48 29.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 112.462 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -126.59 138.59 53.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.578 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 50.82 17.53 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.442 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 22.56 37.89 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -123.26 136.23 54.62 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.05 154.74 41.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.056 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.7 ttt -51.3 -56.77 17.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 142' ' ' MET . 1.6 Cg_endo -43.76 -36.75 7.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -69.88 -56.73 6.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.267 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 56.5 m95 -56.95 -57.33 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 142' ' ' MET . 2.2 mm? -43.38 -37.1 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.508 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -60.06 -35.85 76.05 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.29 -42.76 98.9 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -80.41 -25.75 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.076 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.503 ' O ' HD13 ' A' ' 154' ' ' LEU . 18.4 t80 -64.55 -48.53 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.625 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 152' ' ' ALA . 13.3 tt -67.19 -41.81 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.467 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -50.68 -47.89 58.66 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.476 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.97 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.711 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.534 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 2.3 mp -70.07 -34.12 72.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.71 -27.17 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 160' ' ' VAL . 54.9 t -71.44 -38.88 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -69.54 -52.9 22.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -56.18 -32.11 33.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.79 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.9 tp -81.37 -30.51 33.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 156' ' ' VAL . 25.6 t -75.49 -25.64 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.97 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.76 -46.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.3 mp -71.12 -16.73 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.965 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 85.6 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.885 0.374 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -57.55 -33.36 68.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.82 -44.83 76.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 mt -51.11 -38.55 52.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.9 t-20 -64.61 -28.79 69.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.34 -48.5 11.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.696 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.04 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 12.0 m -76.7 -37.12 56.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.611 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 24.1 mm-40 -67.11 5.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.491 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.19 145.98 17.86 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -69.22 -48.66 61.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.639 0.257 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.68 6.11 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.78 83.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 18' ' ' MET . 60.3 m95 -59.36 -43.48 92.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.171 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -30.06 71.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' THR . 1.7 mp -70.18 -26.67 64.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.455 ' SD ' ' CE3' ' A' ' 15' ' ' TRP . 52.2 mtt -76.29 -34.3 59.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.741 0.305 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.34 23.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.823 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.0 -45.65 78.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.3 p -52.17 -62.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.73 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.71 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.661 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -79.75 -38.98 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.7 -38.05 63.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.06 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.824 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.02 -43.97 50.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.16 -56.24 10.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -48.72 -42.9 36.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.45 -28.87 59.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.22 -17.56 64.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.037 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.4 t-105 -86.61 -38.84 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.534 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.36 -35.06 79.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -80.86 2.78 25.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.779 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -117.01 -49.64 2.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.657 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 31' ' ' TRP . 12.1 m -72.88 -27.35 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.748 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' LEU . 8.7 tpp -109.35 13.88 23.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.673 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' MET . 9.7 mt 37.73 37.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.0 147.71 52.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.677 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -109.38 124.78 32.97 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 178.35 7.75 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.245 1.963 . . . . 0.0 112.263 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.74 172.18 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.637 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.2 t -56.46 -51.73 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 91' ' ' HIS . 4.1 mm? -56.23 -38.42 71.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.558 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.2 t -58.37 -43.31 88.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.143 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.4 mm -61.36 -50.95 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.81 73.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.021 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.93 -37.97 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -36.98 84.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.14 80.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.93 -47.28 87.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.344 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 mt -77.18 -53.58 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.31 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -43.18 -41.89 3.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.08 94.99 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 51' ' ' LEU . 39.1 t -61.19 -19.4 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.266 0.555 . . . . 0.0 110.164 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.72 -41.23 23.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.053 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.17 -28.59 73.28 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.08 -47.74 23.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.99 68.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.389 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -44.73 77.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.37 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.56 -39.36 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.42 -16.67 75.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.55 0.88 48.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.77 0.319 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.5 mt -78.42 -38.36 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.7 73.51 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.86 21.46 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.92 2.413 . . . . 0.0 112.046 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -97.4 -10.14 26.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.148 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.07 179.27 0.8 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.549 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 50.3 Cg_exo -52.22 -0.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.232 1.954 . . . . 0.0 112.164 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' THR . 14.5 mt -56.19 -33.01 64.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 77.0 mtm180 -38.77 -61.6 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.774 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.845 ' O ' HG23 ' A' ' 75' ' ' VAL . 42.2 m-85 -52.1 -35.41 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.226 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' LEU . 14.5 t -63.29 -52.86 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.961 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.93 61.54 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.275 0.56 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 15.7 mmt -57.94 -13.3 4.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 71' ' ' TYR . 43.6 t -59.31 -36.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.595 0.712 . . . . 0.0 110.279 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -89.83 -27.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.285 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 4.6 t-105 -69.58 -52.85 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.983 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 7.0 tt -67.07 -47.6 70.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.1 m-85 -46.79 -44.39 19.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.369 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -74.57 -24.68 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 78' ' ' LEU . . . -59.62 -59.77 4.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.41 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.84 -51.25 16.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -44.64 73.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.9 -48.1 84.52 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.5 t -70.45 -53.54 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.848 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -47.98 -23.53 0.82 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.832 0.349 . . . . 0.0 110.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.57 -35.93 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 84' ' ' GLY . 37.8 p -58.64 -23.36 58.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.628 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.11 -44.37 60.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.581 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -59.56 -34.25 72.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.472 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.489 ' CE1' HD12 ' A' ' 43' ' ' LEU . 2.3 m-70 -72.3 -44.8 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -43.52 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.654 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 97' ' ' TYR . 50.1 mtp -55.63 -42.23 74.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.599 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.34 -47.29 64.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.37 -42.4 91.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.37 -18.83 29.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.371 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.099 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 111.297 0.11 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -125.1 -5.28 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.81 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.597 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.1 mt -111.56 72.74 1.01 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 9.9 Cg_endo -54.31 4.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.524 2.149 . . . . 0.0 112.058 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.597 ' H ' ' C ' ' A' ' 114' ' ' LEU . 18.6 mt -74.66 -24.67 58.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -98.83 -38.85 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.499 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -82.35 -45.82 14.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.786 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -69.83 -16.92 63.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.632 -179.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 116' ' ' LEU . 6.0 p -154.34 72.03 6.21 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 110.837 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 125' ' ' VAL . 2.5 Cg_endo -77.9 -4.51 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.068 2.512 . . . . 0.0 111.799 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.67 -52.26 41.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.7 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.57 49.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.464 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.28 -44.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 121' ' ' PRO . 29.8 m -57.96 132.68 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.088 0.471 . . . . 0.0 110.689 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.54 161.04 13.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.474 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 t -165.75 99.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.543 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.68 -177.96 20.07 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 17.3 t0 -85.84 148.4 25.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 110.151 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 52.5 m -101.21 129.57 47.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.762 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 94.69 -8.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.727 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.74 148.77 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -86.09 123.6 31.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.456 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -128.37 -23.21 3.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -172.95 125.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.58 158.81 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 111.719 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -113.45 139.56 48.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.928 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 mt 47.91 17.02 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.488 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.35 21.98 30.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.041 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 139' ' ' GLY . 2.9 mp -125.06 138.53 54.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 141' ' ' GLU . 16.3 mp0 -70.97 147.07 49.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.433 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.5 mmt -46.49 -61.81 2.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.161 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 80.9 Cg_exo -33.73 -39.61 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.878 2.385 . . . . 0.0 112.648 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -70.72 -55.66 8.16 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.917 0.389 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.584 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -55.6 -57.1 13.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.963 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -43.79 -37.67 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -57.32 -37.31 72.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.49 -45.73 95.07 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.17 -30.7 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 110.194 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -58.85 -48.55 80.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.12 -46.25 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.26 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.42 -46.76 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.487 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -58.45 -44.05 89.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 158' ' ' VAL . 9.7 mt -60.63 -30.25 69.74 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.292 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.64 -27.43 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 160' ' ' VAL . 94.9 t -75.03 -36.11 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 111.111 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -74.63 -53.13 9.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 159' ' ' LEU . 32.6 m -56.39 -42.65 75.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.497 ' N ' HG23 ' A' ' 158' ' ' VAL . 6.9 tp -73.07 -31.67 64.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.259 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 156' ' ' VAL . 33.8 t -78.2 -28.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.229 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.86 -51.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.394 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 52.1 mt -62.32 -33.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.05 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 2' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.774 0.321 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -53.87 -34.09 58.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.348 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -72.51 -44.38 62.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.287 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp -47.19 -37.66 10.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -67.54 -27.52 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' PHE . 9.6 tp-100 -80.77 -47.57 13.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.692 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -39.5 86.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.67 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLY . 53.2 p -76.67 -37.28 56.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 18.3 tt0 -65.21 2.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.472 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.69 148.82 19.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -69.71 -20.47 63.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.76 -45.12 59.84 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -51.1 68.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.185 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -56.1 -45.78 79.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 tp -64.64 -30.44 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.37 -32.41 70.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.1 mmt -71.14 -33.34 69.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.58 -51.96 30.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -50.02 -45.9 52.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.683 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 p -59.01 -60.88 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.04 8.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tp -80.07 -40.48 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.8 -41.99 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.6 mp -69.08 -26.87 65.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.81 -37.78 76.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.95 -57.53 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -44.15 -39.9 4.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.51 -35.07 63.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.767 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.72 -18.49 62.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.761 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.41 -24.89 20.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.854 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -73.56 -38.02 65.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.59 0.84 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -119.15 -52.59 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.24 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.31 -40.48 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 37' ' ' LEU . 29.8 mtt -108.17 15.16 24.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.64 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 36' ' ' MET . 29.1 mt 37.03 41.85 0.21 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.064 0.459 . . . . 0.0 110.15 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 153.35 40.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.016 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' NZ ' ' CB ' ' A' ' 39' ' ' LYS . 6.5 mtmp? -124.7 108.12 28.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.69 169.03 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.229 1.953 . . . . 0.0 112.111 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -110.36 -175.4 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.461 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 2.6 p -64.37 -44.52 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.55 -48.29 81.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.779 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.0 m -60.8 -46.98 88.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.15 -49.8 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 28.9 t80 -54.52 -48.3 72.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -53.67 -47.57 70.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.084 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -50.7 -36.01 33.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -63.51 -40.91 98.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.492 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.08 79.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 51' ' ' LEU . 9.5 mp -72.62 -50.69 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -43.39 -41.95 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.08 -37.82 92.02 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 51.8 t -62.64 -19.23 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.403 0.62 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 tt -79.76 -46.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.817 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.85 -31.77 81.53 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.44 74.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.891 0.377 . . . . 0.0 110.018 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.45 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.004 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.22 -31.22 62.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.475 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.6 mt -80.46 -42.89 21.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.09 77.0 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 7.49 3.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.654 0.264 . . . . 0.0 110.855 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.48 -55.06 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.269 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.77 84.29 0.29 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.03 24.04 0.7 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.678 2.252 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -99.25 -11.62 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -106.52 179.26 0.93 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 76.5 Cg_exo -47.46 -5.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.019 1.813 . . . . 0.0 112.02 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -49.98 -33.04 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.236 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -38.32 -66.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.031 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -57.49 -36.84 72.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.639 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.4 -52.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.804 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.31 -34.55 78.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.335 0.588 . . . . 0.0 109.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 78' ' ' LEU . 2.4 ttt -63.61 -8.33 9.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.765 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.11 -40.85 90.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.452 0.644 . . . . 0.0 111.069 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.4 pp -89.23 -28.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.676 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.527 ' N ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -69.15 -47.48 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.689 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.438 HD11 ' SD ' ' A' ' 74' ' ' MET . 7.6 mt -65.97 -45.78 80.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -49.2 -44.36 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.105 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -80.22 -23.26 41.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.741 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.43 -60.08 4.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.336 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -77.78 -45.37 24.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.282 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -69.96 -40.89 75.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.805 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 88' ' ' THR . . . -64.6 -46.47 89.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 81' ' ' ALA . 12.7 m -79.26 -35.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -26.27 67.05 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.958 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.4 -28.46 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.704 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 84' ' ' GLY . 20.0 p -60.94 -51.9 67.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.572 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -50.87 -29.71 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.527 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.67 -37.93 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.145 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -68.37 -37.07 80.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.272 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.1 p -72.46 -39.24 67.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.471 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.0 ttt -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.17 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.74 -38.52 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.663 HE22 HE22 ' A' ' 144' ' ' GLN . 81.2 mt-30 -72.16 -38.02 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.769 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.57 -22.66 20.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 93' ' ' MET . 86.2 m-85 . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 2.0 p-90 -113.23 10.62 18.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 tp -119.75 86.24 35.11 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 40.7 Cg_exo -54.48 15.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.847 2.365 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.638 ' H ' ' C ' ' A' ' 114' ' ' LEU . 40.6 tp -75.63 -30.44 59.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.005 0.431 . . . . 0.0 110.004 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -97.38 -39.64 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.191 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -72.46 -45.2 60.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.99 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.5 t90 -75.69 -12.44 60.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.388 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.6 67.91 78.77 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 71.7 Cg_endo -80.41 -22.07 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.906 2.404 . . . . 0.0 111.689 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -55.53 -53.97 49.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.19 54.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.544 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.4 t80 -159.07 -35.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' PRO . 75.3 t -65.64 130.48 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.821 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . . . -96.83 163.04 13.15 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.3 t -174.67 101.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 141.46 177.95 17.18 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.47 135.74 36.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 15.0 m -91.16 129.42 37.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.56 -1.63 0.24 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.653 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -67.98 145.09 54.84 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -87.3 116.06 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -117.51 -22.3 8.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -175.75 128.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.474 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -140.54 158.74 43.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.269 0.557 . . . . 0.0 112.238 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 17.5 t80 -117.09 139.18 51.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.936 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.0 mm? 49.95 17.09 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.379 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.63 21.85 35.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.794 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -125.87 137.11 53.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.73 149.6 47.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.44 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -49.14 -51.5 56.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' HD13 ' A' ' 147' ' ' LEU . 89.0 Cg_exo -44.06 -37.98 10.08 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.542 2.161 . . . . 0.0 112.454 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.663 HE22 HE22 ' A' ' 95' ' ' GLN . 0.3 OUTLIER -70.71 -46.93 62.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.156 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.6 m95 -63.84 -57.25 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.3 mt -43.68 -38.56 3.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 143' ' ' PRO . 2.4 mp -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -54.39 -39.07 64.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -80.96 -27.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 110.118 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' LEU . 75.7 t80 -59.67 -51.62 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.134 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 9.8 tt -64.2 -42.47 95.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.238 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -52.85 -47.69 67.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.179 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -57.82 -38.64 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.58 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 150' ' ' PHE . 74.6 mt -66.75 -32.32 73.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.852 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -33.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 160' ' ' VAL . 42.0 t -59.5 -43.37 90.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.424 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -73.51 -48.79 30.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.23 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 69.0 t -51.25 -43.37 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.751 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.1 -43.59 52.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.761 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.8 t -62.07 -29.46 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.202 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -80.51 -47.76 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 162' ' ' ILE . 74.2 mt -70.64 -2.72 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.397 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.846 -179.825 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -52.76 -38.24 60.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLN . 7.2 t80 -71.69 -46.3 59.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -45.48 -44.06 12.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.322 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 47.2 t30 -70.96 -20.87 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PHE . 44.2 tp60 -79.92 -47.86 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.21 74.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 78.4 p -76.46 -34.17 58.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 6' ' ' ASN . 15.7 mt-30 -73.9 10.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.513 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.03 140.91 15.33 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -19.7 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.68 59.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.21 68.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -53.47 -41.54 66.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.303 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.64 -29.57 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.294 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -34.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mtm -73.95 -34.58 64.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.091 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.33 65.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.604 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -60.83 -33.1 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.608 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.7 m -56.75 -54.85 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.88 -27.48 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.361 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.14 -41.84 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.12 -45.11 61.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.687 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.28 -33.28 74.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.07 -44.61 68.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.9 tt -65.29 -58.09 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -47.21 -36.67 9.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.43 -31.12 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -63.32 -18.55 63.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.416 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.475 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 11.0 t-105 -86.69 -41.03 14.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 110.36 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -56.15 -38.42 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.037 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.426 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 12.9 tm0? -79.05 -23.74 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.217 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 36' ' ' MET . 11.7 p -108.41 -44.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.562 ' N ' HG13 ' A' ' 35' ' ' VAL . 9.3 tpt -77.15 -2.38 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt 46.16 45.75 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.08 146.33 54.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -110.57 108.58 58.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.961 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.1 145.11 17.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.25 1.967 . . . . 0.0 111.513 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -107.49 -161.87 0.8 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.595 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.6 t -63.32 -42.6 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.2 tp -62.57 -49.31 75.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.198 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -54.66 -49.48 70.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.676 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.83 -45.35 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -59.71 -46.58 88.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.24 -47.69 84.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.257 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -56.74 -33.15 66.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.356 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.56 74.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -73.31 -50.67 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -43.8 -41.73 5.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.32 94.11 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.43 -47.73 90.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.97 -46.52 16.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.502 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -48.79 76.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.66 62.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.127 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.92 73.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 tp -72.28 -25.53 61.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.101 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.29 -39.53 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.67 -25.87 75.06 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.49 7.8 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.46 -48.52 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -179.45 80.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.61 31.56 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.68 -9.7 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.946 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.99 170.52 5.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.784 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.84 -12.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 mt -43.73 -32.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.51 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -41.05 -70.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -54.68 -27.37 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.677 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.32 -46.15 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.565 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.67 -35.05 60.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.599 . . . . 0.0 109.619 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 ttt -59.59 -15.72 20.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 70.9 t -55.22 -40.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.262 0.554 . . . . 0.0 110.345 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.2 mm -85.48 -34.86 8.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.228 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.586 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 5.0 t-105 -61.89 -56.15 22.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.8 tp -62.84 -50.28 71.56 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -42.88 -44.87 4.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.187 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.52 -21.37 45.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.495 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.38 -59.91 4.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.184 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.53 -46.69 58.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -77.32 -40.29 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.32 -48.92 83.64 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.397 -0.906 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 81' ' ' ALA . 25.3 m -67.77 -44.74 85.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.819 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.518 ' N ' HG23 ' A' ' 85' ' ' VAL . 3.9 tt0 -54.91 -28.41 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.112 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.35 61.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.236 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 70.0 p -54.79 -30.69 57.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.332 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.23 -48.34 76.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.13 -30.77 66.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 3.8 m170 -77.46 -49.04 15.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -64.56 -48.42 75.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 97' ' ' TYR . 26.7 ttt -52.71 -51.39 60.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.484 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.74 -49.36 73.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -52.35 -44.65 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.9 mm? -88.39 -13.31 40.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 93' ' ' MET . 7.8 t80 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.277 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.546 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 1.1 p-90 -110.13 0.64 18.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -114.34 94.25 34.82 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.033 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.03 0.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.698 2.265 . . . . 0.0 112.935 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.8 tp -70.27 -26.13 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.71 -34.78 11.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -67.01 -35.16 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 -95.99 -23.96 16.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.364 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.8 t -149.64 87.79 5.08 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.52 -15.73 8.45 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.606 2.204 . . . . 0.0 112.521 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -85.69 -4.01 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.722 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.3 p -112.54 18.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.109 0.48 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -147.24 -43.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.433 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.67 129.96 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.407 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.88 154.57 17.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.7 p -158.53 99.78 1.61 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.509 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.55 -176.97 20.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -96.65 150.13 21.01 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 73.9 m -102.22 132.2 48.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.89 -10.35 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.999 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -69.53 129.16 38.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.657 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -67.96 109.45 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -115.7 -23.54 8.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.781 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 16.9 t90 -172.02 132.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 1.1 p30 -146.16 159.37 43.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -120.68 139.89 52.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.899 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.49 17.35 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.91 21.25 53.62 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -123.21 135.26 54.21 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 141' ' ' GLU . 9.7 mp0 -71.65 148.81 46.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.465 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtt -45.25 -63.7 1.12 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.25 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 88.2 Cg_exo -32.35 -38.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.092 2.528 . . . . 0.0 112.801 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.455 ' CD ' ' N ' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -72.47 -51.68 19.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.004 0.43 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 72.6 m95 -56.36 -57.46 12.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.903 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -43.76 -39.14 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.1 tt -56.27 -35.77 67.84 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -63.01 -48.42 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.489 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.45 -26.23 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.57 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.4 t80 -64.08 -41.49 97.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 148' ' ' GLY . 3.5 tt -73.75 -29.73 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.66 -52.02 62.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.272 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -57.06 -41.74 79.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.534 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -61.32 -30.91 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.736 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.48 -26.8 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.223 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' VAL . 74.6 t -73.35 -35.1 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.586 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -71.98 -53.76 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.263 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 159' ' ' LEU . 34.9 m -53.71 -45.92 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.913 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 158' ' ' VAL . 2.3 tp -67.11 -30.21 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.731 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 156' ' ' VAL . 18.4 t -74.98 -29.92 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.9 t -83.66 -51.53 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 110.318 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 162' ' ' ILE . 40.0 mm -68.67 -12.72 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.107 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.067 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.905 0.383 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -54.96 -36.49 65.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.313 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 7' ' ' GLN . 2.6 t80 -69.77 -43.02 73.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.174 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -48.45 -38.31 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 2.3 m-20 -68.32 -26.8 65.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.275 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.1 mm-40 -78.08 -48.86 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.382 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.74 80.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 40.1 m -76.65 -37.3 56.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.538 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 11.3 mm100 -70.24 7.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.372 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.64 145.77 16.25 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -72.33 -51.54 20.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.632 0.254 . . . . 0.0 110.744 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.97 -47.3 6.29 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.29 86.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -58.7 -37.28 75.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.19 -29.58 69.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.721 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' THR . 2.3 tp -69.98 -27.73 64.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.44 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.1 mtp -76.09 -34.07 59.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.3 -54.85 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 23' ' ' LEU . 66.7 t80 -52.1 -52.69 49.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 15.4 p -44.11 -51.62 7.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -21.69 65.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.51 -42.37 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.468 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.63 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.54 -35.29 68.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' CD ' ' NH1' ' A' ' 48' ' ' ARG . 4.9 tp10 -64.99 -35.61 81.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.55 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.42 -56.54 4.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.659 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -45.26 -41.5 8.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.78 -32.35 65.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.567 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -64.03 -19.77 65.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.583 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -93.5 -19.79 20.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.21 -50.36 19.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 34' ' ' HIS . 2.0 pp0? -73.61 -9.15 58.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.12 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.608 ' N ' ' NE2' ' A' ' 33' ' ' GLN . 14.3 t-160 -77.89 -31.01 51.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.102 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.78 -9.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.8 mmt -107.05 -3.19 20.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.631 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.2 mt 47.21 50.19 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 110.282 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 39' ' ' LYS . 2.1 tt -65.07 142.19 58.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.629 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.861 ' N ' HD23 ' A' ' 38' ' ' LEU . 14.9 mttm -107.31 99.66 29.03 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.455 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 127' ' ' SER . 72.1 Cg_exo -46.5 168.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.575 2.183 . . . . 0.0 112.784 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.9 161.49 32.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.187 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.506 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.7 t -48.81 -46.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.6 mm? -73.0 -33.88 66.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.1 t -58.07 -45.8 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.824 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 126' ' ' ALA . 24.2 pt -69.56 -35.99 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.3 -47.36 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.91 -36.71 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' NH1' ' CD ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -63.42 -32.58 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.63 77.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.233 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.44 77.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.4 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.88 -55.51 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -44.52 -38.34 4.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.42 94.67 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -62.22 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 109.831 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -45.83 -44.63 14.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.591 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.27 -27.98 73.04 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.98 -43.21 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.616 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.74 65.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.463 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -80.84 -36.08 31.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.428 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -80.89 -34.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -75.49 -32.83 54.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.56 6.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -88.43 -22.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.518 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 67.82 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.82 24.61 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.672 2.248 . . . . 0.0 111.845 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 64' ' ' ALA . 37.5 mttp -111.3 -6.16 14.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.13 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.33 163.86 17.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.647 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.17 -13.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.442 2.095 . . . . 0.0 112.217 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mt -43.07 -34.46 1.04 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 59.0 mtm-85 -38.57 -66.57 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.732 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -54.15 -27.22 32.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.786 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.2 t -72.86 -51.12 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.496 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.244 0.545 . . . . 0.0 109.913 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 5.7 ttt -62.23 -15.75 48.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.882 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.2 p -56.58 -36.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.453 0.644 . . . . 0.0 110.408 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.2 mt -87.38 -34.51 7.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.775 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.581 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 6.0 t-105 -60.61 -54.59 43.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.926 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.88 -44.93 91.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.83 -23.04 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 154' ' ' LEU . . . -60.96 -60.83 3.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.623 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -72.47 -56.24 5.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.177 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -68.26 -47.73 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.1 -46.81 84.29 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 81' ' ' ALA . 92.6 t -67.57 -36.09 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.58 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.45 -34.89 69.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.255 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.28 -44.64 17.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.548 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 84' ' ' GLY . 49.2 p -45.3 -32.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.58 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -73.45 -40.83 63.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -56.34 -37.66 70.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.5 m170 -68.62 -42.7 77.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -66.47 -51.4 57.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.7 ttt -49.48 -49.54 45.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 97' ' ' TYR . 3.8 tp -61.48 -47.92 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -54.33 -37.89 65.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 96' ' ' LEU . 11.1 mp -90.58 -15.79 29.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.465 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 37.2 t80 . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.283 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.561 0.219 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -125.41 -6.06 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.782 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -119.52 78.47 20.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.39 11.37 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.263 1.975 . . . . 0.0 112.22 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.9 mt -77.36 -29.76 53.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.111 0.481 . . . . 0.0 109.771 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.475 ' OD1' ' CD2' ' A' ' 124' ' ' PHE . 3.4 m-20 -96.2 -42.19 8.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.729 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' NZ ' ' CB ' ' A' ' 118' ' ' LYS . 5.4 ttpm? -64.88 -44.75 88.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.066 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 27.1 t-105 -76.12 -12.95 60.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.88 73.64 13.55 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.781 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.78 -12.9 13.35 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.819 2.346 . . . . 0.0 111.948 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.525 ' O ' ' NE2' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -55.87 -54.11 48.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.289 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.74 26.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.249 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CD2' ' OD1' ' A' ' 117' ' ' ASP . 39.8 m-85 -134.69 -6.4 2.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.193 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.88 132.65 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -101.48 154.85 18.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' PRO . 69.6 m -167.64 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.355 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.71 -174.3 21.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.73 154.14 21.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.293 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 97.9 m -101.48 131.77 47.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.14 1.19 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.49 160.26 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.043 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -100.14 140.01 34.99 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -132.71 -27.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -174.77 142.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.72 167.9 20.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.527 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 69.4 t80 -145.58 118.46 8.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.509 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 3.5 tp 78.89 17.34 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.86 11.33 79.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.7 mp -116.82 132.9 56.58 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -71.07 153.02 42.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.276 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.1 mmm -50.71 -59.5 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.708 ' O ' HD13 ' A' ' 147' ' ' LEU . 83.2 Cg_exo -36.55 -41.31 0.59 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.458 2.105 . . . . 0.0 112.237 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -71.79 -44.7 63.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.333 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.2 m95 -61.26 -56.82 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.065 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 tp -43.41 -44.55 5.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.007 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' PRO . 4.5 mp -53.61 -36.45 62.0 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.85 -42.29 94.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.24 -29.76 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 110.628 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.16 -48.31 80.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.103 0.478 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 155' ' ' ILE . 12.9 pt -68.01 -41.55 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.11 -45.91 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.524 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 5.6 m-85 -64.28 -39.66 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -60.0 -45.31 93.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.258 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -73.97 -26.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.93 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 155' ' ' ILE . 5.8 t -68.62 -33.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.106 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -71.98 -46.88 55.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.851 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.16 -24.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.093 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.96 -41.48 51.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.057 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 156' ' ' VAL . 21.9 m -78.78 -21.87 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.832 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.6 t -74.56 -48.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.115 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 162' ' ' ILE . 2.2 pp -69.26 -28.57 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.442 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.992 0.425 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -58.12 -31.97 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.119 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.62 -42.94 67.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.068 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 mp -50.54 -38.74 46.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -67.95 -30.55 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -79.69 -49.89 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.47 78.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.742 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -76.72 -30.48 56.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.822 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 28.6 tt0 -73.39 6.07 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 110.515 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.49 146.47 17.25 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -66.42 -20.69 66.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.339 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.13 -44.39 76.89 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.512 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.89 -51.25 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -60.53 -43.84 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.73 -35.54 81.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 21' ' ' THR . 10.1 tp -69.52 -28.83 66.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -72.56 -32.82 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.29 26.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.523 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.42 -46.76 63.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.829 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 18' ' ' MET . 27.4 p -52.72 -53.13 52.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.37 81.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.613 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.6 tt -69.76 -42.15 74.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.942 0.401 . . . . 0.0 110.702 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.47 -42.45 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -71.17 -34.45 70.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.735 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.59 -43.84 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 27' ' ' LEU . 2.6 tt -74.32 -58.17 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.519 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 24' ' ' ALA . 35.0 p -44.43 -32.62 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.62 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.45 -41.53 16.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.568 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tp -49.13 -21.98 0.86 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.772 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -85.46 -32.53 22.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -58.81 -44.32 90.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.139 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.423 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 15.6 pt20 -75.98 -28.96 58.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.712 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -65.41 -31.42 72.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.497 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.78 -47.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 5.4 tpt -73.22 1.78 8.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.705 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.2 mt 43.53 45.62 5.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -69.67 145.96 51.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.949 ' N ' HD23 ' A' ' 38' ' ' LEU . 46.4 mttp -115.23 90.82 25.54 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.51 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 127' ' ' SER . 51.4 Cg_exo -51.23 165.88 0.5 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.669 2.246 . . . . 0.0 112.518 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 8.3 t -112.95 -175.45 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.316 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.438 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.2 p -69.09 -36.9 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' ND1' ' A' ' 91' ' ' HIS . 5.9 mp -77.76 -49.64 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.605 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 t -49.15 -51.51 31.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 46' ' ' TYR . 18.5 tt -64.27 -38.95 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.218 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 19.4 t80 -55.6 -44.62 77.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -56.97 -47.43 80.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.263 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -52.62 -30.41 31.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.926 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -70.33 -38.25 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.91 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.565 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 8.8 mp -73.28 -50.96 19.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.82 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -44.29 -38.54 3.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.85 90.28 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' ALA . 24.8 t -61.61 -47.35 93.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 109.725 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.37 -45.78 9.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.682 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.67 -29.48 75.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.57 -40.03 84.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.619 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.56 58.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -73.67 -47.04 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.377 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.78 -29.75 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -74.54 -33.96 54.98 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 2.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 110.585 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -84.54 -23.64 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.71 74.15 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.91 21.93 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.857 2.371 . . . . 0.0 112.023 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -115.55 -4.68 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.091 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.59 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -110.51 159.91 30.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.693 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -36.09 -22.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 mp -44.18 -26.18 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -43.68 -65.46 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.608 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.6 m-85 -55.3 -37.71 67.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.979 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.55 -48.69 84.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.776 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 -31.76 65.2 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.436 0.636 . . . . 0.0 109.749 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.3 ttp -63.18 -11.81 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.355 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 71' ' ' TYR . 63.4 t -62.84 -39.24 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.399 0.618 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.7 mt -83.65 -36.59 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.784 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 15.9 t90 -59.65 -52.61 64.79 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.688 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.4 tt -58.98 -53.66 55.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 110.529 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -42.27 -45.13 4.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.748 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -81.49 -24.53 36.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.25 -61.41 2.62 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.801 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 5.8 m-85 -75.13 -53.72 8.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -65.08 -45.03 86.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.89 -45.89 95.05 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' ALA . 90.2 t -69.55 -35.67 67.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.603 0.239 . . . . 0.0 111.227 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 82' ' ' PHE . 1.1 mp0 -71.29 -39.52 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.708 0.289 . . . . 0.0 110.934 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 tp -73.05 -43.94 61.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.6 p -52.68 -52.25 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -47.37 -38.63 13.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -59.52 -40.93 88.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.863 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.576 ' ND1' HD23 ' A' ' 43' ' ' LEU . 1.8 m-70 -60.95 -35.85 77.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.367 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.3 p -76.49 -42.54 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.0 ttt -50.34 -49.88 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.13 -47.81 81.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -52.91 -37.81 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.5 mp -94.35 -15.87 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 93' ' ' MET . 13.3 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.7 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.555 ' CG ' ' O ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.82 -3.47 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.609 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.6 tp -125.81 79.37 68.43 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 121.017 0.437 . . . . 0.0 110.043 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.1 Cg_exo -54.59 9.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.731 2.288 . . . . 0.0 112.52 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.609 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -65.48 -32.91 74.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.048 0.451 . . . . 0.0 109.925 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -97.71 -40.1 8.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.014 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.9 -45.34 67.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.9 t90 -76.12 -12.16 60.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.189 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.89 70.74 36.06 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.42 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.8 Cg_endo -77.19 -18.67 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.705 2.27 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -55.46 -54.12 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.897 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.495 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 10.6 m -105.48 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.828 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.2 m-85 -164.96 -38.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.1 p -58.23 129.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.548 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.83 152.68 18.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' PRO . 54.0 p -156.53 104.99 2.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.09 -169.75 21.57 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 3.6 m-20 -96.19 170.26 9.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 110.238 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.2 m -119.04 128.44 54.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.72 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.49 -10.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -69.56 149.03 48.63 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.712 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -100.01 134.09 43.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.827 ' NE2' HD21 ' A' ' 38' ' ' LEU . 1.6 pt20 -132.58 -13.59 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -173.9 133.73 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -145.37 158.0 43.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.178 0.513 . . . . 0.0 112.002 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.427 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.5 t80 -114.29 140.28 48.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.159 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp 49.11 16.72 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.088 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.97 23.02 31.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.072 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 144' ' ' GLN . 77.6 mt -127.42 138.99 53.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.985 0.392 . . . . 0.0 110.174 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -68.05 146.18 53.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.435 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.62 -54.32 19.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.455 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.3 Cg_exo -41.48 -34.17 1.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.334 2.023 . . . . 0.0 111.941 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.459 ' OE1' HD22 ' A' ' 140' ' ' LEU . 12.4 tt0 -72.03 -48.46 44.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 94.6 m95 -60.44 -57.79 11.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.827 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 146' ' ' LEU . 10.8 mp -43.97 -37.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.085 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.45 -35.1 73.4 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.6 -40.88 98.5 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.48 -25.8 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.451 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -44.91 87.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.35 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 151' ' ' ILE . 5.8 tt -66.47 -38.12 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.026 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -51.4 -48.73 62.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.904 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.92 -39.9 91.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.644 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.8 ' O ' HD23 ' A' ' 154' ' ' LEU . 7.3 tt -59.98 -30.96 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.353 0.597 . . . . 0.0 109.868 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -82.67 -30.84 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.815 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -67.88 -42.74 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.784 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.34 -48.34 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.581 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -51.98 -34.42 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.217 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.1 -36.13 21.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.0 t -67.02 -30.46 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.292 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.5 p -79.26 -49.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.587 ' N ' HG13 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -64.21 -10.53 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.113 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.585 179.816 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -61.28 -51.17 70.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 110.037 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -45.53 -42.0 10.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.549 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -62.79 -41.06 99.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -49.7 -41.15 42.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.01 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -67.49 -29.56 69.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.891 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -74.9 -50.72 15.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 p -76.76 -36.44 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.771 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -70.7 2.57 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.09 148.98 18.95 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -70.78 -49.24 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.291 . . . . 0.0 110.702 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.21 -44.86 6.24 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.3 81.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.559 -0.32 . . . . 0.0 110.253 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -58.53 -46.55 86.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.234 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.19 -28.27 67.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.0 -31.45 67.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.634 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . 55.7 mtt -70.65 -33.93 71.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.66 32.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.674 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.74 -31.47 64.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -67.23 -52.57 39.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.512 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -65.57 -29.12 69.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.471 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -77.75 -41.79 36.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.68 -33.87 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -73.23 -35.46 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.277 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -71.42 -43.3 67.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.652 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.07 -57.91 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 p -51.06 -30.24 15.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.297 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.36 -43.44 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -14.56 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -91.96 -36.62 13.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.426 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 36' ' ' MET . 2.6 m-85 -58.67 -40.32 83.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -75.78 -35.78 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.221 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -28.89 66.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.484 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 36' ' ' MET . 22.5 m -105.24 -38.21 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.652 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 36' ' ' MET . 1.8 tmt? -80.5 -0.04 35.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.511 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 48.52 47.57 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tt -83.63 150.76 25.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -117.88 137.85 24.78 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.3 Cg_endo -75.44 167.72 26.03 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.454 2.102 . . . . 0.0 112.155 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.45 175.51 7.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.099 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 33.2 t -58.38 -53.72 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 2.0 tp -65.16 -48.28 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 p -48.75 -47.84 41.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.591 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.52 -44.27 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.364 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.33 -46.6 89.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.92 -38.04 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.327 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -60.7 -29.4 69.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.821 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.01 -37.01 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.478 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.54 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.483 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' VAL . 6.1 tp -76.37 -54.02 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.28 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -44.03 -38.87 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.44 -41.63 90.42 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.6 t -62.62 -47.81 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-O 121.212 0.529 . . . . 0.0 109.757 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -49.23 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.218 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.54 -29.38 69.4 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -69.47 -33.13 72.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.667 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.86 -24.3 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 59' ' ' LEU . 3.2 mm? -73.92 -39.28 63.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.405 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.18 -35.29 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.695 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -65.49 -38.5 94.87 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.94 11.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.919 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.3 mt -83.7 -29.01 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.533 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.03 78.1 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.404 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.23 22.81 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.58 2.187 . . . . 0.0 112.083 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -111.09 -6.27 14.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.78 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.55 163.19 20.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.672 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -40.92 -13.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.505 2.137 . . . . 0.0 112.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 mt -42.42 -34.99 0.91 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' NH1' ' CB ' ' A' ' 164' ' ' GLN . 94.2 mtt180 -39.0 -67.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.338 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.9 m-85 -48.96 -34.27 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.9 t -68.34 -46.02 81.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -43.87 21.86 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.992 -0.442 . . . . 0.0 111.137 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.473 ' SD ' ' C ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.07 -16.73 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.797 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -57.78 -32.5 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.637 0.732 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.7 -34.09 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.895 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.9 t-105 -64.3 -45.18 89.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.933 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 81' ' ' ALA . 1.3 tp -68.62 -46.33 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.221 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -45.69 -41.92 11.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.122 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -80.77 -23.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.387 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.24 -59.59 5.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -74.84 -53.62 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.21 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -66.23 -46.89 75.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.78 -47.3 86.83 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.5 t -66.39 -47.39 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.451 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 1.4 tm0? -56.85 -44.74 82.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.531 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.2 tt -64.81 -51.41 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.8 p -48.13 -23.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.256 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.66 -45.16 54.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.53 -38.09 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.136 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -67.95 -42.11 81.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -66.62 -51.56 54.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.729 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' TYR . 16.5 ttt -56.34 -51.49 68.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.95 -41.6 99.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.423 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -55.97 -44.29 78.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.228 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 96' ' ' LEU . 5.9 tt -95.54 -6.56 40.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' MET . 9.5 t80 -139.11 67.05 39.93 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.305 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.47 116.11 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 80.6 p -170.17 58.72 0.31 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.415 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -71.75 176.82 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.675 2.25 . . . . 0.0 112.161 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.67 -140.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.585 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.19 -79.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.694 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 t -140.59 44.62 1.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.626 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 106' ' ' PHE . 58.9 p -49.64 -25.79 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -66.1 74.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.532 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 104' ' ' SER . 60.8 t80 -122.66 77.31 1.42 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 29.8 mtt 44.98 -164.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.535 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -95.99 121.59 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.536 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.6 108.56 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.39 147.39 59.89 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.397 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 113' ' ' TRP . 37.5 Cg_endo -67.42 135.12 35.46 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.465 2.11 . . . . 0.0 112.06 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 14.2 mp0 -68.02 7.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.543 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.536 ' CG ' ' O ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.88 -2.76 58.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.157 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.628 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.9 mt -126.34 80.19 69.36 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 48.6 Cg_exo -52.89 5.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.69 2.26 . . . . 0.0 112.164 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.628 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -61.67 -33.31 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.201 0.524 . . . . 0.0 110.075 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -96.94 -43.04 7.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -45.24 80.75 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.221 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.1 t90 -74.63 -12.9 60.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.792 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.9 t -142.63 72.67 20.19 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.59 -17.08 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.712 2.274 . . . . 0.0 111.8 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -54.96 -53.78 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.798 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.6 t -105.94 58.18 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.6 m-85 -162.85 -42.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 130.4 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.4 156.32 16.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' PRO . 67.3 m -160.99 99.93 1.23 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.66 179.89 17.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.34 150.29 23.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 110.235 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 68.4 m -101.43 129.07 47.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.821 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.56 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.21 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.66 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.859 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.486 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -100.58 132.84 45.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.536 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -130.28 -8.24 4.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.812 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.432 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 10.1 t-105 -173.91 132.41 0.42 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.86 160.32 39.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.93 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -117.87 139.04 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.078 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mt 49.66 17.05 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.56 20.64 40.09 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.7 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.03 139.19 54.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -70.24 146.4 50.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.149 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.37 -58.88 5.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.366 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.1 Cg_exo -37.21 -37.84 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -70.52 -45.19 66.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.111 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.6 m95 -66.95 -57.39 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.232 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 mt -43.49 -37.03 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.978 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 88' ' ' THR . 28.6 tp -63.57 -36.35 83.5 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -55.59 -39.68 75.9 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.3 mt -71.02 -44.27 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 110.463 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -47.69 -42.54 25.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.23 -46.29 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.801 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -56.66 -54.24 48.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.0 m-85 -57.2 -36.88 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.697 ' C ' HD23 ' A' ' 154' ' ' LEU . 6.1 tt -63.53 -29.79 71.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.89 -39.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 m -62.02 -38.82 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.827 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.579 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -72.24 -48.41 42.98 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.71 -37.08 74.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.73 -41.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 156' ' ' VAL . 75.5 t -72.0 -23.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 157' ' ' ALA . 15.0 t -76.05 -45.74 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.45 -21.49 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.0 m -61.93 -13.36 24.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.428 ' CB ' ' NH1' ' A' ' 70' ' ' ARG . 10.0 pt20 -52.37 148.44 12.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.294 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -38.22 -30.11 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.461 2.108 . . . . 0.0 112.019 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 164' ' ' GLN . 10.0 t80 42.56 -135.04 0.39 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.669 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 26.0 tttp 60.24 -131.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 167' ' ' LYS . . . 65.49 124.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.379 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 170' ' ' LYS . 45.8 mtpt -97.52 -25.4 15.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.837 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' LYS . 10.8 mtpp -48.37 -99.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 48.82 72.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 173' ' ' LEU . 3.7 p30 -74.72 122.78 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 172' ' ' ASP . 13.7 mt 57.57 142.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.796 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -172.6 103.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 94.95 136.1 8.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -80.82 160.45 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.638 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -101.26 -96.49 2.26 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 54.87 81.71 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.603 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -160.21 15.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 44.7 t-80 -78.7 -15.55 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.471 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.98 -158.92 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.419 ' O ' ' OXT' ' A' ' 183' ' ' HIS . 18.2 t60 -152.51 152.74 32.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.419 ' OXT' ' O ' ' A' ' 182' ' ' HIS . 63.9 t60 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.17 -40.09 82.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.422 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -57.59 -28.29 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -76.92 -43.29 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.544 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mt -50.58 -41.02 53.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.357 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -65.62 -27.57 68.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 110.064 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.44 -47.91 14.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.522 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.81 71.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.668 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.4 m -76.53 -39.69 52.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.62 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.542 HE22 ' C ' ' A' ' 65' ' ' PRO . 19.1 tp60 -66.85 5.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.481 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.75 141.97 15.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -68.11 -48.22 66.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.01 -45.36 6.02 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.62 76.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.108 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -54.62 -42.48 71.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.6 -26.95 65.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.995 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -70.16 -35.01 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.662 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.451 ' O ' ' OG1' ' A' ' 21' ' ' THR . 2.0 mtt -71.6 -32.93 68.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.35 45.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -52.31 -43.79 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.4 p -58.23 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.691 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.42 -39.04 31.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -42.03 69.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.839 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . . . -45.98 -42.27 12.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.709 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -71.12 -32.08 68.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 30' ' ' LEU . 3.4 tm-20 -70.68 -49.93 41.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.07 -57.72 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.578 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 24' ' ' ALA . 68.7 p -49.95 -30.34 10.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.622 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.93 -47.09 13.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -54.45 -14.22 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.42 -36.3 10.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.36 . . . . 0.0 110.515 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -42.1 79.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.437 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 40' ' ' PRO . 39.6 mt-30 -69.57 -46.08 67.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.17 -18.81 50.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -101.61 -43.92 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 mmt -89.96 8.45 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.767 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLN . 3.8 tp 44.87 45.74 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.646 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -80.05 154.43 28.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -127.53 83.84 64.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.361 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 75.5 Cg_exo -47.02 178.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 8.4 t -116.29 -175.83 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.384 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.1 p -64.52 -36.18 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.314 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.55 -47.53 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.543 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -53.61 -49.56 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.691 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.7 mt -65.8 -37.81 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.368 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -59.76 -48.36 81.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.16 -37.05 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -32.37 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.95 79.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.33 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -77.19 -52.1 9.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.07 -40.12 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.4 -44.71 89.83 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 t -61.21 -47.67 92.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.49 . . . . 0.0 109.758 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -44.62 -46.05 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.785 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.47 80.89 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.2 -40.71 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.358 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.04 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.367 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.03 -28.47 49.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.428 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.14 -39.35 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.493 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.99 -32.76 77.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.36 5.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 61' ' ' GLY . 76.7 mt -76.56 -36.8 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.94 72.06 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.499 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' C ' HE22 ' A' ' 10' ' ' GLN . 16.4 Cg_exo -64.36 16.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.879 2.386 . . . . 0.0 112.131 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 64' ' ' ALA . 2.0 tmtm? -109.37 -5.67 15.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.004 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.38 164.31 16.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.567 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -41.19 -12.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.6 mm? -44.84 -34.79 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.406 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.2 ptt180 -40.43 -68.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.736 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.453 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 27.4 t80 -54.0 -28.48 38.27 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 t -70.86 -52.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.697 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.08 63.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.269 0.557 . . . . 0.0 109.987 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 23.4 ttt -59.3 -10.42 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.047 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 72' ' ' VAL . 4.4 p -62.78 -36.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.428 0.632 . . . . 0.0 110.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 76' ' ' ILE . 35.7 mm -86.65 -32.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.754 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 8.3 t-105 -62.96 -52.64 62.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.935 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -46.33 88.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.609 ' CD2' ' NH1' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -47.05 -45.78 21.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.56 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.5 p -76.59 -25.94 54.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.669 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.0 -60.6 3.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.024 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -73.33 -54.24 8.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 79' ' ' TYR . 23.0 ttm105 -67.26 -47.49 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' THR . . . -54.68 -48.47 65.74 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.1 -50.89 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.438 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -48.34 -28.05 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -77.83 -39.25 44.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.448 HG21 ' HG ' ' A' ' 147' ' ' LEU . 80.6 p -54.13 -29.56 45.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.31 -48.75 69.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.342 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -54.95 -39.84 69.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.469 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -71.84 -56.79 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -53.16 -52.78 57.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' TYR . 61.7 mmm -49.41 -46.59 47.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.8 -45.37 78.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.359 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -57.84 -38.82 76.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.2 -12.12 28.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.702 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.0 t80 -137.96 65.78 45.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.93 124.39 11.28 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.733 2.289 . . . . 0.0 112.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.5 ' N ' ' CD ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -87.32 -48.85 0.47 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.639 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 99' ' ' SER . 97.4 Cg_endo -84.18 -170.44 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.656 2.237 . . . . 0.0 112.056 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -173.18 111.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . 63.15 7.42 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.721 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 20.4 m -166.24 121.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.55 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 p -136.96 168.37 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.503 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 29.5 m-20 -85.35 -160.3 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.582 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 51.4 m-85 -157.31 -160.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.503 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.553 ' C ' ' H ' ' A' ' 109' ' ' ARG . 17.9 mmt -142.62 -92.37 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.277 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t 66.97 -34.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.145 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 107' ' ' MET . 31.7 ttt85 -77.75 101.24 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.666 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.75 159.45 36.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.156 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.59 155.42 58.7 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.606 2.204 . . . . 0.0 111.815 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -103.61 -14.56 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -96.52 -4.57 41.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.932 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 mt -123.65 78.77 55.84 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.201 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.4 Cg_exo -51.87 -0.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.896 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -59.21 -33.21 70.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.106 0.479 . . . . 0.0 110.367 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -96.8 -42.08 8.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.636 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -70.12 -45.09 67.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.568 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.3 t90 -74.1 -16.13 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.04 71.32 48.44 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.21 -19.58 10.43 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.854 2.37 . . . . 0.0 111.77 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -52.46 -44.98 65.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.683 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 t -118.98 56.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.947 0.403 . . . . 0.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.523 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.3 t80 -160.35 -40.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.256 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.23 127.53 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.483 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.14 22.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 127' ' ' SER . 17.2 p -169.13 103.49 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.472 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.35 -175.43 21.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.3 140.87 29.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.799 0.333 . . . . 0.0 110.225 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.1 m -89.65 135.47 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.98 1.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 133' ' ' ARG . 2.4 tm-20 -67.11 145.27 55.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.493 ' N ' ' OE2' ' A' ' 132' ' ' GLU . 6.6 ptp180 -100.07 130.23 46.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -118.83 -25.17 6.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 140.74 52.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.98 119.46 11.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.218 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.18 133.83 51.44 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.17 17.51 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.349 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.93 58.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.26 145.11 50.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.2 mp0 -75.94 157.38 33.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.1 mtt -56.47 -50.93 84.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.911 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 142' ' ' MET . 88.1 Cg_exo -43.86 -38.03 9.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.357 2.038 . . . . 0.0 112.158 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -70.76 -52.67 19.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.06 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.6 m95 -58.62 -57.17 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.967 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.46 -37.77 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -60.3 -35.91 76.68 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.8 -44.9 95.6 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.14 -39.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.243 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -52.68 -47.84 66.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.903 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.12 -48.05 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.33 -46.59 66.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.703 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.453 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 6.1 m-85 -55.12 -40.54 70.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.294 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 158' ' ' VAL . 1.4 mt -65.85 -30.58 71.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.12 -29.5 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.622 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.3 t -69.8 -36.55 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.486 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -79.99 -35.99 36.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.202 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 154' ' ' LEU . 47.3 t -65.4 -38.93 83.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.101 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.79 -27.81 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.736 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 156' ' ' VAL . 41.3 t -78.31 -26.23 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.25 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 74' ' ' MET . 2.5 p -83.25 -41.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.438 ' N ' ' CG1' ' A' ' 161' ' ' VAL . 70.2 mt -74.22 -19.31 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.48 ' C ' HE21 ' A' ' 164' ' ' GLN . 74.9 p -85.14 0.22 52.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.72 HE21 ' N ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -87.04 -55.37 0.36 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.792 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' ' 166' ' ' PHE . 77.4 Cg_exo -42.84 -43.23 9.1 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 165' ' ' PRO . 22.0 t80 36.92 43.78 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.938 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -116.46 156.44 26.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.528 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -176.24 140.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.507 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -134.95 156.31 49.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -163.55 18.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.519 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -153.46 124.64 7.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -45.81 -66.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.2 mt -56.67 162.32 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 59.26 172.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.665 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 177.47 -104.97 0.19 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -56.92 -50.04 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.512 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.92 -160.66 13.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -156.24 -26.22 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.327 . . . . 0.0 110.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.7 m80 46.67 32.3 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 12.2 t-80 -73.71 8.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 32.7 m-70 -141.9 -178.04 5.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.374 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 182' ' ' HIS . 58.2 t-80 -84.78 11.47 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.554 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.2 t60 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.607 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 tp -49.87 -39.08 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.989 0.423 . . . . 0.0 110.018 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 3' ' ' ARG . 36.7 mtp180 -56.84 -28.1 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.299 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.34 -42.95 58.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.2 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 5' ' ' LEU . 4.1 mm? -51.51 -41.54 61.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.406 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 1.1 m-20 -66.37 -31.72 72.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -77.54 -49.51 14.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.9 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -76.65 -34.2 58.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -74.16 5.91 3.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.583 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.11 145.64 17.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -70.54 -21.15 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.614 0.245 . . . . 0.0 110.673 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 -45.14 67.09 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.93 75.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.83 0.348 . . . . 0.0 110.178 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -56.48 -41.63 76.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.328 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -69.16 -31.36 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.001 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.14 -28.84 66.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.558 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.82 -32.97 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.978 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.55 5.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -49.35 -48.43 46.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -51.76 -62.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.776 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -55.25 -31.69 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.2 tt -73.04 -41.72 63.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.505 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.13 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.77 -34.38 71.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.29 -42.6 71.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.755 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.98 -57.82 3.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.485 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 p -48.17 -31.86 6.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.72 -32.18 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.71 -17.31 62.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -94.41 -37.54 11.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.672 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -54.35 -45.97 72.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -74.56 -31.56 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.42 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.449 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -61.0 -32.16 71.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.576 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 36' ' ' MET . 19.9 m -103.23 -41.55 7.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 5.2 tpt -78.03 -0.61 28.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt 48.96 49.87 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.01 147.95 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.82 136.53 20.0 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.202 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.91 143.81 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.353 2.035 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -100.23 161.57 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 41.4 t -51.21 -51.58 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.409 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 4.1 mt -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.068 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 p -48.63 -43.03 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 124' ' ' PHE . 25.2 mt -63.27 -47.16 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.61 -46.54 80.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -40.25 96.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.554 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -63.66 -35.85 81.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.121 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.93 76.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.55 -46.96 85.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.62 -49.9 11.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -46.42 -41.36 13.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.04 88.65 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 54.1 t -62.94 -44.16 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.276 0.56 . . . . 0.0 109.681 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.3 -48.3 9.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.323 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.69 89.58 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -63.01 -37.69 88.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 110.304 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.29 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.316 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.42 -25.4 57.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.541 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -84.21 -40.77 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.2 -30.85 76.1 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.92 9.81 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.503 ' H ' ' C ' ' A' ' 61' ' ' GLY . 67.1 mt -79.79 -41.92 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.49 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.95 71.04 0.34 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.318 . . . . 0.0 110.385 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.43 13.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.959 2.44 . . . . 0.0 112.228 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 64' ' ' ALA . 19.5 pttp -113.09 -5.38 13.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.493 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.14 161.27 29.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.691 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.73 -12.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.325 2.017 . . . . 0.0 112.045 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -42.95 -35.55 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' LEU . 89.5 mtt180 -37.82 -65.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -51.46 -25.04 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.833 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.4 t -78.39 -52.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.78 -45.31 52.45 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.135 0.493 . . . . 0.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.49 -8.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.085 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.9 p -61.75 -34.59 63.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.596 0.712 . . . . 0.0 110.145 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.31 -31.82 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.594 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -65.65 -51.06 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.934 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.56 -43.87 83.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -46.24 -45.56 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.956 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -58.38 8.81 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.215 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.51 -53.85 9.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.354 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -67.87 -45.91 73.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.29 -47.91 78.89 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.7 t -68.78 -46.31 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.506 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.407 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 1.6 tm0? -54.43 -24.96 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 tp -87.25 -41.85 13.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.634 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 22.5 p -51.61 -25.74 7.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.381 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -71.31 -35.33 71.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.11 -33.85 75.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.26 -44.94 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -59.72 -52.6 64.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.518 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.646 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.7 ttt -54.34 -48.49 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.46 -37.96 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.805 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.52 -39.2 85.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.8 mm? -90.02 -5.56 56.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.7 t80 -130.48 77.46 75.9 Favored Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.161 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 97' ' ' TYR . 49.3 Cg_exo -53.04 -143.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.998 2.466 . . . . 0.0 112.56 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 98' ' ' PRO . 1.2 t 78.4 54.17 0.16 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.62 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 99' ' ' SER . 43.6 Cg_endo -70.1 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.698 2.266 . . . . 0.0 112.107 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 103' ' ' THR . 46.4 m-85 -39.91 -52.6 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.724 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.11 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 101' ' ' PHE . 19.2 p 54.71 58.32 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -70.46 166.18 20.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' SD ' ' A' ' 107' ' ' MET . 1.5 m-20 -76.77 120.71 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.501 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -44.84 107.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 107' ' ' MET . 1.1 mpt? -74.91 151.18 38.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.672 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t 57.38 92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -122.07 117.93 27.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.79 129.89 90.72 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.395 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 160.34 25.96 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.573 2.182 . . . . 0.0 111.789 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.26 -40.98 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.676 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -126.64 15.24 7.57 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.378 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.2 mt -120.52 80.25 30.33 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.707 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 11.3 Cg_exo -68.07 7.95 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.637 2.225 . . . . 0.0 111.386 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -76.51 -30.87 57.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 110.357 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.37 -41.11 8.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -67.58 -44.87 77.12 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.418 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.7 t90 -77.32 -13.11 60.0 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.519 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.54 74.28 71.3 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.87 -25.68 4.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.846 2.364 . . . . 0.0 111.872 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -52.43 -52.16 55.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.7 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.72 55.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.709 ' O ' HD13 ' A' ' 45' ' ' ILE . 38.1 t80 -158.93 -40.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 125' ' ' VAL . 12.1 p -54.99 128.81 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.67 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.37 148.9 21.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.1 p -155.91 128.66 7.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 106.11 -163.22 13.78 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -102.02 156.52 17.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.394 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 21.0 m -108.11 130.94 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.85 -7.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 158.03 32.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' CZ ' ' OD2' ' A' ' 136' ' ' ASP . 53.2 ttt180 -97.67 141.93 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.236 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -134.42 -31.66 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.69 146.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.707 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.476 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.0 p30 -143.24 161.1 39.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 111.993 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -114.44 136.39 53.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.773 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.22 16.77 0.28 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.99 19.7 33.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.194 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.416 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 35.2 mt -125.64 140.44 52.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.052 0.426 . . . . 0.0 110.254 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.21 148.03 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -48.7 -51.96 49.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.546 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 142' ' ' MET . 87.8 Cg_exo -44.23 -34.51 7.08 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.35 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -48.82 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.579 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.1 m95 -57.94 -57.98 10.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.879 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.0 mt -43.89 -38.74 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.589 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.2 tt -56.83 -37.3 71.03 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.31 -41.2 96.77 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 mt -76.61 -25.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.767 0.318 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.53 -46.16 80.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.36 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 pt -64.26 -41.54 92.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.288 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.34 -49.45 77.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.358 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.439 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 4.1 m-85 -59.77 -45.13 93.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.724 HD12 ' C ' ' A' ' 154' ' ' LEU . 0.4 OUTLIER -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.836 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.51 -32.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.565 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 34.1 t -67.66 -48.4 76.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.502 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -57.28 -53.63 55.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 154' ' ' LEU . 96.1 t -51.44 -49.2 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.8 t -73.4 -23.11 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.1 t -81.56 -50.83 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.918 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 164' ' ' GLN . 34.4 mm -68.66 -12.38 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.274 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.8 p -53.87 -10.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.388 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 162' ' ' ILE . 15.4 tp60 -152.22 84.05 4.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.383 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -84.57 34.64 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.878 2.385 . . . . 0.0 112.157 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.97 89.85 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -52.05 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.45 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . 64.01 -161.6 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.598 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 168' ' ' ALA . 63.7 mttm 53.39 104.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.599 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -62.97 -96.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -159.91 -149.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.589 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 13.8 t70 -131.41 -148.82 0.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.37 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.508 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 1.0 OUTLIER -160.75 107.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.35 113.77 2.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -155.33 36.53 0.64 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 47.58 -155.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.487 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 178' ' ' HIS . . . -157.68 -15.28 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.421 ' H ' ' H ' ' A' ' 177' ' ' GLY . 41.1 t60 -84.33 96.54 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.556 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -78.59 67.95 4.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.662 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 43.19 -165.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -70.81 -93.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.639 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 0.9 OUTLIER -160.13 -137.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.639 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 8.2 t60 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 2' ' ' LEU . 9.6 mp -58.59 -45.33 89.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.331 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -56.53 -37.36 70.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.561 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.99 -45.46 88.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.16 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -50.22 -41.27 49.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.071 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 6' ' ' ASN . 1.7 m120 -68.75 -26.75 65.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.898 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.4 -50.48 15.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.448 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.63 69.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -76.47 -37.69 56.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.661 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -73.68 8.83 1.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.83 141.11 15.17 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 13' ' ' GLY . 3.8 ptp85 -68.49 -49.7 57.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.656 0.265 . . . . 0.0 110.713 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 12' ' ' ARG . . . -43.05 -45.77 6.16 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.12 87.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -60.49 -44.52 95.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.152 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.12 -30.14 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 21' ' ' THR . 20.9 tp -69.8 -28.06 65.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.633 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.459 ' O ' ' OG1' ' A' ' 21' ' ' THR . 20.1 mmt -74.5 -33.64 62.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.52 -54.67 15.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.564 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.22 -49.25 53.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.703 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 18' ' ' MET . 20.3 p -48.7 -57.08 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.13 -39.5 28.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.647 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.55 -41.47 69.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' THR . . . -47.14 -36.41 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.544 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.85 -36.32 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.23 -53.54 42.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.818 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -62.41 -57.97 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.833 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.9 p -46.96 -29.24 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.732 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -45.41 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.8 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -52.27 -15.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.8 t90 -93.32 -34.7 13.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.483 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.98 -42.38 80.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -69.02 -47.68 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.01 -9.05 13.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.498 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' TRP . 55.7 t -107.17 -41.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.6 mmt -96.39 10.12 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 tp 48.47 45.33 20.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.6 mt -79.54 146.65 32.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.352 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -107.61 131.22 21.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.444 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 165.22 28.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.137 1.892 . . . . 0.0 111.761 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -127.96 -175.22 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.512 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.1 mm? -69.88 -49.93 47.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.612 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.2 p -49.68 -51.14 40.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.488 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.55 -40.49 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -59.48 -43.15 93.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.787 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -59.02 -44.41 91.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.432 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -58.97 -29.63 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.25 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.51 72.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.316 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 54' ' ' VAL . . . -62.7 -52.3 63.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -54.82 9.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.035 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -48.65 -32.11 7.79 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.814 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.31 -46.29 72.31 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.945 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -70.73 -31.24 45.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.366 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.03 -46.47 75.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.284 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.71 86.41 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.01 95.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.78 -0.71 . . . . 0.0 110.557 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -29.54 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.503 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.5 tp -74.25 -32.03 62.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.57 -33.81 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.558 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -78.08 -30.13 51.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.57 5.25 1.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 0.0 110.317 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.4 mt -89.12 -23.97 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.607 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.02 70.09 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.794 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.45 26.6 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.702 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -109.2 -7.19 15.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.395 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.88 173.73 2.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.13 -8.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.22 1.947 . . . . 0.0 111.852 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -42.27 -38.74 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.4 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 10.4 mtp180 -40.04 -70.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.606 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -51.6 -18.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.092 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 69' ' ' LEU . 4.0 t -83.16 -46.6 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.61 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -40.04 68.41 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -58.81 -8.84 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.353 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.84 -43.97 81.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.396 0.617 . . . . 0.0 110.145 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.49 -33.36 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.4 t-105 -60.19 -55.9 28.21 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.801 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.54 -48.2 82.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -45.17 -43.95 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.6 p -79.84 -24.54 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.577 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.05 -61.24 2.75 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.69 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.42 -55.94 5.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -65.97 -51.5 57.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.68 -47.31 58.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 81' ' ' ALA . 91.1 t -68.86 -47.5 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -53.17 -30.23 36.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -42.61 63.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.4 p -54.61 -28.59 47.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.969 0.414 . . . . 0.0 110.237 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -63.34 -46.1 88.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -61.86 -40.17 94.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.718 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -70.81 -45.88 63.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.773 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.5 p -64.61 -47.69 77.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.727 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 97' ' ' TYR . 28.6 ttt -56.24 -51.35 68.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -59.57 -50.98 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.329 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -51.91 -37.78 53.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.388 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.515 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -91.71 -15.69 28.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.315 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 93' ' ' MET . 84.9 t80 -140.04 74.85 30.43 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -47.21 117.09 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.828 2.352 . . . . 0.0 112.297 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 101' ' ' PHE . 42.0 t -137.95 66.14 46.54 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.463 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -44.23 87.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.862 2.375 . . . . 0.0 112.252 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 99' ' ' SER . 37.0 p90 -82.3 -11.95 58.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.59 75.12 0.84 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.236 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.1 p -42.57 138.1 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 p 47.24 -151.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t0 63.74 28.32 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.685 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -48.7 -40.53 28.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.7 ptm -55.75 143.64 30.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.94 130.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.56 100.04 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.318 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -62.53 150.15 86.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.34 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.67 153.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.34 2.027 . . . . 0.0 112.062 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.61 -2.57 47.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.535 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.44 5.75 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.622 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.599 ' C ' ' H ' ' A' ' 116' ' ' LEU . 77.9 mt -117.37 83.48 16.48 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -54.14 7.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.583 2.188 . . . . 0.0 112.428 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 116' ' ' LEU . 8.2 mp -74.88 -28.43 60.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.693 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -95.8 -40.8 9.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -65.65 -33.69 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -88.63 -20.73 24.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.184 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.51 69.03 12.39 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.82 -18.06 52.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.712 2.274 . . . . 0.0 111.538 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.59 -3.81 42.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.179 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 123' ' ' VAL . 48.3 t -131.76 36.13 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.102 0.477 . . . . 0.0 110.741 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 15.9 m-85 -161.33 -43.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.72 129.8 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.066 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.09 152.83 18.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.5 t -160.68 99.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.05 -174.11 22.31 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 13.2 m-20 -88.0 157.34 18.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 2.6 m -107.86 127.63 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.05 -4.25 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.131 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -67.58 128.84 37.95 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.791 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.789 ' H ' ' NE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -74.08 142.63 45.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.472 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -131.96 -26.81 1.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.792 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -173.0 147.82 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 20.0 p-10 -142.98 167.57 21.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 112.112 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -134.75 138.15 44.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.844 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.68 17.32 3.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.457 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 83.41 21.02 59.22 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 139' ' ' GLY . 7.0 mp -120.87 131.52 54.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.3 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -68.99 150.58 47.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.6 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.67 -54.4 23.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.082 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.97 -36.47 11.27 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.246 1.964 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.95 -46.04 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.0 m95 -65.31 -56.98 9.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.873 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -42.99 -37.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.15 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.36 -34.06 77.42 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.97 -40.68 91.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.79 -40.53 76.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.683 0.277 . . . . 0.0 110.279 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.37 -40.63 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.99 -46.62 93.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.75 -51.16 66.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.405 ' CD2' ' CZ2' ' A' ' 77' ' ' TRP . 4.6 m-85 -66.76 -43.69 83.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.6 tt -49.11 -30.76 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.313 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.69 -37.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.938 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 160' ' ' VAL . 87.0 t -51.64 -37.45 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.587 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -79.91 -44.36 20.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.935 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 154' ' ' LEU . 67.0 t -52.07 -44.48 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.215 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tp -81.3 -36.43 29.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.792 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.9 t -69.94 -31.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.259 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.7 -49.29 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.107 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.3 mp -62.78 -19.34 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m -52.72 -6.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 162' ' ' ILE . 1.9 mm100 -124.86 76.29 65.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.08 21.41 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.591 2.194 . . . . 0.0 112.132 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 55.6 165.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.531 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -173.23 -56.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.406 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.78 112.67 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.416 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.16 17.29 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.476 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -92.93 21.57 5.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.549 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -80.58 -67.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.525 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 172' ' ' ASP . 1.2 p30 -151.87 88.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 173' ' ' LEU . 0.1 OUTLIER -71.16 131.51 43.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.364 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -165.43 -41.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 45.79 -163.65 0.1 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -125.52 132.21 52.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.42 76.61 0.22 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -171.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.737 0.303 . . . . 0.0 110.537 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.4 -179.18 7.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.603 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.601 ' CG ' ' H ' ' A' ' 181' ' ' HIS . 76.5 t60 -160.81 175.45 12.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 180' ' ' HIS . 4.3 t-80 67.38 -72.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.448 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 10.7 t-80 39.19 -130.37 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.7 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.57 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 43.8 t60 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.65 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.13 -45.35 83.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -51.62 -43.41 62.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.44 -39.87 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 159' ' ' LEU . 1.4 tt -53.43 -44.8 69.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.75 -31.81 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -75.22 -48.57 22.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -64.75 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.654 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.7 p -76.16 -32.03 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 4.4 tt0 -74.24 9.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.965 0.412 . . . . 0.0 110.319 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.82 151.8 17.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 16' ' ' LEU . 57.9 mtm180 -69.05 -20.24 64.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.74 -44.09 64.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.24 -51.39 61.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.533 0.206 . . . . 0.0 110.991 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -54.85 -51.08 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 12' ' ' ARG . 7.0 mp -59.76 -27.61 66.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -70.46 -26.09 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.09 -34.85 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.67 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.725 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 27.0 t80 -52.9 -53.41 49.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.715 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.4 p -43.74 -53.4 5.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.442 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -26.58 66.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -79.92 -42.24 24.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.42 -36.24 61.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.756 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.38 -38.95 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.14 -45.75 79.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -57.79 5.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.572 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 24' ' ' ALA . 28.1 p -46.76 -31.67 3.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.477 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.67 -44.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 tp -51.06 -17.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.654 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' VAL . 31.4 t90 -91.44 -35.83 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 1.7 m-85 -56.47 -36.99 69.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.349 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.95 -39.71 23.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.53 -22.4 61.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -109.03 -44.01 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 35' ' ' VAL . 5.4 ttt -83.98 6.47 21.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.6 mt 40.57 42.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.729 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.71 154.11 39.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.339 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -123.61 115.54 28.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.5 Cg_endo -78.29 179.95 6.02 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.274 1.983 . . . . 0.0 112.283 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 2.2 t -119.61 -175.73 3.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -65.12 -39.68 86.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.297 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.584 HD11 ' CG ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -65.21 -50.12 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.257 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.2 m -49.74 -48.21 50.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.703 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.95 -42.97 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.36 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -56.74 -45.89 81.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.053 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.17 -42.37 98.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.3 ttp85 -62.44 -34.83 77.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.45 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.137 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.59 -47.29 82.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -76.99 -47.95 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -46.9 -44.31 19.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.087 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.08 93.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 27.6 t -61.42 -47.33 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.154 0.502 . . . . 0.0 110.0 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.507 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.3 tt -46.46 -45.38 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.63 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.56 74.11 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -65.04 -30.67 71.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.908 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.25 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.223 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.0 -43.1 99.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 mm -79.22 -35.97 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.45 -33.41 81.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 9.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 91.9 mt -83.35 -35.06 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.723 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.22 76.45 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.712 0.291 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.78 20.7 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.579 2.186 . . . . 0.0 112.062 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -109.61 -7.28 15.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.158 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.09 162.86 18.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.6 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -38.69 -16.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.512 2.141 . . . . 0.0 112.256 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 67' ' ' THR . 38.9 mt -44.05 -31.18 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 69' ' ' LEU . 61.0 mtt180 -38.13 -65.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.39 -33.15 52.62 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.416 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.9 t -66.36 -57.75 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.496 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.35 82.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.307 0.575 . . . . 0.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -14.94 45.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.262 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 72' ' ' VAL . 1.9 p -60.25 -32.64 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.499 0.666 . . . . 0.0 110.198 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -89.34 -32.97 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.927 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.4 t-105 -67.16 -49.58 64.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.874 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 78' ' ' LEU . 4.4 tt -63.9 -51.84 62.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.924 0.393 . . . . 0.0 110.158 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -40.96 -43.21 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.36 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 p -78.89 -21.5 47.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.53 -61.22 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.816 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.61 -53.56 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.38 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -68.1 -39.24 82.89 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . . . -66.44 -44.79 89.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.43 -38.47 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.563 0.22 . . . . 0.0 111.453 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -66.46 -43.91 84.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.278 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.17 -45.91 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.9 p -46.94 -50.28 19.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.502 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -53.05 -30.68 37.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.506 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.45 -39.96 89.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.584 ' CG ' HD11 ' A' ' 43' ' ' LEU . 2.8 m170 -64.75 -43.62 92.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.189 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -65.19 -38.87 91.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' TYR . 37.6 ttp -52.06 -45.02 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.4 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.302 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -55.9 -41.24 74.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.433 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 tp -89.09 -18.24 27.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.8 t80 -142.35 75.9 19.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.94 0.4 . . . . 0.0 110.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 97' ' ' TYR . 52.0 Cg_exo -51.41 -167.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.722 2.281 . . . . 0.0 112.173 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -139.25 168.1 16.61 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.356 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 99' ' ' SER . 77.4 Cg_exo -44.85 175.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.628 2.218 . . . . 0.0 112.291 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -126.69 121.41 32.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.433 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -161.19 49.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.8 p 45.73 33.16 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.553 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 m -75.9 78.59 2.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -76.55 118.37 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.419 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' A' ' 107' ' ' MET . 29.2 t80 -62.34 -56.38 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 106' ' ' PHE . 12.8 ttp 59.65 123.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.561 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 108' ' ' VAL . 8.4 p -48.06 120.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -150.9 99.73 2.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.469 ' O ' ' OE1' ' A' ' 112' ' ' GLU . 1.6 m-85 -132.4 156.64 79.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.023 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -37.68 150.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.801 2.334 . . . . 0.0 112.433 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.469 ' OE1' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -107.08 7.98 30.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.468 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.544 ' HE1' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.8 -3.21 58.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.662 ' C ' ' H ' ' A' ' 116' ' ' LEU . 20.7 mt -118.76 88.11 34.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.917 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.6 Cg_exo -53.76 11.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.153 . . . . 0.0 112.261 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.662 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -71.4 -30.12 65.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 109.868 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.444 ' CG ' ' CE1' ' A' ' 124' ' ' PHE . 74.5 m-20 -97.29 -40.79 8.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -72.36 -45.77 58.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.821 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.8 t90 -72.91 -12.84 61.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.77 74.01 39.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.563 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.55 -20.69 10.63 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.756 2.304 . . . . 0.0 112.038 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.22 -53.11 55.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.23 55.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.017 0.437 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.444 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 37.2 t80 -158.78 -42.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.22 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 125' ' ' VAL . 12.4 p -58.02 128.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.584 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.43 160.61 14.2 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' PRO . 43.2 p -173.8 103.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.562 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.66 177.29 18.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -81.61 140.11 34.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.183 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 57.2 m -87.93 132.83 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.947 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.97 2.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.223 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -67.54 144.76 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -93.74 125.3 38.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 110.797 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.56 -23.26 6.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.764 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.45 138.95 47.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.841 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -141.7 119.68 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -123.04 132.99 54.35 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.29 17.31 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.65 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.88 17.54 56.16 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.633 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.2 mp -123.49 144.08 49.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.0 mp0 -77.72 157.82 29.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.646 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.6 OUTLIER -51.12 -53.58 47.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.8 Cg_exo -40.54 -38.86 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.375 2.05 . . . . 0.0 112.304 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.447 HE21 ' CD ' ' A' ' 141' ' ' GLU . 58.2 mt-30 -69.8 -54.19 14.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.508 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.607 ' O ' ' N ' ' A' ' 148' ' ' GLY . 82.1 m95 -62.81 -57.79 9.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.463 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 tt -42.92 -36.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.509 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.77 -33.02 74.91 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.86 -44.99 96.57 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.724 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -76.04 -25.88 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 154' ' ' LEU . 32.5 t80 -62.63 -44.85 95.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.486 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.655 ' O ' HD13 ' A' ' 155' ' ' ILE . 20.4 pt -69.4 -36.65 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.358 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.91 71.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.97 -49.43 66.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.793 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.541 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 19.3 mt -62.65 -31.94 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.3 mp -72.68 -32.47 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -70.63 -46.01 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -55.09 -48.56 73.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.77 -24.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 5' ' ' LEU . 9.8 tp -78.01 -41.54 35.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.251 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.4 -20.38 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 157' ' ' ALA . 39.7 t -81.19 -50.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.81 -21.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.446 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 164' ' ' GLN . 44.3 m -52.86 -44.42 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.284 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.538 ' C ' ' H ' ' A' ' 166' ' ' PHE . 37.9 mt-30 55.52 151.5 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.62 17.89 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.313 2.008 . . . . 0.0 111.862 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.538 ' H ' ' C ' ' A' ' 164' ' ' GLN . 74.8 t80 -94.89 138.53 32.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.538 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.472 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -109.6 -177.14 3.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -178.06 -91.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.363 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.21 158.41 31.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.407 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -134.77 -111.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.506 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -130.03 139.93 50.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 173' ' ' LEU . 42.4 t0 -158.99 -100.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.583 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 172' ' ' ASP . 14.1 mt 54.51 108.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.492 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -150.75 135.52 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.17 157.41 23.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -160.74 -34.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.07 131.07 4.96 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 178' ' ' HIS . 26.8 p-80 -152.61 83.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.512 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -151.64 161.96 41.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -93.24 158.75 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 53.74 91.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -140.2 121.38 14.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 20.2 m170 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.537 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 2.1 pp -64.25 -37.85 88.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.335 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -53.2 -32.47 48.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.586 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 91.9 t80 -76.86 -42.61 39.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -46.59 -45.1 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.545 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 4.3 p-10 -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 8.5 tt0 -78.41 -48.28 15.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.499 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.16 96.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 11' ' ' GLY . 14.7 m -76.69 -36.11 57.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 13.9 tt0 -64.45 2.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.287 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.66 150.69 19.54 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.2 mtt85 -70.48 -45.53 65.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.465 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.11 -45.26 15.01 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.37 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -60.93 -48.44 81.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -57.64 -31.22 66.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.081 0.467 . . . . 0.0 109.781 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.49 -25.71 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.791 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.3 mmt -74.34 -34.17 63.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.22 -54.29 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.861 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.04 -47.92 61.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.752 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 p -52.54 -50.22 63.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.29 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.734 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.29 -39.17 82.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.04 -36.78 60.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.78 -35.6 62.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' OE1' ' NH2' ' A' ' 48' ' ' ARG . 3.8 tp10 -68.73 -46.89 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.927 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 27' ' ' LEU . 2.3 tt -65.71 -58.16 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 p -48.91 -32.35 8.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.637 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.62 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.6 mt -53.37 -13.56 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -95.1 -31.89 13.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.69 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.13 -34.36 77.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.73 -43.17 23.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -18.63 53.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.81 -48.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.647 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 tpt -83.33 6.49 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 41.69 41.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.44 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 39' ' ' LYS . 5.8 tt -62.83 151.85 37.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.117 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -113.47 90.61 17.88 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.241 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.62 146.39 34.58 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.554 2.169 . . . . 0.0 112.337 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.9 t -99.83 173.25 6.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.09 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 10.0 p -61.04 -41.4 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.8 mp -68.11 -47.79 67.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.272 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 m -50.2 -48.95 53.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.703 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.47 -44.24 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.49 -45.7 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.07 -39.8 93.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.679 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' NH2' ' OE1' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -61.11 -34.43 74.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.289 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 -39.04 88.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.568 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.5 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.1 -51.45 15.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -45.33 -43.19 10.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.053 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.9 96.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' ALA . 66.2 t -57.72 -46.47 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.26 0.553 . . . . 0.0 110.172 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.1 tp -48.48 -43.25 34.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.698 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.99 71.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.72 -35.15 60.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.566 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.93 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.75 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.45 ' O ' HD11 ' A' ' 63' ' ' ILE . 12.0 mt -75.42 -40.86 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.789 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -78.63 -31.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.23 -31.82 33.34 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.32 0.88 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.709 0.29 . . . . 0.0 110.885 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 59' ' ' LEU . 7.8 mm -88.45 -24.08 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.98 65.6 0.3 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.808 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.55 18.7 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.736 2.291 . . . . 0.0 111.625 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -106.54 -10.24 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.627 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -109.77 176.48 1.53 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.819 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.06 1.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.234 1.956 . . . . 0.0 111.796 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 67' ' ' THR . 12.2 tp -58.35 -31.27 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -39.86 -64.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.757 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 75' ' ' VAL . 23.7 t80 -53.19 -33.56 53.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.57 -46.56 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.85 -40.43 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.214 0.531 . . . . 0.0 109.925 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.8 mmt -59.89 -25.99 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.367 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.1 t -52.28 -29.08 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.488 0.661 . . . . 0.0 109.712 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.11 -31.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.091 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.469 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.8 t-105 -63.91 -46.26 85.6 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 78' ' ' LEU . 3.9 tt -67.77 -52.46 37.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -41.75 -41.55 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.297 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 p -81.39 -24.49 36.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.65 -59.04 6.08 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.989 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -74.89 -51.4 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.204 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.38 -46.09 77.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.78 -47.36 90.8 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.4 t -68.6 -56.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.217 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -49.87 -21.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.818 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.77 -35.91 14.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.033 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.9 p -59.05 -55.18 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.03 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.531 ' CZ ' ' SD ' ' A' ' 93' ' ' MET . 87.6 t80 -52.23 -38.61 58.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -57.14 -40.14 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -35.04 79.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.4 p -72.92 -36.54 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' TYR . 58.8 mmm -54.02 -49.06 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -60.52 -49.93 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.422 ' C ' HD12 ' A' ' 96' ' ' LEU . 29.6 mt-30 -50.23 -36.46 31.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 96' ' ' LEU . 11.1 mp -102.06 -9.77 20.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.641 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 93' ' ' MET . 25.5 t80 -125.59 75.75 69.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.42 89.03 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -141.2 153.6 66.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -38.45 99.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.5 44.09 2.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -37.6 102.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.4 p -56.31 149.78 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.7 p -85.14 -87.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.78 61.29 0.76 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.588 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.47 69.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.488 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.634 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -166.98 95.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.158 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.7 -15.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.634 ' H ' ' C ' ' A' ' 107' ' ' MET . 14.0 ttp180 -95.41 106.55 18.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.395 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 157.43 76.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.348 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -36.76 125.76 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.851 2.367 . . . . 0.0 112.264 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -86.9 -11.02 51.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -2.24 56.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 116' ' ' LEU . 41.5 mt -120.11 87.12 38.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.6 Cg_exo -51.78 4.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.64 2.227 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 114' ' ' LEU . 13.8 mt -64.07 -30.23 71.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.1 -43.05 7.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.6 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -71.53 -44.96 63.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.437 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.3 t90 -74.64 -15.98 60.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.71 71.15 64.94 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.2 -22.87 10.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 111.919 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.1 -53.98 48.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.25 63.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.547 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -169.28 -42.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.81 131.05 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.67 156.45 16.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.59 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 85.2 p -166.76 100.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.4 -167.3 25.03 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -100.27 166.88 10.76 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -112.23 130.1 56.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 96.74 6.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.028 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.28 139.33 46.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -100.14 126.38 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.661 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.2 -14.4 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.6 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -173.38 132.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -143.25 161.29 38.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.258 0.551 . . . . 0.0 112.077 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 23.6 t80 -123.22 138.98 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.158 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 1.1 mm? 54.26 17.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.164 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.19 57.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 9.5 mt -124.41 136.64 54.21 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.02 148.32 50.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.424 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mtp -49.12 -52.01 51.54 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 142' ' ' MET . 71.1 Cg_exo -45.6 -38.12 16.24 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.41 2.073 . . . . 0.0 112.321 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -68.92 -46.18 68.94 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 148' ' ' GLY . 62.1 m95 -62.75 -56.15 20.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.211 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mt -43.12 -37.94 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.943 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -63.91 -35.22 79.94 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.92 -36.82 75.07 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.02 -33.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.75 -44.35 90.52 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.034 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.56 -49.24 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.022 0.439 . . . . 0.0 109.843 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.37 57.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.066 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -61.16 -49.83 75.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.332 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 154' ' ' LEU . 8.1 tt -47.53 -32.23 5.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.442 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.27 -38.11 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.14 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.3 t -54.39 -39.88 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.34 -45.55 25.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.313 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 34.7 t -52.27 -42.53 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.202 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mt -84.12 -41.41 17.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.433 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 156' ' ' VAL . 44.5 t -61.87 -25.37 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.756 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' ALA . 64.7 t -83.08 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 109.969 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 162' ' ' ILE . 80.6 mt -65.0 -8.59 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.312 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 60.2 p -53.9 -10.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.821 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.548 ' C ' ' H ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -135.48 75.17 58.45 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.647 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.96 20.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.857 2.371 . . . . 0.0 112.097 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.548 ' H ' ' C ' ' A' ' 164' ' ' GLN . 42.5 t80 -64.43 163.01 14.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.45 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.5 tttt 59.03 49.51 9.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.447 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -178.64 134.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.615 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.0 159.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -73.15 -136.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.38 -174.81 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.534 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -157.6 146.02 19.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER 51.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -175.2 115.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.536 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -177.44 -35.72 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -142.73 136.26 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.844 0.354 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 179' ' ' HIS . . . 161.75 -85.91 0.11 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 179' ' ' HIS . 0.8 OUTLIER 63.4 -6.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.71 0.29 . . . . 0.0 110.767 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 177' ' ' GLY . 29.1 m80 -158.76 80.14 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.524 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 180' ' ' HIS . 0.0 OUTLIER -162.73 83.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.582 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 86.0 t60 -69.98 -107.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.564 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.582 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 91.7 m-70 56.54 86.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.559 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.598 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 2' ' ' LEU . 6.7 mp -66.4 -38.54 87.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.192 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -50.48 -36.1 32.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' GLN . 44.6 m-85 -75.47 -40.23 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.323 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.9 tp -45.06 -40.48 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -70.16 -21.75 63.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.404 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' PHE . 40.7 tt0 -79.93 -47.0 15.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.92 -31.72 73.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.95 0.405 . . . . 0.0 110.314 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 28.9 m -76.03 -41.47 50.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.21 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.428 ' CD ' ' O ' ' A' ' 10' ' ' GLN . 1.6 pp0? -70.4 8.93 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.558 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.76 142.43 16.08 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -65.76 -20.64 66.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.659 0.266 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.82 -47.57 54.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.36 -51.61 68.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 0.0 110.469 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -55.78 -46.36 77.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.517 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.63 -31.73 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -69.39 -28.11 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -74.89 -33.91 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.796 0.331 . . . . 0.0 110.138 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.49 43.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 71.4 t80 -54.33 -53.44 53.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.73 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.1 p -43.12 -49.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.678 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.74 -34.49 69.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.3 tt -76.98 -38.72 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.639 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.25 42.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -75.85 -31.45 59.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.571 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -49.89 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.4 tt -63.96 -57.55 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.599 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -45.19 -34.82 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' C ' ' N ' ' A' ' 31' ' ' TRP . . . -82.96 -46.44 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.97 -16.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.531 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.402 ' N ' ' C ' ' A' ' 29' ' ' ALA . 44.1 t90 -94.19 -25.98 16.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 135' ' ' TRP . 0.2 OUTLIER -70.26 -43.15 71.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.519 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' LEU . 34.8 tt0 -73.74 -48.04 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.613 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -49.99 -28.63 7.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.714 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.12 -45.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.696 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 2.07 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.506 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLN . 16.2 mt 43.15 43.64 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.4 149.66 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.395 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -115.37 88.31 18.59 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.79 174.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 112.008 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.59 -172.58 2.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.39 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 43' ' ' LEU . 10.7 m -64.44 -42.94 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' N ' HG23 ' A' ' 42' ' ' VAL . 7.6 mt -64.94 -49.09 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.304 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -59.1 -50.54 73.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.17 -47.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.11 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' OH ' ' CE1' ' A' ' 110' ' ' PHE . 3.7 m-85 -57.76 -44.18 85.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 109.971 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -61.7 -38.52 88.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.464 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -60.96 -33.49 73.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 -34.64 76.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.225 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.6 77.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.326 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.8 tt -72.9 -55.36 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.906 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -42.51 -38.41 1.93 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.35 -41.32 94.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -61.7 -47.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.38 -46.12 18.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.505 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.6 -27.64 70.08 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.71 -31.12 70.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 110.293 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.65 -30.99 59.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.329 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.21 -37.92 72.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.334 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.84 -36.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.34 -26.39 63.79 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.79 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -83.14 -28.71 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.667 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.61 77.07 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.86 22.2 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.6 2.2 . . . . 0.0 112.129 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -113.29 -7.56 13.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -109.87 161.67 23.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.677 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.62 -15.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.482 2.121 . . . . 0.0 112.091 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.7 mp -44.64 -29.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttp180 -40.67 -67.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.577 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.745 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.9 t80 -56.03 -28.7 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 t -69.11 -45.72 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.34 -34.58 36.51 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.302 0.573 . . . . 0.0 110.244 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 74' ' ' MET . 7.0 tmm? -61.72 -13.55 24.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.276 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 71' ' ' TYR . 75.0 t -57.97 -36.82 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 110.257 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 mm -88.05 -31.97 5.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.177 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.501 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.0 t-105 -64.11 -52.81 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -65.2 -47.29 77.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.681 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -44.27 -43.69 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 p -79.97 -22.77 42.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.654 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.08 -60.99 2.95 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.07 -53.2 9.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.209 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -66.4 -46.27 77.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.64 -46.85 91.68 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' ALA . 87.6 t -67.73 -44.93 85.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -58.07 -27.21 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 tp -81.29 -44.06 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.415 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 17.2 p -52.8 -25.47 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 0.0 110.168 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -48.49 53.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.6 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -51.93 -38.33 56.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -65.57 -46.77 78.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.2 p -65.37 -47.06 77.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' TYR . 27.2 mmm -44.74 -47.67 10.78 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.5 -50.17 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.628 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.7 -29.62 7.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.39 -15.5 17.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.384 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 m-85 -128.81 75.48 79.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.212 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -48.35 175.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.697 2.265 . . . . 0.0 112.181 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -170.7 67.73 0.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.437 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.58 154.5 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.761 2.307 . . . . 0.0 112.124 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.59 166.27 33.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.58 -25.7 54.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.633 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.439 HG23 ' CZ ' ' A' ' 106' ' ' PHE . 10.6 t -130.55 143.75 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.566 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 106' ' ' PHE . 78.1 p -92.63 -75.64 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -48.0 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 104' ' ' SER . 6.2 m-85 -91.62 77.71 5.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.374 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ttt -62.73 140.34 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.284 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.59 161.8 34.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.694 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -130.62 99.75 5.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.507 ' CE1' ' OH ' ' A' ' 46' ' ' TYR . 1.7 m-85 -79.43 158.81 73.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.146 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 110' ' ' PHE . 82.8 Cg_exo -35.6 158.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.685 2.257 . . . . 0.0 112.157 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 8.8 mp0 -105.81 15.31 26.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.558 ' O ' ' CE3' ' A' ' 113' ' ' TRP . 2.2 p-90 -87.52 -1.28 57.83 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.315 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.0 79.78 50.97 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.388 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.5 Cg_exo -49.5 -1.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.619 2.213 . . . . 0.0 112.298 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -57.84 -33.1 68.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.479 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 46.3 m-20 -96.3 -43.64 7.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.3 -45.17 77.34 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.413 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 34.1 t-105 -73.93 -16.81 61.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.912 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 123' ' ' VAL . 2.4 t -147.8 68.69 10.83 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.78 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.72 -11.72 26.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.871 2.381 . . . . 0.0 111.649 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -71.67 -6.4 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.205 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 120' ' ' VAL . 17.4 m -138.57 35.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.479 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 72.7 t80 -153.29 -39.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.351 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.56 128.25 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.93 155.76 16.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -166.29 108.14 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.706 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 133.52 177.83 15.19 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.1 138.04 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 26.9 m -89.95 132.4 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.04 -4.14 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.97 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.19 129.11 38.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.174 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -85.0 117.44 23.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -122.32 -3.82 8.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.52 ' NE1' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 t90 -172.78 129.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -145.52 158.54 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.293 0.568 . . . . 0.0 112.019 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -122.98 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.632 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 55.38 17.28 2.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.53 53.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mt -123.91 134.28 53.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.698 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 7.0 pm0 -71.06 149.6 46.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 145' ' ' TRP . 8.2 mtt -45.83 -62.16 1.99 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.1 Cg_exo -34.57 -37.66 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -41.15 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.625 ' O ' ' N ' ' A' ' 148' ' ' GLY . 70.5 m95 -67.06 -58.26 5.26 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.758 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.0 mt -43.98 -38.22 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -34.49 75.76 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -62.68 -48.93 77.63 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.53 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.08 -35.09 73.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -38.86 72.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.846 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.17 -40.04 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.019 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.42 73.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.149 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.0 -41.39 97.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.339 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.0 tt -52.24 -33.25 40.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.9 mt -82.71 -38.72 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.659 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 160' ' ' VAL . 64.8 t -52.92 -40.53 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.71 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.501 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -78.07 -46.89 19.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 154' ' ' LEU . 70.5 t -52.71 -50.17 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.982 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.26 -33.99 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.023 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 156' ' ' VAL . 48.0 t -75.74 -26.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.9 t -68.87 -45.28 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -71.87 -25.74 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.8 p -54.83 -7.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.704 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 162' ' ' ILE . 5.4 pt20 -43.56 148.98 0.64 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.437 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.436 2.091 . . . . 0.0 112.044 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -66.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.477 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -139.91 126.72 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -165.91 -149.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.459 ' CB ' ' NZ ' ' A' ' 169' ' ' LYS . 6.1 mtpm? 55.74 164.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -172.48 167.92 5.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.519 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -45.21 118.65 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -163.87 71.15 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.71 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.0 mt -145.96 -16.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.372 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 174' ' ' PHE . 38.7 p90 -73.12 129.77 38.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.706 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 177' ' ' GLY . . . -126.93 54.2 0.77 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 64.52 -68.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.833 0.349 . . . . 0.0 110.423 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 175' ' ' GLY . . . 71.37 -115.49 5.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -52.04 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.585 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.495 ' ND1' ' N ' ' A' ' 180' ' ' HIS . 1.2 p80 -167.25 -149.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 179' ' ' HIS . 77.1 m80 -79.32 119.18 22.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.92 115.54 22.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.328 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -49.5 106.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.573 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 tpt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.62 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.4 tt -54.2 -36.32 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -31.86 68.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.3 -45.07 67.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.111 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 5' ' ' LEU . 4.4 mm? -50.08 -37.59 34.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.996 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -66.89 -28.79 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.183 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -80.22 -49.43 11.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.702 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.23 -32.59 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.9 p -76.86 -38.69 53.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.504 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.503 HE22 ' HZ2' ' A' ' 66' ' ' LYS . 36.5 mt-30 -68.01 5.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.26 141.04 15.23 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -69.13 -51.14 41.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 110.661 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.92 -45.58 5.95 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.32 90.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -62.3 -40.05 95.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.123 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.79 -31.11 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 21' ' ' THR . 5.3 mt -70.6 -28.51 64.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.68 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.66 -34.49 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.103 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.13 27.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' LEU . 13.8 t80 -53.7 -53.8 46.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.751 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 17' ' ' LEU . 36.4 p -44.59 -55.18 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.613 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' OE2' ' A' ' 26' ' ' GLU . . . -58.54 -22.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.62 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.17 -41.57 15.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -40.03 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -72.53 -35.77 68.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.772 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -70.6 -44.25 67.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.17 -58.08 4.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.622 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p -47.22 -34.14 6.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.254 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -79.09 -42.88 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.6 -16.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.794 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.443 ' O ' HG12 ' A' ' 35' ' ' VAL . 66.9 t-105 -91.68 -34.0 14.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.629 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' MET . 4.9 m-85 -62.48 -31.21 71.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.459 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 6.9 mp0 -81.02 -44.86 17.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.749 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -63.62 -17.67 63.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 36' ' ' MET . 9.8 p -109.3 -41.59 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.51 ' N ' HG13 ' A' ' 35' ' ' VAL . 8.1 tpt -85.9 4.9 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.754 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.4 mp 48.06 34.61 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 134' ' ' GLN . 20.8 mt -79.63 154.71 28.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -125.24 128.23 24.81 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.563 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.83 -179.84 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.383 2.055 . . . . 0.0 112.073 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -128.31 -170.97 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.297 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.9 p -66.26 -44.72 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' N ' HG13 ' A' ' 42' ' ' VAL . 83.8 mt -67.22 -50.43 60.79 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -50.35 -50.89 49.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.52 -41.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.96 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -57.28 -47.81 80.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.854 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.94 -43.28 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.089 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -56.46 -33.64 66.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.901 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.117 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.8 -48.68 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.084 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.4 mm? -75.0 -47.47 28.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 51' ' ' LEU . 38.9 t80 -44.01 -39.67 4.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.42 -39.82 87.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' LEU . 71.5 t -60.33 -17.47 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.368 0.604 . . . . 0.0 109.423 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 tp -83.43 -39.49 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.79 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.3 -38.94 81.98 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.81 72.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.61 -23.22 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.26 -37.09 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.852 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.69 -38.22 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.018 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -63.64 -40.57 98.75 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.52 11.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.064 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' H ' ' C ' ' A' ' 61' ' ' GLY . 90.8 mt -88.32 -25.67 5.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.25 68.76 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.697 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.65 21.01 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.609 2.206 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HZ2' HE22 ' A' ' 10' ' ' GLN . 26.5 tttp -112.62 -3.67 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.87 166.02 12.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -42.57 -11.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.238 1.959 . . . . 0.0 112.076 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -41.51 -38.55 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.345 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.7 mtm105 -38.66 -69.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.26 -17.1 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.042 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.6 t -83.14 -48.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.249 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 -34.49 60.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.274 0.559 . . . . 0.0 110.043 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.2 ttt -59.51 -9.56 2.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.112 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.65 -43.39 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.425 0.631 . . . . 0.0 110.423 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -88.26 -29.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.645 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.654 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.1 t-105 -65.63 -53.34 42.85 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.781 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.98 -45.36 85.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -44.19 -45.49 8.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.966 0.412 . . . . 0.0 110.357 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 p -80.3 -21.06 42.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.049 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.53 -62.28 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.921 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -73.59 -49.34 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.297 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -72.24 -43.69 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' THR . . . -58.72 -48.33 85.6 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' O ' ' OG1' ' A' ' 88' ' ' THR . 75.1 t -72.83 -50.94 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.637 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' C ' ' OE1' ' A' ' 86' ' ' GLN . 1.1 tm0? -50.11 -23.39 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.022 0.439 . . . . 0.0 109.991 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.67 -41.33 14.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.589 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 84' ' ' GLY . 23.6 p -51.87 -23.68 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -71.19 -31.02 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.492 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.44 -37.61 51.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -70.29 -58.61 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -54.69 -43.28 72.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.706 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.7 ttt -57.78 -44.77 86.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.58 -48.4 81.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.663 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -52.26 -43.04 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 96' ' ' LEU . 10.1 mp -91.08 -9.77 44.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.17 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.6 t80 -131.33 71.51 81.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.85 -167.92 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.379 2.053 . . . . 0.0 111.912 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.08 164.66 17.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -39.26 117.7 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 43.21 -165.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.45 42.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.553 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 p -79.36 -156.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.535 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m -123.96 -58.4 1.56 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.406 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 49.59 -136.13 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' MET . 88.4 m-85 -69.22 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 106' ' ' PHE . 5.6 mmt 56.73 114.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.463 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.722 ' O ' HG22 ' A' ' 108' ' ' VAL . 8.1 p 37.5 43.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.156 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.09 99.91 2.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.132 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -122.22 160.85 45.96 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.237 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -38.41 137.15 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.822 2.348 . . . . 0.0 112.236 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.98 -4.62 58.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.522 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -0.85 54.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.605 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' A' ' 116' ' ' LEU . 11.8 mt -121.81 81.81 41.83 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.289 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.2 Cg_exo -51.25 2.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.757 2.305 . . . . 0.0 112.635 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.8 mt -62.57 -32.74 73.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.947 0.403 . . . . 0.0 110.142 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 110' ' ' PHE . 2.7 p30 -96.43 -40.59 9.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.47 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 78.1 tttt -72.1 -45.4 60.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.663 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -72.78 -15.57 61.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.128 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.54 73.39 29.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.66 -17.89 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.848 2.366 . . . . 0.0 111.886 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -52.59 -49.24 65.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.847 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.49 54.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.78 -41.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.296 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.07 129.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.48 155.05 17.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -167.34 112.08 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.594 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 129.42 -179.98 16.37 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 2.2 m-20 -81.97 137.08 35.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.225 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -90.68 132.49 35.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.82 -6.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -67.88 152.35 45.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -85.08 138.0 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.634 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.465 ' HB3' HD22 ' A' ' 38' ' ' LEU . 15.2 mt-30 -128.79 -29.43 2.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -174.92 138.96 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -133.65 163.44 29.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.48 0.657 . . . . 0.0 112.394 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.688 ' CE2' HD23 ' A' ' 138' ' ' LEU . 35.7 t80 -123.32 135.55 54.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.766 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.688 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.8 mm? 51.43 17.13 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.649 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 94.09 14.28 52.11 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.189 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 139' ' ' GLY . 4.0 mm? -119.68 139.84 51.6 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' CD ' ' N ' ' A' ' 141' ' ' GLU . 24.4 mp0 -73.2 154.11 40.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.598 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.46 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 5.9 mtt -49.24 -63.17 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.256 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.541 ' O ' HD13 ' A' ' 147' ' ' LEU . 86.6 Cg_exo -31.72 -41.72 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.95 2.433 . . . . 0.0 112.594 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.75 -49.48 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.408 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -63.91 -57.44 9.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt -43.7 -39.57 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 143' ' ' PRO . 3.5 mp -61.89 -35.76 79.29 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.84 -41.38 91.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.6 mp -80.41 -26.77 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 154' ' ' LEU . 43.2 t80 -60.99 -48.78 80.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.533 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 tt -67.73 -39.52 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -48.76 -45.81 40.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.096 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -65.4 -44.27 88.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.007 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 150' ' ' PHE . 66.6 mt -63.33 -30.87 71.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.74 -27.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 160' ' ' VAL . 25.6 t -75.29 -29.8 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.654 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -73.67 -50.87 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.989 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 159' ' ' LEU . 19.6 m -54.27 -52.07 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.934 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 158' ' ' VAL . 5.3 mt -63.29 -36.65 84.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.623 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 156' ' ' VAL . 9.4 t -65.76 -33.91 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.7 -52.73 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 109.818 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.7 mp -60.69 -9.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.214 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 92.1 p -52.25 -8.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 162' ' ' ILE . 16.4 mt-30 -86.33 153.88 56.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -36.72 -26.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.789 2.326 . . . . 0.0 112.421 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 164' ' ' GLN . 79.0 t80 -54.46 119.02 4.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.621 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -94.79 -173.72 3.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.8 171.53 12.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.763 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 170' ' ' LYS . 14.3 pttt -88.85 -52.08 5.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.445 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 169' ' ' LYS . 39.9 mttp -150.36 -177.39 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -71.57 148.62 46.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.555 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.67 -166.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -80.21 -167.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.306 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 173' ' ' LEU . 9.8 m-85 -45.08 171.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -165.58 -142.98 3.58 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -157.15 91.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.52 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -107.46 79.28 0.25 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -78.59 167.17 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.355 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -81.76 139.13 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.497 ' H ' ' CD2' ' A' ' 180' ' ' HIS . 8.5 p80 -86.31 -113.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.517 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 39.6 t-80 -162.5 161.08 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.617 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.477 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 0.3 OUTLIER -48.37 110.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.481 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpp? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt -58.5 -38.45 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.449 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -56.0 -39.89 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.564 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLN . 17.9 m-85 -69.72 -42.8 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.61 -40.41 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.176 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.72 -21.69 63.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.102 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.1 tp-100 -80.53 -47.01 14.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.541 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 -32.68 73.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.625 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 11' ' ' GLY . 9.2 p -76.45 -33.66 58.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.12 10.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 110.489 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.31 142.57 15.52 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -65.05 -20.51 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.244 . . . . 0.0 110.416 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.45 -46.23 71.73 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.12 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 0.0 110.366 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -56.19 -49.43 74.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.712 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.77 -31.77 73.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.525 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.09 -27.76 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.545 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 31.9 mtt -76.76 -33.85 58.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.348 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.09 -55.2 11.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.696 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . 83.0 t80 -53.88 -54.64 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.661 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -42.72 -58.87 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.662 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . . . -58.33 -24.51 59.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' PHE . 6.2 tp -80.26 -41.32 25.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.4 -34.32 61.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.521 HD21 HD11 ' A' ' 146' ' ' LEU . 6.1 tt -70.57 -35.04 72.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.54 -49.94 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.613 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 30' ' ' LEU . 35.8 mt -64.91 -57.37 8.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.612 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 m -44.24 -40.42 5.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.47 -27.14 46.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.36 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.4 tp -63.98 -18.76 64.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.653 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -83.32 -37.3 23.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' O ' ' CB ' ' A' ' 36' ' ' MET . 13.7 m-85 -62.75 -36.65 83.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -79.46 -47.02 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.919 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 57.9 t-80 -62.6 -15.88 53.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.35 -46.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.439 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tpt -87.71 9.92 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.065 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.7 mp 43.26 48.58 5.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.33 146.5 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.377 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -115.47 84.18 11.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.246 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.78 172.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.531 2.154 . . . . 0.0 112.235 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.69 171.59 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.569 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 61.8 t -47.59 -42.99 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.313 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.9 mp -75.05 -40.66 60.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.572 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.4 t -55.74 -49.77 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.007 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 124' ' ' PHE . 13.0 pt -66.16 -37.02 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.451 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.26 -45.82 92.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.936 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.95 -39.87 79.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.88 -31.22 70.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.28 76.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.305 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.76 -48.58 81.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.26 -51.58 11.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -45.12 -37.74 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.79 84.38 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 78.1 t -65.81 -47.1 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.934 0.397 . . . . 0.0 110.025 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.72 -48.51 10.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.474 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.57 97.95 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -50.85 -44.38 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.539 . . . . 0.0 110.695 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.41 64.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tp -76.64 -37.75 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -81.76 -31.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.686 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.71 -30.46 66.18 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.66 5.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.56 0.219 . . . . 0.0 111.149 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -85.52 -25.59 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.624 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.22 74.91 0.27 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 73.6 Cg_endo -79.38 16.81 1.33 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.728 2.286 . . . . 0.0 112.242 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -113.76 -3.86 13.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.39 162.18 22.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.691 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.69 -16.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.038 . . . . 0.0 111.792 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 tp -42.95 -33.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.362 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.69 -67.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -55.86 -21.82 22.03 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.69 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' LEU . 10.5 t -76.99 -43.34 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.584 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.26 62.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -60.19 -10.42 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.267 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.09 -43.42 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.349 0.595 . . . . 0.0 110.144 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -86.96 -32.59 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.818 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -61.49 -55.57 29.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.051 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.14 -47.19 80.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -44.38 -45.3 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.311 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -79.24 -22.88 44.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.78 -59.43 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.991 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.02 -53.49 9.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -66.66 -46.02 77.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.08 -47.84 84.3 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 88' ' ' THR . 78.8 t -68.47 -50.32 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -48.63 -26.12 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.97 -38.76 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 68.8 p -55.49 -29.56 59.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.765 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.15 -41.82 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.721 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.12 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -43.04 40.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.651 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.4 p -72.14 -43.6 64.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 22.4 ttp -54.49 -51.11 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.705 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -49.32 75.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.425 ' NE2' ' CD ' ' A' ' 141' ' ' GLU . 26.8 tt0 -55.71 -44.72 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.37 -22.55 35.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.754 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 12.3 t80 -144.27 81.8 11.16 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.3 134.12 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.633 2.222 . . . . 0.0 111.972 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 161.07 60.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 101' ' ' PHE . 55.4 Cg_endo -71.12 94.87 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.637 2.224 . . . . 0.0 112.03 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 100' ' ' PRO . 74.8 t80 55.72 111.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.91 4.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -48.02 97.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.7 t -155.45 54.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 105' ' ' ASP . 2.0 p30 -151.91 97.25 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -81.4 -171.82 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.0 tpt -161.71 -37.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 109' ' ' ARG . 29.2 m -40.91 -40.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' N ' HG23 ' A' ' 108' ' ' VAL . 20.7 mtt85 -81.26 100.04 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.344 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.61 155.48 37.35 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.85 159.12 9.74 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.582 2.188 . . . . 0.0 111.892 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.23 -12.16 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.34 11.68 35.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.75 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.7 tp -123.13 61.16 17.64 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.13 11.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.6 2.2 . . . . 0.0 112.038 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -77.72 -29.96 51.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 109.655 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 4.3 p-10 -96.05 -42.34 8.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.266 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 118' ' ' LYS . 20.4 mtpt -60.38 -38.09 82.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -83.4 -12.59 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.583 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.3 76.52 18.61 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.889 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 125' ' ' VAL . 73.0 Cg_endo -79.51 -19.39 10.19 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 111.909 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -68.63 -3.88 13.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.336 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 124' ' ' PHE . 2.4 t -145.22 37.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 123' ' ' VAL . 16.9 m-85 -153.56 -40.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.534 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 121' ' ' PRO . 16.4 m -62.0 131.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.564 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.3 146.9 23.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 t -159.64 100.11 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.7 -171.43 23.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -96.96 151.8 19.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.27 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.1 m -103.79 129.81 51.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.58 -7.63 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -67.83 156.91 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.514 ' H ' ' CD ' ' A' ' 132' ' ' GLU . 29.8 mtp85 -97.11 126.51 42.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.807 0.337 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.2 -29.84 4.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -174.1 141.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.45 161.11 39.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.193 0.52 . . . . 0.0 111.83 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.0 139.8 49.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.144 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.5 16.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.42 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.3 23.02 32.99 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.887 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.414 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 10.2 mt -127.67 139.61 52.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.425 ' CD ' ' NE2' ' A' ' 95' ' ' GLN . 9.9 mt-10 -68.45 145.01 54.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.441 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.9 mtt -47.29 -53.75 26.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.45 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 142' ' ' MET . 82.5 Cg_exo -41.55 -36.64 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.356 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.464 ' O ' ' NE2' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -69.76 -52.96 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 109.9 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 77.9 m95 -56.88 -56.82 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.908 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 25' ' ' LEU . 4.0 mm? -42.9 -36.13 1.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -61.67 -37.03 82.56 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.488 0.661 . . . . 0.0 109.325 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.35 -45.97 94.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.736 HD13 ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -74.38 -30.45 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.43 -45.14 92.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.2 mt -63.64 -43.74 98.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.282 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.26 -47.52 62.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.42 -41.38 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.728 ' C ' HD23 ' A' ' 154' ' ' LEU . 4.5 tt -55.31 -34.52 64.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.138 0.494 . . . . 0.0 110.318 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.69 -45.04 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 160' ' ' VAL . 84.4 t -48.99 -32.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.868 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.5 -42.92 58.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.53 -33.81 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.72 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.1 mm? -85.07 -36.32 21.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.743 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 156' ' ' VAL . 7.1 p -76.63 -23.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.375 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 157' ' ' ALA . 70.1 t -81.95 -51.64 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 162' ' ' ILE . 38.9 mm -71.86 -11.84 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.394 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 -22.1 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 166' ' ' PHE . 28.6 mt-30 -94.09 148.58 35.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.2 32.1 0.31 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.57 2.18 . . . . 0.0 112.169 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 164' ' ' GLN . 69.6 m-85 -135.93 142.5 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.537 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -108.31 137.48 46.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.17 166.46 12.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.546 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -74.96 155.19 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -120.06 170.07 9.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.622 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -84.27 177.31 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -92.35 -90.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.445 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tp 61.38 122.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.803 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -96.54 -41.79 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.371 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.28 -25.99 8.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -54.99 -23.52 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.69 177.88 49.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -99.89 95.59 6.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.589 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -80.27 122.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.462 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -62.25 -156.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.6 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 181' ' ' HIS . 0.2 OUTLIER 177.11 7.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.533 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' HIS . 5.3 t-160 55.37 109.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.553 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.6 mp -64.05 -44.82 91.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.272 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -50.94 -42.51 59.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.385 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.5 -39.93 95.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.504 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -52.37 -38.58 59.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.122 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.25 -31.28 72.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.491 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 31.5 mm-40 -74.85 -48.23 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -67.13 -29.66 69.45 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.483 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 95.8 p -75.92 -42.41 48.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -71.52 10.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.156 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -104.62 145.6 16.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.3 OUTLIER -63.13 -19.91 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.745 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.94 -47.68 64.65 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.88 -51.36 67.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -52.72 -49.73 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.86 -29.31 68.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.569 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 21' ' ' THR . 61.6 tp -69.18 -31.38 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.9 mtt -74.37 -34.02 63.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.62 -53.45 41.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.486 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.85 -54.13 49.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.756 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.9 p -41.17 -56.41 2.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.36 65.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.483 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.97 -40.28 78.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.86 -43.12 48.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.585 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 11.0 mp -70.59 -31.94 69.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.6 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.03 -43.27 71.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 8.3 tp -72.81 -57.87 3.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.613 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' ALA . 36.0 p -44.81 -37.72 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.151 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.12 -31.83 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.115 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LEU . 5.5 tp -59.13 -18.68 37.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -87.97 -27.54 22.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.351 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' MET . 4.6 m-85 -69.67 -50.93 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.7 -12.29 61.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -79.22 -34.97 42.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.293 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.48 -16.56 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.613 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.6 tpp -99.51 -9.39 23.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.39 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tp 45.68 49.11 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.27 143.98 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.441 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -105.49 130.8 22.47 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.169 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.0 167.58 25.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.302 2.002 . . . . 0.0 112.341 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.83 166.4 21.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.36 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 86.4 t -53.52 -48.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.7 mp -70.1 -47.34 62.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.462 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 23.3 t -52.73 -51.11 61.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.067 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.07 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.336 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -43.37 71.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -62.29 -39.25 92.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -59.68 -38.6 81.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.72 -34.15 76.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.02 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -61.65 -43.81 98.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.544 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.49 -53.07 7.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -45.96 -43.33 13.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.0 -44.15 89.41 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' ALA . 40.7 t -63.35 -46.98 94.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -44.78 -48.3 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.638 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.98 -48.03 88.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -30.46 12.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.257 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.73 66.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.78 -42.59 85.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.52 -35.64 75.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.21 -22.99 78.64 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 1.27 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.3 mt -83.89 -36.88 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.683 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.1 73.11 0.23 Allowed Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.036 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.07 22.7 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.709 2.273 . . . . 0.0 111.72 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -108.32 -12.57 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.159 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -107.41 161.28 23.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.715 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.34 -15.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.564 2.176 . . . . 0.0 112.203 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 mt -46.25 -27.41 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 69' ' ' LEU . 45.7 mtm180 -38.81 -62.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 75' ' ' VAL . 28.9 t80 -52.87 -37.66 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.192 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 69' ' ' LEU . 17.8 t -60.93 -43.56 96.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.57 -35.8 57.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.195 0.522 . . . . 0.0 110.067 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.1 mtp -59.37 -17.86 33.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.492 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 71.5 t -52.37 -41.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.408 0.623 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 mm -88.1 -31.52 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.767 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 3.8 t-105 -66.65 -54.75 19.98 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.9 tp -64.19 -49.07 73.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.769 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -42.84 -42.24 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -78.57 -21.66 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.59 -62.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.692 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -72.9 -53.47 11.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.426 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -69.45 -45.41 69.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.75 86.99 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.1 -49.81 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.348 . . . . 0.0 110.499 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -50.76 -24.78 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD12 ' OE2' ' A' ' 90' ' ' GLU . 56.9 tp -79.83 -38.34 33.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.26 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.3 p -56.06 -29.95 61.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.13 -42.06 85.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.648 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE2' HD12 ' A' ' 87' ' ' LEU . 37.3 mt-10 -58.8 -39.43 81.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.366 . . . . 0.0 110.611 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.51 -44.1 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.2 p -69.26 -50.6 45.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 mmt -46.31 -47.58 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -47.19 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.47 -34.7 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.3 mt -100.87 -12.09 19.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 -136.56 74.17 53.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.615 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.85 133.17 50.1 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.83 2.353 . . . . 0.0 112.068 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.9 p -97.49 116.55 65.87 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.301 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.18 -55.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.143 1.895 . . . . 0.0 112.242 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -79.32 134.3 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.654 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 51.23 92.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.626 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.4 p -72.1 57.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.497 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 t 45.06 61.65 2.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.524 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 31.7 t0 61.25 -138.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 80.3 m-85 -159.74 -99.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.9 ttp -66.72 134.74 52.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.427 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.23 149.18 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.611 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -127.59 121.69 31.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.375 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -97.5 130.0 30.37 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.494 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -41.5 159.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.386 2.057 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -77.34 3.68 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.571 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -125.47 27.27 6.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 tp -118.42 61.16 4.39 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.69 6.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.698 2.265 . . . . 0.0 112.685 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -78.5 -25.47 45.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.392 0.615 . . . . 0.0 109.863 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 110' ' ' PHE . 4.1 t70 -96.22 -42.79 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.914 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.47 -44.68 95.8 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.048 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 36.4 m0 -78.23 -15.61 58.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.16 77.09 10.99 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.65 -14.89 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.52 -3.61 31.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 124' ' ' PHE . 9.8 p -136.07 32.61 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.225 0.536 . . . . 0.0 110.768 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.478 ' CD2' HG13 ' A' ' 123' ' ' VAL . 19.5 m-85 -155.45 -44.58 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.38 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.18 129.39 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.05 153.49 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.565 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t -167.28 99.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.85 -165.02 26.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.9 148.39 22.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.246 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.4 m -101.72 132.0 47.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.962 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.2 -2.95 0.5 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.896 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.13 129.42 39.85 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.139 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.88 130.06 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -16.94 5.42 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.507 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -172.84 138.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -145.74 160.93 41.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.179 0.514 . . . . 0.0 112.0 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -121.98 138.48 54.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.063 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.3 17.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.15 22.1 53.1 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.2 mp -122.49 133.58 54.59 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.27 146.0 53.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.431 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.8 mtt -45.78 -54.11 17.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 142' ' ' MET . 89.1 Cg_exo -41.86 -35.47 2.98 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.4 2.066 . . . . 0.0 112.16 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -71.57 -52.11 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.952 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.4 m95 -59.92 -57.24 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.106 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -44.18 -36.97 2.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -61.94 -33.02 73.51 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.13 -50.78 58.17 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.315 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.5 mt -69.83 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.024 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.514 ' CE2' HD11 ' A' ' 154' ' ' LEU . 33.9 t80 -63.54 -42.9 98.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.145 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 155' ' ' ILE . 1.7 tp -69.95 -31.64 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.262 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.17 70.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.74 -51.21 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.675 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.514 HD11 ' CE2' ' A' ' 150' ' ' PHE . 33.7 mt -56.22 -31.59 63.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.635 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.1 mp -76.78 -35.84 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.073 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 160' ' ' VAL . 46.9 t -61.87 -36.88 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -68.56 -43.3 76.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.59 -24.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.928 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.445 ' O ' ' OG ' ' A' ' 163' ' ' SER . 44.5 tp -80.76 -43.76 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 156' ' ' VAL . 27.7 m -73.37 -34.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.29 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 157' ' ' ALA . 74.8 t -68.36 -48.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -22.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 21.3 m -52.68 -44.11 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.587 ' C ' ' H ' ' A' ' 166' ' ' PHE . 47.2 tt0 58.52 84.65 0.2 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.168 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.35 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.556 2.17 . . . . 0.0 111.912 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.587 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.1 OUTLIER 60.01 -166.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.487 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.32 39.93 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.43 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.39 143.88 10.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.708 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -84.17 165.74 18.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -173.43 46.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.417 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -87.82 128.59 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -158.59 49.71 0.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.519 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 7.4 tp -153.57 130.26 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.777 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 176' ' ' ARG . 2.4 m-85 -159.23 -24.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.348 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.34 -25.92 1.07 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.481 ' H ' ' C ' ' A' ' 174' ' ' PHE . 53.6 ttp85 -45.39 133.88 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 178' ' ' HIS . . . 159.56 23.36 0.03 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 177' ' ' GLY . 14.6 m-70 -49.37 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 110.6 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' A' ' 180' ' ' HIS . 0.4 OUTLIER -102.6 178.81 4.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.537 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.49 ' ND1' ' C ' ' A' ' 179' ' ' HIS . 0.0 OUTLIER -142.72 103.51 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.41 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 181' ' ' HIS . 0.1 OUTLIER -42.62 158.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 12.7 t-80 63.05 -171.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.594 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 25.4 m80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.05 -45.2 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.3 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -51.12 -34.53 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -69.36 -44.39 71.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.2 tp -47.8 -38.7 16.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -67.43 -26.16 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.485 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -80.48 -47.02 14.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.791 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.36 -38.74 90.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -76.67 -32.39 57.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 8.2 tt0 -71.38 5.62 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.008 0.432 . . . . 0.0 110.576 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.2 148.34 18.71 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -70.01 -20.79 63.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 17' ' ' LEU . . . -69.91 -45.74 55.93 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -60.95 -50.49 73.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.74 0.305 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -56.4 -44.79 80.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.487 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.63 -30.43 71.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.306 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 13' ' ' GLY . 3.6 mp -70.21 -26.94 64.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.686 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.469 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -76.87 -34.27 57.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -56.55 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -52.81 -51.12 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.692 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.0 p -45.3 -60.91 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.564 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -33.37 61.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.463 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.58 -41.44 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.91 -33.18 61.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.216 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.21 -32.69 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.252 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.41 -45.37 55.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.46 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.2 tt -65.06 -52.06 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.332 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 17.4 m -56.06 -30.77 62.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -33.36 38.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.884 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -17.22 64.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . 65.5 t90 -91.03 -34.63 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' MET . 27.3 t80 -60.5 -39.07 86.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.07 -40.3 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.594 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.52 -22.66 65.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 36' ' ' MET . 9.7 p -109.3 -42.83 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.493 ' N ' HG13 ' A' ' 35' ' ' VAL . 6.7 tpt -84.82 5.91 26.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.684 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt 42.99 44.67 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.976 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -63.11 147.05 51.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.976 ' N ' HD23 ' A' ' 38' ' ' LEU . 81.8 mttt -113.13 90.83 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.225 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.11 172.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.45 2.1 . . . . 0.0 112.415 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.96 168.98 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.943 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 91.6 t -53.94 -51.33 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 43' ' ' LEU . 9.9 mp -66.15 -50.0 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 41' ' ' CYS . 14.8 m -50.57 -49.86 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.752 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.37 -42.45 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -47.5 75.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 88' ' ' THR . 3.1 tp10 -57.78 -40.19 79.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -58.12 -33.96 69.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.38 84.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.443 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.38 73.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.4 tp -73.06 -53.28 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -42.86 -41.25 3.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.89 -40.38 95.42 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 55.4 t -61.11 -47.66 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.223 0.535 . . . . 0.0 109.559 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -45.5 -47.12 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.491 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.64 -28.26 69.55 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.39 -34.96 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.61 -34.14 75.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.237 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.39 -32.39 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.218 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -77.59 -42.65 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.342 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -23.79 75.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.6 4.73 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.625 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.9 mt -84.9 -34.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.738 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.55 73.63 0.11 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.54 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.51 12.37 2.9 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.891 2.394 . . . . 0.0 111.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -96.93 -10.01 27.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.61 161.29 28.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.692 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -38.14 -19.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.519 2.146 . . . . 0.0 112.197 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' THR . 8.3 mp -43.7 -30.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.24 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 69' ' ' LEU . 5.5 ttm180 -38.14 -51.7 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -55.21 -35.78 65.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.503 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.7 t -61.96 -58.45 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.152 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.73 79.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.366 0.603 . . . . 0.0 109.774 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -8.88 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 72' ' ' VAL . 53.4 t -60.58 -43.86 95.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.529 0.68 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.8 mt -87.98 -29.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.894 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.1 t-105 -65.0 -52.33 56.72 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.772 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.8 tp -64.85 -48.56 73.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.586 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -43.69 -42.79 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.888 0.375 . . . . 0.0 110.356 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -23.09 36.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.87 -61.7 2.42 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.912 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE2' ' OE1' ' A' ' 86' ' ' GLN . 70.4 t80 -75.43 -46.96 29.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.397 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -72.11 -41.01 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.78 -48.19 87.48 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 81' ' ' ALA . 16.5 m -71.46 -45.83 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.545 ' N ' HG23 ' A' ' 85' ' ' VAL . 56.4 tt0 -52.24 -27.5 15.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.401 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.2 tt -82.74 -44.19 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.37 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 84' ' ' GLY . 48.4 p -49.5 -25.29 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.82 -45.18 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.75 -45.7 85.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.739 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.22 -40.91 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.0 p -71.57 -41.95 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.585 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -47.12 -47.71 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.326 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.65 -47.22 82.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -51.47 -40.23 59.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.71 -12.49 27.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.551 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 98' ' ' PRO . 30.9 t80 -129.89 77.71 76.27 Favored Pre-proline 0 N--CA 1.462 0.169 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 97' ' ' TYR . 44.1 Cg_exo -53.84 -141.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.954 2.436 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 m 62.87 143.9 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.231 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 -177.31 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.408 2.072 . . . . 0.0 112.23 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -174.17 -31.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.57 133.18 35.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' SER . 3.3 m -85.27 45.27 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' THR . 45.9 p 46.11 97.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.576 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -161.51 -59.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 85.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.053 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.553 ' C ' ' H ' ' A' ' 109' ' ' ARG . 11.2 mtt -153.69 108.33 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.595 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.9 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 107' ' ' MET . 82.4 mtt180 -88.4 108.4 19.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.45 146.31 56.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.284 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -37.35 138.17 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.583 2.189 . . . . 0.0 112.193 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -94.4 6.01 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.706 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.64 -5.62 19.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 18.6 mt -120.05 83.3 30.69 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.8 Cg_exo -54.4 4.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 112.052 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.6 mm? -66.01 -30.23 70.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.084 0.468 . . . . 0.0 110.321 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.19 -42.19 7.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -73.63 -45.23 54.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -73.27 -15.58 61.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.375 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.29 72.25 32.37 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.9 -16.87 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.91 2.407 . . . . 0.0 112.042 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 -19.14 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.878 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.33 39.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.464 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.29 -42.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.069 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.06 128.09 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.41 156.24 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.6 t -168.29 99.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.19 -172.3 23.53 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.61 150.9 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.5 m -102.26 132.29 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.027 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.44 -3.52 0.29 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -69.32 150.06 47.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.253 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -86.38 113.16 22.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -106.61 -16.31 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.536 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 135' ' ' TRP . 13.7 t90 -173.92 119.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.4 t70 -109.08 151.64 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.205 0.526 . . . . 0.0 112.034 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 8.2 t80 -153.7 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.901 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 50.9 mt 79.06 17.87 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.45 7.04 88.77 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 mt -120.63 150.65 40.59 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 44.1 mm-40 -77.36 161.07 28.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.331 0.586 . . . . 0.0 111.3 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.505 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 4.3 ttt -44.09 -58.66 4.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.425 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 142' ' ' MET . 6.8 Cg_endo -49.33 -20.45 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.298 1.999 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 141' ' ' GLU . 6.6 mm-40 -75.45 -58.11 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.811 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -64.35 -53.4 49.21 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.983 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 tt -43.42 -45.83 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 88' ' ' THR . 29.2 tp -52.85 -37.62 60.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -56.22 -40.19 83.6 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.544 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -77.3 -35.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.682 0.277 . . . . 0.0 110.302 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.29 69.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.09 -39.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.161 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.6 -48.99 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.37 -45.68 93.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.682 ' C ' HD23 ' A' ' 154' ' ' LEU . 7.8 tt -54.7 -31.11 57.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.411 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.69 -26.88 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.25 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 58.0 t -74.3 -32.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.388 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.521 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -51.41 8.73 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.534 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 154' ' ' LEU . 27.7 m -56.68 -40.41 69.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.355 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -77.21 -35.13 55.91 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.378 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.8 t -76.87 -22.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.057 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 157' ' ' ALA . 30.8 t -77.15 -46.66 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.342 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.9 pt -74.99 -19.62 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 -26.29 68.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -171.03 79.85 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.697 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 166' ' ' PHE . 73.8 Cg_endo -81.24 7.04 5.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.591 2.194 . . . . 0.0 111.661 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 62.4 m-85 -160.71 157.35 26.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -134.23 158.81 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.305 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.52 112.98 4.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.641 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 171' ' ' ARG . 3.9 tptm -52.2 155.4 1.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.319 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -136.34 8.59 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.738 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.471 ' O ' ' NZ ' ' A' ' 169' ' ' LYS . 10.4 ptp85 -157.99 140.49 14.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -114.7 -16.95 11.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 16.6 mt 52.87 -97.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.445 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -72.75 130.41 40.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -85.65 -60.69 1.77 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -141.28 -92.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.66 -55.91 0.72 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 178' ' ' HIS . 0.9 OUTLIER -81.53 -178.42 6.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.751 0.31 . . . . 0.0 110.545 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 180' ' ' HIS . 10.1 p80 -176.28 176.74 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 179' ' ' HIS . 36.0 m170 -50.55 -175.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.574 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -135.23 142.66 46.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.541 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 56.5 p-80 -100.71 -144.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.451 ' N ' ' CD2' ' A' ' 182' ' ' HIS . 16.1 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.522 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.68 -37.09 80.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.207 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 ttm105 -55.7 -41.06 73.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.31 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.35 -44.77 95.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.406 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -49.36 -41.07 37.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 19.2 t30 -67.0 -29.72 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -77.16 -49.64 14.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.69 71.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.5 m -76.52 -42.32 43.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.451 ' NE2' HH21 ' A' ' 70' ' ' ARG . 1.1 mp0 -67.61 5.69 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.37 141.07 15.24 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -69.07 -50.32 49.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.593 0.235 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -46.31 6.18 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.7 89.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.114 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -59.81 -38.99 83.49 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.78 -30.15 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.949 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.95 -27.83 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.4 mtt -75.88 -33.92 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.77 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 4.3 m-85 -57.58 -50.15 74.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.558 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.0 m -42.87 -60.27 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.643 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.16 -25.94 48.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -78.94 -40.62 31.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.41 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -70.58 -35.21 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.593 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.41 -49.6 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.531 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.02 -57.88 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.626 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -46.33 -37.88 8.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -55.36 -17.32 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.716 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -95.56 -36.46 11.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.927 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CZ ' ' CZ2' ' A' ' 135' ' ' TRP . 2.5 m-85 -54.46 -46.14 73.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.733 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -40.74 76.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -60.03 -20.05 55.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.33 -35.32 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 31.7 mtt -87.72 3.49 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt 50.66 49.81 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.692 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.38 155.76 18.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 140.91 40.0 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.266 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.52 177.47 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.52 2.147 . . . . 0.0 112.091 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -131.75 -166.41 1.72 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.632 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 35.8 t -65.55 -51.3 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.833 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 10.6 mp -65.95 -50.1 65.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -48.59 -45.2 37.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.21 -38.16 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.094 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.9 -48.06 82.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.958 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -61.28 -38.1 85.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -58.96 -40.1 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.24 83.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.4 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.333 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.78 -52.45 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.198 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.46 -39.63 7.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.77 -43.84 90.78 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 57' ' ' ALA . 34.8 t -62.7 -47.36 93.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.166 0.507 . . . . 0.0 109.748 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.53 -45.87 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.603 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -30.05 76.64 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.73 -40.06 91.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.71 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.01 -25.22 60.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 3.3 mm? -79.47 -37.75 36.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -79.94 -35.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -22.99 72.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.94 6.65 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 110.74 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -80.24 -31.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.426 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.7 77.14 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.633 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.87 26.88 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.661 2.241 . . . . 0.0 111.947 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -106.84 -9.77 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.059 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.29 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.464 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.4 -5.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.089 1.859 . . . . 0.0 111.773 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.55 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 tt -44.44 -37.66 3.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.451 HH21 ' NE2' ' A' ' 10' ' ' GLN . 59.7 mtt180 -40.78 -70.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.666 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' HG23 ' A' ' 75' ' ' VAL . 47.4 t80 -51.03 -31.54 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.133 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.61 -46.95 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.84 -33.87 52.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.235 0.54 . . . . 0.0 110.109 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.16 -17.35 40.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.539 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 71' ' ' TYR . 69.2 t -53.41 -40.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.425 0.631 . . . . 0.0 110.38 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.87 -33.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.524 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 10.7 t-105 -61.79 -55.88 25.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.48 -48.49 77.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -45.86 -45.71 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.259 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -76.84 -25.3 53.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.387 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 154' ' ' LEU . . . -60.68 -59.07 5.98 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.01 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.37 -54.33 8.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.174 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -66.14 -45.36 81.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.67 -47.23 89.93 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 81' ' ' ALA . 89.3 t -68.74 -52.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.393 . . . . 0.0 110.578 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -51.16 -25.14 4.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.06 -40.91 17.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.548 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 84' ' ' GLY . 42.1 p -54.11 -24.99 19.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -73.47 -48.16 35.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -51.19 -32.76 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.426 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 12.5 t-80 -73.38 -45.23 56.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.671 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -45.86 70.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' TYR . 32.9 ttp -51.36 -49.77 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -49.82 54.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.455 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 5.4 tt0 -52.36 -48.81 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.25 -19.5 26.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.023 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -139.53 83.46 17.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.74 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.42 82.53 2.37 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.594 2.196 . . . . 0.0 111.91 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 100' ' ' PRO . 0.3 OUTLIER -67.71 -43.04 38.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 99' ' ' SER . 72.7 Cg_endo -83.45 11.87 3.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.622 2.215 . . . . 0.0 112.287 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' PRO . 3.7 m-85 54.58 109.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.17 -167.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.55 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.89 -26.85 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' PHE . 20.0 t 47.24 -104.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 107' ' ' MET . 9.9 t70 62.44 -71.48 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER 66.43 -71.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.538 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.16 141.88 44.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.28 103.31 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.443 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -62.91 146.54 95.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.11 144.58 57.99 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.49 2.127 . . . . 0.0 111.945 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -101.45 5.31 41.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 9.6 p-90 -124.56 -5.13 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.5 tp -119.69 80.49 23.98 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.48 -5.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.688 2.259 . . . . 0.0 112.556 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.1 mt -57.89 -28.97 64.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.473 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 12.6 t0 -96.53 -39.39 9.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.598 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HZ2' ' HD1' ' A' ' 119' ' ' TRP . 6.0 ttpp -68.61 -45.28 72.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.473 ' HD1' ' HZ2' ' A' ' 118' ' ' LYS . 41.5 m0 -77.74 -18.55 56.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.86 76.43 17.18 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 -17.68 9.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.742 2.294 . . . . 0.0 111.654 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -52.41 -50.84 61.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.865 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.81 55.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.473 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -157.59 -44.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.0 p -56.11 130.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.61 146.55 24.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.801 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -159.04 99.81 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.14 -171.56 22.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.97 160.38 14.3 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.66 0.267 . . . . 0.0 110.363 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.658 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 85.4 m -108.11 134.95 50.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.38 -9.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.736 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.72 129.23 39.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.9 ptt85 -65.84 129.18 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -124.17 -29.45 3.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.435 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.551 ' CZ2' ' CZ ' ' A' ' 32' ' ' PHE . 5.4 t90 -173.74 137.82 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.779 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -142.21 160.44 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 112.135 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 138' ' ' LEU . 89.8 t80 -118.98 138.41 52.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.046 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.603 HD23 ' CE2' ' A' ' 137' ' ' PHE . 0.7 OUTLIER 51.68 17.35 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.155 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 87.78 22.87 40.99 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 139' ' ' GLY . 5.7 mp -123.81 135.88 54.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.455 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 8.9 mt-10 -68.74 146.36 53.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.598 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtp -48.75 -52.41 45.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.63 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 142' ' ' MET . 81.1 Cg_exo -44.46 -37.07 10.43 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.049 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.428 ' NE2' ' C ' ' A' ' 144' ' ' GLN . 0.6 OUTLIER -70.92 -49.33 46.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.98 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.571 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.1 m95 -59.54 -56.77 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.244 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -44.07 -39.35 4.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.2 tt -57.9 -37.24 73.64 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.33 -43.34 97.4 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.731 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.6 mt -69.61 -26.7 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.8 0.333 . . . . 0.0 110.408 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -42.89 94.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.976 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER -60.64 -47.98 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.045 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.3 -50.57 73.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.78 -44.38 96.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.739 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.756 ' C ' HD23 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -61.33 -30.02 70.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.157 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.705 ' N ' HD23 ' A' ' 154' ' ' LEU . 4.1 mt -73.55 -39.45 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 160' ' ' VAL . 78.1 t -59.08 -38.2 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -74.1 -43.49 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.403 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 154' ' ' LEU . 91.1 t -58.97 -37.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.398 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.67 -25.02 38.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.792 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.0 t -78.33 -25.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.526 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 162' ' ' ILE . 5.9 p -82.97 -45.08 19.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.347 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 164' ' ' GLN . 35.3 mm -65.39 -28.57 44.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 13.3 p -57.16 0.06 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.518 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.577 ' H ' ' C ' ' A' ' 162' ' ' ILE . 8.2 mm100 -124.49 67.76 49.0 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.7 18.6 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.501 2.134 . . . . 0.0 112.087 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.455 ' CD2' ' N ' ' A' ' 167' ' ' LYS . 66.1 t80 -87.56 -105.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.455 ' N ' ' CD2' ' A' ' 166' ' ' PHE . 67.3 mmtt 43.08 -122.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.684 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -175.42 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.436 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -161.05 133.21 5.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -111.77 -48.04 3.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 62.6 138.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.534 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.84 170.63 8.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.441 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.12 -174.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.356 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -41.72 117.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -129.51 -63.16 0.11 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.5 mmt-85 45.27 -161.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -161.06 -151.96 6.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.499 ' CG ' ' H ' ' A' ' 179' ' ' HIS . 29.1 t-80 -102.11 177.05 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.338 . . . . 0.0 110.549 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.549 ' ND1' ' N ' ' A' ' 179' ' ' HIS . 0.6 OUTLIER -84.73 95.91 9.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.503 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 13.3 m80 62.14 -72.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 179' ' ' HIS . 0.1 OUTLIER -154.08 -159.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.493 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -82.95 151.38 25.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 10.5 t60 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.613 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.5 mm? -68.75 -45.5 71.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -51.1 -33.99 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.09 -40.69 64.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -49.3 -45.17 44.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -67.06 -24.21 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.025 0.441 . . . . 0.0 110.066 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -78.69 -47.39 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -32.23 73.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.5 m -76.1 -37.79 57.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.236 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -72.11 11.95 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.245 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.14 141.46 15.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.84 -50.57 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.22 5.72 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -61.05 -46.29 91.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.307 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -61.83 -34.04 75.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.19 -30.92 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.017 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 21' ' ' THR . 56.3 mt -70.84 -28.52 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.646 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.47 -34.76 60.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.79 -54.8 16.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.723 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -54.51 -51.64 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.615 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 17' ' ' LEU . 6.3 p -43.22 -56.01 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.7 56.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -77.56 -39.58 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.539 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.02 -44.5 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.621 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp -71.54 -32.08 67.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.458 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.57 -48.51 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.516 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.5 tt -68.1 -58.09 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 110.527 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -46.03 -33.68 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.78 -32.02 27.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.393 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -62.43 -16.02 52.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.636 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -91.41 -38.74 12.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 36' ' ' MET . 5.1 m-85 -56.08 -45.62 79.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.442 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -73.24 -36.77 66.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.554 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -56.65 -35.62 68.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.547 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.05 -50.82 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 7.8 tpp -69.91 0.64 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 42.25 45.5 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 110.115 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.83 149.29 47.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.896 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.87 83.46 18.65 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.77 154.38 1.98 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 112.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 4.7 t -106.52 -171.68 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.538 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.406 HG22 ' CB ' ' A' ' 126' ' ' ALA . 47.1 t -66.53 -50.5 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.652 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 43' ' ' LEU . 10.4 mp -58.39 -40.79 83.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.097 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -53.85 -42.51 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 124' ' ' PHE . 79.2 mt -64.41 -46.53 92.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.328 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.65 -48.62 72.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -64.56 -36.02 82.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.74 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -68.92 -39.26 79.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.499 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.18 88.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.15 -48.28 73.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -48.98 22.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.12 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.73 -43.21 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 109.811 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.93 97.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 53.6 t -59.46 -47.26 91.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.782 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.553 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.8 tt -45.56 -46.5 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.371 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.01 -27.69 70.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -67.96 -33.45 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.72 71.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.68 -35.3 80.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.0 -37.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.41 -16.62 71.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.82 2.04 32.0 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.015 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 63' ' ' ILE . 1.4 mp -84.05 -38.85 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.69 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.99 78.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.614 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.62 20.5 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.718 2.279 . . . . 0.0 112.164 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -107.56 -7.07 16.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.34 165.01 13.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.49 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -39.64 -14.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.45 2.1 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 67' ' ' THR . 75.0 mt -44.64 -32.0 1.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 69' ' ' LEU . 41.2 mtm180 -40.03 -63.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -57.27 -22.36 40.95 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.122 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 69' ' ' LEU . 20.5 t -76.17 -44.27 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.993 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.84 59.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -57.5 -14.05 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.799 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.68 -44.99 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.44 0.638 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -88.19 -28.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.838 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t-105 -64.66 -53.65 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.209 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.73 -45.3 71.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -45.47 -46.16 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.592 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -77.82 -23.38 49.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' CB ' HD13 ' A' ' 154' ' ' LEU . . . -59.93 -60.01 4.52 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.279 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.47 -52.02 13.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -67.26 -41.69 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.891 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.94 -46.12 92.31 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.7 t -75.18 -56.87 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -47.19 -27.57 1.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.838 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.43 -35.32 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.988 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 84' ' ' GLY . 29.4 p -56.7 -51.38 69.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.139 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -33.87 3.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.196 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.79 -40.15 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.922 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 88' ' ' THR . 1.6 t60 -66.99 -40.7 87.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.426 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.4 p -73.32 -51.82 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.875 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.8 ttt -43.75 -43.03 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.49 -40.08 77.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -66.95 -46.38 74.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.915 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.03 -28.97 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.6 OUTLIER -126.39 91.59 47.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.41 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.34 154.77 21.73 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.486 2.124 . . . . 0.0 112.162 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 t -150.3 76.94 8.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.12 21.78 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.589 2.193 . . . . 0.0 112.05 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.82 109.94 22.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.91 34.34 23.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 104' ' ' SER . 0.8 OUTLIER -84.58 -145.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.391 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.526 ' H ' HG22 ' A' ' 103' ' ' THR . 1.4 t 163.48 179.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.249 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 51.6 m-20 -157.67 156.62 32.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.558 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 81.2 m-85 -158.51 164.6 35.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.649 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.0 mmt -75.97 169.59 17.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.36 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 108' ' ' VAL . 11.8 p -76.29 108.89 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 110.397 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -103.43 99.93 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.374 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -98.51 148.54 34.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.46 138.7 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.535 2.157 . . . . 0.0 112.354 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -84.01 9.58 12.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.279 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.671 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -114.73 7.27 15.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.598 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.0 tp -120.68 83.63 35.79 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.948 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -52.69 6.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.777 2.318 . . . . 0.0 112.699 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -66.39 -31.09 71.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 109.942 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 1.1 m-20 -96.73 -41.17 8.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.365 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -70.37 -44.14 68.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.752 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.452 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.7 t90 -76.63 -14.81 59.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.59 69.36 13.63 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.743 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 -11.2 17.43 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.765 2.31 . . . . 0.0 112.068 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.503 ' CD ' ' H ' ' A' ' 122' ' ' GLN . 25.1 mp0 -59.66 -54.21 49.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 123' ' ' VAL . 31.0 m -99.11 50.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 111.103 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -156.32 -38.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.176 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 125' ' ' VAL . 14.4 p -56.16 124.24 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -92.75 157.6 16.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.756 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.1 t -162.96 144.6 10.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.239 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.4 23.25 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 4.4 p30 -103.65 168.91 8.84 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -115.02 135.34 54.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.797 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.95 -0.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -67.98 152.06 46.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.566 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -89.34 137.33 32.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.43 -30.37 2.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.02 139.78 0.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.05 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -140.0 167.83 21.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.521 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.8 t80 -143.59 120.14 11.06 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.6 tp 78.39 16.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 12.84 76.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 mt -119.99 135.24 54.99 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.842 0.354 . . . . 0.0 110.195 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -72.89 154.25 40.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.409 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -48.24 -61.73 2.87 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.614 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.554 ' O ' HD23 ' A' ' 147' ' ' LEU . 95.3 Cg_exo -34.09 -39.18 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.71 2.273 . . . . 0.0 112.506 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -72.43 -49.2 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.598 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.9 m95 -60.46 -57.67 11.77 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.022 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.4 tp -43.35 -40.54 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.219 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.6 mm? -59.08 -34.09 71.58 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.88 -44.62 95.92 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.5 mt -76.14 -36.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.347 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.75 -47.2 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.97 -41.71 90.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.585 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -49.29 -46.3 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.409 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -64.87 -44.66 88.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.573 HD13 ' CB ' ' A' ' 81' ' ' ALA . 6.0 tp -49.34 -46.81 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.036 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.46 -45.3 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.264 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 160' ' ' VAL . 75.1 t -49.8 -36.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 111.022 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.536 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . . . -76.56 -31.73 57.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.38 -46.36 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 0.0 110.989 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 159' ' ' LEU . 10.1 mp -77.4 -28.18 52.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' VAL . 46.3 t -78.17 -35.2 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.918 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 162' ' ' ILE . 6.4 p -73.62 -46.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.201 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.516 ' N ' HG13 ' A' ' 161' ' ' VAL . 5.6 pt -71.99 -24.89 23.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.058 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m -52.66 -11.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.368 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 166' ' ' PHE . 20.4 pt20 -61.69 147.75 88.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 166' ' ' PHE . 43.7 Cg_endo -68.16 36.86 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 111.916 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 164' ' ' GLN . 80.6 t80 58.84 130.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -143.96 -172.11 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.336 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -39.13 149.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -47.26 171.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.667 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -157.77 121.95 4.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -167.68 -141.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.549 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 39.8 t0 -154.94 -179.17 7.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 0.1 OUTLIER -149.13 106.66 3.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.474 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -79.75 134.16 36.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 157.29 170.8 22.59 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -168.62 -62.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.706 0.289 . . . . 0.0 110.679 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.476 ' C ' ' ND1' ' A' ' 178' ' ' HIS . . . 76.65 156.48 7.05 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.476 ' ND1' ' C ' ' A' ' 177' ' ' GLY . 5.5 m80 -153.35 132.89 12.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.341 . . . . 0.0 110.6 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -79.97 127.87 32.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.257 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 156.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.422 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -89.15 -157.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -166.87 -145.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.6 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.453 ' N ' ' CG ' ' A' ' 182' ' ' HIS . 73.0 t60 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.541 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.26 -49.89 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -55.73 -36.19 66.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.38 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 7' ' ' GLN . 1.4 t80 -68.64 -46.27 69.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.181 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 1' ' ' MET . 4.8 mp -46.15 -40.77 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -69.11 -22.85 63.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.351 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' PHE . 14.1 tm0? -81.07 -46.95 14.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.713 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.74 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLY . 52.2 p -76.2 -30.93 58.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -75.92 12.14 1.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.333 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.44 144.46 16.27 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -19.07 63.49 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.386 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.07 -46.41 65.93 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -51.27 68.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -56.53 -40.12 74.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.779 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.2 -32.6 63.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 21' ' ' THR . 9.1 mt -68.89 -30.75 69.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.531 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.25 -34.29 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.88 -56.67 7.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.446 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.77 -53.35 49.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 17' ' ' LEU . 10.2 p -42.96 -56.64 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.04 -33.71 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.452 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.04 -40.38 68.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.69 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.4 mp -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.485 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -72.39 -43.88 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.681 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.42 -57.78 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.512 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.2 p -47.37 -36.99 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.68 -35.35 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.474 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -61.26 -18.0 56.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.358 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -94.75 -34.02 12.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -55.48 -48.87 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.564 HE21 ' CB ' ' A' ' 38' ' ' LEU . 5.3 mt-30 -75.18 -20.82 59.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.446 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -68.88 -28.99 67.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.56 -31.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 mtt -84.48 0.52 49.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.729 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.7 mt 48.86 48.65 20.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.898 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.564 ' CB ' HE21 ' A' ' 33' ' ' GLN . 13.3 mt -97.51 156.5 16.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.308 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -119.72 148.54 46.41 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.252 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.47 175.02 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.44 2.094 . . . . 0.0 112.179 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -128.91 175.36 8.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.5 t -61.5 -54.73 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.757 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.495 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 7.9 mt -67.2 -46.67 73.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -48.7 -46.12 40.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.516 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.44 -43.7 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.94 -45.55 74.86 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.51 -30.9 71.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.037 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -63.33 -37.94 89.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.969 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.99 -33.16 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.11 77.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.2 tt -77.28 -56.06 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.033 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -43.36 -38.25 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.48 -41.0 91.11 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 14.8 t -65.92 -43.26 92.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 109.73 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -47.6 -47.54 28.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.721 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.95 -34.38 89.77 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -59.18 -44.72 92.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.091 -0.554 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.25 75.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.377 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.11 -36.23 77.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.631 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.95 -33.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.52 -12.51 83.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.74 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 111.043 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -91.52 -24.11 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.89 73.27 0.11 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.6 22.6 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.911 2.407 . . . . 0.0 112.371 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -115.65 -4.64 12.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -110.46 161.29 25.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.848 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -37.07 -19.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.683 2.256 . . . . 0.0 112.196 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.0 mm? -44.67 -29.03 0.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -40.59 -67.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.679 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -53.6 -34.7 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.289 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 75' ' ' VAL . 11.7 t -63.67 -57.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.362 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.89 -35.29 80.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.0 ttt -64.88 -13.68 57.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.9 p -60.44 -35.11 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.292 0.567 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -88.67 -32.46 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.032 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.578 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.0 t-105 -59.59 -51.92 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.84 -43.06 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.624 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -47.44 -47.31 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 p -78.52 -23.64 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.03 -58.09 10.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.205 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.9 -53.86 9.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.974 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -66.1 -45.53 80.85 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.48 -47.28 91.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.9 t -65.0 -39.36 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.52 -31.36 69.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -78.03 -45.7 22.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.346 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 84' ' ' GLY . 63.1 p -49.13 -31.46 8.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -42.47 79.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.291 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -60.67 -31.65 70.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -75.94 -46.68 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.56 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -66.44 -49.39 66.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.2 mmt -50.35 -49.71 53.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.487 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 33.8 tt0 -51.18 -39.36 56.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.68 -11.97 22.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.739 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.1 t80 -127.81 103.18 21.69 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.565 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.73 -167.58 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.195 1.93 . . . . 0.0 112.136 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.4 m 56.67 67.84 2.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.47 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.77 179.76 5.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.666 2.244 . . . . 0.0 112.101 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -151.85 -9.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.22 -175.58 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.587 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -74.68 113.53 12.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.618 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.6 t -172.94 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.524 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.62 43.1 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.552 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 1.3 m-85 65.5 124.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.553 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 106' ' ' PHE . 29.7 tpp 53.08 106.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.573 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -87.36 -173.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.665 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -106.11 116.26 31.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.453 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -68.42 145.83 97.5 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.445 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.99 151.65 67.83 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.42 2.08 . . . . 0.0 111.867 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -110.0 17.3 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.69 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -125.56 -5.77 7.02 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.608 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.6 mt -115.57 87.64 17.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.44 6.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.696 2.264 . . . . 0.0 112.73 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tp -73.74 -26.36 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -96.38 -36.97 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.844 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.04 -41.44 67.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -75.59 -20.78 58.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.913 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 116' ' ' LEU . 3.3 p -165.13 84.93 1.08 Allowed Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.607 ' O ' HG22 ' A' ' 125' ' ' VAL . 65.9 Cg_endo -80.74 -2.52 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.784 2.323 . . . . 0.0 111.816 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -60.12 -54.32 47.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.6 p -97.49 59.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.628 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -165.67 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 121' ' ' PRO . 21.6 m -57.52 128.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.8 153.94 17.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.837 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 t -170.15 99.96 0.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.473 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.12 -167.6 26.35 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' O ' ' OE2' ' A' ' 132' ' ' GLU . 4.0 m-20 -99.84 146.22 26.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.698 0.285 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 62.7 m -98.77 136.72 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.991 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 91.44 -3.62 0.21 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.872 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' OE2' ' O ' ' A' ' 129' ' ' ASP . 12.3 pt-20 -67.74 153.23 44.16 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.309 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -88.4 138.81 31.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.26 -31.04 2.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.648 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -171.94 136.22 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.265 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 10.3 t70 -119.61 158.35 26.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 111.943 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.548 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 83.2 t80 -144.82 111.16 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.95 17.38 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 136' ' ' ASP . . . 84.76 9.22 81.48 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 6.4 mt -115.49 133.95 55.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.128 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.487 ' OE1' ' NE2' ' A' ' 95' ' ' GLN . 5.2 mt-10 -70.46 154.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.443 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -54.17 -51.0 81.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.995 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 142' ' ' MET . 69.5 Cg_exo -47.11 -40.13 26.47 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.383 2.055 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -71.2 -38.73 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 148' ' ' GLY . 32.6 m95 -67.11 -56.56 9.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.271 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 tp -43.06 -42.95 4.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.705 HD13 ' C ' ' A' ' 147' ' ' LEU . 2.6 tm? -59.7 -37.07 77.83 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.31 -40.92 92.66 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.924 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 149' ' ' ILE . 2.3 mp -70.59 -25.59 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.682 0.277 . . . . 0.0 110.357 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -42.75 92.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.084 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.6 mm -63.0 -43.68 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.024 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 156' ' ' VAL . . . -63.25 -51.78 64.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.456 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.473 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.6 m-85 -56.2 -37.28 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 158' ' ' VAL . 33.7 tp -66.34 -30.22 70.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.412 . . . . 0.0 110.6 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.9 -39.99 59.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.06 -34.52 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.026 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.05 -31.03 58.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.16 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 154' ' ' LEU . 24.2 t -64.24 -42.89 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.413 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.99 -24.05 38.29 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.205 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 156' ' ' VAL . 6.0 t -65.1 -39.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.344 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.2 p -81.02 -50.15 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.577 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 161' ' ' VAL . 36.8 mm -63.65 -8.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.289 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 p -52.58 -45.16 66.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 166' ' ' PHE . 1.7 pt20 179.28 81.74 0.17 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.567 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -47.48 -6.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.655 2.236 . . . . 0.0 112.191 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 164' ' ' GLN . 28.4 p90 -131.53 -162.39 1.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.377 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -171.55 115.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -133.24 -109.85 0.23 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.618 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -142.72 131.7 23.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.58 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -84.44 -72.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.421 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 41.15 39.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.03 105.56 2.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.5 -63.3 1.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.45 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -73.96 87.0 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.465 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -163.29 54.5 0.29 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -81.57 -159.06 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.453 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.494 ' O ' ' ND1' ' A' ' 178' ' ' HIS . . . 160.11 175.95 31.66 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 177' ' ' GLY . 28.3 m80 -152.32 -13.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' A' ' 178' ' ' HIS . 2.0 p-80 -53.71 -167.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.517 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -39.37 127.02 1.82 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 183' ' ' HIS . 82.9 m-70 -86.23 122.99 31.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.618 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 57.56 -78.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 181' ' ' HIS . 39.4 t-80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.519 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.8 mp -75.29 -49.71 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.405 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -50.95 -46.39 61.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.54 -45.53 92.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.475 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.67 -46.42 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -68.01 -21.85 65.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.077 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.97 -46.17 18.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.642 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.27 75.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.545 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.7 p -76.2 -38.01 57.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.534 HE22 ' C ' ' A' ' 65' ' ' PRO . 18.7 tp60 -70.75 10.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.151 0.5 . . . . 0.0 110.235 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -105.71 141.61 15.42 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.696 ' HE ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -69.8 -49.98 47.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.522 0.201 . . . . 0.0 110.822 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.72 -46.02 5.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -63.13 -46.71 86.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.166 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -56.62 -40.69 75.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.1 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.04 -26.44 66.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.92 -43.43 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.32 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -64.73 -30.79 71.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.0 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.576 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.94 -36.57 70.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.948 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 18' ' ' MET . 15.5 p -66.94 -44.64 80.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.608 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.91 98.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.766 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -75.44 -36.72 60.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.704 -179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.74 -37.07 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.073 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.22 -39.47 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 0.0 110.668 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 26' ' ' GLU . 2.2 tm-20 -63.42 -38.83 92.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.584 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 27' ' ' LEU . 2.2 tt -74.92 -57.81 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.646 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.7 p -45.22 -27.24 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.633 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.9 -37.24 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' CD1' ' OE1' ' A' ' 26' ' ' GLU . 19.2 mt -63.07 -13.85 41.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.563 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.526 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.4 t-105 -96.49 -28.54 14.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.499 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.9 m-85 -71.59 -50.05 34.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.22 -58.05 10.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.94 0.4 . . . . 0.0 110.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -56.17 -14.04 2.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.949 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' TRP . 79.4 t -108.99 -21.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.0 tpt -104.33 0.76 29.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt 49.14 31.04 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 HE22 ' A' ' 134' ' ' GLN . 0.6 OUTLIER -80.23 154.41 27.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.02 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -116.75 127.34 26.8 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.5 -179.9 5.77 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.322 2.015 . . . . 0.0 112.063 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.88 178.45 5.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 43' ' ' LEU . 9.2 p -64.99 -41.25 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 42' ' ' VAL . 5.2 tp -64.28 -49.05 73.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -50.08 -48.84 53.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.662 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.528 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.97 -46.94 81.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.43 -35.36 78.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.314 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -64.19 -34.38 77.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.53 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -62.74 -47.7 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.7 tt -77.53 -55.44 5.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -44.55 -40.98 6.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.56 96.39 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 57' ' ' ALA . 42.7 t -60.17 -46.99 93.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.157 0.503 . . . . 0.0 109.834 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.1 tt -46.99 -44.36 20.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.393 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -25.85 71.23 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.87 -42.19 61.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -63.19 -27.06 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 63' ' ' ILE . 11.8 tp -74.66 -39.94 61.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.52 -35.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.084 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.22 -18.95 70.51 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . -82.88 0.54 43.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.612 0.244 . . . . 0.0 110.938 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 59' ' ' LEU . 6.3 mm -88.11 -22.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.568 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.81 65.58 0.19 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.534 ' C ' HE22 ' A' ' 10' ' ' GLN . 59.1 Cg_endo -75.77 19.17 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.609 2.206 . . . . 0.0 112.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -109.64 -7.79 15.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -110.93 161.67 23.95 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.563 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -34.97 -19.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.749 2.299 . . . . 0.0 112.404 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.661 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 mm? -42.24 -29.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.386 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.667 HH12 ' NE2' ' A' ' 164' ' ' GLN . 64.0 mtm180 -40.27 -66.07 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.657 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.2 -36.13 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.148 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.28 -51.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.609 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.74 -33.07 71.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.184 0.516 . . . . 0.0 109.741 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttm -61.49 -9.45 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.535 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 40.5 t -61.07 -41.74 90.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.05 -27.79 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.196 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.534 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.0 t-105 -69.05 -54.48 14.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.6 tp -62.17 -50.13 73.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.309 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.5 m-85 -42.58 -41.57 3.08 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.012 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.2 p -80.08 -22.48 42.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.72 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.752 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 2.0 t80 -74.2 -49.54 23.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.204 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -69.85 -43.32 72.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.87 -46.01 94.49 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.51 -37.39 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.436 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 82' ' ' PHE . 55.3 tt0 -68.32 -31.26 70.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 110.93 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.52 -42.17 17.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.944 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 84' ' ' GLY . 5.5 p -49.68 -51.79 35.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.495 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -50.13 59.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.143 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -43.66 -41.84 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -65.64 -53.16 45.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.8 p -51.8 -40.7 60.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.616 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.3 ttm -61.41 -40.92 96.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.476 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tp -67.4 -35.12 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -67.06 -40.45 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.469 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.79 -13.97 25.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -149.72 81.0 7.27 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.169 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.04 -37.74 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.655 2.237 . . . . 0.0 112.884 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.78 93.36 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.359 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.06 133.36 8.85 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.393 2.062 . . . . 0.0 112.191 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -105.67 -68.11 0.89 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.624 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -172.25 27.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.571 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 t -169.87 156.77 6.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.1 t -77.0 -112.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.587 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.9 p-10 -108.51 -61.12 1.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.58 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 22.6 t80 57.94 97.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.512 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.532 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -134.71 -109.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.534 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 3.3 t 60.78 -1.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.565 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 107' ' ' MET . 76.3 mtt180 -95.4 108.67 20.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.583 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -117.91 162.31 29.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.167 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.89 120.97 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.553 2.169 . . . . 0.0 111.708 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' OE2' ' CH2' ' A' ' 113' ' ' TRP . 10.4 pt-20 -84.34 2.05 42.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.919 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.481 ' CH2' ' OE2' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -101.22 -6.53 24.09 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.268 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.657 ' C ' ' H ' ' A' ' 116' ' ' LEU . 34.6 mt -119.35 91.94 44.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.932 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 52.1 Cg_exo -52.52 9.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.543 2.162 . . . . 0.0 112.344 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.657 ' H ' ' C ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -68.98 -30.1 68.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.994 0.426 . . . . 0.0 110.168 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 2.0 m-20 -98.17 -39.33 8.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.488 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -73.4 -45.34 55.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.889 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.446 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 13.6 t-105 -76.19 -13.69 60.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.217 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.64 71.19 13.98 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 125' ' ' VAL . 70.3 Cg_endo -78.15 -12.62 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.71 2.273 . . . . 0.0 111.621 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.46 -28.89 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.782 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.489 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 3.0 t -129.97 49.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.691 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 3.4 m-85 -156.83 -39.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.053 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 125' ' ' VAL . 9.1 p -64.7 126.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.71 159.14 16.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.576 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.6 t -177.32 99.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.417 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.99 -162.49 27.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -97.68 142.82 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.4 m -94.37 132.16 39.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.5 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.57 4.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -70.95 142.84 51.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.203 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' C ' ' OE1' ' A' ' 134' ' ' GLN . 32.0 ptt85 -99.11 133.84 42.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.951 HE22 HD12 ' A' ' 38' ' ' LEU . 2.5 mm100 -103.22 -28.35 11.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 13.3 t-105 -174.17 145.83 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 6.3 p30 -133.85 163.48 29.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 112.462 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -126.59 138.59 53.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.578 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 50.82 17.53 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.442 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 22.56 37.89 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -123.26 136.23 54.62 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.05 154.74 41.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.056 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.7 ttt -51.3 -56.77 17.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 142' ' ' MET . 1.6 Cg_endo -43.76 -36.75 7.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -69.88 -56.73 6.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.267 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 148' ' ' GLY . 56.5 m95 -56.95 -57.33 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 142' ' ' MET . 2.2 mm? -43.38 -37.1 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.508 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -60.06 -35.85 76.05 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.29 -42.76 98.9 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -80.41 -25.75 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.966 0.412 . . . . 0.0 110.076 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.503 ' O ' HD13 ' A' ' 154' ' ' LEU . 18.4 t80 -64.55 -48.53 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.625 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 152' ' ' ALA . 13.3 tt -67.19 -41.81 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.467 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -50.68 -47.89 58.66 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.476 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.97 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.711 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.534 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 2.3 mp -70.07 -34.12 72.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.71 -27.17 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 160' ' ' VAL . 54.9 t -71.44 -38.88 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -69.54 -52.9 22.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.7 m -56.18 -32.11 33.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.79 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.9 tp -81.37 -30.51 33.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 156' ' ' VAL . 25.6 t -75.49 -25.64 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.97 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.76 -46.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.3 mp -71.12 -16.73 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.965 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 85.6 p -52.9 -11.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.667 ' NE2' HH12 ' A' ' 70' ' ' ARG . 3.4 tp-100 -43.21 128.14 3.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.267 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.17 16.81 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.209 1.939 . . . . 0.0 111.948 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 164' ' ' GLN . 2.4 m-85 43.28 -146.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.0 pttp -97.69 -4.65 36.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.827 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 56.88 -77.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -41.12 143.78 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.655 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 60.23 91.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -64.39 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -159.75 -68.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.371 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 175' ' ' GLY . 5.9 tp -166.62 -25.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.39 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.0 t80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.641 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 173' ' ' LEU . . . 92.54 115.37 2.24 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.498 ' CG ' ' H ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -53.48 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.483 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 176' ' ' ARG . . . 89.35 171.94 45.55 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.481 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 0.5 OUTLIER -84.25 34.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.602 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 50.35 -166.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.479 ' H ' ' CD2' ' A' ' 180' ' ' HIS . 0.2 OUTLIER -131.47 -174.54 3.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -150.1 -23.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -155.7 -16.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.557 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.517 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.638 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -64.05 -43.69 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -57.55 -33.36 68.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.82 -44.83 76.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 mt -51.11 -38.55 52.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.9 t-20 -64.61 -28.79 69.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.34 -48.5 11.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.696 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.04 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 11' ' ' GLY . 12.0 m -76.7 -37.12 56.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.611 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 24.1 mm-40 -67.11 5.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.491 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.19 145.98 17.86 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -69.22 -48.66 61.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.639 0.257 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.68 6.11 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.78 83.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 18' ' ' MET . 60.3 m95 -59.36 -43.48 92.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.171 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -30.06 71.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' THR . 1.7 mp -70.18 -26.67 64.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.455 ' SD ' ' CE3' ' A' ' 15' ' ' TRP . 52.2 mtt -76.29 -34.3 59.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.741 0.305 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.34 23.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.823 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.0 -45.65 78.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 17' ' ' LEU . 11.3 p -52.17 -62.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.73 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.71 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.661 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -79.75 -38.98 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.7 -38.05 63.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.06 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.824 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.02 -43.97 50.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.16 -56.24 10.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -48.72 -42.9 36.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.45 -28.87 59.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.22 -17.56 64.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.037 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.4 t-105 -86.61 -38.84 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.534 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.36 -35.06 79.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -80.86 2.78 25.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.779 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -117.01 -49.64 2.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.657 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 31' ' ' TRP . 12.1 m -72.88 -27.35 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.748 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' LEU . 8.7 tpp -109.35 13.88 23.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.673 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' MET . 9.7 mt 37.73 37.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.0 147.71 52.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.677 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -109.38 124.78 32.97 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 178.35 7.75 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.245 1.963 . . . . 0.0 112.263 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -130.74 172.18 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.637 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.2 t -56.46 -51.73 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 91' ' ' HIS . 4.1 mm? -56.23 -38.42 71.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.558 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.2 t -58.37 -43.31 88.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.143 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.4 mm -61.36 -50.95 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.81 73.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.021 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.93 -37.97 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -36.98 84.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.14 80.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -60.93 -47.28 87.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.344 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 mt -77.18 -53.58 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.31 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -43.18 -41.89 3.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.08 94.99 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 51' ' ' LEU . 39.1 t -61.19 -19.4 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.266 0.555 . . . . 0.0 110.164 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.72 -41.23 23.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.053 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.17 -28.59 73.28 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.08 -47.74 23.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.99 68.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.389 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -44.73 77.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.37 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.56 -39.36 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.42 -16.67 75.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.55 0.88 48.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.77 0.319 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.5 mt -78.42 -38.36 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.7 73.51 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.86 21.46 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.92 2.413 . . . . 0.0 112.046 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -97.4 -10.14 26.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.148 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.07 179.27 0.8 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.549 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 50.3 Cg_exo -52.22 -0.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.232 1.954 . . . . 0.0 112.164 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' THR . 14.5 mt -56.19 -33.01 64.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 77.0 mtm180 -38.77 -61.6 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.774 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.845 ' O ' HG23 ' A' ' 75' ' ' VAL . 42.2 m-85 -52.1 -35.41 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.226 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' LEU . 14.5 t -63.29 -52.86 53.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.961 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.93 61.54 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.275 0.56 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 15.7 mmt -57.94 -13.3 4.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 71' ' ' TYR . 43.6 t -59.31 -36.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.595 0.712 . . . . 0.0 110.279 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.5 mt -89.83 -27.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.285 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 4.6 t-105 -69.58 -52.85 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.983 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 7.0 tt -67.07 -47.6 70.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.1 m-85 -46.79 -44.39 19.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.369 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -74.57 -24.68 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 78' ' ' LEU . . . -59.62 -59.77 4.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.41 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.84 -51.25 16.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -44.64 73.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.9 -48.1 84.52 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' O ' ' OG1' ' A' ' 88' ' ' THR . 94.5 t -70.45 -53.54 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.848 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -47.98 -23.53 0.82 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.832 0.349 . . . . 0.0 110.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.57 -35.93 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 84' ' ' GLY . 37.8 p -58.64 -23.36 58.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.628 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.11 -44.37 60.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.581 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -59.56 -34.25 72.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.472 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.489 ' CE1' HD12 ' A' ' 43' ' ' LEU . 2.3 m-70 -72.3 -44.8 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -68.64 -43.52 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.654 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 97' ' ' TYR . 50.1 mtp -55.63 -42.23 74.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.599 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.34 -47.29 64.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.37 -42.4 91.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.37 -18.83 29.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.371 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.4 OUTLIER -141.6 72.62 24.93 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.099 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 97' ' ' TYR . 43.8 Cg_exo -53.86 -153.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.963 2.442 . . . . 0.0 112.315 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.8 166.8 4.54 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.174 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -40.52 123.54 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.666 2.244 . . . . 0.0 112.127 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.2 118.48 5.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.04 -43.17 10.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.3 m 54.96 72.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 p -163.37 -3.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.585 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 34.4 t70 -69.7 -119.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.498 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 73.38 -72.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.455 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 59.2 mtm -99.23 127.9 45.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.545 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.3 m -87.15 -178.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.753 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -100.64 113.77 26.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.18 132.69 95.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.728 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -77.68 160.65 31.25 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.535 2.157 . . . . 0.0 112.114 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -110.41 -7.18 14.81 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.297 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -125.1 -5.28 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.81 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.597 ' C ' ' H ' ' A' ' 116' ' ' LEU . 8.1 mt -111.56 72.74 1.01 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 9.9 Cg_endo -54.31 4.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.524 2.149 . . . . 0.0 112.058 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.597 ' H ' ' C ' ' A' ' 114' ' ' LEU . 18.6 mt -74.66 -24.67 58.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -98.83 -38.85 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.499 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -82.35 -45.82 14.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.786 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -69.83 -16.92 63.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.632 -179.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 116' ' ' LEU . 6.0 p -154.34 72.03 6.21 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 110.837 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 125' ' ' VAL . 2.5 Cg_endo -77.9 -4.51 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.068 2.512 . . . . 0.0 111.799 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.67 -52.26 41.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.7 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.57 49.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.464 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.28 -44.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 121' ' ' PRO . 29.8 m -57.96 132.68 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.088 0.471 . . . . 0.0 110.689 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.54 161.04 13.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.474 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 t -165.75 99.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.543 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.68 -177.96 20.07 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 17.3 t0 -85.84 148.4 25.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.331 . . . . 0.0 110.151 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 52.5 m -101.21 129.57 47.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.762 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 94.69 -8.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.727 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.74 148.77 50.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -86.09 123.6 31.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.456 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -128.37 -23.21 3.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -172.95 125.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.58 158.81 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 111.719 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.6 t80 -113.45 139.56 48.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.928 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 mt 47.91 17.02 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.488 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.35 21.98 30.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.041 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 139' ' ' GLY . 2.9 mp -125.06 138.53 54.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 141' ' ' GLU . 16.3 mp0 -70.97 147.07 49.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.389 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.433 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.5 mmt -46.49 -61.81 2.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.161 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 80.9 Cg_exo -33.73 -39.61 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.878 2.385 . . . . 0.0 112.648 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -70.72 -55.66 8.16 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.917 0.389 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.584 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.0 m95 -55.6 -57.1 13.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.963 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -43.79 -37.67 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -57.32 -37.31 72.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.49 -45.73 95.07 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.17 -30.7 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 110.194 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -58.85 -48.55 80.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.12 -46.25 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.26 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.42 -46.76 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.487 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -58.45 -44.05 89.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 158' ' ' VAL . 9.7 mt -60.63 -30.25 69.74 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.292 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.64 -27.43 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 160' ' ' VAL . 94.9 t -75.03 -36.11 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 111.111 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -74.63 -53.13 9.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.564 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 159' ' ' LEU . 32.6 m -56.39 -42.65 75.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.497 ' N ' HG23 ' A' ' 158' ' ' VAL . 6.9 tp -73.07 -31.67 64.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.259 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 156' ' ' VAL . 33.8 t -78.2 -28.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.229 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.4 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 46.1 t -74.86 -51.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.394 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 164' ' ' GLN . 52.1 mt -62.32 -33.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.05 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.1 p -59.05 0.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 166' ' ' PHE . 3.3 pt20 -65.66 146.99 98.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 166' ' ' PHE . 73.7 Cg_exo -42.87 -14.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.518 2.145 . . . . 0.0 112.265 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 164' ' ' GLN . 10.4 t80 77.84 -49.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -140.5 -74.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.503 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -167.84 -95.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.54 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 62.3 mttm 52.83 105.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.635 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -69.61 154.06 42.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -143.26 -144.94 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.61 -162.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.53 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 173' ' ' LEU . 0.3 OUTLIER -140.59 -73.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.511 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -78.84 -60.64 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.586 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.85 125.41 0.66 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -168.44 -38.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.797 0.332 . . . . 0.0 110.591 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.88 -158.68 20.78 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -127.28 159.64 33.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.827 0.346 . . . . 0.0 110.547 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -153.21 -18.63 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.43 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -83.7 116.1 22.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -117.72 -103.57 0.41 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 182' ' ' HIS . 4.0 t-80 56.74 52.4 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.441 ' OXT' ' O ' ' A' ' 182' ' ' HIS . 52.5 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 2' ' ' LEU . 5.6 mp -74.22 -41.78 60.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.457 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -53.87 -34.09 58.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.348 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -72.51 -44.38 62.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.287 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp -47.19 -37.66 10.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -67.54 -27.52 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' PHE . 9.6 tp-100 -80.77 -47.57 13.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.692 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.22 -39.5 86.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.67 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLY . 53.2 p -76.67 -37.28 56.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 18.3 tt0 -65.21 2.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.472 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -97.69 148.82 19.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -69.71 -20.47 63.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.76 -45.12 59.84 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -51.1 68.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.185 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -56.1 -45.78 79.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 tp -64.64 -30.44 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.37 -32.41 70.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.1 mmt -71.14 -33.34 69.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.58 -51.96 30.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -50.02 -45.9 52.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.683 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 p -59.01 -60.88 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.04 8.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tp -80.07 -40.48 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.8 -41.99 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.6 mp -69.08 -26.87 65.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.81 -37.78 76.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.95 -57.53 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -44.15 -39.9 4.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.51 -35.07 63.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.767 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.72 -18.49 62.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.761 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.41 -24.89 20.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.732 0.301 . . . . 0.0 110.854 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -73.56 -38.02 65.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.59 0.84 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.801 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -119.15 -52.59 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.24 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.31 -40.48 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 37' ' ' LEU . 29.8 mtt -108.17 15.16 24.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.64 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 36' ' ' MET . 29.1 mt 37.03 41.85 0.21 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.064 0.459 . . . . 0.0 110.15 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 153.35 40.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.016 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' NZ ' ' CB ' ' A' ' 39' ' ' LYS . 6.5 mtmp? -124.7 108.12 28.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.69 169.03 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.229 1.953 . . . . 0.0 112.111 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -110.36 -175.4 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.461 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 2.6 p -64.37 -44.52 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.55 -48.29 81.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.779 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.0 m -60.8 -46.98 88.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.15 -49.8 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 28.9 t80 -54.52 -48.3 72.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.785 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -53.67 -47.57 70.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.084 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -50.7 -36.01 33.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -63.51 -40.91 98.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.492 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.08 79.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 51' ' ' LEU . 9.5 mp -72.62 -50.69 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -43.39 -41.95 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.08 -37.82 92.02 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 51.8 t -62.64 -19.23 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.403 0.62 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 tt -79.76 -46.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.817 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.85 -31.77 81.53 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.44 74.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.891 0.377 . . . . 0.0 110.018 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.45 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.004 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.22 -31.22 62.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.475 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.6 mt -80.46 -42.89 21.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.09 77.0 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 7.49 3.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.654 0.264 . . . . 0.0 110.855 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.48 -55.06 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.269 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.77 84.29 0.29 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.03 24.04 0.7 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.678 2.252 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -99.25 -11.62 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -106.52 179.26 0.93 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 76.5 Cg_exo -47.46 -5.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.019 1.813 . . . . 0.0 112.02 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' H ' ' C ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -49.98 -33.04 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.236 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' NH1' ' CD ' ' A' ' 164' ' ' GLN . 24.8 mtt180 -38.32 -66.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.031 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -57.49 -36.84 72.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.639 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.4 -52.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.804 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.31 -34.55 78.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.335 0.588 . . . . 0.0 109.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 78' ' ' LEU . 2.4 ttt -63.61 -8.33 9.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.765 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.11 -40.85 90.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.452 0.644 . . . . 0.0 111.069 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.4 pp -89.23 -28.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.676 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.527 ' N ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -69.15 -47.48 64.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.689 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD11 ' SD ' ' A' ' 74' ' ' MET . 7.6 mt -65.97 -45.78 80.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -49.2 -44.36 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.105 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -80.22 -23.26 41.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.741 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.43 -60.08 4.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.336 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -77.78 -45.37 24.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.282 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -69.96 -40.89 75.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.805 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 88' ' ' THR . . . -64.6 -46.47 89.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 81' ' ' ALA . 12.7 m -79.26 -35.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -26.27 67.05 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.958 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.4 -28.46 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.704 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 84' ' ' GLY . 20.0 p -60.94 -51.9 67.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.572 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -50.87 -29.71 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.527 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.67 -37.93 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.145 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -68.37 -37.07 80.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.272 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.1 p -72.46 -39.24 67.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.471 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.0 ttt -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.17 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.74 -38.52 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.663 HE22 HE22 ' A' ' 144' ' ' GLN . 81.2 mt-30 -72.16 -38.02 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.769 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.57 -22.66 20.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 93' ' ' MET . 86.2 m-85 -148.85 83.11 6.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.906 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.26 -19.93 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.61 2.206 . . . . 0.0 112.194 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.44 166.04 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 101' ' ' PHE . 76.2 Cg_exo -43.12 110.14 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.725 2.283 . . . . 0.0 112.21 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' PRO . 13.4 t80 60.09 123.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.666 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -137.77 -9.76 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m 60.07 153.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -154.71 41.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.492 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -166.38 108.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.695 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -152.41 157.13 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.315 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 29.9 ttm -85.84 130.37 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 m -43.55 108.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -102.84 100.36 10.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.551 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.484 ' CD2' ' OD2' ' A' ' 117' ' ' ASP . 1.4 m-85 -128.31 159.55 66.79 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.136 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -38.61 151.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.678 2.252 . . . . 0.0 112.165 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.47 1.37 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.573 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 2.0 p-90 -113.23 10.62 18.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 tp -119.75 86.24 35.11 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 40.7 Cg_exo -54.48 15.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.847 2.365 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.638 ' H ' ' C ' ' A' ' 114' ' ' LEU . 40.6 tp -75.63 -30.44 59.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.005 0.431 . . . . 0.0 110.004 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -97.38 -39.64 9.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.191 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -72.46 -45.2 60.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.99 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.5 t90 -75.69 -12.44 60.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.388 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.6 67.91 78.77 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 71.7 Cg_endo -80.41 -22.07 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.906 2.404 . . . . 0.0 111.689 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -55.53 -53.97 49.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.19 54.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.594 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.544 ' CZ ' ' OD2' ' A' ' 117' ' ' ASP . 2.4 t80 -159.07 -35.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' PRO . 75.3 t -65.64 130.48 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.821 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . . . -96.83 163.04 13.15 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.3 t -174.67 101.81 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . 141.46 177.95 17.18 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.0 OUTLIER -80.47 135.74 36.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 15.0 m -91.16 129.42 37.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.56 -1.63 0.24 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.653 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -67.98 145.09 54.84 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -87.3 116.06 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -117.51 -22.3 8.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -175.75 128.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.474 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -140.54 158.74 43.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.269 0.557 . . . . 0.0 112.238 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.594 ' CE2' HD23 ' A' ' 138' ' ' LEU . 17.5 t80 -117.09 139.18 51.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.936 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 137' ' ' PHE . 3.0 mm? 49.95 17.09 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.379 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.63 21.85 35.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.794 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -125.87 137.11 53.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.73 149.6 47.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.44 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -49.14 -51.5 56.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' HD13 ' A' ' 147' ' ' LEU . 89.0 Cg_exo -44.06 -37.98 10.08 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.542 2.161 . . . . 0.0 112.454 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.663 HE22 HE22 ' A' ' 95' ' ' GLN . 0.3 OUTLIER -70.71 -46.93 62.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.156 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.6 m95 -63.84 -57.25 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.3 mt -43.68 -38.56 3.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 143' ' ' PRO . 2.4 mp -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -54.39 -39.07 64.07 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -80.96 -27.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 110.118 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' LEU . 75.7 t80 -59.67 -51.62 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.134 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 9.8 tt -64.2 -42.47 95.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.238 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -52.85 -47.69 67.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.179 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -57.82 -38.64 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.58 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 150' ' ' PHE . 74.6 mt -66.75 -32.32 73.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.852 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -33.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 160' ' ' VAL . 42.0 t -59.5 -43.37 90.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.424 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -73.51 -48.79 30.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.23 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 69.0 t -51.25 -43.37 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.751 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.1 -43.59 52.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.761 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.8 t -62.07 -29.46 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.202 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -80.51 -47.76 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 162' ' ' ILE . 74.2 mt -70.64 -2.72 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.397 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.5 m -61.69 -30.28 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 166' ' ' PHE . 1.0 OUTLIER -71.47 146.17 91.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.29 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.4 20.03 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.546 2.164 . . . . 0.0 112.164 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 168' ' ' ALA . 8.5 m-85 47.77 79.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.35 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 54.9 mttp -73.69 34.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.399 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 166' ' ' PHE . . . 53.3 169.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.513 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -157.44 -2.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.355 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -154.52 121.36 5.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 -41.94 147.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 174' ' ' PHE . 18.6 t70 -154.56 175.58 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.44 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.4 mp -73.75 34.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 172' ' ' ASP . 67.0 t80 -91.54 59.51 3.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.43 -178.37 44.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -150.9 35.94 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.768 0.318 . . . . 0.0 110.665 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -65.4 -18.24 65.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -90.2 123.31 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.614 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -166.31 159.91 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 180' ' ' HIS . 6.6 p-80 -48.23 138.87 9.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 182' ' ' HIS . 27.4 t60 -163.25 -3.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 181' ' ' HIS . 20.0 t60 50.32 70.19 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.55 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.687 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -57.89 -34.11 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.356 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -52.76 -38.24 60.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 7' ' ' GLN . 7.2 t80 -71.69 -46.3 59.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -45.48 -44.06 12.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.322 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 47.2 t30 -70.96 -20.87 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PHE . 44.2 tp60 -79.92 -47.86 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.21 74.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 78.4 p -76.46 -34.17 58.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 6' ' ' ASN . 15.7 mt-30 -73.9 10.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.513 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -106.03 140.91 15.33 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -19.7 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.68 59.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.21 68.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -53.47 -41.54 66.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.303 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.64 -29.57 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.294 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -34.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mtm -73.95 -34.58 64.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.091 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.33 65.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.604 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -60.83 -33.1 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.608 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.7 m -56.75 -54.85 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.88 -27.48 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.361 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.14 -41.84 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.12 -45.11 61.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.687 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.28 -33.28 74.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.07 -44.61 68.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.9 tt -65.29 -58.09 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -47.21 -36.67 9.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.43 -31.12 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -63.32 -18.55 63.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.416 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.475 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 11.0 t-105 -86.69 -41.03 14.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 110.36 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -56.15 -38.42 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.037 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.426 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 12.9 tm0? -79.05 -23.74 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.217 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 36' ' ' MET . 11.7 p -108.41 -44.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.562 ' N ' HG13 ' A' ' 35' ' ' VAL . 9.3 tpt -77.15 -2.38 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt 46.16 45.75 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.08 146.33 54.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -110.57 108.58 58.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.961 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.1 145.11 17.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.25 1.967 . . . . 0.0 111.513 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -107.49 -161.87 0.8 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.595 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.6 t -63.32 -42.6 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.2 tp -62.57 -49.31 75.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.198 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -54.66 -49.48 70.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.676 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.83 -45.35 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.524 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -59.71 -46.58 88.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.24 -47.69 84.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.257 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -56.74 -33.15 66.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.356 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.56 74.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.6 mm? -73.31 -50.67 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -43.8 -41.73 5.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.32 94.11 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.43 -47.73 90.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.97 -46.52 16.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.502 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.17 -48.79 76.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.66 62.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.127 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.92 73.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 tp -72.28 -25.53 61.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.101 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.29 -39.53 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.67 -25.87 75.06 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.49 7.8 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.46 -48.52 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -179.45 80.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.61 31.56 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.68 -9.7 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.946 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -112.99 170.52 5.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.784 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.84 -12.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 mt -43.73 -32.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.51 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -41.05 -70.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -54.68 -27.37 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.677 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.32 -46.15 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.565 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.67 -35.05 60.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.599 . . . . 0.0 109.619 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 ttt -59.59 -15.72 20.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 70.9 t -55.22 -40.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.262 0.554 . . . . 0.0 110.345 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.2 mm -85.48 -34.86 8.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.228 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.586 ' CE2' ' HB2' ' A' ' 157' ' ' ALA . 5.0 t-105 -61.89 -56.15 22.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.8 tp -62.84 -50.28 71.56 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -42.88 -44.87 4.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.187 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.52 -21.37 45.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.495 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.38 -59.91 4.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.184 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.53 -46.69 58.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -77.32 -40.29 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.32 -48.92 83.64 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.397 -0.906 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 81' ' ' ALA . 25.3 m -67.77 -44.74 85.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.819 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.518 ' N ' HG23 ' A' ' 85' ' ' VAL . 3.9 tt0 -54.91 -28.41 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.112 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -42.35 61.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.236 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 70.0 p -54.79 -30.69 57.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.332 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.23 -48.34 76.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.13 -30.77 66.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 3.8 m170 -77.46 -49.04 15.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -64.56 -48.42 75.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 97' ' ' TYR . 26.7 ttt -52.71 -51.39 60.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.484 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.74 -49.36 73.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -52.35 -44.65 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.9 mm? -88.39 -13.31 40.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 93' ' ' MET . 7.8 t80 -133.88 71.77 73.64 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.75 122.61 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.831 2.354 . . . . 0.0 112.378 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -167.57 63.32 0.65 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.522 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.02 113.07 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.765 2.31 . . . . 0.0 112.287 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -87.77 120.36 29.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.339 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.79 121.24 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.652 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.693 HG23 ' N ' ' A' ' 104' ' ' SER . 8.5 t -159.2 -55.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.693 ' N ' HG23 ' A' ' 103' ' ' THR . 45.2 t -176.79 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 15.0 t70 54.53 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.638 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.4 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 13.6 t80 54.44 87.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 ttt 58.17 95.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.305 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 m -92.45 -172.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.759 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -111.47 116.2 30.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.399 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -70.22 147.67 95.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.483 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.56 143.81 58.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.479 2.12 . . . . 0.0 112.196 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.88 3.91 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.546 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 1.1 p-90 -110.13 0.64 18.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -114.34 94.25 34.82 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.033 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.03 0.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.698 2.265 . . . . 0.0 112.935 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.8 tp -70.27 -26.13 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.71 -34.78 11.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -67.01 -35.16 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 -95.99 -23.96 16.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.364 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.8 t -149.64 87.79 5.08 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.52 -15.73 8.45 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.606 2.204 . . . . 0.0 112.521 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -85.69 -4.01 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.722 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.3 p -112.54 18.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.109 0.48 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -147.24 -43.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.433 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.67 129.96 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.407 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.88 154.57 17.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.7 p -158.53 99.78 1.61 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.509 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.55 -176.97 20.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -96.65 150.13 21.01 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 73.9 m -102.22 132.2 48.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.89 -10.35 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.999 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -69.53 129.16 38.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.657 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -67.96 109.45 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -115.7 -23.54 8.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.781 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 136' ' ' ASP . 16.9 t90 -172.02 132.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 135' ' ' TRP . 1.1 p30 -146.16 159.37 43.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -120.68 139.89 52.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.899 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.49 17.35 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 85.91 21.25 53.62 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -123.21 135.26 54.21 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 141' ' ' GLU . 9.7 mp0 -71.65 148.81 46.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.465 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 1.8 mtt -45.25 -63.7 1.12 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.25 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 88.2 Cg_exo -32.35 -38.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.092 2.528 . . . . 0.0 112.801 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.455 ' CD ' ' N ' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -72.47 -51.68 19.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.004 0.43 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 72.6 m95 -56.36 -57.46 12.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.903 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -43.76 -39.14 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.1 tt -56.27 -35.77 67.84 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -63.01 -48.42 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.489 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.45 -26.23 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.57 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.4 t80 -64.08 -41.49 97.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 148' ' ' GLY . 3.5 tt -73.75 -29.73 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.66 -52.02 62.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.272 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -57.06 -41.74 79.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.534 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -61.32 -30.91 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.736 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.48 -26.8 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.223 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' VAL . 74.6 t -73.35 -35.1 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.586 ' HB2' ' CE2' ' A' ' 77' ' ' TRP . . . -71.98 -53.76 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.263 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 159' ' ' LEU . 34.9 m -53.71 -45.92 61.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.913 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 158' ' ' VAL . 2.3 tp -67.11 -30.21 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.731 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 156' ' ' VAL . 18.4 t -74.98 -29.92 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.9 t -83.66 -51.53 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 110.318 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 162' ' ' ILE . 40.0 mm -68.67 -12.72 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.107 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -52.66 -39.61 62.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.067 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 166' ' ' PHE . 12.5 mt-30 54.17 157.3 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.519 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.28 25.02 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.479 2.119 . . . . 0.0 111.916 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 164' ' ' GLN . 34.7 m-85 54.84 -110.18 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.674 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp 66.94 -2.92 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.513 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 166' ' ' PHE . . . -159.15 149.1 19.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.519 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.618 ' NZ ' ' NH1' ' A' ' 171' ' ' ARG . 51.2 tttm -164.44 129.86 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.531 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -159.97 -54.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.618 ' NH1' ' NZ ' ' A' ' 169' ' ' LYS . 16.7 mtm-85 53.81 -131.56 2.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.56 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -156.53 179.67 9.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.503 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.73 165.67 24.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -85.7 99.91 11.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 170.26 -135.36 3.5 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -147.64 -63.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.542 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.3 -158.4 31.35 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 179' ' ' HIS . 2.2 t-80 -162.05 -136.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.623 ' N ' ' ND1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 48.55 -176.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.316 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -60.09 -21.97 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.457 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 49.47 41.33 20.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -81.27 -36.56 29.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 11.5 m-70 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.501 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt -76.42 -44.69 34.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.322 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -54.96 -36.49 65.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.313 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 7' ' ' GLN . 2.6 t80 -69.77 -43.02 73.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.174 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -48.45 -38.31 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 2.3 m-20 -68.32 -26.8 65.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.275 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.1 mm-40 -78.08 -48.86 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.382 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.74 80.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' GLY . 40.1 m -76.65 -37.3 56.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.538 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' ASN . 11.3 mm100 -70.24 7.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.372 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.64 145.77 16.25 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -72.33 -51.54 20.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.632 0.254 . . . . 0.0 110.744 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.97 -47.3 6.29 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.29 86.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -58.7 -37.28 75.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.19 -29.58 69.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.721 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' THR . 2.3 tp -69.98 -27.73 64.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.44 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.1 mtp -76.09 -34.07 59.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.871 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.3 -54.85 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 23' ' ' LEU . 66.7 t80 -52.1 -52.69 49.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.599 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 15.4 p -44.11 -51.62 7.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.65 -21.69 65.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.51 -42.37 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.468 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.63 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.54 -35.29 68.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' CD ' ' NH1' ' A' ' 48' ' ' ARG . 4.9 tp10 -64.99 -35.61 81.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.55 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.42 -56.54 4.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.659 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -45.26 -41.5 8.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.78 -32.35 65.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.567 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -64.03 -19.77 65.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.583 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -93.5 -19.79 20.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.21 -50.36 19.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 34' ' ' HIS . 2.0 pp0? -73.61 -9.15 58.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.12 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.608 ' N ' ' NE2' ' A' ' 33' ' ' GLN . 14.3 t-160 -77.89 -31.01 51.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.102 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.78 -9.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.8 mmt -107.05 -3.19 20.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.631 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.2 mt 47.21 50.19 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 110.282 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 39' ' ' LYS . 2.1 tt -65.07 142.19 58.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.629 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.861 ' N ' HD23 ' A' ' 38' ' ' LEU . 14.9 mttm -107.31 99.66 29.03 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.455 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 127' ' ' SER . 72.1 Cg_exo -46.5 168.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.575 2.183 . . . . 0.0 112.784 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.9 161.49 32.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.187 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 60.7 t -48.81 -46.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.6 mm? -73.0 -33.88 66.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.1 t -58.07 -45.8 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.824 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 126' ' ' ALA . 24.2 pt -69.56 -35.99 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.337 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.3 -47.36 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.91 -36.71 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' NH1' ' CD ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -63.42 -32.58 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.63 77.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.233 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.44 77.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.4 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.88 -55.51 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -44.52 -38.34 4.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.42 94.67 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 57' ' ' ALA . 53.6 t -62.22 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 109.831 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -45.83 -44.63 14.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.591 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.27 -27.98 73.04 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.98 -43.21 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.142 -0.529 . . . . 0.0 110.616 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.74 65.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.463 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -80.84 -36.08 31.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.428 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -80.89 -34.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -75.49 -32.83 54.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.56 6.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.6 mt -88.43 -22.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.518 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 67.82 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.82 24.61 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.672 2.248 . . . . 0.0 111.845 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 64' ' ' ALA . 37.5 mttp -111.3 -6.16 14.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.13 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.33 163.86 17.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.647 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.17 -13.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.442 2.095 . . . . 0.0 112.217 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mt -43.07 -34.46 1.04 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 59.0 mtm-85 -38.57 -66.57 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.732 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -54.15 -27.22 32.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.786 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.2 t -72.86 -51.12 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.496 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.244 0.545 . . . . 0.0 109.913 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 161' ' ' VAL . 5.7 ttt -62.23 -15.75 48.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.882 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 72' ' ' VAL . 3.2 p -56.58 -36.37 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.453 0.644 . . . . 0.0 110.408 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.2 mt -87.38 -34.51 7.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.775 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.581 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 6.0 t-105 -60.61 -54.59 43.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.926 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.88 -44.93 91.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.3 p -79.83 -23.04 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 154' ' ' LEU . . . -60.96 -60.83 3.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.623 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -72.47 -56.24 5.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.177 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -68.26 -47.73 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 88' ' ' THR . . . -56.1 -46.81 84.29 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 81' ' ' ALA . 92.6 t -67.57 -36.09 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.58 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.45 -34.89 69.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.255 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.28 -44.64 17.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.548 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 84' ' ' GLY . 49.2 p -45.3 -32.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.58 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -73.45 -40.83 63.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -56.34 -37.66 70.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.5 m170 -68.62 -42.7 77.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -66.47 -51.4 57.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.7 ttt -49.48 -49.54 45.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 97' ' ' TYR . 3.8 tp -61.48 -47.92 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -54.33 -37.89 65.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 96' ' ' LEU . 11.1 mp -90.58 -15.79 29.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.465 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 37.2 t80 -109.06 114.74 57.84 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.283 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -77.29 97.2 1.13 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.217 1.944 . . . . 0.0 112.065 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -173.18 60.04 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 27.8 Cg_endo -63.88 106.83 0.68 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.577 2.184 . . . . 0.0 111.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 100' ' ' PRO . 48.4 p90 43.97 -175.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.835 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 101' ' ' PHE . . . 175.54 10.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.423 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.2 m -150.47 -62.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.1 p -148.0 166.01 29.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.496 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.45 ' OD2' ' CB ' ' A' ' 101' ' ' PHE . 67.2 m-20 -157.65 151.05 23.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.69 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.11 177.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.407 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.3 ttm -171.19 84.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.536 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.756 ' O ' HG22 ' A' ' 108' ' ' VAL . 7.2 p 35.1 43.62 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.211 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -93.6 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.12 145.23 37.64 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.99 160.49 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.696 2.264 . . . . 0.0 111.865 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -101.27 5.49 42.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -125.41 -6.06 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.782 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -119.52 78.47 20.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.39 11.37 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.263 1.975 . . . . 0.0 112.22 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.9 mt -77.36 -29.76 53.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.111 0.481 . . . . 0.0 109.771 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.475 ' OD1' ' CD2' ' A' ' 124' ' ' PHE . 3.4 m-20 -96.2 -42.19 8.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.729 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' NZ ' ' CB ' ' A' ' 118' ' ' LYS . 5.4 ttpm? -64.88 -44.75 88.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.066 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 27.1 t-105 -76.12 -12.95 60.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.88 73.64 13.55 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.781 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.78 -12.9 13.35 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.819 2.346 . . . . 0.0 111.948 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.525 ' O ' ' NE2' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -55.87 -54.11 48.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.289 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.74 26.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.249 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CD2' ' OD1' ' A' ' 117' ' ' ASP . 39.8 m-85 -134.69 -6.4 2.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.193 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.88 132.65 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -101.48 154.85 18.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' PRO . 69.6 m -167.64 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.355 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.71 -174.3 21.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.73 154.14 21.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.293 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 97.9 m -101.48 131.77 47.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.14 1.19 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.49 160.26 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.043 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -100.14 140.01 34.99 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -132.71 -27.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -174.77 142.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.72 167.9 20.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.527 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 69.4 t80 -145.58 118.46 8.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.509 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 3.5 tp 78.89 17.34 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.86 11.33 79.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.7 mp -116.82 132.9 56.58 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -71.07 153.02 42.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.276 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 5.1 mmm -50.71 -59.5 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.708 ' O ' HD13 ' A' ' 147' ' ' LEU . 83.2 Cg_exo -36.55 -41.31 0.59 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.458 2.105 . . . . 0.0 112.237 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -71.79 -44.7 63.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.333 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.2 m95 -61.26 -56.82 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.065 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 tp -43.41 -44.55 5.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.007 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' PRO . 4.5 mp -53.61 -36.45 62.0 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.85 -42.29 94.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.24 -29.76 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 110.628 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.16 -48.31 80.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.103 0.478 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 155' ' ' ILE . 12.9 pt -68.01 -41.55 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.11 -45.91 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.524 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 5.6 m-85 -64.28 -39.66 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -60.0 -45.31 93.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.258 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -73.97 -26.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.93 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 155' ' ' ILE . 5.8 t -68.62 -33.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.106 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -71.98 -46.88 55.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.851 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.16 -24.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.093 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.96 -41.48 51.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.057 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 156' ' ' VAL . 21.9 m -78.78 -21.87 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.832 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 157' ' ' ALA . 24.6 t -74.56 -48.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.115 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 162' ' ' ILE . 2.2 pp -69.26 -28.57 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 100.0 p -56.18 -19.71 14.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -124.33 78.43 61.1 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 166' ' ' PHE . 65.2 Cg_endo -77.42 24.63 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.143 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 22.0 p90 41.33 -167.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.79 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -139.62 -14.58 1.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.05 85.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.671 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -146.33 29.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.352 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.05 -97.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -159.88 -31.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.545 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 56.7 170.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.09 0.16 54.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.58 -66.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.21 -152.55 52.08 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -76.76 54.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.563 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -88.57 -121.17 1.78 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 178' ' ' HIS . 2.0 m-70 -62.29 158.82 16.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 110.546 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.425 ' CD2' ' N ' ' A' ' 179' ' ' HIS . 0.4 OUTLIER -149.69 36.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.581 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -171.92 -9.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.595 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.412 ' O ' ' CD2' ' A' ' 181' ' ' HIS . 21.3 t60 -117.49 19.52 13.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.544 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.563 ' H ' ' CD2' ' A' ' 182' ' ' HIS . 8.8 p80 -88.03 80.67 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.552 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.86 -36.35 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 109.92 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -58.12 -31.97 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.119 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.62 -42.94 67.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.068 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 mp -50.54 -38.74 46.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -67.95 -30.55 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -79.69 -49.89 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.47 78.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.742 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -76.72 -30.48 56.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.822 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 28.6 tt0 -73.39 6.07 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 110.515 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.49 146.47 17.25 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -66.42 -20.69 66.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.339 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.13 -44.39 76.89 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.512 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.89 -51.25 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -60.53 -43.84 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.73 -35.54 81.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 21' ' ' THR . 10.1 tp -69.52 -28.83 66.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -72.56 -32.82 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.29 26.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.523 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.42 -46.76 63.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.829 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 18' ' ' MET . 27.4 p -52.72 -53.13 52.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.37 81.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.613 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.6 tt -69.76 -42.15 74.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.942 0.401 . . . . 0.0 110.702 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.47 -42.45 43.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -71.17 -34.45 70.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.735 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.59 -43.84 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 27' ' ' LEU . 2.6 tt -74.32 -58.17 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.519 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 24' ' ' ALA . 35.0 p -44.43 -32.62 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.62 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.45 -41.53 16.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.568 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tp -49.13 -21.98 0.86 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.772 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -85.46 -32.53 22.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -58.81 -44.32 90.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.139 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.423 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 15.6 pt20 -75.98 -28.96 58.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.712 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -65.41 -31.42 72.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.497 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.78 -47.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 5.4 tpt -73.22 1.78 8.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.705 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.2 mt 43.53 45.62 5.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 39' ' ' LYS . 4.8 tt -69.67 145.96 51.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.949 ' N ' HD23 ' A' ' 38' ' ' LEU . 46.4 mttp -115.23 90.82 25.54 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.51 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 127' ' ' SER . 51.4 Cg_exo -51.23 165.88 0.5 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.669 2.246 . . . . 0.0 112.518 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 8.3 t -112.95 -175.45 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.316 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.438 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.2 p -69.09 -36.9 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' ND1' ' A' ' 91' ' ' HIS . 5.9 mp -77.76 -49.64 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.605 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 t -49.15 -51.51 31.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 46' ' ' TYR . 18.5 tt -64.27 -38.95 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.218 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 19.4 t80 -55.6 -44.62 77.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -56.97 -47.43 80.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.263 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -52.62 -30.41 31.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.926 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 46' ' ' TYR . . . -70.33 -38.25 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.91 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.565 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 8.8 mp -73.28 -50.96 19.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.82 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -44.29 -38.54 3.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.85 90.28 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' ALA . 24.8 t -61.61 -47.35 93.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 109.725 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.37 -45.78 9.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.682 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.67 -29.48 75.33 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -67.57 -40.03 84.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.619 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.56 58.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -73.67 -47.04 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.377 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.78 -29.75 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -74.54 -33.96 54.98 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 2.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 110.585 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt -84.54 -23.64 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.71 74.15 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.91 21.93 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.857 2.371 . . . . 0.0 112.023 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -115.55 -4.68 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.091 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.59 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -110.51 159.91 30.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.693 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -36.09 -22.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 mp -44.18 -26.18 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -43.68 -65.46 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.608 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.6 m-85 -55.3 -37.71 67.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.979 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.55 -48.69 84.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.776 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 -31.76 65.2 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.436 0.636 . . . . 0.0 109.749 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.3 ttp -63.18 -11.81 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.355 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 71' ' ' TYR . 63.4 t -62.84 -39.24 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.399 0.618 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.7 mt -83.65 -36.59 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.784 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 15.9 t90 -59.65 -52.61 64.79 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.688 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.4 tt -58.98 -53.66 55.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 110.529 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -42.27 -45.13 4.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.748 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 p -81.49 -24.53 36.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.25 -61.41 2.62 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.801 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 5.8 m-85 -75.13 -53.72 8.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -65.08 -45.03 86.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.89 -45.89 95.05 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' ALA . 90.2 t -69.55 -35.67 67.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.603 0.239 . . . . 0.0 111.227 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 82' ' ' PHE . 1.1 mp0 -71.29 -39.52 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.708 0.289 . . . . 0.0 110.934 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 tp -73.05 -43.94 61.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.6 p -52.68 -52.25 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -47.37 -38.63 13.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -59.52 -40.93 88.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.863 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.576 ' ND1' HD23 ' A' ' 43' ' ' LEU . 1.8 m-70 -60.95 -35.85 77.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.367 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.3 p -76.49 -42.54 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' TYR . 9.0 ttt -50.34 -49.88 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.13 -47.81 81.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -52.91 -37.81 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.5 mp -94.35 -15.87 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 93' ' ' MET . 13.3 m-85 -156.26 75.44 4.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.625 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.12 160.15 8.69 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.795 2.33 . . . . 0.0 112.058 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 t -168.31 60.59 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.761 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.7 81.93 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.853 2.369 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -163.08 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.546 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.82 67.21 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.592 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -167.26 131.17 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.486 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.4 m -81.97 45.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.66 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -111.42 125.12 53.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.713 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -161.02 -38.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.541 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.5 ptm -156.64 156.77 34.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -58.62 113.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -145.76 100.03 3.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -125.3 148.55 61.28 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.169 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 113' ' ' TRP . 85.7 Cg_exo -38.99 132.16 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.451 2.101 . . . . 0.0 112.149 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 3.7 mp0 -69.75 11.02 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.555 ' CG ' ' O ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -88.82 -3.47 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.609 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.6 tp -125.81 79.37 68.43 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 121.017 0.437 . . . . 0.0 110.043 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.1 Cg_exo -54.59 9.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.731 2.288 . . . . 0.0 112.52 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.609 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -65.48 -32.91 74.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.048 0.451 . . . . 0.0 109.925 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -97.71 -40.1 8.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.014 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.9 -45.34 67.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.9 t90 -76.12 -12.16 60.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.189 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.89 70.74 36.06 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.42 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.8 Cg_endo -77.19 -18.67 14.11 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.705 2.27 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -55.46 -54.12 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.897 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.495 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 10.6 m -105.48 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.828 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.2 m-85 -164.96 -38.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.1 p -58.23 129.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.548 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.83 152.68 18.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' PRO . 54.0 p -156.53 104.99 2.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.09 -169.75 21.57 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 3.6 m-20 -96.19 170.26 9.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 110.238 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.2 m -119.04 128.44 54.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.72 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.49 -10.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -69.56 149.03 48.63 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.712 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -100.01 134.09 43.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.827 ' NE2' HD21 ' A' ' 38' ' ' LEU . 1.6 pt20 -132.58 -13.59 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -173.9 133.73 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -145.37 158.0 43.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.178 0.513 . . . . 0.0 112.002 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.427 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.5 t80 -114.29 140.28 48.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.159 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp 49.11 16.72 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.088 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.97 23.02 31.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.072 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 144' ' ' GLN . 77.6 mt -127.42 138.99 53.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.985 0.392 . . . . 0.0 110.174 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -68.05 146.18 53.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.435 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -46.62 -54.32 19.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.455 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 142' ' ' MET . 85.3 Cg_exo -41.48 -34.17 1.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.334 2.023 . . . . 0.0 111.941 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.459 ' OE1' HD22 ' A' ' 140' ' ' LEU . 12.4 tt0 -72.03 -48.46 44.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 94.6 m95 -60.44 -57.79 11.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.827 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 146' ' ' LEU . 10.8 mp -43.97 -37.39 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.085 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.45 -35.1 73.4 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.6 -40.88 98.5 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.48 -25.8 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.451 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -44.91 87.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.35 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 151' ' ' ILE . 5.8 tt -66.47 -38.12 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.026 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -51.4 -48.73 62.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.904 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.92 -39.9 91.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.644 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.8 ' O ' HD23 ' A' ' 154' ' ' LEU . 7.3 tt -59.98 -30.96 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.353 0.597 . . . . 0.0 109.868 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -82.67 -30.84 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.815 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -67.88 -42.74 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.784 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.34 -48.34 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.581 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -51.98 -34.42 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.217 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.1 -36.13 21.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' VAL . 40.0 t -67.02 -30.46 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.292 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 162' ' ' ILE . 7.5 p -79.26 -49.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.587 ' N ' HG13 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -64.21 -10.53 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.113 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 m -54.31 -38.54 66.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.585 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -164.78 73.4 1.52 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.74 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.17 1.04 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.933 2.422 . . . . 0.0 112.127 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.542 ' CG ' ' N ' ' A' ' 167' ' ' LYS . 91.3 t80 -149.89 165.42 32.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.612 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.542 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 21.2 ttmt -85.0 58.5 5.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.535 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.48 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.341 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -141.51 43.88 1.74 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.598 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -72.73 125.94 28.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -126.4 -137.14 0.26 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.428 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.516 ' OD1' ' CZ ' ' A' ' 174' ' ' PHE . 1.7 p30 -55.22 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.15 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 0.2 OUTLIER 59.17 101.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 1.3 m-85 -89.62 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 176' ' ' ARG . . . -54.05 100.5 0.07 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 175' ' ' GLY . 9.0 ttt180 58.26 127.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.931 0.396 . . . . 0.0 110.569 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -88.36 -134.02 4.61 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -162.01 106.28 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.484 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.96 -65.02 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 46.27 -109.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -98.58 -114.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.92 -23.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.561 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.528 ' H ' ' CD2' ' A' ' 183' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.552 -179.926 . . . . . . . . 2 2 . 1 stop_ save_